AU2012241173B2 - Nucleoside Phosphoramidate Prodrugs - Google Patents
Nucleoside Phosphoramidate Prodrugs Download PDFInfo
- Publication number
- AU2012241173B2 AU2012241173B2 AU2012241173A AU2012241173A AU2012241173B2 AU 2012241173 B2 AU2012241173 B2 AU 2012241173B2 AU 2012241173 A AU2012241173 A AU 2012241173A AU 2012241173 A AU2012241173 A AU 2012241173A AU 2012241173 B2 AU2012241173 B2 AU 2012241173B2
- Authority
- AU
- Australia
- Prior art keywords
- methyl
- alkyl
- fluoro
- dioxo
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
- -1 Nucleoside Phosphoramidate Chemical class 0.000 title claims description 389
- 229940002612 prodrug Drugs 0.000 title abstract description 8
- 239000000651 prodrug Substances 0.000 title abstract description 8
- 239000002777 nucleoside Substances 0.000 title description 24
- 150000001875 compounds Chemical class 0.000 claims abstract description 75
- 239000002253 acid Substances 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims abstract description 7
- 238000011282 treatment Methods 0.000 claims abstract description 7
- 230000009385 viral infection Effects 0.000 claims abstract description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 176
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 39
- 241000711549 Hepacivirus C Species 0.000 claims description 29
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 20
- 241000700605 Viruses Species 0.000 claims description 16
- 241000710780 Bovine viral diarrhea virus 1 Species 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 7
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 6
- 241000710842 Japanese encephalitis virus Species 0.000 claims description 3
- 241000710772 Yellow fever virus Species 0.000 claims description 3
- 239000003443 antiviral agent Substances 0.000 claims description 3
- 229940051021 yellow-fever virus Drugs 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 2
- 208000010710 hepatitis C virus infection Diseases 0.000 claims description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Substances CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 6
- LFGREXWGYUGZLY-UHFFFAOYSA-N phosphoryl Chemical group [P]=O LFGREXWGYUGZLY-UHFFFAOYSA-N 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- QDKWLJJOYIFEBS-UHFFFAOYSA-N 1-fluoro-4-$l^{1}-oxidanylbenzene Chemical group [O]C1=CC=C(F)C=C1 QDKWLJJOYIFEBS-UHFFFAOYSA-N 0.000 claims 2
- 241000725619 Dengue virus Species 0.000 claims 2
- 241000709661 Enterovirus Species 0.000 claims 2
- 241000991587 Enterovirus C Species 0.000 claims 2
- 241000709721 Hepatovirus A Species 0.000 claims 2
- CNOYKAWNGYFDHD-NSSBGZJMSA-N OC(=O)[C@H](C)N=P(=O)OC1=CC=CC=C1OC[C@@H]1[C@@H](O)[C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1 Chemical compound OC(=O)[C@H](C)N=P(=O)OC1=CC=CC=C1OC[C@@H]1[C@@H](O)[C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1 CNOYKAWNGYFDHD-NSSBGZJMSA-N 0.000 claims 2
- 241000710886 West Nile virus Species 0.000 claims 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 2
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 claims 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- URXASQSEFNHSRL-INGMEPTHSA-N CC(C)OC(=O)[C@H](C)N=P(=O)OC([C@H]1[C@H]([C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1)O)OC1=CC=C(Br)C=C1 Chemical compound CC(C)OC(=O)[C@H](C)N=P(=O)OC([C@H]1[C@H]([C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1)O)OC1=CC=C(Br)C=C1 URXASQSEFNHSRL-INGMEPTHSA-N 0.000 claims 1
- MBDAKGRZCKTFKV-INGMEPTHSA-N CC(C)OC(=O)[C@H](C)N=P(=O)OC([C@H]1[C@H]([C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1)O)OC1=CC=CC=C1Cl Chemical compound CC(C)OC(=O)[C@H](C)N=P(=O)OC([C@H]1[C@H]([C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1)O)OC1=CC=CC=C1Cl MBDAKGRZCKTFKV-INGMEPTHSA-N 0.000 claims 1
- XVVLESMRYHJYLT-RFQRIQSBSA-N CC(C)OC(=O)[C@H](C)N=P(=O)OC1=CC=CC=C1OC[C@@H]1[C@@H](O)[C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1 Chemical compound CC(C)OC(=O)[C@H](C)N=P(=O)OC1=CC=CC=C1OC[C@@H]1[C@@H](O)[C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1 XVVLESMRYHJYLT-RFQRIQSBSA-N 0.000 claims 1
- HGPLXBBXBDOENH-HVYVWJKCSA-N CC(C)OC(=O)[C@H](CC)N=P(=O)OC1=CC=CC=C1OC[C@@H]1[C@@H](O)[C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1 Chemical compound CC(C)OC(=O)[C@H](CC)N=P(=O)OC1=CC=CC=C1OC[C@@H]1[C@@H](O)[C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1 HGPLXBBXBDOENH-HVYVWJKCSA-N 0.000 claims 1
- ZZEKVAJKGTWNAQ-WBAFMLPDSA-N CCCCCOC(=O)[C@H](C)N=P(=O)OC1=CC=CC=C1OC[C@@H]1[C@@H](O)[C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1 Chemical compound CCCCCOC(=O)[C@H](C)N=P(=O)OC1=CC=CC=C1OC[C@@H]1[C@@H](O)[C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1 ZZEKVAJKGTWNAQ-WBAFMLPDSA-N 0.000 claims 1
- QETWHEVWPGAKTI-UENURJEQSA-N CCCCOC(=O)[C@H](C)N=P(=O)OC([C@H]1[C@H]([C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1)O)OC1=CC=C(Cl)C=C1Cl Chemical compound CCCCOC(=O)[C@H](C)N=P(=O)OC([C@H]1[C@H]([C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1)O)OC1=CC=C(Cl)C=C1Cl QETWHEVWPGAKTI-UENURJEQSA-N 0.000 claims 1
- YMXCXDMMCZIPTD-LDZBRYNHSA-N CCCCOC(=O)[C@H](C)N=P(=O)OC1=CC=C(F)C=C1OC[C@@H]1[C@@H](O)[C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1 Chemical compound CCCCOC(=O)[C@H](C)N=P(=O)OC1=CC=C(F)C=C1OC[C@@H]1[C@@H](O)[C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1 YMXCXDMMCZIPTD-LDZBRYNHSA-N 0.000 claims 1
- RVHKSZIFYYPRSW-DVRJWERCSA-N CCCCOC(=O)[C@H](C)N=P(=O)OC1=CC=C(OC)C=C1OC[C@@H]1[C@@H](O)[C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1 Chemical compound CCCCOC(=O)[C@H](C)N=P(=O)OC1=CC=C(OC)C=C1OC[C@@H]1[C@@H](O)[C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1 RVHKSZIFYYPRSW-DVRJWERCSA-N 0.000 claims 1
- YAZDOTJHYJRYGL-LNYBLPJFSA-N CCOC(=O)[C@H](C)N=P(=O)OC([C@H]1[C@H]([C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1)O)OC1=CC=C(Cl)C(Cl)=C1 Chemical compound CCOC(=O)[C@H](C)N=P(=O)OC([C@H]1[C@H]([C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1)O)OC1=CC=C(Cl)C(Cl)=C1 YAZDOTJHYJRYGL-LNYBLPJFSA-N 0.000 claims 1
- ZNRYONSQVQXDJP-RVMRSRQISA-N CCOC(=O)[C@H](C)N=P(=O)OC([C@H]1[C@H]([C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1)O)OC1=CC=C(Cl)C=C1 Chemical compound CCOC(=O)[C@H](C)N=P(=O)OC([C@H]1[C@H]([C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1)O)OC1=CC=C(Cl)C=C1 ZNRYONSQVQXDJP-RVMRSRQISA-N 0.000 claims 1
- WARCXNDRHZHSSB-AGXWGAAFSA-N CCOC(=O)[C@H](C)N=P(=O)OC1=CC=CC=C1OC[C@@H]1[C@@H](O)[C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1 Chemical compound CCOC(=O)[C@H](C)N=P(=O)OC1=CC=CC=C1OC[C@@H]1[C@@H](O)[C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1 WARCXNDRHZHSSB-AGXWGAAFSA-N 0.000 claims 1
- CZLPPJRZYLHGKC-VVHMCBODSA-N COC(=O)CN=P(=O)OC1=CC=CC=C1OC[C@@H]1[C@@H](O)[C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1 Chemical compound COC(=O)CN=P(=O)OC1=CC=CC=C1OC[C@@H]1[C@@H](O)[C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1 CZLPPJRZYLHGKC-VVHMCBODSA-N 0.000 claims 1
- JNWADQXDGSDGAO-NKFUEYJGSA-N COC(=O)[C@H](C(C)C)N=P(=O)OC1=CC=CC=C1OC[C@@H]1[C@@H](O)[C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1 Chemical compound COC(=O)[C@H](C(C)C)N=P(=O)OC1=CC=CC=C1OC[C@@H]1[C@@H](O)[C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1 JNWADQXDGSDGAO-NKFUEYJGSA-N 0.000 claims 1
- YMTFFYKACJYOGK-RXIBCSDBSA-N COC(=O)[C@H](C)N=P(=O)OC([C@H]1[C@H]([C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1)O)OC1=CC=C(Br)C=C1 Chemical compound COC(=O)[C@H](C)N=P(=O)OC([C@H]1[C@H]([C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1)O)OC1=CC=C(Br)C=C1 YMTFFYKACJYOGK-RXIBCSDBSA-N 0.000 claims 1
- FQFOGVIZBOMEON-KPTXFZLCSA-N COC(=O)[C@H](C)N=P(=O)OC([C@H]1[C@H]([C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1)O)OC1=CC=C(Cl)C(Cl)=C1 Chemical compound COC(=O)[C@H](C)N=P(=O)OC([C@H]1[C@H]([C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1)O)OC1=CC=C(Cl)C(Cl)=C1 FQFOGVIZBOMEON-KPTXFZLCSA-N 0.000 claims 1
- QWNDHYSAMZFJNQ-JLIQXZNTSA-N COC(=O)[C@H](C)N=P(=O)OC1=CC=C(F)C=C1OC[C@@H]1[C@@H](O)[C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1 Chemical compound COC(=O)[C@H](C)N=P(=O)OC1=CC=C(F)C=C1OC[C@@H]1[C@@H](O)[C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1 QWNDHYSAMZFJNQ-JLIQXZNTSA-N 0.000 claims 1
- MSRFHJCLOMVKFL-AGXWGAAFSA-N COC(=O)[C@H](CC)N=P(=O)OC1=CC=CC=C1OC[C@@H]1[C@@H](O)[C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1 Chemical compound COC(=O)[C@H](CC)N=P(=O)OC1=CC=CC=C1OC[C@@H]1[C@@H](O)[C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1 MSRFHJCLOMVKFL-AGXWGAAFSA-N 0.000 claims 1
- VNUWVEUIPKYTOC-LDZBRYNHSA-N COC1=CC=C(OP(=O)=N[C@@H](C)C(=O)OC(C)C)C(OC[C@@H]2[C@H]([C@@](C)(F)[C@H](N3C(NC(=O)C=C3)=O)O2)O)=C1 Chemical compound COC1=CC=C(OP(=O)=N[C@@H](C)C(=O)OC(C)C)C(OC[C@@H]2[C@H]([C@@](C)(F)[C@H](N3C(NC(=O)C=C3)=O)O2)O)=C1 VNUWVEUIPKYTOC-LDZBRYNHSA-N 0.000 claims 1
- VFQNQWCLKGJBRM-BZMMVCHVSA-N FC(F)COC(=O)[C@H](C)N=P(=O)OC1=CC=CC=C1OC[C@@H]1[C@@H](O)[C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1 Chemical compound FC(F)COC(=O)[C@H](C)N=P(=O)OC1=CC=CC=C1OC[C@@H]1[C@@H](O)[C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1 VFQNQWCLKGJBRM-BZMMVCHVSA-N 0.000 claims 1
- SAJZPHHTEZPZRG-WSOBARQNSA-N FCC(CF)OC(=O)[C@H](C)N=P(=O)OC1=CC=CC=C1OC[C@@H]1[C@@H](O)[C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1 Chemical compound FCC(CF)OC(=O)[C@H](C)N=P(=O)OC1=CC=CC=C1OC[C@@H]1[C@@H](O)[C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1 SAJZPHHTEZPZRG-WSOBARQNSA-N 0.000 claims 1
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical compound CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 claims 1
- JIOYWNZWTJDVJP-XKNCWQHRSA-N N1([C@@H]2O[C@@H]([C@H]([C@]2(F)C)O)COC2=C(C3=CC=CC=C3C=C2)OP(=O)=N[C@@H](C)C(=O)OC)C=CC(=O)NC1=O Chemical compound N1([C@@H]2O[C@@H]([C@H]([C@]2(F)C)O)COC2=C(C3=CC=CC=C3C=C2)OP(=O)=N[C@@H](C)C(=O)OC)C=CC(=O)NC1=O JIOYWNZWTJDVJP-XKNCWQHRSA-N 0.000 claims 1
- SRPOFJSHNMPGGU-CCCBTKDRSA-N N1([C@@H]2O[C@@H]([C@H]([C@]2(F)C)O)COC2=C(Cl)C(Cl)=CC=C2OP(=O)=N[C@@H](C)C(=O)OCC=2C=CC=CC=2)C=CC(=O)NC1=O Chemical compound N1([C@@H]2O[C@@H]([C@H]([C@]2(F)C)O)COC2=C(Cl)C(Cl)=CC=C2OP(=O)=N[C@@H](C)C(=O)OCC=2C=CC=CC=2)C=CC(=O)NC1=O SRPOFJSHNMPGGU-CCCBTKDRSA-N 0.000 claims 1
- JKSMVJROHCQZBP-SZCJYMSISA-N N1([C@@H]2O[C@@H]([C@H]([C@]2(F)C)O)COC2=CC(Br)=CC=C2OP(=O)=N[C@@H](C)C(=O)OC2CCCCC2)C=CC(=O)NC1=O Chemical compound N1([C@@H]2O[C@@H]([C@H]([C@]2(F)C)O)COC2=CC(Br)=CC=C2OP(=O)=N[C@@H](C)C(=O)OC2CCCCC2)C=CC(=O)NC1=O JKSMVJROHCQZBP-SZCJYMSISA-N 0.000 claims 1
- BAWWJIHVLYRFKN-CWPHUKAXSA-N N1([C@@H]2O[C@@H]([C@H]([C@]2(F)C)O)COC2=CC(F)=CC=C2OP(=O)=N[C@@H](C)C(=O)OCC=2C=CC=CC=2)C=CC(=O)NC1=O Chemical compound N1([C@@H]2O[C@@H]([C@H]([C@]2(F)C)O)COC2=CC(F)=CC=C2OP(=O)=N[C@@H](C)C(=O)OCC=2C=CC=CC=2)C=CC(=O)NC1=O BAWWJIHVLYRFKN-CWPHUKAXSA-N 0.000 claims 1
- JMELFAZAZNPJDW-OVRMDKARSA-N N1([C@@H]2O[C@@H]([C@H]([C@]2(F)C)O)COC2=CC=CC=C2OP(=O)=N[C@@H](C)C(=O)OC2CCCCC2)C=CC(=O)NC1=O Chemical compound N1([C@@H]2O[C@@H]([C@H]([C@]2(F)C)O)COC2=CC=CC=C2OP(=O)=N[C@@H](C)C(=O)OC2CCCCC2)C=CC(=O)NC1=O JMELFAZAZNPJDW-OVRMDKARSA-N 0.000 claims 1
- PYCJKVWYPDPKTE-CWPHUKAXSA-N N1([C@@H]2O[C@@H]([C@H]([C@]2(F)C)O)COC2=CC=CC=C2OP(=O)=N[C@@H](C)C(=O)OCC=2C=CC(F)=CC=2)C=CC(=O)NC1=O Chemical compound N1([C@@H]2O[C@@H]([C@H]([C@]2(F)C)O)COC2=CC=CC=C2OP(=O)=N[C@@H](C)C(=O)OCC=2C=CC(F)=CC=2)C=CC(=O)NC1=O PYCJKVWYPDPKTE-CWPHUKAXSA-N 0.000 claims 1
- SGHWDHYFAMOYBZ-FDUYRLPTSA-N N1([C@@H]2O[C@@H]([C@H]([C@]2(F)C)O)COC2=CC=CC=C2OP(=O)=N[C@@H](C)C(=O)OCC=2C=CC=CC=2)C=CC(=O)NC1=O Chemical compound N1([C@@H]2O[C@@H]([C@H]([C@]2(F)C)O)COC2=CC=CC=C2OP(=O)=N[C@@H](C)C(=O)OCC=2C=CC=CC=2)C=CC(=O)NC1=O SGHWDHYFAMOYBZ-FDUYRLPTSA-N 0.000 claims 1
- WJQRLMGSDQNSRZ-TXCNUOAPSA-N N1([C@@H]2O[C@@H]([C@H]([C@]2(F)C)O)COC2=CC=CC=C2OP(=O)=N[C@@H](CC)C(=O)OC2CCCC2)C=CC(=O)NC1=O Chemical compound N1([C@@H]2O[C@@H]([C@H]([C@]2(F)C)O)COC2=CC=CC=C2OP(=O)=N[C@@H](CC)C(=O)OC2CCCC2)C=CC(=O)NC1=O WJQRLMGSDQNSRZ-TXCNUOAPSA-N 0.000 claims 1
- KCRZRDIQSDNESC-GENZXHNBSA-N N1([C@@H]2O[C@@H]([C@H]([C@]2(F)C)O)COC2=CC=CC=C2OP(=O)=N[C@@H](CC)C(=O)OC2CCCCC2)C=CC(=O)NC1=O Chemical compound N1([C@@H]2O[C@@H]([C@H]([C@]2(F)C)O)COC2=CC=CC=C2OP(=O)=N[C@@H](CC)C(=O)OC2CCCCC2)C=CC(=O)NC1=O KCRZRDIQSDNESC-GENZXHNBSA-N 0.000 claims 1
- RPNFCMVSCNDSHV-QGTWPWHYSA-N N1([C@@H]2O[C@@H]([C@H]([C@]2(F)C)O)COC=2C(C)=CC=C(C=2)OP(=O)=N[C@@H](C)C(=O)OCC=2C=CC=CC=2)C=CC(=O)NC1=O Chemical compound N1([C@@H]2O[C@@H]([C@H]([C@]2(F)C)O)COC=2C(C)=CC=C(C=2)OP(=O)=N[C@@H](C)C(=O)OCC=2C=CC=CC=2)C=CC(=O)NC1=O RPNFCMVSCNDSHV-QGTWPWHYSA-N 0.000 claims 1
- NPFZFHJDNKXBAI-AZWVZOCHSA-N cyclohexyl (2s)-2-[[[(2r,3r,4r,5r)-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate Chemical compound N1([C@@H]2O[C@@H]([C@H]([C@]2(F)C)O)CO[P@](=O)(N[C@@H](C)C(=O)OC2CCCCC2)OC=2C=CC=CC=2)C=CC(=O)NC1=O NPFZFHJDNKXBAI-AZWVZOCHSA-N 0.000 claims 1
- NPFZFHJDNKXBAI-JPXKIWHRSA-N cyclohexyl (2s)-2-[[[(2r,3r,4r,5r)-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate Chemical compound N1([C@@H]2O[C@@H]([C@H]([C@]2(F)C)O)CO[P@@](=O)(N[C@@H](C)C(=O)OC2CCCCC2)OC=2C=CC=CC=2)C=CC(=O)NC1=O NPFZFHJDNKXBAI-JPXKIWHRSA-N 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- DHWPNTXNFNHSFE-IJDMJUJQSA-N methyl (2s)-1-[[(2r,3r,4r,5r)-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy-phenoxyphosphoryl]pyrrolidine-2-carboxylate Chemical compound COC(=O)[C@@H]1CCCN1P(=O)(OC=1C=CC=CC=1)OC[C@@H]1[C@@H](O)[C@@](C)(F)[C@H](N2C(NC(=O)C=C2)=O)O1 DHWPNTXNFNHSFE-IJDMJUJQSA-N 0.000 claims 1
- SASYBZIIPQSWBV-MNKZNHEVSA-N methyl (2s)-2-[[[(2r,3r,4r,5r)-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate Chemical compound N1([C@@H]2O[C@@H]([C@H]([C@]2(F)C)O)CO[P@](=O)(N[C@@H](C)C(=O)OC)OC=2C=CC=CC=2)C=CC(=O)NC1=O SASYBZIIPQSWBV-MNKZNHEVSA-N 0.000 claims 1
- SASYBZIIPQSWBV-ZWXZMKCMSA-N methyl (2s)-2-[[[(2r,3r,4r,5r)-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate Chemical compound N1([C@@H]2O[C@@H]([C@H]([C@]2(F)C)O)CO[P@@](=O)(N[C@@H](C)C(=O)OC)OC=2C=CC=CC=2)C=CC(=O)NC1=O SASYBZIIPQSWBV-ZWXZMKCMSA-N 0.000 claims 1
- ZTQLVEDNERGEDY-SAXKHWHFSA-N methyl 2-[[[(2r,3r,4r,5r)-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy-phenoxyphosphoryl]amino]acetate Chemical compound N1([C@@H]2O[C@@H]([C@H]([C@]2(F)C)O)CO[P@](=O)(NCC(=O)OC)OC=2C=CC=CC=2)C=CC(=O)NC1=O ZTQLVEDNERGEDY-SAXKHWHFSA-N 0.000 claims 1
- 150000004702 methyl esters Chemical class 0.000 claims 1
- IQTPCFQZYFPTLL-PHNQOMTRSA-N propan-2-yl (2s)-2-[[(4-chlorophenoxy)-[[(2r,3r,4r,5r)-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy]phosphoryl]amino]propanoate Chemical compound N1([C@@H]2O[C@@H]([C@H]([C@]2(F)C)O)CO[P@](=O)(N[C@@H](C)C(=O)OC(C)C)OC=2C=CC(Cl)=CC=2)C=CC(=O)NC1=O IQTPCFQZYFPTLL-PHNQOMTRSA-N 0.000 claims 1
- TTZHDVOVKQGIBA-YBSJRAAASA-N propan-2-yl (2s)-2-[[[(2r,3r,4r,5r)-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate Chemical compound N1([C@@H]2O[C@@H]([C@H]([C@]2(F)C)O)CO[P@](=O)(N[C@@H](C)C(=O)OC(C)C)OC=2C=CC=CC=2)C=CC(=O)NC1=O TTZHDVOVKQGIBA-YBSJRAAASA-N 0.000 claims 1
- FKRCODPIKNYEAC-UHFFFAOYSA-N propionic acid ethyl ester Natural products CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 claims 1
- 150000003833 nucleoside derivatives Chemical class 0.000 abstract description 13
- 150000003839 salts Chemical class 0.000 abstract description 5
- 241000124008 Mammalia Species 0.000 abstract description 3
- PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 abstract description 3
- 239000012453 solvate Substances 0.000 abstract description 3
- 208000036142 Viral infection Diseases 0.000 abstract description 2
- 125000000217 alkyl group Chemical group 0.000 description 763
- 125000006302 indol-3-yl methyl group Chemical group [H]N1C([H])=C(C2=C([H])C([H])=C([H])C([H])=C12)C([H])([H])* 0.000 description 495
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 378
- 125000006306 4-iodophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1I 0.000 description 356
- 229910052739 hydrogen Inorganic materials 0.000 description 355
- 229910052731 fluorine Inorganic materials 0.000 description 349
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 description 342
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 342
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 305
- 229910052794 bromium Inorganic materials 0.000 description 276
- 239000001257 hydrogen Substances 0.000 description 253
- 229910052801 chlorine Inorganic materials 0.000 description 243
- 229910052740 iodine Inorganic materials 0.000 description 208
- 125000003342 alkenyl group Chemical group 0.000 description 158
- 125000000753 cycloalkyl group Chemical group 0.000 description 155
- 125000002252 acyl group Chemical group 0.000 description 145
- 125000000304 alkynyl group Chemical group 0.000 description 136
- 150000002431 hydrogen Chemical group 0.000 description 135
- 125000004432 carbon atom Chemical group C* 0.000 description 118
- 229910052736 halogen Inorganic materials 0.000 description 109
- 150000002367 halogens Chemical class 0.000 description 108
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 97
- 125000001188 haloalkyl group Chemical group 0.000 description 86
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 85
- 229910052757 nitrogen Inorganic materials 0.000 description 80
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 78
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 75
- 229920002554 vinyl polymer Polymers 0.000 description 75
- 125000003118 aryl group Chemical group 0.000 description 68
- 229910004013 NO 2 Inorganic materials 0.000 description 63
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 63
- 125000003545 alkoxy group Chemical group 0.000 description 61
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 48
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 48
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 48
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 48
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 46
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 45
- 125000000266 alpha-aminoacyl group Chemical group 0.000 description 41
- 125000000623 heterocyclic group Chemical group 0.000 description 36
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 35
- 125000004122 cyclic group Chemical group 0.000 description 33
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 33
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 33
- 125000004433 nitrogen atom Chemical group N* 0.000 description 33
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical group NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 30
- 125000001072 heteroaryl group Chemical group 0.000 description 30
- 125000004093 cyano group Chemical group *C#N 0.000 description 29
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 29
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 28
- 125000001624 naphthyl group Chemical group 0.000 description 24
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 22
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical group N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 21
- 229910004749 OS(O)2 Inorganic materials 0.000 description 17
- 229940104302 cytosine Drugs 0.000 description 15
- 241000710778 Pestivirus Species 0.000 description 14
- 229910052799 carbon Inorganic materials 0.000 description 14
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 description 14
- 125000002140 imidazol-4-yl group Chemical group [H]N1C([H])=NC([*])=C1[H] 0.000 description 14
- 125000004076 pyridyl group Chemical group 0.000 description 14
- 125000003107 substituted aryl group Chemical group 0.000 description 14
- 108010011222 cyclo(Arg-Pro) Proteins 0.000 description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- 241000711557 Hepacivirus Species 0.000 description 12
- 125000004442 acylamino group Chemical group 0.000 description 10
- 150000001345 alkine derivatives Chemical class 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 125000003003 spiro group Chemical group 0.000 description 10
- 150000001413 amino acids Chemical class 0.000 description 9
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 9
- 235000018102 proteins Nutrition 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 101800001554 RNA-directed RNA polymerase Proteins 0.000 description 8
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 8
- 229940024606 amino acid Drugs 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 8
- 125000005843 halogen group Chemical group 0.000 description 8
- 208000015181 infectious disease Diseases 0.000 description 8
- 239000003112 inhibitor Substances 0.000 description 8
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 7
- 108700026244 Open Reading Frames Proteins 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 229910052760 oxygen Inorganic materials 0.000 description 7
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 7
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- OJRUSAPKCPIVBY-KQYNXXCUSA-N C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(CP(=O)(O)O)O)O)O)I)N Chemical compound C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(CP(=O)(O)O)O)O)O)I)N OJRUSAPKCPIVBY-KQYNXXCUSA-N 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- 101710144111 Non-structural protein 3 Proteins 0.000 description 6
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 6
- 229940125758 compound 15 Drugs 0.000 description 6
- 230000000670 limiting effect Effects 0.000 description 6
- 230000010076 replication Effects 0.000 description 6
- 108060004795 Methyltransferase Proteins 0.000 description 5
- 108010076039 Polyproteins Proteins 0.000 description 5
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 5
- 101100054666 Streptomyces halstedii sch3 gene Proteins 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 108700008776 hepatitis C virus NS-5 Proteins 0.000 description 5
- 125000003835 nucleoside group Chemical group 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 125000001424 substituent group Chemical group 0.000 description 5
- 125000000547 substituted alkyl group Chemical group 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 description 4
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 description 4
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- 125000002877 alkyl aryl group Chemical group 0.000 description 4
- 125000003710 aryl alkyl group Chemical group 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 4
- 125000004437 phosphorous atom Chemical group 0.000 description 4
- 229910052698 phosphorus Inorganic materials 0.000 description 4
- 230000026731 phosphorylation Effects 0.000 description 4
- 238000006366 phosphorylation reaction Methods 0.000 description 4
- 125000004426 substituted alkynyl group Chemical group 0.000 description 4
- 125000005346 substituted cycloalkyl group Chemical group 0.000 description 4
- 239000001226 triphosphate Substances 0.000 description 4
- 235000011178 triphosphate Nutrition 0.000 description 4
- 230000029812 viral genome replication Effects 0.000 description 4
- 230000003612 virological effect Effects 0.000 description 4
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- 101100274575 Caenorhabditis elegans clh-3 gene Proteins 0.000 description 3
- 101100139910 Danio rerio rarab gene Proteins 0.000 description 3
- 241000710781 Flaviviridae Species 0.000 description 3
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 3
- 101800001020 Non-structural protein 4A Proteins 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- 102000012479 Serine Proteases Human genes 0.000 description 3
- 108010022999 Serine Proteases Proteins 0.000 description 3
- 108010067390 Viral Proteins Proteins 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229940125898 compound 5 Drugs 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 125000005842 heteroatom Chemical group 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 230000008520 organization Effects 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 150000008298 phosphoramidates Chemical group 0.000 description 3
- 150000003212 purines Chemical class 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 3
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- ZKBQDFAWXLTYKS-UHFFFAOYSA-N 6-Chloro-1H-purine Chemical compound ClC1=NC=NC2=C1NC=N2 ZKBQDFAWXLTYKS-UHFFFAOYSA-N 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 101001053401 Arabidopsis thaliana Acid beta-fructofuranosidase 3, vacuolar Proteins 0.000 description 2
- 101001053395 Arabidopsis thaliana Acid beta-fructofuranosidase 4, vacuolar Proteins 0.000 description 2
- 101100459319 Arabidopsis thaliana VIII-2 gene Proteins 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
- 241001118702 Border disease virus Species 0.000 description 2
- 101150065749 Churc1 gene Proteins 0.000 description 2
- 241000710777 Classical swine fever virus Species 0.000 description 2
- 101710118188 DNA-binding protein HU-alpha Proteins 0.000 description 2
- 206010012310 Dengue fever Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- 241000710831 Flavivirus Species 0.000 description 2
- 241000531123 GB virus C Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 101710144128 Non-structural protein 2 Proteins 0.000 description 2
- 101800001019 Non-structural protein 4B Proteins 0.000 description 2
- 101800001014 Non-structural protein 5A Proteins 0.000 description 2
- 101710199667 Nuclear export protein Proteins 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 108091000080 Phosphotransferase Proteins 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 102100038239 Protein Churchill Human genes 0.000 description 2
- 108030002536 RNA-directed RNA polymerases Proteins 0.000 description 2
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 2
- 101710172711 Structural protein Proteins 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- LXEKPEMOWBOYRF-UHFFFAOYSA-N [2-[(1-azaniumyl-1-imino-2-methylpropan-2-yl)diazenyl]-2-methylpropanimidoyl]azanium;dichloride Chemical compound Cl.Cl.NC(=N)C(C)(C)N=NC(C)(C)C(N)=N LXEKPEMOWBOYRF-UHFFFAOYSA-N 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- 229960003767 alanine Drugs 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 125000003282 alkyl amino group Chemical group 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 229960003121 arginine Drugs 0.000 description 2
- 125000001769 aryl amino group Chemical group 0.000 description 2
- 229960001230 asparagine Drugs 0.000 description 2
- 235000009582 asparagine Nutrition 0.000 description 2
- 229940009098 aspartate Drugs 0.000 description 2
- 125000002837 carbocyclic group Chemical group 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000007882 cirrhosis Effects 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 229940125773 compound 10 Drugs 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 229960002433 cysteine Drugs 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- 201000002950 dengue hemorrhagic fever Diseases 0.000 description 2
- VILAVOFMIJHSJA-UHFFFAOYSA-N dicarbon monoxide Chemical compound [C]=C=O VILAVOFMIJHSJA-UHFFFAOYSA-N 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000009509 drug development Methods 0.000 description 2
- 241001493065 dsRNA viruses Species 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 229930195712 glutamate Natural products 0.000 description 2
- 229940049906 glutamate Drugs 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- 229960002743 glutamine Drugs 0.000 description 2
- 235000004554 glutamine Nutrition 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 229960002885 histidine Drugs 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 150000004677 hydrates Chemical class 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 238000009169 immunotherapy Methods 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 2
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 2
- 229960003136 leucine Drugs 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 229960003646 lysine Drugs 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 229960004452 methionine Drugs 0.000 description 2
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 2
- 125000004372 methylthioethyl group Chemical group [H]C([H])([H])SC([H])([H])C([H])([H])* 0.000 description 2
- 150000004712 monophosphates Chemical class 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 229960005190 phenylalanine Drugs 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 102000020233 phosphotransferase Human genes 0.000 description 2
- 125000004193 piperazinyl group Chemical group 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 229960002429 proline Drugs 0.000 description 2
- 235000013930 proline Nutrition 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 229960000329 ribavirin Drugs 0.000 description 2
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 description 2
- 230000000405 serological effect Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 229960002898 threonine Drugs 0.000 description 2
- 235000008521 threonine Nutrition 0.000 description 2
- 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- 229960004799 tryptophan Drugs 0.000 description 2
- 229960004441 tyrosine Drugs 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 235000002374 tyrosine Nutrition 0.000 description 2
- 229960004295 valine Drugs 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- JIDDDPVQQUHACU-YFKPBYRVSA-N (2s)-pyrrolidine-2-carbaldehyde Chemical group O=C[C@@H]1CCCN1 JIDDDPVQQUHACU-YFKPBYRVSA-N 0.000 description 1
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 description 1
- FYADHXFMURLYQI-UHFFFAOYSA-N 1,2,4-triazine Chemical compound C1=CN=NC=N1 FYADHXFMURLYQI-UHFFFAOYSA-N 0.000 description 1
- 125000006083 1-bromoethyl group Chemical group 0.000 description 1
- 125000004972 1-butynyl group Chemical group [H]C([H])([H])C([H])([H])C#C* 0.000 description 1
- 125000001478 1-chloroethyl group Chemical group [H]C([H])([H])C([H])(Cl)* 0.000 description 1
- 125000004776 1-fluoroethyl group Chemical group [H]C([H])([H])C([H])(F)* 0.000 description 1
- HNEGJTWNOOWEMH-UHFFFAOYSA-N 1-fluoropropane Chemical group [CH2]CCF HNEGJTWNOOWEMH-UHFFFAOYSA-N 0.000 description 1
- 125000006017 1-propenyl group Chemical group 0.000 description 1
- 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 description 1
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- 125000004778 2,2-difluoroethyl group Chemical group [H]C([H])(*)C([H])(F)F 0.000 description 1
- 125000005999 2-bromoethyl group Chemical group 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- 125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 description 1
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 description 1
- 125000004777 2-fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- QBWKPGNFQQJGFY-QLFBSQMISA-N 3-[(1r)-1-[(2r,6s)-2,6-dimethylmorpholin-4-yl]ethyl]-n-[6-methyl-3-(1h-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine Chemical compound N1([C@H](C)C2=NSC(NC=3C4=NC=C(N4C=C(C)N=3)C3=CNN=C3)=C2)C[C@H](C)O[C@H](C)C1 QBWKPGNFQQJGFY-QLFBSQMISA-N 0.000 description 1
- 125000000474 3-butynyl group Chemical group [H]C#CC([H])([H])C([H])([H])* 0.000 description 1
- SVXNJCYYMRMXNM-UHFFFAOYSA-N 5-amino-2h-1,2,4-triazin-3-one Chemical compound NC=1C=NNC(=O)N=1 SVXNJCYYMRMXNM-UHFFFAOYSA-N 0.000 description 1
- NPYPQKXJJZZSAX-UHFFFAOYSA-N 5-benzylpyrimidine Chemical class C=1N=CN=CC=1CC1=CC=CC=C1 NPYPQKXJJZZSAX-UHFFFAOYSA-N 0.000 description 1
- LZGICTBSBIWVFA-UHFFFAOYSA-N 5-bromo-2-ethenylpyrimidine Chemical compound BrC1=CN=C(C=C)N=C1 LZGICTBSBIWVFA-UHFFFAOYSA-N 0.000 description 1
- HXXVIKZQIFTJOQ-UHFFFAOYSA-N 5-ethenylpyrimidine Chemical compound C=CC1=CN=CN=C1 HXXVIKZQIFTJOQ-UHFFFAOYSA-N 0.000 description 1
- DNWRLMRKDSGSPL-UHFFFAOYSA-N 5-iodopyrimidine Chemical compound IC1=CN=CN=C1 DNWRLMRKDSGSPL-UHFFFAOYSA-N 0.000 description 1
- LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 1
- NOYDQGFVFOQSAJ-UHFFFAOYSA-N 5-nitropyrimidine Chemical compound [O-][N+](=O)C1=CN=CN=C1 NOYDQGFVFOQSAJ-UHFFFAOYSA-N 0.000 description 1
- 108091027075 5S-rRNA precursor Proteins 0.000 description 1
- PVRBGBGMDLPYKG-UHFFFAOYSA-N 6-benzyl-7h-purine Chemical compound N=1C=NC=2N=CNC=2C=1CC1=CC=CC=C1 PVRBGBGMDLPYKG-UHFFFAOYSA-N 0.000 description 1
- DBCMWACNZJYUHS-UHFFFAOYSA-N 6-ethenyl-7h-purine Chemical compound C=CC1=NC=NC2=C1NC=N2 DBCMWACNZJYUHS-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- MSSXOMSJDRHRMC-UHFFFAOYSA-N 9H-purine-2,6-diamine Chemical compound NC1=NC(N)=C2NC=NC2=N1 MSSXOMSJDRHRMC-UHFFFAOYSA-N 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- OMSPNIGCBQFQFQ-UHFFFAOYSA-N BrC1=CC=NC(C=C)=N1 Chemical compound BrC1=CC=NC(C=C)=N1 OMSPNIGCBQFQFQ-UHFFFAOYSA-N 0.000 description 1
- 125000006577 C1-C6 hydroxyalkyl group Chemical group 0.000 description 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 description 1
- JGLMVXWAHNTPRF-CMDGGOBGSA-N CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(=CC(OC)=C2N1C\C=C\CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(=CC(OCCCN3CCOCC3)=C12)C(N)=O)C(N)=O Chemical compound CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(=CC(OC)=C2N1C\C=C\CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(=CC(OCCCN3CCOCC3)=C12)C(N)=O)C(N)=O JGLMVXWAHNTPRF-CMDGGOBGSA-N 0.000 description 1
- 101100518011 Caenorhabditis elegans nxf-2 gene Proteins 0.000 description 1
- 208000001490 Dengue Diseases 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 241001337814 Erysiphe glycines Species 0.000 description 1
- 102100040550 FXYD domain-containing ion transport regulator 4 Human genes 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- 241000414862 GBV-A-like agents Species 0.000 description 1
- 229940126656 GS-4224 Drugs 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010061192 Haemorrhagic fever Diseases 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- 150000008575 L-amino acids Chemical class 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108010011356 Nucleoside phosphotransferase Proteins 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- 241000682990 Pegivirus A Species 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 208000004571 Pestivirus Infections Diseases 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- 229940123066 Polymerase inhibitor Drugs 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 101800001838 Serine protease/helicase NS3 Proteins 0.000 description 1
- 208000009714 Severe Dengue Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000007875 V-40 Substances 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 208000003152 Yellow Fever Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 125000005160 aryl oxy alkyl group Chemical group 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- 125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 description 1
- 125000000254 aspartoyl group Chemical group 0.000 description 1
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 description 1
- 125000002393 azetidinyl group Chemical group 0.000 description 1
- 125000004267 aziridin-2-yl group Chemical group [H]N1C([H])([H])C1([H])* 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 125000005997 bromomethyl group Chemical group 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000000423 cell based assay Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 229940125810 compound 20 Drugs 0.000 description 1
- 229940125846 compound 25 Drugs 0.000 description 1
- 108010070092 corticosteroid hormone-induced factor Proteins 0.000 description 1
- LXWYCLOUQZZDBD-LIYNQYRNSA-N csfv Chemical compound C([C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C1=CC=C(O)C=C1 LXWYCLOUQZZDBD-LIYNQYRNSA-N 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- 208000025729 dengue disease Diseases 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 125000004772 dichloromethyl group Chemical group [H]C(Cl)(Cl)* 0.000 description 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 229940072240 direct acting antivirals Drugs 0.000 description 1
- 229940125371 direct-acting antiviral drugs Drugs 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 239000003596 drug target Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- XRECTZIEBJDKEO-UHFFFAOYSA-N flucytosine Chemical compound NC1=NC(=O)NC=C1F XRECTZIEBJDKEO-UHFFFAOYSA-N 0.000 description 1
- 229960004413 flucytosine Drugs 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 description 1
- 150000005694 halopyrimidines Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- HRDXJKGNWSUIBT-UHFFFAOYSA-N methoxybenzene Chemical group [CH2]OC1=CC=CC=C1 HRDXJKGNWSUIBT-UHFFFAOYSA-N 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- 125000006431 methyl cyclopropyl group Chemical group 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000006225 natural substrate Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- LBQAJLBSGOBDQF-UHFFFAOYSA-N nitro azanylidynemethanesulfonate Chemical compound [O-][N+](=O)OS(=O)(=O)C#N LBQAJLBSGOBDQF-UHFFFAOYSA-N 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 208000025858 pestivirus infectious disease Diseases 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- FVLAYJRLBLHIPV-UHFFFAOYSA-N pyrimidin-5-amine Chemical compound NC1=CN=CN=C1 FVLAYJRLBLHIPV-UHFFFAOYSA-N 0.000 description 1
- XVIAPHVAGFEFFN-UHFFFAOYSA-N pyrimidine-5-carbonitrile Chemical compound N#CC1=CN=CN=C1 XVIAPHVAGFEFFN-UHFFFAOYSA-N 0.000 description 1
- 238000009790 rate-determining step (RDS) Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 235000004400 serine Nutrition 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000003419 tautomerization reaction Methods 0.000 description 1
- ILMRJRBKQSSXGY-UHFFFAOYSA-N tert-butyl(dimethyl)silicon Chemical group C[Si](C)C(C)(C)C ILMRJRBKQSSXGY-UHFFFAOYSA-N 0.000 description 1
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000000037 tert-butyldiphenylsilyl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1[Si]([H])([*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 125000005147 toluenesulfonyl group Chemical group C=1(C(=CC=CC1)S(=O)(=O)*)C 0.000 description 1
- 125000004665 trialkylsilyl group Chemical group 0.000 description 1
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000002264 triphosphate group Chemical group [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
- 125000005454 tryptophanyl group Chemical group 0.000 description 1
- 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 210000002845 virion Anatomy 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Disclosed herein are phosphoramidate prodrugs of nucleoside derivatives for the treatment of viral infections in mammals, which is a compound, its stereoisomer, salt (acid or basic addition salt), hydrate, solvate, or crystalline 5 form thereof, represented by the following structure: R3b IBase R3a N---P- O O C0 2 R4 ORI R \R 6 Also disclosed are methods of treatment, uses, and processes for preparing each of which utilize the compound represented by formula I. '7C 1
Description
Regulation 3.2 AUSTRALIA Patents Act 1990 ORIGINAL COMPLETE SPECIFICATION STANDARD PATENT Name of Applicant: Gilead Pharmasset LLC Actual Inventors Peiyuan WANG Jinfa DU Michael Joseph SOFIA Dhanapalan NAGARATHNAM Address for service is: WRAYS Ground Floor, 56 Ord Street West Perth WA 6005 Attorney code: WR Invention Title: Nucleoside Phosphoramidate Prodrugs The following statement is a full description of this invention, including the best method of performing it known to me: la NUCLEOSIDE PHOSPHORAMIDATE PRODRUGS This application is being filed on March 25, 2008, as a PCT International Patent application in the name of Pharmasset, Inc., a U.S. national corporation, 5 applicant for the designation of all countries except the US, and Michael Joseph Sofia, a citizen of the U.S.; Jinfa Du, a citizen of the U.S.; Peiyuan Wang, a citizen of the People's Republic of China; and Dhanapalan Nagarathnam, a citizen of the U.S.; applicants for the designation of the US only, and claims priority to U.S. Provisional Application Nos. 60/909,315, filed March 30, 2007; 10 60/982,309, filed October 24, 2007; and U.S. Non-Provisional Application No. 12/053,015, filed March 21, 2008. The contents of each of the above-noted applications is hereby incorporated by reference in its entirety. Field (if Invention 15 The present invention pertains to nucleoside phosphoramidates and their use as agents for treating viral diseases. These compounds are inhibitors of RNA-dependent RNA viral replication and are useful as inhibitors of HCV NS5B polymerase, as inhibitors of HCV replication and for treatment of hepatitis C infection in mammals. The invention provides novel chemical 20 compounds, and the use of these compounds alone or in combination with other antiviral agents for treating HCV infection. Background Hepatitis C virus (HCV) infection is a major health problem that leads to chronic liver disease, such as cirrhosis and hepatocellular carcinoma, in a - lb substantial number of infected individuals, estimated to be 2-15% of the world's population. There are an estimated 4.5 million infected people in the United States alone, according to the U.S. Center for Disease Control. According to the World Health Organization, there are more than 200 million 5 infected individuals worldwide, with at least 3 to 4 million people being infected each year. Once infected, about 20% of people clear the virus, but the rest can harbor HCV the rest of their lives. Ten to twenty percent of chronically infected individuals eventually develop liver-destroying cirrhosis or cancer. The viral disease is transmitted parenterally by contaminated blood and blood products, 10 contaminated needles, or sexually and vertically from infected mothers or carrier mothers to their offspring. Current treatments for HCV infection, which are restricted to immunotherapy with recombinant interferon-a alone or in combination with the nucleoside analog ribavirin, are of limited clinical benefit. Moreover, there is no established vaccine for HCV. Consequently, there is an 15 urgent need for improved therapeutic agents that effectively combat chronic HCV infection. The HCV virion is an enveloped positive-strand RNA virus with a single oligoribonucleotide genomic sequence of about 9600 bases which encodes a polyprotein of about 3,010 amino acids. The protein products of the HCV gene 20 consist of the structural proteins C, El, and E2, and the non-structural proteins NS2, NS3, NS4A and NS4B, and NS5A and NS5B. The nonstructural (NS) proteins are believed to provide the catalytic machinery for viral replication. The NS3 protease releases NS5B, the RNA-dependent RNA polymerase from the polyprotein chain. HCV NS5B polymerase is required for the synthesis of a 25 double-stranded RNA from a single-stranded viral RNA that serves as a template -2in the replication cycle of HCV. Therefore, NS5B polymerase is considered to be an essential component in the HCV replication complex (K. Ishi, et al, Heptology, 1999, 29: 1227-1235; V. Lohmann, et al., Virology, 1998, 249: 108 118). Inhibition of HCV NS5B polymerase prevents formation of the double 5 stranded HCV RNA and therefore constitutes an attractive approach to the development of HCV-specific antiviral therapies. HCV belongs to a much larger family of viruses that share many common features. Flaviviridae Viruses 10 The Flaviviridae family of viruses comprises at least three distinct genera: pestiviruses, which cause disease in cattle and pigs;flavivruses, which are the primary cause of diseases such as dengue fever and yellow fever; and hepaciviruses, whose sole member is HCV. The flavivirus genus includes more than 68 members separated into groups on the basis of serological relatedness 15 (Calisher et al., J. Gen. Virol, 1993,70,37-43). Clinical symptoms vary and include fever, encephalitis and hemorrhagic fever (Fields Virology, Editors: Fields, B. N., Knipe, D. M., and Howley, P. M., Lippincott-Raven Publishers, Philadelphia, PA, 1996, Chapter 31, 931-959). Flaviviruses of global concern that are associated with human disease include the Dengue Hemorrhagic Fever 20 viruses (DHF), yellow fever virus, shock syndrome and Japanese encephalitis virus (Halstead, S. B., Rev. Infect. Dis., 1984, 6, 251-264; Halstead, S. B., Science, 239:476-481, 1988; Monath, T. P., New Eng. J. Med, 1988, 319, 64 1 643).
The pestivirus genus includes bovine viral diarrhea virus (BVDV), classical swine fever virus (CSFV, also called hog cholera virus) and border disease virus (BDV) of sheep (Moennig, V. et al. Adv. Vir. Res. 1992, 41, 53 98). Pestivirus infections of domesticated livestock (cattle, pigs and sheep) cause 5 significant economic losses worldwide. BVDV causes mucosal disease in cattle and is of significant economic importance to the livestock industry (Meyers, G. and Thiel, H.J., Advances in Virus Research, 1996, 47, 53-118; Moennig V., et al, Adv. Vir. Res. 1992, 41, 53-98). Human pestiviruses have not been as extensively characterized as the animal pestiviruses. However, serological 10 surveys indicate considerable pestivirus exposure in humans. Pestiviruses and hepaciviruses are closely related virus groups within the Flaviviridae family. Other closely related viruses in this family include the GB virus A, GB virus A-like agents, GB virus-B and GB virus-C (also called hepatitis G virus, HGV). The hepacivirus group (hepatitis C virus; HCV) 15 consists of a number of closely related but genotypically distinguishable viruses that infect humans. There are at least 6 HCV genotypes and more than 50 subtypes. Due to the similarities between pestiviruses and hepaciviruses, combined with the poor ability of hepaciviruses to grow efficiently in cell culture, bovine viral diarrhea virus (BVDV) is often used as a surrogate to study 20 the HCV virus. The genetic organization of pestiviruses and hepaciviruses is very similar. These positive stranded RNA viruses possess a single large open reading frame (ORF) encoding all the viral proteins necessary for virus replication. These proteins are expressed as a polyprotein that is co- and post-translationally processed by both cellular and virus-encoded proteinases to yield the mature viral proteins. The viral proteins responsible for the replication of the viral genome RNA are located within approximately the carboxy-terminal. Two thirds of the ORF are termed nonstructural (NS) proteins. The genetic 5 organization and polyprotein processing of the nonstructural protein portion of the ORF for pestiviruses and hepaciviruses is very similar. For both the pestiviruses and hepaciviruses, the mature nonstructural (NS) proteins, in sequential order from the amino-terminus of the nonstructural protein coding region to the carboxy-terminus of the ORF, consist of p7, NS2, NS3, NS4A, 10 NS4B, NS5A, and NS5B. The NS proteins of pestiviruses and hepaciviruses share sequence domains that are characteristic of specific protein functions. For example, the NS3 proteins of viruses in both groups possess amino acid sequence motifs characteristic of serine proteinases and of helicases (Gorbalenya et al., Nature, 15 1988, 333, 22; Bazan and Fletterick Virology, 1989,171,637-639; Gorbalenya et al., Nucleic Acid Res., 1989, 17, 3889-3897). Similarly, the NS5B proteins of pestiviruses and hepaciviruses have the motifs characteristic of RNA-directed RNA polymerases (Koonin, E.V. and Dolja, V.V., Crir. Rev. Biochem. Molec. Biol. 1993, 28, 375-430). 20 The actual roles and functions of the NS proteins of pestiviruses and hepaciviruses in the lifecycle of the viruses are directly analogous. In both cases, the NS3 serine proteinase is responsible for all proteolytic processing of polyprotein precursors downstream of its position in the ORF (Wiskerchen and Collett, Virology, 1991, 184, 341-350; Bartenschlager et al., J. Virol. 1993, 67, 3835-3844; Eckart et al. Biochem. Biophys. Res. Comm. 1993,192, 399-406; Grakoui et al., J. Virol. 1993, 67, 2832-2843; Grakoui et al., Proc. Natl. Acad Sci. USA 1993, 90, 10583-10587; Hijikata et al., J Virol. 1993, 67, 4665-4675; Tome et al., J. Virol., 1993, 67, 4017-4026). The NS4A protein, in both cases, 5 acts as a cofactor with the NS3 serine protease (Bartenschlager et al., J. Virol. 1994, 68, 5045-5055; Failla et al., J. Virol. 1994, 68, 3753-3760; Xu et al., J. Virol., 1997, 71:53 12-5322). The NS3 protein of both viruses also functions as a helicase (Kim et al., Biochem. Biophys. Res. Comm., 1995, 215, 160-166; Jin and Peterson, Arch. Biochem. Biophys., 1995, 323, 47-53; Warrener and Collett, 10 J. Virol. 1995, 69,1720-1726). Finally, the NS5B proteins of pestiviruses and hepaciviruses have the predicted RNA-directed RNA polymerases activity (Behrens et al., EMBO, 1996, 15, 12-22; Lechmann et al., J. Virol., 1997, 71, 8416-8428; Yuan et al., Biochem. Biophys. Res. Comm. 1997, 232, 231-235; Hagedorn, PCT WO 97/12033; Zhong et al, J. Virol., 1998, 72, 9365-9369). 15 Currently, there are limited treatment options for individuals infected with hepatitis C virus. The current approved therapeutic option is the use of immunotherapy with recombinant interferon-ca alone or in combination with the nucleoside analog ribavirin. This therapy is limited in its clinical effectiveness and only 50% of treated patients respond to therapy. Therefore, there is 20 significant need for more effective and novel therapies to address the unmet medical need posed by HCV infection. A number of potential molecular targets for drug development of direct acting antivirals as anti -HCV therapeutics have now been identified including, but not limited to, the NS2-NS3 autoprotease, the N3 protease, the N3 helicase and the NS5B polymerase. The RNA-dependent RNA polymerase is absolutely essential for replication of the single-stranded, positive sense, RNA genome and this enzyme has elicited significant interest among medicinal chemists. Inhibitors of HCV NS5B as potential therapies for HCV infection have 5 been reviewed: Tan, S.-L., et al., Nature Rev. Drug Discov., 2002, 1, 867-881; Walker, M.P. et al., Exp. Opin. Investigational Drugs, 2003, 12, 1269-1280; Ni, Z-J., et al., Current Opinion in Drug Discovery and Development, 2004, 7, 446 459; Beaulieu, P. L., et al., Current Opinion in Investigational Drugs, 2004, 5, 838-850; Wu, J., et al., Current Drug Targets-Infectious Disorders, 2003, 3, 10 207-219; Griffith, R.C., et al, Annual Reports in Medicinal Chemistry, 2004, 39, 223-237; Carrol, S., et al., Infectious Disorders-Drug Targets, 2006, 6, 17-29. The potential for the emergence of resistant HCV strains and the need to identify agents with broad genotype coverage supports the need for continuing efforts to identify novel and more effective nucleosides as HCV NS5B inhibitors. 15 Nucleoside inhibitors of NS5B polymerase can act either as a non-natural substrate that results in chain termination or as a competitive inhibitor which competes with nucleotide binding to the polymerase. To function as a chain terminator the nucleoside analog must be taken up by the cell and converted in vivo to a triphosphate to compete for the polymerase nucleotide binding site. 20 This conversion to the triphosphate is commonly mediated by cellular kinases which imparts additional structural requirements on a potential nucleoside polymerase inhibitor. Unfortunately, this limits the direct evaluation of nucleosides as inhibitors of HCV replication to cell-based assays capable of in situ phosphorylation.
In some cases, the biological activity of a nucleoside is hampered by its poor substrate characteristics for one or more of the kinases needed to convert it to the active triphosphate form. Formation of the monophosphate by a nucleoside kinase is generally viewed as the rate limiting step of the three 5 phosphorylation events. To circumvent the need for the initial phosphorylation step in the metabolism of a nucleoside to the active triphosphate analog, the preparation of stable phosphate prodrugs has been reported. Nucleoside phosphoramidate prodrugs have been shown to be precursors of the active nucleoside triphosphate and to inhibit viral replication when administered to 10 viral infected whole cells (McGuigan, C., et al., J Med. Chem., 1996, 39, 1748 1753; Valette, G., et al., J. Med. Chem., 1996, 39, 1981-1990; Balzarini, J., et al., Proc. National Acad Sci USA, 1996, 93, 7295-7299; Siddiqui, A. Q., et al., J. Med. Chem., 1999, 42, 4122-4128; Eisenberg, E. J., et al., Nucleosides, Nucleotides and Nucleic Acids, 2001, 20, 1091-1098; Lee, W.A., et al., 15 Antimicrobial Agents and Chemotherapy, 2005, 49, 1898); US 2006/0241064; and WO 2007/095269. Also limiting the utility of nucleosides as viable therapeutic agents is their sometimes poor physicochemical and pharmacokinetic properties. These poor properties can limit the intestinal absorption of an agent and limit uptake 20 into the target tissue or cell. To improve on their properties prodrugs of nucleosides have been employed. It has been demonstrated that preparation of nucleoside phosphoramidates improves the systemic absorption of a nucleoside and furthermore, the phosphoramidate moiety of these "pronucleotides" is masked with neutral lipophilic groups to obtain a suitable partition coefficient to 25 optimize uptake and transport into the cell dramatically enhancing the 0 intracellular concentration of the nucleoside monophosphate analog relative to administering the parent nucleoside alone. Enzyme-mediated hydrolysis of the phosphate ester moiety produces a nucleoside monophosphate wherein the rate limiting initial phosphorylation is unnecessary. 5 SUMMARY OF THE INVENTION The present invention is directed toward novel phosphoramidate prodrugs of nucleoside derivatives for the treatment of viral infections in mammals, which is a compound, its stereoisomers, salts (acid or basic addition salts), hydrates, solvates, or crystalline forms thereof, represented by the 10 following structure: R2 0
R
3 b I I Base R3a N-P-O C0 2
R
4 OR' R
R
6 Y X wherein (a) R1 is hydrogen, n-alkyl; branched alkyl; cycloalkyl; or aryl, which 15 includes, but is not limited to, phenyl or naphthyl, where phenyl or naphthyl are optionally substituted with at least one of C 1
.
6 alkyl, C 2 .6 alkenyl, C 2 -6 alkynyl,
C
1 . alkoxy, F, Cl, Br, I, nitro, cyano, C 1
.
6 haloalkyl, -N(R') 2 , C 1
-
6 acylamino, NHSO 2
C
1 -6 alkyl, -SO 2
N(R")
2 , COR'", and -SO 2 C .
6 alkyl; (R is independently hydrogen or alkyl, which includes, but is not limited to, C 1
.
20 alkyl, CI.
1 0 alkyl, 20 or C 1
-
6 alkyl, Rr is -OR' or -N(R )2); (b) R2 is hydrogen, C 1.10 alkyl, R 3 a or R and R 2 together are (CH 2 )n so as to form a cyclic ring that includes the adjoining N and C atoms, C(0)CR 3 aR 3 bNHRI, where n is 2 to 4 and R', R 3 a, and R 3 b; n (c) R 3 a and R 3 b are (i) independently selected from hydrogen, C 1
-
10 alkyl, cycloalkyl, -(CH 2 )c(NR") 2 , C 1
-
6 hydroxyalkyl, -CH 2 SH, -(CH 2
)
2 S(O)dMe, (CH 2
)
3
NHC(=NH)NH
2 , (1 H-indol-3-yl)methyl, (1 H-imidazol-4-yl)methyl, (CH 2 )eCOR 3 , aryl and aryl C 1
.
3 alkyl, said aryl groups optionally substituted 5 with a group selected from hydroxyl, CI-Io alkyl, CI.
6 alkoxy, halogen, nitro and cyano; (ii) R 3 a and R 3 b both are CI- 6 alkyl; (iii) R 3 a and R 3 b together are(CH 2 )f so as to form a spiro ring; (iv) R 3 a is hydrogen and R 3 b and R 2 together are (CH 2 ). so as to form a cyclic ring that includes the adjoining N and C atoms (v) R3b is hydrogen and R3a and R2 together are (CH 2 )n so as to form a cyclic ring that 10 includes the adjoining N and C atoms, where c is I to 6, d is 0 to 2, e is 0 to 3, f is 2 to 5, n is 2 to 4, and where R 3 is independently hydrogen or C 1 -6 alkyl and
R
3 is -OR' or -N(R 3
)
2 ); (vi) R 3 a is H and R 3 b is H, CH 3 , CH 2
CH
3 , CH(CH 3
)
2 ,
CH
2
CH(CH
3
)
2 , CH(CH 3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, -CH 2
CH
2
SCH
3 ,
CH
2
CO
2 H, CH 2
C(O)NH
2 , CH 2
CH
2 COOH, CH 2
CH
2
C(O)NH
2 , 15 CH 2
CH
2
CH
2
CH
2
NH
2 , -CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl,
CH
2 OH, CH(OH)CH 3 , CH 2 ((4'-OH)-Ph), CH 2 SH, or lower cycloalkyl; or (viii) R 3 is CH 3 , -CH 2
CH
3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 , CH(CH 3
)CH
2
CH
3 , CH 2 Ph,
CH
2 -indol-3-yl, -CH 2
CH
2
SCH
3 , CH 2
CO
2 H, CH 2
C(O)NH
2 , CH 2
CH
2 COOH,
CH
2
CH
2
C(O)NH
2 , CH 2
CH
2
CH
2
CH
2
NH
2 , -CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 20 imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4'-OH)-Ph), CH 2 SH, or lower cycloalkyl and R 3 b is H, where R is independently hydrogen or alkyl, which includes, but is not limited to, CI- 2 0 alkyl, CI 10 alkyl, or C 1
.
6 alkyl, R is -OR' or -N(R 3)2); (d) R4 is hydrogen, C 1
.
1 0 alkyl, Ci.
1 0 alkyl optionally substituted with 25 a lower alkyl, alkoxy, di(lower alkyl)-amino, or halogen, C 1
.
1 0 haloalkyl, C 3
.
10 cycloalkyl, cycloalkyl alkyl, cycloheteroalkyl, aminoacyl, aryl, such as phenyl, heteroaryl, such as, pyridinyl, substituted aryl, or substituted heteroaryl; (e) R 5 is H, a lower alkyl, CN, vinyl, 0-(lower alkyl), hydroxyl lower alkyl, i.e., -(CH 2 )pOH, where p is 1 -6, including hydroxyl methyl (CH 2 OH), 30 CH 2 F, N 3 , CH 2 CN, CH 2
NH
2 , CH 2
NHCH
3 , CH 2
N(CH
3
)
2 , alkyne (optionally substituted), or halogen, including F, Cl, Br, or I, with the provisos that when X 1 A is OH, base is cytosine and R 6 is H, R 5 cannot be N 3 and when X is OH, R 6 is
CH
3 or CH 2 F and B is a purine base, R 5 cannot be H; (f) R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , F, or CN; (g) X is H, OH, F, OMe, halogen, NH 2 , or N 3 ; 5 (h) Y is OH, H, C14 alkyl, C24 alkenyl, C24 alkynyl, vinyl, N 3 , CN, Cl, Br, F, I, NO 2 , OC(O)O(C 1 4 alkyl), OC(O)O(C1.4 alkyl), OC(O)O(C 2 -4 alkynyl), OC(O)O(C24 alkenyl), OCI 10 haloalkyl, O(aminoacyl), O(CI 10 acyl), O(CI- alkyl), O(C24 alkenyl), S(C 14 acyl), S(CIA alkyl), S(C24 alkynyl), S(C 24 alkenyl), SO(CI4 acyl), SO(C 14 alkyl), SO(C 24 alkynyl), SO(C24 alkenyl), 10 SO2(CIA acyl), SO2(CIA alkyl), SO2(C24 alkynyl), SO2(C24 alkenyl), OS(0) 2
(C
1 . 4 acyl), OS(O)2(CI4 alkyl), OS(0)2(C24 alkenyl), NH 2 , NH(C14 alkyl), NH(C24 alkenyl), NH(C 2 4 alkynyl), NH(CI4 acyl), N(C.4 alkyl) 2 , N(CIs 18 acyl) 2 , wherein alkyl, alkynyl, alkenyl and vinyl are optionally substituted by N 3 , CN, one to three halogen (Cl, Br, F, I), NO 2 , C(O)O(CI.4 alkyl), C(O)O(Cia alkyl), 15 C(O)O(C24 alkynyl), C(O)O(C24 alkenyl), O(C 14 acyl), O(CI4 alkyl), O(C 2 4 alkenyl), S(C14 acyl), S(CI.4 alkyl), S(C 2 4 alkynyl), S(C2A alkenyl), SO(C 1 4 acyl), SO(CI 4 alkyl), SO(C 2 4 alkynyl), SO(C 2
.
4 alkenyl), SO2(CI4 acyl), S0 2
(C
1 4 alkyl), S0 2
(C
2 4 alkynyl), S0 2
(C
2 4 alkenyl), OS(O)2(CI4 acyl), OS(0) 2
(C
14 alkyl), OS(O)2(C24 alkenyl), NH 2 , NH(C 1 4 alkyl), NH(C24 20 alkenyl), NH(C 2 4 alkynyl), NH(C 14 acyl), N(Cia alkyl) 2 , N(Cia acyl)2; the base is a naturally occurring or modified purine or pyrimidine base represented by the following structures: 1 1
R
9 O R0 O
R
8
R
8 N N I NH Z N N N NH 7t 7 N-1 N : R7 N O R N O N R" N N NH 2 a b c d wherein Z is N or CR'1; 5 R , R',R 9 , R'", and R"are independently H, F, Cl, Br, I, OH, OR', SH, SR', NH 2 , NHR', NR' 2 , lower alkyl of CI-C 6 , halogenated (F, Cl, Br, I) lower alkyl of Ci-C 6 , lower alkenyl of C 2
-C
6 , halogenated (F, Cl, Br, I) lower alkenyl of C 2
-C
6 , lower alkynyl of C 2
-C
6 such as C=CH, halogenated (F, Cl, Br, I) lower alkynyl of C 2
-C
6 , lower alkoxy of Ci-C 6 , halogenated (F, Cl, Br, I) lower alkoxy 10 of CI-C 6 , CO 2 H, CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or
CH=CHCO
2 R', wherein R' is an optionally substituted alkyl , which includes, but is not limited to, an optionally substituted CI- 20 alkyl, an optionally substituted CI.1 0 alkyl, an optionally substituted lower alkyl; an optionally substituted cycloalkyl; 15 an optionally substituted alkynyl of C 2
-C
6 , an optionally substituted lower alkenyl of C 2
-C
6 , or optionally substituted acyl, which includes but is not limited to C(O) alkyl, C(O)(C 1
-
20 alkyl), C(O)(CI-Io alkyl), or C(O)(lower alkyl) or alternatively, in the instance of NR' 2 , each R' comprise at least one C atom that are joined to form a heterocycle comprising at least two carbon atoms; and 20 R1 2 is H, halogen (including F, Cl, Br, I), OH, OR', SH, SR', NH 2 , NHR',
NR'
2 , NO 2 lower alkyl of CI-C 6 , halogenated (F, Cl, Br, I) lower alkyl of CI-C 6 , lower alkenyl of C 2
-C
6 , halogenated (F, Cl, Br, I) lower alkenyl of C 2
-C
6 , lower alkynyl of C 2
-C
6 , halogenated (F, Cl, Br, I) lower alkynyl of C 2
-C
6 , lower alkoxy of C,-C 6 , halogenated (F, Cl, Br, 1) lower alkoxy of CI-C 6 , CO 2 H, CO 2 R', 25 CON H2, CONHR', CONR' 2 , CH=CHCO 2 H, or CH=CHCO 2 R'; with the proviso that when base is represented by the structure c with R 1 being .hydrogen, R 2 is not a: (i) -C-C-H, (ii) -C=CH 2 , or (iii) -NO 2 . DEFINITIONS 5 The phrase "a" or "an" entity as used herein refers to one or more of that entity; for example, a compound refers to one or more compounds or at least one compound. As such, the terms "a" (or "an"), "one or more", and "at least one" can be used interchangeably herein. The phrase "as defined herein above" refers to the first definition 10 provided in the Summary of the Invention. The terms "optional" or "optionally" as used herein means that a subsequently described event or circumstance may but need not occur, and that the description includes instances where the event or circumstance occurs and instances in which it does not. For example, "optional bond" means that the 15 bond may or may not be present, and that the description includes single, double, or triple bonds. The term "independently" is used herein to indicate that a variable is applied in any one instance without regard to the presence or absence of a variable having that same or a different definition within the same compound. 20 Thus, in a compound in which R appears twice and is defined as "independently carbon or nitrogen", both R's can be carbon, both R's can be nitrogen, or one R' can be carbon and the other nitrogen. The term "alkenyl" refers to an unsubstituted hydrocarbon chain radical having from 2 to 10 carbon atoms having one or two olefinic double bonds, 25 preferably one olefinic double bond. The term "C2-N alkenyl" refers to an alkenyl comprising 2 to N carbon atoms, where N is an integer having the following values: 3, 4, 5, 6, 7, 8, 9, or 10. The term "C 2
-
10 alkenyl" refers to an alkenyl comprising 2 to 10 carbon atoms. The term "C24 alkenyl" refers to an alkenyl comprising 2 to 4 carbon atoms. Examples include, but are not limited 30 to, vinyl, 1-propenyl, 2-propenyl (allyl) or 2-butenyl (crotyl).
The term "halogenated alkenyl" refers to an alkenyl comprising at least one of F, Cl, Br, and I. The term "alkyl" refers to an unbranched or branched chain, saturated, monovalent hydrocarbon residue containing 1 to 30 carbon atoms. The term "Ci. 5 m alkyl" refers to an alkyl comprising I to M carbon atoms, where M is an integer having the following values: 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, or 30. The term "C 4 4alkyl" refers to an alkyl containing 1 to 4 carbon atoms. The term "lower alkyl" denotes a straight or branched chain hydrocarbon residue comprising I to 6 10 carbon atoms. "C 120 alkyl" as used herein refers to an alkyl comprising I to 20 carbon atoms. "CI- 10 alkyl" as used herein refers to an alkyl comprising I to 10 carbons. Examples of alkyl groups include, but are not limited to, lower alkyl groups include methyl, ethyl, propyl, i-propyl, n-butyl, i-butyl, t-butyl or pentyl, isopentyl, neopentyl, hexyl, heptyl, and octyl. The term (ar)alkyl or 15 (heteroaryl)alkyl indicate the alkyl group is optionally substituted by an aryl or a heteroaryl group respectively. The term "cycloalkyl" refers to an unsubstituted or substituted carbocycle, in which the carbocycle contains 3 to 10 carbon atoms; preferably 3 to 8 carbon atoms; more preferably 3 to 6 carbon atoms (i.e., lower cycloalkyls). 20 Examples of cycloalkyl groups include, but are not limited to, cyclopropyl, 2 methyl-cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl. The term "cycloalkyl alkyl" refers to an additionally unsubstituted or substituted alkyl substituted by a lower cycloalkyl. Examples of cycloalkyl alkyls include, but are not limited to, any one of methyl, ethyl, propyl, i-propyl, 25 n-butyl, i-butyl, t-butyl or pentyl, isopentyl, neopentyl, hexyl, heptyl, and octyl that is substituted with cyclopropyl, 2-methyl-cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl. The term "cycloheteroalkyl" refers to an unsubstituted or substituted heterocycle, in which the heterocycle contains 2 to 9 carbon atoms; preferably 2 30 to 7 carbon atoms; more preferably 2 to 5 carbon atoms. Examples of cycloheteroalkyls include, but are not limited to, aziridin-2-yl, N-Cl.
3 -alkyl S1A aziridin-2-yl, azetidinyl, N-CI--alkyl-azetidin-m'-yl, pyrrolidin-m'-yl, N-CI.3 alkyl-pyrrolidin-m'-yl, piperidin-m'-yi, and N-C I3-alkyl-piperidin-m'-yl, where m' is 2, 3, or 4 depending on the cycloheteroalkyl. Specific examples of N-CI.
3 alkyl-cycloheteroalkyls include, but are not limited to, N-methyl-aziridin-2-yl, 5 N-methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-vl, N methyl-piperidin-2-yl, N-methyl-piperidin-3-yl, and N-methyl-piperidin-4-yl. In the instance of R 4 , the point of attachment between the cycloheteroalkyl ring carbon and the oxygen occurs at any one of m' The term "heterocycle" refers to an unsubstituted or substituted 10 heterocycle containing carbon, hydrogen, and at least one of N, 0, and S, where the C and N can be trivalent or tetravalent, i.e., sp - or sp 3 -hybridized. Examples of heterocycles include, but are not limited to, aziridine, azetidine, pyrrolidine, piperidine, imidazole, oxazole, piperazine, etc. In the instance of piperazine, as related to R1 0 for NR' 2 , the corresponding opposite nitrogen atom of the 15 piperazinyl is substituted by a lower alkyl represented by the following structure: Iowcr alkyl-%/ Preferably, the opposite nitrogen of the piperazinyl is substituted by a methyl group. The term "halogenated alkyl" (or "haloalkyl") refers to an unbranched or 20 branched chain alkyl comprising at least one of F, Cl, Br, and I. The term "CI-m haloalkyl" refers to an alkyl comprising I to M carbon atoms that comprises at least one of F, Cl, Br, and I, where M is an integer having the following values: 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, or 30. "CI- 3 haloalkyl" refers to a haloalkyl comprising I to 3 25 carbons and at least one of F, Cl, Br, and I. The term "halogenated lower alkyl" (or "lower haloalkyl") refers to a haloalkyl comprising 1 to 6 carbon atoms and at least one of F, Cl, Br, and I. Examples include, but are not limited to, fluoromethyl, chloromethyl, bromomethyl, iodomethyl, difluoromethyl, dichloromethyl, dibromomethyl, diiodomethyl, trifluoromethyl, trichloromethyl, 30 tribromomethyl, triiodomethyl, 1-fluoroethyl, 1-chloroethyl, 1-bromoethyl, 11 1 1 iodoethyl, 2-fluoroethyl, 2-chloroethyl, 2-bromoethyl, 2-iodoethyl, 2,2 difluoroethyl, 2,2-dichloroethyl, 2,2-dibromomethyl, 2-2-diiodomethyl, 3 fluoropropyl, 3-chloropropyl, 3-bromopropyl, 2,2,2-trifluoroethyl or 1,1,2,2,2 pentafluoroethyl. 5 The term "alkynyl" refers to an unbranched or branched hydrocarbon chain radical having from 2 to 10 carbon atoms, preferably 2 to 5 carbon atoms, and having one triple bond. The term "C2-N alkynyl" refers to an alkynyl comprising 2 to N carbon atoms, where N is an integer having the following values: 3, 4, 5, 6, 7, 8, 9, or 10. The term "C C24 alkynyl" refers to an alkynyl 10 comprising 2 to 4 carbon atoms. The term "C 2
-
1 0 alkynyl" refers to an alkynyl comprising 2 to 10 carbons. Examples include, but are limited to, ethynyl, 1 propynyl, 2-propynyl, 1-butynyl, 2-butynyl or 3-butynyl. The term "halogenated alkynyl" refers to an unbranched or branched hydrocarbon chain radical having from 2 to 10 carbon atoms, preferably 2 to 5 15 carbon atoms, and having one triple bond and at least one of F, Cl, Br, and I. The term "cycloalkyl" refers to a saturated carbocyclic ring comprising 3 to 8 carbon atoms, i.e. cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl or cyclooctyl. The term "C 3 7 cycloalkyl" as used herein refers to a cycloalkyl comprising 3 to 7 carbons in the carbocyclic ring. 20 The term "alkoxy" refers to an -0-alkyl group or an -0-cycloalkyl group, wherein alkyl and cycloalkyl are as defined above. Examples of -0-alkyl groups include, but are not limited to, methoxy, ethoxy, n-propyloxy, i propyloxy, n-butyloxy, i-butyloxy, t-butyloxy. "Lower alkoxy" as used herein denotes an alkoxy group with a "lower alkyl" group as previously defined. "C 1
-
1 o 25 alkoxy" refers to an-O-alkyl wherein alkyl is C 1
.
10 . Examples of -O-cycloalkyl groups include, but are not limited to, -O-c-propyl, -O-c-butyl, -O-c-pentyl, and -O-c-hexyl. The term "halogenated alkoxy" refers to an -0-alkyl group in which the alkyl group comprises at least one of F, Cl, Br, and I.
The term "halogenated lower alkoxy" refers to an -O-(lower alkyl) group in which the lower alkyl group comprises at least one of F, Cl, Br, and I. The term "amino acid" includes naturally occurring and synthetic a, $ y or 8 amino acids, and includes but is not limited to, amino acids found in 5 proteins, i.e. glycine, alanine, valine, leucine, isoleucine, methionine, phenylalanine, tryptophan, proline, serine, threonine, cysteine, tyrosine, asparagine, glutamine, aspartate, glutamate, lysine, arginine and histidine. In a preferred embodiment, the amino acid is in the L-configuration. Alternatively, the amino acid can be a derivative of alanyl, valinyl, leucinyl, isoleucinyl, 10 prolinyl, phenylalaninyl, tryptophanyl, methioninyl, glycinyl, serinyl, threoninyl, cysteinyl, tyrosinyl, asparaginyl, glutaminyl, aspartoyl, glutaroyl, lysinyl, argininyl, histidinyl, p-alanyl, p-valinyl, p-leucinyl, 0-isoleucinyl, p-prolinyl, p phenylalaninyl, p-tryptophanyl, p-methioninyl, p-glycinyl, p-serinyl, p threoninyl, p-cysteinyl, p-tyrosinyl, p-asparaginyl, p-glutaminyl, p-aspartoyl, p 15 glutaroyl, -lysinyl, p-argininyl or p-histidinyl. When the term amino acid is used, it is considered to be a specific and independent disclosure of each of the esters of a, p y or 6 glycine, alanine, valine, leucine, isoleucine, methionine, phenylalanine, tryptophan, proline, seine, threonine, cysteine, tyrosine, asparagine, glutamine, aspartate, glutamate, lysine, arginine and histidine in the 20 D and L-configurations. The term "aminoacyl" includes N,N-unsubstituted, N,N-monosubstituted, and N,N-disubstituted derivatives of naturally occurring and synthetic a, P y or 8 amino acyls, where the amino acyls are derived from amino acids. The amino nitrogen can be substituted or unsubstituted. When the amino-nitrogen is 25 substituted, the nitrogen is either mono- or di-substituted, where the substituent bound to the amino-nitrogen is a lower alkyl or an alkaryl. In the instance of its use for Y, the expression "O(aminoacyl)" is used. It is understood that the C3' carbon of the ribose is bound to the oxygen "0", which is then bound to the carbonyl carbon of the aminoacyl. 30 The terms "alkylamino" or "arylamino" refer to an amino group that has one or two alkyl or aryl substituents, respectively. 1 '7 The term "protected," as used herein and unless otherwise defined, refers to a group that is added to an oxygen, nitrogen, or phosphorus atom to prevent its further reaction or for other purposes. A wide variety of oxygen and nitrogen protecting groups are known to those skilled in the art of organic synthesis. Non 5 limiting examples include: C(O)-alkyl, C(O)Ph, C(O)aryl, CH 3 , CH 2 -alkyl, CH 2 alkenyl, CH 2 Ph, CH 2 -aryl, CH 2 0-alkyl, CH 2 O-aryl, S0 2 -alkyl, S0 2 -aryl, tert butyldimethylsilyl, tert-butyldiphenylsilyl, and 1,3-(1,1,3,3 tetraisopropyldisiloxanylidene). The term "aryl," as used herein, and unless otherwise specified, refers to 10 substituted or unsubstituted phenyl (Ph), biphenyl, or naphthyl, preferably the term aryl refers to substituted or unsubstituted phenyl. The aryl group can be substituted with one or more moieties selected from among hydroxyl, F, Cl, Br, I, amino, alkylamino, arylamino, alkoxy, aryloxy, nitro, cyano, sulfonic acid, sulfate, phosphonic acid, phosphate, and phosphonate, either unprotected, or 15 protected as necessary, as known to those skilled in the art, for example, as taught in T.W. Greene and P.G. M. Wuts, "Protective Groups in Organic Synthesis," 3rd ed., John Wiley & Sons, 1999. The terms "alkaryl" or "alkylaryl" refer to an alkyl group with an aryl substituent, such as benzyl. The terms "aralkyl" or "arylalkyl" refer to an aryl 20 group with an alkyl substituent. The term "di(lower alkyl)amino-lower alkyl" refers to a lower alkyl substituted by an amino group that is itself substituted by two lower alkyl groups. Examples include, but are not limited to, (CH 3
)
2
NCH
2 ,
(CH
3
)
2
NCH
2
CH
2 , (CH 3
)
2
NCH
2
CH
2
CH
2 , etc. The examples above show lower 25 alkyls substituted at the terminus carbon atom with an N,N-dimethyl-amino substituent. These are intended as examples only and are not intended to limit the meaning of the term "di(lower alkyl)amino-lower alkyl" so as to require the same. It is contemplated that the lower alkyl chain can be substituted with an N,N-di(lower alkyl)-amino at any point along the chain, e.g., CH 3 CH(N-(lower 30 alkyl) 2
)CH
2
CH
2 . The term "halo," as used herein, includes chloro, bromo, iodo and fluoro.
The term "acyl" refers to a substituent containing a carbonyl moiety and a non-carbonyl moiety. The carbonyl moiety contains a double-bond between the carbonyl carbon and a heteroatom, where the heteroatom is selected from among 0, N and S. When the heteroatom is N, the N is substituted by a lower 5 alkyl. The non-carbonyl moiety is selected from straight, branched, and cyclic alkyl, which includes, but is not limited to, a straight, branched, or cyclic CI- 2 0 alkyl, CIo 10 alkyl, or lower alkyl; alkoxyalkyl, including methoxymethyl; aralkyl, including benzyl; aryloxyalkyl, such as phenoxymethyl; or aryl, including phenyl optionally substituted with halogen (F, Cl, Br, I), hydroxyl, CI to C 4 10 alkyl, or C, to C 4 alkoxy, sulfonate esters, such as alkyl or aralkyl sulphonyl, including methanesulfonyl, the mono, di or triphosphate ester, trityl or monomethoxytrityl, substituted benzyl, trialkylsilyl (e.g. dimethyl-t-butylsilyl) or diphenylmethylsilyl. When at least one aryl group is present in the non carbonyl moiety, it is preferred that the aryl group comprises a phenyl group. 15 The term "lower acyl" refers to an acyl group in which the non-carbonyl moiety is lower alkyl. The term "purine" or "pyrimidine" base includes, but is not limited to, adenine, N 6 -alkylpurines, N -acylpurines (wherein acyl is C(0)(alkyl, aryl, alkylaryl, or arylalkyl), N 6 -benzylpurine, N 6 -halopurine, N 6 -vinylpurine, N 20 acetylenic purine, N 6 -acyl purine, N 6 -hydroxyalkyl purine, N6_ allcylaminopurine, N -thioallcyl purine, N 2 -alkylpurines, N 2-alkyl-6-thiopurines, thymine, cytosine, 5-fluorocytosine, 5-methylcytosine, 6-azapyrimidine, including 6-azacytosine, 2- and/or 4-mercaptopyrmidine, uracil, 5-halouracil, including 5-fluorouracil, C 5 -alkylpyrimidines, C 5 -benzylpyrimidines, C 5 25 halopyrimidines, C 5 -vinylpyrimidine, C 5 -acetylenic pyrimidine, C 5 -acyl pyrimidine, C 5 -hydroxyalkyl purine, C 5 -amidopyrimidine, C 5 -cyanopyrimidine,
,C
5 -iodopyrimidine, C6-lodo-pyrimidine, C5 -Br-vinyl pyrimidine, C6 -Br-vinyl pyrimidine, C 5 -nitropyrimidine, C 5 -amino-pyrimidine, N 2 -alkylpurines, N2_ alkyl-6-thiopurines, 5-azacytidinyl, 5-azauracilyl, triazolopyridinyl, 30 imidazolopyridinyl, pyrrolopyrimidinyl, and pyrazolopyrimidinyl. Purine bases include, but are not limited to, guanine, adenine, hypoxanthine, 2,6 diaminopurine, and 6-chloropurine. Functional oxygen and nitrogen groups on 1 the base can be protected as necessary or desired. Suitable protecting groups are well known to those skilled in the art, and include trimethylsilyl, dimethylhexylsilyl, t-butyldimethylsilyl, and t-butyldiphenylsilyl, trityl, alkyl groups, and acyl groups such as acetyl and propionyl, methanesulfonyl, and p 5 toluenesulfonyl. The term "tautomerism" and "tautomers" have their accepted plain meanings. The term "P*" means that the phosphorous atom is chiral and that it has a corresponding Cahn-Ingold-Prelog designation of "R" or "S" which have their 10 accepted plain meanings. It is contemplated that compounds of the formula I are racemic because the chirality at phosphorous. Applicants contemplate use of the racemate and/or the resolved enantiomers. In some instances, an asterisk does not appear next to the phosphoroamidate phosphorous atom. In these instances, it is understood that the phosphorous atom is chiral and that one of ordinary skill 15 understands this to be so unless the substituents bound to the phosphorous exclude the possibility of chirality at phosphorous, such as in P(O)Cl 3 . DETAILED DESCRIPTION OF THE INVENTION An aspect of the invention is directed to a compound, its salts, hydrates, solvates, crystalline forms, and the like represented by formula I: R3b 2 Base R3a
N--P
C0 2
R
4 OR' R6 20 Y X wherein (a) R' is hydrogen, n-alkyl; branched alkyl; cycloalkyl; or aryl, which includes, but is not limited to, phenyl or naphthyl, where phenyl or naphthyl are optionally substituted with at least one of C 1 -6 alkyl, C 2 .6 alkenyl, C 2
-
6 alkynyl, 25 C1.
6 alkoxy, F, Cl, Br, I, nitro, cyano, Ci- haloalkyl, -N(R') 2 , C 1
-
6 acylamino, -
NHSO
2 CI-6 alkyl, -SO 2
N(R")
2 , COR , and -S0 2
CI-
6 alkyl; (R" is independently hydrogen or alkyl, which includes, but is not limited to, CI- 2 0 alkyl, C 1 .i 0 alkyl, or C 1 s alkyl, Rr is -OR' or -N(R )2); (b) R2 is hydrogen, C 1.10 alkyl, R 3 a or R 3 b and R 2 together are (CH 2 )n 5 so as to form a cyclic ring that includes the adjoining N and C atoms,
C(O)CR
3 aR 3 'NHRI, where n is 2 to 4 and R1, R , and R 3 b; (c) R and R are (i) independently selected from hydrogen, CI.io alkyl, cycloalkyl, -(CH 2 )c(NR 3
)
2 , C 1 -6 hydroxyalkyl, -CH 2 SH, -(CH 2
)
2 S(O)dMe, (CH 2
)
3
NHC(=NH)NH
2 , (1 H-indol-3-yl)methyl, (1 H-imidazol-4-yl)methyl, 10 (CH 2 )eCOR , aryl and aryl C- 3 alkyl, said aryl groups optionally substituted with a group selected from hydroxyl, CI 10 alkyl, Ci- 6 alkoxy, halogen, nitro and cyano; (ii) R3a and R both are CI- 6 alkyl; (iii) R a and R 3 b together are(CH 2 )f so as to form a spiro ring; (iv) R3a is hydrogen and R 3 b and R 2 together are (CH 2 )n so as to form a cyclic ring that includes the adjoining N and C atoms (v) R 3 b is 15 hydrogen and R and R2 together are (CH 2 )n so as to form a cyclic ring that includes the adjoining N and C atoms, where c is I to 6, d is 0 to 2, e is 0 to 3, f is 2 to 5, n is 2 to 4, and where R 3 is independently hydrogen or CI- 6 alkyl and R is -OR' or -N(R )2); (vi) R3a is H and R 3 b is H, CH 3 , CH 2
CH
3 , CH(CH 3
)
2 ,
CH
2
CH(CH
3
)
2 , CH(CH 3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, -CH 2
CH
2
SCH
3 , 20 CH 2
CO
2 H, CH 2
C(O)NH
2 , CH 2
CH
2 COOH, CH 2
CH
2
C(O)NH
2 ,
CH
2
CH
2
CH
2
CH
2
NH
2 , -CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl,
CH
2 OH, CH(OH)CH 3 , CH 2 ((4'-OH)-Ph), CH 2 SH, or lower cycloalkyl; or (viii) R3a is CH 3 , -CH 2
CH
3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 , CH(CH 3
)CH
2
CH
3 , CH 2 Ph,
CH
2 -indol-3-yl, -CH 2
CH
2
SCH
3 , CH 2
CO
2 H, CH 2
C(O)NH
2 , CH 2
CH
2 COOH, 25 CH 2
CH
2
C(O)NH
2 , CH 2
CH
2
CH
2
CH
2
NH
2 , -CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4'-OH)-Ph), CH 2 SH, or lower cycloalkyl and R 3 b is H, where R 3 is independently hydrogen or alkyl, which includes, but is not limited to, CI120 alkyl, CI 10 alkyl, or C 1
-
6 alkyl, Rr is -OR' or -N(R 3 )2); 30 (d) R 4 is hydrogen, CI.
10 alkyl, CI 10 alkyl optionally substituted with a lower alkyl, alkoxy, di(lower alkyl)-amino, or halogen, CI 10 haloalkyl, C 3
.
1 0 cycloalkyl, cycloalkyl alkyl, cycloheteroalkyl, aminoacyl, aryl, such as phenyl, heteroaryl, such as, pyridinyl, substituted aryl, or substituted heteroaryl; (e) R 5 is H, a lower alkyl, CN, vinyl, 0-(lower alkyl), hydroxyl lower alkyl, i.e., -(CH 2 )pOH, where p is 1 -6, including hydroxyl methyl (CH 2 OH), 5 CH 2 F, N 3 , CH 2 CN, CH 2
NH
2 , CH 2
NHCH
3 , CH 2
N(CH
3
)
2 , alkyne (optionally substituted), or halogen, including F, Cl, Br, or I, with the provisos that when X is OH. base is cytosine and R 6 is H, R 5 cannot be N 3 and when X is OH, R6 is
CH
3 or CH 2 F and B is a purine base, R 5 cannot be H; (f) R6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , F, or CN; 10 (g) X is H, OH, F, OMe, halogen, NH 2 , or N 3 ; (h) Y is OH, H, C 14 alkyl, C 2 4 alkenyl, C 2 4 alkynyl, vinyl, N 3 , CN, Cl, Br, F, I, NO 2 , OC(O)O(Ci 4 alkyl), OC(O)O(C.
4 alkyl), OC(O)O(C 2 4 alkynyl), OC(O)O(C 24 alkenyl), OCI 10 haloalkyl, O(aminoacyl), O(CI.io acyl),
O(C
14 alkyl), O(C 2 4 alkenyl), S(Ci 4 acyl), S(C.
4 alkyl), S(C 2 4 alkynyl), S(C 2 4 15 alkenyl), SO(C 14 acyl), SO(Ci 4 alkyl), SO(C 24 alkynyl), SO(C 24 alkenyl), S0 2
(C
1 4 acyl), SO 2
(CI
4 alkyl), SO 2
(C
24 alkynyl), SO 2
(C
24 alkenyl), OS(O) 2 (C. 4 acyl), OS(O) 2
(C,
4 alkyl), OS(O) 2
(C
24 alkenyl), NH 2 , NH(C 14 alkyl), NH(C 2 -4 alkenyl), NH(C 24 alkynyl), NH(C 14 acyl), N(C 14 alkyl) 2 , N(C 1 i 18 acyl) 2 , wherein alkyl, alkynyl, alkenyl and vinyl are optionally substituted by N 3 , CN, 20 one to three halogen (Cl, Br, F, I), NO 2 , C(O)O(CI 4 alkyl), C(O)O(C 1 4 alkyl),
C(O)C(C
24 alkynyl), C(O)O(C2 4 alkenyl), O(C 1 4 acyl), O(CI 4 alkyl), O(C 24 alkenyl), S(C 14 acyl), S(C 1 4 alkyl), S(C 24 alkynyl), S(C 2 4 alkenyl), SO(C 1 4 acyl), SO(CI 4 alkyl), SO(C 24 alkynyl), SO(C 24 alkenyl), S0 2
(CI
4 acyl), S0 2
(CI
4 alkyl), S0 2
(C
24 alkynyl), S0 2
(C
24 alkenyl), OS(O) 2
(C
1 4 acyl), 25 OS(O) 2 (Ci 4 alkyl), OS(0) 2
(C
2 4 alkenyl), NH 2 , NH(C 14 alkyl), N-I(C 24 alkenyl), NH(C 24 alkynyl), NH(C 14 acyl), N(C 1 4 alkyl) 2 , N(C 1 4 acyl) 2 ; the base is a naturally occurring or modified purine or pyrimidine base represented by the following structures:
R
9 - RIO 0
R
8 R8 zN R I N R8NH N NH
R
7 N O R 7 N 0 N N Ri 1 N N NH 2 _ I a b c d wherein Z is N or CR'12 5 R , R 8
,R
9 , RI4, and R"are independently H, F, Cl, Br, I, OH, OR', SH, SR', NH 2 , NHR', NR' 2 , lower alkyl of CI-C 6 , halogenated (F, Cl, Br, I) lower alkyl of Ci-C 6 , lower alkenyl of C 2
-C
6 , halogenated (F, Cl, Br, I) lower alkenyl of C 2
-C
6 , lower alkynyl of C 2
-C
6 such as C=CH, halogenated (F, Cl, Br, 1) lower alkynyl of C 2
-C
6 , lower alkoxy of CI-C 6 , halogenated (F, Cl, Br, I) lower alkoxy 10 of CI-C 6 , CO 2 H, CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or
CH=CHCO
2 R', wherein R' is an optionally substituted alkyl , which includes, but is not limited to, an optionally substituted CI- 20 alkyl, an optionally substituted CI.io alkyl, an optionally substituted lower alkyl; an optionally substituted cycloalkyl; 15 an optionally substituted alkynyl of C 2
-C
6 , an optionally substituted lower alkenyl of C 2
-C
6 , or optionally substituted acyl, which includes but is not limited to C(O) alkyl, C(O)(C- 2 0 alkyl), C(O)(CI-Io alkyl), or C(O)(lower alkyl) or alternatively, in the instance of NR' 2 , each R' comprise at least one C atom that are joined to form a heterocycle comprising at least two carbon atoms; and 20 R1 2 is H, halogen (including F, Cl, Br, I), OH, OR', SH, SR', NH 2 , NHR',
NR'
2 , NO 2 lower alkyl of Ci-C 6 , halogenated (F, Cl, Br, I) lower alkyl of C1-C 6 , lower alkenyl of C 2
-C
6 , halogenated (F, Cl, Br, I) lower alkenyl of C 2
-C
6 , lower alkynyl of C 2
-C
6 , halogenated (F, Cl, Br, I) lower alkynyl of C 2
-C
6 , lower alkoxy of Ci--C 6 , halogenated (F, Cl, Br, 1) lower alkoxy of Ci-C 6 , CO 2 H, CO 2 R', 25 CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or CH=CHCO 2 R'; with the proviso '1 2 that when base is represented by the structure c with R" being hydrogen, R 2 is not a: (i) -C-C-H, (ii) -C=CH 2 , or (iii) -NO 2 . As can be appreciated from the structure represented by formula I above, there are myriad ways to express the several embodiments and aspects of each 5 embodiment of the present invention. As seen below, the inventors have disclosed certain embodiments directed to the compound of formula I, each having several aspects, based on the identity of the modified purine or pyrimidine base. This is not intended to be an explicit or implicit admission that the three embodiments are independent or distinct nor should it be interpreted as 10 such. Rather, it is intended to convey information so that the full breadth of the present invention can be understood. Furthermore, the following embodiments, and aspects thereof, are not meant to be limiting on the full breadth of the invention as recited by the structure of formula I. A first embodiment of the invention is directed to a compound 15 represented by formula I-1: R9 R8 N R7 N 0 R2 0 R3b R3a N-P* O C0 2
R
4 OR' R5 R6 Y X I-1 wherein (a) R' is hydrogen, n-alkyl; branched alkyl; cycloalkyl; or aryl, which 20 includes, but is not limited to, phenyl or naphthyl, where phenyl or naphthyl are optionally substituted with at least one of CI.
6 alkyl, C 2 -6 alkenyl, C 2
-
6 alkynyl,
C
1
.
6 alkoxy, F, Cl, Br, I, nitro, cyano, C 1 -6 haloalkyl, -N(R') 2 , CI.
6 acylamino, NHSO 2 CI-6 alkyl, -SO 2
N(R")
2 , COR'", and -SO 2
CI-
6 alkyl; (R" is independently hydrogen or alkyl, which includes, but is not limited to, CI- 20 alkyl, CI.- 0 alkyl, 5 or C 1 ., alkyl, Rr is -OR' or -N(R )2); (b) R2 is hydrogen, C 1-1o alkyl, R 3 a or R 3 b and R 2 together are (CH 2 )n so as to form a cyclic ring that includes the adjoining N and C atoms,
C(O)CR
3 aR 3 NHRI, where n is 2 to 4 and R', R 3 a, and R 3 b; (c) R 3 a and R 3 b are (i) independently selected from hydrogen, C 1
.
10 10 alkyl, cycloalkyl, -(CH 2 )c(NR 3
)
2 , CI- 6 hydroxyalkyl, -CH 2 SH, -(CH 2
)
2 S(O)dMe, (CH 2 ).3NHC(=NH)NH 2 , (1 H-indol-3-yl)methyl, (1 H-imidazol-4-yl)methyl, (CH 2 )cCOR 3 , aryl and aryl C 1
.
3 alkyl, said aryl groups optionally substituted with a group selected from hydroxyl, C 1 .i 0 alkyl, CI- 6 alkoxy, halogen, nitro and cyano; (ii) R3a and R 3 b both are Ci.
6 alkyl; (iii) R 3 a and R 3 b together are(CH 2 )f so 15 as to form a spiro ring; (iv) R 3 a is hydrogen and R 3 b and R 2 together are (CH 2 )n so as to form a cyclic ring that includes the adjoining N and C atoms (v) R 3 b is hydrogen and R3a and R 2 together are (CH 2 )n so as to form a cyclic ring that includes the adjoining N and C atoms, where c is 1 to 6, d is 0 to 2, e is 0 to 3, f is 2 to 5, n is 2 to 4, and where R 3 is independently hydrogen or C1- 6 alkyl and 20 R is -OR' or -N(R )2); (vi) R3a is H and R is H, CH 3 , CH 2
CH
3 , CH(CH 3
)
2 ,
CH
2
CH(CH
3
)
2 , CH(CH 3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, -CH 2
CH
2
SCH
3 ,
CH
2
CO
2 H, CH 2
C(O)NH
2 , CH 2
CH
2 COOH, CH 2
CH
2 C(0)NH 2 ,
CH
2 C H 2
CH
2
CH
2
NH
2 , -CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl,
CH
2 OH, CH(OH)CH 3 , CH 2 ((4'-OH)-Ph), CH 2 SH, or lower cycloalkyl; or (viii) 25 R3a is CH 3 , -CH 2
CH
3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 , CH(CH 3
)CH
2
CH
3 , CH 2 Ph,
CH
2 -indol-3-yl, -CH 2
CH
2
SCH
3 , CH 2
CO
2 H, CH 2
C(O)NH
2 , CH 2
CH
2 COOH,
CH
2
CH
2
C(O)NH
2 , CH 2
CH
2
CH
2
CH
2
NH
2 , -CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4'-OH)-Ph), CH 2 SH, or lower cycloalkyl and R is H, where R 3 is independently hydrogen or alkyl, which 30 includes, but is not limited to, CI- 2 0 alkyl, CI.
10 alkyl, or CI- 6 alkyl, R 3 is -OR' or -N(R 3)2); (d) R 4 is hydrogen, CI.io alkyl, CI.io alkyl optionally substituted with a lower alkyl, alkoxy, di(lower alkyl)-amino, or halogen, CI.
10 haloalkyl, C 3
.
10 cycloalkyl, cycloalkyl alkyl, cycloheteroalkyl, aminoacyl, di(lower alkyl)-anino, aryl, such as phenyl, heteroaryl, such as, pyridinyl, substituted aryl, or 5 substituted heteroaryl; (e) R 5 is H, a lower alkyl, CN, vinyl, O-(lower alkyl), hydroxyl lower alkyl, i.e., -(CH 2 )pOH, where p is 1 -6, including hydroxyl methyl (CH 2 OH),
CH
2 F, N 3 , CH 2 CN, CH 2
NH
2 , CH 2
NHCH
3 , CH 2
N(CH
3
)
2 , alkyne (optionally substituted), or halogen, including F, Cl, Br, or I, with the provisos that when X 10 is OH, base is cytosine and R 6 is H, R 5 cannot be N 3 and when X is OH, R 6 is
CH
3 or CH 2 F and B is a purine base, R 5 cannot be H; (f) R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , F, or CN; (g) X is H, OH, F, OMe, Cl, Br, I, NH 2 , or N 3 ; (h) Y is OH, H, C1.4 alkyl, C 2
.
4 alkenyl, C 2 -4 alkynyl, vinyl, N 3 , CN, 15 Cl, Br, F, I, NO 2 , OC(O)O(C 14 alkyl), OC(O)O(CI.4 alkyl), OC(0)O(C 24 alkynyl), OC(O)O(C 2 4 alkenyl), OCI.
10 haloalkyl, O(aminoacyl), O(CI-jo acyl), O(CI.4 alkyl), O(C 2 .4 alkenyl), S(Ci.4 acyl), S(Ci.4 alkyl), S(C 2 -4 alkynyl), S(C 2 4 alkenyl), SO(CI-4 acyl), SO(CI.4 alkyl), SO(C 2 4 alkynyl), SO(C 2 -4 alkenyl), S0 2 (Ci.4 acyl), S0 2 (CI.4 alkyl), S0 2
(C
2 4 alkynyl), S0 2
(C
2 4 alkenyl), OS(O) 2 (Ci. 20 4 acyl), OS(O) 2 (Ci4 alkyl), OS(O) 2
(C
24 alkenyl), NH 2 , NH(CI.4 alkyl), NH(C 2 -4 alkenyl), NH(C 2 -4 alkynyl), NH(C 14 acyl), N(CI.4 alkyl) 2 , N(CI.
18 acyl)2, wherein alkyl, alkynyl, alkenyl and vinyl are optionally substituted by N 3 , CN, one to three halogen (Cl, Br, F, I), NO 2 , C(O)O(CI. alkyl), C(O)O(Ci4 alkyl),
C(O)O(C
2 4 alkynyl), C(O)O(C 2 4 alkenyl), O(CI.4 acyl), O(CI 4 alkyl), O(C 2 4 25 alkenyl), S(CIA acyl), S(C1.4 alkyl), S(C 24 alkynyl), S(C 2 .4 alkenyl), SO(CI.4 acyl), SO(C 14 alkyl), SO(C 24 alkynyl), SO(C 2 .4 alkenyl), S0 2 (Ci.4 acyl),
SO
2 (C .
4 alkyl), SO 2
(C
2 .4 alkynyl), SO 2
(C
24 alkenyl), OS(O) 2 (Ci.4 acyl),
OS(O)
2 (Ci4 alkyl), OS(O) 2
(C
2 .4 alkenyl), NH 2 , NH(Ci.4 alkyl), NH(C 2 -4 alkenyl), NH(C 2 4 alkynyl), NH(Ci.4 acyl), N(C 14 alkyl) 2 , N(Ci4 acyl)2; 30 (i) R', R',R 9 are independently H, F, Cl, Br, I, OH, OR', SH, SR',
NH
2 , NHR', NR' 2 , lower alkyl, halogenated (F, Cl, Br, I) lower alkyl, lower alkenyl of C 2
-C
6 , CO 2 H, CO 2 R', CONH 2 , CONHR', CONR' 2 , wherein R' is a C1. 20 alkyl; a CI- 2 0 cycloalkyl; a C 2
-C
6 alkenyl, a C 2
-C
6 alkynyl. A first aspect of the first embodiment is directed to a compound represented by formula 1-1 5 wherein (a) R' is hydrogen, n-alkyl or aryl, which includes, but is not limited to, phenyl or naphthyl, where phenyl or naphthyl are optionally substituted with at least one of C 1 .6 alkyl, C 1
-
6 alkoxy, F, Cl, Br, I, nitro, cyano, C 1 -6 haloalkyl; (b) R 2 is hydrogen or CH 3 ; 10 (c) R 3 a and R 3 b are independently (i) R 3 a is hydrogen and R 3 b and R 2 together are (CH 2 )n so as to form a cyclic ring that includes the adjoining N and C atoms (v) R is hydrogen and R 3 a and R 2 together are (CH 2 )n so as to form a cyclic ring that includes the adjoining N and C atoms, where c is 1 to 6, d is 0 to 2, e is 0 to 3, f is 3 to 5, n is 2 to 4, and where R 3 is independently hydrogen or 15 CI- 6 alkyl and R 3 is -OR' or -N(R 3
)
2 ); (vi) R a is H and R 3 1 is H, CH 3 ,
CH(CH
3
)
2 , CH 2
CH(CH
3
)
2 , CH(CH 3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, CH 2
CH
2
SCH
3 , CH 2
CO
2 H, CH 2
C(O)NH
2 , CH 2
CH
2 COOH, CH 2
CH
2 C(0)NH 2 ,
CH
2
CH
2
CH
2
CH
2
NH
2 , -CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl,
CH
2 OH-, CH(OH)CH 3 , CH 2 ((4'-OH)-Ph), CH 2 SH, or lower cycloalkyl; or (viii) 20 R 3 a is CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 , CH(CH 3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3 yl, -CH 2
CH
2
SCH
3 , CH 2
CO
2 H, CH 2
C(O)NH
2 , CH 2
CH
2 COOH,
CH
2
CH
2
C(O)NH
2 , CH 2
CH
2
CH
2
CH
2
NH
2 , -CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4'-OH)-Ph), or CH 2 SH and R 3 b is H; (d) R 4 is hydrogen, CI 10 alkyl, C 1
-
1 0 alkyl optionally substituted with 25 a lower alkyl, alkoxy, di(lower alkyl)-amino, or halogen, C 1
.
1 0 haloalkyl, C 3
.
1 0 cycloalkyl, cycloalkyl alkyl, cycloheteroalkyl, aminoacyl, aryl, such as phenyl, heteroaryl, such as, pyridinyl, substituted aryl, or substituted heteroaryl; (e) R 5 is H, CN, CH 3 , vinyl, OCH 3 , OCH 2
CH
3 , CH 2 OH, CH 2 (halo), such as CH 2 F, N 3 , CH 2 CN, CH 2
N
3 , CH 2
NH
2 , CH 2
NHCH
3 , CH 2
N(CH
3
)
2
,
halogen, including F, Cl, Br, or I, with the provisos that when X is OH , base is cytosine and R 6 is H, R 5 cannot be N 3 ; (f) R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , F, or CN; (g) X is H, OH, F, OMe, Cl, Br, I, NH 2 , or N 3 ; 5 (h) Y is OH, H, C 14 alkyl, vinyl, N 3 , CN, Cl, Br, F, I, O(C 1 - acyl),
O(C
1 4 alkyl), NH 2 , NH(C 14 alkyl), NH(C24 alkenyl), NH(C24 alkynyl), NH(C 14 acyl), N(CI 4 alkyl) 2 , N(C 1
I
18 acyl) 2 , wherein alkyl, alkynyl, alkenyl and vinyl are optionally substituted by N 3 , CN, one to three halogen (Cl, Br, F, I), NO 2 ,
OC(O)O(CI
4 alkyl), OC(O)O(C 1 4 alkyl), OC(O)O(C 2 4 alkynyl), OC(O)O(C24 10 alkenyl), OC 1 4 haloalkyl, O(aminoacyl), O(CI 4 acyl), O(C 14 alkyl), O(C 24 alkenyl), S(C 1 4 acyl), S(C 14 alkyl), S(C 24 alkynyl), S(C 2 4 alkenyl), SO(C 14 acyl), SO(CIA alkyl), SO(C 24 alkynyl), SO(C 24 alkenyl), SO2(CI4 acyl),
SO
2 (C 1 alkyl), SO2(C24 alkynyl), S0 2
(C
24 alkenyl), OS(O)2(CI1 acyl),
OS(O)
2 (C 14 alkyl), OS(0)2(C24 alkenyl), NH 2 , NH(C 1 alkyl), NH(C 2 4 15 alkenyl), NH(C 2 4 alkynyl), NH(C1- acyl), N(C 14 alkyl) 2 , or N(CA acyl) 2 ; (i) R', R ,R' are independently H, F, Cl, Br, I, OH, OR', SH, SR',
NH
2 , NHR', NR' 2 , lower alkyl, halogenated (F, Cl, Br, I) lower alkyl, lower alkenyl of C 2
-C
6 , CO 2 H, CO 2 R', CONH 2 , CONHR', CONR' 2 , wherein R' is a Cl. 20 alkyl; a CI- 20 cycloalkyl; a C 2
-C
6 alkenyl, a C 2
-C
6 alkynyl. 20 A second aspect of the first embodiment is directed to a compound represented by formula I-1 wherein (a) R' is hydrogen, n-alkyl or a substituted or unsubstituted phenyl, where the substitutent of the substituted phenyl is at least one of a C 1
.
3 alkyl, a 25 C 1
.
3 alkoxy, F, Cl, Br, I, nitro, cyano, and a C 1
.
3 haloalkyl; (b) R2 is hydrogen or CH 3 ; (c) R 3 a and R 3 b are independently (i) R 3 a is hydrogen and R 3 b and R 2 together are (CH 2 )n so as to form a cyclic ring that includes the adjoining N and C atoms (v) R 3 b is hydrogen and R 3 a and R 2 together are (CH 2 )n so as to form a cyclic ring that includes the adjoining N and C atoms, where c is 1 to 6, d is 0 to 2, e is 0 to 3, f is 3 to 5, n is 2 to 4, and where R 3 is independently hydrogen or
C
1
-
6 alkyl and R 3 is -OR' or -N(R 3
)
2 ); (vi) R 3 a is H and R 3 b is H, CH 3 , 5 CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 , CH(CH 3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, CH 2
CH
2
SCH
3 , CH 2
CO
2 H, CH 2
C(O)NH
2 , CH 2
CH
2 COOH, CH 2
CH
2
C(O)NH
2 ,
CH
2
CH
2
CH
2
CH
2
NH
2 , -CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl,
CH
2 OH, CH(OH)CH 3 , CH 2 ((4'-OH)-Ph), CH 2 SH, or lower cycloalkyl; or (viii) R3a is CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 , CH(CH 3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3 10 yl, -CH 2
CH
2
SCH
3 , CH 2
CO
2 H, CH 2
C(O)NH
2 , CH 2
CH
2 COOH,
CH
2
CH
2
C(O)NH
2 , CH 2
CH
2
CH
2
CH
2
NH
2 , -CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4'-OH)-Ph), or CH 2 SH and R 3 b is H; (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N 15 methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N methyl-piperidin-4-yl, lower haloalkyl, di(lower alkyl)amino-lower alkyl, or aminoacyl; (e) R 5 is H, CN, CR 3 , OCH 3 , CH 2 OH, CH 2 (halo), such as CH 2 F, N 3 ,
CH
2 CN, CH 2
N
3 , CH 2
NH
2 , CH 2
NHCH
3 , CH 2
N(CH
3
)
2 , halogen, including F, Cl, 20 Br, or I, with the provisos that when X is OH , base is cytosine and R 6 is H, R 5 cannot be N 3 ; (f) R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , F, or CN; (g) X is H, OH, F, OCH 3 , NH 2 , or N 3 ; (h) Y is OH, H, CH 3 , vinyl, N 3 , CN, Cl, Br, F, I, OC(O)CH 3 , OCH 3 , 25 NH 2 , NHCH 3 , NH(vinyl), NH(acetyl), NH(C(O)CH 3 ), N(CH 3
)
2 , N(C(O)CH 3
)
2 , or O(aminoacyl); (i) R 7 and R 8 are independently H, F, Cl, Br, I, OH, OCH 3 , SH,
SCH
3 , NH 2 , NHCH 3 , N(CH 3
)
2 , CH 3 , CH3.qXq, where X is F, Cl, Br, or I and q is 1 to 3, vinyl, CO 2 H, CO 2
CH
3 , CONH 2 , CONHCH 3 , or CON(CH 3
)
2 ; and (j) R 9 is selected from among OH, OCH 3 , SH, SCH 3 , NH 2 , NHCH 3 ,
N(CH
3
)
2 , OC(O)(C1-20 alkyl), which include but are not limited to
OC(O)(CH
2 )sCH 3 , NHC(O)(C 1-20 alkyl), which include but are not limited to
NHC(O)(CH
2 )sCH 3 , and N(C(O)(CH 2 )sCH 3
)
2 , which include but is not limited to 5 N(C(O)(CH 2 )sCH 3
)
2 , where s is an integer selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9,10,11, 12,13, 14,15,16,17, 18, and 19. A third aspect of the first embodiment is directed to a compound represented by formula I-1 wherein 10 (a) R' is hydrogen, n-alkyl or a substituted or unsubstituted phenyl, where the substitutent of the substituted phenyl is at least one of a CH 3 , OCH 3 , F, Cl, Br, I, nitro, cyano, and a CH3.gXq, where X is F, Cl, Br, or I, and q is 1-3; (b) R2 is hydrogen or CH 3 ; (c) R3a is H and R is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 , 15 CH(CH 3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, -CH 2
CH
2
SCH
3 , CH 2
CO
2 H,
CH
2
C(O)NH
2 , CH 2
CH
2 COOH, CH 2
CH
2
C(O)NH
2 , CH 2
CH
2
CH
2
CH
2
NH
2 , CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4' OH)-Ph), CH 2 SH, or lower cycloalkyl or R 3 " is CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, -CH 2
CH
2
SCH
3 , CH 2
CO
2 H, 20 CH 2
C(O)NH
2 , CH 2
CH
2 COOH, CH 2
CH
2
C(O)NH
2 , CH 2
CH
2
CH
2
CH
2
NH
2 , CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4' OH)-Ph), CH 2 SH, or lower cycloalkyl and R 3 b is H; (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N 25 methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, lower haloalkyl, di(lower alkyl)amino-lower alkyl, or aminoacyl; (e) R 5 is H, CN, CH 3 , OCH 3 , CH 2 OH, CH 2 (halo), such as CH 2 F, N 3 ,
CH
2 CN, CH 2
N
3 , CH 2
NH
2 , CH 2
NHCH
3 , CH 2
N(CH
3
)
2 , halogen, including F, Cl, Br, or I, with the provisos that when X is OH , base is cytosine and R6 is H, R 5 cannot be N 3 ; (f) R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , F, or CN; (g) X is H, OH, F, OCH 3 , NH 2 , or N 3 ; 5 (h) Y is OH, H, CH 3 , vinyl, N 3 , CN, Cl, Br, F, I, OC(O)CH 3 , OCH 3 ,
NH
2 , NHCH 3 , NH(vinyl), NH(acetyl), NH(C(O)CH 3 ), N(CH 3
)
2 , N(C(O)CH 3
)
2 , or O(aminoacyl); (i) R 7 and R 8 are independently H, F, Cl, Br, I, OH, OCH 3 , SH,
SCH
3 , NH 2 , NHCH 3 , N(CH 3
)
2 , CH 3 , CH3.qXq, where X is F, Cl, Br, or I and q is 10 1 to 3, vinyl, CO 2 H, CO 2
CH
3 , CONH 2 , CONHCH 3 , or CON(CH 3
)
2 , wherein R' is a C 1
-
20 alkyl; a C 1
-
20 cycloalkyl; a C 2
-C
6 alkenyl, a C 2
-C
6 alkynyl'; and (j) R 9 is selected from among OH, OCH 3 , SH, SCH 3 , NH 2 , NHCH 3 ,
N(CH
3
)
2 , OC(O)(C1-20 alkyl), which include but are not limited to
OC(O)(CH
2 )sCH 3 , NHC(O)(C1-20 alkyl), which include but are not limited to 15 NHC(O)(CH 2 )sCH 3 , and N(C(O)(CH 2 )sCH 3
)
2 , which include but is not limited to
N(C(O)(CH
2 )sCH 3
)
2 , where s is an integer selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, and 19. A fourth aspect of the first embodiment is directed to a compound represented by formula 1-2
R
9
R
8 N R7 N 0 R2 0 R3b I P0* 0 R3a N-P* OO C0 2
R
4 OR' R R6 Y X 1-2 wherein (a) R1 is hydrogen, methyl, ethyl, n-propyl, i-propyl, or a substituted 5 or unsubstituted phenyl, where the substitutent of the substituted phenyl is at least one of a CH 3 , OCH 3 , F, Cl, Br, I, nitro, cyano, and a CH3.qXq, where X is F, Cl, Br, or I, and q is 1-3; (b) R 2 is hydrogen or CH 3 ; (c) R3a is H and R is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 , 10 CH(CH 3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, -CH 2
CH
2
SCH
3 , CH 2
CO
2 H,
CH
2
C(O)NH
2 , CH 2
CH
2 COOH, CH 2
CH
2
C(O)NH
2 , CH 2
CH
2
CH
2
CH
2
NH
2 , CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4' OH)-Ph), CH 2 SH, or lower cycloalkyl or R 3 a is CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, -CH 2
CH
2
SCH
3 , CH 2
CO
2 H, 15 CH 2
C(O)NH
2 , CH 2
CH
2 COOH, CH 2
CH
2
C(O)NH
2 , CH 2
CH
2
CH
2
CH
2
NH
2 , CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4' OH)-Ph), CH 2 SH, or lower cycloalkyl and R 3 b is H; (d) R 4 is hydrogen, CI.io alkyl, CI-io alkyl optionally substituted with a lower alkyl, alkoxy or halogen, C1.10 haloalkyl, C 3
.
10 cycloalkyl, cycloalkyl 20 alkyl, cycloheteroalkyl, aminoacyl, di(lower alkyl)amino-lower alkyl, aryl, such 111%.
as phenyl, heteroaryl, such as, pyridinyl, substituted aryl, or substituted heteroaryl; (e) R 5 is H, CN, CH 3 , OCH 3 , CH 2 OH, CH 2 F, N 3 , CH 2 CN, CH 2
N
3 ,
CH
2
NH
2 , CH 2
NHCH
3 , CH 2
N(CH
3
)
2 , halogen, including F, Cl, Br, or I, with the 5 provisos that when X is OH , base is cytosine and R6 is H, R cannot be N 3 ; (f) R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , F, or CN; (g) X is H, OH, F, OCH 3 , Cl, Br, I, NH 2 , or N 3 ; (h) Y is OH, H, CH 3 , vinyl, N 3 , CN, Cl, Br, F, I, OC(O)CH 3 , OCH 3 ,
NH
2 , NHCH 3 , NH(vinyl), NH(acetyl), NH(C(O)CH 3 ), N(CH 3
)
2 , N(C(O)CH 3
)
2 , 10 or O(aminoacyl); (i) R 7 and R 8 are independently H, F, Cl, Br, I, OH, OCH 3 , SH,
SCH
3 , NH 2 , NHCH 3 , N(CH 3
)
2 , CH 3 , CH3.qXq, where X is F, Cl, Br, or I and q is 1 to 3, vinyl, CO 2 H, CO 2
CH
3 , CONH 2 , CONHCH 3 , or CON(CH 3
)
2 , wherein R' is a C 1
-
20 alkyl; a C 1
-
20 cycloalkyl; a C 2
-C
6 alkenyl, a C 2
-C
6 alkynyl; and 15 (j) R 9 is selected from among OH, OCH 3 , SH, SCH 3 , NH 2 , NHCH 3 ,
N(CH
3
)
2 , OC(O)(C1-20 alkyl), which include but are not limited to
OC(O)(CH
2 )sCH 3 , NHC(O)(C 1-20 alkyl), which include but are not limited to
NHC(O)(CH
2 )sCH 3 , and and N(C(O)(CH 2 )sCH 3 , which include but is not limited to N(C(O)(CH 2 )sCH 3
)
2 , where s is an integer selected from 0, 1, 2, 3, 4, 5, 6, 7, 20 8, 9, 1.0, 11, 12, 13, 14, 15, 16, 17, 18, and 19. A fifth aspect of the first embodiment is directed to a compound represented by formula 1-2 wherein (a) R 1 is hydrogen, methyl, ethyl, n-propyl, i-propyl, phenyl, p-tolyl, 25 p-bromo-phenyl, p-chloro-phenyl, p-fluorophenyl; (b) R 2 is hydrogen or CH 3
;
(c) R 3 , is H and R 3 b is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, -CH 2
CH
2
SCH
3 , CH 2
CO
2 H,
CH
2
C(O)NH
2 , CH 2
CH
2 COOH, CH 2
CH
2
C(O)NH
2 , CH 2
CH
2
CH
2
CH
2
NH
2 , CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4' 5 OH)-Ph), CH 2 SH, or lower cycloalkyl; (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, lower haloalkyl, di(lower alkyl)amino-lower alkyl, or aminoacyl; 10 (e) R 5 is H, CN, CH 3 , OCH 3 , CH 2 OH, CH 2 F, halogen, including F, Cl, Br, or I; (f) R6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , F, or CN; (g) X is H, OH, F, OCH 3 , NH 2 , or N 3 ; (h) Y is OH, H, CH 3 , vinyl, N 3 , CN, Cl, Br, F, I, OC(O)CH 3 , OCH 3 , 15 or O(aminoacyl); (i) R 7 and R 8 are independently H, F, Cl, Br, I, OH, OCH 3 , SH,
SCH
3 . NH 2 , NHCH 3 , N(CH 3
)
2 , CH 3 , CH3.gXq, where X is F, Cl, Br, or I and q is 1 to 3. vinyl, CO 2 H, C0 2
CH
3 , CONH 2 , CONHCH 3 , or CON(CH 3
)
2 , wherein R' is a C 1
-
2 0 alkyl; a C 1
-
2 0 cycloalkyl; a C 2
-C
6 alkenyl, a C 2
-C
6 alkynyl; and 20 () R 9 is selected from among OH, OCH 3 , SH, SCH 3 , NH 2 , NHCH 3 ,
N(CH
3
)
2 , OC(O)(Ci.
2 0 alkyl), which include but are not limited to
OC(O)(CH
2 )sCH 3 , NHC(O)(CI- 2 0 alkyl), which include but are not limited to
NHC(O)(CH
2 )sCH 3 , and N(C(O)(CH 2 )sCH 3
)
2 , which include but is not limited to
N(C(O)(CH
2 )sCH 3
)
2 , where s is an integer selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 25 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, and 19. A sixth aspect of the first embodiment is directed to a compound represented by formula 1-2 wherein I A (a) R' is hydrogen, methyl, ethyl, n-propyl, i-propyl, phenyl, p-tolyl, p-bromo-phenyl, p-chloro-phenyl, p-fluorophenyl; (b) R2 is hydrogen or CH 3 ; (c) R 3 , is H and R 3 b is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 , 5 CH(CH 3
)CH
2
CH
3 , CH 2 Ph, or lower cycloalkyl; (d) R 4 is hydrogen, C 1
.
10 alkyl, C 1 .Io alkyl optionally substituted with a lower alkyl, alkoxy or halogen, CI- 10 haloalkyl, C 3
.
10 cycloalkyl, cycloalkyl alkyl, cycloheteroalkyl, aminoacyl, di(lower alkyl)amino-lower alkyl, aryl, such as phenyl, heteroaryl, such as, pyridinyl, substituted aryl, or substituted 10 heteroaryl; (e) R 5 is H, OMe, CN, CH 2 F, F, Cl, Br, or I; (f) R is H, CH 3 , C.1 2 F, CHF 2 , CF 3 , or F; (g) X is H, OH, F, OCH 3 , F, Cl, Br, I, or N 3 ; (h) Y is H, OH, CH 3 , F, Cl, Br, I, or N 3 , OCH 3 , OC(O)CH 3 , or 15 O(aminoacyl); (i) R and R8 are independently H, F, Br, SCH 3 , CH 3 , CH3.qXq, where X is F, Cl, Br, or I and q is 1 to 3, vinyl, CO 2
CH
3 , CONH 2 , CONHCH 3 , or
CON(CH
3
)
2 ; and (j) R 9 is selected from among OH, OCH 3 , SH, SCH 3 , NH 2 , NHCH 3 , 20 N(CH 3
)
2 , OC(O)(CI- 2 0 alkyl), which include but are not limited to
OC(O)(CH
2 )sCH 3 , NHC(O)(CI 2 0 alkyl), which include but are not limited to
NHC(O)(CH
2 )sCH 3 , and N(C(O)(CH 2 )sCH 3
)
2 , which include but is not limited to
N(C(C))(CH
2 )sCH 3
)
2 , where s is an integer selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, and 19. 25 A seventh aspect of the first embodiment is directed to a compound represented by formula 1-2 wherein (a) R' is hydrogen, methyl, ethyl, n-propyl, i-propyl, phenyl, p-tolyl, p-brorno-phenyl, p-chloro-phenyl, p-fluorophenyl; (b) R2 is hydrogen; (c) R 3 a is H and R 3 1 is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 , 5 CH(CH 3
)CH
2
CH
3 , CH 2 Ph, or lower cycloalkyl; (d) R4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; 10 (e) R 5 is H; (f) R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , or F; (g) X is H, OH, OCH 3 , F, or N 3 ; (h) Y is OH, OCH 3 , OC(O)CH 3 , or O(aminoacyl); (i) R 7 and R 8 are independently H, F, Br, SCH 3 , CH 3 , CH3.qX, 15 where X is F, Cl, Br, or I and q is I to 3, vinyl, CO 2
CH
3 , CONH 2 , CONHCH 3 , or
CON(CH
3
)
2 ; and (j) R 9 is selected from among OH, OCH 3 , NH- 2 , NHCH 3 , N(CH 3
)
2 , OC(O)(Ci- 2 0 alkyl), which include but are not limited to OC(O)(CH 2 )sCH 3 ,
NHC(O)(CI-
2 0 alkyl), which include but are not limited to NHC(O)(CH 2 )sCH 3 , 20 and N(C(O)(CH 2 )sCH 3
)
2 , which include but is not limited to
N(C(O)(CH
2 )sCH 3
)
2 , where s is an integer selected from among 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, and 19. An eighth aspect of the first embodiment is directed to a compound represented by formula 1-2 25 wherein (a) R' is hydrogen, methyl, phenyl, p-bromo-phenyl, p-chloro phenyl, p-fluorophenyl; (b) R 2 is hydrogen; (c) R 3 is H and R 3 b is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, or lower cycloalkyl; (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, 5 cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; (e) R 5 is H; (f) R is H, CH 3 , CH 2 F, CHF 2 , CF 3 , or F; 10 (g) X is H, OH, OCH 3 , F, or N 3 ; (h) Y is OH, OCH 3 , OC(O)CH 3 , or O(aminoacyl); (i) R 7 and R 8 are independently H, F, Br, SCH 3 , CH 3 , CH3.qXq, where X is F, Cl, Br, or I and q is I to 3, vinyl, CO 2
CH
3 , CONH 2 , CONHCH 3 , or
CON(CH
3
)
2 ; 15 (j) R 9 is selected from among OH, OCH 3 , NH 2 , NHCH 3 , N(CH 3
)
2 ,
OC(O)(CI-
2 0 alkyl), which include but are not limited to OC(O)(CH 2 )sCH 3 ,
NHC(O)(C
20 alkyl), which include but are not limited to NHC(O)(CH 2 )sCH 3 , and N(C(O)(CH 2 )sCH 3
)
2 , which include but is not limited to
N(C(O)(CH
2 )sCH 3
)
2 , where s is an integer selected from among 0, 1, 2, 3, 4, 5, 6, 20 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, and 19. A second embodiment of the invention is directed to a compound represented by formula I in which the base is a structure represented by formula b above, wherein R1, R2, R3, R 3, R4, R5, R6, X, Y, R7, and R 8 are defined in the Summary of the Invention section above. 25 A first aspect of the second embodiment is directed to a compound represented by formula 1-3 0
R
8 2 0NH
R
3 b R O 0R7 N O R3a N - 0 C0 2
R
4 OR' R5
R
6 Y X 1-3 wherein (a) R 1 is hydrogen, n-alkyl; branched alkyl; cycloalkyl; or aryl, which 5 includes, but is not limited to, phenyl or naphthyl, where phenyl or naphthyl are optionally substituted with at least one of C1- 6 alkyl, C 2 -6 alkenyl, C 2
-
6 alkynyl,
CI.
6 alkoxy, F, Cl, Br, I, nitro, cyano, CI- 6 haloalkyl, -N(R') 2 , C 1
-
6 acylamino, NHSO 2 CI.6 alkyl, -SO 2 N(Rl') 2 , COR"', and -S0 2
CI.
6 alkyl; (R" is independently hydrogen or alkyl, which includes, but is not limited to, CI-20 alkyl, CI-io alkyl, 10 or C1.
6 alkyl, R' is -OR' or -N(R 1)2); (b) R2 is hydrogen or CH 3 ; (c) R 3 a and R 3 b are (i) independently selected from hydrogen, CI.Io alkyl, cycloalkyl, -(CH 2 )c(NR 3
)
2 , CI.
6 hydroxyalkyl, -CH 2 SH, -(CH 2
)
2 S(O)dMe, (CH 2
)-NHC(=NH)NH
2 , (1 H-indol-3-yl)methyl, (1 H-imidazol-4-yl)methyl, 15 (CH 2 )eCORr, aryl and aryl C,.
3 alkyl, said aryl groups optionally substituted with a group selected from hydroxyl, CI.o alkyl, C,.
6 alkoxy, halogen, nitro and cyano; (ii) R3a and R both are C,- 6 alkyl; (iii) R3a and R together are(CH 2 )r so as to form a spiro ring; (iv) R 3 a is hydrogen and R 3 b and R2 together are (CH 2 )n so as to form a cyclic ring that includes the adjoining N and C atoms (v) R 3b is 20 hydrogen and R 3 a and R 2 together are (CH 2 )n so as to form a cyclic ring that includes the adjoining N and C atoms, where c is 1 to 6, d is 0 to 2, e is 0 to 3, f is 2 to 5, n is 2 to 4, and where R 3 is independently hydrogen or C1.
6 alkyl and
R
3 is -- OR' or -N(R 3
)
2 ); (vi) R 3a is H and RWb is H, CH 3 , CH 2
CH
3 , CH(CH 3
)
2 , 12 Q
CH
2
CH(CH
3
)
2 , CH(CH 3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, -CH 2
CH
2
SCH
3 ,
CH
2
CO
2 H, CH 2
C(O)NH
2 , CH 2
CH
2 COOH, CH 2
CH
2
C(O)NH
2 ,
CH
2
CH
2
CH
2
CH
2
NH
2 , -CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl,
CH
2 OH, CH(OH)CH 3 , CH 2 ((4'-OH)-Ph), CH 2 SH, or lower cycloalkyl; or (viii) 5 R 3 a is CH 3 , -CH 2
CH
3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 , CH(CH 3
)CH
2
CH
3 , CH 2 Ph,
CH
2 -indol-3-yl, -CH 2
CH
2
SCH
3 , CH 2
CO
2 H, CH 2
C(O)NH
2 , CH 2
CH
2 COOH,
CH
2
CH
2
C(O)NH
2 , CH 2
CH
2
CH
2
CH
2
NH
2 , -CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4'-OH)-Ph), CH 2 SH, or lower cycloalkyl and R is H, where R 3 is independently hydrogen or alkyl, which 10 includes, but is not limited to, Ci- 20 alkyl, C 1
.
1 0 alkyl, or CI- 6 alkyl, R 3 is -OR' or
-N(R
3 )2); (d) R 4 is hydrogen, C 1
.
1 0 alkyl, Cl.
10 alkyl optionally substituted with a lower alkyl, alkoxy or halogen, CI.
1 0 haloalkyl, C 3
.
10 cycloalkyl, cycloalkyl alkyl, cycloheteroalkyl, aminoacyl, di(lower alkyl)amino-lower alkyl, aryl, such 15 as phenyl, heteroaryl, such as, pyridinyl, substituted aryl, or substituted heteroaryl; (e) R 5 is H, a lower alkyl, CN, vinyl, 0-(lower alkyl), hydroxyl lower alkyl, i.e., -(CH 2 )pOH, where p is 1 -6, including hydroxyl methyl (CH 2 OH),
CH
2 F, N 3 , CH 2 CN, CH 2
NH
2 , CH 2
NHCH
3 , CH 2
N(CH
3
)
2 , alkyne (optionally 20 substituted), or halogen, including F, Cl, Br, or I, with the provisos that when X is OH, base is cytosine and R6 is H, R 5 cannot be N 3 and when X is OH, R 6 is
CH
3 or CH 2 F and B is a purine base, R 5 cannot be H; (f) R6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , F, or CN; (g) X is H, OH, F, OMe, Cl, Br, I, NH 2 , or N 3 ; 25 (h) Y is OH, H, C1A alkyl, C24 alkenyl, C24 alkynyl, vinyl, N 3 , CN, Cl, Br,. F, I, NO 2 , OC(O)O(C1A alkyl), OC(O)O(C14 alkyl), OC(O)O(C24 alkynyl), OC(O)O(C 2 4 alkenyl), 0C 1
.
1 0 haloalkyl, O(aminoacyl), O(Ci.io acyl),
O(CI
4 alkyl), O(C 24 alkenyl), S(CjA acyl), S(C1A alkyl), S(C24 alkynyl), S(C24 alkenyl), SO(CIA acyl), SO(CIA alkyl), SO(C 24 alkynyl), SO(C24 alkenyl), 30 SO 2
(C
14 acyl), SO2(CI4 alkyl), SO2(C24 alkynyl), SO 2
(C
24 alkenyl), OS(O) 2 (Ci. 4 acyl), OS(0) 2
(C
14 alkyl), OS(0)2(C24 alkenyl), NH 2 , NH(C 1 4 alkyl), NH(C 24 alkenyl), NH(C 2 .4 alkynyl), NH(C 1 4 acyl), N(C 1 4 alkyl) 2 , or N(C .
18 acyl) 2 , wherein alkyl, alkynyl, alkenyl and vinyl are optionally substituted by N 3 , CN, one to three halogen (Cl, Br, F, I), NO 2 , C(O)O(Ci_4 alkyl), C(O)O(C1A alkyl),
C(O)O(C
24 alkynyl), C(O)O(C24 alkenyl), O(C14 acyl), O(C14 alkyl), O(C 2 4 5 alkenyl), S(C14 acyl), S(C14 alkyl), S(C 24 alkynyl), S(C 24 alkenyl), SO(CI.
4 acyl), SO(C 14 alkyl), SO(C 2 4 alkynyl), SO(C24 alkenyl), SO2(C14 acyl), S02(CI.4 alkyl), SO2(C24 alkynyl), SO2(C24 alkenyl), OS(O)2(Ci4 acyl), OS(O)2(Cia alkyl), OS(O) 2
(C
2 4 alkenyl), NH 2 , NH(CI 4 alkyl), NH(C 2 4 alkenyl), NH(C 2 -4 alkynyl), NH(C 1 4 acyl), N(C 1 4 alkyl) 2 , or N(C14 acyl) 2 ; 10 (i) R 7 and R 8 are independently H, F, Cl, Br, I, OH, OR', SH, SR',
NH
2 , NHR', NR' 2 , lower alkyl, halogenated (F, Cl, Br, I) lower alkyl, lower alkenyl of C 2
-C
6 , CO 2 H, CO 2 R', CONH 2 , CONHR', CONR' 2 , wherein R' is a CI. 20 alkyl; a CI- 2 0 cycloalkyl; a C 2
-C
6 alkenyl, a C 2
-C
6 alkynyl. The second aspect of the second embodiment is directed to a compound 15 represented by formula 1-3 wherein (a) R' is hydrogen, n-alkyl or aryl, which includes, but is not limited to, phenyl or naphthyl, where phenyl or naphthyl are optionally substituted with at least one of CI- 6 alkyl, Ci- 6 alkoxy, F, Cl, Br, I, nitro, cyano, C 1 -6 haloalkyl; 20 (b) R 2 is hydrogen or CH 3 ; (c) R 3 a and R 3 b are independently (i) R 3 a is hydrogen and R 3 b and R 2 together are (CH 2 )n so as to form a cyclic ring that includes the adjoining N and C atoms (v) R is hydrogen and R 3 a and R 2 together are (CH 2 )n so as to form a cyclic ring that includes the adjoining N and C atoms, where c is 1 to 6, d is 0 to 25 2, e is 0 to 3, f is 3 to 5, n is 2 to 4, and where R 3 is independently hydrogen or
C
1
.
6 alkyl and R 3 is -OR' or -N(R 3
)
2 ); (vi) R 3 a is H and R 3 " is H, CH 3 ,
CH(CH
3
)
2 , CH 2
CH(CH
3
)
2 , CH(CH 3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, CH 2
CH
2
SCH
3 , CH 2
CO
2 H, CH 2
C(O)NH
2 , CH 2
CH
2 COOH, CH 2
CH
2
C(O)NH
2 ,
CH
2
CH
2
CH
2
CH
2
NH
2 , -CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl, 30 CH 2 OH, CH(OH)CH 3 , CH 2 ((4'-OH)-Ph), CH 2 SH, or lower cycloalkyl; or (viii) R.a is CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 , CH(CH 3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3 yl, -CH 2
CH
2
SCH
3 , CH 2
CO
2 H, CH 2
C(O)NH
2 , CH 2
CH
2 COOH,
CH
2
CH
2
C(O)NH
2 , CH 2
CH
2
CH
2
CH
2
NH
2 , -CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4'-OH)-Ph), or CH 2 SH and R 3b is H; 5 (d) R 4 is hydrogen, C 1
.
1 0 alkyl, C 1
.
1 0 alkyl optionally substituted with a lower alkyl, alkoxy or halogen, CI.
10 haloalkyl, C 3
.
10 cycloalkyl, cycloalkyl alkyl, cycloheteroalkyl, aminoacyl, di(lower alkyl)amino-lower alkyl, aryl, such as phenyl, heteroaryl, such as, pyridinyl, substituted aryl, or substituted heteroaryl; 10 (e) R 5 is H, CN, CH 3 , vinyl, OCH 3 , OCH 2
CH
3 , CH 2 OH, CH 2 (halo), such as CH 2 F, N 3 , CH 2 CN, CH 2
N
3 , CH 2
NH
2 , CH 2
NHCH
3 , CH 2
N(CH
3
)
2 , halogen, including F, Cl, Br, or I; (f) R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , F, or CN; (g) X is H, OH, F, OMe, halogen, NH 2 , or N 3 ; 15 (h) Y is OH, H, C 1 4 alkyl, vinyl, N 3 , CN, Cl, Br, F, I, O(C 1
.
6 acyl),
O(C
14 alkyl), NH 2 , NH(C 14 alkyl), NH(C 2 4 alkenyl), NH(C 24 alkynyl), NH(C 14 acyl), N(C 14 alkyl) 2 , N(CI.
18 acyl) 2 , wherein alkyl, alkynyl, alkenyl and vinyl are optionally substituted by N 3 , CN, one to three halogen (Cl, Br, F, I), NO 2 , OC(O)O(Ci 4 alkyl), OC(O)O(C 1 4 alkyl), OC(O)O(C 24 alkynyl), OC(0)O(C 24 20 alkenyl), OCI 10 haloalkyl, O(aminoacyl), O(C 14 acyl), O(C 14 alkyl), O(C 2
.
4 alkenyl), S(C 14 acyl), S(C 14 alkyl), S(C 24 alkynyl), S(C 2 4 alkenyl), SO(Ci 4 acyl), SO(C 14 alkyl), SO(C 2 4 alkynyl), SO(C 2 4 alkenyl), S0 2
(C,
4 acyl),
SO
2
(C
14 alkyl), S0 2
(C
2
-
4 alkynyl), S0 2
(C
24 alkenyl), OS(O) 2
(C[
4 acyl),
OS(O)
2
(C
1 4 alkyl), OS(0) 2
(C
2 4 alkenyl), NH 2 , NH(CI4 alkyl), NH(C 2 4 25 alkenyl), NH(C 2 4 alkynyl), N:H(C.
4 acyl), N(C 14 alkyl) 2 , N(C 14 acyl)2; (i) R7 and R8 are independently H, F, Cl, Br, I, OH, OR', SH, SR',
NH
2 , NHR', NR' 2 , lower alkyl, halogenated (F, Cl, Br, I) lower alkyl, lower alkenyl of C 2
-C
6 , CO 2 H, CO 2 R', CONH 2 , CONHR', CONR' 2 , wherein R' is a C 1 . 20 alkyl; a CI- 2 0 cycloalkyl; a C 2
-C
6 alkenyl, a C 2
-C
6 alkynyl. A 1 The third aspect of the second embodiment is directed to a compound represented by formula 1-3 wherein (a) R1 is hydrogen, n-alkyl or a substituted or unsubstituted phenyl, 5 where the substitutent of the substituted phenyl is at least one of a C 1
.
3 alkyl, a Ci.
3 alkoxy, F, Cl, Br, I, nitro, cyano, and a CI.
3 haloalkyl; (b) R2 is hydrogen, CH 3 , R 3 a or R 3 1 and R 2 together are (CH 2
)
3 so as to fonr a cyclic ring that includes the adjoining N and C atoms,
C(O)CR
3 aR 3 NHRI, where n is 2 to 4 and R1, R 3 a, and R 3 b are as defined herein; 10 (c) R 3 a and R 3 b are independently (i) R 3 a is hydrogen and R3b and R 2 together are (CH 2 )n so as to form a cyclic ring that includes the adjoining N and C atoms (v) R 3 b is hydrogen and R 3 " and R 2 together are (CH 2 )n so as to form a cyclic ring that includes the adjoining N and C atoms, where c is 1 to 6, d is 0 to 2, e is 0 to 3, f is 3 to 5, n is 2 to 4, and where R is independently hydrogen or 15 CI.6 alkyl and R 3 is -OR' or -N(R 3
)
2 ); (vi) R 3 a is H and R 3 b is H, CH 3 ,
CH(CH
3
)
2 , CH 2
CH(CH
3
)
2 , CH(CH 3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, CH 2
CH
2
SCH
3 , CH 2
CO
2 H, CH 2
C(O)NH
2 , CH 2
CH
2 COOH, CH 2
CH
2
C(O)NH
2 ,
CH
2
CH
2
CH
2
CH
2
NH
2 , -CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl,
CH
2 OH, CH(OH)CH 3 , CH 2 ((4'-OH)-Ph), CH 2 SH, or lower cycloalkyl; or (viii) 20 R 3 a is CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 , CH(CH 3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3 yl, -CH 2
CH
2
SCH
3 , CH 2
CO
2 H, CH 2
C(O)NH
2 , CH 2
CH
2 COOH,
CH
2
C:H
2
C(O)NH
2 , CH 2
CH
2
CH
2
CH
2
NH
2 , -CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4'-OH)-Ph), CH 2 SH, or lower cycloalkyl and R is H; 25 (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; (e) R 5 is H, CN, CH1 3 , OCH 3 , CH 2 OH, CH 2 (halo), such as CH 2 F, N 3 ,
CH
2 CN, CH 2
N
3 , CH 2
NH
2 , CH 2
NHCH
3 , CH 2
N(CH
3
)
2 , halogen, including F, Cl, Br, or I; (f) R6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , F, or CN; 5 (g) X is H, OH, F, OCH 3 , halogen, NH 2 , or N 3 (h) Y is OH, H, CH7I 3 , vinyl, N 3 , CN, Cl, Br, F, I, OC(O)CH 3 , OCH 3 ,
NH
2 , NHCH 3 , NH(vinyl), NH(acetyl), NH(C(O)CH 3 ), N(CH 3
)
2 , N(C(O)CH 3
)
2 ; (i) R 7 and R 8 are independently H, F, Cl, Br, I, OH, OCH 3 , SH,
SCH
3 , NH 2 , NHCH 3 , N(CH 3
)
2 , CH 3 , CH3.qXq, where X is F, Cl, Br, or I and q is 10 1 to 3, vinyl, CO 2 H, CO 2
CH
3 , CONH 2 , CONHCH 3 , or CON(CH 3
)
2 . The fourth aspect of the second embodiment is directed to a compound represented by formula 1-3 wherein (a) R' is hydrogen, n-alkyl or a substituted or unsubstituted phenyl, 15 where the substitutent of the substituted phenyl is at least one of a CH 3 , OCH 3 , F, Cl. Br, I, nitro, cyano, and a CH3.qXq, where X is F, Cl, Br, or I, and q is 1-3; (b) R 2 is hydrogen or CH 3 ; (c) R 3 a is H and R 3 b is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, -CH 2
CH
2
SCH
3 , CH 2
CO
2 H, 20 CH 2
C(O)NH
2 , CH 2
CH
2 COOH, CH 2
CH
2
C(O)NH
2 , CH 2
CH
2
CH
2
CH
2
NH
2 , CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4' OH)-Ph), CH 2 SH, or lower cycloalkyl or R 3 a is CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, -CH 2
CH
2
SCH
3 , CH 2
CO
2 H,
CH
2
C(O)NH
2 , CH 2
CH
2 COOH, CH 2
CH
2
C(O)NH
2 , CH 2
CH
2
CH
2
CH
2
NH
2 , 25 CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4' OH)-Ph), CH 2 SH, or lower cycloalkyl and R 3 b is H; (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, Nmethyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; (e) R 5 is H, CN, CH 3 , OCH 3 , CH 2 OH, CH 2 (halo), such as CH 2 F, N 3 ,
CH
2 CN, CH 2
N
3 , CH 2
NH
2 , CH 2
NHCH
3 , CH 2
N(CH
3
)
2 , halogen, including F, Cl, 5 Br, or I; (f) R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , F, or CN; (g) X is H, OH, F, OCH 3 , NH 2 , or N 3 ; (h) Y is OH, H, CH 3 , vinyl, N 3 , CN, Cl, Br, F, I, OC(O)CH 3 , OCH 3 ,
NH
2 , NHCH 3 , NH(vinyl), NH(acetyl), NH(C(O)CH 3 ), N(CH 3
)
2 , N(C(O)C1 3
)
2 ; 10 (i) R 7 and R 8 are independently H, F, Cl, Br, I, OH, OCH 3 , SH,
SCH
3 , NH 2 , NHCH 3 , N(CH 3
)
2 , CH 3 , CH3.qXq, where X is F, Cl, Br, or I and q is I to 3, vinyl, CO 2 H, CO 2
CH
3 , CONH 2 , CONHCH 3 , or CON(CH 3
)
2 , wherein R' is a C1 20 alkyl; a C 1
.
20 cycloalkyl; a C 2
-C
6 alkenyl, a C 2
-C
6 alkynyl. The fifth aspect of the second embodiment is directed to a compound 15 represented by formula 1-4 0 R8 NH R2 0 R3b
R
7 N 0 R3a 'sN-P-O C0 2
R
4 OR' R5 R6 Y X 1-4 wherein (a) R1 is hydrogen, methyl, ethyl, n-propyl, i-propyl, or a substituted 20 or unsubstituted phenyl, where the substitutent of the substituted phenyl is at
,AA
least one of a CH 3 , OCH 3 , F, Cl, Br, I, nitro, cyano, and a CH3.qXq, where X is F, Cl, Br, or I, and q is 1-3; (b) R 2 is hydrogen or CH 3 ; (c) R3a is H and RA is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 , 5 CH(CH 3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, -CH 2
CH
2
SCH
3 , CH 2
CO
2 H,
CH
2
C(O)NH
2 , CH 2
CH
2 COOH, CH 2
CH
2
C(O)NH
2 , CH 2
CH
2
CH
2
CH
2
NH
2 , CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4' OH)-Ph), CH 2 SH, or lower cycloalkyl or R 3 a is CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, -CH 2
CH
2
SCH
3 , CH 2
CO
2 H, 10 CH 2
C(O)NH
2 , CH 2
CH
2 COOH, CH 2
CH
2
C(O)NH
2 , CH 2
CH
2
CH
2
CH
2
NH
2 , CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4' OH)-Ph), CH 2 SH, or lower cycloalkyl and R is H; (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N 15 methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; (e) R 5 is H, CN, CH4 3 , OCH 3 , CH 2 OH, CH 2 F, N 3 , CH 2 CN, CH 2
N
3 ,
CH
2
N*H
2 , CH 2
NHCH
3 , CH 2
N(CH
3
)
2 , halogen, including F, Cl, Br, or I; (f) R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , F, or CN; 20 (g) X is H, OH, F, OCH 3 , Cl, Br, I, NH 2 , or N 3 ; (h) Y is OH, H, CH- 3 , vinyl, N 3 , CN, Cl, Br, F, I, OC(O)CH 3 , OCH 3 ,
NH
2 , NHCH 3 , NH(vinyl), NH(acetyl), NH(C(O)CH 3 ), N(CH 3
)
2 , N(C(O)CH 3
)
2 ; (i) R and R are independently H, F, Cl, Br, I, OH, OCH 3 , SH,
SCH
3 , NH 2 , NHCH 3 , N(CH 3
)
2 , CH 3 , CH3.qXq, where X is F, Cl, Br, or I and q is 25 1 to 3, vinyl, CO 2 H, CO 2
CH
3 , CONH 2 , CONHCH 3 , or CON(CH 3
)
2 , wherein R' is a CI-20 alkyl; a CI- 20 cycloalkyl; a C 2
-C
6 alkenyl, a C 2
-C
6 alkynyl, The sixth aspect of the second embodiment is directed to a compound represented by formula 1-4 wherein (a) R' is hydrogen, methyl, ethyl, n-propyl, i-propyl, phenyl, p-tolyl, p-bromo-phenyl, p-chloro-phenyl, p-fluorophenyl; (b) R2 is hydrogen or CH 3 ; 5 (c) R is H and R is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, -CH 2
CH
2
SCH
3 , CH 2
CO
2 H,
CH
2
C(O)NH
2 , CH 2
CH
2 COOH, CH 2
CH
2
C(O)NH
2 , CH 2
CH
2
CH
2
CH
2
NH
2 , CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4' OH)-Ph), CH 2 SH, or lower cycloalkyl; 10 (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; (e) R 5 is H, CN, CH 3 , OCH 3 , CH 2 OH, CH 2 F, halogen, including F, 15 Cl, Br, or I; (f) R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , F, or CN; (g) X is H, OH, F, OCH 3 , NH 2 , or N 3 ; (h) Y is OH, H, CH 3 , vinyl, NH 2 , N 3 , CN, Cl, Br, F, I, OC(O)CH 3 ,
OCH
3 ; 20 (i) R 7 and R 8 are independently H, F, Cl, Br, I, OH, OCH 3 , SH,
SCH
3 , NH 2 , NHCH 3 , N(CH 3
)
2 , CH 3 , CH3.gXq, where X is F, Cl, Br, or I and q is 1 to 3, vinyl, CO 2 H, CO 2
CH
3 , CONH 2 , CONHCH 3 , or CON(CH 3
)
2 , wherein R' is a CI- 2 0 alkyl; a C 1
-
2 0 cycloalkyl; a C 2
-C
6 alkenyl, a C 2
-C
6 alkynyl. The seventh aspect of the second embodiment is directed to a compound 25 represented by formula 1-4 wherein A 4 (a) R1 is hydrogen, methyl, ethyl, n-propyl, i-propyl, phenyl, p-tolyl, p-bromo-phenyl, p-chloro-phenyl, p-fluorophenyl; (b) R 2 is hydrogen or CH 3 ; (c) R 3 a is H and R 3 b is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 , 5 CH(CH 3
)CH
2
CH
3 , CH 2 Ph, or lower cycloalkyl; (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; 10 (e) R 5 is H, OMe, CN, CH 2 F, F, Cl, Br, or I; (f) R6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , or F; (g) X is H, OH, F, OCH 3 , F, Cl, Br, I, NH 2 or N 3 ; (h) Y is H, OH, CH 3 , F, Cl, Br, I, NH 2 or N 3 , OCH3, or OC(O)CH 3 ; (i) R 7 and R 8 are independently H, F, Br, SCH 3 , CH 3 , CH3.qXq, 15 where X is F, Cl, Br, or I and q is I to 3, vinyl, CO 2
CH
3 , CONH 2 , CONHCH 3 , or
CON(CH
3
)
2 ; The eighth aspect of the second embodiment is directed to a compound represented by formula 1-4 wherein 20 (a) R' is hydrogen, methyl, ethyl, n-propyl, i-propyl, phenyl, p-tolyl, p-bromo-phenyl, p-chloro-phenyl, p-fluorophenyl; (b) R 2 is hydrogen; (c) R 3 , is H and R 3 b is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, or lower cycloalkyl; A 7 (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; 5 (e) R 5 is H; (f) R' is H, CH 3 , CH 2 F, CHF 2 , CF 3 , or F; (g) X is H, OH, OCH 3 , F, NH 2 or N 3 ; (h) Y is OH, NH 2 , OCH 3 , or OC(O)CH 3 ; (i) R 7 and R 8 are independently H, F, Br, SCH 3 , CH 3 , CH3.qXq, 10 where X is F, Cl, Br, or I and q is I to 3, vinyl, CO 2
CH
3 , CONH 2 , CONHCH 3 , or
CON(CH
3
)
2 . The ninth aspect of the second embodiment is directed to a compound represented by formula 1-4 wherein 15 (a) R' is hydrogen, methyl, phenyl, p-bromo-phenyl, p-chloro phenyl, p-fluorophenyl; (b) R2 is hydrogen; (c) R is H and R is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, or lower cycloalkyl; 20 (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; (e) R 5 is H; 25 (f) R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , or F; A Q (g) X is H, OH, OCH 3 , F, or N 3 ; (h) Y is OH, OCH 3 , or OC(O)CH 3 ; (i) R 7 and R 8 are independently H, F, Br, SCH 3 , CH 3 , CH3.qXq, where X is F, Cl, Br, or I and q is 1 to 3, vinyl, CO 2
CH
3 , CONH 2 , CONHCH 3 , or 5 CON(CH 3
)
2 . A third embodiment of the invention is directed to a compound represented by formula I in which the base is a structure represented by formula c above, wherein R1, R2, R3", R3b, R4, R, R , X, Y, Z, R1 0 , R", and R2 are defined in the Summary of the Invention section above; with the proviso that R" 10 is not H. A first aspect of the third embodiment is directed to a compound represented by formula 1-5
R
10
R
3 b R2 O N R3a R N-P O N 00" N C0 2
R
4 ORI R 5
R
6 Y X I-5 15 wherein (a) R1 is hydrogen, n-alkyl; branched alkyl; cycloalkyl; or aryl, which includes, but is not limited to, phenyl or naphthyl, where phenyl or naphthyl are optionally substituted with at least one of C1.
6 alkyl, C 2 -6 alkenyl, C 2
-
6 alkynyl, C1- 6 alkoxy, F, Cl, Br, I, nitro, cyano, C1- 6 haloalkyl, -N(R') 2 , C1- 6 acylamino, 20 NHSO 2 Ci.6 alkyl, -SO 2
N(R")
2 , COR', and -SO 2
CI-
6 alkyl; (R" is independently hydrogen or alkyl, which includes, but is not limited to, CI- 20 alkyl, CI-1 0 alkyl, or C1- 6 alkyl, Rr is -OR' or -N(Rl')2); A t (b) R2 is hydrogen or CH 3 ; (c) R 3 a and R 3 b are (i) independently selected from hydrogen, CI-Io alkyl, cycloalkyl, -(CH 2 )c(NR 3
)
2 , C 1
-
6 hydroxyalkyl, -CH 2 SH, -(CH 2
)
2 S(O)dMe, (CH 2
)
3
NHC(=NH)NH
2 , (1 H-indol-3-yl)methyl, (1 H-imidazol-4-yl)methyl, 5 (CH 2 )eCORr, aryl and aryl C 1
.
3 alkyl, said aryl groups optionally substituted with a group selected from hydroxyl, C 1
.
1 0 alkyl, C 1 o alkoxy, halogen, nitro and cyano; (ii) R3' and R 3 b both are C 1 .6 alkyl; (iii) R3a and R 3 b together are(CH 2 )f so as to form a spiro ring; (iv) R 3 " is hydrogen and R 3 b and R 2 together are (CH 2 )n so as to form a cyclic ring that includes the adjoining N and C atoms (v) R 3 b is 10 hydrogen and R3a and R2 together are (CH 2 )n so as to form a cyclic ring that includes the adjoining N and C atoms, where c is 1 to 6, d is 0 to 2, e is 0 to 3, f is 2 to 5, n is 2 to 4, and where R 3 is independently hydrogen or CI- 6 alkyl and Rr is -OR' or -N(R ) 2 ); (vi) R 3 a is H and R 3 b is from H, CH 3 , CH 2
CH
3 ,
CH(CH
3
)
2 , CH 2
CH(CH
3
)
2 , CH(CH 3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, 15 CH 2
CH
2
SCH
3 , CH 2
CO
2 H, CH 2
C(O)NH
2 , CH 2
CH
2 COOH, CH 2
CH
2
C(O)NH
2 ,
CH
2
CH
2
CH
2
CH
2
NH
2 , -CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl,
CH
2 OH, CH(OH)CH 3 , CH 2 ((4'-OH)-Ph), CH 2 SH, or lower cycloalkyl; or (viii)
R
3 a is CH 3 , -CH 2
CH
3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 , CH(CH 3
)CH
2
CH
3 , CH 2 Ph,
CH
2 -indol-3-yl, -CH 2
CH
2
SCI
3 , CH 2
CO
2 H, CH 2
C(O)NH
2 , CH 2
CH
2 COOH, 20 CH 2
CH
2
C(O)NH
2 , CH 2
CH
2
CH
2
CH
2
NH
2 , -CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4'-OH)-Ph), CH 2 SH, or lower cycloalkyl and R is H, where R 3 ' is independently hydrogen or alkyl, which includes, but is not limited to, CI- 20 alkyl, C 1
.
10 alkyl, or CI- 6 alkyl, R 3 is -OR' or -N(R")2); 25 (d) R 4 is hydrogen, CI-Io alkyl, CIo 10 alkyl optionally substituted with a lower alkyl, alkoxy or halogen, CI 10 haloalkyl, C 3
.
1 0 cycloalkyl, cycloalkyl alkyl, cycloheteroalkyl, aminoacyl, di(lower alkyl)amino-lower alkyl, aryl, such as phenyl, heteroaryl, such as, pyridinyl, substituted aryl, or substituted heteroaryl; 30 (e) R 5 is H, a lower alkyl, CN, vinyl, 0-(lower alkyl), hydroxyl lower alkyl, i.e., -(CH 2 )pOH, where p is 1 -6, including hydroxyl methyl (CH 2 OH),
CH
2 F, N 3 , CH 2 CN, CH 2
NH
2 , CH 2
NHCH
3 , CH 2
N(CH
3
)
2 , alkyne (optionally substituted), or halogen, including F, Cl, Br, or I, with the provisos that when X is OH, base is cytosine and R 6 is H, R 5 cannot be N 3 and when X is OH, R 6 is
CH
3 or CH 2 F and B is a purine base, R 5 cannot be H; (f) R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , F, or CN; 5 (g) X is H, OH, F, OMe, halogen, NH 2 , or N 3 ; (h) Y is OH, H, C14 alkyl, C24 alkenyl, C24 alkynyl, vinyl, N 3 , CN, Cl, Br, F, I, NO 2 , OC(O)O(Cia alkyl), OC(O)O(C14 alkyl), OC(O)O(C24 alkynyl), OC(O)O(C24 alkenyl), OCI.
1 o haloalkyl, O(aminoacyl), O(CIo 10 acyl),
O(C
1
.
4 alkyl), O(C24 alkenyl), S(CI.4 acyl), S(CIA alkyl), S(C24 alkynyl), S(C24 10 alkenyl), SO(CJ4 acyl), SO(CIA alkyl), SO(C24 alkynyl), SO(C24 alkenyl),
SO
2
(C
14 acyl), SO2(C 14 alkyl), S0 2
(C
24 alkynyl), SO2(C24 alkenyl), OS(0) 2 (Cl. 4-acyl), OS(O)2(CI4 alkyl), OS(O) 2
(C
2 4 alkenyl), NH 2 , NH(C14 alkyl), NH(C 2 4 alkenyl), NH(C 2 4 alkynyl), N H(CIA acyl), N(C 14 alkyl) 2 , N(C 1
I
18 acyl) 2 , wherein alkyl, alkynyl, alkenyl and vinyl are optionally substituted by N 3 , CN, 15 one to three halogen (Cl, Br, F, I), NO 2 , C(O)O(Ci 4 alkyl), C(O)O(CIA alkyl),
C(O)O(C
24 alkynyl), C(O)O(C 2 4 alkenyl), O(CI4 acyl), O(Cia alkyl), O(C24 alkenyl), S(Cia acyl), S(C14 alkyl), S(C24 alkynyl), S(C24 alkenyl), SO(CI4 acyl)., SO(C14 alkyl), SO(C 24 alkynyl), SO(C24 alkenyl), S02(CIA acyl), S02(CI4 alkyl), S0 2
(C
24 alkynyl), S02(C24 alkenyl), OS(O) 2
(C
14 acyl), 20 OS(O)2(CI4 alkyl), OS(O)2(C24 alkenyl), NH 2 , NH(C14 alkyl), NH(C 2 4 alkenyl), NH(C 2 4 alkynyl), NH(C 14 acyl), N(CI_4 alkyl) 2 , N(C 1 4 acyl) 2 ; (i) R' 0 and R" are independently H, F, Cl, Br, I, OH, OR', SH, SR',
NH
2 , NHR', NR'2, lower alkyl of CI-C 6 , halogenated (F, Cl, Br, I) lower alkyl of Ci-C 6 , lower alkenyl of C 2
-C
6 , halogenated (F, Cl, Br, I) lower alkenyl of C 2
-C
6 , 25 lower alkynyl of C 2
-C
6 such as C=CH, halogenated (F, Cl, Br, I) lower alkynyl of C 2
-C
6 , lower alkoxy of CI-C 6 , halogenated (F, Cl, Br, I) lower alkoxy of CI
C
6 , CO 2 H, CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or
CH=CHCO
2 R', with the proviso that when R' 0 is OH and R" is not NH 2 ; wherein R' is an optionally substituted alkyl , which includes, but is not 30 limited to, an optionally substituted CI- 20 alkyl, an optionally substituted CI.
1 0 alkyl, an optionally substituted lower alkyl; an optionally substituted cycloalkyl; an optionally substituted alkynyl of C 2
-C
6 , an optionally substituted lower alkenyl of C 2
-C
6 , or optionally substituted acyl, which includes but is not limited to C(O) alkyl, C(O)(CI- 20 alkyl), C(O)(C 1
.
10 alkyl), or C(O)(lower alkyl) or alternatively, in the instance of NR' 2 , each R' comprise at least one C atom that 5 are joined to form a heterocycle comprising at least two carbon atoms; and (j) Z is N or CR12; and R 1 is an H, halogen (including F, Cl, Br, I), OH, OR', SH, SR', NH 2 , NHR', NR' 2 , NO 2 lower alkyl of CI-C 6 , halogenated (F, Cl, Br, I) lower alkyl of Cl-C(,, lower alkenyl of C 2
-C
6 , halogenated (F, Cl, Br, I) lower alkenyl of C 2
-C
6 , 10 lower alkynyl of C 2
-C
6 , halogenated (F, Cl, Br, I) lower alkynyl of C 2
-C
6 , lower alkoxy of C 1
-C
6 , halogenated (F, Cl, Br, I) lower alkoxy of CI-C 6 , CO 2 H, CO 2 R', CON [12, CONHR', CONR' 2 , CH=CHCO 2 H, or CH=CHCO 2 R'. A second aspect of the third embodiment is directed to a compound represented by formula 1-5 15 wherein (a) R 1 is hydrogen, methyl, ethyl, n-propyl, i-propyl, phenyl, p-tolyl, p-bromo-phenyl, p-chloro-phenyl, p-fluorophenyl; (b) R 2 is hydrogen or CH 3 ; (c) R is H and R 3 b is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 , 20 CH(CH 3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, -CH 2
CH
2
SCH
3 , CH 2
CO
2 H,
CH
2
C(O)NH
2 , CH 2
CH
2 COOH, CH 2
CH
2
C(O)NH
2 , CH 2
CH
2
CH
2
CH
2
NH
2 , CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4' OH)-Ph), CH 2 SH, or lower cycloalkyl; (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, 25 cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; (e) R 5 is H, CN, CH 3 , OCH 3 , CH 2 OH, CH 2 F, halogen, including F, Cl, Br, or I, with the provisos that when X is OH, R 6 is CH 3 or CH 2 F, R 5 cannot be H. (f) R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , F, or CN; 5 (g) X is H, OH, F, OCH 3 , Cl, Br, I, NH 2 , or N 3 ; (h) Y is OH, H, CH-I 3 , vinyl, NH 2 , N 3 , CN, Cl, Br, F, I, OC(O)CH 3 , OCH-3; (i) R" 0 and R" are independently H, F, Br, I, OH, OR', NH 2 , NHR',
NR'
2 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or CH=CHCO 2 R', 10 with the proviso that when R1 0 is OH and R 1 is not NH 2 ; wherein R' is a lower alkyl, a lower cycloalkyl, or C(O)(lower alkyl) or alternatively, in the instance of NR' 2 , each R' comprise at least one C atom that are joined to form a heterocycle comprising at least two carbon atoms; and () Z is N or CR1 2 ; and 15 R1 2 is an H, halogen (including F, Cl, Br, I), OR', NH 2 , NHR', NR' 2 , NO 2 , lower alkyl of CI-C 6 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or
CH=CHCO
2 R'. A third aspect of the third embodiment is directed to a compound 20 represented by formula 1-5 wherein (a) R1 is hydrogen, methyl, ethyl, n-propyl, i-propyl, phenyl, p-tolyl, p-bromo-phenyl, p-chloro-phenyl, p-fluorophenyl; (b) R 2 is hydrogen or CH 3 ; 25 (c) R 3 a is H and R 3 b is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, or lower cycloalkyl; (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; 5 (e) R5 is H, CN, CH 2 F, F, Cl, Br, or I; with the proviso that X is OH, R6 is CH 3 or CH 2 F, R5 cannot be H; (f) R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , or F; (g) X is H, OH, F, OCH 3 , F, Cl, Br, I, NH 2 or N 3 ; (h) Y is H, OH, CH 3 , F, Cl, Br, I, NH 2 or N 3 , OCH 3 , or OC(O)CH 3 ; 10 (i) R 0 and R" are independently H, F, Br, I, OH, OR', NH 2 , NHR',
NR'
2 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or CH=CHCO 2 R', with the proviso that when R' 0 is OH and R" is not NH 2 ; wherein R' is a lower alkyl, a lower cycloalkyl, or C(O)(lower alkyl) or alternatively, in the instance of NR' 2 , each R' comprise at least one C atom that 15 are joined to form a heterocycle comprising at least two carbon atoms; and (j) Z is N or CR 2 ; and R 2 is an H, halogen (including F, Cl, Br, I), OR', NH 2 , NHR', NR' 2 , NO 2 , lower alkyl of CI-C 6 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or
CH=CHCO
2 R'. 20 A fourth aspect of the third embodiment is directed to a compound represented by formula 1-5 wherein (a) R1 is hydrogen, methyl, ethyl, n-propyl, i-propyl, phenyl, p-tolyl, 25 p-bromo-phenyl, p-chloro-phenyl, p-fluorophenyl; (b) R 2 is hydrogen; Lr A (c) R is H and R 3 b is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, or lower cycloalkyl; (d) R4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N 5 methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; (e) R is H, with the provisos that when X is OH, R6 is CH 3 or CH 2 F, R cannot be H; (f) R is H, CH 3 , CH 2 F, CHF 2 , CF 3 , or F; 10 (g) X is H, OH, OCH 3 , F, NH 2 or N 3 ; (h) Y is OH. NH 2 , OCH 3 , or OC(O)CH 3 ; (i) R'" and R" are independently H, F, Br, I, OH, OR', NH 2 , NHR',
NR'
2 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or CH=CHCO 2 R', with the proviso that when R' is OH and R" is not NH 2 ; 15 wherein R' is a lower alkyl, a lower cycloalkyl, or C(O)(lower alkyl) or alternatively, in the instance of NR' 2 , each R' comprise at least one C atom that are joined to form a heterocycle comprising at least two carbon atoms; and (j) Z is N or CR 1; and R 1 is an H, halogen (including F, Cl, Br, 1), OR', NH 2 , NHR', NR' 2 , NO 2 , 20 lower alkyl of CI-C 6 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or
CH=CHCO
2 R'. A fifth aspect of the third embodiment is directed to a compound represented by formula 1-5 25 wherein (a) R' is hydrogen, methyl, phenyl, p-bromo-phenyl, p-chloro phenyl, p-fluorophenyl; (b) R 2 is hydrogen; (c) R is H and R3b is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, or lower cycloalkyl; (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, 5 cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; (e) R 5 is H, with the provisos that when X is OH, R 6 is CH 3 or CH 2 F, R cannot be H; 10 (f) R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , or F; (g) X is H, OH, OCH 3 , F, NH 2 or N 3 ; (h) Y is OH, NH 2 , OCH 3 , or OC(O)CH 3 ; (i) R'" and R" are independently H, F, Br, I, OH, OR', NH 2 , NHR',
NR'
2 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or CH=CHCO 2 R', 15 with the proviso that when R' 0 is OH and R" is not NH 2 ; wherein R' is a lower alkyl, a lower cycloalkyl, or C(O)(lower alkyl) or alternatively, in the instance of NR' 2 , each R' comprise at least one C atom that are joined to form a heterocycle comprising at least two carbon atoms; and (j) Z is N or CR1 2 ; and 20 R 12 is an H, halogen (including F, Cl, Br, I), OR', NH 2 , NHR', NR' 2 , NO 2 , lower alkyl of CI-C 6 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or
CH=CHCO
2 R'. A sixth aspect of the third embodiment is directed to a compound represented by formula 1-5 25 wherein (a) R' is hydrogen, methyl, ethyl, n-propyl, i-propyl, phenyl, p-tolyl, p-bromo-phenyl, p-chloro-phenyl, p-fluorophenyl; (b) R 2 is hydrogen or CH 3 ; (c) Ra is H and R 3 b is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 , 5 CH(CH 3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, -CH 2
CH
2
SCH
3 , CH 2
CO
2 H,
CH
2
C(O)NH
2 , CH 2
CH
2 COOH, CH 2
CH
2
C(O)NH
2 , CH 2
CH
2
CH
2
CH
2
NH
2 , CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4' OH)-Ph), CH 2 SH, or lower cycloalkyl; (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, 10 cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; (e) R 5 is H, CN, CH 3 , OCH 3 , CH 2 OH, CH 2 F, halogen, including F, Cl, Br, or I, with the provisos that when X is OH, R6 is CH 3 or CH 2 F, R 5 cannot 15 be H. (f) R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , F, or CN; (g) X is H, OH, F, OCH 3 , Cl, Br, I, NH 2 , or N 3 ; (h) Y is OH, H, CH 3 , vinyl, NH 2 , N 3 , CN, Cl, Br, F, I, OC(O)CH 3 ,
OCH[
3 ; 20 (i) R' 0 is NH 2 and R" is H, F, Br, I, OH, OR', NH 2 , NHR', NR' 2 ,
CO
2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or CH=CHCO 2 R'; wherein R' is a lower alkyl, a lower cycloalkyl, or C(O)(lower alkyl) or alternatively, in the instance of NR' 2 , each R' comprise at least one C atom that are joined to form a heterocycle comprising at least two carbon atoms; and 25 ) Z is N or CR 12 ; and R is an H, halogen (including F, Cl, Br, I), OR', NH 2 , NHR', NR' 2 . NO 2 , lower alkyl of C 1
-C
6 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or
CH=CHCO
2 R'. A seventh aspect of the third embodiment is directed to a compound 5 represented by formula 1-5 wherein (a) R' is hydrogen, methyl, ethyl, n-propyl, i-propyl, phenyl, p-tolyl, p-bromo-phenyl, p-chloro-phenyl, p-fluorophenyl; (b) R2 is hydrogen or CH 3 ; 10 (c) R is H and R3b is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, or lower cycloalkyl; (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yi, N 15 methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; (e) R 5 is H, CN, CH 2 F, F, Cl, Br, or I; with the proviso that X is OH, R is CH 3 or CH 2 F, R 5 cannot be H; (f) R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , or F; (g) X is H, OH, F, OCH 3 , F, Cl, Br, I, NH 2 or N 3 ; 20 (h) Y is H, OH, CH 3 , F, Cl, Br, I, NH 2 or N 3 , OCH 3 , or OC(O)CH 3 ; (i) R'o is NH 2 and R" is H, F, Br, I, OH, OR', NH 2 , NHR', NR' 2 ,
CO
2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or CH=CHCO 2 R'; wherein R' is a lower alkyl, a lower cycloalkyl, or C(O)(lower alkyl) or alternatively, in the instance of NR' 2 , each R' comprise at least one C atom that 25 are joined to form a heterocycle comprising at least two carbon atoms; and (j) Z is N or CR' 2 ; and Co R 12 is an H, halogen (including F, Cl, Br, I), OR', NH 2 , NHR', NR' 2 , NO 2 , lower alkyl of CI-C 6 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or
CH=CHCO
2 R'. An eighth aspect of the third embodiment is directed to a compound 5 represented by formula 1-5 wherein (a) R1 is hydrogen, methyl, ethyl, n-propyl, i-propyl, phenyl, p-tolyl, p-bromo-phenyl, p-chloro-phenyl, p-fluorophenyl; (b) R 2 is hydrogen; 10 (c) R 3 a is H and R 3 b is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, or lower cycloalkyl; (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N 15 methyl-piperidin-4-yl, lower haloalkyl; (e) R is H, with the provisos that when X is OH, R6 is CH 3 or CH 2 F,
R
5 cannot be H; (f) R is H, CH 3 , CH 2 F, CHF 2 , CF 3 , or F; (g) X is H, OH, OCH 3 , F, NH 2 or N 3 ; 20 (h) Y is OH, NH 2 , OCH 3 , or OC(O)CH 3 ; (i) R' is NH 2 and R" is H, F, Br, I, OH, OR', NH 2 , NHR', NR' 2 ,
CO
2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or CH=CHCO 2 R'; wherein R' is a lower alkyl, a lower cycloalkyl, or C(O)(lower alkyl) or alternatively, in the instance of NR' 2 , each R' comprise at least one C atom that 25 are joined to form a heterocycle comprising at least two carbon atoms; and ) Z is N or CR 1; and R 1 is an H, halogen (including F, Cl, Br, I), OR', NH 2 , NHR', NR' 2 , NO 2 , lower alkyl of CI-C 6 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or
CH=CHCO
2 R'. A ninth aspect of the third embodiment is directed to a compound 5 represented by formula 1-5 wherein (a) R' is hydrogen, methyl, phenyl, p-bromo-phenyl, p-chloro phenyl, p-fluorophenyl; (b) R 2 is hydrogen; 10 (c) R 3 is H and R3b is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, or lower cycloalkyl; (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, or N-methyl-pyrrolidin-4-yl, 15 lower haloalkyl, or di(lower alkyl)amino-lower alkyl; (e) R 5 is H, with the provisos that when X is OH, R 6 is CH 3 or CH 2 F, R5 cannot be H; 6I (f) R6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , or F; (g) X is H, OH, OCH 3 , F, NH 2 or N 3 ; 20 (h) Y is OH, NH 2 , OCH 3 , or OC(O)CH 3 ; (i) R'" is NH 2 and R" is H, F, Br, I, OH, OR', NH 2 , NHR', NR' 2 ,
CO
2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or CH=CHCO 2 R'; wherein R' is a lower alkyl, a lower cycloalkyl, or C(O)(lower alkyl) or alternatively, in the instance of NR' 2 , each R' comprise at least one C atom that 25 are joined to form a heterocycle comprising at least two carbon atoms; and (j) Z is N or CR 2 ; and R12 is an H, halogen (including F, Cl, Br, I), OR', NH 2 , NHR', NR' 2 , NO 2 , lower alkyl of CI-C 6 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or
CH=CHCO
2 R'. 5 A tenth aspect of the third embodiment is directed to a compound represented by formula 1-6 Rio R3b R 2 O N R3a N- P* N N R C0 2
R
4 ORR Y X 1-6 wherein 10 (a) R' is hydrogen, n-alkyl; branched alkyl; cycloalkyl; or aryl, which includes, but is not limited to, phenyl or naphthyl, where phenyl or naphthyl are optionally substituted with at least one of Ci.6 alkyl, C 2 -6 alkenyl, C 2
-
6 alkynyl,
C
1 -6 alkoxy, F, Cl, Br, 1, nitro, cyano, CI- 6 haloalkyl, -N(R') 2 , C 1
-
6 acylamino, NHSO 2 CI-6 alkyl, -S0 2
N(R')
2 , COR'", and -SO 2 Ci-6 alkyl; (R" is independently 15 hydrogen or alkyl, which includes, but is not limited to, CI- 20 alkyl, C 1
.
1 0 alkyl, or C-6 alkyl, Rr is -OR' or -N(R")2); (b) R 2 is hydrogen or CH 3 ; (c) R 3 a and R 3 b are (i) independently selected from hydrogen, CI., 0 alkyl, cycloalkyl, -(CH 2 )c(NR 3
)
2 , CI- 6 hydroxyalkyl, -CH 2 SH, -(CH 2
)
2 S(O)dMe, 20 (CH 2
)
3
NHC(=NH)NH
2 , (1 H-indol-3-yl)methyl, (1 H-imidazol-4-yl)methyl, (CH 2 )eCOR3", aryl and aryl CI- 3 alkyl, said aryl groups optionally substituted with a group selected from hydroxyl, C 1
-
1 0 alkyl, CI- 6 alkoxy, halogen, nitro and cyano; (ii) R3a and R 3 b both are CI.6 alkyl; (iii) R3a and R 3 b together are(CH 2 )f so 41 as to form a spiro ring; (iv) R 3 a is hydrogen and R 3 b and R 2 together are (CH 2 )n so as to form a cyclic ring that includes the adjoining N and C atoms (v) R 0 is hydrogen and R 3 a and R 2 together are (CH 2 )n so as to form a cyclic ring that includes the adjoining N and C atoms, where c is 1 to 6, d is 0 to 2, e is 0 to 3, f 5 is 2 to 5, n is 2 to 4, and where R 3 is independently hydrogen or C 1
.
6 alkyl and
R
3 is -OR' or -N(R 3
)
2 ); (vi) R 3 a is H and R 3 b is H, CH 3 , CH 2
CH
3 , CH(CH 3
)
2 ,
CH
2
CH(CH
3
)
2 , CH(CH 3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, -CH 2
CH
2
SCH
3 ,
CH
2
CO
2 H, CH 2
C(O)NH
2 , CH 2
CH
2 COOH, CH 2
CH
2
C(O)NH
2 ,
CH
2
CH
2
CH
2
CH
2
NH
2 , -CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl, 10 CH 2 OH, CH(OH)CH 3 , CH 2 ((4'-OH)-Ph), CH 2 SH, or lower cycloalkyl; or (viii)
R
3 a is CH 3 , -CH 2
CH
3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 , CH(CH 3
)CH
2
CH
3 , CH 2 Ph,
CH
2 -indol-3-yl, -CH 2
CH
2
SCH
3 , CH 2
CO
2 H, CH 2
C(O)NH
2 , CH 2
CH
2 COOH,
CH
2
CH
2
C(O)NH
2 , CH 2
CH
2
CH
2
CH
2
NH
2 , -CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4'-OH)-Ph), CH 2 SH, or lower 15 cycloalkyl and R3b is H, where R 3 is independently hydrogen or alkyl, which includes, but is not limited to, CI- 2 0 alkyl, C 1
.
1 0 alkyl, or CI- 6 alkyl, R" is -OR' or -N(R 3)2); (d) R 4 is hydrogen, CI.io alkyl, C.
10 alkyl optionally substituted with a lower alkyl, alkoxy or halogen, C1.10 haloalkyl, C 3
.
10 cycloalkyl, cycloalkyl 20 alkyl, cycloheteroalkyl, aminoacyl, di(lower alkyl)amino-lower alkyl, aryl, such as phenyl, heteroaryl, such as, pyridinyl, substituted aryl, or substituted heteroaryl; (e) R 5 is H, a lower alkyl, CN, vinyl, O-(lower alkyl), hydroxyl lower alkyl, i.e., -(CH 2 )pOH, where p is 1 -6, including hydroxyl methyl (CH 2 OH), 25 CH 2 F, N 3 , CH 2 CN, CH 2
NH
2 , CH 2
NHCH
3 , CH 2
N(CH
3
)
2 , alkyne (optionally substituted), or halogen, including F, Cl, Br, or I, with the provisos that when X is OH, base is cytosine and R 6 is H, R 5 cannot be N 3 and when X is OH, R 6 is
CH
3 or CH 2 F and B is a purine base, R 5 cannot be H; (f) R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , F, or CN; 30 (g) X is H, OH, F, OMe, Cl, Br, I, NH 2 , or N 3
;
(h) Y is OH, H, C 1 alkyl, C2-4 alkenyl, C24 alkynyl, vinyl, N 3 , CN, Cl, Br, F, I, NO 2 , OC(O)O(Cia alkyl), OC(O)O(Cia alkyl), OC(O)O(C2A alkynyl), OC(O)O(C24 alkenyl), OC- 1 i 0 haloalkyl, O(aminoacyl), O(CI-o acyl),
O(CI
4 alkyl), O(C 24 alkenyl), S(CIA acyl), S(CI4 alkyl), S(C24 alkynyl), S(C24 5 alkenyl), SO(CI 4 acyl), SO(CIA alkyl), SO(C24 alkynyl), SO(C24 alkenyl),
SO
2
(C
14 acyl), SO 2
(C
1 .4 alkyl), SO 2
(C
24 alkynyl), SO 2
(C
24 alkenyl), OS(0) 2 (C I. 4 acyl), OS(O)2(C14 alkyl), OS(0)2(C24 alkenyl), NH 2 , NH(C 1 4 alkyl), NH(C24 alkenyl), NH(C 2 4 alkynyl), NH(CI4 acyl), N(Ci- alkyl) 2 , N(CIs 18 acyl)2, wherein alkyl, alkynyl, alkenyl and vinyl are optionally substituted by N 3 , CN, 10 one to three halogen (Cl, Br, F, I), NO 2 , C(O)O(CI4 alkyl), C(O)O(CI4 alkyl), C(O)O(C24 alkynyl), C(O)O(C24 alkenyl), O(CI4 acyl), O(C 1 .4 alkyl), O(C 2 -4 alkenyl), S(CIA acyl), S(C 1 4 alkyl), S(C24 alkynyl), S(C24 alkenyl), SO(CI4 acyl), SO(CIA alkyl), SO(C 2 4 alkynyl), SO(C 24 alkenyl), S0 2
(C
14 acyl), SO2(CI4 alkyl), SO2(C24 alkynyl), SO 2
(C
2 4 alkenyl), OS(0) 2
(C.
4 acyl), 15 OS(O)2(Cia alkyl), OS(O) 2
(C
2 4 alkenyl), NH 2 , NH(CI4 alkyl), NH(C 2 4 alkenyl), NH(C 24 alkynyl), NH(C 1 4 acyl), N(CI.4 alkyl) 2 , N(Cia acyl) 2 ; (i) R' 0 and R" are independently H, F, Br, I, OH, OR', NH 2 , NHR',
NR'
2 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or CH=CHCO 2 R', with the proviso that when R' 0 is OH and R" is not NH 2 ; 20 wherein R' is a lower alkyl, a lower cycloalkyl, or C(O)(lower alkyl) or alternatively, in the instance of NR' 2 , each R' comprise at least one C atom that are joined to form a heterocycle comprising at least two carbon atoms; and (j) Z is N or CR1 2 ; and R 1 is an H, halogen (including F, Cl, Br, I), OR', NH 2 , NHR', NR' 2 , NO 2 , 25 lower alkyl of CI-C 6 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H. or
CH:=CHCO
2 R'. An eleventh aspect of the third embodiment is directed to a compound represented by formula 1-6 wherein tK;j (a) R 1 is hydrogen, methyl, ethyl, n-propyl, i-propyl, phenyl, p-tolyl, p-bromo-phenyl, p-chloro-phenyl, p-fluorophenyl; (b) R 2 is hydrogen or CH 3 ; (c) R 3 , is H and R 3 A is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 , 5 CH(CH 3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, -CH 2
CH
2
SCH
3 , CH 2
CO
2 H,
CH
2
C(O)NH
2 , CH 2
CH
2 COOH, CH 2
CH
2
C(O)NH
2 , CH 2
CH
2
CH
2
CH
2
NH
2 , CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4' OH)-Ph), CH 2 SH, or lower cycloalkyl; (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, 10 cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; (e) R 5 is H, CN, CH 3 , OCH 3 , CH 2 OH, CH 2 F, halogen, including F, Cl, Br, or I, with the provisos that when X is OH, R 6 is CH 3 or CH 2 F, R 5 cannot 15 be H; (f) R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , F, or CN; (g) X is H, OH, F, OCH 3 , Cl, Br, I, NH 2 , or N 3 ; (h) Y is OH, H, ClH 3 , vinyl, NH 2 , N 3 , CN, Cl, Br, F, I, OC(O)CH 3 ,
OCH
3 ; 20 (i) R' 0 and R 1 are independently H, F, Br, I, OH, OR', NH 2 , NHR',
NR'
2 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or CH=CHCO 2 R', with the proviso that when R' 0 is OH and R 1 is not NH 2 ; wherein R' is a lower alkyl, a lower cycloalkyl, or C(O)(lower alkyl) or alternatively, in the instance of NR' 2 , each R' comprise at least one C atom that 25 are joined to form a heterocycle comprising at least two carbon atoms; and (j) Z is N or CR 2 ; and A tA R 12is an H, halogen (including F, Cl, Br, 1), OR', NH 2 , NHR', NR' 2 , NO 2 , lower alkyl of CI-C 6 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or
CH=CHCO
2 R'. 5 A twelvth aspect of the third embodiment is directed to a compound represented by formula 1-6 wherein (a) R 1 is hydrogen, methyl, ethyl, n-propyl, i-propyl, phenyl, p-tolyl, p-bromo-phenyl, p-chloro-phenyl, p-fluorophenyl; 10 (b) R 2 is hydrogen or CH 3 ; (c) R 3 a is H and R'b is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, or lower cycloalkyl; (d) R4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N 15 methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; (e) Rs is H, CN, CH 2 F, F, Cl, Br, or I, with the provisos that when X is OH, R6 is CH 3 or CH 2 F, R5 cannot be H; (f R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , or F; 20 (g) X is H, OH, F, OCH 3 , F, Cl, Br, I, NH 2 or N 3 ; (h) Y is H, OH, CH 3 , F, Cl, Br, I, NH 2 or N 3 , OCH 3 , or OC(O)CH 3 ; (i) R'" and R" are independently H, F, Br, I, OH, OR', NH 2 , NHR',
NR'
2 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or CH=CHCO 2 R', with the proviso that when R' 0 is OH and R 1 is not NH 2 ; 25 wherein R' is a lower alkyl, a lower cycloalkyl, or C(O)(lower alkyl) or alternatively, in the instance of NR' 2 , each R' comprise at least one C atom that are joined to form a heterocycle comprising at least two carbon atoms; and (j) Z is N or CR 2 ; and R 1 is a H, halogen (including F, Cl, Br, I), OR', NH 2 , NHR', NR' 2 , NO 2 , lower alkyl of CI-C 6 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or
CH=CHCO
2 R'. 5 A thirteenth aspect of the third embodiment is directed to a compound represented by formula 1-6 wherein (a) R' is hydrogen, methyl, ethyl, n-propyl, i-propyl, phenyl, p-tolyl, p-bromo-phenyl, p-chloro-phenyl, p-fluorophenyl; 10 (b) R 2 is hydrogen; (c) R is H and R 3 b is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, or lower cycloalkyl; (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N 15 methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; (e) R 5 is H, with the provisos that when X is OH, R 6 is CH 3 or CH 2 F,
R
5 cannot be H; (f) R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , or F; 20 (g) X is H, OH, OCH 3 , F, NH 2 or N 3 ; (h) Y is OH, NH 2 , OCH 3 , or OC(O)CH 3 ; (i) R" 0 and R" are independently H, F, Br, I, OH, OR', NH 2 , NHR',
NR'
2 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or CH=CHCO 2 R', with the proviso that when R1 0 is OH and R" is not NH 2
;
wherein R' is a lower alkyl, a lower cycloalkyl, or C(O)(lower alkyl) or alternatively, in the instance of NR' 2 , each R' comprise at least one C atom that are joined to form a heterocycle comprising at least two carbon atoms; and (j) Z is N or CR 12 ; and 5 R 12 is an H, halogen (including F, Cl, Br, I), OR', NH 2 , NHR', NR' 2 , NO 2 , lower alkyl of CI-C 6 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or
CH=CHCO
2 R'. A fourteenth aspect of the third embodiment is directed to a compound represented by formula 1-6 10 wherein (a) R 1 is hydrogen, methyl, phenyl, p-bromo-phenyl, p-chloro phenyl, p-fluorophenyl; (b) R2 is hydrogen; (c) R is H and R 3 b is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 , 15 CH(CH 3
)CH
2
CH
3 , CH 2 Ph, or lower cycloalkyl; (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; 20 (e) R 5 is H, with the provisos that when X is OH, R 6 is CH 3 or CH 2 F,
R
5 cannot be H; (f) R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , or F; (g) X is H, OH, OCH 3 , F, NH 2 or N 3 ; (h) Y is OH, NH 2 , OCH 3 , or OC(O)CH 3
;
(i) R" 0 and R" are independently H, F, Br, I, OH, OR', NH 2 , NHR',
NR'
2 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or CH=CHCO 2 R', with the proviso that when R1 0 is OH and R" is not NH 2 ; wherein R' is a lower alkyl, a lower cycloalkyl, or C(O)(lower alkyl) or 5 alternatively, in the instance of NR' 2 , each R' comprise at least one C atom that are joined to form a heterocycle comprising at least two carbon atoms; and () Z is N or CR 2 ; and R 1 is an H, halogen (including F, Cl, Br, I), OR', NH 2 , NHR', NR' 2 , NO 2 , lower alkyl of Ci-C 6 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or 10 CH=CHCO 2 R'. A fifteenth aspect of the third embodiment is directed to a compound represented by formula 1-6 wherein (a) R1 is hydrogen, n-alkyl; branched alkyl; cycloalkyl; or aryl, which 15 includes, but is not limited to, phenyl or naphthyl, where phenyl or naphthyl are optionally substituted with at least one of CI- 6 alkyl, C 2
-
6 alkenyl, C 2
-
6 alkynyl, C - 6 alkoxy, F, Cl, Br, I, nitro, cyano, C 1
.
6 haloalkyl, -N(R 1
)
2 , CI- 6 acylamino, NHSO 2 CI-6 alkyl, -SO 2
N(R")
2 , COR', and -SO 2
CI-
6 alkyl; (R" is independently hydrogen or alkyl, which includes, but is not limited to, CI- 2 0 alkyl, C 1 .1o alkyl, 20 or C 1
.
6 alkyl, Rr is -OR' or -N(R)2); (b) R 2 is hydrogen or CH 3 ; (c) R and R are (i) independently selected from hydrogen, CI-io alkyl, cycloalkyl, -(CH 2 )c(NR ) 2 , Ci.
6 hydroxyalkyl, -CH 2 SH, -(CH 2
)
2 S(O)dMe, (CH.2) 3
NHC(=NH)NH
2 , (1 H-indol-3-yl)methyl, (1 H-imidazol-4-yl)methyl, 25 (CH:2)eCOR 3 , aryl and aryl CI.
3 alkyl, said aryl groups optionally substituted with a group selected from hydroxyl, CI.Io alkyl, CI.
6 alkoxy, halogen, nitro and cyano; (ii) R and R 3 b both are CI- 6 alkyl; (iii) R a and R 3 b together are(CH 2 )f so as to form a spiro ring; (iv) R 3 a is hydrogen and R 3 b and R 2 together are (CH 2 )n so as to form a cyclic ring that includes the adjoining N and C atoms (v) R 3 b is 4O hydrogen and R3a and R2 together are (CH 2 )n so as to form a cyclic ring that includes the adjoining N and C atoms, where c is 1 to 6, d is 0 to 2, e is 0 to 3, f is 2 to 5, n is 2 to 4, and where R 3 ' is independently hydrogen or C 1 -6 alkyl and
R
3 " is -OR' or -N(R 3
)
2 ); (vi) R 3 a is H and R 3 b is H, CH 3 , CH 2
CH
3 , CH(CH 3
)
2 , 5 CH 2
CH(CH
3
)
2 , CH(CH 3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, -CH 2
CH
2
SCH
3 ,
CH
2
CO
2 H, CH 2
C(O)NH
2 , CH 2
CH
2 COOH, CH 2
CH
2
C(O)NH
2 ,
CH
2
CH
2
CH
2
CH
2
NH
2 , -CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl,
CH
2 OH, CH(OH)CH 3 , CH 2 ((4'-OH)-Ph), CH 2 SH, or lower cycloalkyl; or (viii) 3a i C2HC2h R is CH 3 , -CH 2
CH
3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 , CH(CH 3
)CH
2
CH
3 , CH 2 Ph, 10 CH 2 -indol-3-yl, -CH 2
CH
2
SCH
3 , CH 2
CO
2 H, CH 2
C(O)NH
2 , CH 2
CH
2 COOH,
CH
2
CH
2
C(O)NH
2 , CH 2
CH
2
CH
2
CH
2
NH
2 , -CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4'-OH)-Ph), CH 2 SH, or lower cycloalkyl and R 3 b is H, where R 3 is independently hydrogen or alkyl, which includes, but is not limited to, C 1
-
2 0 alkyl, CI.
10 alkyl, or C 1
.
6 alkyl, R3" is -OR' or 15 -N(R ) 2 ); (d) R4 is hydrogen, CI.Io alkyl, CI-io alkyl optionally substituted with a lower alkyl, alkoxy or halogen, CI.10 haloalkyl, C 3
-
10 cycloalkyl, cycloalkyl alkyl, cycloheteroalkyl, aminoacyl, di(lower alkyl)amino-lower alkyl, aryl, such as phenyl, heteroaryl, such as, pyridinyl, substituted aryl, or substituted 20 heteroaryl; (e) R 5 is H, a lower alkyl, CN, vinyl, O-(lower alkyl), hydroxyl lower alkyl, i.e., -(CH 2 )pOH, where p is 1 -6, including hydroxyl methyl (CH 2 OH),
CH
2 F, N 3 , CH 2 CN, CH 2
NH
2 , CH 2
NHCH
3 , CH 2
N(CH
3
)
2 , alkyne (optionally substituted), or halogen, including F, Cl, Br, or I, with the provisos that when X 25 is OH, base is cytosine and R 6 is H, R 5 cannot be N 3 and when X is OH, R 6 is
CH
3 or CH 2 F and B is a purine base, R 5 cannot be H; (f) R is H, CH 3 , CH 2 F, CHF 2 , CF 3 , F, or CN; (g) X is H, OH, F, OMe, halogen, NH 2 , or N 3 ; (h) Y is OH, H, C14 alkyl, C24 alkenyl, C24 alkynyl, vinyl, N 3 , CN, 30 Cl, Br, F, 1, NO 2 , OC(O)O(CI.4 alkyl), OC(O)O(C1.4 alkyl), OC(O)O(C24 alkynyl), OC(O)O(C2-4 alkenyl), OCI 10 haloalkyl, O(aminoacyl), O(C 1 io acyl),
A~O
O(C
1 4 alkyl), O(C 24 alkenyl), S(C 14 acyl), S(C A alkyl), S(C 2 4 alkynyl), S(C24 alkenyl), SO(CIA acyl), SO(C14 alkyl), SO(C 24 alkynyl), SO(C24 alkenyl), S02(CI.4 acyl), SO2(CIA alkyl), SO 2
(C
24 alkynyl), SO2(C24 alkenyl), OS(0) 2 (Ci. 4 acyl), OS(0) 2 (Ci 4 alkyl), OS(0)2(C24 alkenyl), NH 2 , NH(C1A alkyl), NH(C24 5 alkenyl), NH(C 2 4 alkynyl), NH(C1A acyl), N(C14 alkyl) 2 , N(CI 18 acyl) 2 , wherein alkyl, alkynyl, alkenyl and vinyl are optionally substituted by N 3 , CN, one to three halogen (Cl, Br, F, I), NO 2 , C(O)O(CI1 alkyl), C(O)O(C 1 4 alkyl),
C(O)O(C
24 alkynyl), C(O)O(C24 alkenyl), O(CI 4 acyl), O(CI4 alkyl), O(C24 alkenyl), S(C1A acyl), S(C 1 4 alkyl), S(C 2 4 alkynyl), S(C 24 alkenyl), SO(CI4 10 acyl), SO(CI4 alkyl), SO(C 24 alkynyl), SO(C 24 alkenyl), SO 2
(C
1 4 acyl), SO2(CIA alkyl), S0 2
(C
2 4 alkynyl), SO 2
(C
24 alkenyl), OS(O)2(CA acyl),
OS(O)
2
(C
1 4 alkyl), OS(O)2(C24 alkenyl), NH 2 , NH(C1A alkyl), NH(C24 alkenyl), NH(C 2 4 alkynyl), NH(Ci4 acyl), N(C1A alkyl) 2 , N(CI 4 acyl) 2 ; (i) R" is NH 2 and R" is H, F, Br, I, OH, OR', NH 2 , NHR', NR' 2 , 15 CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or CH=CHCO 2 R'; wherein R' is a lower alkyl, a lower cycloalkyl, or C(O)(lower alkyl) or alternatively, in the instance of NR' 2 , each R' comprise at least one C atom that are joined to form a heterocycle comprising at least two carbon atoms; and () Z is Nor CR 2 ; and 20 R 12 is an H, halogen (including F, Cl, Br, I), OR', NH 2 , NHR', NR' 2 , NO 2 , lower alkyl of CI-C 6 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or
CH=CHCO
2 R'. An sixteenth aspect of the third embodiment is directed to a compound represented by formula 1-6 25 wherein (a) R' is hydrogen, methyl, ethyl, n-propyl, i-propyl, phenyl, p-tolyl, p-bromo-phenyl, p-chloro-phenyl, p-fluorophenyl; (b) R2 is hydrogen or CH 3 ; '7A (c) R is H and R is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, -CH 2
CH
2
SCH
3 , CH 2
CO
2 H,
CH
2
C(O)NH
2 , CH 2
CH
2 COOH, CH 2
CH
2
C(O)NH
2 , CH 2
CH
2
CH
2
CH
2
NH
2 , CH 2
(H
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4' 5 OH)-Ph), CH 2 SH, or lower cycloalkyl; (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; 10 (e) R 5 is H, CN, CH 3 , OCH 3 , CH 2 OH, CH 2 F, halogen, including F, Cl, Br, or I, with the provisos that when X is OH, R 6 is CH 3 or CH 2 F, R 5 cannot be H; (f) R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , F, or CN; (g) X is H, OH, F. OCH 3 , Cl, Br, I, NH 2 , or N 3 ; 15 (h) Y is OH, H, CH 3 , vinyl, NH 2 , N 3 , CN, Cl, Br, F, I, OC(O)CH 3 , OCHl3; (i) R' 0 is NH 2 and R" is H, F, Br, I, OH, OR', NH 2 , NHR', NR' 2 ,
CO
2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or CH=CHCO 2 R'; wherein R' is a lower alkyl, a lower cycloalkyl, or C(O)(lower alkyl) or 20 alternatively, in the instance of NR' 2 , each R' comprise at least one C atom that are joined to form a heterocycle comprising at least two carbon atoms; and () Z is N or CR 12 ; and R 2 is an H, halogen (including F, Cl, Br, I), OR', NH 2 , NHR', NR' 2 , NO 2 , lower alkyl of CI-C 6 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or 25 CH=CHCO 2 R'. A seventeenth aspect of the third embodiment is directed to a compound represented by formula 1-6 '71 wherein (a) R' is hydrogen, methyl, ethyl, n-propyl, i-propyl, phenyl, p-tolyl, p-bromo-phenyl, p-chloro-phenyl, p-fluorophenyl; (b) R 2 is hydrogen or CH 3 ; 5 (c) R is H and R 3 b is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, or lower cycloalkyl; (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N 10 methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; (e) R 5 is H, CN, CH 2 F, F, Cl, Br, or I, with the provisos that when X is OI, R 6 is CH 3 or CH 2 F, R 5 cannot be H; (f) R6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , or F; (g) X is H, OH, F, OCH 3 , F, Cl, Br, I, NH 2 or N 3 ; 15 (h) Y is H, OH, CH 3 , F, Cl, Br, I, NH 2 or N 3 , OCH 3 , or OC(O)CH 3 ; (i) R'" is NH 2 and R" is H, F, Br, I, OH, OR', NH 2 , NHR', NR' 2 ,
CO
2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or CH=CHCO 2 R'; wherein R' is a lower alkyl, a lower cycloalkyl, or C(O)(lower alkyl) or alternatively, in the instance of NR' 2 , each R' comprise at least one C atom that 20 are joined to form a heterocycle comprising at least two carbon atoms; and (j) Z is N or CR12; and R 1 is an H, halogen (including F, Cl, Br, I), OR', NH 2 , NHR', NR' 2 , NO 2 , lower alkyl of C 1
-C
6 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or
CH=CHCO
2 R'. 25 An eighteenth aspect of the third embodiment is directed to a compound represented by formula 1-6 wherein (a) R1 is hydrogen, methyl, ethyl, n-propyl, i-propyl, phenyl, p-tolyl, p-bromo-phenyl, p-chloro-phenyl, p-fluorophenyl; (b) R2 is hydrogen; 5 (c) R 3 , is H and R 3 " is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH((H
3
)CH
2
CH
3 , CH 2 Ph, or lower cycloalkyl; (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N 10 methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; (e) R 5 is H, with the provisos that when X is OH, R 6 is CH 3 or CH 2 F, R cannot be H; (f) R6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , or F; (g) X is H, OH, OCH 3 , F, NH 2 or N 3 ; 15 (h) Y is OH, NH 2 , OCH 3 , or OC(O)CH 3 ; (i) R'" is NH 2 and R" is H, F, Br, I, OH, OR', NH 2 , NHR', NR' 2 ,
CO
2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or CH=CHCO 2 R'; wherein R' is a lower alkyl, a lower cycloalkyl, or C(O)(lower alkyl) or alternatively, in the instance of NR' 2 , each R' comprise at least one C atom that 20 are joined to form a heterocycle comprising at least two carbon atoms; and () Z is N or CR 2 ; and R 1 is an H, halogen (including F, Cl, Br, I), OR', NH 2 , NHR', NR' 2 , NO 2 , lower alkyl of CI-C 6 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or
CH=CHCO
2 R'. 25 A ninteenth aspect of the third embodiment is directed to a compound represented by formula 1-6 wherein (a) R1 is hydrogen, methyl, phenyl, p-bromo-phenyl, p-chloro phenyl, p-fluorophenyl; (b) R 2 is hydrogen; 5 (c) R' is H and R is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, or lower cycloalkyl; (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N 10 methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; (e) R is H, with the provisos that when X is OH, R is CH 3 or CH 2 F, R5 cannot be H; (f) R6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , or F; (g) X is H, OH, OCH 3 , F, NH 2 or N 3 ; 15 (h) Y is OH, NH 2 , OCH 3 , or OC(O)CH 3 ; (i) R'" is NH 2 and R" are independently H, F, Br, 1, OH, OR', NH 2 , NHR', NR' 2 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or
CH=CHCO
2 R'; wherein R' is a lower alkyl, a lower cycloalkyl, or C(O)(lower alkyl) or 20 alternatively, in the instance of NR' 2 , each R' comprise at least one C atom that are joined to form a heterocycle comprising at least two carbon atoms; and (j) Z is N or CR1; and
R'
2 is an H, halogen (including F, Cl, Br, I), OR', NH 2 , NHR', NR' 2 , NO 2 , lower alkyl of CI-C 6 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or 25 CH=CHCO 2 R'. I 'A A fourth embodiment of the invention is directed to a compound represented by formula I in which the base is a structure represented by formula c above, where R1 1 is H and R 2 , R 3 a, R b, R, R', R', X, and Y are defined in the Summary of the Invention section above. 5 A first aspect of the fourth embodiment is directed to a compound represented by formula 1-7 RIO 7 Z R2 O N R3aN P 0 --- ON I N C0 2
R
4
OR
1
R
6 Y X 1-7 10 wherein (a) R' is hydrogen, n-alkyl; branched alkyl; cycloalkyl; or aryl, which includes, but is not limited to, phenyl or naphthyl, where phenyl or naphthyl are optionally substituted with at least one of CI.6 alkyl, C 2 -6 alkenyl, C 2 .6 alkynyl,
C
1
-
6 alkoxy, F, Cl, Br, I, nitro, cyano, CI-6 haloalkyl, -N(R') 2 , C 1
-
6 acylamino, 15 NHSO 2 CI-6 alkyl, -SO 2
N(R")
2 , COR', and -S0 2
CI-
6 alkyl; (R" is independently hydrogen or alkyl, which includes, but is not limited to, CI- 20 alkyl, Ci.
1 0 alkyl, or CI-6 alkyl, R' is -OR' or -N(R )2); (b) R2 is hydrogen or CH 3 ; (c) R 3 a and R 3 b are (i) independently selected from hydrogen, CI-Io 20 alkyl, cycloalkyl, -(CH 2 )c(NR") 2 , C 1
-
6 hydroxyalkyl, -CH 2 SH, -(CH 2
)
2 S(O)dMe, (CH 2
)
3
NHC(=NH)NH
2 , (1 H-indol-3-yl)methyl, (1 H-imidazol-4-yl)methyl, (CH 2 )eCOR 3 , aryl and aryl C 1
.
3 alkyl, said aryl groups optionally substituted with a group selected from hydroxyl, C 1
.
1 0 alkyl, C 1
.
6 alkoxy, halogen, nitro and cyano; (ii) R 3 a and R 3 b both are CI.6 alkyl; (iii) R 3 a and R 3 b together are(CH 2 )f so as to form a Spiro ring; (iv) R 3 a is hydrogen and R 3 b and R 2 together are (CH 2 )n so as -to form a cyclic ring that includes the adjoining N and C atoms (v) R 3 b is hydrogen and R3a and R 2 together are (CH 2 )n so as to form a cyclic ring that 5 includes the adjoining N and C atoms, where c is I to 6, d is 0 to 2, e is 0 to 3, f is 2 to 5, n is 2 to 4, and where R 3 is independently hydrogen or C 1 -6 alkyl and
R
3 is -OR' or -N(R 3
)
2 ); (vi) R 3 a is H and R 3 b is H, CH 3 , CH 2
CH
3 , CH(CH 3
)
2 ,
CH
2
CH(CH
3
)
2 , CH(CH 3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, -CH 2
CH
2
SCH
3 ,
CH
2
CO
2 H, CH 2
C(O)NH
2 , CH 2
CH
2 COOH, CH 2
CH
2
C(O)NH
2 , 10 CH 2
CH
2
CH
2
CH
2
NH
2 , -CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl,
CH
2 OH, CH(OH)CH 3 , CH 2 ((4'-OH)-Ph), CH 2 SH, or lower cycloalkyl; or (viii) R3a is CH 3 , -CH 2
CH
3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 , CH(CH 3
)CH
2
CH
3 , CH 2 Ph,
CH
2 -- indol-3-yl, -CH 2
CH
2
SCH
3 , CH 2
CO
2 H, CH 2
C(O)NH
2 , CH 2
CH
2 COOH,
CH
2
CH
2
C(O)NH
2 , CH 2
CH
2
CH
2
CH
2
NH
2 , -CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 15 imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4'-OH)-Ph), CH 2 SH, or lower cycloalkyl and R is H, where R 3 is independently hydrogen or alkyl, which includes, but is not limited to, C 1
-
20 alkyl, C 1
.
10 alkyl, or C 1
-
6 alkyl, R is -OR' or -N(R 3)2); (d) R 4 is hydrogen, Ci-io alkyl, CI-Io alkyl optionally substituted with 20 a lower alkyl, alkoxy or halogen, C 1
.
10 haloalkyl, C 3
.
1 0 cycloalkyl, cycloalkyl alkyl, cycloheteroalkyl, aminoacyl, di(lower alkyl)amino-lower alkyl, aryl, such as phenyl, heteroaryl, such as, pyridinyl, substituted aryl, or substituted heteroaryl; (e) R 5 is H, a lower alkyl, CN, vinyl, O-(lower alkyl), hydroxyl lower 25 alkyl, i.e., -(CH 2 )pOH, where p is 1 -6, including hydroxyl methyl (CH 2 OH),
CH
2 F, N 3 , CH 2 CN, CH 2
NH
2 , CH 2
NHCH
3 , CH 2
N(CH
3
)
2 , alkyne (optionally substituted), or halogen, including F, Cl, Br, or I, with the provisos that when X is OH, base is cytosine and R 6 is H, R 5 cannot be N 3 and when X is OH, R 6 is
CH
3 or CH 2 F and B is a purine base, R 5 cannot be H; 30 (f) R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , F, or CN; (g) X is H, OH, F, OMe, halogen, NH 2 , or N 3
;
(h) Y is OH, H, C 1 4 alkyl, C24 alkenyl, C24 alkynyl, vinyl, N 3 , CN, Cl, Br, F, I, NO 2 , OC(O)O(Ci 4 alkyl), OC(O)O(C 1 4 alkyl), OC(O)O(C24 alkynyl), OC(O)O(C24 alkenyl), OCI 10 haloalkyl, O(aminoacyl), O(Ci-Io acyl), O(CIA alkyl), O(C24 alkenyl), S(CI4 acyl), S(CI4 alkyl), S(C24 alkynyl), S(C24 5 alkenyl), SO(CIA acyl), SO(CI4 alkyl), SO(C24 alkynyl), SO(C 2 -4 alkenyl), SO2(CIA acyl), SO2(CIA alkyl), SO 2
(C
2 4 alkynyl), S0 2
(C
24 alkenyl), OS(O) 2 (Ci. 4 acyl), OS(0) 2 (Ci 4 alkyl), OS(0) 2
(C
2 4 alkenyl), NH 2 , NH(Ci4 alkyl), NH(C 2 4 alkenyl), NH(C 2 4 alkynyl), NH(CI4 acyl), N(CI4 alkyl) 2 , N(C 1
I
18 acyl) 2 , wherein alkyl, alkynyl, alkenyl and vinyl are optionally substituted by N 3 , CN, 10 one to three halogen (Cl, Br, F, I), NO 2 , C(O)O(C 1 4 alkyl), C(O)O(C 1
.
4 alkyl), C(O)O(C24 alkynyl), C(O)O(C 2 4 alkenyl), O(CIA acyl), O(CIA alkyl), O(C24 alkenyl), S(C 14 acyl), S(C 14 alkyl), S(C24 alkynyl), S(C 24 alkenyl), SO(C 14 acyl), SO(Cia alkyl), SO(C 2 -1 alkynyl), SO(C 2 4 alkenyl), SO2(C1.4 acyl), S0 2
(CI
4 alkyl), SO2(C24 alkynyl), SO2(C24 alkenyl), OS(O)2(CIA acyl), 15 OS(O) 2
(C
1 4 alkyl), OS(O) 2
(C
2 4 alkenyl), NH 2 , NH(C 14 alkyl), NH(C 2 4 alkenyl), NH(C24 alkynyl), NH(CIA acyl), N(Ci4 alkyl) 2 , N(CI4 acyl)2; (i) R" 0 is H, F, Cl, Br, I, OH, OR', SH, SR', NH 2 , NHR', NR' 2 , lower alkyl of CI-C 6 , halogenated (F, Cl, Br, I) lower alkyl of C 1
-C
6 , lower alkenyl of
C
2
-C
6 , halogenated (F, Cl, Br, I) lower alkenyl of C 2
-C
6 , lower alkynyl of C 2
-C
6 20 such as C=CH, halogenated (F, Cl, Br, I) lower alkynyl of C 2
-C
6 , lower alkoxy of CI-C 6 , halogenated (F, Cl. Br, I) lower alkoxy of CI-C 6 , CO 2 H, CO 2 R',
CONH
2 , CONHR', CONR' 2 , CH=CHCO 2 H, or CH=CHCO 2 R', wherein R' is an optionally substituted alkyl , which includes, but is not limited to, an optionally substituted CI- 2 0 alkyl, an optionally substituted C 1
.
1 0 25 alkyl, an optionally substituted lower alkyl; an optionally substituted cycloalkyl; an optionally substituted alkynyl of C 2
-C
6 , an optionally substituted lower alkenyl of C 2
-C
6 , or optionally substituted acyl, which includes but is not limited to C(O) alkyl, C(O)(Ci- 20 alkyl), C(O)(CI-o alkyl), or C(O)(lower alkyl) or alternatively, in the instance of NR' 2 , each R' comprise at least one C atom that 30 are joined to form a heterocycle comprising at least two carbon atoms; and (j) Z is N or CR' 2 ; and -7-7 R is H, halogen (including F, Cl, Br, I), OH, OR', SH, SR', NH 2 , NHR', NR'2, NO 2 lower alkyl of CI-C 6 , halogenated (F, Cl, Br, I) lower alkyl of CI-C 6 , lower alkenyl of C 2
-C
6 , halogenated (F, Cl, Br, I) lower alkenyl of C 2
-C
6 , lower alkynyl of C 2
-C
6 , halogenated (F, Cl, Br, I) lower alkynyl of C 2
-C
6 , lower alkoxy 5 of CI-C 6 , halogenated (F, Cl, Br, I) lower alkoxy of CI-C 6 , CO 2 H, CO 2 R',
CONH
2 , CONHR', CONR' 2 , CH=CHCO 2 H, or CH=CHCO 2 R'; with the proviso that R12 is not a: (i) -C=C-H, (ii) -C=CH 2 , or (iii) -NO 2 . A second aspect of the fourth embodiment is directed to a compound represented by formula 1-7 10 wherein (a) R' is hydrogen, methyl, ethyl, n-propyl, i-propyl, phenyl, p-tolyl, p-bromo-phenyl, p-chloro-phenyl, p-fluorophenyl; (b) R 2 is hydrogen or CH3; (c) R3a is H and R is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 , 15 CH(CH 3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, -CH 2
CH
2
SCH
3 , CH 2
CO
2 H,
CH
2
C(O)NH
2 , CH 2
CH
2 COOH, CH 2
CH
2
C(O)NH
2 , CH 2
CH
2
CH
2
CH
2
NH
2 , CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4' OH)-Ph), CH 2 SH, or lower cycloalkyl; (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, 20 cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; (e) R 5 is H, CN, CH 3 , OCH 3 , CH 2 OH, CH 2 F, halogen, including F, Cl, Br, or I, with the provisos that when X is OH, R 6 is CH 3 or CH 2 F, R 5 cannot 25 be H. (f) R6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , F, or CN; (g) X is H, OH, F, OCH 3 , halogen, NH 2 , or N 3 ; I7Q (h) Y is OH, H, CH7I 3 , vinyl, NH 2 , N 3 , CN, Cl, Br, F, I, OC(O)CH 3 ,
OCH
3 ; (i) R' 0 is H, F, Br, I, OH, OR', NH 2 , NHR', NR' 2 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or CH=CHCO 2 R', 5 wherein R' is a lower alkyl, a lower cycloalkyl, or C(O)(lower alkyl) or alternatively, in the instance of NR' 2 , each R' comprise at least one C atom that are joined to form a heterocycle comprising at least two carbon atoms; and 12 (j) ZisNorCR ;and 12 R is H, halogen (including F, Cl, Br, I), OR', NH 2 , NHR', NR' 2 , NO 2 , 10 lower alkyl of CI-C 6 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or
CH=CHCO
2 R'; with the proviso that R 2 is not a: (i) -C=C-H, (ii) -C=CH 2 , or (iii) -N0 2 . A third aspect of the third embodiment is directed to a compound represented by formula 1-7 15 wherein (a) R1 is hydrogen, methyl, ethyl, n-propyl, i-propyl, phenyl, p-tolyl, p-bromo-phenyl, p-chloro-phenyl, p-fluorophenyl; (b) R2 is hydrogen or CH 3 ; (c) R 3 " is H and R 3 b is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 , 20 CH(CH 3
)CH
2
CH
3 , CH 2 Ph, or lower cycloalkyl; (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; 25 (e) R 5 is H, CN, CH 2 F, F, Cl, Br, or I; with the proviso that X is OH, R6 is CH 3 or CH 2 F, R cannot be H; (f) R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , or F; '70 (g) X is H, OH, F,- OCH 3 , F, Cl, Br, I, NH 2 or N 3 ; (h) Y is H, OH, CH 3 , F, Cl, Br, I, NH 2 or N 3 , OCH 3 , or OC(O)CH 3 ; (i) R" is H, F, Br, I, OH, OR', NH 2 , NHR', NR' 2 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or CH=CHCO 2 R', 5 wherein R' is a lower alkyl, a lower cycloalkyl, or C(O)(lower alkyl) or alternatively, in the instance of NR' 2 , each R' comprise at least one C atom that are joined to form a heterocycle comprising at least two carbon atoms; and (j) Z is N or CR 1; and R 2 is H, halogen (including F, Cl, Br, I), OR', NH 2 , NHR', NR' 2 , NO 2 , 10 lower alkyl of CI-C 6 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or
CH=CHCO
2 R'; with the proviso that R' is not a: (i) -C-C-H, (ii) -C=CH 2 , or (iii) -- NO 2 . A fourth aspect of the fourth embodiment is directed to a compound represented by formula 1-7 15 wherein (a) R 1 is hydrogen, methyl, ethyl, n-propyl, i-propyl, phenyl, p-tolyl, p-bromo-phenyl, p-chloro-phenyl, p-fluorophenyl; (b) R2 is hydrogen; (c) R 3 , is H and R 3 b is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 , 20 CH(CH 3
)CH
2
CH
3 , CH 2 Ph, or lower cycloalkyl; (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; 25 (e) R 5 is H, with the provisos that when X is OH, R 6 is CH 3 or CH 2 F,
R
5 cannot be H; (f) R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , or F; (g) X is H, OH, OCH 3 , F, NH 2 or N 3 ; (h) Y is OH, NH 2 , OCH 3 , or OC(O)CH 3 ; (i) R" and R" H, F, Br, I, OH, OR', NH 2 , NHR', NR' 2 , CO 2 R', 5 CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or CH=CHCO 2 R', wherein R' is a lower alkyl, a lower cycloalkyl, or C(O)(lower alkyl) or alternatively, in the instance of NR' 2 , each R' comprise at least one C atom that are joined to form a heterocycle comprising at least two carbon atoms; and (j) Z is N or CR 2 ; and 10 R 2 is an H, halogen (including F, Cl, Br, I), OR', NH 2 , NHR', NR' 2 , NO 2 , lower alkyl of CI-C 6 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or
CH=CHCO
2 R'; with the proviso that R1 2 is not a: (i) -C=C-H, (ii) -C=CH 2 , or (iii) -NO 2 . A fifth aspect of the fourth embodiment is directed to a compound 15 represented by formula 1-7 wherein (a) R' is hydrogen, methyl, phenyl, p-bromo-phenyl, p-chloro phenyl, p-fluorophenyl; (b) R2 is hydrogen; 20 (c) R3a is H and R3A is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, or lower cycloalkyl; (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N 25 methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; 01 (e) R 5 is H, with the provisos that when X is OH, R 6 is CH 3 or CH 2 F, R cannot be H; (f) R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , or F; (g) X is H, OH, OCH 3 , F, NH 2 or N 3 ; 5 (h) Y is OH, NH 2 , OCH 3 , or OC(O)CH 3 ; (i) R" is H, F, Br, I, OH, OR', NH 2 , NHR', NR' 2 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or CH=CHCO 2 R', wherein R' is a lower alkyl, a lower cycloalkyl, or C(O)(lower alkyl) or alternatively, in the instance of NR' 2 , each R' comprise at least one C atom that 10 are joined to form a heterocycle comprising at least two carbon atoms; and (j) Z is N or CR1 2 ; and R12 is H, halogen (including F, Cl, Br, I), OR', NH 2 , NHR', NR' 2 , NO 2 , lower alkyl of Ci-C 6 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or
CH=CHCO
2 R'. 15 A sixth aspect of the fourth embodiment is directed to a compound represented by formula I-8 RIO z R3b R 2 ON N R3a N- P- O 0 N OR'
R
5 CO2R4 R6 Y X 1-8 wherein (a) R' is hydrogen, n-alkyl; branched alkyl; cycloalkyl; or aryl, which includes, but is not limited to, phenyl or naphthyl, where phenyl or naphthvl are optionally substituted with at least one of C 1
.
6 alkyl, C 2 -6 alkenyl, C 2
-
6 alkynyl,
CI-
6 alkoxy, F, Cl, Br, I, nitro, cyano, CI- 6 haloalkyl, -N(R') 2 , CI-6 acylamino, 5 NHSO 2
C
1 6 alkyl, -SO 2
N(R")
2 , COR", and -S0 2
CI-
6 alkyl; (RI, is independently hydrogen or alkyl, which includes, but is not limited to, CI- 20 alkyl, CI.Io alkyl, or C 1
.
6 alkyl, R is -OR' or -N(R )2); (b) R 2 is hydrogen or CH 3 ; (c) R 3 a and R 3 b are (i) independently selected from hydrogen, C 1 io 10 alkyl. cycloalkyl, -(CH 2 )c(NR 3
)
2 , CI- 6 hydroxyalkyl, -CH 2 SH, -(CH 2
)
2 S(O)dMe, (CH 2
)
3
NHC(=NH)NH
2 , (1 H-indol-3-yl)methyl, (1 H-imidazol-4-yl)methyl, (CH 2 )eCOR , aryl and aryl C 1
.
3 alkyl, said aryl groups optionally substituted with a group selected from hydroxyl, CIo 1 0 alkyl, C 1 6 alkoxy, halogen, nitro and cyano; (ii) R 3 a and R 3 b both are CI- 6 alkyl; (iii) R3a and R 3 b together are(CH 2 )f so 15 as to form a spiro ring; (iv) R3a is hydrogen and R 3 b and R2 together are (CH 2 )n so as to form a cyclic ring that includes the adjoining N and C atoms (v) R 3b is hydrogen and R3a and R2 together are (CH 2 )n so as to form a cyclic ring that includes the adjoining N and C atoms, where c is I to 6, d is 0 to 2, e is 0 to 3, f is 2 to 5, n is 2 to 4, and where R 3 is independently hydrogen or CI-6 alkyl and 20 R 3 is -OR' or -N(R 3
)
2 ); (vi) R 3 a is H and R 3b is H, CH 3 , CH 2
CH
3 , CH(CH 3
)
2 ,
CH
2
CH(CH
3
)
2 , CH(CH 3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, -CH 2
CH
2
SCH
3 ,
CH
2
CO
2 H, CH 2
C(O)NH
2 , CH 2
CH
2 COOH, CH 2
CH
2
C(O)NH
2 ,
CH
2
CH
2
CH
2
CH
2
NH
2 , -CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl,
CH
2 OH, CH(OH)CH 3 , CH 2 ((4'-OH)-Ph), CH 2 SH, or lower cycloalkyl; or (viii) 25 R3a is CH 3 , -CH 2
CH
3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 , CH(CH 3
)CH
2
CH
3 , CH 2 Ph,
CH
2 -indol-3-yl, -CH 2
CH
2
SCH
3 , CH 2
CO
2 H, CH 2
C(O)NH
2 , CH 2
CH
2 COOH,
CH
2
CH
2
C(O)NH
2 , CH 2
CH
2
CH
2
CH
2
NH
2 , -CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH- 2 imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4'-OH)-Ph), CH 2 SH, or lower cycloalkyl and R 3 b is H, where R 3 is independently hydrogen or alkyl, which 30 includes, but is not limited to, C 1 20 alkyl, C 11 o alkyl, or Ci.
6 alkyl, R is -OR' or -N(R 3 )2); (d) R 4 is hydrogen, C 1
.
10 alkyl, CI- 1 o alkyl optionally substituted with a lower alkyl, alkoxy or halogen, CIo 10 haloalkyl, C 3
.
10 cycloalkyl, cycloalkyl alkyl. cycloheteroalkyl, aminoacyl, di(lower alkyl)amino-lower alkyl, aryl, such as phenyl, heteroaryl, such as, pyridinyl, substituted aryl, or substituted 5 heteroaryl; (e) R 5 is H, a lower alkyl, CN, vinyl, 0-(lower alkyl), hydroxyl lower alkyl, i.e., -(CH 2 )pOH, where p is 1 -6, including hydroxyl methyl (CH 2 OH),
CH
2 F, N 3 , CH 2 CN, CH 2
NH
2 , CH 2
NHCH
3 , CH 2
N(CH
3
)
2 , alkyne (optionally substituted), or halogen, including F, Cl, Br, or I, with the provisos that when X 10 is OH, base is cytosine and R 6 is H, R 5 cannot be N 3 and when X is OH, R 6 is
CH
3 or CH 2 F and B is a purine base, R 5 cannot be H; (f) R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , F, or CN; (g) X is H, OH, F, OMe, halogen, NH 2 , or N 3 ; (h) Y is OH, H, C1.4 alkyl, C24 alkenyl, C24 alkynyl, vinyl, N 3 , CN, 15 Cl, Br, F, I, NO 2 , OC(O)O(CIA alkyl), OC(O)O(C24 alkynyl), OC(O)O(C 24 alkenyl), OCI-io haloalkyl, O(aminoacyl), O(Ci-io acyl), O(CIA alkyl), O(C24 alkenyl), S(CI4 acyl), S(CIA alkyl), S(C24 alkynyl), S(C24 alkenyl), SO(C14 acyl), SO(CI 4 alkyl), SO(C24 alkynyl), SO(C24 alkenyl), SO2(CIA acyl), S02(Cia alkyl), SO2(C24 alkynyl), SO2(C24 alkenyl), OS(0) 2 (CIA acyl), 20 OS(O)2(CIA alkyl), OS(0)2(C24 alkenyl), NH 2 , NH(CI4 alkyl), NH(C24 alkenyl), NH(C 2 4 alkynyl), NH(CI4 acyl), N(C 14 alkyl) 2 , N(Cis 18 acyl)2, wherein alkyl, alkynyl, alkenyl and vinyl are optionally substituted by N 3 , CN, one to three halogen (Cl, Br, F, I), NO 2 , C(O)O(CIA alkyl), C(O)O(CIA alkyl),
C(O)O(C
24 alkynyl), C(O)O(C2-4 alkenyl), O(CI4 acyl), O(Cia alkyl), O(C24 25 alkenyl), S(CiA acyl), S(CI4 alkyl), S(C24 alkynyl), S(C24 alkenyl), SO(CI4 acyl), SO(C14 alkyl), SO(C24 alkynyl), SO(C24 alkenyl), SO 2
(C
14 acyl), S02(CIA alkyl), SO 2
(C
2 4 alkynyl), S0 2
(C
2 4 alkenyl), OS(O) 2
(C.
4 acyl), OS(O12(C14 alkyl), OS(O)2(C24 alkenyl), NH 2 , NH(Ci4 alkyl), NH(C 2 4 alkenyl), NH(C 2 4 alkynyl), NII(CI4 acyl), N(CI4 alkyl) 2 , N(CIA acyl) 2 ; 30 (i) R' 0 is H, F, Br, 1, OH, OR', NH 2 , NHR', NR' 2 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or CH=CHCO 2 R',
OA
wherein R' is a lower alkyl, a lower cycloalkyl, or C(O)(lower alkyl) or alternatively, in the instance of NR' 2 , each R' comprise at least one C atom that are joined to form a heterocycle comprising at least two carbon atoms; and (j) Z is N or CR 1; and 5 R1 2 is H, halogen (including F, Cl, Br, I), OR', NH 2 , NHR', NR' 2 , NO 2 , lower alkyl of CI-C 6 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or
CH=CHCO
2 R'; with the proviso that when base is represented by the structure c with R 1 being hydrogen, R' is not a: (i) -C-C-H, (ii) -C=CH 2 , or (iii) -NO 2 . A seventh aspect of the fourth embodiment is directed to a compound 10 represented by formula 1-8 wherein (a) R' is hydrogen, methyl, ethyl, n-propyl, i-propyl, phenyl, p-tolyl, p-bromo-phenyl, p-chloro-phenyl, p-fluorophenyl; (b) R2 is hydrogen or CH 3 ; 15 (c) R3a is H and R3b is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, -CH 2
CH
2
SCH
3 , CH 2
CO
2 H,
CH
2
C(O)NH
2 , CH 2
CH
2 COOH, CH 2
CH
2
C(O)NH
2 , CH 2
CH
2
CH
2
CH
2
NH
2 , CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4' OH)-Ph), CH 2 SH, or lower cycloalkyl; 20 (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; (e) R 5 is H, CN, CH 3 , OCH 3 , CH 2 OH, CH 2 F, halogen, including F, 25 Cl, Br, or I, with the provisos that when X is OH, R 6 is CH 3 or CH 2 F, R 5 cannot be H; (f) R6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , F, or CN; 0C (g) X is H, OH, F, OCH 3 , halogen, NH 2 , or N 3 ; (h) Y is OH, H, CH 3 , vinyl, NH 2 , N 3 , CN, Cl, Br, F, I, OC(O)CH 3 ,
OCH
3 ; (i) R' 0 is H, F, Br, I, OH, OR', NH 2 , NHR', NR' 2 , CO 2 R', CONH 2 , 5 CONHR', CONR' 2 , CH=CHCO 2 H, or CH=CHCO 2 R', wherein R' is a lower alkyl, a lower cycloalkyl, or C(O)(lower alkyl) or alternatively, in the instance of NR' 2 , each R' comprise at least one C atom that are joined to form a heterocycle comprising at least two carbon atoms; and (j) Z is N or CR ;and 10 R1 2 is an H, halogen (including F, Cl, Br, I), OR', NH 2 , NHR', NR' 2 , NO 2 , lower alkyl of CI-C 6 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or
CH=CHCO
2 R'; with the proviso that R 2 is not a: (i) -C-C-H, (ii) -C=CH 2 , or (iii) -NO 2 . An eighth aspect of the fourth embodiment is directed to a compound 15 represented by formula 1-8 wherein (a) R' is hydrogen, methyl, ethyl, n-propyl, i-propyl, phenyl, p-tolyl, p-bromo-phenyl, p-chloro-phenyl, p-fluorophenyl; (b) R 2 is hydrogen or CH 3 ; 20 (c) R 3 a is H and R 3 b is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, or lower cycloalkyl; (d) R4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl , N 25 methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; (e) R 5 is H, CN, CH 2 F, F, Cl, Br, or I, with the provisos that when X is OH, R6 is CH 3 or CH 2 F, R5 cannot be H; (f) R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , or F; (g) X is H, OH, F, OCH 3 , F, Cl, Br, I, NH 2 or N 3 ; (h) Y is H, OH, CH 3 , F, Cl, Br, I, NH 2 or N 3 , OCH 3 , or OC(O)CH 3 ; (i) R"m is H, F, Br. I, OH, OR', NH 2 , NHR', NR' 2 , CO 2 R', CONH 2 , 5 CONHR', CONR' 2 , CH=CHCO 2 H, or CH=CHCO 2 R', wherein R' is a lower alkyl, a lower cycloalkyl, or C(O)(lower alkyl) or alternatively, in the instance of NR' 2 , each R' comprise at least one C atom that are joined to form a heterocycle comprising at least two carbon atoms; and () Z is N or CR1 2 : and 10 R1 2 is an H, halogen (including F, Cl, Br, I), OR', NH 2 , NHR', NR' 2 , NO 2 , lower alkyl of CI-C 6 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or
CH=CHCO
2 R'; with the proviso that R1 2 is not a: (i) -C-C-H, (ii) -C=CH 2 , or (iii) -NO 2 . A ninth aspect of the fourth embodiment is directed to a compound 15 represented by formula 1-8 wherein (a) R' is hydrogen, methyl, ethyl, n-propyl, i-propyl, phenyl, p-tolyl, p-bromo-phenyl, p-chloro-phenyl, p-fluorophenyl; (b) R 2 is hydrogen; 20 (c) R 3 a is H and R 3 b is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, or lower cycloalkyl; (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N 25 methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; Q,7 (e) R 5 is H, with the provisos that when X is OH, R 6 is CH 3 or CH 2 F, R5 cannot be H; () R6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , or F; (g) X is H, OH, OCH 3 , F, NH 2 or N 3 ; 5 (h) Y is OH, NH 2 , OCH 3 , or OC(O)CH 3 ; (i) R' 0 is H, F, Br, I, OH, OR', NH 2 , NHR', NR' 2 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or CH=CHCO 2 R', wherein R' is a lower alkyl, a lower cycloalkyl, or C(O)(lower alkyl) or alternatively, in the instance of NR' 2 , each R' comprise at least one C atom that 10 are joined to form a heterocycle comprising at least two carbon atoms; and (j) Z is N or CR1; and R is an H, halogen (including F, Cl, Br, I), OR', NH 2 , NHR', NR' 2 , NO 2 , lower alkyl of CI-C 6 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or
CH=CHCO
2 R'; with the proviso that R 1 is not a: (i) -C-C-H, (ii) -C=CH 2 , or 15 (iii) -NO 2 . A tenth aspect of the fourth embodiment is directed to a compound represented by formula 1-8 wherein (a) R' is hydrogen, methyl, phenyl, p-bromo-phenyl, p-chloro 20 phenyl, p-fluorophenyl; (b) R 2 is hydrogen; (c) R is H and R 3 b is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, or lower cycloalkyl; (d) R4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, 25 cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N
OO
methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; (e) R 5 is H, with the provisos that when X is OH, R 6 is CH 3 or CH 2 F,
R
5 cannot be H; 5 (f) R' is H, CH 3 , CH 2 F, CHF 2 , CF 3 , or F; (g) X is H, OH, OCH 3 , F, NH 2 or N 3 ; (h) Y is OH, NH 2 , OCH 3 , or OC(O)CH 3 ; (i) R'" is H, F, Br, I, OH, OR', NH 2 , NHR', NR' 2 , CO 2 R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or CH=CHCO 2 R', 10 wherein R' is a lower alkyl, a lower cycloalkyl, or C(O)(lower alkyl) or alternatively, in the instance of NR' 2 , each R' comprise at least one C atom that are joined to form a heterocycle comprising at least two carbon atoms; and (j) Z is N or CR 1; and R 2 is an H, halogen (including F, Cl, Br, I), OR', NH 2 , NHR', NR' 2 , NO 2 , 15 lower alkyl of CI-C 6 , CO2R', CONH 2 , CONHR', CONR' 2 , CH=CHCO 2 H, or
CH=CHCO
2 R'; with the proviso that R 1 is not a: (i) -C-C-H, (ii) -C=CH 2 , or (iii) -NO 2 . A fifth embodiment of the invention is directed to a compound represented by formula I in which the base is a structure represented by formula 20 d above, wherein R', R2, R , Rb, R 4 , R , R 6 , X, and Y are defined in the Summary of the Invention section above. The first aspect of the fifth embodiment is directed to a compound represented by formula 1-9
QO
0 N 3b R2 O NH IN 1*0 0 N R3a.. C0 2
R
4 OR' R6
NH
2 Y X 1-9 wherein (a) R1 is hydrogen, n-alkyl; branched alkyl; cycloalkyl; or aryl, which 5 includes, but is not limited to, phenyl or naphthyl, where phenyl or naphthyl are optionally substituted with at least one of CI- 6 alkyl, C 2 -6 alkenyl, C 2
-
6 alkynyl, Ct- 6 alkoxy, F, Cl, Br, I, nitro, cyano, CI- 6 haloalkyl, -N(R') 2 , CI- 6 acylamino, NHSO 2 CI-6 alkyl, -SO 2
N(R")
2 , COR'", and -SO 2 CI-6 alkyl; (R is independently hydrogen or alkyl, which includes, but is not limited to, CI- 20 alkyl, C1.10 alkyl, 10 or CI- 6 alkyl, Rr is -OR' or -N(R )2); (b) R2 is hydrogen or CH 3 ; (c) R 3 a and R 3 " are (i) independently selected from hydrogen, C,.io alkyl, cycloalkyl, -(CH 2 )c(NR 3
)
2 , CI-6 hydroxyalkyl, -CH 2 SH, -(CH 2
)
2 S(O)dMe, (CH 2
)
3
NHC(=NH)NH
2 , (1 H-indol-3-yl)methyl, (1 H-imidazol-4-yl)methyl, 15 (CH 2 )eCOR 3 , aryl and aryl C1.
3 alkyl, said aryl groups optionally substituted with a group selected from hydroxyl, C1.1o alkyl, CI- 6 alkoxy, halogen, nitro and cyano; (ii) R 3 a and R 3 b both are CI-6 alkyl; (iii) R 3 a and R 3 b together are(CH 2 )r so as to form a spiro ring; (iv) R 3 a is hydrogen and R 3 b and R 2 together are (CH 2 )n so as to form a cyclic ring that includes the adjoining N and C atoms (v) R 3 b is 20 hydrogen and R 3 a and R 2 together are (CH 2 )n so as to form a cyclic ring that includes the adjoining N and C atoms, where c is 1 to 6, d is 0 to 2, e is 0 to 3, f is 2 to 5, n is 2 to 4, and where R 3 is independently hydrogen or CI.
6 alkyl and Rr is -OR' or -N(R )2); (vi) R3a is H and R is H, CH 3 , CH 2
CH
3 , CH(CH 3
)
2 ,
CH
2
CH(CH
3
)
2 , CH(CH 3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, -CH 2
CH
2
SCH
3 , On
CH
2
CO
2 H, CH 2
C(O)NH
2 , CH 2
CH
2 COOH, CH 2
CH
2
C(O)NH
2 ,
CH
2
CH
2
CH
2
CH
2
NH
2 , -CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl,
CH
2 OH, CH(OH)CH 3 , CH 2 ((4'-OH)-Ph), CH 2 SH, or lower cycloalkyl; or (viii) R3a is CH 3 , -CH 2
CH
3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 , CH(CH 3
)CH
2
CH
3 , CH 2 Ph, 5 CH 2 -indol-3-yl, -CH 2
CH
2
SCH
3 , CH 2
CO
2 H, CH 2
C(O)NH
2 , CH 2
CH
2 COOH1,
CH
2
CH
2
C(O)NH
2 , CH 2
CH
2
CH
2
CH
2
NH
2 , -CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4'-OH)-Ph), CH 2 SH, or lower cycloalkyl and R is H, where R 3 is independently hydrogen or alkyl, which includes, but is not limited to, C 1
-
20 alkyl, C 1
.
10 alkyl, or CI.6 alkyl, R 3 is -OR' or 10 -N(R 3
)
2 ); (d) R 4 is hydrogen, C 1
.
1 0 alkyl, C 1
.
1 0 alkyl optionally substituted with a lower alkyl, alkoxy or halogen, CI- 1 0 haloalkyl, C 3
.
1 0 cycloalkyl, cycloalkyl alkyl. cycloheteroalkyl, aminoacyl, di(lower alkyl)amino-lower alkyl, aryl, such as phenyl, heteroaryl, such as, pyridinyl, substituted aryl, or substituted 15 heteroaryl; (e) R 5 is H, a lower alkyl, CN, vinyl, 0-(lower alkyl), hydroxyl lower alkyl, i.e., -(CH 2 )pOH, where p is 1 -6, including hydroxyl methyl (CH 2 OH),
CH
2 F, N 3 , CH 2 CN, CH 2
NH
2 , CH 2
NHCH
3 , CH 2
N(CH
3
)
2 , alkyne (optionally substituted), or halogen, including F, Cl, Br, or I, with the provisos that when X 20 is OH, base is cytosine and R 6 is H, R 5 cannot be N 3 and when X is OH, R 6 is
CH
3 or CH 2 F and B is a purine base, R cannot be H; (f) R6 is H, CH 3 , CH 2 F, CHIF 2 , CF 3 , F, or CN; (g) X is H, OH, F, OMe, halogen, NH 2 , or N 3 ; (h) Y is OH, H, C 14 alkyl, C 2 4 alkenyl, C 24 alkynyl, vinyl, N 3 , CN, 25 Cl, Br, F, I, NO 2 , OC(O)O(C 14 alkyl), OC(O)O(C 14 alkyl), OC(O)O(C 24 alkynyl), OC(O)O(C 2 4 alkenyl), OC 1
-
10 haloalkyl, O(aminoacyl), O(CI 10 acyl),
O(C
1
.
4 alkyl), O(C 2 4 alkenyl), S(C.
4 acyl), S(C 1 4 alkyl), S(C 24 alkynyl), S(C 24 alkenyl), SO(C 14 acyl), SO(C 14 alkyl), SO(C 2 4 alkynyl), SO(C 2 4 alkenyl), S0 2
(C.
4 acyl), S0 2 (Ci 4 alkyl), S0 2
(C
2 4 alkynyl), S0 2
(C
24 alkenyl), OS(O) 2
(C
1 . 30 4 acyl), OS(0) 2
(C
14 alkyl), OS(0) 2
(C
24 alkenyl), NH 2 , NH(Ci 4 alkyl), NH(C 24 alkenyl), NH(C 2 4 alkynyl), NH(C 1 4 acyl), N(C 14 alkyl) 2 , N(CIs 18 acyl) 2 , 01 wherein alkyl, alkynyl, alkenyl and vinyl are optionally substituted by N 3 , CN, one to three halogen (Cl, Br, F, I), NO 2 , C(O)O(C 1 .4 alkyl), C(O)O(C 14 alkyl),
C(O)O(C
24 alkynyl), C(O)O(C 24 alkenyl), O(Cia acyl), O(CI4 alkyl), O(C 2 4 alkenyl), S(CIA acyl), S(CI.4 alkyl), S(C 2 4 alkynyl), S(C24 alkenyl), SO(C.
4 5 acyl), SO(C 14 alkyl), SO(C 24 alkynyl), SO(C24 alkenyl), S0 2
(C
14 acyl), S02(C.4 alkyl), SO 2
(C
2 -4 alkynyl), SO2(C24 alkenyl), OS(0) 2
(CI
4 acyl), OS(O)2(Cia alkyl), OS(0) 2
(C
24 alkenyl), NH 2 , NH(Ci4 alkyl), NH(C24 alkenyl), NH(C 2 4 alkynyl), NH(C 1 4 acyl), N(Cia alkyl) 2 , N(C.
4 acyl) 2 . A second aspect of the fifth embodiment is directed to a compound 10 represented by formula 1-9 wherein (a) R' is hydrogen, methyl, ethyl, n-propyl, i-propyl, phenyl, p-tolyl, p-bromo-phenyl, p-chloro-phenyl, p-fluorophenyl; (b) R 2 is hydrogen or CH 3 ; 15 (c) R 3 ' is H and R 3 b is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, -CH 2
CH
2
SCH
3 , CH 2
CO
2 H,
CH
2
C(O)NH
2 , CH 2
CH
2 COOH, CH 2
CH
2
C(O)NH
2 , CH 2
CH
2
CH
2
CH
2
NH
2 , CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4' OH)-Ph), CH 2 SH, or lower cycloalkyl; 20 (d) R4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; (e) R 5 is H, CN, CH 3 , OCH 3 , CH 2 OH, CH 2 F, halogen, including F, 25 Cl, Br, or I, with the provisos that when X is OH, R 6 is CH 3 or CH 2 F, R 5 cannot be H. (f) R is H, CH 3 , CH 2 F, CHF 2 , CF 3 , F, or CN; (g) X is H, OH, F, OCH 3 , halogen, NH2, or N 3
;
(h) Y is OH, H, CH 3 , vinyl, NH 2 , N 3 , CN, Cl, Br, F, I, OC(O)CH 3 ,
OCH
3 ; A third aspect of the fifth embodiment is directed to a compound represented by formula 1-9 5 wherein (a) R' is hydrogen, methyl, ethyl, n-propyl, i-propyl, phenyl, p-tolyl, p-bromo-phenyl, p-chloro-phenyl, p-fluorophenyl; (b) R2 is hydrogen or CH 3 ; (c) R 3 a is H and R 3 b is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 , 10 CH(CH 3
)CH
2
CH
3 , CH 2 Ph, or lower cycloalkyl; (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; 15 (e) R' is H, CN, CH 2 F, F, Cl, Br, or I; with the proviso that X is OH,
R
6 is CH 3 or CH 2 F, R 5 cannot be H; (f) R is H, CH 3 , CH 2 F, CHF 2 , CF 3 , or F; (g) X is H, OH, F, OCH 3 , F, Cl, Br, I, NH 2 or N 3 ; (h) Y is H, OH, CH 3 , F, Cl, Br, I, NH 2
N
3 , OCH 3 , or OC(O)CH 3 ; 20 A fourth aspect of the fifth embodiment is directed to a compound represented by formula 1-9 wherein (a) R' is hydrogen, methyl, ethyl, n-propyl, i-propyl, phenyl, p-tolyl, p-bromo-phenyl, p-chloro-phenyl, p-fluorophenyl; 25 (b) R 2 is hydrogen; (c) R is H and R 3 b is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, or lower cycloalkyl; (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N 5 methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; (e) R 5 is H, with the provisos that when X is OH, R 6 is CH 3 or CH 2 F,
R
5 cannot be H; (f) R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , or F; 10 (g) X is H, OH, OCH 3 , F, NH 2 or N 3 ; (h) Y is OH, NH 2 , OCH 3 , or OC(O)CH 3 ; A fifth aspect of the fifth embodiment is directed to a compound represented by formula 1-9 wherein 15 (a) R' is hydrogen, methyl, phenyl, p-bromo-phenyl, p-chloro phenyl, p-fluorophenyl; (b) R 2 is hydrogen; (c) R3a is H and R 3 b is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, or lower cycloalkyl; 20 (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; (e) R 5 is H, with the provisos that when X is OH, R 6 is CH 3 or CH 2 F, 25 R 5 cannot be H; (f) R6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , or F; nil (g) X is H, OH, OCH 3 , F, NH 2 or N 3 ; (h) Y is OH, NH 2 , OCH 3 , or OC(O)CH 3 ; A sixth aspect of the fifth embodiment is directed to a compound represented by formula 1-10 0 N 3b 2 NH 1 11b I I R3a N- P 0 0N N
CO
2
R
4 OR' R5\ R 6
NH
2 5 Y X 1-10 wherein (a) R1 is hydrogen, methyl, ethyl, n-propyl, i-propyl, or a substituted or unsubstituted phenyl, where the substitutent of the substituted phenyl is at 10 least one of a CH 3 , OCH 3 , F, Cl, Br, I, nitro, cyano, and a CH3.qXq, where X is F, Cl, Br, or I, and q is 1-3; (b) R 2 is hydrogen or CH 3 ; (c) R 3 a is H and R 3 b is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, -CH 2
CH
2
SCH
3 , CH 2
CO
2 H, 15 CH 2
C(O)NH
2 , CH 2
CH
2 COOI, CH 2
CH
2
C(O)NH
2 , CH 2
CH
2
CH
2
CH
2
NH
2 , CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4' OH)-Ph), CH 2 SH, or lower cycloalkyl or R 3 a is CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, -CH 2
CH
2
SCH
3 , CH 2
CO
2 H,
CH
2
C(O)NH
2 , CH 2
CH
2 COOH, CH 2
CH
2 C(0)NH 2 , CH 2
CH
2
CH
2
CH
2
NH
2 , 20 CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4' OH)-Ph), CH 2 SH, or lower cycloalkyl and R 3 b is H; (d) R4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; 5 (e) R 5 is H, CN, CH 3 , OCH 3 , CH 2 OH, CH 2 F, N 3 , CH 2 CN, CH 2
N
3 ,
CH
2
NH
2 , CH 2
NHCH
3 , CH 2
N(CH
3
)
2 , halogen, including F, Cl, Br, or I, with the provisos that when X is OH, R6 is CH 3 or CH 2 F, R 5 cannot be H; (f) R6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , F, or CN; (g) X is H, OH, F, OCH 3 , Cl, Br, I, NH 2 , or N 3 ; 10 (h) Y is OH, H, CH 3 , vinyl, N 3 , CN, Cl, Br, F, I, OC(O)CH 3 , OCH 3 ,
NH
2 , NHCH 3 , NH(vinyl), NH(acetyl), NH(C(O)CH 3 ), N(CH 3
)
2 , N(C(O)CH 3
)
2 ; A seventh aspect of the fifth embodiment is directed to a compound represented by formula 1-10 wherein 15 (a) R' is hydrogen, methyl, ethyl, n-propyl, i-propyl, phenyl, p-tolyl, p-bromo-phenyl, p-chloro-phenyl, p-fluorophenyl; (b) R2 is hydrogen or CH 3 ; (c) R is H and RIb is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, CH 2 -indol-3-yl, -CH 2
CH
2
SCH
3 , CH 2
CO
2 H, 20 CH 2
C(O)NH
2 , CH 2
CH
2 COOH, CH 2
CH
2
C(O)NH
2 , CH 2
CH
2
CH
2
CH
2
NH
2 , CH 2
CH
2
CH
2
NHC(NH)NH
2 , CH 2 -imidazol-4-yl, CH 2 OH, CH(OH)CH 3 , CH 2 ((4' OH)-Ph), CH 2 SH, or lower cycloalkyl; (d) R4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N 25 methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; (e) R 5 is H, CN, CH 3 , OCH 3 , CH 2 OH, CH 2 F, halogen, including F, Cl, Br, or I, with the provisos that when X is OH, R is CH 3 or CH 2 F, R5 cannot be H; (f) R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , F, or CN; 5 (g) X is H, OH, F, OCH 3 , Cl, Br, I, NH 2 , or N 3 ; and (h) Y is OH, H, CH 3 , vinyl, NH 2 , N 3 , CN, Cl, Br, F, I, OC(O)CH 3 ,
OCH*
3 . An eighth aspect of the fifth embodiment is directed to a compound represented by formula 1-10 10 wherein (a) R1 is hydrogen, methyl, ethyl, n-propyl, i-propyl, phenyl, p-tolyl, p-bromo-phenyl, p-chloro-phenyl, p-fluorophenyl; (b) R 2 is hydrogen or CH 3 ; (c) R 3 a is H and R 3 b is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 , 15 CH(CH 3
)CH
2
CH
3 , CH 2 Ph, or lower cycloalkyl; (d) R4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; 20 (e) R5 is H, CN, CH 2 F, F, Cl, Br, or I, with the provisos that when X is OH, R' is CH 3 or CH 2 F, R 5 cannot be H; (f) R6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , or F; (g) X is H, OH, F, OCH 3 , F, Cl, Br, I, NH 2 or N 3 ; (h) Y is H, OH, CH 3 , F, Cl, Br, I, NH 2 or N 3 , OCH 3 , or OC(O)CH3; 25 A ninth aspect of the fifth embodiment is directed to a compound n'7 represented by formula 1-10 wherein (a) R' is hydrogen, methyl, ethyl, n-propyl, i-propyl, phenyl, p-tolyl, p-bromo-phenyl, p-chloro-phenyl, p-fluorophenyl; 5 (b) R2 is hydrogen; (c) R is H and R3b is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, or lower cycloalkyl; (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N 10 methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; (e) R is H, with the provisos that when X is OH, R6 is CH 3 or CH 2 F,
R
5 cannot be H; (f) R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , or F; 15 (g) X is H, OH, OCH 3 , F, NH 2 or N 3 ; (h) Y is OH, NH 2 , OCH 3 , or OC(O)CH 3 ; A tenth aspect of the fifth embodiment is directed to a compound represented by formula 1-10 wherein 20 (a) R1 is hydrogen, methyl, phenyl, p-bromo-phenyl, p-chloro phenyl, p-fluorophenyl; (b) R 2 is hydrogen; (c) R3a is H and R 3 b is H, CH 3 , CH(CH 3
)
2 , CH 2
CH(CH
3
)
2 ,
CH(CH
3
)CH
2
CH
3 , CH 2 Ph, or lower cycloalkyl; nQ (d) R 4 is hydrogen, CH 3 , Et, 'Pr, "Pr, "Bu, 2-butyl, 'Bu, benzyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, N-methyl-aziridin-2-yl, N methyl-azetidin-3-yl, N-methyl-pyrrolidin-3-yl, N-methyl-pyrrolidin-4-yl, N methyl-piperidin-4-yl, lower haloalkyl, or di(lower alkyl)amino-lower alkyl; 5 (e) R 5 is H, with the provisos that when X is OH, R 6 is CH 3 or CH 2 F, R5 cannot be H; (f) R 6 is H, CH 3 , CH 2 F, CHF 2 , CF 3 , or F; (g) X is H, OH, OCH 3 , F, NH 2 or N 3 ; (h). Y is OH, NH 2 , OCH 3 , or OC(O)CH 3 . 10 The following tables contain numeric identifiers associated with various substituent designators that should be viewed in light of the accompanying structure. These structures are contemplated species of the various aspects of the disclosed embodiments and are not intended to be limiting on full breadth of the contemplated compound represented by the structure of formula I. However, it 15 is contemplated that any one of the exemplified nucleoside bases can be used in combination with any one of contemplated species that specify a particular combination of R', R2, R 3a, R11, R4, R 5 , R 6 , X, and Y. In each of the presented tables, the phosphoramidate substituent containing the substituents R 3 a and R 3 b are depicted without reference to stereochemical structure (cf structures 1-1, 1-3, 20 1-5, 1-7, and 1-9 above). It is contemplated that the compounds recited below embody compounds in which R 3 a projects toward the viewer while R 3 b projects away from the viewer (cf. structures 1-2, 1-4, 1-6, 1-8, and I-10). Moreover, it is contemplated that the compounds recited below also embody compounds in which R3a projects away from the viewer while R projects towards the viewer. 25 Not meant to be limiting, however, it is contemplated that preferred compounds are those in which R 3 a projects towards the viewer and R 3 b projects away from the viewer such that the natural L-amino acid (S)-configuration is presented. Additionally, the inventors recognize that the phosphorus atom of the phosphoramidate moiety is another source of chirality. Although the structures 30 below do not specifically depict chirality at phosphorus, the inventors recognize that stereochemical configurations are possible such that in a staggered (or zig on zag) line structure the oxo-substitutent projects towards the viewer while the OR' substitutent projects away from the viewer, and vice versa, i.e., where the Cahn-Ingold-Prelog stereochemical designation of phosphorous is either R or S. Therefore, the structures below include all possible stereochemical 5 configurations possible for phosphorus.
R
9 2 O R3b N1R N 0 R3a, N- -0 C0 2
R
4 OR R 6 Y X II Table II-1. N2 R' R2 Ra Rab R' R' R' X Y R' R' R' I-1-1 CH 3 H H H CH 3 H CH 3 OH OH H H NH 2 11-1-2 CH 3 H H CH 3
CH
3 H CH 3 OH OH H H NH2 II-1-3 CH 3 H H CH(CH 3
)
2
CH
3 H CH 3 OH OH H H NH2 II-1-4 CH 3 H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 OH OH H H NH2 II-1-5 CH 3 H H CH 2 Ph CH 3 H CH 3 OH OH H H NH 2 11-1-6 CH 3 H H CH 2 -indol-3-yl CH 3 H CH 3 OH OH H H NH 2 11-1-7 CH 3 H H CH 2
CH
2
SCH
3
CH
3 H CH 3 OH OH H H NH 2 II-1-8 CH 3 * H * CH 3 H CH 3 OH OH H H NH 2
*R
7 Tand R3b joined together by (CH 2
)
3 to form five-membered ring. 10 Table 11-2. N2 RI R 2
R
3 a R 3 b R 4 R' R' X Y R 7 R R 9 II-2-1 Et H H H CH 3 H CH3 OH OH H H NH 2 II-2-2 Et H H CH 3
CH
3 H CH 3 OH OH H H NH 2 11-2-3 Et H H CH(CH 3
)
2
CR
3 H CH 3 OH OH H H NH 2 11-2-4 Et H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 OH OH H H NH 2 11-2-5 Et H H CH 2 Ph CH 3 H CH 3 OH OH H H NH 2 II-2-6 Et H H CH 2 -indol-3-yl CH 3 H CH 3 OH OH H H NH 2 Ii CH H S RI R 2
R
3 a Rab R' R R X Y R 7
R
8
R
9 H-2-7 Et H H CH 2
CH
2
SCH
3
CH
3 H CH 3 OH OH H H NH2 1-2-8 Et * H * CH3 H
CH
3 OH OH H H NH 2 *R2 and RJb joined together by (CH 2
)
3 to form five-membered ring. Table 11-3. N2 R R2 R 3 a R 3 b R' R' R' X Y R R' R 9 11-3-1 'Pr H H H CH 3 H CH 3 OH OH H H NH 2 H-3-2 'Pr H H CH 3
CH
3 H CH 3 OH OH H H NH 2 11-3-3 'Pr H H CH(CH 3
)
2
CH
3 H CH 3 OH OH H H NH 2 11-3-4 'Pr H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 OH OH H H NH 2 11-3-5 'Pr H H CH 2 Ph CH 3 H CH 3 OH OH H H NH2 11-3-6 'Pr H H CH 2 -indol-3-yl CH 3 H CH 3 OH OH H H NH 2 H-3-7 'Pr H H CH 2
CH
2
SCH
3
CH
3 H CH 3 OH OH H H NH 2 H-3-8 'Pr * H * CH 3 H CH3 OH OH H H NH2 *R and R3b joined together by (CH 2
)
3 to form five-membered ring. Table 11-4. X2 R R2 RaR 3 b R R R X Y R' R' R 9 H-4-1 'Bu H H H CH 3 H CH 3 OH OH H H NH2 1-4-2 'Bu H H CH 3
CH
3 H CH 3 OH OH H H NH 2 1-4-3 'Bu H H CH(CH 3
)
2
CH
3 H CH 3 OH OH H H NH2 11-4-4 'Bu H H CH 2
CH(CH
3
)
2 ' CH 3 H CH 3 OH OH H H NH2 11-4-5 'Bu H H CH 2 Ph CH 3 H CH 3 OH OH H H NH2 U-4-6 'Bu H H CH 2 -indol-3-yl CH 3 H CH 3 OH OH H H NH 2 11-4-7 'Bu H H CH 2
CH
2
SCH
3
CH
3 H CH 3 OH OH H H NH 2 H-4-8 'Bu* H * CH 3 H CH 3 OH OH H H NH 2 5 *R2and R3b joined together by (CH 2
)
3 to form five-membered ring. Table 11-5. X2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y R 7 R" R 9 -5-1 Ph H H H CH 3 H CH 3 OH OH H H NH 2 -5-2 Ph H H CH 3
CH
3 H CH 3 OH OH H H NH 2 11-5-3 Ph H H CH(CH 3
)
2
CH
3 H CH 3 OH OH H H NH2 11-5-4 Ph H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 OH OH H H NH2 11-5-5 Ph H H CH 2 Ph CH 3 H CH 3 OH OH H H NH 2 11-5-6 Ph H H CH 2 -indol-3-yl CH 3 H CH 3 OH OH H H NH2 H-5-7 Ph H H CH 2
CH
2
SCH
3
CH
3 H CH 3 OH OH H H NH 2 , irn~ X2 RI R 2
R
3 2 R 3 b R' R' R' X Y R' R' R' U-5-8 Ph * H * CH 3 H CH 3 OH OH H H NH2 *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table 11-6. N2 R' R R 3 a R 3 b R 4
R
5
R
6 X Y R' R 8
R
9 11- p-Me- H H H CH3 H CH 3 OH OH H H NH2 6-1 Ph II- p-Me- H H CH 3
CH
3 H CH 3 OH OH H H NH 2 6-2 Ph H- p-Me- H H CH(CH3) 2
CH
3 H CH 3 OH OH H H NH 2 6-3 Ph H- p-Me- H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 OH OH H H NH 2 6-4 Ph H- p-Me- H H CH 2 Ph CH 3 H CH 3 OH OH H H NH 2 6-5 H- p-Me- H H CH 2 -indol-3- CH 3 H CH 3 OH OH H H NH4 2 6-6 Ph YI H- p-Me- H H CH 2
CH
2
SCH
3
CH
3 H CH 3 OH OH H H NH 2 6-7 Ph H- p-Me-* H * CH 3 H CH 3 OH OH H H NH2 6-8 Ph *R and Rib joined together by (CH 2
)
3 to form five-membered ring. Table 11-7. N2 R' R 2 Ria Rb R 4 R' R 6 X Y R 7
IR
8
R
9 H-7- p-F- H H H CH 3 H CH 3 OH OH H H NH 2 1 Ph 11-7- p-F- H H CH 3
CH
3 H CH 3 OH OH H H NH2 2 Ph H-7- p-F- H H CH(CH 3
)
2
CH
3 H CH 3 OH OH H H NH 2 3 Ph 11-7- p-F- H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 OH OH H H NH 2 4 Ph U-7- p-F- H H CH 2 Ph CH 3 H CH 3 OH OH H H NH 2 6 Ph 1 A\l N2 R R2 R 3 a R 3 b R 4 R' R' X Y R' Rs RY H-7- p-F- H H CH 2 -indol-3- CH 3 H CH 3 OH OH H H NH 2 7 Ph Y H-7- p-F- H H CH 2
CH
2
SCH
3
CH
3 H CH 3 OH OH H H NH 2 8 Ph 11-7- p-F- * H * CH 3 H CH 3 OH OH H H NH 2 20 Ph *R and R~b joined together by (CH 2
)
3 to form five-membered ring. Table 11-8. N2 R' R2 RaR 3 b R 4 R' R' X Y R' R" RY II- p-Cl- H H H CH3 H CH 3 OH OH H H NH 2 8-1 Ph 11- p-Cl- H H CH 3
CH
3 H CH 3 OH OH H H NH 2 8-2 Ph H- p-Cl- H H CH(CH 3
)
2
CH
3 H CH 3 OH OH H H NH 2 8-3 Ph II- p-Cl- H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 OH OH H H NH 2 8-4 Ph H- p-Cl- H H CH 2 Ph CH 3 H CH 3 OH OH H H NH 2 8-5 Ph H- p-Cl- H H CH 2 -indol-3- CH 3 H CH 3 OH OH H H NH 2 8-6 Ph Yl 1I- p-Cl- H H CH 2
CH
2
SCH
3
CH
3 H CH 3 OH OH H H NH 2 8-7 Ph H- p-Cl- * H * CH 3 H CH 3 OH OH H H NH 2 8-8 Ph *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table 11-9. N2 Rl R2 R 3 a R 3 b R 4 R' R' X Y R' R 8
R
9 11-9- p-Br- H H H CH 3 H CH 3 OH OH H H NH 2 1 Ph 11-9- p-Br- H H CH 3
CH
3 H CH 3 OH OH H H NH 2 2 Ph 11-9- p-Br- H H CH(CH 3
)
2
CH
3 H CH 3 OH OH H H NH 2 Ph 3 N2 R' R 2 RaR 3 b R' R' R X Y R 7
R
8
R
9 H-9- p-Br- H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 OH OH H H NH 2 Ph H-9- p-Br- H H CH 2 Ph CH 3 H CH 3 OH OH H H NH 2 6 Ph 1-9- p-Br- H H CH 2 -indol-3- CH 3 H CH 3 OH OH H H NH 2 7 Ph Y 11-9- p-Br- H H CH 2
CH
2
SCH
3
CH
3 H CH 3 OH OH H H NH2 8 Ph H-9- p-Br-* H * CH 3 H CH 3 OH OH H H NH 2 20 Ph *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table II-10. N2 Rt R2 R 3 a R 3 b R 4 R' R 6 X Y R' R' R 9 H- p-I- H H H CH3 H CH 3 OH OH H H NH 2 10-1 Ph H- p-I- H H CH 3
CH
3 H CH3 OH OH H H NH 2 10-2 Ph H- p-I- H H CH(CH 3
)
2
CH
3 H CH 3 OH OH H H NH 2 10-3 Ph U- p-I- H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 OH OH H H NH 2 10-4 Ph H- p-I- H H CH 2 Ph CH 3 H CH 3 OH OH H H NH 2 10-5 Ph H- p-I- H H CH 2 -indol-3- CH 3 H CH 3 OH OH H H NH 2 10-6 PhY H- p-I- H H CH 2
CH
2
SCH
3
CH
3 H CH 3 OH OH H H NH 2 10-7 Ph H- p-I- * H * CH 3 H CH 3 OH OH H H NH2 10-8 Ph *Ra 2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table 11-l. N2 R' R2 R 3 a Rb R4 R' R 6 X Y R' R 8
R
9 H-11-1 CH 3 H H H Et H CH3 OH OH H H NH 2 11-11-2 CH 3 H H CH 3 Et H CH 3 OH OH H H NH 2 _in0 _ Xe R R 2 RaRab RRR R X Y R' R' R 9 II-11-3 CH 3 H H CH(CH 3
)
2 Et H CH 3 OH OH H H N-H2 11-11-4 CH 3 H H CH 2
CH(CH
3
)
2 Et H CH 3 OH OH H H NH 2 1-11-5 CH 3 H H CH 2 Ph Et H CH 3 OH OH H H NH 2 11-11-6 CH 3 H H CH 2 -indol-3-yl Et H CH 3 OH OH H H NH2 H-11-7 CH 3 H H CH 2
CH
2
SCH
3 Et H CH 3 OH OH H H NH 2 U-11-8 CH 3 * H * Et H CH 3 OH OH H H NH2 *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table 11-12. Xe R R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7 R" R 9 11-12-1 Et H H H Et H CH 3 OH OH H H NH 2 11-12-2 Et H H CH 3 Et H CH 3 OH OH H H NH 2 11-12-3 Et H H CH(CH 3
)
2 Et H CH 3 OH OH H H NH 2 1-12-4 Et H H CH 2
CH(CH
3
)
2 Et H CH 3 OH OH H H NH 2 H-12-5 Et H H CH 2 Ph Et H CH 3 OH OH H H NH 2 H-12-6 Et H H CH 2 -indol-3-yl Et H CH 3 OH OH H H NH2 H-12-7 Et H H CH 2 CH1 2
SCH
3 Et H CH 3 OH OH H H NH 2 11-12.-8 Et* H * Et H CH 3 OH OH H H NH 2 *R nd R~b joined together by (CH 2
)
3 to form five-membered ring. Table 11-13. X R' R2 R 3 a R b R 4 R' R' X Y R 7 R R 9 H1-13-1 'Pr H H H Et H CH 3 OH OH H H NH2 11-13-2 'Pr H H CH 3 Et H CH 3 OH OH H H NH 2 H-13--3 'Pr H H CH(CH3) 2 Et H CH 3 OH OH H H NH 2 11-13-4 'Pr H H CH 2
CH(CH
3
)
2 Et H CH 3 OH OH H H NH 2 11-13-5 'Pr H H CH 2 Ph Et H CH 3 OH OH H H NH 2 11-13--6 'Pr H H CH 2 -indol-3-yl Et H CH 3 OH OH H H NH2 11-13-7 'Pr H H CH 2
CH
2
SCH
3 Et H CH 3 OH OH H H NH 2 11-13-8 'Pr * H * tH CH 3 OH O H H NH 2 5 *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table 11-14. X R' R2 R R 3 b R4 R R 6 X Y R 7 RS R 3a 11-14-1 'Bu H H HEt H CH 3 OH OH H H NH 2 11-14-2 'Bu H H CH 3 Et H CH 3 OH OH H H NH 2 _ 1(Z X2 R' R2 R R 3 b R 4 R' R X Y R' R' R 9 3a 11-14-3 'Bu H H CH(CH 3
)
2 Et H CH 3 OH OH H H NH 2 11-14-4 'Bu H H CH 2
CH(CH
3
)
2 Et H CH 3 OH OH H H NH 2 11-14-5 'Bu H H CH 2 Ph Et H CH 3 OH OH H H NH 2 11-14-6 'Bu H H CH 2 -indol-3-yl Et H CH 3 OH OH H H NH 2 11-14-7 'Bu H H CH 2
CH
2
SCH
3 Et H CH 3 OH OH H H NH 2 H-14-8 'Bu* H * Et H CH 3 OH OH H H NH2 *RTand RJb joined together by (CH 2
)
3 to form five-membered ring. Table 11-15. N2 RI R 2
R
3 a R 3 b R4 R 5
R
6 X Y R R' R 9 11-15- Ph H H H Et H CH 3 OH OH H H NH- 2 H-15-2 Ph H H CH 3 Et H CH 3 OH OH H H NH 2 U-15-3 Ph H H CH(CH 3
)
2 Et H CH 3 OH OH H H NH 2 1-15-4 Ph H H CH 2
CH(CH
3
)
2 Et H CH 3 OH OH H H NH 2 11-15-5 Ph H H CH 2 Ph Et H CH 3 OH OH H H NH 2 H-15-6 Ph H H CH 2 -indol-3-yl Et H CH 3 OH OH H H NH- 2 1-15-7 Ph H H CH 2
CH
2
SCH
3 Et H CH 3 OH OH H H NH 2 H-15-8 Ph * H * Et H CH 3 OH OH H H NH 2 *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table 11-16. N2 R' R2 R 3 a R 3 b R 4
R
5 R' X Y R' R'R H- p-Me- H H H Et H CH 3 OH OH H~ H NH 2 16-1 Ph H- p-Me- H H CH 3 Et H CH 3 OH OH H H NH 2 16-2 Ph 11- p-Me- H H CH(CH 3
)
2 Et H CH 3 OH OH H H NH 2 16-3 Ph Hi- p-Me- H H CH 2
CH(CH
3
)
2 Et H CH 3 OH OH H H NH 2 16-4 Ph H- p-Me- H H CH 2 Ph Et H CH 3 OH OH H H NH 2 16-5 Ph H- p-Me- H H CHr-indol-3- Et H CH 3 OH OH H H NH 2 16-6 Ph YA 11- p-Me- H H CH 2
CH
2
SCH
3 Et H CH 3 OH OH H H NH 2 Ph 1 AK X2 R R 2 R3a R 3 R R' R' X Y R' R' R 9 16-7 II- p-Me- * H * Et H CH 3 OH OH H H NH 2 16-8 Ph *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table 11-17. X2 R' R 2 R"Rb R 4 R R 6 X Y R R 8
R
9 II-17- p-F- H H H Et H CH 3 OH OH H H NH 2 1 Ph H-17- p-F- H H CH 3 Et H CH 3 OH OH H H N 2 2 Ph 11-17- p-F- H H CH(CH 3
)
2 Et H CH 3 OH OH H H NH 2 3 Ph 11-17- p-F- H H CH2CH(CH 3
)
2 Et H CH 3 OH OH H H NH 2 4 Ph H-17- p-F- H H CH 2 Ph Et H CH 3 OH OH H H NH 2 5 Ph 11-17- p-F- H H CH 2 -indol-3- Et H CH 3 OH OH H H NH 2 6 Ph YI U-17- p-F- H H CH 2
CH
2
SCH
3 Et H CH 3 OH OH H H NH 2 7 Ph 11-17- p-F- * H * Et HCH 3 OH OH H H NH 2 8 Ph *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table 11-18. N2 R R 2
R
3 a R 3 b R 4 R' R" X Y R 7
R
8
R
9 H- p-Cl- H H H Et H CH 3 OH OH H H NH 2 18-1 Ph H- p-Cl- H H CH 3 Et H CH 3 OH OH H H NH 2 18-2 Ph II- p-Cl- H H CH(CH 3
)
2 Et H CH 3 OH OH H H NH 2 18-3 Ph 11- p-Cl- H H CH 2
CH(CH
3
)
2 Et H CH 3 OH OH H H NH 2 18-4 Ph II- p-Cl- H H CH 2 Ph Et H CH 3 OH OH H H NH 2 Ph 1 '7 R2 R' R 2 Raa R 3 b R 4 R' R' X Y R' R R 9 18-5 H- p-Cl- H H CH 2 -indol-3- Et H CH 3 OH OH H H NH2 18-6 Ph Yl H- p-Cl- H H CH 2
CH
2
SCH
3 Et H CH 3 OH OH H H NH 2 18-7 Ph H- p-Cl- * H * Et H CH 3 OH OH H H NH 2 18-8 Ph *R2 and R2b joined together by (CH 2
)
3 to form five-membered ring. Table II-19. X2 R R 2
R
3 a R 3 b R 4 R R 6 X Y R' R' R 9 11- p-Br- H H H Et H CH3 OH OH H H NH2 19-1 Ph H- p-Br- H H CH 3 Et H CH 3 OH OH H H NH 2 19-2 Ph H- p-Br- H H CH(CH 3
)
2 Et H CH 3 OH OH H H NH 2 19-3 Ph U- p-Br- H H CH 2
CH(CH
3
)
2 Et H CH 3 OH OH H H NH 2 19-4 Ph H- p-Br- H H CH 2 Ph Et H CH 3 OH OH H H NH2 19-5 Ph [- p-Br- H H CH 2 -indol-3- Et H CH 3 OH OH H H NH2 19-6 Ph Yl H- p-Br- H H CH 2
CH
2
SCH
3 Et H CH 3 OH OH H H NH 2 19-7 Ph H- p-Br- * H * Et H CH3 OH OH H H NH2 19-8 Ph *R2and R3b joined together by (CH 2
)
3 to form five-membered ring. Table 11-20. S R R 2
R
3
R
3 b R 4 R R' X Y R' R' R 9 H-20- p-I- H H H Et H CH 3 OH OH H H NH 2 1 Ph H-20- p-I- H H CH 3 Et H CH 3 OH OH H H NH 2 2 Ph U-20- p-I- H H CH(CH 3
)
2 Et H CH 3 OH OH H H NH 2 Ph 1 10 N9 Rl R 2
R
3 a R 3 b R' R' R' X Y R' R' R 9 3 H-20- p-I- H H CH2CH(CH 3
)
2 Et H CH 3 OH OH H H NH 2 4 Ph H-20- p-I- H H CH 2 Ph Et H CH 3 OH OH H H NH 2 5 Ph II-20- p-I- H H CH 2 -indol-3- Et H CH 3 OH OH H H NH 2 6 Ph YI II-20- p-I- H H CH 2
CH
2
SCH
3 Et H CH 3 OH OH H H NH 2 7 Ph
H-
2 0 - p-I- * H * Et H CH 3 OH OH H H NH 2 8 Ph *R" and R 3 joined together by (CH 2
)
3 to form five-membered ring. Table 11-21. N2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y R 7 R R 9 11-21-1 CH 3 H H H 'Pr H CH 3 OH OH H H NH 2 H-21-2 CH 3 H H CH 3 'Pr H CH 3 OH OH H H NH2 11-21-3 CH 3 H H CH(CH 3
)
2 'Pr H CH 3 OH OH H H NH 2 H-21-4 CH 3 H H CH 2
CH(CH
3
)
2 'Pr H CH 3 OH OH H H Nil 2 II-21-5 CH 3 H H CH 2 Ph 'Pr H CH 3 OH OH H H NH 2 11-21-6 CH 3 H H CH 2 -indol-3-yl 'Pr H CH 3 OH OH H H NH 2 II-21-7 CH3 H H CH 2
CH
2
SCH
3 'Pr H CH 3 OH OH H H NH2 11-21-8 CH 3 * H * 'Pr H CH 3 OH OH H H NH 2 *R and R joined together by (CH 2
)
3 to form five-membered ring. Table 11-22. N9 RI R 2
R
3 a R 3 b R 4 R' R 6 X Y R' Rr R 9 11-22- Et H H H 'Pr H CH 3 OH OH H H NH2 11-22-2 Et H H CH 3 'Pr H CH 3 OH OH H H NH 2 II-22-3 Et H H CH(CH3) 2 'Pr H CH 3 OH OH H H NH 2 H-22-4 Et H H CH 2
CH(CH
3
)
2 'Pr H CH 3 OH OH H H NH 2 1-22-5 Et H H CH 2 Ph 'Pr H CH 3 OH OH H H NH 2 11-22-6 Et H H CH2-indol-3-yl 'Pr H CH 3 OH OH H H NH 2 11-22-7 Et H H CH 2
CH
2
SCH
3 'Pr H CH 3 OH OH H H NH 2 1-22-8 Et* H * 'Pr H CH 3 OH OH H H NH 2 5 *R and R3b joined together by (CH 2
)
3 to form five-membered ring. 1A() Table 11-23. N2 RI R 2 Ra Rb R 4 R' R' X Y R' R 8
R
9 II-23-1 'Pr H H H 'Pr H CH 3 OH OH HH NH 2 H-23-2 'Pr H H CH 3 'Pr H CH 3 OH OH H H NH 2 U-23-3 'Pr H H CH(CH 3
)
2 'Pr H CH 3 OH OH H H NH 2 H-23-4 'Pr H H CH 2
CH(CH
3
)
2 'Pr H CH 3 OH OH H H NH2 U-23-5 'Pr H H CH 2 Ph 'Pr H CH 3 OH OH H H NH 2 U-23-6 'Pr H H CH 2 -indol-3-yl 'Pr H CH 3 OH OH H H NH2 U-23-7 'Pr H H CH 2
CH
2
SCH
3 'Pr H CH 3 OH OH H H NH2 1-23.-8 'Pr * H * 'Pr H CH 3 OH OH H H NH 2 *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table 11-24. N2 R' R2 R 3 a R 3 b R 4 R R 6 X Y R 7 R R 9 U-24-1 'Bu H H H 'Pr H CH 3 OH OH H H NH 2 11-24-2 'Bu H H CH 3 'Pr H CH 3 OH OH H H NH 2 1-24-3 'Bu H H CH(CH 3
)
2 'Pr H CH 3 OH OH H H NH2 U-24-4 'Bu H H CH 2
CH(CH
3
)
2 'Pr H CH 3 OH OH H H NH 2 U-24-5 'Bu H H CH 2 Ph 'Pr H CH 3 OH OH H H NH 2 U-24-6 'Bu H H CH 2 -indol-3-yl 'Pr H CH 3 OH OH H H NH 2 H-24-7 'Bu H H CH 2
CH
2
SCH
3 'Pr H CH 3 OH OH H H NH 2 H-24-8 'Bu* H * 'Pr H CH 3 OH OH H H NH 2 5 *Rand R3b joined together by (CH 2
)
3 to form five-membered ring. Table 11-25. N2 R' R2 R 3 a R 3 b R R R 6 X Y R 7 R R 9 U-25-1 Ph H H H 'Pr H CH 3 OH OH H H NH 2 H-25-2 Ph H H CH 3 'Pr H CH 3 OH OH H H NH 2 U-25-3 Ph H H CH(CH 3
)
2 'Pr H CH 3 OH OH H H NH 2 U-25-4 Ph H H CH 2
CH(CH
3
)
2 'Pr H CH 3 OH OH H H NH 2 U-25-5 Ph H H CH 2 Ph 'Pr H CH 3 OH OH H H NH 2 U-25-6 Ph H H CH 2 -indol-3-yl 'Pr H CH 3 OH OH H H NH 2 U-25-7 Ph H H CH 2
CH
2
SCH
3 'Pr H CH 3 OH OH H H NH 2 E-25-8 Ph * H * 'Pr H CH 3 OH OH H H NH 2 *R2 and R"b joined together by (CH 2
)
3 to form five-membered ring. -1 I _ Table 11-26. X R' R 2 Ra R 3
R
4 R R 6 X Y R 7
R
8
R
9 II- p-Me- H H H 'Pr H CH 3 OH OH H H NH 2 26-1 Ph H- p-Me- H H CH 3 'Pr H CH 3 OH OH H H NH 2 26-2 Ph II- p-Me- H H CH(CH 3
)
2 'Pr H CH 3 OH OH H H NH 2 26-3 11- p-Me- H H CH2CH(CH 3
)
2 'Pr H CH 3 OH OH H H NH2 26-4 Ph I1- p-Me- H H CH 2 Ph 'Pr H CH 3 OH OH H H NH 2 26-5 Ph H- p-Me- H H CH 2 -indol-3- 'Pr H CH 3 OH OH H H NH 2 26-6 Ph YI I- p-Me- H H CH 2
CH
2
SCH
3 'Pr H CH 3 OH OH H H NH 2 26-7 Ph H- p-Me-* H * 'Pr H CH 3 OH OH H H NH2 26-8 Ph *RT and R joined together by (CH 2
)
3 to form five-membered ring. Table 11-27. N2 R R 2 R R 3 b R 4 R' R 6 X Y R' R" R' H-27- p-F- H H H 'Pr H CH 3 OH OH H H NH 2 1 Ph 11-27- p-F- H H CH 3 Pr H CH 3 OH OH H H NH 2 2 Ph H-27- p-F- H H CH(CH 3
)
2 'Pr H CH 3 OH OH H H NH 2 3 Ph 11-27- p-F- H H CH 2
CH(CH
3
)
2 'Pr H CH 3 OH OH H H NH 2 4 Ph 11-27- p-F- H H CH 2 Ph 'Pr H CH 3 OH OH H H NH 2 5 Ph 11-27- p-F- H H CH 2 -indol-3- 'Pr H CH 3 OH OH H H NH 2 6 Phy H-27- p-F- H H CH 2
CH
2
SCH
3 'Pr H CH 3 OH OH H H NH 2 7 Ph 11 1 X2 R' R 2
R
3 Rb R R R X Y R' R R 9 ll-2 7 - p-F- * H * 'Pr H CH 3 OH OH H H NH 2 8 Ph *RTand R3b joined together by (CH 2
)
3 to form five-membered ring. Table 11-28. X2 R1 R 2
R
3 a R3b R 4
R
5
R
6 X Y R' R 8
R
9 H- p-Cl- H H H 'Pr H CH 3 OH OH H H NH 2 28-1 Ph H1- p-Cl- H H CH 3 'Pr H CH 3 OH OH H H N H2 28-2 Ph H p-Cl- H H CH(CH 3
)
2 'Pr H CH 3 OH OH H H NH2 28-3 Ph H- p-Cl- H H CH 2
CH(CH
3
)
2 'Pr H CH 3 OH OH H H NH 2 28-4 Ph 11- p-Cl- H H CH 2 Ph 'Pr H CH 3 OH OH H H NH2 28-5 Ph H- p-Cl- H H CH 2 -indol-3- 'Pr H CH 3 OH OH H H NH2 28-6 Ph yl 11- p-Cl- H H CH 2
CH
2
SCH
3 'Pr H CH 3 OH OH H H NH 2 28-7 Ph 11- p-Cl- * H * 'Pr H CH 3 OH OH H H NH 2 28-8 Ph *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table 11-29. N2 R R 2
R
3 a R 3 b R' R' R 6 X Y R R' R 9 H- p-Br- H H H 'Pr H CH 3 OH OH H H NH- 2 29-1 Ph fl- p-Br- H H CH 3 'Pr H CH 3 OH OH H H NH 2 29-2 Ph II- p-Br- H H CH(CH 3
)
2 'Pr H CH 3 OH OH H H NH 2 29-3 Ph H- p-Br- H H CH 2
CH(CH
3
)
2 'Pr H CH 3 OH OH H H NH- 2 29-4 Ph II- p-Br- H H CH 2 Ph 'Pr H CH 3 OH OH H H NH 2 29-5 Ph 119 X2 R' R2 R 3 a R 3 b R 4 R' R X Y R R' R 9 H- p-Br- H H CH 2 -indol-3- 'Pr H CH 3 OH OH H H NH 2 29-6 Phy 11- p-Br- H H CH 2
CH
2
SCH
3 'Pr H CH 3 OH OH H H NH 2 29-7 Ph 11- p-Br- * H * 'Pr H CH 3 OH OH H H NH 2 29-8 Ph *R2 and R b joined together by (CH 2
)
3 to form five-membered ring. Table 11-30. 2 R' R 2 R aR 3 b R4 R 5
R
6 X Y R' R' R 9 11- 3 0- p-I- H H H 'Pr H CH 3 OH OH H H NH 2 Ph 1-30- p-I- H H CH- 'Pr H CH 3 OH OH H H NH 2 2 Ph 11-30- p-I- H H CH(CH 3
)
2 'Pr H CH 3 OH OH H H NH2 3 Ph H-30- p-I- H H CHCH(CH 3
)
2 'Pr H CH 3 OH OH H H NH 2 4 Ph H-30- p-I- H H CH 2 Ph 'Pr H CH 3 OH OH H H NH 2 5 Ph H-30- p-I- H H CH 2 -indol-3- 'Pr H CH 3 OH OH H H NH 2 6 Ph YI H-30- p-I- H H CH 2
CH
2
SCH
3 'Pr H CH 3 OH OH H H NH 2 7 Ph
U-
30 - p-I- H * 'Pr H CH 3 OH OH H H NH 2 8 Ph R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table 11-31. N9 R' R2 R 3 a R 3 b R 4 R' R' X Y R' R' R 11-31- CH 3 H H H "Bu H CH 3 OH OH H H NH 2 1 H-31- CH 3 H H CH, "Bu H CH 3 OH OH H H NH 2 2 H-31- CH 3 H H CH(CH 3
)
2 "Bu H CH 3 OH OH H H NH 2 3 11~2 X2 R' R2 R 3 aR R R' R 6 X Y R' R' R 9 H-31- CH 3 H H CH 2
CH(CH
3
)
2 "Bu H CH 3 OH OH H H NH 2 4 H-31- CH 3 H H CH 2 Ph "Bu H CH 3 OH OH H H NH 2 5 H-31-. CH 3 H H CH 2 -indol-3- "Bu H CH 3 OH OH H H NH 2 6 yl H-31- CH 3 H H CH 2
CH
2
SCH
3 "Bu H CH 3 OH OH H H NH 2 7 H-31.- CH 3 * H * "Bu H CH 3 OH OH H H NH 2 8 *R Rzd joined together by (CH 2
)
3 to form five-membered ring. Table 11-32. X RIR 2
R
3 a R 3 b R 4
R
5 R6 X Y R' R" R 9 H-32-1 Et H H H "Bu H CH 3 OH OH H H NH 2 11-32-2 Et H H CH 3 "Bu H CH 3 OH OH H H NH 2 11-32-3 Et H H CH(CH 3
)
2 "Bu H CH 3 OH OH H H NH 2 11-32-4 Et H H CH 2
CH(CH
3
)
2 "Bu H CH 3 OH OH H H NH 2 11-32-5 Et H H CH 2 Ph "Bu H CH 3 OH OH H H NH 2 1-32-6 Et H H CH 2 -indol-3-yl "Bu H CH 3 OH OH H H NH- 2 11-32-7 Et H H CH 2
CH
2
SCH
3 "Bu H CH3 OH OH H H NH 2 H-32-8 Et* H * "Bu H CH 3 OH OH H H NH 2 *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table 11-33. X2 R' R2 R 3 aR 3 b R 4 R' R' X Y R' R' R 9 H-33-1 'Pr H H H "Bu H CH 3 OH OH H H NH 2 1-33-2 'Pr H H CH 3 "Bu H CH 3 OH OH H H NH 2 11-33-3 'Pr H H CH(CH 3
)
2 "Bu H CH 3 OH OH H H NH 2 U-33-4 'Pr H H CH 2
CH(CH
3
)
2 "Bu H CH 3 OH OH H H NH 2 11-33-5 'Pr H H CH 2 Ph "Bu H CH 3 OH OH H H NH 2 H-33-6 'Pr H H CH 2 -indol-3-yl "Bu H CH 3 OH OH H H NH 2 11-33-7 'Pr H H CH 2
CH
2
SCH
3 "Bu H CH 3 OH OH H H NH 2 11-33-8 'Pr * H * "Bu H CH 3 OH OH H H NH 2 5 *R 2 and Rib joined together by (CH 2
)
3 to form five-membered ring. 1 1 A Table 11-34. N2 R' R2 R 3 a R 3 b R 4 R' R' X Y R' R' R 9 H-34-1 'Bu H H H "Bu H CH 3 OH OH H H NH2 H-34-2 'Bu H H CH 3 "Bu H CH 3 OH OH H H NH2 11-34-3 'Bu H H CH(CH 3
)
2 "Bu H CH 3 OH OH H H NH 2 II-34-4 'Bu H H CH 2
CH(CH
3
)
2 "Bu H CH 3 OH OH H H NH2 11-34-5 'Bu H H CH 2 Ph "Bu H CH 3 OH OH H H NH 2 II-34-.6 'Bu H H CH 2 -indol-3-yl "Bu H CH 3 OH OH H H NH 2 11-34-7 'Bu H H CH 2
CH
2
SCH
3 "Bu H CH 3 OH OH H H NH 2 II-34-8 'Bu* H * "Bu H CH 3 OH OH H H NH 2 *R2 and Rb joined together by (CH 2
)
3 to form five-membered ring. Table 11-35. N2 R' R2 R 3 a R 3 b R 4
R
5
R
6 X Y R' R' R 9 11-35-1 Ph H H H "Bu H CH 3 OH OH H H NH II-35-2 Ph H H CH 3 "Bu H CH 3 OH OH H H NH2 11-35-3 Ph H H CH(CH 3
)
2 "Bu H CH 3 OH OH H H NH 2 U-35-4 Ph H H CH 2
CH(C
3
)
2 "Bu H CH 3 OH OH H H NH 2 11-35-5 Ph H H CH2Ph "Bu H CH 3 OH OH H H NH 2 11-35-6 Ph H H CH 2 -indol-3-yI "Bu H CH 3 OH OH H H NH 2 11-35-7 Ph H H CH 2
CH
2
SCH
3 "Bu H CH 3 OH OH H H NH 2 H-35-8 Ph * H * "Bu H CH 3 OH OH H H NH 2 *RT and R"b joined together by (CH 2
)
3 to form five-membered ring. 5 Table 11-36. X2 R2 R 3 a R 3 b R 4 R' R 6 X Y R' R' R' 11- p- H- H H "Bu HCH 3 OHOH H H NH 2 36-1 Me Ph H- p- H H CH 3 "Bu H CH 3 OH OH H H NH 2 36-2 Me Ph H- p- H H CH(CH 3
)
2 "Bu H CH 3 OH OH H H NH 2 36-3 Me Ph H- p- H H CH 2
CH(CH
3
)
2 "Bu H CH 3 OH OH H H NH 2 36-4 Me Ph H- p- H H CH 2 Ph "Bu H CH 3 OH OH H H NH 2 36-5 Me Ph H- p- H H CH 2 -indol-3- "Bu H CH 3 OH OH H H NH 2 1 1 C N2 R' R2 R 3 a R 3 b R 4
R
5
R
6 X Y R R' R 9 36-6 Me- yl Ph H- p- H H CH 2
CH
2
SCH
3 "Bu H CH 3 OH OH H H NH 2 36-7 Me Ph H- p- * H * "Bu H CH 3 OH OH H H NH 2 36-8 Me Ph *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table 11-37. X2 R1 R 2
R
3 a R 3 b R 4 R' R' X Y R' R' R' H- p-F- H H H "Bu H CH 3 OH OH H H NH 2 37-1 Ph H- p-F- H H CH 3 "Bu H CH 3 OH OH H H NH 2 37-2 Ph H- p-F- H H CH(CH 3
)
2 "Bu H CH 3 OH OH H H NH 2 37-3 Ph H- p-F- H H CH 2
CH(CH
3
)
2 "Bu H CH 3 OH OH H H NH2 37-4 Ph H- p-F- H H CH 2 Ph "Bu H CH 3 OH OH H H NH 2 37-5 Ph H- p-F- H H CH 2 -indol-3- "Bu H CH 3 OH OH H H NH 2 37-6 Ph YI H- p-F- H H CH 2
CH
2
SCH
3 "Bu H CH 3 OH OH H H NH 2 37-7Ph H- p-F- * H * "Bu H CH 3 OH OH H H NH 2 37-8 Ph *R1 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table 11-38. N2 R' R 2
R
3 a R 3
R
4 R' R' X Y R 7 R' R 9 H- p-Cl- H H H "Bu H CH 3 OH OH H H NH 2 38-1 Ph H- p-Cl- H H CH 3 "Bu H CH 3 OH OH H H NH 2 38-2 Ph H- p-Cl- H H CH(CH 3
)
2 "Bu H CH 3 OH OH H H NH 2 38-3 Ph 1 14 X2 R' R2 R 3 a R 3 b R 4
R
5
R
6 X Y R 7 8
R
9 II- p-Cl- H H CH 2
CH(CH
3
)
2 "Bu H CH 3 OH OH H H NH 2 38-4 Ph 11- p-Cl- H H CH 2 Ph "Bu H CH 3 OH OH H H NH2 38-5 Ph H- p-Cl- H H CH 2 -indol-3- "Bu H CH 3 OH OH H H NH 2 38-6 Ph yl H- p-Cl- H H CH 2
CH
2
SCH
3 "Bu H CH 3 OH OH H H NH 2 38-7 Ph H- p-Cl-* H * "Bu H CH 3 OH OH H H NH 2 38-8 Ph
*R
2 and RJb joined together by (CH 2
)
3 to form five-membered ring. Table 11-39. N2 R' R2 R 3 a R 3 b R 4 R' R' X Y R 7
R
8
R
9 H- p-Br- H H H "Bu H CH 3 OH OH H H NH 2 39-1 Ph 11- p-Br- H H CH 3 "Bu H CH 3 OH OH H H NH2 39-2 Ph 11- p-Br- H H CH(CH 3
)
2 "Bu H CH 3 OH OH H H NH 2 39-3 Ph H- p-Br- H H CH 2
CH(CH
3
)
2 "Bu H CH 3 OH OH H H NH 2 39-4 Ph II- p-Br- H H CH 2 Ph "Bu H CH 3 OH OH H H NH2 39-5 Ph H- p-Br- H H CH 2 -indol-3- "Bu H CH 3 OH OH H H NH 2 39-6 Ph Y1 H- p-Br- H H CH 2
CH
2
SCH
3 "Bu H CH 3 OH OH H H NH 2 39-7Ph H- p-Br-* H * "Bu H CH 3 OH OH H [[ NH 2 39-8 Ph
*R
2 and R b joined together by (CH 2
)
3 to form five-membered ring. Table 11-40. N2 R' R2 R 3 a R 3 b R4 R' R' X Y R' R' R 9 II- p-I- H H H "Bu H CH 3 OH OH H H NH 2 40-1 Ph 11'7 X2 R' R2 R 3 " R 3 b R4 R' R 6 X Y R' R' R' II- p-I- H H CH 3 "Bu H CH 3 OH OH H H NH 2 40-2 Ph - p-I- H H CH(CH 3
)
2 "Bu H CH 3 OH OH H H NH 2 40-3 Ph 11- p-I- H H CH 2
CH(CH
3
)
2 "Bu H CH 3 OH OH H H NH 2 40-4 Ph 11- p-I- H H CH 2 Ph "Bu H CH 3 OH OH H H NH2 40-5 Ph II- p-I- H H CH 2 -indol-3- "Bu H CH 3 OH OH H H NH 2 40-6 Ph YI II- p-I- H H CH 2
CH
2
SCH
3 "Bu H CH 3 OH OH H H NH 2 40-7 Ph - p-1- * H * "Bu H CH3 OH OH H H NH2 40-8 Ph *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table 11-41. X2 R' R2 R 3 a R 3 b R4 R 5
R
6 X Y R' R' R' 11-41-1 CH 3 H H H Bz H CH 3 OH OH H H NH 2 H-41-2 CH 3 H H CH 3 Bz H CH 3 OH OH H H NH 2 11-41-3 CH 3 H H CH(CH 3
)
2 Bz H CH 3 OH OH H H NH 2 H-41-4 CH3 H H CH 2
CH(CH
3
)
2 Bz H CH3 OH OH H H NH 2 H-41-5 CH 3 H H CH 2 Ph Bz H CH 3 OH OH H H NH 2 11-41-6 CH 3 H H CH 2 -indol-3-yl Bz H CH3 OH OH H H NH 2 11-41-7 CH 3 H H CH 2
CH
2
SCH
3 Bz H CH 3 OH OH H H NH 2 H-41-8 CH 3 * H * Bz H CH 3 OH OH H H NH 2 *R and Rib joined together by (CH 2
)
3 to form five-membered ring. Table 11-42. N2 RI R 2 R3a R 3 b R4 R 5
R
6 X Y R' R' R 9 11-42-1 Et H H H Bz H CH 3 OH OH H H NH 2 H-42-2 Et H H CH 3 Bz H CH 3 OH OH H H NH 2 11-42-3 Et H H CH(CH 3
)
2 Bz H CH 3 OH OH H H NH4 2 1-42-4 Et H H CH 2
CH(CH
3
)
2 Bz H CH 3 OH OH H H NH 2 11-42-5 Et H H CH 2 Ph Bz H CH 3 OH OH H H NH 2 1-42-6 Et H H CH 2 -indol-3-yl Bz H CH 3 OH OH H H NH 2 _ 11 _ 2 RIR R aR 3 b R' R' R' X Y R R' R 11-42-7 Et H H CH 2
CH
2
SCH
3 Bz H CH 3 OH OH H H NH 2 H-42-8 Et * H * Bz H CH 3 OH OH H H NH 2
*R
2 and RJb joined together by (CH 2
)
3 to form five-membered ring. Table 11-43. X R' R2 R 3 a R 3 b R 4 R' R' X Y R' R' R 9 11-43-1 'Pr H H H Bz H CH 3 OH OH H H NH 2 H-43-2 'Pr H H CH 3 Bz H CH 3 OH OH H H NH2 H-43-3 'Pr H H CH(CH 3
)
2 Bz H CH 3 OH OH H H NH2 11-43-4 'Pr H H CH 2
CH(CH
3
)
2 Bz H CH 3 OH OH H H NH 2 11-43-5 'Pr H H CH 2 Ph Bz H CH 3 OH OH H H NH2 11-43-6 'Pr H H CH 2 -indol-3-yl Bz H CH 3 OH OH H H NH 2 H-43-7 'Pr H H CH 2
CH
2
SCH
3 Bz H CH 3 OH OH H H NH 2 H-43-8 'Pr* H * Bz H CH 3 OH OH H H NH 2 *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table 11-44. X R' R2 R 3 a RWb R4 R 5
R
6 X Y R' R 8
R
9 H-44-1 'Bu H H H Bz H CH 3 OH OH H H NH 2 II-44-2 'Bu H H CH 3 Bz H CH 3 OH OH H H NH 2 11-44-3 'Bu H H CH(CH 3
)
2 Bz H CH 3 OH OH H H NH2 11-44-4 'Bu H H CH 2
CH(CH
3
)
2 Bz H CH 3 OH OH H H NH 2 11-44-5 'Bu H H CH 2 Ph Bz H CH 3 OH OH H H NH 2 11-44-6 'Bu H H CH 2 -indol-3-yl Bz H CH 3 OH OH H H NH2 H-44-7 'Bu H H CH 2
CH
2
SCH
3 Bz H CH 3 OH OH H H NH 2 11-44-8 'Bu * H * Bz H CH 3 OH OH H H NH 2 5 *Fand R"b joined together by (CH 2
)
3 to form five-membered ring. Table 11-45. Xe RI R 2
R
3 a R 3 b R 4 R R 6 X Y R R' R 9 1I-45-1 Ph H H H Bz H CH 3 OH OH H H NH 2 II-45-2 Ph H H CH 3 Bz H CH 3 OH OH H H NH 2 11-45-3 Ph H H CH(CH 3
)
2 Bz H CH 3 OH OH H H NH 2 II-45-4 Ph H H CH 2
CH(CH
3
)
2 Bz H CH 3 OH OH H H NH 2 II-45-5 Ph H H CH2Ph Bz H CH 3 OH OH H H NH 2 1-45-6 Ph H H CH 2 -indol-3-yl Bz H CH 3 OH OH H H NH 2 11-45-7 Ph H H CH 2
CH
2
SCH
3 Bz H CH 3 OH OH H H NH2 _ 10 N RI R 2
R
3 a R 3 b R' R' R' X Y R' R' R 9 H-45-8 Ph* H * Bz H CH 3 OH OH H H NH 2 *R7and RJb joined together by (CH 2
)
3 to form five-membered ring. Table 11-46. N2 R' R2 R 3 aRb R 4 R' R' X Y R' R" R 9 H- p-Me- H H H Bz H CH 3 OH OH H H NH 2 46-1 Ph H- p-Me- H H CH 3 Bz H CH 3 OH OH H H NH 2 46-2 Ph H- p-Me- H H CH(CH 3
)
2 Bz H CH 3 OH OH H H NH2 46-3 Ph H- p-Me- H H CH 2
CH(CH
3
)
2 Bz H CH 3 OH OH H H NH2 46-4 Ph H- p-Me- H H CH 2 Ph Bz H CH 3 OH OH H H N 2 46-5 Ph H- p-Me- H H CH 2 -indol-3- Bz H CH 3 OH OH H H NHl 2 46-6 Ph Yl II- p-Me- H H CH 2
CH
2
SCH
3 Bz H CH 3 OH OH H H NH 2 46-7 Ph H- p-Me-* H * Bz H CH 3 OH OH H H NH 2 46-8 Ph
*R
2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table 11-47. N2 R1 R 2 Ra R 3 b R' R' R 6 X Y R' R' R 9 H-4 7 - p-F- H H H Bz H CH 3 OH OH H H NH 2 1 Ph 11-47- p-F- H H CH 3 Bz H CH 3 OH OH H H NH 2 2 Ph 11-47- p-F- H H CH(CH 3
)
2 Bz H CH 3 OH OH H H NH2 3 Ph 11-47- p-F- H H CH 2
CH(CH
3
)
2 Bz H CH 3 OH OH H H NH 2 4 Ph 11-47- p-F- H H CH 2 Ph Bz H CH 3 OH OH H H NH 2 5 Ph H-47- p-F- H H CH: 2 -indol-3- Bz H CH 3 OH OH H H NH 2 Ph 1 ''fl X R R 2
R
3 a R 3 b R R R X Y R 7
R
8
R
9 6 yI H-47-. p-F- H H CH 2
CH
2
SCH
3 Bz H CH 3 OH OH H H NH 2 7 Ph H-47- p-F- * H * Bz H CH 3 OH OH H H NH2 8 Ph *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table 11-48. XV R' R2 R 3 a R 3 b R 4 R' R' X Y R' R' R 9 1d- p-Cl- H H H Bz H CH 3 OH OH H H NH2 48-1 Ph II- p-Cl- H H CH 3 Bz H CH3 OH OH H H NH 2 48-2 Ph 11- p-Cl- H H CH(CH 3
)
2 Bz H CH 3 OH OH H H NH2 48-3 Ph H- p-Cl- H H CH 2
CH(CH
3
)
2 Bz H CH 3 OH OH H H NH 2 48-4 Ph H- p-Cl- H H CH 2 Ph Bz H CH 3 OH OH H H NH 2 48-5 Ph II- p-Cl- H H CHr-indol-3- Bz H CH 3 OH OH H H NH 2 48-6 Ph YI H- p-Cl- H H CH 2
CH
2
SCH
3 Bz H CH 3 OH OH H H NH 2 48-7 Ph H- p-Cl- * H * Bz H CH 3 OH OH H H NH2 48-8 Ph *R Stand R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table 11-49. X2 R' R 2
R
3 a R 3 b R 4 R R 6 X Y R R R 9 H- p-Br- H H H Bz H CH 3 OH OH H H NH 2 49-1 Ph Ii- p-Br- H H CH 3 Bz H CH 3 OH OH H H NH2 49-2 Ph H- p-Br- H H CH(CH 3
)
2 Bz H CH 3 OH OH H H NH 2 49-3 Ph H- p-Br- H H CH 2
CH(CH
3
)
2 Bz H CH 3 OH OH H H NH 2 Ph 111 X2 R R2 R 3 a R 3 b R' R' R 6 X Y R' R' R 9 49-4 H- p-Br- H H CH 2 Ph Bz H CH 3 OH OH H H NH 2 49-5 Ph H- p-Br- H H CH 2 -indol-3- Bz H CH 3 OH OH H H NH2 49-6 Phyl H- p-Br- H H CH 2
CH
2
SCH
3 Bz H CH 3 OH OH H H NH2 49-7 Ph 11- p-Br- * H * Bz H CH 3 OH OH H H NH 2 49-8 Ph *R2and Rp joined together by (CH 2
)
3 to form five-membered ring. Table 11-50. 2 Rl R 2
R
3 a R 3 b R 4 R R 6 X Y R' R' R 9 H-50- p-I- H H H Bz H CH 3 OH OH H H NH 2 1 Ph 11-50- p-I- H H CH 3 Bz H CH 3 OH OH H H NH 2 2 Ph II-50- p-I- H H CH(CH 3
)
2 Bz H CH 3 OH OH H H NH 2 3 Ph 11-50- p-I- H H CH 2
CH(CH
3
)
2 Bz H CH 3 OH OH H H NH 2 4 Ph 11-50- p-I- H H CH 2 Ph Bz H CH 3 OH OH H H NH 2 5 Ph 11-50- p-I- H H CH 2 -indol-3- Bz H CH 3 OH OH H H NH2 6 Ph yl H-50- p-I- H H CH2CH 2
SCH
3 Bz H CH 3 OH OH H H NH 2 7 Ph H-50- p-I- * H * Bz H CH 3 OH OH H H NI 2 8 Ph
*R
2 and R3b joined together by (CH 2
)
3 to form five-membered ring. R9
R
8 R2N 3b R2 || R7 N 0 R3a_ N--P--OO C0 2
R
4
OR
1 R5 R 6 Y X HI Table 111-1. N2 R' R2 Ra R 3 b R 4 R R 6 X Y R' R" R 9 II-1-1 CH 3 H H H CH3 H CH 3 F OH H H NH 2 I-1.-2 CH 3 H H CH 3
CH
3 H CH 3 F OH H H NH2 111-1-3 CH 3 H H CH(CH 3
)
2
CH
3 H CH 3 F OH H H NH 2 III-1-4 CH 3 H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH H H NH 2 1-1-5 CH 3 H H CH 2 Ph CH 3 H CH 3 F OH H H NH2 111-1-6 CH 3 H H CH 2 -indol-3-yl CH 3 H CH 3 F OH H H NH 2 M-1-7 CH 3 H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH H H NH2 M-1-8 CH 3 * H * CH 3 H CH 3 F OH H H NH2 5 *Rand R"b joined together by (CH 2
)
3 to form five-membered ring. Table 111-2. X2 Rl R 2
R
3 a R 3 b R 4 R' R' X Y R 7
R
8
R
9 M-2-1 Et H H H CH3 H CH 3 F OH H H NH 2 111-2-2 Et H H CH 3
CH
3 H CH 3 F OH H H NH 2 M-2-3 Et H H CH(CH 3
)
2
CH
3 H CH 3 F OH H H NH 2 M-2-4 Et H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH H H NH 2 M-2-5 Et H H CH 2 Ph CH3 H CH 3 F OH H H NH 2 m-2-6 Et H H CH 2 -indol-3-yl CH 3 H CH 3 F OH H H NH 2 IH-2-7 Et H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH H H NH2 M-2-8 Et * H * CH3 H
CH
3 F OH H H NH 2 *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 1 T2 Table 111-3. N? RI R 2
R
3 a R 3 b R' R' R' X Y R' R R 9 I11-3-1 'Pr H H H CH3 H CH 3 F OH H H NH2 M-3-2 'Pr H H CH 3 CH3 H CH 3 F OH H H NH 2 111-3-3 'Pr H H CH(CH 3
)
2
CH
3 H CH 3 F OH H H NH 2 M-3-4 'Pr H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH H H NH 2 M-3-5 'Pr H H CH 2 Ph CH 3 H CH 3 F OH H H NH 2 111-3-6 'Pr H H CH 2 -indol-3-yl CH 3 H CH 3 F OH H H NH2 111-3-7 'Pr H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH H H NH 2 M-3-8 'Pr * H * CH 3 H CH 3 F OH H H NH2 *R2 and R b joined together by (CH 2
)
3 to form five-membered ring. Table 111-4. N2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y R' R R 9 m11-4-1 'Bu H H H CH3 H CH 3 F OH H H NH 2 IH-4-2 'Bu H H CH 3 CH3 H CH 3 F OH H H NH2 111-4--3 'Bu H H CH(CH 3
)
2
CH
3 H CH 3 F OH H H NH2 M-4-4 'Bu H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH H H NH2 M-4--5 'Bu H H CH 2 Ph CH 3 H CH 3 F OH H H NH 2 M-4--6 'Bu H H CH 2 -indol-3-yl CH 3 H CH 3 F OH H H NH2 [1-4-7 'Bu H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH H H NH 2 M-4-8 'Bu * H * CH 3 H CH 3 F OH H H NH 2
*R
2 and R-b joined together by (CH 2
)
3 to form five-membered ring. 5 Table 111-5. X2 RI R 2
R
3 a R 3 b R 4
R
5
R
6 X Y R' R 8
R
9 IH-5-1 Ph H H H CH3 H CH 3 F OH H H NH2 m-5-2 Ph H H CH 3 CH3 H CH 3 F OH H H NH 2 M-5-3 Ph H H CH(CH 3
)
2
CH
3 H CH 3 F OH H H NH 2 111-5-4 Ph H H CH2CH(CH 3 )2 CH 3 H CH 3 F OH H H NH 2 111-5-5 Ph H H CH 2 Ph CH 3 H CH 3 F OH H H NH 2 M1-5-6 Ph H H CH 2 -indol-3-yl CH 3 H CH 3 F OH H H NH 2 m1-5-7 Ph H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH H H NH 2 M-5-8 Ph* H * CH 3 H CH3 F OH H H NH2 *R2and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 1 ')A Table 111-6. X2 R R 2
R
3 a R 3 b R 4
R
5
R
6 X Y R' R R 9 I1- p-Me- H H H CH3 H CH 3 F OH H H NH 2 6-1 Ph IH- p-Me- H H CH 3 CH3 H CH 3 F OH H H NH2 6-2 Ph IH- p-Me- H H CH(CH 3
)
2
CH
3 H CH 3 F OH H H NH 2 6-3 Ph IH- p-Me- H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH H H NH 2 6-4 Ph M- p-Me- H H CH 2 Ph CH3 H CH 3 F OH H H NH2 6-5 Ph M- p-Me- H H CH 2 -indol-3- CH 3 H CH 3 F OH H H NH 2 6-6 Ph yl IH- p-Me- H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH H H NH 2 6-7 Ph Hl- p-Me-* H * CH 3 H CH3 F OH H H NH 2 6-8 Ph *R" and R3 joined together by (CH 2
)
3 to form five-membered ring. Table 111-7. N2 Rl R 2
R
3 a R 3 b R 4 R' R 6 X Y R' R' R 9 111-7.- p-F- H H H CH3 H CH 3 F OH H H NH2 1 Ph 111-7- p-F- H H CH 3 CH3 H CH 3 F OH H H NH 2 2 Ph M-7- p-F- H H CH(CH 3
)
2
CH
3 H CH 3 F OH H H NH 2 3 Ph M-7- p-F- H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH H H NH 2 4 Ph 111-7- p-F- H H CH 2 Ph CH 3 H CH 3 F OH H H NH 2 6 Ph 111-7- p-F- H H CH 2 -indol-3- CH 3 H CH 3 F OH H H NH 2 7 Ph YI 111-7- p-F- H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH H H NH 2 8 Ph 111-7- p-F- * H * CH3 H CH 3 F OH H H NH 2 N2 Rl R2 R3a R3b R4 R5 R6 X Y R R8 R9 20 Ph *R7 and R"b joined together by (CH 2
)
3 to form five-membered ring. Table 111-8. X2 R R 2
R
3 a R 3 b R R' R 6 X Y R' R" R 9 m-8- p-Cl- H H H CH3 H CH 3 F OH H H NH 2 1 Ph 111-8- p-Cl- H H CH 3
CH
3 H CH 3 F OH H H NH 2 2 Ph HI-8- p-Cl- H H CH(CH 3
)
2
CH
3 H CH 3 F OH H H NH 2 3 Ph M-8- p-Cl- H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH H H NH 2 4 Ph M-8-. p-Cl- H H CH 2 Ph CH 3 H CH 3 F OH H H NH 2 5 Ph 11-8- p-Cl- H H CH 2 -iiidol-3- CH 3 H CH 3 F OH H H NH 2 6 Ph yl M-8- p-Cl- H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH H H NH4 2 7 Ph 11-8- p-Cl- * H * CH3 H CH 3 F OH H H NH2 8 Ph *R7 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table 111-9. X2 R R 2
R
3 a R 3 b R R' R' X Y R 7 R' R 9 IM-9- p-Br- H H H CH3 H CH 3 F OH H H NH 2 1 Ph 111-9- p-Br- H H CH 3
CH
3 H CH 3 F OH H H NH 2 2 Ph IM-9- p-Br- H H CH(CH 3
)
2
CH
3 H CH 3 F OH H H NH 2 3 Ph III-9- p-Br- H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH H H NH2 4 Ph HI-9- p-Br- H H CH 2 Ph CH 3 H CH 3 F OH H H NH 2 6 Ph M-9- p-Br- H H CH 2 -indol-3- CH 3 H CH 3 F OH H H NH 2 Ph 114 N2 R1 R 2 R3a R3b R R R X Y R' R" R 9 7 yI 11-9- p-Br- H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH H H NH 2 8 Ph HI-9- p-Br-* H * CH 3 H CH 3 F OH H H NH 2 20 Ph *Rland R3b joined together by (CH 2
)
3 to form five-membered ring. Table 111-10. N2 R1 R 2 R3aRb R 4
R
5
R
6 X Y R R' R 9 II- p-I- H H H CH 3 H CH 3 F OH H H NH2 10-1 Ph in- p-I- H H CH 3 CH3 H CH 3 F OH H H NH 2 10-2 Ph in- p-I- H H CH(CH 3
)
2
CH
3 H CH 3 F OH H H NH 2 10-3 Ph M- p-I- H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH H H NH 2 10-4 Ph II- p-I- H H CH 2 Ph CH3 H CH 3 F OH H H NH 2 10-5 Ph M- p-I- H H CH 2 -indol-3- CH 3 H CH 3 F OH H H NH2 10-6 Phy m- p-I- H H CH 2
CH
2
SCH
3
CH
3 H CH 3 ' F OH H H NH 2 10-7 Ph S p-I- * H * CH 3 H CH 3 F OH H H NH 2 10-8 Ph *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table 111-11. X2 R1 R 2 R Rb . R 4
R
5 R X Y R' R' R 9 M-11-1 CH 3 H H H Et H CH 3 F OH H H NH2 111-11-2 CH 3 H H CH 3 Et H CH 3 F OH H H NH 2 m-11-3 CH 3 H H CH(CH 3
)
2 Et H CH 3 F OH H H NH 2 Il-I 1-4 CH 3 H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH H H NH 2 M-11-5 CH 3 H H CH 2 Ph Et H CH 3 F OH H H NH2 M-11-6 CH 3 H H CH 2 -indol-3-yl Et H CH 3 F OH H H NH 2 111-11-7 CH 3 H H CH 2
CH
2
SCH
3 Et H CH 3 F OH H H NH 2 1 T"7 X2 R' R2 R 3 a R 3 b R' R' R' X Y R' R' R 9 m-11-8 CH 3 * H * Et H CH 3 F OH H H NH 2 *iand R"b joined together by (CH 2
)
3 to form five-membered ring. Table 111-12. RI R 2 RaRb R 4 R R X Y R' R' R 9 m-12-1 Et H H H Et H CH 3 F OH H H NH 2 m-12-2 Et H H CH 3 Et H CH 3 F OH H H NH 2 m-12-3 Et H H CH(CH 3
)
2 Et H CH 3 F OH H H NH2 111-12-4 Et H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH H H NH 2 m-12-5 Et H H CH 2 Ph Et H CH 3 F OH H H NH 2 m-12-6 Et H H CH 2 -indol-3-yl Et H CH 3 F OH H H NH 2 m-12-7 Et H H CH 2
CH
2
SCH
3 Et H CH 3 F OH H H NH2 m-12-8 Et* H * Et H CH 3 F OH H H NH 2 *Rrand R3b joined together by (CH 2
)
3 to form five-membered ring. Table 111-13. X2 R R 2 Ra Rb R 4 R R X Y R' R' R 9 M-13-1 Pr H H H Et H CH 3 F OH H H NH2 111-13-2 'Pr H H CH 3 Et H CH 3 F OH H H NH 2 m-13-3 'Pr H H CH(CH 3
)
2 Et H CH 3 F OH H H NH 2 m-13-4 'Pr H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH H H NH 2 m-13-5 'Pr H H CH 2 Ph Et H CH 3 F OH H H NH 2 m-13-6 'Pr H H CH 2 -indol-3-yl Et H CH 3 F OH H H NH 2 m-13-7 'Pr H H CH 2
CH
2
SCH
3 Et H CH 3 F OH H H NH 2 11-13-8 'Pr * H * Et H CH 3 F OH H H NH 2 5 *R 2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table 111-14. N2 R' R2 R R 3 b R 4 R 5
R
6 X Y R'R R 9 3a m11-14- 'Bu H H H Et H CH 3 F OH H H NH 2 1 1ll-14- 'Bu H H CH 3 Et H CH 3 F OH H H NH 2 2 m-14- 'Bu H H CH(CH 3
)
2 Et H CH 3 F OH H H NH 2 3 11-14- 'Bu H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH H H NH 2 110 N2 R' R2 R R 3 b R 4 R' R' X Y R' R" R 9 3a 4 11-14- 'Bu H H CH 2 Ph Et H CH 3 F OH H H NH2 5 m1-14- 'Bu H H CH 2 -indol-3-yl Et H CH 3 F OH H H NH2 6 UH-14- 'Bu H H CH 2
CH
2
SCH
3 Et H CH 3 F OH H H NH 2 7 1-14- 'Bu* H* Et H CH 3 F OH H H NH 2 8 *R and R b joined together by (CH 2
)
3 to form five-membered ring. Table 111-15. X2 RI R 2
R
3 aRb R 4 R' R' X Y R' R' R' IH-15-1 Ph H H H Et H CH 3 F OH H H NH 2 m-15-2 Ph H H CH 3 Et H CH 3 F OH H H NH 2 111-15-3 Ph H H CH(CH 3
)
2 Et H CH 3 F OH H H NH 2 m-15-4 Ph H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH H H NH2 HI-15-5 Ph H H CH 2 Ph Et H CH 3 F OH H H NH2 III-15-6 Ph H H CH 2 -indol-3-yl Et H CH 3 F OH H H NH 2 11-15-7 Ph H H CH 2
CH
2
SCH
3 Et H CH 3 F OH H H NH 2 M-15-8 Ph* H * Et H CH 3 F OH H H NH 2 *R Tand R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table 111-16. X2 R'_ R 2 R'" R31 R' R' R 6 X Y R' R8 R7_ HI- p-Me- H H H Et H CH 3 F OH H H NH 2 16-1 Ph III- p-Me- H H CHA 3 Et H CH 3 F OH H H NH 2 16-2 Ph HI- p-Me- H H CH(CH 3
)
2 Et H CH 3 F OH H H NH 2 16-3 Ph III- p-Me- H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH H H NH 2 16-4 Ph III- p-Me- H H CH 2 Ph Et H CH 3 F OH H H NH 2 16-5 Ph 1 ') X2 R 2
R
3 a R 3 ) R 4 R3 R 6 X Y R 7 R' R 9 in- p-Me- H H CH 2 -indol-3- Et H CH 3 F OH H H NH2 1&6 Phy M- p-Me- H H CH 2
CH
2
SCH
3 Et H CH 3 F OH H H NH 2 16-7 Ph HI- p-Me- * H * Et H CH 3 F OH H H NH 2 16-8 Ph *RTand RJb joined together by (CH 2
)
3 to form five-membered ring. Table 111-17. X R R 2
R
3 a R 3 b R' R' R 6 X Y R R' R 9 m-17- p-F- H H H Et H CH 3 F OH H H NH 2 1 Ph HI-17- p-F- H H CH 3 Et H CH 3 F OH H H NH 2 2 Ph M-17- p-F- H H CH(CH 3
)
2 Et H CH 3 F OH H H NH2 3 Ph M-17- p-F- H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH H H NH 2 4 Ph mH-17- p-F- H H CH 2 Ph Et H CH 3 F OH H H NH 2 5 Ph 11-17- p-F- H H CH 2 -indol-3- Et H CH 3 F OH H H NH 2 6 Ph Yl M-17- p-F- H H CH 2
CH
2
SCH
3 Et H CH 3 F OH H H NH 2 7 Ph M-17- p-F- * H * Et H CH 3 F OH H H NH 2 8 Ph
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table 111-18. N2 R- R 2
R
3 a R 3 b R 4
R
5 R X Y R R' R 9 M-18- p-Cl- H H H Et H CH 3 F OH H H NH 2 1 Ph 111-18- p-Cl- H H CH 3 Et H CH 3 F OH H H NH 2 2 Ph M-18- p-Cl- H H CH(CH 3
)
2 Et H CH 3 F OH H H NH 2 3 Ph N2 R' R 2
R
3 a R 3 b R' R' R 6 X Y R R' R 9 M-18- p-Cl- H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH H H NH 2 4 Ph M-18- p-Cl- H H CH1 2 Ph Et H CH 3 F OH H H NH2 5 Ph M-18- p-Cl- H H CH 2 -indol-3- Et H CH 3 F OH H H NH 2 6 Ph YI M-18- p-Cl- H H CH 2
CH
2
SCH
3 Et H CH 3 F OH H H NH 2 7 Ph 111-18- p-Cl- * H * Et H CH 3 F OH H H NH 2 8 Ph *R2 and Rb joined together by (CH 2
)
3 to form five-membered ring. Table 111-19. S R R 2
R
3 aR Rb R 4 R' R 6 X Y R' R' R 111-19- p-Br- H H H Et H CH 3 F OH H H NH 2 1 Ph m-19- p-Br- H H CH 3 Et H CH 3 F OH H H NH 2 2 Ph m-19- p-Br- H H CH(CH 3
)
2 Et H CH 3 F OH H H NH 2 3 Ph 11-19- p-Br- H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH H H NH 2 4 Ph 111-19- p-Br- H H CH 2 Ph Et H CH 3 F OH H H NH 2 5 Ph M-19- p-Br- H H CH 2 -indol-3- Et H CH 3 F OH H H NH 2 6 Ph YI m-19- p-Br- H H CH 2
CH
2
SCH
3 Et H CH 3 F OH H H NH 2 7 Ph M-19- p-Br- * H * Et H CH3 F OH H H NH 2 8 Ph *R and R 3 " joined together by (CH 2
)
3 to form five-membered ring. Table 111-20. X2 R R 2
R
3 a R 3 b R 4 R R X Y R' R R 9 m-20- p-I- H H H Et H CH 3 F OH H H NH 2 1 Ph 1'21 X2 R' R 2
R
3 a R3 R 4 R R 6 X Y R' R' R 9 11-20- p-I- H H CH 3 Et H CH 3 F OH H H NH2 2 Ph 11-20- p-I- H H CH(CH 3
)
2 Et H CH 3 F OH H H NH2 3 Ph M-20- p-I- H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH H H NH 2 4 Ph m-20- p-I- H H CH 2 Ph Et H CH 3 F OH H H NH 2 5 Ph 111-20- p-I- H H CH 2 -indol-3- Et H CH 3 F OH H H NH2 6 Ph yl 111-20- p-I- H H CH 2
CH
2
SCH
3 Et H CH 3 F OH H H NH 2 7 Ph 111-20- p-I- * H * Et H CH 3 F OH H H NH 2 8 Ph *R" and R3b joined together by (CH 2
)
3 to form five-membered ring. Table 111-21. 2 R R 2
R
3 a RI R 4
RR
6 XY R R R 9 m-21-1 CH 3 H' H H 'Pr H CH 3 F OH H H NH 2 m-21-2 CH 3 H H CH 3 'Pr H CH 3 F OH H H NH 2 111-21-3 CH 3 H H CH(CH 3
)
2 'Pr H CH 3 F OH H H NH 2 111-21-4 CH 3 H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH H H NH 2 m-21-5 CH 3 H H CH 2 Ph 'Pr H CH 3 F OH H H NH 2 m-21-6 CH 3 H H CH 2 -indol-3-yl 'Pr H CH 3 F OH H H NH 2 m-21-7 CH 3 H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH H H NH 2 m-21-8 CH 3 * H * 'Pr H CH3 F OH H H NH 2 *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table 111-22. X2 RI R 2
R
3 a R 3 b R R R X Y R R' R 9 111-22-1 Et H H H 'Pr H CH 3 F OH H H NH 2 m-22-2 Et H H CH 3 'Pr H CH 3 F OH H H NH 2 m-22-3 Et H H CH(CH 3
)
2 'Pr H CH 3 F OH H H NH 2 111-22-4 Et H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH H H NH2 m-22-5 Et H H CH 2 Ph Pr H CH 3 F OH H H NH 2 m-22-6 Et H H CH 2 -indol-3-yl 'Pr H CH 3 F OH H H NH 2 X RI R 2
R
3 a R 3 b R' R' R 6 X Y R' R 8
R
9 m-22-7 Et H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH H H NH 2 m-22-8 Et * H * 'Pr H CH 3 F OH H H NH 2 *R and Rb joined together by (CH 2
)
3 to form five-membered ring. Table 111-23. RI R 2 R R R R 4 R' R X Y R' R" R 9 M-23-1 'Pr H H H 'Pr H CH 3 F OH H H NH 2 M-23-2 'Pr H H CH 3 'Pr H CH 3 F OH H H NH 2 111-23-3 'Pr H H CH(CH 3
)
2 'Pr H CH 3 F OH H H NH 2 11-23-4 'Pr H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH H H NH 2 M-23-5 'Pr H H CH 2 Ph 'Pr H CH 3 F OH H H NH 2 1I-23-6 'Pr H H CH 2 -indol-3-yl 'Pr H CH 3 F OH H H NH 2 M-23-7 'Pr H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH H H NH2 IH-23-8 'Pr * H * 'Pr H CH 3 F OH H H NH 2 *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table 111-24. 2 R R 2 R R R R 4 R' R 6 X Y R R' R 9 M-24-1 'Bu H H H 'Pr H CH 3 F OH H H NH 2 mI-24-2 'Bu H H CH 3 'Pr H CH 3 F OH H H NH 2 111-24-3 'Bu H H CH(CH 3
)
2 'Pr H CH 3 F OH H H NH 2 m-24-4 'Bu H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH H H NH 2 M-24-5 'Bu H H CH 2 Ph 'Pr H CH 3 F OH H H NH 2 11-24-6 'Bu H H CH 2 -indol-3-yl 'Pr H CH 3 F OH H H NH 2 m-24-7 'Bu H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH H H NH 2 m-24-8 'Bu* H * 'Pr H CH 3 F OH H H NH 2 5 *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table 111-25. RI R 2 R R Rb R 4 R R X Y R 7
R
8
R
9 m11-25-1 Ph H H H 'Pr H CH 3 F OH H H NH 2 IH-25-2 Ph H H CH 3 'Pr H CH 3 F OH H H NH2 I1-25-3 Ph H H CH(CH 3
)
2 'Pr H CH 3 F OH H H NH 2 Hm-25-4 Ph H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH H H NH 2 M-25-5 Ph H H CH 2 Ph 'Pr H CH 3 F OH H H NH 2 M-25-6 Ph H H CH 2 -indol-3-yl 'Pr H CH 3 F OH H H NH 2 11-25-7 Ph H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH H H NH 2 III2~ X2 R' R2 R 3 a Rb R 4 R' R X Y R 7
R
8
R
9 m-25-8 Ph * H * PrH CH 3 F OH H H NH 2 * R2 and R"b joined together by (CH 2
)
3 to form five-membered ring. Table 111-26. N2 R' R 2 RaR 3 b R 4 R R X Y R' R" R 9 m- p-Me- H H H 'Pr H CH 3 F OH H H NH2 26-1 Ph I- p-Me- H H CH 3 'Pr H CH 3 F OH H H NH 2 26-2 Ph iI- p-Me- H H CH(CH 3
)
2 'Pr H CH 3 F OH H H NH2 26-3 Ph m- p-Me- H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH H H NH 2 26-4 Ph III- p-Me- H H CH 2 Ph 'Pr H CH 3 F OH H H NH2 26-5 Ph III- p-Me- H H CH 2 -indol-3- 'Pr H CH 3 F OH H H NH 2 26-6 Ph Y1 III- p-Me- H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH H H NH 2 26-7 Ph in- p-Me- * H * 'Pr H CH3 F OH H H NH 2 26-8 Ph *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table 111-27. N 2 R2 R 3 a R3b R 4 R' R 6 X Y R 7 R' R 9 11-27- p-F- H H H 'Pr H CH 3 F OH H H NH2 1 Ph 11-27- p-F- H H CH 3 'Pr H CH 3 F OH H H NH 2 2 Ph m-2'7- p-F- H H CH(CH 3
)
2 'Pr H CH 3 F OH H H NH 2 3 Ph HI-27- p-F- H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH H H NH 2 4 Ph 111-27- p-F- H H CH 2 Ph 'Pr H CH 3 F OH H H NH 2 5 Ph m-27- p-F- H H CH 2 -indol-3- 'Pr H CH 3 F OH H H NH 2 Ph S1'A N2 R' R 2
R
3 a R b R 4 R' R 6 X Y R' R' R 9 6 yl M-27- p-F- H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH H H NH 2 7 Ph H-27- p-F- * H * 'Pr H CH 3 F OH H H NH2 8 Ph *R and Rib joined together by (CH 2
)
3 to form five-membered ring. Table 111-28. N2 R7 RI 2 R 3 a R 3 ) R 4 R' R 6 X Y R' R' R 9 III-28- p-Cl- H H H 'Pr H CH 3 F OH H H NI-H2 1 Ph M-28- p-Cl- H H CH 3 'Pr H CH 3 F OH H H NH 2 2 Ph M-28- p-Cl- H H CH(CH 3
)
2 'Pr H CH 3 F OH H H NH2 3 Ph m1-28- p-Cl- H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH H H NH 2 4 Ph m1-28- p-Cl- H H CH 2 Ph 'Pr H CH 3 F OH H H NH 2 5 Ph M-28- p-Cl- H H CH 2 -indol-3- Pr H CH 3 F OH H H NH 2 6 Ph Yl M-28- p-Cl- H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH H H NH- 2 7 Ph m-28- p-Cl- * H * 'Pr H CH 3 F OH H H NH 2 8 Ph *R' and R 3 joined together by (CH 2
)
3 to form five-membered ring. Table 111-29. N2 RI R2 R3a RWb R 4 R' R 6 X Y R 7
R
8
R
9 11-29- p-Br- H H H 'Pr H CH 3 F OH H H NH 2 1 Ph M-29- p-Br- H H CH 3 'Pr H CH 3 F OH H H NH 2 2 Ph M-29- p-Br- H H CH(CH 3
)
2 'Pr H CH 3 F OH H H NH 2 3 Ph 11-29- p-Br- H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH H H NH 2 Ph X2 RI R 2
R
3 a R 3 b R 4 R' R 6 X Y R' R R 9 4 M-29- p-Br- H H CH 2 Ph Pr H CH 3 F OH H H NH2 5 Ph 111-29- p-Br- H H CH 2 -indol-3- 'Pr H CH 3 F OH H H NH 2 6 Ph Y1 m-29- p-Br- H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH H H NH 2 7 Ph III-29- p-Br- * H * Pr H CH 3 F OH H H NH 2 8 Ph *Rand R"b joined together by (CH 2
)
3 to form five-membered ring. Table 111-30. X R R 2
R
3 a R 3 R4 R 5
R
6 X Y R' R' R 9 m-30- p-I- H H H 'Pr H CH 3 F OH H H NH 2 1 Ph M-30- p-l- H H CH 3 'Pr H CH 3 F OH H H NH 2 2 Ph m-30- p-I- H H CH(CH 3
)
2 'Pr H CH 3 F OH H H NH2 3 Ph HI-30- p-I- H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH H H NH 2 4 Ph I1-30- p-I- H H CH 2 Ph 'Pr H CH 3 F OH H H NH 2 5 Ph IH-30- p-I- H H CH 2 -indol-3- 'Pr H CH 3 F OH H H NH 2 6 Ph Yl m-30- p-I- H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH H H NH 2 7 Ph 111-30- p-I- * H * 'Pr H CH 3 F OH H H NH 2 8 Ph *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table 111-3 1. Xe R' R 2 R3aRb R 4 R' R X Y R 7 R R 9 111-31-1 CH 3 H H H "Bu H CH 3 F OH H H NH 2 II-31-2 CH 3 H H CH 3 "Bu H CH 3 F OH H H NH 2 In-31-3 CH 3 H H CH(CH 3
)
2 "Bu H CH 3 F OH H H NH2 N2 R' R2 R 3 a R 3 b R R' R' X Y R' R' R 9 M-31-4 CH 3 H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH H H NH 2 m-31-5 CH 3 H H CH 2 Ph "Bu H CH 3 F OH H H NiH2 m-31-6 CH 3 H H CH 2 -indol-3-yl "Bu H CH 3 F OH H H NH 2 M-31-7 CH 3 H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH H H NH2 11-31-8 CH 3 * H * Bu H CH 3 F OH H H NH 2
*R
2 and R b joined together by (CH 2
)
3 to form five-membered ring. Table 111-32. RI R 2 R Rb R 4 R R X Y RI R'R m-32-1 Et H H H "Bu H CH 3 F OH H H NH2 HI-32-2 Et H H CH 3 "Bu H CH 3 F OH H H NH 2 111-32-3 Et H H CH(CH 3
)
2 "Bu H CH 3 F OH H H NH2 111-32-4 Et H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH H H NH2 IH-32-5 Et H H CH 2 Ph "Bu H CR 3 F OH H H NH2 M-32-6 Et H H CH 2 -indol-3-yl "Bu H CH 3 F OH H H NH 2 IH-32-7 Et H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH H H NH 2 m-32-8 Et * H * "Bu H CH 3 F OH H H NH 2
*R
2 and R b joined together by (CH 2
)
3 to form five-membered ring. Table 111-33. N RI R 2 R R R 4
R
5 R X Y R R' R 9 m-33-1 'Pr H H H "Bu H CH 3 F OH H H NH 2 IH-33-2 'Pr H H CH 3 "Bu H CH 3 F OH H H NH 2 m-33-3 'Pr H H CH(CH 3
)
2 "Bu H CH 3 F OH H H NH 2 IH-33-4 'Pr H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH H H NH2 1H-33-5 'Pr H H CH 2 Ph "Bu H CH 3 F OH H H NH 2 [1-33-6 'Pr H H CH 2 -indol-3-yl "Bu H CH 3 F OH H H NH 2 M-33-7 'Pr H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH H H NH 2 111-33-8 'Pr * H * "Bu H CH 3 F OH H H NH 2 5 *R1 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 1 )'"" Table 111-34. N2 R' R2 R 3 a R 3 b R 4
R'R
6 X Y R'R R 9 IH-34-1 'Bu H H H 'Bu H CH 3 F OH H H NH 2 m1-34-2 'Bu H H CH 3 "Bu H CH 3 F OH H H NH 2 mI-34-3 'Bu H H CH(CH 3
)
2 "Bu H CH 3 F OH H H NH 2 mI-34-4 'Bu H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH H H NH 2 111-34-5 'Bu H H CH 2 Ph "Bu H CH 3 F OH H H NH 2 IH-34-6 'Bu H H CH 2 -indol-3-yl "Bu H CH 3 F OH H H NH 2 111-34-7 'Bu H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH H H NH 2 H-34-8 'Bu* H * "Bu H CH 3 F OH H H NH 2 *R and Rib joined together by (CH 2
)
3 to form five-membered ring. Table 111-35. NO RT R2 R 3 a R3b R 4 R' R 6 X Y R' R' R 9 IH-35-1 Ph H H H "Bu H CH 3 F OH H H NH 2 IH-35-2 Ph H H CH 3 "Bu H CH 3 F OH H H NH 2 11-35-3 Ph H H CH(CH 3
)
2 "Bu H CH 3 F OH H H NH 2 111-35-4 Ph H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH H H NH 2 IM-35-5 Ph H H CH 2 Ph "Bu H CH 3 F OH H H NH 2 m-35-6 Ph H H CH 2 -indol-3-yl "Bu H CH 3 F OH H H NH 2 mH-35-7 Ph H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH H H NH 2 HI-35-8 Ph* H * "Bu H CH 3 F OH H H NH 2 U*R'and RIb joined together by (CH 2
)
3 to form five-membered ring. 5 Table 111-36. N R R2 R 3 a Rab R 4 R' R" X Y R 7
R
8
R
9 Im- p-Me- H H H "Bu H CH3 F OH H H NH 2 36-1 Ph IH- p-Me- H H CH 3 "Bu H CH 3 F OH H H NH 2 36-2 Ph III- p-Me- H H CH(CH 3
)
2 "Bu H CH 3 F OH H H NH 2 36-3 Ph Ill- p-Me- H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH H H NH 2 36-4 Ph 11- p-Me- H H CH 2 Ph "Bu H CH 3 F OH H H NH2 36-5 Ph IH- p-Me- H H CH 2 -indol-3- "Bu H CH 3 F OH H H NH 2 Ph 1'2Q X2 R R 2
R
3 a R b R' R' R 6 X Y R' R' R 9 36-6 yI m- p-Me- H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH H H NH 2 36-7 Ph m- p-Me-* H * "Bu H CH 3 F OH H H NH 2 36-8 Ph
*R
2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table 111-37.
SRR
3 aR Rb R 4 R R X Y R R' R 9 m- p-F- H H H "Bu H CH3 F OH H H NH2 37-1 Ph HI- p-F- H H CH 3 "Bu H CH 3 F OH H H NH 2 37-2 Ph m- p-F- H H CH(CH 3
)
2 "Bu H CH 3 F OH H H NH 2 37-3 Ph HI- p-F- H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH H H NH2 37-4 Ph HI- p-F- H H CH 2 Ph "Bu H CH 3 F OH H H NH 2 37-5 Ph ]I- p-F- H H CH 2 -indol-3- "Bu H CH 3 F OH H H NH 2 37-6 Ph YI I- p-F- H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH H H NH 2 37-7 Ph I- p-F- * H * BuHCH 3 FOH H H NH 2 37-8 Ph *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table 111-38.
R
2 Ra R 3 b R 4 R R 6 X Y R 7 R' R7 HI- p-Cl- H H H "Bu H CH 3 F OH H H NH 2 38-1 Ph M- p-Cl- H H CH 3 "Bu H CH3 F OH H H NH2 38-2 Ph M- p-Cl- H H CH(CH 3
)
2 "Bu H CH 3 F OH H H NH 2 38-3 Ph l- p-Cl- H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH H H NH2 Ph X2 Rl R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7 R R 9 38-4 II- p-Cl- H H CH 2 Ph "Bu H CH 3 F OH H H NH 2 38-5 Ph M- p-Cl- H H CH 2 -indol-3- "Bu H CH 3 F OH H H NH 2 38-6 Ph YI III- p-Cl- H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH H H NH 2 38-7 Ph m1- p-Cl- * H * Bu H CH 3 F OH H H NH2 38-8 Ph *R2 and R-b joined together by (CH 2
)
3 to form five-membered ring. Table 111-39. R R 2 Rsa R 3 b R6 RR 6 XY R 7 R R 9 III- p-Br- H H H "Bu H CH 3 F OH H H NH2 39-1 Ph m- p-Br- H H CH 3 "Bu H CH 3 F OH H H NH 2 39-2 Ph uI- p-Br- H H CH(CH3) 2 "Bu H CH 3 F OH H H NH 2 39-3 Ph I][- p-Br- H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH H H NH 2 39-4 Ph IIII- p-Br- H H CH 2 Ph "Bu H CH 3 F OH H H NH 2 39-5 Ph IlI- p-Br- H H CH 2 -indol-3- "Bu H CH 3 F OH H H NH 2 39-6 Ph YI m- p-Br- H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH H H NH 2 39-7 Ph m- p-Br- * H * Bu H CH 3 F OH H H NH 2 39-8 Ph *R2and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table 111-40. X2 RT R 2
R
3 a R 3 b R' R' R' X Y R' R' R 9
M-
4 0- p-l- H H H "Bu H CH 3 F OH H H NH 2 1 Ph 111-40- p-I- H H CH 3 "Bu H CH 3 F OH H H NH 2 Ph 1 AA N2 R R 2 RaR 3 b R 4 R R 6 X Y R 7 R R 9 2 UI-40- p-I- H H CH(CH 3
)
2 "Bu H CH 3 F OH H H NH 2 3 Ph 111-40- p-I- H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH H H NH 2 4 Ph 111-40- p-I- H H CH2Ph "Bu H CH 3 F OH H H NH4 2 5 Ph 111-40- p-I- H H CH 2 -indol-3- "Bu H CH 3 F OH H H NH2 6 Ph YI 111-40- p-I- H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH H H NH 2 7 Ph
III-
4 0- p-I- * H * "Bu H CH 3 F OH H H NH2 8 Ph *R and Rb joined together by (CH 2
)
3 to form five-membered ring. Table 111-41. N2 R 1
R
2
R
3 a Rb R 4 R R 6 X Y R 7 R' R 9 U1-41-1 CH 3 H H H Bz H CH 3 F OH H H NH 2 IU-41-2 CH 3 H H CH 3 Bz H CH 3 F OH H H NH 2 111-41-3 CH 3 H H CH(CH 3
)
2 Bz H CH 3 F OH H H NH2 IH-41-4 CH 3 H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH H H NH 2 1I-41-5 CH 3 H H CH 2 P)h Bz H CH 3 F OH H H NH 2 111-41-6 CH 3 H H CH 2 -indol-3-yl Bz H CH 3 F OH H H NH 2 IH-41-7 CH 3 H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH H H NH 2 IJ-41-8 CH 3 * H * Bz H CH 3 F OH H H NH 2
*R
2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table 111-42. R R 2
R
3 a R 3 b R 4 RR X Y R R' R IH-42-1 Et H H H Bz H CH 3 F OH H H NH 2 I-42-2 Et H H CH 3 Bz H CH 3 F OH H H NH 2 HI-42-3 Et H H CH(CH 3
)
2 Bz H CH 3 F OH H H NH 2 1I-42-4 Et H H CH 2
CII(CH
3
)
2 Bz H CH 3 F OH H H NH 2 I-42-5 Et H H CH 2 Ph Bz H CH 3 F OH H H NH 2 111-42-6 Et H H CH 2 -indol-3-yl Bz H CH 3 F OH H H NH 2 IH-42-7 Et H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH H H NH 2 1A1 2 RI R 2
R
3 a R 3 b R 4 R' R* X Y R' R" R 9 HI-428 Et* H * Bz H CH3 F OH H H NH 2 *R2 and RIb joined together by (CH 2
)
3 to form five-membered ring. Table 111-43. NR R 2
R
3 a Rb R R R X Y R R 8
R
9 M-43-1 Pr H H H Bz H CH 3 F OH H H NH2 m-43-2 'Pr H H CH 3 Bz H CH 3 F OH H H NH 2 m-43-3 'Pr H H CH(CH 3
)
2 Bz H CH 3 F OH H H NH 2 11-43-4 'Pr H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH H H NH2 111-43-5 'Pr H H CH 2 Ph Bz H CH 3 F OH H H NH2 111-43-6 'Pr H H CH 2 -indol-3-yl Bz H CH 3 F OH H H NH 2 111-43-7 'Pr H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH H H NH2 111-43-8 Pr* H * Bz H CH 3 F OH H H NH 2 *R1 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table 111-44. N R' R 2 RaRab R 4 R' R X Y R' RR 9 Il-44-1 'Bu H H H Bz H CH 3 F OH H H NH 2 111-44-2 'Bu H H CH 3 Bz H CH 3 F OH H H NH 2 m-44-3 'Bu H H CH(CH 3
)
2 Bz H CH 3 F OH H H NH 2 M-44-4 'Bu H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH H H NH 2 111-44-5 'Bu H H CH 2 Ph Bz H CH 3 F OH H H NH 2 I1-44-6 'Bu H H CH 2 -indol-3-yl Bz H CH 3 F OH H H NH 2 m-44-7 'Bu H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH H H NH 2 HI-44-8 'Bu* H * Bz H CH 3 F OH H H NH 2 5 *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. 1 A I Table 111-45. 2 R' R 2 RaR 3 b R R' R X Y R' R' R 9 H-45-1 Ph H H H Bz H CH 3 F OH H H NH 2 1II-45-2 Ph H H CH 3 Bz H CH 3 F OH H H NH2 M-45-3 Ph H H CH(CH 3
)
2 Bz H CH 3 F OH H H NH 2 M-45-4 Ph H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH H H NH2 M-45-5 Ph H H CH 2 Ph Bz H CH 3 F OH H H NH 2 M-45-6 Ph H H CH 2 -indol-3-yl Bz H CH 3 F OH H H NH 2 M-45-7 Ph H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH H H NH 2 11-45-8 Ph* H * Bz H CH 3 F OH H H NH 2 *RTand R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table 111-46. N2 R' R 2
R
3 a RA R 4 R' R 6 X Y R 7 R' R 9 III- p-Me- H H H Bz H CH 3 F OH H H NH 2 46-1 Ph III- p-Me- H H CH 3 Bz H CH 3 F OH H H NH 2 46-2 Ph m- p-Me- H H CH(CH 3
)
2 Bz H CH 3 F OH H H NH 2 46-3 Ph 11- p-Me- H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH H H NH 2 46-4 Ph III- p-Me- H H CH 2 Ph Bz H CH 3 F OH H H NH 2 46-5 Ph I- p-Me- H H CH 2 -indol-3- Bz H CH 3 F OH H H NH 2 46-6 Ph yl III- p-Me- H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH H H NH 2 46-7 Ph HI- p-Me- * H * Bz H CH 3 F OH H H NH 2 46-8 Ph
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table 111-47. N2 R R 2 Ra RA R4 R R X Y R 7 R R 9 M-47- p-F- H H H Bz H CH 3 F OH H H NH2 1 Ph 111-47- p-F- H H CH1 3 Bz H CH 3 F OH H H NH 2 Ph 1A'2
SR
2
R
3 a Rb R 4 R' R 6 X Y R' R' R9 2 111-47- p-F- H H CH(CH 3
)
2 Bz H CH 3 F OH H H NH2 3 Ph III-47- p-F- H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH H H NH 2 4 Ph II-47- p-F- H H CH 2 Ph Bz H CH 3 F OH H H NH 2 5 Ph HI-47- p-F- H H CH 2 -indol-3- Bz H CH 3 F OH H H NH 2 6 Ph Yl 111-47- p-F- H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH H H NH 2 7 Ph 111-47- p-F- * H * Bz H CH 3 F OH H H NH 2 8 Ph *R and Rib joined together by (CH 2
)
3 to form five-membered ring. Table 111-48. N2 R 2
R
3 a R 3 b R 4 R7R XY R RR 9 in- p-Cl- H H H Bz H CH 3 F OH H H NH 2 48-1 Ph III- p-Cl- H H CH 3 Bz H CH 3 F OH H H NH 2 48-2 Ph III- p-Cl- H H CH(CH 3
)
2 Bz H CH 3 F OH H H NH 2 48-3 Ph UI- p-Cl- H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH H H NH2 48-4 Ph III- p-Cl- H H CH 2 Ph Bz H CH 3 F OH H H NH 2 48-5 Ph III- p-Cl- H H CH 2 -indol-3- Bz H CH 3 F OH H H NH2 48-6 Ph yl III- p-Cl- H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH H H NH1 2 48-7 Ph III- p-Cl- * H * Bz H CH 3 F OH H H NH2 48-8 Ph *R and Rib joined together by (CH 2
)
3 to form five-membered ring. 1 AA Table 111-49. X2 R R 2
R
3 a Rb R 4 R' R' X Y R RS R 9 m- p-Br- H H H Bz H CH 3 F OH H H NH2 49-1 Ph m- p-Br- H H CH 3 Bz H CH 3 F OH H H NH2 49-2 Ph III- p-Br- H H CH(CH 3 )2 Bz H CH 3 F OH H H NH2 49-3 Ph M- p-Br- H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH H H NH 2 49-4 Ph mH- p-Br- H H CH 2 Ph Bz H CH 3 F OH H H NH 2 49-5 Ph I- p-Br- H H CH 2 -indol-3- Bz H CH 3 F OH H H NH 2 49-6 Ph yl in- p-Br- H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH H H NH 2 49-7 Ph III- p-Br- * H * Bz H CH 3 F OH H H NH2 49-8 Ph *Rz and Rb joined together by (CH 2
)
3 to form five-membered ring. Table 111-50. N2 R7 R2 R 3 a R 3 b R 4 R' R 6 X Y R 7 R' R 9 111-50- p-I- H H H Bz H CH 3 F OH H H NH 2 1 Ph HI-50- p-I- H H CH 3 Bz H CH 3 F OH H H NH2 2 Ph 111-50- p-I- H H CH(CH 3
)
2 Bz H CH 3 F OH H H NH2 3 Ph 111-50- p-I- H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH H H NH 2 4 Ph H1-50- p-I- H H CH 2 Ph Bz H CH 3 F OH H H Ni- 2 5 Ph HI-50- p-I- H H CH 2 -indol-3- Bz H CH 3 F OH H H NH 2 6 Ph YI I-50- p-I- H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH H H NH 2 7 Ph I-50- p-I- * H * Bz H CH3 F OH H H NH 2 X2 Rl R R R R 4 R' R X Y R R' R 9 8 Ph *Rand R 3 b joined together by (CH 2
)
3 to form five-membered ring. R9
R
2 R N R R7Nb R3a N- P- O O N 0 C0 2
R
4 OR' R6 Y X IV Table IV-1. N2 R' R2 Ra REb R 4 R' R 6 X Y R'R R 9 IV-1- CH 3 H H H CH 3 H F F OH H H NH 2 IV-1-2 CH 3 H H CH 3
CH
3 H F F OH H H NH 2 IV-1-3 CH 3 H H CH(CH 3
)
2
CH
3 H F F OH H H NH2 IV-1-4 CH 3 H H CH 2
CH(CH
3
)
2
CH
3 H F F OH H H NH 2 IV-1-5 CH 3 H H CH 2 Ph CH 3 H F F OH H H NH2 IV-1-6 CH 3 H H CH 2 -indol-3-yl CH 3 H F F OH H H NH 2 IV-1-7 CH 3 H H CH 2
CH
2
SCH
3
CH
3 H F F OH H H NH2 IV-1-8 CH 3 * H * CH 3 H F F OH H H NH 2 5 *Rz and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table IV-2. 2 RI R 2 R R 3 b R' R' R 6 X Y R 7 R' R' IV-2-1 Et H H H CH 3 H F F OH H H NH 2 IV-2-2 Et H H CH 3
CH
3 H F F OH H H NH 2 IV-2-3 Et H H CH(CH3) 2
CH
3 H F F OH H H NH 2 IV-2-4 Et H H CH 2 CH(CH3) 2
CH
3 H F F OH H H NH 2 IV-2-5 Et H H CH 2 Ph CH 3 H F F OH H H NH 2 IV-2-6 Et H H CH 2 -indol-3-yl CH 3 H F F OH H H NH2 IV-2-7 Et H H CH 2
CH
2
SCH
3
CH
3 H F F OH H H NH 2 1AA X RI R 2
R
3 a R 3 b R' R' R 6 X Y R' R' R 9 IV-2-8 Et * H * CH 3 H F F OH H H NH 2 *R2 and R lb joined together by (CH 2
)
3 to form five-membered ring. Table IV-3. N2 RI R 2
R
3 a R 3 b R 4 R' R 6 X Y R' R R:' IV-3-1 'Pr H H H CH 3 H F F OH H H NH 2 IV-3-2 'Pr H H CH 3
CH
3 H F F OH H H NH 2 IV-3-3 'Pr H H CH(CH 3
)
2
CH
3 H F F OH H H NH 2 IV-3-4 'Pr H H CH 2
CH(CH
3
)
2
CH
3 H F F OH H H NH 2 IV-3-5 'Pr H H CH 2 Ph CH 3 H F F OH H H NH 2 IV-3-6 'Pr H H CH 2 -indol-3-yl CH 3 H F F OH H H NH 2 IV-3-7 'Pr H H CH 2
CH
2
SCH
3
CH
3 H F F OH H H NH 2 IV-3-8 'Pr * H * CH 3 H F F OH H H NH2
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table IV-4. N2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y R 7 R' R 9 IV-4-1 'Bu H H H CH 3 H CH 3 F OH H H NH2 IV-4-2 'Bu H H CH 3 CH3 H CH 3 F OH H H NH 2 IV-4-3 'Bu H H CH(CH 3
)
2
CH
3 H CH 3 F OH H H NH 2 IV-4-4 'Bu H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH H H NH 2 IV-4-5 'Bu H H CH 2 Ph CH 3 H CH 3 F OH H H NH 2 IV-4-6 'Bu H H CH 2 -indol-3-yl CH 3 H CH 3 F OH H H NH 2 V-4-7 'Bu H H CH 2
CIH
2
SCH
3
CH
3 H CH 3 F OH H H NH2 IV-4-8 'Bu * H * CH 3 H CH 3 F OH H H NH 2 5 *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 1 A'7 Table IV-5. N2 R' R2 R 3 a R 3 b R 4 R' R' X Y R' R' RO IV-5-1 Ph H H H CH 3 H F F OH H H NH2 IV-5-2 Ph H H CH 3
CH
3 H F F OH H H NH 2 IV-5-3 Ph H H CH(CH 3
)
2
CH
3 H F F OH H H NH 2 IV-5-4 Ph H H CH 2
CH(CH
3
)
2
CH
3 H F F OH H H NH 2 IV-5-5 Ph H H CH 2 Ph CH3 H F F OH H H NH2 IV-5-6 Ph H H CH 2 -indol-3-yl CH 3 H F F OH H H NH 2 IV-5-7 Ph H H CH 2
CH
2
SCH
3
CH
3 H F F OH H H NH 2 IV-5-8 Ph* H * CH 3 H F F OH H H NH 2 *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table IV-6. N2 Rl R 2
R
3 a R 3 b R 4 R' R 6 X Y R' R' R 9 IV-6- p-Me- H H H CH 3 H F F OH H H NH 2 1 Ph IV-6- p-Me- H H ClH 3
CH
3 H F F OH H H NH 2 2 Ph IV-6- p-Me- H H CH(CH 3
)
2
CH
3 H F F OH H H NH 2 3 Ph IV-6- p-Me- H H CH 2
CH(CH
3
)
2
CH
3 H F F OH H H NH 2 4 Ph IV-6- p-Me- H H CH 2 Ph CH 3 H F F OH H H NH 2 5 Ph IV-6- p-Me- H H CH 2 -indol-3- CH 3 H F F OH H H NH 2 6 Ph IV-6- p-Me- H H CH 2
CH
2
SCH
3
CH
3 H F F OH H H NH 2 7 Ph IV-6- p-Me- * H * CH 3 H F F OH H H NH 2 8 Ph *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table IV-7. N2 Rl R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7 R' R 9 IV-7-1 p-F- H H H CH 3 H F F OH H H NH 2 Ph IV-7-2 p-F- H H Cl 3
CH
3 H F F OH H H NH 2 Ph IV-7-3 p-F- H H CH(CH 3
)
2
CH
3 H F F OH H H NH 2 1A2 X2 R2 R 3 a R 3 b R R' R 6 X Y R 7
R
8
R
9 Ph IV-7-4 p-F- H H CH 2
CH(CH
3
)
2
CH
3 H F F OH H H NH 2 Ph IV-7-6 p-F- H H CH 2 Ph CH 3 H F F OH H H NH2 Ph IV-7-7 p-F- H H CH 2 -indol-3- CH 3 H F F OH H H NH2 Ph YI IV-7-8 p-F- H H CH 2
CH
2
SCH
3
CH
3 H F F OH H H NH2 Ph IV-7- p-F- * H * CH 3 H F F OH H H NH 2 20 Ph *R and R b joined together by (CH 2
)
3 to form five-membered ring. Table IV-8. N2 R 2 R R R R 4 R R XY R R R 9 IV-8- p-Cl- H H H CH 3 H F F OH H H NH 2 1 Ph IV-8- p-Cl- H H CH 3
CH
3 H F F OH H H NH 2 2 Ph IV-8- p-Cl- H H CH(CH 3
)
2
CH
3 H F F OH H H NH 2 3 Ph IV-8- p-Cl- H H CH 2
CH(CH
3
)
2
CH
3 H F F OH H H NH2 4 Ph IV-8- p-Cl- H H CH 2 Ph CH3 H F F OH H H NH2 5 Ph IV-8- p-Cl- H H CH 2 -indol-3- CH 3 H F F OH H H NH 2 6 Ph yl IV-8- p-Cl- H H CH 2
CH
2
SCH
3
CH
3 H F F OH H H NH 2 7 Ph IV-8- p-Cl- * H * CH 3 H F F OH H H NH2 8 Ph *RTand R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table IV-9. N Rl R 2
R
3 a R A R 4 R' R 6 X Y R'R R 9 IV-9- p-Br- H H H CH 3 H F F OH H H NH2 Ph IV-9-2 p-Br- H H CH 3
CH
3 H F F OH H H NH2 Ph _ 1AQ_ 2 R' R2 R 3 a R 3 b R' R' R 6 X Y R R' R 9 IV-9-3 p-Br- H H CH(CH 3
)
2
CH
3 H F F OH H H NH 2 Ph IV-9-4 p-Br- H H CH 2
CH(CH
3
)
2
CH
3 H F F OH H H NH 2 Ph IV-9-6 p-Br- H H CH 2 Ph CH 3 H F F OH H H NH 2 Ph IV-9-7 p-Br- H H CH 2 -indol-3- CH 3 H F F OH H H NH 2 Ph yl IV-9-8 p-Br- H H CH 2
CH
2
SCH
3
CH
3 H F F OH H H NH 2 Ph IV-9- p-Br- * H * CH3 H F F OH H H NH 2 20 Ph *R' and R3b joined together by (CH 2
)
3 to form five-membered ring. Table IV-10. X2 R7 R 2
R
3 "a R R1 R' R 6 X Y R' R' R' IV-10- p-I- H H H CH 3 H F F OH H H NH2 1 Ph IV-10- p-I- H H CH 3
CH
3 H F F OH H H NH 2 2 Ph IV-10- p-I- H H CFI(CH 3
)
2
CH
3 H F F OH H H NH 2 3 Ph IV-10- p-I- H H CH 2
CH(CH
3
)
2
CH
3 H F F OH H H NH 2 4 Ph IV-10- p-I- H H CH 2 Ph CH 3 H F F OH H H NH 2 5 Ph IV-10- p-I- H H CH 2 -indol-3- CH 3 H F F OH H H NH 2 6 Ph yl IV-10- p-I- H H CH1 2
CH
2
SCH
3
CH
3 H F F OH H H NH 2 7 Ph IV-10- p-I- * H * CH 3 H F F OH H H NH 2 8 Ph *R and Rab joined together by (CH 2
)
3 to form five-membered ring. Table IV-11. N2 R R2 R 3 a R 3 b R 4 R' R 6 X Y R' R' R' IV-11-1 CH 3 H H H Et H F F OH H H NH 2 IV-11-2 CH 3 H H CH 3 Et H F F OH H H NH, Na2 R' R2 R 3 A R 3 b R 4 R' R' X Y R' R' R 9 IV-11-3 CH 3 H H CH(CH 3
)
2 Et H F F OH H H NH 2 IV-11-4 CH 3 H H CH 2
CH(CH
3
)
2 Et H F F OH H H NH 2 IV-11-5 CH3 H H CH 2 Ph Et H F F OH H H NH 2 IV-11-6 CH 3 H H CH 2 -indol-3-yl Et H F F OH H H NH2 IV-11-7 CH 3 H H CH 2
CH
2
SCH
3 Et H F F OH H H NH2 IV-11-8 CH 3 * H * Et H F F OH H H NH 2 *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table IV-12. N2 RI R 2
R
3 a Rb R 4 R' R' X Y R 7
R
8
R
9 IV-12-1 Et H H H Et H F F OH H H NH 2 IV-12-2 Et H H CH 3 Et H F F OH H H NH 2 IV-12-3 Et H H CH(CH 3
)
2 Et H F F OH H H NH2 IV-12-4 Et H H CH 2
CH(CH
3
)
2 Et H F F OH H H NH 2 IV-12-5 Et H H CH 2 Ph Et H F F OH H H NH 2 IV-12-6 Et H H CH 2 -indol-3-yl Et H F F OH H H NH 2 IV-12-7 Et H H CH 2
CH
2
SCH
3 Et H F F OH H H NH 2 IV-12-8 Et* H * Et H F F OH H H NH 2 *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table IV-13. NV R' R 2
R
3 a R 3 b R 4 R' R' X Y R' R' R 9 IV-13-1 'Pr H H H Et H F F OH H H NH 2 IV-13-2 'Pr H H CH 3 Et H F F OH H H NH 2 IV-13-3 'Pr H H CH(CH 3
)
2 Et H F F OH H H NH 2 IV-13-4 'Pr H H CH 2
CH(CH
3
)
2 Et H F F OH H H NHF1 2 IV-13-5 'Pr H H CH 2 Ph Et H F F OH H H NH 2 IV-13-6 'Pr H H CH 2 -indol-3-yl Et H F F OH H H NH 2 IV-13-7 'Pr H H CH 2
CH
2
SCH
3 Et H F F OH H H NH 2 V-13-8 'Pr* H * Et H F F OH H H NI- 2 5 *R and R3b joined together by (CH 2
)
3 to form five-membered ring. Table IV-14. Nq R' R2 R R 3 b R 4 R' R 6 X Y R 7
R
8
R
9 3a IV-14- 'Bu H H H Et H F F OH H H NH 2 1 1 C1 XN R R 2 R Rab R 4 R' R' X Y R' R 8 R 3a IV-14- 'Bu H H CH 3 Et H F F OH H H NH 2 2 IV-14- 'Bu H H CH(CH 3
)
2 Et H F F OH H H NH 2 3 IV-14- 'Bu H H CH 2
CH(CH
3
)
2 Et H F F OH H H NH 2 4 IV-14- 'Bu H H CH 2 Ph Et H F F OH H H NH 2 5 IV-14- 'Bu H H CH 2 -indol-3-yl Et H F F OH H H NH2 6 IV-14- 'Bu H H CH 2
CH
2
SCH
3 Et H F F OH H H NH 2 7 IV-14- 'Bu * H * Et H F F OH H H NH 2 8 *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table IV-15. Xe R R RR R R' R' R 6 X Y R' R' R 9 IV-15-1 Ph H H H Et H F F OH H H NH 2 IV-15-2 Ph H H CH 3 Et H F F OH H H NH 2 IV-15-3 Ph H H CH(CH 3
)
2 Et H F F OH H H NH 2 IV-15-4 Ph H H CH 2
CH(CH
3
)
2 Et H F F OH H H NH 2 IV-15-5 Ph H H CH 2 Ph Et H F F OH H H NH 2 IV-15-6 Ph H H CH 2 -indol-3-yl Et H F F OH H H NH1I 2 IV-15-7 Ph H H CH 2
CH
2
SCH
3 Et H F F OH H H NH 2 IV-15-8 Ph* H * Et H F F OH H H NH 2 *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table IV-16. X R' R 2
R
3 "R R 4 R R X Y R' R' R 9 IV-16- p-Me- H H HA Et H F F OH H H NH2 1 Ph IV-16- p-Me- H H CH 3 Et H F F OH H H NH 2 2 Ph IV-16- p-Me- H H CH(CH 3
)
2 Et H F F OH H H NH 2 Ph _ 1e') N2 R' R 2 R a R 3 b R' R' R 6 X Y R' R' R 9 3 IV-16- p-Me- H H CH 2
CH(CH
3
)
2 Et H F F OH H H NH2 4 Ph IV-16- p-Me- H H CH 2 Ph Et H F F OH H H NH 2 5 Ph IV-16- p-Me- H H CH 2 -indol-3- Et H F F OH H H NH2 6 Ph Y1 IV-16- p-Me- H H CH 2
CH
2
SCH
3 Et H F F OH H H NH 2 7 Ph IV-16- p-Me- * H * Et H F F OH H H NH2 8 Ph R2and R 3 " joined together by (CH 2
)
3 to form five-membered ring. Table IV-17. NR R 3 a R 3 b R 4 R' R XY R R R 9 IV-17-1 p-F-Ph H H H Et H F F OH H H NH2 IV-17-2 p-F-Ph H H CH 3 Et H F F OH H H NH2 IV-17-3 p-F-Ph H H CH(CH 3
)
2 Et H F F OH H H NH 2 IV-17-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Et H F F OH H H NH 2 IV-17-5 p-F-Ph H H CH 2 Ph Et H F F OH H H NH 2 IV-17-6 p-F-Ph H H CH 2 -indol-3-yl Et H F F OH H H NH 2 IV-17-7 p-F-Ph H H CH 2
CH
2
SCH
3 Et H F F OH H H NH 2 IV-17-8 p-F-Ph* H * Et H F F OH H H NH 2 *R2 and R 3 joined together by (CH 2
)
3 to form five-membered ring. Table IV-18. S R 3R 2 a R 3 b R 4 R' R 6 X Y R' R' R 9 IV-18- p-Cl- H H H Et H F F OH H H NH 2 1 Ph IV-18- p-Cl- H H CH 3 Et H F F OH H H NH 2 2 Ph IV-18- p-Cl- H H CH(CH 3
)
2 Et H F F OH H H NH2 3 Ph IV-18- p-Cl- H H CH 2
CH(CH
3
)
2 Et H F F OH H H NH 2 4 Ph IV-18- p-Cl- H H CH 2 Ph Et H F F OH H H NH 2 Ph 1C2 X2 R R 2
R
3 a R 3 b R 4 R' R 6 X Y R' R' R 9 5 IV-18- p-Cl- H H CH 2 -indol-3- Et H F F OH H H NH2 6 Ph Y1 IV-18- p-Cl- H H CH 2
CH
2
SCH
3 Et H F F OH H H NH 2 7 Ph IV-18- p-Cl- * H * Et H F F OH H H NH 2 8 Ph *R and Rib joined together by (CH 2
)
3 to form five-membered ring. Table IV-19. N2 R R2 R 3 a R 3 b R R 6 X Y R 7
R
8
R
9 IV-19- p-Br- H H H Et H F F OH H H NH 2 1 Ph IV-19- p-Br- H H CH 3 Et H F F OH H H NH 2 2 Ph IV-19- p-Br- H H CH(CH 3
)
2 Et H F F OH H H NH 2 3 Ph IV-19- p-Br- H H CH 2
CH(CH
3
)
2 Et H F F OH H H NH2 4 Ph IV-19- p-Br- H H CH 2 Ph Et H F F OH H H NH2 5 Ph IV-19.- p-Br- H H CH 2 -indol-3- Et H F F OH H H NH2 6 Ph YI IV-19-- p-Br- H H CH 2
CH
2
SCH
3 Et H F F OH H H NH2 7 Ph IV-19-- p-Br- * H * Et H F F OH H H NH 2 8 Ph *RT2nd RIb joined together by (CH 2
)
3 to form five-membered ring. Table IV-20. S R R 2
R
3 R R 4 R R 6 XY R' RR 9 IV-20-1 p--Ph H H H Et H F F OH H H NH 2 IV-20-2 p-I-Ph H H CH 3 Et H F F OH H H NH2 IV-20-3 p-I-Ph H H CH(CH 3
)
2 Et H F F OH H H NH2 IV-20-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Et H F F OH H H NH 2 IV-20-5 p-I-Ph H H CH 2 Ph Et H F F OH H H NH 2 _ 1CA X R' R 2
R
3 a Rb R' R' R X Y R R' R 9 IV-20-6 p-I-Ph H H CH 2 -indol-3-yl Et H F F OH H H NH2 IV-20-7 p-I-Ph H H CH 2
CH
2
SCH
3 Et H F F OH H H NH 2 IV-20-8 p-I-Ph* H * Et H F F OH H H N1 2 *R7 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table IV-2 1. X R' R2 Ria Rb R 4 R' R 6 X Y R' R' R' IV-21-1 CH 3 H H H 'Pr H F F OH H H NH 2 IV-21-2 CH 3 H H CH 3 'Pr H F F OH H H NH2 IV-21-3 CH 3 H H CH(CH 3
)
2 'Pr H F F OH H H NH 2 IV-21-4 CH 3 H H CH2CH(CH 3
)
2 'Pr H F F OH H H NH 2 IV-21-5 CH 3 H H CH2Ph 'Pr H F F OH H H NH 2 IV-21-6 CH 3 H H CH 2 -indol-3-yl 'Pr H F F OH H H NH2 IV-21-7 CH 3 H H CH 2
CH
2
SCH
3 'Pr H F F OH H H NH 2 IV-21-8 CH 3 * H * 'Pr H F F OH H H NH 2 *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table IV-22. X RT R 2 R aRi R 4 R' R' X Y R' R' R' IV-22-1 Et H H H 'Pr H F F OH H H NH 2 IV-22-2 Et H H CH 3 'Pr H F F OH H H NH 2 IV-22-3 Et H H CH(CH 3
)
2 'Pr H F F OH H H NH 2 IV-22-4 Et H H CH 2
CH(CH
3
)
2 'Pr H F F OH H H NH 2 IV-22-5 Et H H CH 2 Ph 'Pr H F F OH H H NH 2 IV-22-6 Et H H CH 2 -indol-3-yl 'Pr H F F OH H H NH 2 IV-22-7 Et H H CH 2
CH
2
SCH
3 'Pr H F F OH H H NH 2 IV-22-8 Et* H * 'Pr H F F OH H H NH 2 5 R and R joined together by (CH 2
)
3 to form five-membered ring. Table IV-23. X R' R 2 Ra Rb R 4 R'R XY RR R 9 IV-23-1 'Pr HH H 'Pr H F F OH H H NH 2 IV-23-2 'Pr H H CH 3 'Pr H F F OH H H NH 2 IV-23-3 'Pr H H CH(CH 3
)
2 'Pr H F F OH H H NH 2 IV-23-4 'Pr H H CH 2
CH(CH
3
)
2 'Pr H F F OH H H NH 2 IV-23-5 'Pr H H CH 2 Ph 'Pr H F F OH H H NH 2 IV-23-6 'Pr H H CH 2 -indol-3-yl 'Pr H F F OH H H NH 2 X2 R' R2 Ra R 3 b R 4 R' R' X Y R 7 R R 9 IV-23-7 'Pr H H CH 2
CH
2
SCH
3 'Pr H F F OH H H NH 2 IV-23-8 'Pr* H * 'Pr H F F OH H H NH 2 *R" and RIb joined together by (CH 2
)
3 to form five-membered ring. Table IV-24. N2 R' R2 R 3 a R3b R' R' R' X Y R 7 R' R 9 IV-24-1 'Bu H H H 'Pr H F F OH H H NH 2 IV-24-2 'Bu H H CH 3 'Pr H F F OH H H NH 2 IV-24-3 'Bu H H CH(CH 3
)
2 'Pr H F F OH H H NH 2 IV-24-4 'Bu H H CH 2
CH(CH
3
)
2 'Pr H F F OH H H NH 2 IV-24-5 'Bu H H CH 2 Ph 'Pr H F F OH H H NH 2 IV-24-6 'Bu H H CH 2 -indol-3-yl 'Pr H F F OH H H NH 2 IV-24-7 'Bu H H CH 2
CH
2
SCH
3 'Pr H F F OH H H NH 2 IV-24-8 'Bu* H * 'Pr H F F OH H H NH 2 *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table IV-25. N2 RT R2 R 3 a R3b R' R' R' X Y R 7
R
8
R
9 IV-25-1 Ph H H H 'Pr H F F OH H H NH 2 IV-25-2 Ph H H CH 3 'Pr H F F OH H H NH 2 IV-25-3 Ph H H CH(CH 3
)
2 'Pr H F F OH H H NH 2 IV-25-4 Ph H H CH 2
CH(CH
3
)
2 'Pr H F F OH H H NH 2 IV-25-5 Ph H H CH 2 Ph 'Pr H F F OH H H NH 2 IV-25--6 Ph H H CH 2 -indol-3-yl 'Pr H F F OH H H NH 2 IV-25-7 Ph H H CH 2
CH
2
SCH
3 'Pr H F F OH H H NH2 IV-25-8 Ph* H * 'Pr H F F OH H H NH2 5 *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table IV-26. N2 R R 2
R
3 a Rab R4 R' R 6 X Y R' R' R 9 IV-26- p-Me- H H H 'Pr H F F OH H H NH 2 1 Ph IV-26- p-Me- H H CH 3 'Pr H F F OH H H NH 2 2 Ph IV-26- p-Me- H H CH(CH 3
)
2 'Pr H F F OH H H NH 2 3 Ph IV-26- p-Me- H H CH 2
CH(CH
3
)
2 'Pr H F F OH H H NH 2 1 4z X2 R 2
R
3 a RA R 4 R' R' X Y R' R' R 9 4 Ph IV-26- p-Me- H H CH 2 Ph 'Pr H F F OH H H NH 2 5 Ph IV-26- p-Me- H H CH 2 -indol-3- 'Pr H F F OH H H NH 2 6 Ph yl IV-26- p-Me- H H CH 2
CH
2
SCH
3 'Pr H F F OH H H Ni- 2 7 Ph IV-26- p-Me- * H * 'Pr H F F OH H H NH2 Ph *R7 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table IV-27. X2 R 2
R
3 a R R 4 R R X Y R R' R 9 IV-27-1 p-F-Ph H H H 'Pr H F F OH H H NH 2 IV-27-2 p-F-Ph H H CH 3 'Pr H F F OH H H NH 2 IV-27-3 p-F-Ph H H CH(CH 3
)
2 'Pr H F F OH H H NH 2 IV-27-4 p-F-Ph H H CH 2
CH(CH
3
)
2 'Pr H F F OH H H NH 2 IV-27-5 p-F-Ph H H CH 2 Ph 'Pr H F F OH H H NH 2 IV-27-6 p-F-Ph H H CH 2 -indol-3-yl 'Pr H F F OH H H NH 2 IV-27.-7 p-F-Ph H H CH 2
CH
2
SCH
3 'Pr H F F OH H H NH 2 IV-27-8 p-F-Ph * H * 'Pr H F F OH H H NH 2 *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table IV-28. N2 R1 R 2
R
3 aRE R 4 R' R 6 X Y R 7
R
8
R
9 IV-28- p-Cl- H H H 'Pr H F F OH H H NH 2 1 Ph IV-28-. p-Cl- H H CH 3 'Pr H F F OH H H NH 2 2 Ph IV-28- p-Cl- H H CH(CH 3
)
2 'Pr H F F OH H H NH 2 3 Ph IV-28- p-Cl- H H CH 2
CH(CH
3
)
2 'Pr H F F OH H H NH 2 4 Ph IV-28- p-Cl- H H CH 2 Ph 'Pr H F F OH H H NH 2 5 Ph IV-28- p-Cl- H H CH 2 -indol-3- 'Pr H F F OH H H NH 2 Ph 10-7 X2 R' R 2 R3a R3b R' R' R 6 X Y R' R' R 9 6 yl IV-28- p-Cl- H H CH 2
CH
2
SCH
3 'Pr H F F OH H H N1 2 7 Ph IV-28- p-Cl- * H * 'Pr H F F OH H H NH 2 8 Ph *R and R b joined together by (CH 2
)
3 to form five-membered ing. Table IV-29. N2 RR R 2 R Rb R 4
R
6 X Y R 7
R
8
R
9 IV-29- p-Br- H H 1 'Pr H F F OH H H Nil 2 1 Ph IV-29- p-Br- H H CH 3 'Pr H F F OH H H NH 2 2 Ph IV-29- p-Br- H H CH(CH 3
)
2 'Pr H F F OH H H NH 2 3 Ph IV-29- p-Br- H H CH 2
CH(CH
3
)
2 'Pr H F F OH H H NH 2 4 Ph IV-29- p-Br- H H CH 2 Ph Pr H F F OH H H NH 2 5 Ph IV-29- p-Br- H H CH 2 -indol-3- 'Pr H F F OH H H NH 2 6 Ph IV-29- p-Br- H H CH 2
CH
2
SCH
3 'Pr H F F OH H H NH 2 7 Ph IV-29- p-Br- * H * 'Pr H F F OH H H NH 2 8 Ph *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table IV-30. N2 R RR R 3 b R 4 R' R X Y R R' R 9 IV-30-1 p-I-Ph H H H 'Pr H F F OH H H NH 2 IV-30--2 p-I-Ph H H CF 3 'Pr H F F OH H H NH 2 IV-30-3 p-I-Ph H H CH(CH 3
)
2 'Pr H F F OH H H Ni 2 IV-30--4 p-I-Ph H H CH1 2
CH(CH
3
)
2 'Pr H F F OH H H NH 2 IV-30-5 p-I-Ph H H CH 2 Ph 'Pr H F F OH H H NH 2 IV-30--6 p-I-Ph H H CH 2 -indol-3-yl 'Pr H F F OH H H NH 2 IV-30-7 p-I-Ph H H CH 2
CH
2
SCH
3 'Pr H F F OH H H NH 2 140Q N2 R' R 2
R
3 a R b R 4 R' R' X Y R R' R 9 IV-30-8 p-I-Ph * H * 'Pr H F F OH H H NH 2 *R and Rib joined together by (CH 2
)
3 to form five-membered ring. Table IV-31. X2 R' R2 Ra R 3 b R4 R' R' X Y R 7
R
8
R
9 IV-31-1 CH 3 H H H "Bu H F F OH H H NH 2 IV-31-2 CH 3 H H CH 3 "Bu H F F OH H H NH 2 IV-31-3 CH 3 H H CH(CH 3
)
2 "Bu H F F OH H H NH 2 IV-31-4 CH 3 H H CH 2
CH(CH
3
)
2 "Bu H F F OH H H NH2 IV-31-5 CH 3 H H CH 2 Ph "Bu H F F OH H H NH 2 IV-31-6 CH 3 H H CH 2 -indol-3-yl "Bu H F F OH H H NH 2 IV-31-7 CH 3 H H CH 2
CH
2
SCH
3 "Bu H F F OH H H NH 2 IV-31-8 CH 3 * H * "Bu H F F OH H H NH 2 *R and RIb joined together by (CH 2
)
3 to form five-membered ring. Table IV-32. N2 RI R 2 Ra R 3 b R' R' R 6 X Y R R' R 9 IV-32-1 Et H H H "Bu H F F OH H H NH 2 IV-32-2 Et H H CH 3 "Bu H F F OH H H NH 2 IV-32-3 Et H H CH(CH 3
)
2 "Bu H F F OH H H NH 2 IV-32-4 Et H H CH 2
CH(CH
3
)
2 "Bu H F F OH H H NH IV-32-5 Et H H CH 2 Ph "Bu H F F OH H H N-H2 IV-32-6 Et H H CH 2 -indol-3-yl "Bu H F F OH H H NIi 2 IV-32-7 Et H H CH 2
CH
2
SCH
3 "Bu H F F OH H H NH 2 IV-32-8 Et* H * "Bu H F F OH H H NH 2 5 *Rad R3b joined together by (CH 2
)
3 to form five-membered ring. Table IV-33. N2 R1 R 2 R3a R 3 b R 4 R' R 6 X Y R' R' R9 IV-331 'Pr H H H "Bu H F F OH H H NH 2 IV-33-2 'Pr H H CH 3 "Bu H F F OH H H NH 2 IV-33-3 'Pr H H CH(CH 3
)
2 "Bu H F F OH H H NH 2 IV-33-4 'Pr H H CH 2
CH(CH
3
)
2 "Bu H F F OH H H NH 2 IV-33-5 'Pr H H CH 2 Ph "Bu H F F OH H H NH 2 IV-33-6 'Pr H H CH 2 -indol-3-yl "Bu H F F OH H H NH 2 IV-33-7 'Pr H H CH 2
CH
2
SCH
3 "Bu H F F OH H H NH 2 IV-33-8 'Pr* H * "Bu H F F OH H H NH2 1 CO
*R
2 and R joined together by (CH 2
)
3 to form five-membered ring. Table IV-34. Xe R' R 2
R
3 a R 3 b R 4 R' R' X Y R' R' R 9 IV-34-1 'Bu H H H "Bu H F F OH H H NH2 IV-34-2 'Bu H H CH 3 "Bu H F F OH H H NH2 IV-34-3 'Bu H H CH(CH 3
)
2 "Bu H F F OH H H NH 2 IV-34-4 'Bu H H CH 2
CH(CH
3
)
2 "Bu H F F OH H H NH 2 IV-34-5 'Bu H H CH 2 Ph Bu H F F OH H H NH2 IV-34-6 'Bu H H CH 2 -indol-3-yl "Bu H F F OH H H NH- 2 IV-34-7 'Bu H H CH 2
CH
2
SCH
3 "Bu H F F OH H H NH 2 IV-34-8 'Bu* H * "Bu H F F OH H H NH 2 *RTand Rib joined together by (CH 2
)
3 to form five-membered ring. Table IV-35. Xe R 1 R2 R 3 " Rb R 4 R' R 6 X Y ' 7 R R 9 IV-35-1 Ph H H H "Bu H F F OH H H NH 2 IV-35-2 Ph H H CH 3 "Bu H F F OH H H NH 2 IV-35-3 Ph H H CH(CH 3
)
2 "Bu H F F OH H H NH 2 IV-35-4 Ph H H CH 2
CH(CH
3
)
2 "Bu H F F OH H H NH 2 IV-35-5 Ph H H CH 2 Ph "Bu H F F OH H H NH 2 IV-35-6 Ph H H CH 2 -indol-3-yl "Bu H F F OH H H NH 2 IV-35-7 Ph H H CH 2
CH
2
SCH
3 "Bu H F F OH H H NH 2 IV-35-8 Ph* H * "Bu H F F OH H H NH 2 5 *R and Rib joined together by (CH 2
)
3 to form five-membered ring. Table IV-36. Xe R' R2 R 3 a R 3 b R 4
R
5
R
6 X Y R 7
R
8
R
9 IV- p-Me- H H H "Bu H F F OH H H NH 2 36-1 Ph IV- p-Me- H H CH 3 "Bu H F F OH H H NH 2 36-2 Ph IV- p-Me- H H CH(CH 3
)
2 "Bu H F F OH H H NH 2 36-3 Ph IV- p-Me- H H CH 2
CH(CH
3
)
2 "Bu H F F OH H H NH 2 36-4 Ph IV- p-Me- H H CH 2 Ph "Bu H F F OH H H NH 2 36-5 Ph 1 AA X2 R1 R 2
R
3 a R 3 b R 4 R' R 6 X Y R' R' R 9 IV- p-Me- H H CH 2 -indol-3- "Bu H F F OH H H NH 2 36-6 Ph IV- p-Me- H H CH 2
CH
2
SCH
3 "Bu H F F OH H H NH 2 36-7 Ph IV- p-Me- * H * Bu H F F OH H H NH2 36-8 Ph *Rland R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table IV-37. X2 R7 R 2 Ra Rb R 4 R' R 6 X Y R 7 R' R IV-37- p-F- H H H "Bu H F F OH H H NH 2 1 Ph IV-37- p-F- H H CH 3 "Bu H F F OH H H NH 2 2 Ph IV-37- p-F- H H CH(CH 3
)
2 "Bu H F F OH H H NH 2 3 Ph IV-37- p-F- H H CH 2
CH(CH
3
)
2 "Bu H F F OH H H NiH2 4 Ph IV-37- p-F- H H CH 2 Ph "Bu H F F OH H H NH 2 5 Ph IV-37- p-F- H H CH 2 -indol-3- "Bu H F F OH H H NH 2 6 Ph Yl IV-37- p-F- H H CH 2
CH
2
SCH
3 "Bu H F F OH H H NH 2 7 Ph IV-37- p-F- * H * Bu H F F OH H H NH 2 8 Ph *R" and R3b joined together by (CH2)3 to form five-membered ring. Table IV-38. N2 R R 2 RRa R 3 b R 4 R R X Y R/ R 8
R
9 IV-38-- p-Cl- H H H "Bu H F F OH H H NH 2 I Ph IV-38-- p-Cl- H H CH 3 "Bu H F F OH H H NH 2 2 Ph IV-38-- p-Cl- H H CH(CH 3
)
2 "Bu H F F OH H H NH 2 3 Ph 1 £1 X2 R R 2
R
3 a R 3 b R' R' R' X Y R' R" R 9 IV-38- p-Cl- H H CH 2
CH(CH
3
)
2 "Bu H F F OH H H NH 2 4 Ph IV-38- p-Cl- H H CH 2 Ph "Bu H F F OH H H NH 2 5 Ph IV-38- p-Cl- H H C1 2 -indol-3- "Bu H F F OH H H NH 2 6 Ph yl IV-38- p-Cl- H H CH 2
CH
2
SCH
3 "Bu H F F OH H H NH 2 7 Ph IV-38- p-Cl- * H * Bu H F F OH H H NH2 8 Ph RTand R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table IV-39. X2 R 2 Ra R 3 ) R 4 R' R 6 X Y R 7
R
8
R
9 IV-39- p-Br- H H H "Bu H F F OH H H NH 2 1 Ph IV-39.- p-Br- H H CH-3 "Bu H F F OH H H NH 2 2 Ph IV-39.. p-Br- H H CH(CH 3
)
2 "Bu H F F OH H H Nil 2 3 Ph IV-39-. p-Br- H H CH 2
CH(CH
3
)
2 "Bu H F F OH H H NH 2 4 Ph IV-39- p-Br- H H CH 2 Ph "Bu H F F OH H H NH 2 5 Ph IV-39- p-Br- H H CH 2 -indol-3- "Bu H F F OH H H NH2 6 Ph yl IV-39- p-Br- H H CH 2
CH
2
SCH
3 "Bu H F F OH H H NH 2 7 Ph V-39- p-Br- * H * Bu H F F OH H H NH 2 8 Ph Rian d R3b joined together by (CH 2
)
3 to form five-membered ring. Table IV-40. X2 R R R 3 a R 3 b R4 R' R 6 X Y R 7
R
8
R
9 IV-40- p-I- H H H "Bu H F F OH H H NH 2 Ph 141 X2 R' R 2 R 3aRb R 4 R' R' X Y R'R R 9 IV-40- p-I- H H CH 3 "Bu H F F OH H H NH 2 2 Ph IV-40- p-I- H H CH(CH 3
)
2 "Bu H F F OH H H NH2 3 Ph IV-40- p-I- H H CH 2
CH(CH
3
)
2 "Bu H F F OH H H NH2 4 Ph IV-40- p-I- H H CH 2 Ph "Bu H F F OH H H NH 2 5 Ph IV-40- p-I- H H CH 2 -indol-3- "Bu H F F OH H H NH2 6 Ph yl IV-40- p-I- H H CH 2
CH
2
SCH
3 "Bu H F F OH H H NH 2 7 Ph IV-40- p-I- * H * "Bu H F F OH H H NH 2 Ph *R' and R3b joined together by (CH 2
)
3 to form five-membered ring. Table IV-41. X2 R' R 2 R Rb R 4 R' R 6 X Y R 7
R
8
R
9 IV-41.- CH 3 H H H Bz H F F OH H H NH 2 IV-41-2 CH 3 H H CH 3 Bz H F F OH H H N1 2 IV-41--3 CH 3 H H CH(CH 3
)
2 Bz H F F OH H H NH 2 IV-41-4 CH 3 H H CH 2
CH(CH
3
)
2 Bz H F F OH H H NH 2 IV-41-5 CH 3 H H CH 2 Ph Bz H F F OH H H NH 2 IV-41-6 CH 3 H H CH 2 -indol-3-yl Bz H F F OH H H NH2 IV-41-.7 CH 3 H H CH 2
CH
2
SCH
3 Bz H F F OH H H NH 2 IV-41-8 CH 3 * H * Bz H F F OH H H NH 2 *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table IV-42. 2 R R 2 R 3 aR 3 b R' R' R 6 X Y R'R R 9 IV-42-1 Et H H H Bz H F F OH H H NH 2 IV-42-2 Et H H CH 3 Bz H F F OH H H NH 2 IV-42-3 Et H H CH(CH 3
)
2 Bz H F F OH H H NH 2 IV-42-4 Et H H CH 2
CH(CH
3
)
2 Bz H F F OH H H NH 2 IV-42-5 Et H H CH 2 Ph Bz H F F OH H H NH 2 IV-42-6 Et H H CH 2 -indol-3-yl Bz H F F OH H H NH 2 I1K12 X2 RI R 2
R
3 a Rb R 4 R' R' X Y R' RR 9 IV-42-7 Et H H CH 2
CH
2
SCH
3 Bz H F F OH H H NH 2 IV-42-8 Et * H * Bz H F F OH H H NH 2 *R" and R 3 ) joined together by (CH 2
)
3 to form five-membered ring. Table IV-43. N RIR 2
R
3 a R 3 b R 4 R' R' X Y R 7 R R IV-43-1 'Pr H H H Bz H F F OH H H NH 2 IV-43-2 'Pr H H CH3 Bz H F F OH H H NH2 IV-43-3 'Pr H H CH(CH 3
)
2 Bz H F F OH H H NH2 IV-43-4 'Pr H H CH 2
CH(CH
3
)
2 Bz H F F OH H H NH 2 IV-43-5 'Pr H H CH 2 Ph Bz H F F OH H H NH 2 IV-43-6 'Pr H H CH 2 -indol-3-yl Bz H F F OH H H Nil 2 IV-43-7 'Pr H H CH 2
CH
2
SCH
3 Bz H F F OH H H NI 2 IV-43-8 'Pr* H * Bz H F F OH H H NH2 *R and RJb joined together by (CH 2
)
3 to form five-membered ring. Table IV-44. N Rr R 2
R
3 "Rb R 4
R
5
R
6 XY R'R R 9 IV-44-1 'Bu H H H Bz H F F OH H H NH 2 IV-44-2 'Bu H H CH 3 Bz H F F OH H H NH 2 IV-44-3 'Bu H H CH(CH 3
)
2 Bz H F F OH H H NH 2 IV-444 'Bu H H CH 2
CH(CH
3
)
2 Bz H F F OH H H NH 2 IV-44-5 'Bu H H CH 2 Ph Bz H F F OH H H NH 2 IV-44-6 'Bu H H CH 2 -indol-3-yl Bz H F F OH H H NH 2 IV-44.7 'Bu H H CH 2
CH
2
SCH
3 Bz H F F OH H H NH 2 IV-44-8 'Bu * H * Bz H F F OH H H NH 2 5 * R and R"b joined together by (CH 2
)
3 to form five-membered ring. Table IV-45. N2 RI R 2
R
3 aR 3 b R 4 R R 6 X Y R' R' R 9 IV-451 Ph H H H Bz H F F OH H H NH 2 IV-45-2 Ph H H CH 3 Bz H F F OH H H NH 2 IV-45-3 Ph H H CH(CH 3
)
2 Bz H F F OH H H NH 2 IV-45-4 Ph H H CH 2
CH(CH
3
)
2 Bz H F F OH H H NH 2 IV-45-5 Ph H H CH 2 Ph Bz H F F OH H H NH 2 IV-45-6 Ph H H CH 2 -indol-3-yl Bz H F F OH H H NH 2 IV-45-7 Ph H H CH 2
CH
2
SCH
3 Bz H F F OH H H NH 2 _ 1AA N2 R' R2 R 3 a R 3 b R 4 R' R' X Y R 7
R
8
R
9 IV-45-8 Ph * H * Bz H F F OH H H NH 2 *R and RJb joined together by (CH 2
)
3 to form five-membered ring. Table IV-46. S RR R 3 aR Rb R 4 R' R 6 X Y R R' R' IV-46- p-Me- H H H Bz H F F OH H H NH 2 1 Ph IV-46- p-Me- H H CH 3 Bz H F F OH H H NH 2 2 Ph IV-46- p-Me- H H CH(CH 3
)
2 Bz H F F OH H H NH 2 3 Ph IV-46- p-Me- H H CH 2
CH(CH
3
)
2 Bz H F F OH H H NH 2 4 Ph IV-46- p-Me- H H CH 2 Ph Bz H F F OH H H NH 2 5 Ph IV-46.. p-Me- H H CH 2 -indol-3- Bz H F F OH H H NH 2 6 Ph yl IV-46- p-Me- H H CH 2
CH
2
SCH
3 Bz H F F OH H H NH 2 7 Ph IV-46- p-Me- * H * Bz H F F OH H H NH 2 8 Ph
*R
2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table IV-47. N9 R' R 2 Ra Rb R 4 R' R 6 X Y R' R R' IV-47- p-F-Ph H H H Bz H F F OH H H NH2 1 IV-47- p-F-Ph H H CH- 3 Bz H F F OH H H NH 2 2 IV-47- p-F-Ph H H CH(CH 3
)
2 Bz H F F OH H H NH 2 3 IV-47- p-F-Ph H H CH 2
CH(CH
3
)
2 Bz H F F OH H H NH 2 4 IV-47- p-F-Ph H H CH 2 Ph Bz H F F OH H H NH 2 5 IV-47- p-F-Ph H H CH 2 -indol-3-yl Bz H F F OH H H NH 2 1JC N2 R1 R 2
R
3 a Rb R 4 R' R 6 X Y R 7 Rs R 9 6 IV-47- p-F-Ph H H CH 2
CH
2
SCH
3 Bz H F F OH H H NH 2 7 IV-47- p-F-Ph* H * Bz H F F OH H H NH 2 8 *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table IV-48. S R R 2
R
3 a Rb R' R' R' X Y R R R 9 IV-48- p-Cl- H H H Bz H F F OH H H NH2 1 Ph IV-48- p-Cl- H H CH 3 Bz H F F OH H H NH 2 2 Ph IV-48- p-Cl- H H CH(CH 3
)
2 Bz H F F OH H H NHl 2 3 Ph IV-48- p-Cl- H H CH 2
CH(CH
3
)
2 Bz H F F OH H H NH 2 Ph IV-48- p-Cl- H H CH 2 Ph Bz H F F OH H H NH 2 5 Ph IV-48- p-Cl- H H CH 2 -indol-3- Bz H F F OH H H NH 2 6 Ph IV-48- p-Cl- H H CH 2
CH
2
SCH
3 Bz H F F OH H H NH 2 7 Ph IV-48- p-Cl- * H * Bz H F F OH H H NH 2 8 Ph *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table IV-49. N R R 2
R
3 a R 3 b R 4 R' R' X Y R' R' R 9 IV-49- p-Br- H H H Bz H F F OH H H NH2 1 Ph IV-49-. p-Br- H H CH 3 Bz H F F OH H H NiH2 2 Ph IV-49-. p-Br- H H CH(CH 3
)
2 Bz H F F OH H H NH 2 3 Ph IV-49- p-Br- H H CH 2
CH(CH
3
)
2 Bz H F F OH H H NH 2 Ph 144g X R' R 2
R
3 a R 3 b R 4 R' R' X Y R 7
R
8
R
9 4 IV-49- p-Br- H H CH 2 Ph Bz H F F OH H H NH 2 5 Ph IV-49- p-Br- H H CH 2 -indol-3- Bz H F F OH H H NH 2 6 Ph Y' IV-49- p-Br- H H CH 2
CH
2
SCH
3 Bz H F F OH H H NH 2 7 Ph IV-49- p-Br- * H * Bz H F F OH H H NH 2 8 Ph *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table IV-50. N R R 2
R
3 a R b R 4 R' R X Y R R R 9 IV-50-1 p-I-Ph H H H Bz H F F OH H H NH 2 IV-50-2 p-I-Ph H H CH 3 Bz H F F OH H H NH 2 IV-50-3 p-I-Ph H H CH(CH 3
)
2 Bz H F F OH H H NH 2 IV-50-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Bz H F F OH H H NH 2 IV-50-5 p-I-Ph H H CH 2 Ph Bz H F F OH H H NH2 IV-50-6 p-I-Ph H H CH 2 -indol-3-yl Bz H F F OH H H NH 2 IV-50-7 p-I-Ph H H CH 2
CH
2
SCH
3 Bz H F F OH H H NH 2 IV-50-8 p-I-Ph * H * Bz H F F OH H H NH2
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 R9 R2R RI0 0
R
7 N 0 C0 2
R
4 OR' R5 R6 Y X V 1 I"7 Table V-1. X * R' R 2
R
3 a Rb R 4 R' R' X Y R' R' R 9 V-1-1 CH 3 H H H CH3 H H F OH H H NH 2 V-1-2 CH 3 H H CH 3
CH
3 H H F OH H H NH2 V-1-3 CH 3 H H CH(CH 3
)
2
CH
3 H H F OH H H NH 2 V-1-4 CH 3 H H CH 2
CH(CH
3
)
2
CH
3 H H F OH H H NH 2 V-1-5 CH 3 H H CH 2 Ph CH 3 H H F OH H H NH 2 V-1-6 CH 3 H H CH 2 -indol-3-yl CH 3 H H F OH H H NH 2 V-1-7 CH 3 H H CH 2
CH
2
SCH
3
CH
3 H H F OH H H NH2 V-1-8 CH 3 * H * CH 3 H H F OH H H NH 2 *RT and R joined together by (CH 2
)
3 to form five-membered ring. Table V-2. X2 RI R 2
R
3 a Rb R 4 R' R 6 X Y R' RF R 9 V-2-1 Et H H H CH 3 H H F OH H H NH, V-2-2 Et H H CH 3
CH
3 H H F OH H H NH 2 V-2-3 Et H H CH(CH 3
)
2
CH
3 H H F OH H H NH 2 V-2-4 Et H H CH 2
CH(CH
3
)
2
CH
3 H H F OH H H NH 2 V-2-5 Et H H CH 2 Ph CH 3 H H F OH H H NH2 V-2-6 Et H H CH 2 -indol-3-yl CH 3 H H F OH H H NH- 2 V-2-7 Et H H CH 2
CH
2
SCH
3
CH
3 H H F OH H H NH 2 V-2-8 Et* H * CH 3 H H F OH H H NH2 *R and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table V-3. X2 R R2 R 3 a R 3 b R 4 R R 6 X Y R 7 R' R 9 V-3-1 'Pr H H H CH 3 H H F OH H H NH 2 V-3-2 'Pr H H CH 3
CH
3 H H F OH H H NH2 V-3-3 'Pr H H CH(CH 3
)
2
CH
3 H H F OH H H NH 2 V-3-4 'Pr H H CH 2
CH(CH
3
)
2
CH
3 H H F OH H H NH 2 V-3-5 'Pr H H CH 2 Ph CH 3 H H F OH H H NH 2 V-3-6 'Pr H H CH 2 -indol-3-yl CH 3 H H F OH H H NH 2 V-3-7 'Pr H H CH 2
CH
2
SCH
3
CH
3 H H F OH H H NH 2 V-3-8 'Pr * H * CH 3 H H F OH H H NH 2 *R and R3b joined together by (CH 2
)
3 to form five-membered ring. 1 KO Table V-4. N2 R' R2 R 3 a R 3 b4 R' R X Y R' R 8
R
9 V-4-1 'Bu H H H CH3 H H F OH H H NH 2 V-4-2 'Bu H H CH 3
CH
3 H H F OH H H NH 2 V-4-3 'Bu H H CH(CH 3
)
2
CH
3 H H F OH H H NH 2 V-4-4 'Bu H H CH 2
CH(CH
3
)
2
CH
3 H H F OH H H NH 2 V-4-5 'Bu H H CH 2 Ph CH3 H H F OH H H NH 2 V-4-6 'Bu H H CH 2 -indol-3-yl CH 3 H H F OH H H NH 2 V-4-7 'Bu H H CH 2
CH
2
SCH
3
CH
3 H H F OH H H NH 2 V-4-8 'Bu * H * CH 3 H H F OH H H NH 2 *R" and R3b joined together by (CH 2
)
3 to form five-membered ring. Table V-5. N2 R R 2 RaRb R 4 R' R 6 X Y R 7 R R 9 V-5-1 Ph H H H CH 3 H H F OH H H NH 2 V-5-2 Ph H H CH 3
CH
3 H H F OH H H N 2 V-5-3 Ph H H CH(CH 3
)
2
CH
3 H H F OH H H NH 2 V-5-4 Ph H H CH 2
CH(CH
3
)
2
CH
3 H H F OH H H NH 2 V-5-5 Ph H H CH 2 Ph CH3 H H F OH H H NH 2 V-5-6 Ph H H CH 2 -indol-3-yl CH 3 H H F OH H H NH 2 V-5-7 Ph H H CH 2
CH
2
SCH
3
CH
3 H H F OH H H NH 2 V-5-8 Ph* H * CH 3 H H F OH H H NH 2 *R and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table V-6. N RR RR a b R 4 R R XY R' R' R 9 V-6- p-Me- H H H CH 3 H H F OH H H NH 2 1 Ph V-6- p-Me- H H CH 3 CH3 H H F OH H H NH 2 2 Ph V-6- p-Me- H H CH(CH 3
)
2
CH
3 H H F OH H H NH 2 Ph V-6- p-Me- H H CH 2
CH(CH
3
)
2
CH
3 H H F OH H H NH 2 4 Ph V-6- p-Me- H H CH 2 Ph CH3 H H F OH H H NH 2 5 Ph V-6- p-Me- H H CH 2 -indol-3- CH 3 H H F OH H H NH 2 Ph _1 140 X2 R R 2
R
3 a R 3 b R 4 R' R' X Y R 7
R
8
R
9 6 yl V-6- p-Me- H H CH 2
CH
2
SCH
3
CH
3 H H F OH H H NH2 7 Ph V-6- p-Me- * H * CH 3 H H F OH H H NH2 8 Ph *R2and R"' joined together by (CH 2
)
3 to form five-membered ring. Table V-7. N R R R R 2 RaRR R 4 R' R X Y R 7 R' R 9 V-7-1 p-F- H H H CH 3 H H F OH H H NH 2 Ph V-7-2 p-F- H H CH 3
CH
3 H H F OH H H NH 2 Ph V-7-3 p-F- H H CH(CH 3
)
2
CH
3 H H F OH H H NH 2 Ph V-7-4 p-F- H H CH 2
CH(CH
3
)
2
CH
3 H H F OH H H NH 2 Ph V-7-6 p-F- H H CH 2 Ph CH 3 H H F OH H H NH 2 Ph V-7-7 p-F- H H CH 2 -indol-3- CH 3 H H F OH H H NH 2 Ph yl V-7-8 p-F- H H CH 2
CH
2
SCH
3
CH
3 H H F OH H H NH 2 Ph V-7- p-F- * H * CH 3 H H F OH H H NH 2 20 Ph
*R
2 and RJt joined together by (CH 2
)
3 to form five-membered ring. Table V-8. N2 R R 2 RaR 3 b R 4 R' R' X Y R' R R 9 V-8- p-Cl- H H H CH 3 H H F OH H H NH 2 1 Ph V-8- p-Cl- H H CH 3
CH
3 H H F OH H H NH2 2 Ph V-8- p-Cl- H H CH(CH 3
)
2
CH
3 H H F OH H H NH 2 3 Ph V-8- p-Cl- H H CH 2
CH(CH
3
)
2
CH
3 H H F OH H H NH 2 4 Ph V-8- p-Cl- H H CH 2 Ph CH 3 H H F OH H H NH 2 5 Ph 1'7A NXf 2
R
2
R
3 a R 3 b R 4 R R X Y .. R' R' R 9 V-8- p-Cl- H H CH 2 -indol-3- CH 3 H H F OH H H NH 2 6 Ph Y1 V-8- p-Cl- H H CH 2
CH
2
SCH
3
CH
3 H H F OH H H NH 2 7 Ph V-8- p-Cl- * H * CH 3 H H F OH H H NH 2 8 Ph R and R3b joined together by (CH 2
)
3 to form five-membered ring. Table V-9. S R R 2
R
3 a R R 4 R' R' X Y R R R 9 V-9-1 p-Br- H H H CH3 H H F OH H H NH 2 Ph V-9-2 p-Br- H H CH 3 CH3 H H F OH H H NH2 Ph V-9-3 p-Br- H H CH(CH 3
)
2
CH
3 H H F OH H H NH2 Ph V-9-4 p-Br- H H CH 2
CH(CH
3
)
2
CH
3 H H F OH H H NH 2 Ph V-9-6 p-Br- H H CH 2 Ph CH 3 H H F OH H H NH 2 Ph V-9-7 p-Br- H H CH 2 -indol-3- CH 3 H H F OH H H NH 2 Ph Y1 V-9-8 p-Br- H H CH 2
CH
2
SCH
3
CH
3 H H F OH H H NH 2 Ph V-9- p-Br- * H * CH 3 H H F OH H H NH2 20 Ph *R" and R3b joined together by (CH 2
)
3 to form five-membered ring. Table V-10. N2 R1 R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7 R' R 9 V-10-1 p-I-Ph H H H CH3 H H F OH H H NH 2 V-10-2 p-I-Ph H H CH 3
CH
3 H H F OH H H NH 2 V-10-3 p-I-Ph H H CH(CH 3
)
2
CH
3 H H F OH H H NH2 V-10-4 p-I-Ph H H CH 2
CH(CH
3
)
2
CH
3 H H F OH H H NH 2 V-10-5 p-I-Ph H H CH 2 Ph CH 3 H H F OH H H NH 2 V-10-6 p-I-Ph H H CH 2 -indol-3-yl CH 3 H H F OH H H NH 2 V-10-7 p-I-Ph H H CH 2
CH
2
SCH
3
CH
3 H H F OH H H NH 2 V-10-8 p-I-Ph* H * CH 3 H H F OH H H NH 2 5 *R 2 and Rb joined together by (CH 2
)
3 to form five-membered ring. 1 '71 Table V-11. N2 R1 R 2
R
3 a R 3 b R 4 R' R 6 X Y R' R' R 9 V-11-1 CH 3 H H H Et H H F OH H H NH2 V-11-2 CH 3 H H CH 3 Et H H F OH H H NH 2 V-11-3 CH 3 H H CH(CH 3
)
2 Et H H F OH H H NH 2 V-11-4 CH 3 H H CH 2
CH(CH
3
)
2 Et H H F OH H H NH 2 V-11-5 CH 3 H H CH 2 Ph Et H H F OH H H NH 2 V-11-6 CH 3 H H CH 2 -indol-3-yl Et H H F OH H H NH 2 V-11-7 CH 3 H H CH 2
CH
2
SCH
3 Et H H F OH H H NH 2 V-11-8 CH 3 * H * Et H H F OH H H NH 2 *RTand R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table V-12. N2 RI R 2 R 3 aR R 4 R' R 6 X Y R 7
R
8
R
9 V-12-1 Et H H H Et H H F OH H H N1 2 V-12-2 Et H H CH 3 Et H H F OH H H Ni- 2 V-12-3 Et H H CH(CH 3
)
2 Et H H F OH H H NH 2 V-12-4 Et H H CH 2
CH(CH
3
)
2 Et H H F OH H H NH 2 V-12-5 Et H H CH 2 Ph Et H H F OH H H NH 2 V-12-6 Et H H CH 2 -indol-3-yl Et H H F OH H H NH 2 V-12-7 Et H H CH 2
CH
2
SCH
3 Et H H F OH H H NH 2 V-12.-8 Et * H * Et H H F OH H H NH,
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table V-13. N2 R' R2 R 3 a R 3 b R 4 R' R' X Y R 7
R
8 R9 V-13-1 'Pr H H H Et- H H F OH H H NH2 V-13-2 'Pr H H CH 3 Et H H F OH H H NH 2 V-13-3 'Pr H H CH(CH 3
)
2 Et H H F OH H H NH 2 V-13-4 'Pr H H CH 2
CH(CH
3
)
2 Et H H F OH H H NH 2 V-13-5 'Pr H H CH 2 Ph Et H H F OH H H NH 2 V-13-6 'Pr H H CH2-indol-3-yl Et H H F OH H H NH 2 V-13-7 'Pr H H CH 2
CH
2
SCH
3 Et H H F OH H H NH 2 V-13-8 'Pr* H * EtH H F OH H H NH 2 *Rrand R 3 b joined together by (CH 2
)
3 to form five-membered ring. 1 '7'9 Table V-14. X2 R' R 2 R R 3 b R 4 R' R' X Y R R R 9 3a V-14-1 'Bu H H H Et H H F OH H H NH 2 V-14-2 'Bu H H CH 3 Et H H F OH H H NH2 V-14-3 'Bu H H CH(CH 3
)
2 Et H H F OH H H NH 2 V-14-4 'Bu H H CH 2
CH(CH
3
)
2 Et H H F OH H H NH 2 V-14-5 'Bu H H CH 2 Ph Et H H F OH H H NH 2 V-14-6 'Bu H H CH 2 -indol-3-yl Et H H F OH H H NH 2 V-14-7 'Bu H H CH 2
CH:
2
SCH
3 Et H H F OH H H NH 2 V-14-8 'Bu * H * Et H H F OH H H NH 2 *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table V-15. N2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y R' R' R 9 V-15-1 Ph H H H Et H H F OH H H NH2 V-15-2 Ph H H CH 3 Et H H F OH H H NH V-15-3 Ph H H CH(CH 3
)
2 Et H H F OH H H NH 2 V-15-4 Ph H H CH 2
CH(CH
3
)
2 Et H H F OH H H NH2 V-15-5 Ph H H CH 2 Ph Et H H F OH H H NH2 V-15-6 Ph H H CH 2 -indol-3-yl Et H H F OH H H NH4 2 V-15-.7 Ph H H CH 2
CH
2
SCH
3 Et H H F OH H H NH2 V-15-8 Ph * H * Et H H F OH H H NH 2 *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table V-16. N2 R' R 2
R
3 a R 3 b R' R' R 6 X Y R' R' R V-16.- p-Me- H H H Et H H F OH H H NH2 1 Ph V-16- p-Me- H H CH 3 Et H H F OH H H NH2 2 Ph V-16- p-Me- H H CH(CH 3
)
2 Et H H F OH H H NH 2 3 Ph V-16- p-Me- H H CH 2
CH(CH
3
)
2 Et H H F OH H H NH 2 4 Ph V-16- p-Me- H H CH 2 Ph Et H H F OH H H NH 2 5 Ph 1 '72 X2 R' R 2
R
3 a R 3 b R 4 R' R' X Y R' R' R 9 V-16- p-Me- H H CH 2 -indol-3- Et H H F OH H H NH 2 6 Ph V-16- p-Me- H H CH 2
CH
2
SCH
3 Et H H F OH H H NH 2 7 Ph V-16- p-Me- * H * Et H H F OH H H NH 2 8 Ph *R2ad Ra b joined together by (CH 2
)
3 to form five-membered ring. Table V-17. 2 R R R 3 aR R R 4 R R 6 X Y R R R 9 V-17-1 p-F-Ph H H H Et H H F OH H H NH2 V-17-2 p-F-Ph H H CH 3 Et H H F OH H H NH 2 V-17-3 p-F-Ph H H CH(CH 3
)
2 Et H H F OH H H NH 2 V-17-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Et H H F OH H H NH 2 V-17-5 p-F-Ph H H CH 2 Ph Et H H F OH H H NH2 V-17-6 p-F-Ph H H CH 2 -indol-3-yi Et H H F OH H H NH 2 V-17-7 p-F-Ph H H CH 2
CH
2
SCH
3 Et H H F OH H H Nl 2 V-17-8 p-F-Ph * H * Et H H F OH H H NH 2 *R" and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table V-18. N2 R' R2 R 3 a R 3 b R 4 R R X Y R 7 R' R 9 V-18-1 p-Cl-Ph H H H Et H H F OH H H NH 2 V-18-2 p-Cl-Ph H H CH 3 Et H H F OH H H NH 2 V-18-3 p-Cl-Ph H H CH(CH 3
)
2 Et H H F OH H H NH 2 V-18-4 p-Cl-Ph H H CH 2
CH(CH
3 )2 Et H H F OH H H NH2 V-18-5 p-Cl-Ph H H CH 2 Ph Et H H F OH H H NH2 V-18-6 p-Cl-Ph H H CH 2 -indol-3-yl Et H H F OH H H NH 2 V-18-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Et H H F OH H H NH 2 V-18-8 p-Cl-Ph* H * Et H H F OH H H NH2 5 *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table V-19. S RR 2
R
3 a Rb R RR RT R 9 V-19-1 p-Br-Ph H H H Et H H F OH H H NH 2 V-19-2 p-Br-Ph H H CH 3 Et H H F OH H H NH 2 V-19-3 p-Br-Ph H H CH(CH 3
)
2 Et H H F OH H H NH 2 1 -7A X2 Rl R 2
R
3 a R 3 b R' R' R 6 X Y R' R" R9 V-19-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Et H H F OH H H NH 2 V-19-5 p-Br-Ph H H CH 2 Ph Et H H F OH H H NH2 V-19-6 p-Br-Ph H H CH 2 -indol-3-yl Et H H F OH H H NH 2 V-19-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Et H H F OH H H NH 2 V-19-8 p-Br-Ph * H * Et H H F OH H H NH 2 *R2 and R b joined together by (CH 2
)
3 to form five-membered ring. Table V-20. N2 Rl R 2
R
3 a R 3 b R 4 R' R' X Y R' R' R 9 V-20-1 p-I-Ph H H H Et H H F OH H H NH 2 V-20-2 p-I-Ph H H CH 3 Et H H F OH H H NH 2 V-20-3 p-I-Ph H H CH(CH 3
)
2 Et H H F OH H H NH 2 V-20-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Et H H F OH H H NH2 V-20-5 p-I-Ph H H CH 2 Ph Et H H F OH H H NH 2 V-20-6 p-I-Ph H H CH 2 -indol-3-yl Et H H F OH H H NH 2 V-20-7 p-I-Ph H H CH 2
CH
2
SCH
3 Et H H F OH H H NH2 V-20-8 p-I-Ph* H * Et H H F OH H H NH 2 *R and Rdb joined together by (CH 2
)
3 to form five-membered ring. Table V-2 1. N2 R' R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7 R' R 9 V-21-1 CH 3 H H H 'Pr H H F OH H H NH2 V-21-2 CH 3 H H CH 3 'Pr H H F OH H H N1 2 V-21-3 CH 3 H H CH(CH 3
)
2 'Pr H H F OH H H NH2 V-21-4 CH 3 H H CH 2
CH(CH
3
)
2 'Pr H H F OH H H NH 2 V-21-.5 CH 3 H H CH 2 Ph 'Pr H H F OH H H NH 2 V-21-6 CH 3 H H CH 2 -indol-3-yl 'Pr H H F OH H H NH 2 V-21-7 CH 3 H H CH 2
CH
2
SCH
3 'Pr H H F OH H H NH 2 V-21-8 CH 3 * H * 'Pr H H F OH H H NH 2 5 *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table V-22. N R R 2 R" R 3 b R R R X Y R' R' R 9 V-22-1 Et H H H 'Pr H H F OH H H NH 2 V-22-2 Et H H CH 3 'Pr H H F OH H H NH 2 V-22-3 Et H H CH(CH 3
)
2 'Pr H H F OH H H NH 2 V-22-4 Et H H CH 2
CH(CH
3
)
2 'Pr H H F OH H H NH 2 1'7C X2 RI R 2
R
3 a R 3 b R R' R 6 X Y R' R' R 9 V-22-5 Et H H CH 2 Ph 'Pr H H F OH H H NH 2 V-22-6 Et H H CH 2 -indol-3-yl 'Pr H H F OH H H NH 2 V-22-7 Et H H CH 2
CH
2
SCH
3 'Pr H H F OH H H NH2 V-22-8 Et * H * 'Pr H H F OH H H NH 2 *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table V-23. N2 R' R2 R 3 a R 3 b R R' R 6 X Y R' R" R 9 V-23-1 'Pr HH H 'Pr H H F OH H H NH 2 V-23-2 'Pr H H CH 3 'Pr H H F OH H H NH 2 V-23-3 'Pr H H CH(CFH 3
)
2 'Pr H H F OH H H Ni 2 V-23-4 'Pr H H CH 2
CH(CH
3
)
2 'Pr H H F OH H H NH 2 V-23-5 Pr H H CH 2 Ph 'Pr H H F OH H H NH2 V-23.6 'Pr H H CH 2 -indol-3-yl 'Pr H H F OH H H NH 2 V-23-7 'Pr H H CH 2
CH
2
SCH
3 'Pr H H F OH H H NH 2 V-23-8 'Pr* H * 'Pr H H F OH H H NH2 *R and Rdb joined together by (CH 2
)
3 to form five-membered ring. Table V-24. 2 R' R 2
R
3 a R 3 b R 4 R' R 6 X Y R' R' R9 V-24-1 'Bu H H H 'Pr H H F OH H H NH 2 V-24-2 'Bu H H CH 3 'Pr H H F OH H H NH 2 V-24-3 'Bu H H CH(CH 3
)
2 'Pr H H F OH H H NH 2 V-24-4 'Bu H H CH 2
CH(CH
3
)
2 'Pr H H F OH H H NH 2 V-24-5 'Bu H H CH 2 Ph 'Pr H H F OH H H NH 2 V-24-6 'Bu H H CH 2 -indol-3-yl 'Pr H H F OH H H NH 2 V-24-7 'Bu H H CH 2
CH
2
SCH
3 'Pr H H F OH H H NH 2 V-24-8 'Bu* H * 'Pr H H F OH H H NH 2 5 *R and R-" joined together by (CH 2
)
3 to form five-membered ring. Table V-25. X2 R' R 2
R
3 a R 3 b R 4
R
5 R6 X Y R' R' R' V-25-1 Ph H H H 'Pr H H F OH H H NH 2 V-25-2 Ph H H CH 3 'Pr H H F OH H H NH 2 V-25-3 Ph H H CH(CH 3
)
2 'Pr H H F OH H H NH 2 V-25-4 Ph H H CH 2
CH(CH
3
)
2 'Pr H H F OH H H NH 2 V-25-5 Ph H H CH 2 Ph 'Pr H H F OH H H NH 2 1 '7 4 X2 RI R 2
R
3 a R 3 b R 4 R' R 6 X Y R' R' R 9 V-25-6 Ph H H CH 2 -indol-3-yl Pr H H F OH H H NH 2 V-25-7 Ph H H CH 2
CH
2
SCH
3 'Pr H H F OH H H NH 2 V-25-8 Ph* H * 'Pr H H F OH H H NH 2 *R and Rb joined together by (CH 2
)
3 to form five-membered ring. Table V-26. X2 R 2
R
3 a R 3 b R4 R' R 6 X Y R' R' R 9 V-26- p-Me- H H H Pr H H F OH H H NH 2 1 Ph V-26- p-Me- H H CH 3 'Pr H H F OH H H NH 2 2 Ph V-26- p-Me- H H CH(CH 3
)
2 Pr H H F OH H H NH2 3 Ph V-26- p-Me- H H CH 2
CH(CH
3
)
2 'Pr H H F OH H H NH2 4 Ph V-26- p-Me- H H CH 2 Ph Pr H H F OH H H NH 2 5 Ph V-26- p-Me- H H CH 2 -indol-3- 'Pr H H F OH H H NH2 6 Ph Yl V-26- p-Me- H H CH 2
CH
2
SCH
3 'Pr H H F OH H H NH 2 7 Ph V-26- p-Me- * H * 'Pr H H F OH H H NH 2 8 Ph *R and Rb joined together by (CH 2
)
3 to form five-membered ring. Table V-27. N2 R R 2
R
3 a R 3 b R' R' R 6 X Y R' R' R 9 V-27-1 p-F-Ph H H H 'Pr H H F OH H H NH 2 V-27-2 p-F-Ph H H CH 3 'Pr H H F OH H H NH 2 V-27-3 p-F-Ph H H CH(CH 3
)
2 'Pr H H F OH H H NH 2 V-27-4 p-F-Ph H H CH 2
CH(CH
3
)
2 'Pr H H F OH H H NH 2 V-27-5 p-F-Ph H H CH 2 Ph 'Pr H H F OH H H NH 2 V-27-6 p-F-Ph H H CH 2 -indol-3-yl 'Pr H H F OH H H NH 2 V-27-7 p-F-Ph H H CH 2
CH
2
SCH
3 'Pr H H F OH H H N-H2 V-27-8 p-F-Ph* H * 'Pr H H F OH H H NH 2 5 *R 2 and Rb joined together by (CH 2
)
3 to form five-membered ring. 1 '7'7 Table V-28. N2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y R' R 8
R
9 V-28-1. p-Cl-Ph H H H 'Pr H H F OH H H NH 2 V-28-2 p-Cl-Ph H H CH- 3 'Pr H H F OH H H NH 2 V-28-3 p-Cl-Ph H H CH(CH 3
)
2 'Pr H H F OH H H NH 2 V-28-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 'Pr H H F OH H H NH 2 V-28-5 p-Cl-Ph H H CH 2 Ph 'Pr H H F OH H H NH 2 V-28-6 p-Cl-Ph H H CH 2 -indol-3-yl 'Pr H H F OH H H NH 2 V-28-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 'Pr H H F OH H H NH 2 V-28-8 p-Cl-Ph *Tr * 'Pr H F OH H H NH 2 *R and R~b joined together by (CH 2
)
3 to form five-membered ring. Table V-29. Ne Rl R 2 R V R 3 b R R' R 6 X Y R' R' R 9 V-29-1 p-Br-Ph H H H 'Pr H H F OH H H NH 2 V-29-2 p-Br-Ph H H CH 3 'Pr H H F OH H H NH 2 V-29-3 p-Br-Ph H H CH(CH 3
)
2 'Pr H H F OH H H NH 2 V-29-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 'Pr H H F OH H H NH 2 V-29-5 p-Br-Ph H H CH 2 Ph 'Pr H H F OH H H NH 2 V-29-6 p-Br-Ph H H CH 2 -indol-3-yl 'Pr H H F OH H H NH 2 V-29-7 p-Br-Ph H H CH 2
CH
2
SCH
3 'Pr H H F OH H H NH2 V-29-8 p-Br-Ph* H * 'Pr H H F OH H NH2 *R and RJb joined together by (CH 2
)
3 to form five-membered ring. 5 Table V-30. X R R 2
R
3 a R 3 b R 4
R
5
R
6 X Y R 7
R
8
R
9 V-30-1 p-I-Ph H H H 'Pr H H F OH H H NH 2 V-30-2 p-I-Ph H H CH 3 'Pr H H F OH H H NH 2 V-30-3 p-I-Ph H H CH(CH 3
)
2 'Pr H H F OH H H NH 2 V-30-4 p-I-Ph H H CH 2
CH(CH
3
)
2 'Pr H H F OH H H NH 2 V-30-.5 p-I-Ph H H CH 2 Ph 'Pr H H F OH H H NH 2 V-30--6 p-I-Ph H H CH 2 -indol-3-yl 'Pr H H F OH H H NH 2 V-30-7 p-I-Ph H H CH 2
CH
2
SCH
3 'Pr H H F OH H H NH 2 V-30-8 p-I-Ph* H * 'Pr H H F OH H H NH2 *R aind Rib joined together by (CH 2
)
3 to form five-membered ring. 1'7Q Table V-31. X2 R' R2 R 3 a R 3 b R 4 R' R' X Y R' R R 9 V-31-1 CH 3 H H H "Bu H H F OH H H Ni 2 V-31-2 CH 3 H H CH 3 "Bu H H F OH H H NH 2 V-31-3 CH 3 H H CH(CH 3
)
2 "Bu H H F OH H H NH 2 V-31-4 CH 3 H H CH 2
CH(CH
3
)
2 "Bu H H F OH H H NH 2 V-31-5 CH 3 H H CH 2 Ph 'Bu H H F OH H H NH2 V-31-6 CH 3 H H CH 2 -indol-3-yl "Bu H H F OH H H NH 2 V-31-7 CH 3 H H CH 2
CH
2
SCH
3 "Bu H H F OH H H NH 2 V-31-8 CH 3 * H * Bu H H F OH H H NH 2 *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table V-32. X2 R R 2
R
3 aRab R 4 R' R' X Y R 7 R' R 9 V-32-1 Et H H H "Bu H H F OH H H NH 2 V-32-2 Et H H CH 3 "Bu H H F OH H H NH 2 V-32-3 Et H H CH(CH 3
)
2 "Bu H H F OH H H NH 2 V-32-4 Et H H CH 2
CH(CH
3
)
2 "Bu H H F OH H H NH 2 V-32-5 Et H H CH 2 Ph "Bu H H F OH H H NH 2 V-32-6 Et H H CH 2 -indol-3-yl "Bu H H F OH H H NH2 V-32-7 Et H H CH 2
CH
2
SCH
3 "Bu H H F OH H H NH 2 V-32-8 Et * H * "Bu H H F OH H H NH 2
*R
2 and RIb joined together by (CH 2
)
3 to form five-membered ring. 5 Table V-33. N2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y R' RF R 9 V-33-1 Pr H H H "Bu H H F OH H H NH 2 V-33-2 Pr H H CH 3 "Bu H H F OH H H NH 2 V-33-3 'Pr H H CH(CH 3
)
2 "Bu H H F OH H H NH 2 V-33-4 'Pr H H CH 2
CH(CH
3
)
2 "Bu H H F OH H H NH 2 V-33-.5 'Pr H H CH 2 Ph "Bu H H F OH H H NH 2 V-33-6 'Pr H H CH 2 -indol-3-yl "Bu H H F OH H H NH 2 V-33-7 'Pr H H CH 2
CH
2
SCH
3 "Bu H H F OH H H NH 2 V-33-.8 'Pr * H * "Bu H H F OH H H NH 2 *R" and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 1"70 Table V-34. X2 R R 2 R3a R 3 b R 4 R' R 6 X Y R R' R 9 V-34-1 'Bu H H H "Bu H H F OH H H NH 2 V-34-2 'Bu H H CH 3 "Bu H H F OH H H NH2 V-34-3 'Bu H H CH(CH 3
)
2 "Bu H H F OH H H NH 2 V-34-4 'Bu H H CH 2
CH(CH
3
)
2 "Bu H H F OH H H NH 2 V-34-5 'Bu H H CH 2 Ph "Bu H H F OH H H NH 2 V-34-6 'Bu H H CH 2 -indol-3-yl "Bu H H F OH H H NH 2 V-34-7 'Bu H H CH 2
CH
2
SCH
3 "Bu H H F OH H H NH 2 V-34-8 'Bu* H * "Bu H H F OH H H NH 2 *R2 and R b joined together by (CH 2
)
3 to form five-membered ring. Table V-35. N2 RI R 2
R
3 a R 3 b R 4 R' R 6 X Y R' R' R' V-35-1 Ph H H H "Bu H H F OH H H NH 2 V-35-2 Ph H H CH 3 "Bu H H F OH H H NH 2 V-35-3 Ph H H CH(CH 3
)
2 "Bu H H F OH H H NH2 V-35-4 Ph H H CH 2
CH(CH
3
)
2 "Bu H H F OH H H NH2 V-35-5 Ph H H CH 2 Ph "Bu H H F OH H H NH 2 V-35-6 Ph H H CH 2 -indol-3-yl "Bu H H F OH H H NH 2 V-35-7 Ph H H CH 2
CH
2
SCH
3 "Bu H H F OH H H NH 2 V-35-8 Ph* H * "Bu H H F OH H H NH 2 *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table V-36. N2 Ri R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7
R
8
R
9 V-36- p-Me- H H H "Bu H H F OH H H NH 2 1 Ph V-36- p-Me- H H CH 3 - Bu H H F OH H H NH 2 2 Ph V-36-- p-Me- H H CH(CH 3
)
2 "Bu H H F OH H H NH 2 3 Ph V-36-- p-Me- H H CH 2
CH(CH
3
)
2 "Bu H H F OH H H NH 2 4 Ph V-36- p-Me- H H CH 2 Ph "Bu H H F OH H H NH 2 5 Ph V-36- p-Me- H H CH 2 -indol-3- "Bu H H F OH H H NH 2 Ph 10Af N2 Rl R 2
R
3 a R b R 4 R' R6 X Y R' R' R 9 6 yl V-36- p-Me- H H CH 2
CH
2
SCH
3 "Bu H H F OH H H NH 2 7 Ph V-36- p-Me- * H * Bu H H F OH H H NH 2 8 Ph *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table V-37. N2 R' R 2 RaR 3 b R 4 R' R 6 X Y R' R' R' V-37- p-F- H H H "Bu H H F OH H H NH 2 1 Ph V-37- p-F- H H CH 3 "Bu H H F OH H H NH 2 2 Ph V-37- p-F- H H CH(CH 3
)
2 "Bu H H F OH H H NH 2 3 Ph V-37- p-F- H H CIH 2
CH(CH
3
)
2 "Bu H H F OH H H NH 2 4 Ph V-37- p-F- H H CH 2 Ph "Bu H H F OH H H NH2 5 Ph V-37- p-F- H H CH 2 -indol-3- "Bu H H F OH H H Nil 2 6 Ph yi V-37- p-F- H H CH 2
CH
2
SCH
3 "Bu H H F OH H H NH 2 7 Ph V-37- p-F- * H * "BuH H F OH H H NH 2 8 Ph *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table V-38. N2 Rl R 2
R
3 a R 3 h R 4 R' R 6 X Y R R' R 9 V-38- p-Cl- H H H "Bu H H F OH H H NH2 1 Ph V-38- p-Cl- H H CH 3 "Bu H H F OH H H NH 2 2 Ph V-38- p-Cl- H H CH(CH 3
)
2 "Bu H H F OH H H NH 2 3 Ph V-38- p-Cl- H H CH 2
CH(CH
3
)
2 "Bu H H F OH H H NH 2 Ph 101 X2 R' R 2
R
3 a Rb R 4 R R X Y R 7 R R 9 4 V-38- p-Cl- H H CH 2 Ph "Bu H H F OH H H NH 2 5 Ph V-38- p-Cl- H H CH 2 -indol-3- "Bu H H F OH H H NH 2 6 Ph yl V-38- p-Cl- H H CH 2
CH
2
SCH
3 "Bu H H F OH H H NH 2 7 Ph V-38- p-Cl- * H * Bu H H F OH H H NH 2 8 Ph *Rand Rab joined together by (CH 2
)
3 to form five-membered ring. Table V-39. N2 R' R 2
R
3 a R 3 b R 4 R' R 6 X Y R' R' R? V-39- p-Br- H H H "Bu H H F OH H H NH 2 1 Ph V-39- p-Br- H H CH 3 "Bu H H F OH H H NH 2 2 Ph V-39- p-Br- H H CH(CH 3
)
2 "Bu H H F OH H H NH 2 3 Ph V-39- p-Br- H H CH 2
CH(CH
3
)
2 "Bu H H F OH H H NH2 4 Ph V-39- p-Br- H H CH 2 Ph "Bu H H F OH H H NH2 5 Ph V-39- p-Br- H H CH 2 -indol-3- "Bu H H F OH H H NH 2 6 Phyl V-39- p-Br- H H CH 2
CH
2
SCH
3 "Bu H H F OH H H NH, 7 Ph V-39- p-Br- * H * "Bu H H F OH H H NH 2 8 Ph *Rand R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table V-40. N2 Rl R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7
R
8
R
9 V-40-1 p-I-Ph H H H "Bu H H F OH H H Ni- 2 V-40-2 p-I-Ph H H CH 3 "Bu H H F OH H H NH2 V-40-.3 p-I-Ph H H CH(CH 3
)
2 "Bu H H F OH H H NH 2 1O1 X2 Rt R 2 R3a R 3 b R 4 R' R' X Y R' R R 9 V-40-4 p-I-Ph H H CH 2
CH(CH
3
)
2 "Bu H H F OH H H NH 2 V-40-5 p-I-Ph H H CH 2 Ph "Bu H H F OH H H NH 2 V-40-6 p-I-Ph H H CH 2 -indol-3-yI "Bu H H F OH H H NH 2 V-40-7 p-I-Ph H H CH 2
CH
2
SCH
3 "Bu H H F OH H H NH 2 V-40-8 p-I-Ph * H * "Bu H H F OH H H NH 2 *R2 and R3" joined together by (CH 2
)
3 to form five-membered ring. Table V-41. N2 RI R2 R 3 a R 3 b R 4 R' R 6 X Y R 7 R' R 9 V-41-1 CH 3 H H H Bz H H F OH H H NH 2 V-41-2 CH 3 H H CH 3 Bz H H F OH H H NH 2 V-41-3 CH 3 H H CH(CH 3
)
2 Bz H H F OH H H NH 2 V-41-4 CH 3 H H CH 2
CH(CH
3
)
2 Bz H H F OH H H NH 2 V-41-5 CH 3 H H CH 2 Ph Bz H H F OH H H NH 2 V-41-6 CH 3 H H CH 2 -indol-3-yl Bz H H F OH H H NH 2 V-41-7 CH 3 H H CH 2
CH
2
SCH
3 Bz H H F OH H H NH 2 V-41-8 CH 3 * H * Bz H H F OH H H NH 2 *R and Rib joined together by (CH 2
)
3 to form five-membered ring. Table V-42. N2 RI R 2 R3a R3b R' R' R' X Y R R' R 9 V-42-1 Et H H H Bz H H F OH H H NH 2 V-42-2 Et H H CH 3 Bz H H F OH H H NH 2 V-42-3 Et H H CH(CH 3
)
2 Bz H H F OH H H NH 2 V-42-4 Et H H CH 2
CH(CH
3
)
2 Bz H H F OH H H NH 2 V-42-5 Et H H CH 2 Ph Bz H H F OH H H NH 2 V-42-6 Et H H CH 2 -indol-3-yl Bz H H F OH H H NH 2 V-42-7 Et H H CH 2
CH
2
SCH
3 Bz H H F OH H H NH 2 V-42-8 Et * H * Bz H H F OH H H NH 2 5 *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table V-43. N R R 2 RaR 3 b R 4 R' R X Y R' R'R 9 V-43-1 'Pr H H H Bz H H F OH H H NH 2 V-43-2 'Pr H H CH 3 Bz H H F OH H H NH2 V-43-3 'Pr H H CH(CH 3
)
2 Bz H H F OH H H NH2 V-43-4 'Pr H H CH 2
CH(CH
3
)
2 Bz H H F OH H H NH 2 V-43-5 'Pr H H CH 2 Ph Bz H H F OH H H NH 2 V-43-6 'Pr H H CH 2 -indol-3-yl Bz H H F OH H H NH 2 V-43-7 'Pr H H CH 2
CH
2
SCH
3 Bz H H F OH H H NH 2 V-43-8 'Pr * H * Bz H H F OH H H NH 2 *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table V-44. N2 R' R2 R 3 a R 3 b R' R' R 6 X Y R 7 R' R 9 V-44-1 'Bu H H H Bz H H F OH H H NH 2 V-44-2 'Bu H H CH 3 Bz H H F OH H H NH 2 V-44-3 'Bu H H CH(CH 3
)
2 Bz H H F OH H H NH 2 V-44-4 'Bu H H CH 2
CH(CH
3
)
2 Bz H H F OH H H NH 2 V-44-5 'Bu H H CH 2 Ph Bz H H F OH H H NH 2 V-44-6 'Bu H H CH 2 -indol-3-yl Bz H H F OH H H NH 2 V-44-7 'Bu H H CH 2
CH
2
SCH
3 Bz H H F OH H H NH 2 V-44-8 'Bu * H * Bz H H F OH H H NH 2 *R and Rab joined together by (CH 2
)
3 to form five-membered ring. Table V-45. N RI R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7 R' R 9 V-45-1 Ph H H H Bz H H F OH H H NH 2 V-45-2 Ph H H CH 3 Bz H H F OH H H NH 2 V-45-3 Ph H H CH(CH 3
)
2 Bz H H F OH H H NH 2 V-45-4 Ph H H CH 2
CH(CH
3
)
2 Bz H H F OH H H NH 2 V-45-5 Ph H H CH 2 Ph Bz H H F OH H H NH 2 V-45-6 Ph H H CH 2 -indol-3-yl Bz H H F OH H H NH 2 V-45-7 Ph H H CH 2
CH
2
SCH
3 Bz H H F OH H H NH 2 V-45-8 Ph * H * Bz H H F OH H H NH 2 5 *R 2 and RAb joined together by (CH 2
)
3 to form five-membered ring. Table V-46. N! Rl R 2
R
3 a R 3 b R' R' R' X Y R 7 R' R 9 V-46- p-Me- H H H Bz H H F OH H H N1 2 1 Ph V-46- p-Me- H H CH 3 Bz H H F OH H H NH 2 2 Ph V-46- p-Me- H H CH(CH 3
)
2 Bz H H F OH H H NH 2 3 Ph 1 0A X2 Rl R 2 R3a R3b R' R' R 6 X Y R' R' R 9 V-46- p-Me- H H CH 2
CH(CH
3
)
2 Bz H H F OH H H NH 2 4 Ph V-46- p-Me- H H CH 2 Ph Bz H H F OH H H NH 2 5 Ph V-46- p-Me- H H CH 2 -indol-3- Bz H H F OH H H NH 2 6 Ph Yl V-46- p-Me- H H CH 2
CH
2
SCH
3 Bz H H F OH H H NH2 7 Ph V-46- p-Me- * H * Bz H H F OH H H NH 2 8 Ph *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table V-47. N2 R' R 2 R3a Rb R 4 R' R 6 X Y R R' R 9 V-47-1 p-F-Ph H H H Bz H H F OH H H NH2 V-47-2 p-F-Ph H H CH 3 Bz H H F OH H H NH 2 V-47-3 p-F-Ph H H CH(CH 3
)
2 Bz H H F OH H H NH 2 V-47-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Bz H H F OH H H NH 2 V-47-5 p-F-Ph H H CH 2 Ph Bz H H F OH H H NH 2 V-47-6 p-F-Ph H H CH 2 -indol-3-y1 Bz H H F OH H H NH 2 V-47-7 p-F-Ph H H CH 2
CH
2
SCH
3 Bz H H F OH H H NH 2 V-47-8 p-F-Ph* H * Bz H H F OH H H NH 2 *R2 and R ib joined together by (CH 2
)
3 to form five-membered ring. Table V-48. 2 R R 2 RaRb R4 R' R 6 X Y R R' R 9 V-48- p-Cl- H H H Bz H H F OH H H NH 2 1 Ph V-48- p-Cl- H H CH 3 Bz H H F OH H H NH2 2 Ph V-48-- p-Cl- H H CH(CH 3
)
2 Bz H H F OH H H NH 2 3 Ph V-48- p-Cl- H H CH 2
CH(CH
3
)
2 Bz H H F OH H H NH 2 4 Ph V-48- p-Cl- H H CH 2 Ph Bz H H F OH H H NH 2 5 Ph 1Q Ng Rl R 2
R
3 a R 3 b R 4 R' R' X Y R' R' R 9 V-48- p-Cl- H H CH 2 -indol-3- Bz H H F OH H H NH 2 6 Ph YI V-48- p-Cl- H H CH 2
CH
2
SCH
3 Bz H H F OH H H NH 2 7 Ph V-48- p-Cl- * H * Bz H H F OH H H NH 2 8 Ph *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table V-49. N2 R' R2 R 3 a R b R' R' R 6 X Y R R' R 9 V-49- p-Br- H H H Bz H H F OH H H NH 2 1 Ph V-49- p-Br- H H CH 3 Bz H H F OH H H NH 2 2 Ph V-49- p-Br- H H CH(CH 3
)
2 Bz H H F OH H H NH 2 3 Ph V-49- p-Br- H H CH 2
CH(CH
3
)
2 Bz H H F OH H H NH 2 4 Ph V-49- p-Br- H H CH 2 Ph Bz H H F OH H H NH2 5 Ph V-49- p-Br- H H CH 2 -indol-3- Bz H H F OH H H NH 2 6 Ph YI V-49- p-Br- H H CH 2
CH
2
SCH
3 Bz H H F OH H H NH 2 7 Ph V-49- p-Br- * H * Bz H H F OH H H NH 2 8 Ph RZ and R-3b joined together by (CH 2
)
3 to form five-membered ring. Table V-50. N Rl R 2 Ra R 3 b R4 R' R' X Y R 7
R
8
R
9 V-50-1 p-I-Ph H H H Bz H H F OH H H NH 2 V-50-2 p-I-Ph H H CH 3 Bz H H F OH H H NH 2 V-50-3 p-I-Ph H H CH(CH 3
)
2 Bz H H F OH H H NH 2 V-50-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Bz H H F OH H H NH 2 V-50-5 p-I-Ph H H CH 2 Ph Bz H H F OH H H NH 2 V-50-6 p-I-Ph H H CH 2 -indol-3-yl Bz H H F OH H H NH 2 1 04 S R R 2
R
3 aR 3 b R 4 R' R' X Y R 7
R
8
R
9 V-50-7 p-I-Ph H H CH 2
CH
2
SCH
3 Bz H H F OH H H NH2 V-50-8 p-I-Ph * H * Bz H H F OH H H NH2 *R and Rab joined together by (CH 2
)
3 to form five-membered ring. 0 R8 O2 0 NH R3b R2 0 R 7 N 0 R3a, N---P-O O C0 2
R
4
OR
1 R5
R
6 Y X VI Table VI-1. N2 R' R 2
R
3 a R 3 b R 4 RR X Y R 7 R' VI-1-1 CH 3 H H H CH 3 H F H OH H H VI-1-2 CH 3 H H CH 3
CH
3 H F H OH H H VI-1-3 CH 3 H H CH(CH 3
)
2
CH
3 H F H OH H H VI-1-4 CH 3 H H CH 2
CH(CH
3
)
2
CH
3 H F H OH H H VI-1-5 CH 3 H H CH 2 Ph CH 3 H F H OH H H VI-1-6 CH 3 H H CH 2 -indol-3-yl CH 3 H F H OH H H VI-1-7 CH 3 H H CH 2
CH
2
SCH
3
CH
3 H F H OH H H VI-1-8 CH 3 * H * CH 3 H F H OH H H 5 *R 2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table VI-2. RI R 2 Ra R 3 b R 4 R R XY R' R" VI-2-1 Et H H H CH 3 H F H OH H H VI-2-2 Et H H CH 3
CH
3 H F H OH H H VI-2-3 Et H H CH(CH 3
)
2
CH
3 H F H OH H H VI-2-4 Et H H CH 2
CH(CH
3
)
2
CH
3 H F H OH H H VI-2-5 Et H H CH 2 Ph CH 3 H F H OH H H VI-2-6 Et H H CH 2 -indol-3-yl CH 3 H F H OH H H 1 07 N! RI R 2
R
3 a R 3 b R' R' R' X Y R' R' VI-2-7 Et H H CH 2
CH
2
SCH
3
CH
3 H F H OH H H VI-2-8 Et * H * CH 3 H F H OH H H *R2ad R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table VI-3. N2 R R 2 RaR 3 b R R R 6 X Y R 7
R
8 VI-3-1 'Pr H H H CH 3 H F H OH H H VI-3-2 'Pr H H CH 3
CH
3 H F H OH H H VI-3-3 'Pr H H CH(CH 3
)
2
CH
3 H F H OH H H VI-3-4 'Pr H H CH 2
CH(CH
3
)
2
CH
3 H F H OH H H VI-3-5 'Pr H H CH 2 Ph CH 3 H F H OH H H VI-3-6 'Pr H H CH 2 -indol-3-yl CH 3 H F H OH H H VI-3-7 'Pr H H CH 2
CHI-SCH
3
CH
3 H F H OH H H VI-3-8 'Pr * H * CH 3 H F H OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table VI-4. X2 R' R2 R 3 a R 3 b R4 R' R 6 X Y R 7 R VI-4-1 'Bu H H H CH 3 H F H OH H H VI-4-2 'Bu H H CH 3
CH
3 H F H OH H H VI-4-3 'Bu H H CH(CH 3
)
2
CH
3 H F H OH H H VI-4-4 'Bu H H CH2CI-I(CH 3
)
2
CH
3 H F H OH H H VI-4-5 'Bu H H CH2Ph CH 3 H F H OH H H VI-4-6 'Bu H H CH 2 -indol-3-yl CH 3 H F H OH H H VI-4-7 'Bu H H CH 2
CH
2
SCH
3
CH
3 H F H OH H H VI-4-8 'Bu * H * CH 3 H F H OH H H 5 *R 2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 1 QQ Table VI-5. NV RI R 2
R
3 a R 3 b R 4
R
5
R
6 X Y R' R' VI-5-1 Ph H H H CH 3 H F H OH H H VI-5-2 Ph H H CH 3
CH
3 H F H OH H H VI-5-3 Ph H H CH(CH 3
)
2
CH
3 H F H OH H H VI-5-4 Ph H H CH 2
CH(CH
3
)
2
CH
3 H F H OH H H VI-5-5 Ph H H CH 2 Ph CH 3 H F H OH H H VI-5-6 Ph H H CH 2 -indol-3-yl CH 3 H F H OH H H VI-5-7 Ph H H CH 2
CH
2
SCH
3
CH
3 H F H OH H H VI-5-8 Ph* H * CH 3 H F H OH H H *R and R~b joined together by (CH 2
)
3 to form five-membered ring. Table VI-6. X2 R2 R 3 a R 3 b R 4 R' R 6 X Y R' R' VI-6-1 p-Me-Ph H H H CH 3 H F H OH H H VI-6-2 p-Me-Ph H H CH 3
CH
3 H F H OH H H VI-6-3 p-Me-Ph H H CH(CH 3
)
2
CH
3 H F H OH H H VI-6-4 p-Me-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F H OH H H VI-6-5 p-Me-Ph H H CH2Ph CH 3 H F H OH H H VI-6-6 p-Me-Ph H H CH 2 -indol-3-yl CH 3 H F H OH H H VI-6-7 p-Me-Ph H H CH 2
CH
2
SCH
3
CH
3 H F H OH H H VI-6-8 p-Me-Ph * H * CH 3 H F H OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table VI-7. N R R R R R' R' R X Y R R VI-7-1 p-F-Ph H H H CH 3 H F H OH H H VI-7-2 p-F-Ph H H CH 3
CH
3 H F H OH H H VI-7-3 p-F-Ph H H CH(CH 3
)
2
CH
3 H F H OH H H VI-7-4 p-F-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F H OH H H VI-7-6 p-F-Ph H H CH 2 Ph CH 3 H F H OH H H VI-7-7 p-F-Ph H H CH 2 -indol-3-yl CH 3 H F H OH H H VI-7-8 p-F-Ph H H CH 2
CH
2
SCH
3
CH
3 H F H OH H H VI-7-20 p-F-Ph * H * CH 3 H F H OH H H *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. 1 Q0 Table VI-8. 2 R' R2 R 3 aRab R R' R 6 X Y R 7 R VI-8-1 p-Cl-Ph H H H CH 3 H F H OH H H VI-8-2 p-Cl-Ph H H CH 3
CH
3 H F H OH H H VI-8-3 p-Cl-Ph H H CH(CH 3
)
2
CH
3 H F H OH H H VI-8-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F H OH H EL VI-8-5 p-Cl-Ph H H CH 2 Ph CH 3 H F H OH H H VI-8-6 p-Cl-Ph H H CH 2 -indol-3-yl CH 3 H F H OH H H VI-8-7 p-Cl-Ph H H CH 2
CH
2
SCH
3
CH
3 H F H OH H H VI-8-8 p-Cl-Ph * H * CH 3 H F H OH H H _*R and R"b joined together by (CH 2
)
3 to form five-membered ring. Table VI-9. 2 R R 2 R3a R 3 b R 4 R' R' X Y R' R' VI-9-1 p-Br-Ph H H H CH 3 H F H OH H H VI-9-2 p-Br-Ph H H CH 3
CH
3 H F H OH H H VI-9-3 p-Br-Ph H H CH(CH 3
)
2
CH
3 H F H OH H H VI-9-4 p-Br-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F H OH H H VI-9-6 p-Br-Ph H H CH 2 Ph CH 3 H F H OH H H VI-9-7 p-Br-Ph H H CH 2 -indol-3-yl CH 3 H F H OH H H1 VI-9-8 p-Br-Ph H H CH 2
CH
2
SCH
3
CH
3 H F H OH H H VI-9-20 p-Br-Ph * H * CH 3 H F H OH H H
*R
2 and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table VI-10. M R' R 2
R
3 " Rab R 4 R' R 6 X Y RI R 8 VI-10-1 p-I-Ph H H H CH 3 H F H OH H H VI-10-2 p-I-Ph H H CH 3
CH
3 H F H OH H H VI-10-3 p-I-Ph H H CH(CH 3
)
2
CH
3 H F H OH H H VI-10-4 p-I-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F H OH H H VI-10-5 p-I-Ph H H CH 2 Ph CH 3 H F H OH H H VI-10-6 p-I-Ph H H CH 2 -indol-3-yl CH 3 H F H OH H H VI-10-7 p-I-Ph H H CH 2
CH
2
SCH
3
CH
3 H F H OH H H VI-10-8 p-I-Ph * H * CH 3 H F H OH H H *R and Rib joined together by (CH 2
)
3 to form five-membered ring. 1 a) Table VI-11. X2 RT R2 R 3 a R'b R 4 R' R' X Y R' R" VI-11-1 CH 3 H H H Et H F H OH H H VI-11-2 CH 3 H H CH 3 Et H F H OH H H VI-11-3 CH 3 H H CH(CH 3
)
2 Et H F H OH H H VI-11-4 CH 3 H H CH 2
CH(CH
3
)
2 Et H F H OH H H VI-11-5 CH 3 H H CH 2 Ph Et H F H OH H H VI-11-6 CH 3 H H CH 2 -indol-3-yl Et H F H OH H H VI-11-7 CH 3 H H CH 2
CH
2
SCH
3 Et H F H OH H H VI-11-8 CH 3 * H * Et H F H OH H H *R and Rib joined together by (CH 2
)
3 to form five-membered ring. Table VI-12. Xe R' R 2
R
3 a Rab R 4 R' R 6 X Y R 7 R' VI-12-1 Et H H H Et H F H OH H H VI-12-2 Et H H CH 3 Et H F H OH H H VI1-12-3 Et H H CH(CH- 3
)
2 Et H F H OH H H VI-12-4 Et H H CH 2
CH(CH
3
)
2 Et H F H OH H H VI-12-5 Et H H CH 2 Ph Et H F H OH H H VI-12-6 Et H H CH 2 -indol-3-yl Et H F H OH H H VI-12-7 Et H H CH 2
CH
2
SCH
3 Et H F H OH H H VI-12-8 Et* H * Et H F H OH H H
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table VI-13. e R 1
R
2
R
3 a R 3 b R 4
R
5 R XY R 7
R
8 VI1-13-1 'Pr H H Ha Ft H F H OH H H VI-13-2 'Pr H H CH 3 Et H F H OH H H VI-13-3 'Pr H H CH(CH 3
)
2 Et H F H OH H H VI-13-4 'Pr H H CH 2
CH(CH
3
)
2 Et H F H OH H H VI-13-5 'Pr H H CH 2 Ph Et H F H OH H H VI-13-6 'Pr H H CH 2 -indol-3-yl Et H F H OH H H VI-13-7 'Pr H H CH 2
CH
2
SCH
3 Et H F H OH H H VI-13-8 'Pr * H * Et H F H OH H H *R2 and Rab joined together by (CH 2
)
3 to form five-membered ring. 1 A1 Table VI-14.
R
2
R
3 a R 3 b R' R' R' X Y R' R' VI-14-1 'Bu H H H Et H F H OH H H VI-14-2 'Bu H H CH 3 Et H F H OH H H VI-14-3 'Bu H H CH(CH 3
)
2 Et H F H OH H H VI-14-4 'Bu H H CH 2
CH(CH
3
)
2 Et H F H OH H H VI-14-5 'Bu H H CH 2 Ph Et H F H OH H H VI-14-6 'Bu H H CH 2 -indol-3-yl Et H F H OH H H VI-14.-7 'Bu H H CH 2
CH
2
SCH
3 Et H F H OH H H VI-14-8 'Bu * H * Et H F H OH H H *R" and RJb joined together by (CH 2
)
3 to form five-membered ring. Table VI-15. X2 R' R 2 R3a R b R' R' R' X Y R 7
R
8 VI-151 Ph H H H Et H F H OH H H VI-15-2 Ph H H CH 3 Et H F H OH H H VI-15-3 Ph H H CH(CH 3
)
2 Et H F H OH H H VI-15-4 Ph H H CH 2
CH(CH
3
)
2 Et H F H OH H H VI-15-5 Ph H H CH 2 Ph Et H F H OH H H VI-15-6 Ph H H CH 2 -indol-3-yl Et H F H OH H H VI-15-.7 Ph H H CH 2
CH
2
SCH
3 Et H F H OH H H VI-15-8 Ph * H * Et H F H OH H H *R2and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table VI-16. N2 R R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7
R
8 VI-16-1 p-Me-Ph H H H Et H F H OH H H VI-16-2 p-Me-Ph H H CH 3 Et H F H OH H H VI-16-3 p-Me-Ph H H CH(CH 3
)
2 Et H F H OH H H VI-16-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Et H F H OH H H VI-16-5 p-Me-Ph H H CH 2 Ph Et H F H OH H H VI-16-6 p-Me-Ph H H CH 2 -indol-3-yl Et H F H OH H H VI-16-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Et H F H OH H H VI-16-8 p-Me-Ph * H * Et H F H OH H H
*R
2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table VI-17. S R R 2
R
3 aR Rb R' R R XY R R X2 R1 R 2
R
3 a Rb R R R' X Y R' R9 VI-17-1 p-F-Ph H H H Et H F H OH H H VI-17-2 p-F-Ph H H CH 3 Et H F H OH H H VI-17-3 p-F-Ph H H CH(CH 3
)
2 Et H F H OH H H VI-17-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Et H F H OH H H VI-17-5 p-F-Ph H H CH 2 Ph Et H F H OH H H VI-17-6 p-F-Ph H H CH 2 -indol-3-yl Et H F H OH H H VI-17-7 p-F-Ph H H CH 2
CH
2
SCH
3 Et H F H OH H H VI-17--8 p-F-Ph * H * Et H F H OH H H *R and R~b joined together by (CH 2
)
3 to form five-membered ring. Table VI-18. N2 RT R 2
R
3 a R 3 b R 4 R' R' X Y R' R' VI-18-1 p-Cl-Ph H H H Et H F H OH H H VI-18-2 p-Cl-Ph H H CH 3 Et H F H OH H H VI-18-3 p-Cl-Ph H H CH(CH 3
)
2 Et H F H OH H H VI-18-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Et H F H OH H H VI-18-5 p-Cl-Ph H H CH 2 Ph Et H F H OH H H VI-18-6 p-Cl-Ph H H CH 2 -indol-3-yl Et H F H OH H H VI-18-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Et H F H OH H H VI-18-8 p-Cl-Ph * H * Et H F H OH H H *R and Rab joined together by (CH 2
)
3 to form five-membered ring. Table VI-19. N RT R 2
R
3 a R 3 b R R R' X Y R R VI-19-1 p-Br-Ph H H H Et H F H OH H H VI-19-2 p-Br-Ph H H CH 3 Et H F H OH H H VI-19--3 p-Br-Ph H H CH(CH 3
)
2 Et H F H OH H H VI-19--4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Et H F H OH H H VI-19-.5 p-Br-Ph H H CH 2 Ph Et H F H OH H H VI-19-6 p-Br-Ph H H CH 2 -indol-3-yl Et H F H OH H H VI-19--7 p-Br-Ph H H CH 2
CH
2
SCH
3 Et H F H OH H H VI-19-8 p-Br-Ph * H * Et H F H OH H H 5 *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table VI-20. S R R 2
R
3 a R R' R' R' X Y R' R" VI-20-1 p-I-Ph H H H Et H F H OH H H 1M -V X2 R R2 R 3 a R 3 ) R 4 R' R' X Y R 7
R
8 VI-20-2 p-I-Ph H H CH 3 Et H F H OH H H VI-20-3 p-I-Ph H H CH(CH 3
)
2 Et H F H OH H H VI-20-4 p-I-Ph H H CF 2
CH(CH
3
)
2 Et H F H OH H H VI-20-5 p-I-Ph H H CH1 2 Ph Et H F H OH H H VI-20--6 p-I-Ph H H CH 2 -indol-3-yl Et H F H OH H H VI-20-7 p-I-Ph H H CH 2
CH
2
SCH
3 Et H F H OH H H VI-20-8 p-I-Ph * H * Et H F H OH H H R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table VI-2 1. Ne RF R R 3 aR 3 b R 4 R R X Y R' R 8 VI-21-1 CH 3 H H H 'Pr H F H OH H H VI-21-2 CH 3 H H CH 3 Pr H F H OH H H VI-21-3 CH 3 H H CH(CH 3
)
2 Pr H F H OH H H VI-21-4 CH 3 H H CH 2
CH(CH
3
)
2 Pr H F H OH H H VI-21-5 CH 3 H H CH 2 Ph Pr H F H OH H H VI-21-6 CH 3 H H CH 2 -indol-3-yl 'Pr H F H OH H H VI-21-7 CH 3 H H CH 2
CH
2
SCH
3 Pr H F H OH H H VI-21-8 CH 3 * H * Pr H F H OH H H *R" and R3b joined together by (CH 2
)
3 to form five-membered ring. Table VI-22. Xe RIR 2 RaR 3 b R 4 R R XY R' R VI-22-1 Et H H H 'Pr H F H OH H H VI-22-2 Et H H CH 3 'Pr H F H OH H H VI-22-3 Et H H CH(CH 3
)
2 'Pr H F H OH H H VI-22-4 Et H H CH 2
CH(CH
3
)
2 'Pr H F H OH H H VI-22-5 Et H H CH 2 Ph 'Pr H F H OH H H VI-22-6 Et H H CH 2 -indol-3-yl 'Pr H F H OH H H VI-22-7 Et H H CH 2
CH
2
SCH
3 'Pr H F H OH H H VI-22-8 Et * H * 'Pr H F H OH H H 5 *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table VI-23. NO R' R 2
R
3 " R 3 b R 4 R' R' X Y R R 8 VI-23-1 'Pr H H H 'Pr H F H OH H H VI-23-2 'Pr H H CH 3 'Pr H F H OH H H 1MA N2 R' R 2
R
3 " R 3 b R 4 R' R 6 X Y R 7
R
8 VI-23-3 'Pr H H CH(CH 3
)
2 'Pr H F H OH H H VI-23.4 'Pr H H CH 2
CH(CH
3
)
2 'Pr H F H OH H H VI-23--5 'Pr H H CH 2 Ph 'Pr H F H OH H H VI-23-6 'Pr H H CH 2 -indol-3-yl 'Pr H F H OH H H VI-23-7 'Pr H H CH 2
CH
2
SCH
3 'Pr H F H OH H H VI-23-8 'Pr * H * 'Pr H F H OH H H *RTand R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table VI-24. X2 RT R 2
R
3 a R 3 b R 4 R R XY RR VI-24-1 'Bu H H H 'Pr H F H OH H H VI-24-2 'Bu H H CH 3 'Pr H F H OH H H VI-24-3 'Bu H H CH(CH 3
)
2 'Pr H F H OH H H VI-24-4 'Bu H H CH 2
CH(CH
3
)
2 'Pr H F H OH H H VI-24-5 'Bu H H CH 2 Ph 'Pr H F H OH H H VI-24-6 'Bu H H CH 2 -indol-3-yl 'Pr H F H OH H H VI-24-7 'Bu H H CH 2
CH
2
SCH
3 'Pr H F H OH H H VI-24-8 'Bu * H CH 'Pr H F H OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table VI-25. X2 R T R 2
R"R
3 b R R' R 6 X Y R' R' VI-25-1 Ph H H H 'Pr H F H OH H H VI-25-2 Ph H H CH 3 'Pr H F H OH H H VI-25-3 Ph H H CH(CH 3
)
2 'Pr H F H OH H H VI-25-4 Ph H H CH 2
CH(CH
3
)
2 'Pr H F H OH H H VI-25-5 Ph H H CH 2 Ph 'Pr H F H OH H H VI-25-6 Ph H H CH2-indol-3-yl 'Pr H F H OH H H VI-25-7 Ph H H CH 2
CH
2
SCH
3 'Pr H F H OH H H VI-25-8 Ph * H * 'Pr H F H OH H H 5 *R" and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table VI-26. N2 R' R2 R3a R 3b R' R' R 6 X Y R 7 R' VI-26-1 p-Me-Ph H H H 'Pr H F H OH H H VI-26-2 p-Me-Ph H H CH 3 'Pr H F H OH H H VI-26-3 p-Me-Ph H H CH(CH 3
)
2 'Pr H F H OH H H 1o X2 R' R2 R 3 a R 3 b R 4 R' R' X Y R R VI-26-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 'Pr H F H OH H H VI-26-5 p-Me-Ph H H CH 2 Ph 'Pr H F H OH H H VI-26-6 p-Me-Ph H H CH 2 -indol-3-yl 'Pr H F H OH H H VI-26-7 p-Me-Ph H H CH 2
CH
2
SCH
3 'Pr H F H OH H H VI-26-8 p-Me-Ph * H * 'Pr H F H OH H H *R and RJb joined together by (CH 2
)
3 to form five-membered ring. Table VI-27.
R
2
R
3 a RIb R 4 R R 6 X Y R' R 8 VI-27-1 p-F-Ph H H H 'Pr H F H OH H H VI-27--2 p-F-Ph H H CH 3 'Pr H F H OH H H VI-27-3 p-F-Ph H H CH(CH 3
)
2 'Pr H F H OH H H VI-27-4 p-F-Ph H H CH 2
CH(CH
3
)
2 'Pr H F H OH H H VI-27-.5 p-F-Ph H H CH 2 Ph 'Pr H F H OH H H VI-27-6 p-F-Ph H H CH 2 -indol-3-yl 'Pr H F H OH H H VI-27-7 p-F-Ph H H CH1 2
CH
2
SCH
3 'Pr H F H OH H H VI-27-8 p-F-Ph * H * 'Pr H F H OH H H *R2 and R b joined together by (CH 2
)
3 to form five-membered ring. Table VI-28. N2 R7 R 2
R
3 a R 3 b R 4 R' R' X Y R 7
R
8 VI-28-1 p-Cl-Ph H H H 'Pr H F H OH H H VI-28-2 p-Cl-Ph H H CH 3 'Pr H F H OH H H VI-28-3 p-Cl-Ph H H CH(CH 3
)
2 'Pr H F H OH H H VI-28-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 'Pr H F H OH H H VI-28-5 p-Cl-Ph H H CH 2 Ph 'Pr H F H OH H H VI-28-6 p-Cl-Ph H H CH 2 -indol-3-yl 'Pr H F H OH H H VI-28-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 'Pr H F H OH H H VI-28-8 p-Cl-Ph * H * 'Pr H F H OH H H 5 *R2 and R 3 joined together by (CH 2
)
3 to form five-membered ring. Table VI-29. N2 Rr R 2
R
3 a R 3 b R 4 R' R' X Y R' R' VI-29-1 p-Br-Ph H H H 'Pr H F H OH H H VI-29-2 p-Br-Ph H H CH 3 'Pr H F H OH H H VI-29-3 p-Br-Ph H H CH(CH 3
)
2 'Pr H F H OH H H VI-29-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 'Pr H F H OH H H 1 O4 S R' R 2
R
3 aRb R 4 R' R' X Y R R VI-29-5 p-Br-Ph H H CH 2 Ph 'Pr H F H OH H H VI-29-6 p-Br-Ph H H CH 2 -indol-3-yl 'Pr H F H OH H H VI-29.-7 p-Br-Ph H H CH 2
CH
2
SCH
3 'Pr H F H OH H H VI-29-8 p-Br-Ph * H * 'Pr H F H OH H H *R and R3b joined together by (CH 2
)
3 to form five-membered ring. Table VI-30. N2 RT R 2
R
3 a R 3 b R 4 R' R 6 X Y R' R' VI-30--1 p-I-Ph H H H 'Pr H F H OH H H VI-30-2 p-I-Ph H H CH 3 'Pr H F H OH H H VI-30-3 p-I-Ph H H CH(CH 3
)
2 'Pr H F H OH H H VI-30-4 p-I-Ph H H CH 2
CH(CH
3
)
2 'Pr H F H OH H H VI-30-5 p-I-Ph H H CH 2 Ph 'Pr H F H OH H H VI-30-6 p-I-Ph H H CH 2 -indol-3-yl 'Pr H F H OH H H VI-30-7 p-I-Ph H H CH 2
CH
2
SCH
3 'Pr H F H OH H H VI-30-8 p-I-Ph * H * 'Pr H F H OH H H *R2and Rib joined together by (CH 2
)
3 to form five-membered ring. Table VI-3 1. 2 R R 2
R
3 a R 3 b R 4 R' R 6 X Y R' R' VI-31-1 CH 3 H H H "Bu H F H OH H H VI-31--2 CH 3 H H CH 3 "Bu H F H OH H H VI-31-3 CH 3 H H CH(CH 3
)
2 "Bu H F H OH H H VI-31-4 CH 3 H H CH 2
CH(CH
3
)
2 "Bu H F H OH H H VI-31-5 CH 3 H H CH 2 Ph "Bu H F H OH H H VI-31-.6 CH 3 H H CH 2 -indol-3-yl "Bu H F H OH H H VI-31-7 CH 3 H H CH 2
CH
2
SCH
3 "Bu H F H OH H H VI-31-8 CH 3 * H * "Bu H F H OH H H 5 *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table VI-32. N2 R IT R 3 a R 3 b R 4 R' R 6 X Y R' R' VI-32-1 Et H H H "Bu H F H OH H H VI-32-2 Et H H CH 3 "Bu H F H OH H H VI-32-3 Et H H CH(CH 3
)
2 "Bu H F H OH H H VI-32-4 Et H H CH 2
CH(CH
3
)
2 "Bu H F H OH H H VI-32-5 Et H H CH 2 Ph "Bu H F H OH H H 1 '7 X2 R1 R 2 R3a R 3 b R 4 R' R 6 X Y R' R' VI-32-6 Et H H CH 2 -indol-3-yl "Bu H F H OH H H VI-32-7 Et H H CH 2
CH
2
SCH
3 "Bu H F H OH H H VI-32-8 Et * H * "Bu H F H OH H H *RTand R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table VI-33. R R 2
R
3 a R 3 b R 4 R' R 6 X Y R'R 8 VI-33-1 'Pr H H H "Bu H F H OH H H VI-33-2 'Pr H H CH 3 "Bu H F H OH H H VI-33-3 'Pr H H CH(CH 3
)
2 "Bu H F H OH H H VI-33-4 'Pr H H CH 2
CH(CH
3
)
2 "Bu H F H OH H H VI-33-5 'Pr H H CH 2 Ph "Bu H F H OH H H VI-33-6 'Pr H H CH 2 -indol-3-yl "Bu H F H OH H H VI-33-7 'Pr H H CH 2
CH
2
SCH
3 "Bu H F H OH H H VI-33-8 'Pr * H * "Bu H F H OH H H *R2and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table VI-34. X2 R' R2 R 3 a RI R4 R' R 6 X Y R' R 8 VI-34-1 'Bu H H H "Bu H F H OH H H VI-34..2 'Bu H H CH 3 "Bu H F H OH H H VI-34-3 'Bu H H CH(CH 3
)
2 "Bu H F H OH H H VI-34-4 'Bu H H CH 2
CH(CH
3
)
2 "Bu H F H OH H H VI-34-5 'Bu H H CH 2 Ph "Bu H F H OH H H VI-34-6 'Bu H H CH 2 -indol-3-yI "Bu H F H OH H H VI-34-7 'Bu H H CH 2
CH
2
SCH
3 "Bu H F H OH H H VI-34-8 'Bu * H * "Bu H F H OH H H 5 *R2 and RJb joined together by (CH 2
)
3 to form five-membered ring. Table VI-35. N2 R' R2R3a R 3b R4 R 5
R
6 X Y R' R' VI-35-1 Ph H H H "Bu H F H OH H H VI-35-.2 Ph H H CH 3 "Bu H F H OH H H VI-35--3 Ph H H CH(CH 3
)
2 "Bu H F H OH H H VI-35-4 Ph H H CH 2
CH(CH
3
)
2 "Bu H F H OH H H VI-35-5 Ph H H CH 2 Ph "Bu H F H OH H H VI-35--6 Ph H H CH 2 -indol-3-yl "Bu H F H OH H H 1(1O X2 R1 R2 R 3 a R 3 b R 4 R' R 6 X Y R' R' VI-35-7 Ph H H CH 2
CH
2
SCH
3 "Bu H F H OH H H VI-35-8 Ph * H * "Bu H F H OH H H *R and R b joined together by (CH 2
)
3 to form five-membered ring. Table VI-36.
R
2 3 aR 3 b R 5 6 Y RR N2 R R RM RA R' R' R X Y R' R' VI-36-1 p-Me-Ph H H H "Bu H F H OH H H VI-36-2 p-Me-Ph H H CH 3 "Bu H F H OH H H VI-36-3 p-Me-Ph H H CH(CH 3
)
2 "Bu H F H OH H H VI-36-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 "Bu H F H OH H H VI-36-.5 p-Me-Ph H H CH 2 Ph "Bu H F H OH H H VI-36-6 p-Me-Ph H H CH 2 -indol-3-yl "Bu H F H OH H H VI-36-7 p-Me-Ph H H CH 2
CH
2
SCH
3 "Bu H F H OH H H VI-36-8 p-Me-Ph * H * "Bu H F H OH H H *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table VI-37. X2 R2 R 3 aRb R 4 R' R' X Y R' R' VI-37-1 p-F-Ph H H H "Bu H F H OH H H VI-37-2 p-F-Ph H H CH 3 "Bu H F H OH H H VI-37-3 p-F-Ph H H CH(CH 3
)
2 "Bu H F H OH H H VI-37-4 p-F-Ph H H CH 2
CH(CH
3
)
2 "Bu H F H OH H H VI-37-5 p-F-Ph H H CH 2 Ph "Bu H F H OH H H VI-37-6 p-F-Ph H H CH 2 -indol-3-yl "Bu H F H OH H H VI-37-7 p-F-Ph H H CH 2
CH
2
SCH
3 "Bu H F H OH H H VI-37-8 p-F-Ph * H * "Bu H F H OH H H 5 *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 1 0Q Table VI-38. S R R 2
R
3
R
3 b R' R' R' X Y R' R VI-38-1 p-Cl-Ph H H H "Bu H F H OH H H VI-38-2 p-Cl-Ph H H CH 3 "Bu H F H OH H H VI-38-3 p-Cl-Ph H H CH(CH 3
)
2 "Bu H F H OH H H VI-38-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 "Bu H F H OH H H VI-38-5 p-Cl-Ph H H CH 2 Ph "Bu H F H OH H H VI-38.6 p-Cl-Ph H H CH 2 -indol-3-yl "Bu H F H OH H H VI-38-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 "Bu H F H OH H H VI-38-8 p-Cl-Ph * H * "Bu H F H OH H H
*R
2 and R"b joined together by (CH 2
)
3 to form five-membered ring. Table VI-39. S R R 2
R
3 a R 3 b R 4 R' R' X Y R' R VI-39-1 p-Br-Ph H H H "Bu H F H OH H H VI-39-2 p-Br-Ph H H CH 3 "Bu H F H OH H H VI-39-3 p-Br-Ph H H CH(CH 3
)
2 "Bu H F H OH H H VI-39-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 "Bu H F H OH H H VI-39-5 p-Br-Ph H H CH 2 Ph "Bu H F H OH H H VI-39-6 p-Br-Ph H H CH 2 -indol-3-yi "Bu H F H OH H H VI-39-7 p-Br-Ph H H CH 2
CH
2
SCH
3 "Bu H F H OH H H VI-39-8 p-Br-Ph * H * "Bu H F H OH H H *R2 and R"b joined together by (CH 2
)
3 to form five-membered ring. 5 Table VI-40. N2 R' R2 R 3 a R
R
4 R' R' XY R 7
R
8 VI-40-1 p-I-Ph H H H "Bu H F H OH H H VI-40-2 p-I-Ph H H CH 3 "Bu H F H OH H H VI-40-3 p-I-Ph H H CH(CH 3
)
2 "Bu H F H OH H H VI-404 p-I-Ph H H CH 2
CH(CH
3
)
2 "Bu H F H OH H H VI-40-5 p-I-Ph H H CH 2 Ph "Bu H F H OH H H VI-40-6 p-I-Ph H H CH 2 -indol-3-yl "Bu H F H OH H H VI-40-7 p-I-Ph H H CH 2
CH
2
SCH
3 "Bu H F H OH H H VI-40-8 p-I-Ph * H * "Bu H F H OH H H *Rland Rib joined together by (CH 2
)
3 to form five-membered ring. ,innf Table VI-4 1. N2 RT R2 R 3 a Rab R' R' R' X Y R' R VI-41-1 CH 3 H H H Bz H F H OH H H VI-41-2 CH 3 H H CH 3 Bz H F H OH H H VI-41-3 CH 3 H H CH(CH 3
)
2 Bz H F H OH H H VI-41-4 CH 3 H H CH 2
CH(CH
3
)
2 Bz H F H OH H H VI-41-5 CH 3 H H CH 2 Ph Bz H F H OH H H VI-41-6 CH 3 H H CH 2 -indol-3-yi Bz H F H OH H H VI-41-7 CH 3 H H CH 2
CH
2
SCH
3 Bz H F H OH H H VI-41-8 CH 3 * H * Bz H F H OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table VI-42. N! R' R 2 R 3a R 3 b R(4 R' R 6 X Y R' R( VI-42-1 Et H H H Bz H F H OH H H VI-42-2 Et H H CH 3 Bz H F H OH H H VI-42-3 Et H H CH(CH 3
)
2 Bz H F H OH H H VI-42-4 Et H H CH 2
CH(CH
3
)
2 Bz H F H OH H H VI-42-5 Et H H CH 2 Ph Bz H F H OH H H VI-42-6 Et H H CH 2 -indol-3-yl Bz H F H OH H H VI-42-7 Et H H CH 2
CH
2
SCH
3 Bz H F H OH H H VI-42-8 Et * H * Bz H F H OH H H *R7and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table VI-43. N R' R2 R3aR3b R4R R R 6 X Y R 7 R' VI-43-1 'Pr H H H Bz H F H OH H H VI-43-2 'Pr H H CH 3 Bz H F H OH H H VI-43-3 'Pr H H CH(CH 3
)
2 Bz H F H OH H H VI-43-4 'Pr H H CH 2
CH(CH
3
)
2 Bz H F H OH H H VI-43-5 'Pr H H CH 2 Ph Bz H F H OH H H VI-43-6 'Pr H H CH 2 -indol-3-yl Bz H F H OH H H VI-43-7 'Pr H H CH 2 CH1 2
SCH
3 Bz H F H OH H 119 VI-43-8 'Pr * H * Bz H F H OH H H
*R
2 and R joined together by (CH 2
)
3 to form five-membered ring. I~A%1 Table VI-44. N R R 2 RaR 3 b R 4 R R' X Y R'R 8 VI-44-1 'Bu H H H Bz H F H OH H H VI-44-2 'Bu H H CH 3 Bz H F H OH H H VI-44-3 'Bu H H CH(CH 3
)
2 Bz H F H OH H H VI-44-4 'Bu H H CH 2
CH(CH
3
)
2 Bz H F H OH H H VI-44-5 'Bu H H CH 2 Ph Bz H F H OH H H VI-44-6 'Bu H H CH 2 -indol-3-yl Bz H F H OH H H VI-44-7 'Bu H H CH 2
CH
2
SCH
3 Bz H F H OH H H VI-44-8 'Bu * H * Bz H F H OH H H * R and R'b joined together by (CH 2
)
3 to form five-membered ring. Table VI-45. X2 RT R 2 RaR 3 b R' R' R 6 X Y R' R VI-45- Ph H H H Bz H F H OH H H VI-45.-2 Ph H H CH 3 Bz H F H OH H H VI-45-3 Ph H H CH(CH 3
)
2 Bz H F H OH H H VI-45-4 Ph H H CH 2
CH(CH
3
)
2 Bz H F H OH H H VI-45-5 Ph H H CH 2 Ph Bz H F H OH H H VI-45.-6 Ph H H CH 2 -indol-3-yl Bz H F H OH H H VI-45-7 Ph H H CH 2
CH
2
SCH
3 Bz H F H OH H H VI-45-8 Ph * H * Bz H F H OH H H *R R joined together by (CH 2
)
3 to form five-membered ring. 5 Table VI-46. N2 R1 R 2
R
3 a R3b R 4 R' R 6 X Y R( R( VI-46-1 p-Me-Ph H H H Bz H F H OH H H VI-46-2 p-Me-Ph H H CH 3 Bz H F H OH H H VI-46-3 p-Me-Ph H H CH(CH 3
)
2 Bz H F H OH H H VI-46--4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Bz H F H OH H H VI-46-5 p-Me-Ph H H CH 2 Ph Bz H F H OH H H VI-46-6 p-Me-Ph H H CH 2 -indol-3-yl Bz H F H OH H H VI-46-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Bz H F H OH H H VI-46-8 p-Me-Ph * H * Bz H F H OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table VI-47. R R R a Rb 4 R R R R 6 X Y R' R' VI-47-1 p-F-Ph H H H Bz H F H OH H H VI-47-2 p-F-Ph H H CH 3 Bz H F H OH H H VI-47.-3 p-F-Ph H H CH(CH 3
)
2 Bz H F H OH H H VI-47-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Bz H F H OH H H VI-47-5 p-F-Ph H H CH 2 Ph Bz H F H OH H H VI-47-6 p-F-Ph H H CH2-indol-3-yl Bz H F H OH H H VI-47-7 p-F-Ph H H CH 2
CH
2
SCH
3 Bz H F H OH H H VI-47-.8 p-F-Ph * H * Bz H F H OH H H *R and R3b joined together by (CH 2
)
3 to form five-membered ring. Table VI-48. N2 R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7 R 8 VI-48-1 p-Cl-Ph H H H Bz H F H OH H H VI-48-2 p-Cl-Ph H H CH 3 Bz H F H OH H H VI-48-3 p-Cl-Ph H H CH(CH 3
)
2 Bz H F H OH H H VI-48-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Bz H F H OH H H VI-48-5 p-Cl-Ph H H CH 2 Ph Bz H F H OH H H VI-48-6 p-Cl-Ph H H CH2-indol-3-yl Bz H F H OH H H VI-48-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Bz H F H OH H H VI-48-8 p-Cl-Ph * H * Bz H F H OH H H
*R
2 and R b joined together by (CH 2
)
3 to form five-membered ring. 5 Table VI-49.
SR
2
R
3 a R 3 b R 4 R R 6 X Y R R VI-49-1 p-Br-Ph H H H Bz H F. H OH H H VI-49-2 p-Br-Ph H H CH 3 Bz H F H OH H H VI-49-3 p-Br-Ph H H CH(CH 3
)
2 Bz H F H OH H H VI-49-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Bz H F H OH H H VI-49-5 p-Br-Ph H H CH 2 Ph Bz H F H OH H H VI-49-6 p-Br-Ph H H CH2-indol-3-yl Bz H F H OH H H VI-49-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Bz H F H OH H H VI-49-8 p-Br-Ph * H * Bz H F H OH H H
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table VI-50. N R R'R aR 3 b R 4 R' R' X Y R' R VI-50-1 p-I-Ph H H H Bz H F H OH H H VI-50-.2 p-I-Ph H H CH 3 Bz H F H OH H H VI-50-3 p-I-Ph H H CFI(CH 3
)
2 Bz H F H OH H H VI-50-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Bz H F H OH H H VI-50-5 p-I-Ph H H CH 2 Ph Bz H F H OH H H VI-50-6 p-I-Ph H H CH 2 -indol-3-yl Bz H F H OH H H VI-50-7 p-I-Ph H H CH 2
CH
2
SCH
3 Bz H F H OH H H VI-50-8 p-I-Ph* H * Bz H F H OH H H *Ri 2 and RJb joined together by (CH 2
)
3 to form five-membered ring.
R
9
R
8 R2 0 RN 0 0 R 7 N 0 C0 2
R
4 OR' R
R
6 Y x 5 VII Table VII-1. N2 R1 R 2 RS"RI R R' RXY R R R 9 VII-1-1 CH 3 H H H CH 3 H F H OH H H NH 2 VH-1-2 CH 3 H H CH 3
CH
3 H F H OH H H NH 2 VII-1-3 CH 3 H H CH(CH 3
)
2
CH
3 H F H OH H H NH 2 VII-1-4 CH 3 H H CH 2
CH(CH
3
)
2
CH
3 H F H OH H H NH 2 VH-1-5 CH3 H H CH 2 Ph CH 3 H F H OH H H NH 2 VII-1-6 CH 3 H H CH 2 -indol-3-yl CH 3 H F H OH H H NH 2 VII-1-7 CH 3 H H CH 2
CH
2
SCH
3
CH
3 H F H OH H H NH 2 VH-1-8 CH 3 * H * CH 3 H F H OH H H NH 2
*R
2 and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table VII-2. N2 RI R 2 R 3 a b R' R' R' X Y R R' R 9 VH-2.1 Et H H H CH 3 H F H OH H H NH 2 VI-2-2 Et H H CH 3
CH
3 H F H OH H H NH 2 VII-2-3 Et H H CH(CH 3
)
2
CH
3 H F H OH H H NH 2 VII-2-4 Et H H CH 2
CH(CH
3
)
2
CH
3 H F H OH H H NH- 2 VII-2-5 Et H H CH 2 Ph CH 3 H F H OH H H NH 2 VII-2-6 Et H H CH 2 -indol-3-yl CH 3 H F H OH H H N-H2 VII-2-7 Et H H CH 2
CH
2
SCH
3
CH
3 H F H OH H H NH 2 VII-2-8 Et* H * CH 3 H F H OH H H NH 2 *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table VII-3. N2 RF R 2 R aR 3 b R 4 R' R 6 X Y R' R"RW VII-3-1 'Pr H H H CH 3 H F H OH H H NH 2 VII-3-2 'Pr H H CH 3
CH
3 H F H OH H H NH 2 VII-3-3 'Pr H H CH(CH 3
)
2
CH
3 H F H OH H H NH 2 VII-3-4 'Pr H H CH 2
CH(CH
3
)
2
CH
3 H F H OH H H NH 2 VII-3-5 'Pr H H CH 2 Ph CH 3 H F H OH H H NH 2 VII-3-6 'Pr H H CH 2 -indol-3-yl CH 3 H F H OH H H NH 2 VII-3-7 'Pr H H CH 2
CH
2
SCH
3
CH
3 H F H OH H H NH 2 VII-3-8 'Pr * H * CH 3 H F H OH H H NH 2
*R
2 and R b joined together by (CH 2
)
3 to form five-membered ring. 5 Table VII-4. 2 R R 2 R R 3 b R 4 R' R XY R' R R 9 VII-4-1 'Bu H H H CH 3 H F H OH H H NH 2 VIH-4-2 'Bu H H CH 3
CH
3 H F H OH H H NH 2 VII-4-3 'Bu H H CH(CH 3
)
2
CH
3 H F H OH H H NH 2 VII-4-4 'Bu H H CH 2
CH(CH
3
)
2
CH
3 H F H OH H H NH 2 VII-4-5 'Bu H H CH 2 Ph CH 3 H F H OH H H NH 2 VII-4-6 'Bu H H CH 2 -indol-3-yl CH 3 H F H OH H H NH 2 VII-4-7 'Bu H H CH 2
CH
2
SCH
3
CH
3 H F H OH H H NH 2 VI-4-8 'Bu* H * CH 3 H F H OH H H NH 2 *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring.
Table VII-5. X2 RT R2 R 3 a R 3 b R 4 R' R 6 X Y R' R' R 9 VII-5-1 Ph H H H CH 3 H F H OH H H NH2 VU-5-2 Ph H H CH 3
CH
3 H F H OH H H NH2 VU-5--3 Ph H H CH(CH 3
)
2
CH
3 H F H OH H H Ni 2 VII-5--4 Ph H H CH 2
CH(CH
3
)
2
CH
3 H F H OH H H NH 2 VH-5-5 Ph H H CH 2 Ph CH 3 H F H OH H H NH 2 VU-5-6 Ph H H CH 2 -indol-3-yl CH 3 H F H OH H H NH 2 VH-5-7 Ph H H CH 2
CH
2
SCH
3
CH
3 H F H OH H H NH 2 VU-5-8 Ph* H * CH3 H F H OH H H NH 2 *R and RJb joined together by (CH 2
)
3 to form five-membered ring. Table VII-6. N R RaRab R' R' R' X Y R' R R 9 VU-6- p-Me- H H H CH 3 H F H OH H H NH 2 1 Ph VH-6- p-Me- H H CH 3
CH
3 H F H OH H H NH 2 2 Ph VU-6- p-Me- H H CH(CH 3
)
2
CH
3 H F H OH H H NH2 3 Ph VH-6- p-Me- H H CH 2
CH(CH
3
)
2
CH
3 H F H OH H H NH 2 4 Ph VH-6- p-Me- H H CH 2 Ph CH 3 H F H OH H H NH 2 5 Ph VU-6- p-Me- H H CH 2 -indol-3- CH 3 H F H OH H H NH2 6 Phy VH-6- p-Me- H H CH 2
CH
2
SCH
3
CH
3 H F H OH H H NH 2 7 Ph VU-6- p-Me- * H * CH 3 H F H OH H H NH 2 8 Ph
*R
2 and Rab joined together by (CH 2
)
3 to form five-membered ring. 5 Table VII-7. N R R 2
R
3 a R 3 b R 4 R' R 6 X Y R7 R 8
R
9 VU-7-1 p-F- H H H CH 3 H F H OH H H NH 2 Ph VU-7-2 p-F- H H CH 3
CH
3 H F H OH H N1H 2 Ph VU-7-3 p-F- H H CH(CH 3
)
2
CH
3 H F H OH H H NH 2 X2 R2 R3a R 3
R
4 R' R' X Y R 7
R
8
R
9 Ph VII-7-4 p-F- H H CH 2
CH(CH
3
)
2
CH
3 H F H OH H H NH 2 Ph VII-7-6 p-F- H H CH 2 Ph CH 3 H F H OH H H NH 2 Ph VH-7-7 p-F- H H CH 2 -indol-3- CH 3 H F H OH H H NH 2 Ph yl VII-7-8 p-F- H H CH 2
CH
2
SCH
3
CH
3 H F H OH H H NH 2 Ph VI-7- p-F- * H * CH 3 H F H OH H H NH 2 20 Ph *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table VII-8. S R R Ra Rb R 4 R R 6 XY R7 R 8 R VII-8- p-Cl- H H H CH 3 H F H OH H H NH 2 1 Ph VII-8- p-Cl- H H CH 3
CH
3 H F H OH H H NH 2 2 Ph VII-8- p-Cl- H H CH(CH 3
)
2
CH
3 H F H OH H H NH 2 3 Ph VII-8- p-Cl- H H CH 2
CH(CH
3
)
2
CH
3 H F H OH H H NH 2 4 Ph VH-8- p-Cl- H H CH 2 Ph CH 3 H F H OH H H NH 2 5 Ph VII-8- p-Cl- H H CH 2 -indol-3- CH 3 H F H OH H H NH 2 6 Ph YI VII-8- p-Cl- H H CH 2
CH
2
SCH
3
CH
3 H F H OH H H NH 2 7 Ph VH-8- p-Cl- * H * CH 3 H F H OH H H NH 2 8 Ph R2 and R-b joined together by (CH 2
)
3 to form five-membered ring. Table VII-9. N Rf2 RR)a R 3
R
4 R' R' X Y R' R R 9 VH-9- p-Br- H H H CH 3 H F H OH H H NH 2 1 Ph VII-9- p-Br- H H CH 3
CH
3 H F H OH H H NH 2 Ph N2 R1 R 2
R
3 a R 3 b R 4 R' R' X Y R' R 8
R
9 2 VII-9- p-Br- H H CH(CH 3
)
2
CH
3 H F H OH H H NH 2 3 Ph VII-9- p-Br- H H CH- 2
CH(CH
3
)
2
CH
3 H F H OH H H NH 2 4 Ph VII-9- p-Br- H H CH 2 Ph CH 3 H F H OH H H NH 2 6 Ph VH-9-. p-Br- H H CH 2 -indol-3- CH 3 H F H OH H H NH2 7 Ph VII-9- p-Br- H H CH 2
CH
2
SCH
3
CH
3 H F H OH H H NH 2 8 Ph VII-9- p-Br- * H * CH 3 H F H OH H H NH 2 20 Ph *R7 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table VII-10.
R
2 RaR 3 b R 4
R
5
R
6 XY R 7
R
8
R
9 VH-10- p-I- H H H CH 3 H F H OH H H NH2 1 Ph VII-10- p-I- H H CH- 3
CH
3 H F H OH H H NH 2 2 Ph VII-10- p-I- H H CH(CH 3
)
2
CH
3 H F H OH H H NH 2 3 Ph VII-10- p-I- H H CH 2
CH(CH
3
)
2
CH
3 H F H OH H H NH 2 4 Ph VII-10-. p-I- H H CH 2 Ph CH 3 H F H OH H H NH 2 5 Ph VII-10- p-I- H H CH 2 -indol-3- CH 3 H F H OH H H NH 2 6 Ph VII-10- p-I- H H CH 2
CH
2
SCH
3
CH
3 H F H OH H H NH 2 7 Ph VII-10- p-1- * H * CH 3 H F H OH H H NH 2 8 Ph RT and R 3 ' joined together by (CH 2
)
3 to form five-membered ring.
Table VII-11. N2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y R 7
R
8
R
9 VII-11-1 CH 3 H H H Et H F H OH H H NH2 VII-1-2 CH 3 H H CH 3 Et H F H OH H H NH2 VII-11-3 CH 3 H H CH(CH 3
)
2 Et H F H OH H H NH 2 VII-1 1-4 CH 3 H H CH 2
CH(CH
3
)
2 Et H F H OH H H NH 2 VII-11-5 CH 3 H H CH 2 Ph Et H F H OH H H NH 2 VI-11-6 CH 3 H H CH 2 -indol-3-yl Et H F H OH H H NH2 VH-11-7 CH 3 H H CH 2
CH
2
SCH
3 Et H F H OH H H NH2 VH-11-8 CH 3 * H * Et H F H OH H H NH2 *R and Rib joined together by (CH 2
)
3 to form five-membered ring. Table VII-12. NR R 2 R R R R 4
R
5
R
6 XY RRR'RR VII-12-1 Et H H H Et H F H OH H H NH1 2 VH-12-2 Et H H CH 3 Et H F H OH H H NH 2 VI-12-3 Et H H CH(CH 3
)
2 Et H F H OH H H NH 2 VII-12-4 Et H H CH 2
CH(CH
3
)
2 Et H F H OH H H NH 2 VII-12-5 Et H H CH 2 Ph Et H F H OH H H NH2 VII-12-6 Et H H CH 2 -indol-3-yl Et H F H OH H H NH 2 VII-12-7 Et H H CH 2
CH
2
SCH
3 Et H F H OH H H NH 2 VH-12-8 Et* H * Et H F H OH H H NH2 *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table VII-13. NX R' R2 R3a R 3 b R4 R' R 6 X Y ' 7 R R 9 VII-13-1 'Pr H H H Et H F H OH H H NH 2 VI-13-2 'Pr H H CH 3 Et H F H OH H H NH 2 VII-13-3 'Pr H H CH(CH 3
)
2 Et H F H OH H H NH 2 VII-13-4 'Pr H H CH 2
CH(CH
3
)
2 Et H F H OH H H NH 2 VII-13-5 'Pr H H CH 2 Ph Et H F H OH H H NH 2 VII-13-6 'Pr H H CH 2 -indol-3-yl Et H F H OH H H NH 2 VU-13-7 'Pr H H CH 2
CH
2
SCH
3 Et H F H OH H H NH 2 VII-13-8 'Pr* H * Et H F H OH H H NH 2
*R
2 and R3b joined together by (CH2) 3 to form five-membered ring.
Table VII-14. N2 R' R2 R R 3 b R 4 R R X Y R' R' R 9 3a VII- 'Bu H H H Et H F H OH H H NH 2 14-1 VH- 'Bu H H CH 3 Et H F H OH H H NH 2 14-2 VII- 'Bu H H CH(CH 3
)
2 Et H F H OH H H NH 2 14-3 VH- 'Bu H H CH 2
CH:(CH
3
)
2 Et H F H OH H H NH 2 14-4 VII- 'Bu H H CH 2 Ph Et H F H OH H H NH 2 14-5 VH- 'Bu H H CH 2 -indol-3-yi Et H F H OH H H NH 2 14-6 VII- 'Bu H H CH 2
CH
2
SCH
3 Et H F H OH H H NH 2 14-7 VII- 'Bu* H * Et H F H OH H H NH 2 14-8 *RTand R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table VII-15. N R' R2 R aR 3 b R R RXY R' R' R 9 VII-15-1 Ph H H H Et H F H OH H H NH 2 VH-15-2 Ph H H CH 3 Et H F H OH H H NH2 VII-15-3 Ph H H CH(CH 3
)
2 Et H F H OH H H NH 2 VII-15-4 Ph H H CH 2
CH(CH
3
)
2 Et H F H OH H H NH 2 VII-15-5 Ph H H CH 2 Ph Et H F H OH H H NH 2 VII-15-6 Ph H H CH 2 -indol-3-yl Et H F H OH H H NH 2 VII-15-7 Ph H H CH 2
CH
2
SCH
3 Et H F H OH H H NH2 VII-15-8 Ph * H * Et H F H OH H H NH 2 *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table VII-16. N2 R1 R2 R3a R.b R4 R5 R6 X Y R' R R9 VII-16- p-Me- H H H Et H F H OH H H NH 2 1 Ph 11A X2 Rl R 2
R
3 a R 3 b R' R' R' X Y R' R' R 9 VII-16- p-Me- H H CH 3 Et H F H OH H H NH 2 2 Ph VII-16- p-Me- H H CH(CH 3
)
2 Et H F H OH H H NH 2 3 Ph VH-16- p-Me- H H CH 2
CH(CH
3
)
2 Et H F H OH H H NH 2 4 Ph VH-16- p-Me- H H CH 2 Ph Et H F H OH H H NH 2 5 Ph VII-16- p-Me- H H CH 2 -indol-3- Et H F H OH H H NH 2 6 Ph VII-16- p-Me- H H CH 2
CH
2
SCH
3 Et H F H OH H H NH2 Ph VII-16- p-Me- * H * Et H F H OH H H NH 2 8 Ph *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table VII-17. 2 R R RaR 3 b R' R' R' X Y R R R 9 VI-17- p-F- H H H Et H F H OH H H NH 2 1 Ph VII-17- p-F- H H CH 3 Et H F H OH H H NH 2 2 Ph VH-17- p-F- H H CH(CH 3
)
2 Et H F H OH H H NH 2 3 Ph VI-17- p-F- H H CH 2
CH(CH
3
)
2 Et H F H OH H H NH 2 4 Ph VH-17- p-F- H H CH 2 Ph Et H F H OH H H NH2 5 Ph VII-17- p-F- H H CH 2 -indol-3- Et H F H OH H H NH 2 6 Ph YI VII-17- p-F- H H CH 2
CH
2
SCH
3 Et H F H OH H H NHi 2 7 Ph VI-17- p-F- * H * Et H F H OH H H NH 2 8 Ph *Rand R 3 b joined together by (CH 2
)
3 to form five-membered ring. I 11 Table VII-18.
R
2
R
3 a R 3 b R 4 R' R' X Y R' R' R 9 VII-18- p-Cl- H H H Et H F H OH H H NH 2 1 Ph VI-18- p-Cl- H H CH 3 Et H F H OH H H NH2 2 Ph VH-18- p-Cl- H H CH(CH 3
)
2 Et H F H OH H H NH 2 3 Ph VI-18- p-Cl- H H CH 2
CH(CH
3
)
2 Et H F H OH H H NH 2 4 Ph.. VH-18- p-Cl- H H CH 2 Ph Et H F H OH H H NH 2 5 Ph VH-18- p-Cl- H H CH 2 -indol-3- Et H F H OH H H NH 2 6 Ph YI VI-18- p-Cl- H H CH 2
CH
2
SCH
3 Et H F H OH H H NH 2 7 Ph VH-18- p-Cl- * H * Et H F H OH H H NH2 8 Ph *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table VII-19. N2 R R 2
R
3
R
3 b R 4 R' R 6 X Y R' R" R 9 VH-19- p-Br- H H H Et H F H OH H H NH 2 1 Ph VH-19- p-Br- H H CH 3 Et H F H OH H H NH2 2 Ph VH-19- p-Br- H H CH(CH 3
)
2 Et H F H OH H H Nil 2 3 Ph VH1-19- p-Br- H H CH 2
CH(CH
3
)
2 Et H F H OH H H NiH2 4 Ph VH-19- p-Br- H H CH 2 Ph Et H F H OH H H NH 2 5 Ph VH-19- p-Br- H H CH 2 -indol-3- Et H F H OH H H NH 2 6 Phyl VH-19- p-Br- H H CH 2
CH
2
SCH
3 Et H F H OH H H NH 2 7 Ph VH1-19- p-Br- * H * Et H F H OH H H NH 2 XS l R2 R3a R3b R4 R'5 6 Xy R7 R8 R9 Xe R R2 Ra RE R4 R Ra XY R RS R9 8 Ph *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table VII-20.
N
2 Rl R 2
R
3 a R 3 b R 4 R' R X Y R 7 R R 9 VII-20-1 p-I-Ph H H H Et H F H OH H H NH 2 VH-20-2 p-I-Ph H H CH 3 Et H F H OH H H NH 2 VH-20-3 p-I-Ph H H CH(CH 3 )2 Et H F H OH H H NH 2 VH-20-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Et H F H OH H H NH 2 VH-20-5 p-I-Ph H H CH 2 Ph Et H F H OH H H NH2 VII-20-6 p-I-Ph H H CH 2 -indol-3-yl Et H F H OH H H NH 2 VH-20-7 p-I-Ph H H CH 2
CH
2
SCH
3 Et H F H OH H H NH 2 VII-20-8 p-I-Ph * H * Et H F H OH H H NH 2 3 b *R and R joined together by (CH 2
)
3 to form five-membered ring. Table VII-2 1. N2 R' R2 R3a R 3 b R R R 6 X Y R R R 9 VH-21-1 CH 3 H H H 'Pr H F H OH H H N 2 VII-21-2 CH 3 H H CH 3 'Pr H F H OH H H NH 2 VII-21-3 CH 3 H H CH(CH 3
)
2 'Pr H F H OH H H NH 2 VH-21-4 CH 3 H H CH 2
CH(CH
3
)
2 'Pr H F H OH H H NH 2 VI-21-5 CH 3 H H CH 2 Ph 'Pr H F H OH H H NH 2 VH-21-6 CH 3 H H CH 2 -indol-3-yl 'Pr H F H OH H H NH 2 VH-21-7 CH 3 H H CH 2
CH
2
SCH
3 'Pr H F H OH H H NH 2 VII-21-8 CH 3 * H * 'Pr H F H OH H H NH 2 5 *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table VII-22. N2 R I R 2
R
3 a R 3 b R 4 R' R 6 X Y R' R' R 9 VII-22-1 Et H H H 'Pr H F H OH H H NH2 VII-22-2 Et H H CH 3 'Pr H F H OH H H NH2 VII-22-3 Et H H CH(CH 3
)
2 'Pr H F H OH H H NH 2 VII-22-4 Et H H CH 2
CH(CH
3
)
2 'Pr H F H OH H H NH 2 VII-22-5 Et H H CH 2 Ph 'Pr H F H OH H H NH 2 VI-22-6 Et H H CH 2 -indol-3-yl 'Pr H F H OH H H NH 2 VII-22-7 Et H H CH 2
CH
2
SCH
3 'Pr H F H OH H H NH 2 VII-22.8 Et* H * 'Pr H F H OH H H NH 2
*R
2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table VII-23. N2 R' R RaR 3 b R 4 R R X Y R' R'RW VH-23-1 'Pr H H H 'Pr H F H OH H H NH 2 VH-23-2 'Pr H H CH 3 'Pr H F H OH H H NH 2 VII-23-3 'Pr H H CH(CH 3 )2 'Pr H F H OH H H Ni- 2 VII-23-4 'Pr H H CH 2
CH(CH
3
)
2 'Pr H F H OH H H NH2 VI-23-5 'Pr H H CH 2 Ph 'Pr H F H OH H H NH2 VII-23-6 'Pr H H CH 2 -indol-3-yl 'Pr H F H OH H H NH 2 VII-23-7 'Pr H H CH 2
CH
2
SCH
3 'Pr H F H OH H H NH 2 VH-23-8 'Pr * H * 'Pr H F H OH H H NH 2
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table VII-24. N2 R' R R Rab R 4 R' R' X Y R' R' R 9 VI-24-1 'Bu H H H 'Pr H F H OH H H NH 2 VH-24-2 'Bu H H CH 3 'Pr H F H OH H H NH 2 VII-24-3 'Bu H H CH(CH 3
)
2 'Pr H F H OH H H NH 2 VII-24-4 'Bu H H CH 2
CH(CH
3
)
2 'Pr H F H OH H H NH 2 VI-24-5 'Bu H H CH 2 Ph 'Pr H F H OH H H NH2 VII-24-6 'Bu H H CH 2 -indol-3-yl 'Pr H F H OH H H NH4 2 VII-24-7 'Bu H H CH 2
CH
2
SCH
3 'Pr H F H OH H H NH 2 VI-24-8 'Bu* H * 'Pr H F H OH H H NH 2 5 *R2 and R.'" joined together by (CH 2
)
3 to form five-membered ring. Table VII-25. NO R R 2 R3a R 3 b R4 R R X Y R 7
R
8
R
9 VI-251 Ph H H H 'Pr H F H OH H H NH 2 VII-25-2 Ph H H CH 3 'Pr H F H OH H H NH 2 VII-25-3 Ph H H CH(CH 3
)
2 'Pr H F H OH H H NH 2 VII-25-4 Ph H H CH 2
CH(CH
3
)
2 'Pr H F H OH H H NH 2 VII-25-5 Ph H H CH 2 Ph 'Pr H F H OH H H NH2 VII-25-6 Ph H H CH 2 -indol-3-yl 'Pr H F H OH H H NH 2 VII-25-7 Ph H H CH 2
CH
2
SCH
3 'Pr H F H OH H H NH 2 VI-25-8 Ph* H * 'Pr H F H OH H H NH 2 *RTFand Rib joined together by (CH 2
)
3 to form five-membered ring. 11 A Table VII-26. X2 RT R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7
R
8
R
9 VII-26- p-Me- H H H 'Pr H F H OH H H NH 2 1 Ph VII-26- p-Me- H H CH 3 'Pr H F H OH H H NH 2 2 Ph VII-26- p-Me- H H CH(CH 3
)
2 'Pr H F H OH H H NH 2 3 Ph VII-26- p-Me- H H CH 2
CH(CH
3
)
2 'Pr H F H OH H H NH2 4 Ph VII-26- p-Me- H H CH 2 Ph 'Pr H F H OH H H NH 2 5 Ph VII-26- p-Me- H H CH 2 -indol-3- 'Pr H F H OH H H NH 2 6 Phy VII-26- p-Me- H H CH 2
CH
2
SCH
3 'Pr H F H OH H H NH2 7 Ph VII-26- p-Me- * H * 'Pr H F H OH H H NH 2 8 Ph *R2 and R joined together by (CH2)3 to form five-membered ring. Table VII-27. N2 R1 R 2
R
3 a R 3 b R' R' R 6 X Y R 7 R R 9 VII-27- p-F- H H H 'Pr H F H OH H H NH 2 .1 Ph VI-27- p-F- H H CH 3 'Pr H F H OH H H NHi 2 2 Ph VII-27- p-F- H H CH(CH 3
)
2 'Pr H F H OH H H NH 2 3 Ph VH-27-. p-F- H H CH 2
CH(CH
3
)
2 'Pr H F H OH H H NH2 4 Ph VII-27- p-F- H H CH 2 Ph 'Pr H F H OH H H NIH2 5 Ph VII-27- p-F- H H CH 2 -indol-3- 'Pr H F H OH H H NH2 6 Ph YI VII-27- p-F- H H CH 2
CH
2
SCH
3 'Pr H F H OH H H NH2 7 Ph VII-27- p-F- * H * 'Pr H F H OH H H NH 2 N! R' R 2 R a R 3 b R4 R' R 6 X Y I 7 R R 9 8 Ph
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table VII-28. 2! R 3 a 3 b R RR X RR NV2 RI R2RaRbR R RR X Y R' R' R VH-28- p-Cl- H H H 'Pr H F H OH H H NH 2 Ph VH-28- p-Cl- H H CH 3 'Pr H F H OH H H NH 2 2 Ph VII-28- p-Cl- H H CH(CH 3
)
2 'Pr H F H OH H H NH 2 3 Ph VII-28- p-Cl- H H CH 2
CH(CH
3
)
2 'Pr H F H OH H H NH 2 4 Ph VII-28- p-Cl- H H CH 2 Ph 'Pr H F H OH H H NH2 5 Ph VII-28- p-Cl- H H CH 2 -indol-3- 'Pr H F H OH H H NH 2 6 Ph YI VII-28- p-Cl- H H CH 2
CH
2
SCH
3 'Pr H F H OH H H Ni- 2 7 Ph VII-28- p-Cl- * H * 'Pr H F H OH H H NH 2 8 Ph *R2 and R b joined together by (CH 2
)
3 to form five-membered ring. Table VII-29. N R R 2
R
3 a R 3 b R4 R' R 6 X Y R 7 R R 9 VII-29- p-Br- H H H 'Pr H F H OH H H Nil 2 1 Ph VII-29- p-Br- H H CH 3 'Pr H F H OH H H NH 2 2 Ph VH-29-. p-Br- H H CH(CH 3
)
2 'Pr H F H OH H H NH 2 3 Ph VH-29- p-Br- H H CH 2
CH(CH
3
)
2 'Pr H F H OH H H NHl 2 4 Ph VII-29- p-Br- H H CH 2 Ph 'Pr H F H OH H H NH 2 5 Ph VH-29- p-Br- H H CH 2 -indol-3- 'Pr H F H OH H H NH2 Ph X2 R' R2 R 3 a R 3 b R 4 R' R' X Y R' R' R 9 6 yI VH-29- p-Br- H H CH 2
CH
2
SCH
3 'Pr H F H OH H H NH 2 7 Ph V'1-29- p-Br- * H * 'Pr H F H OH H H NH 2 8 Ph *R and Rab joined together by (CH 2
)
3 to form five-membered ring. Table VII-30. X Rl R 2
R
3 a R 3 b R 4 R' R 6 X Y R' R 8
R
9 VH-30- p-I-Ph H H H 'Pr H F H OH H H NH 2 I VH-30- p-I-Ph H H CH 3 'Pr H F H OH H H NH 2 2 VII-30- p-I-Ph H H CH(CH 3
)
2 'Pr H F H OH H H NH 2 3 VH1-30- p-I-Ph H H CH 2
CH(CH
3
)
2 'Pr H F H OH H H NH2 4 VH-30- p-I-Ph H H CH 2 Ph 'Pr H F H OH H H Nl 2 5 V'1-30- p-I-Ph H H CH 2 -indol-3-yl 'Pr H F H OH H H NH 2 6 VH-30- p-I-Ph H H CH 2
CH
2
SCH
3 'Pr H F H OH H H NH 2 7 VH-30- p-I-Ph* H * 'Pr H F H OH H H NH 2 8 *RzTand R 3 b joined together by (CH 2
)
3 to form five-membered ring. 1 7 Table VII-3 1. N2 R' R 2
R
3 aRb R 4 R' R 6 XY R' R R 9 VI-31-1 CH 3 H H H "Bu H F H OH H H NH 2 VII-31-2 CH 3 H H CH 3 "Bu H F H OH H H NH2 VII-31-3 CH 3 H H CH(CH 3
)
2 "Bu H F H OH H H NH 2 VII-31-4 CH 3 H H CH 2
CH(CH
3
)
2 "Bu H F H OH H H NH 2 VII-31-5 CH 3 H H CH 2 Ph "Bu H F H OH H H NH 2 VII-31-6 CH 3 H H CH 2 -indol-3-yi "Bu H F H OH H H NH2 VII-31-7 CH 3 H H CH 2
CH
2
SCH
3 "Bu H F H OH H H NH 2 VII-31-8 CH 3 * H * "Bu H F H OH H H NH- 2 *R2 and R 31 b joined together by (CH 2
)
3 to form five-membered ring. Table VII-32. N RI R 2
R
3 aRR' R R' R 6 X Y R R' R 9 VII-32-1 Et H H H "Bu H F H OH H H NH 2 VII-32-2 Et H H CH 3 "Bu H F H OH H H NH 2 VII-32-3 Et H H CH(CH 3
)
2 "Bu H F H OH H H NH2 VII-32-4 Ft H H CH 2
CH(CH
3
)
2 "Bu H F H OH H H NH 2 VII-32-5 Et H H CH 2 Ph "Bu H F H OH H H NH 2 VII-32-6 Et H H CH 2 -indol-3-yl "Bu H F H OH H H NH 2 VII-32-7 Et H H CH 2
CH
2
SCH
3 "Bu H F H OH H H NH 2 VII-32-8 Et * H * "Bu H F H OH H H NH 2 *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table VII-33. N R' R 2
RR
3 b R' R R XY R' R' R 9 VII-33-1 'Pr H H H "Bu H F H OH H H NH2 VII-33-2 'Pr H H CH 3 "Bu H F H OH H H NH 2 VII-33-3 'Pr H H CH(CH 3
)
2 "Bu H F H OH H H NH 2 VII-33-4 'Pr H H CH 2
CH(CH
3
)
2 "Bu H F H OH H H NH 2 VII-33-5 'Pr H H CH 2 Ph "Bu H F H OH H H NH 2 VII-33-6 'Pr H H CH 2 -indol-3-yl "Bu H F H OH H H NH 2 VII-33-7 'Pr H H CH 2
CIH
2
SCH
3 "Bu H F H OH H H NH 2 VII-33--8 Pr* H * "Bu H F H OH H H NH 2 *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. )1 Q Table VII-34. X2 Rl R 2
R
3 Rb R 4 R R X Y R 7 R R 9 VH-34-1 'Bu H H H "Bu H F H OH H H NH 2 VU-34-2 'Bu H H CH 3 "Bu H F H OH H H NH2 VII-34-3 'Bu H H CH(CH 3
)
2 "Bu H F H OH H H NH 2 VII-34-4 'Bu H H CH 2
CH(CH
3
)
2 "Bu H F H OH H H NH 2 VII-34-5 'Bu H H CH 2 Ph "Bu H F H OH H H NH 2 VI-34-6 'Bu H H CH 2 -indol-3-yl "Bu H F H OH H H NH 2 VII-34-7 'Bu H H CH 2
CH
2
SCH
3 "Bu H F H OH H H NH 2 VII-34-8 'Bu * H * "Bu H F H OH H H NH 2 *R2and Rib joined together by (CH 2
)
3 to form five-membered ring. Table VII-35. N2 R R 2 R 3 aR 3 b R R R 6 X Y R 7 R' R 9 VII-3-1 Ph H H H "Bu H F H OH H H NH 2 VII-35-2 Ph H H CH 3 "Bu H F H OH H H NH2 VII-35-3 Ph H H CH(CH 3
)
2 "Bu H F H OH H H NH 2 VII-35-4 Ph H H CH 2
CH(CH
3
)
2 "Bu H F H OH H H NH 2 VII-35-5 Ph H H CH 2 Ph "Bu H F H OH H H NH 2 VII-35-6 Ph H H CH 2 -indol-3-yl "Bu H F H OH H H NH 2 VII-35-7 Ph H H CH 2
CH
2
SCH
3 "Bu H F H OH H H NH 2 VI-35-8 Ph * H * "Bu H F H OH H H NH 2
*R
2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table VII-36. 2 R R2 R 3 a R 3 b R 4 R' R 6 X Y I 7 R R 9 VII- p-Me- H H H "Bu H F H OH H H NH 2 36-1 Ph VII- p-Me- H H CH 3 "Bu H F H OH H H NH 2 36-2 Ph V11- p-Me- H H CH(CH 3
)
2 "Bu H F H OH H H NH 2 36-3 Ph VII- p-Me- H H CH 2
CH(CH
3
)
2 "Bu H F H OH H H NH 2 36-4 Ph VH- p-Me- H H CH 2 Ph "Bu H F H OH H H NH 2 36-5 Ph VII- p-Me- H H CH 2 -indol-3- "Bu H F H OH H H NH 2 Ph '10 M R' R 2
R
3 a Rb R 4 R R 6 X Y R' R 8
R
9 36-6 yI viI- p-Me- H H CH 2
CH
2
SCH
3 "Bu H F H OH H H NH 2 36-7 Ph VII- p-Me- * H * "Bu H F H OH H H NH 2 36-8 Ph *R and Rib joined together by (CH 2
)
3 to form five-membered ring. Table VII-37. N2 R7 R 2 RaR R 4 R' R XY RiR 8 R VII-37- p-F- H H H "Bu H F H OH H H NH 2 1 Ph VII-37- p-F- H H CH 3 "Bu H F H OH H H NH 2 2 Ph VII-37- p-F- H H CH(CH 3
)
2 "Bu H F H OH H H NH 2 3 Ph VII-37- p-F- H H CH 2
CH(CH
3
)
2 "Bu H F H OH H H NH 2 4 Ph VII-37- p-F- H H CH 2 Ph "Bu H F H OH H H NH2 5 Ph VII-37- p-F- H H CH 2 -indol-3- "Bu H F H OH H H NH2 6 Ph YI VII-37- p-F- H H CH 2
CH
2
SCH
3 "Bu H F H OH H H NH 2 7 Ph VII-37- p-F- * H * Bu H F H OH H H NH 2 8 Ph *R Stand Rib joined together by (CH 2
)
3 to form five-membered ring. Table VII-38. N2 RT R 2
R
3 aRab R R' R 6 X Y R' R' R' VII- p-Cl- H H H "Bu H F H OH H H NH 2 38-1 Ph VII- p-Cl- H H CH 3 "Bu H F H OH H H NH 2 38-2 Ph VII- p-Cl- H H CH(CH 3
)
2 "Bu H F H OH H H NH 2 38-3 Ph VII- p-Cl- H H CH 2
CH(CH
3
)
2 "Bu H F H OH H H NH 2 Ph 9 R' R 2 R3a R3b R 4 R' R' X Y R R' R 9 38-4 VH- p-Cl- H H CH 2 Ph "Bu H F H OH H H NH 2 38-5 Ph VII- p-Cl- H H CH 2 -indol-3- "Bu H F H OH H H NH 2 38-6 Ph Y1 VII- p-Cl- H H CH 2
CH
2
SCH
3 "Bu H F H OH H H NH 2 38-7 Ph VII- p-Cl- * H * "Bu H F H OH H H NH 2 38-8 Ph *R1 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table VII-39. M R' R 2 Ra R R' R' R 6 X Y R' R R 9 VII- p-Br- H H H "Bu H F H OH H H NH 2 39-1 Ph VII- p-Br- H H CH 3 "Bu H F H OH H H NH 2 39-2 Ph VII- p-Br- H H CH(CH 3
)
2 "Bu H F H OH H H NH 2 39-3 Ph VII- p-Br- H H CH 2
CH(CH
3
)
2 "Bu H F H OH H H NH 2 39-4 Ph VII- p-Br- H H CH 2 Ph "Bu H F H OH H H NH 2 39-5 Ph VII- p-Br- H H CH 2 -indol-3- "Bu H F H OH H H NH 2 39-6 Ph yl VII- p-Br- H H CH 2
CH
2
SCH
3 "Bu H F H OH H H NH4 2 39-7 Ph VII- p-Br- * H * Bu H F H OH H H NH 2 39-8 Ph *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table VII-40. X2 R R 2
R
3 a R 3 b R 4 R R 6 X Y R R 8
R
9 VII-40- p-I- H H H "Bu H F H OH H H NH 2 1 Ph VII-40- p-I- H H CH- "Bu H F H OH H H NH 2 Ph X2 R 2 R3a R3b R4 R'5 6 Xy R7 R8 R9 N! R RI Ra RE R Rd Ra XY R RS R9 2 VII-40- p-I- H H CH(CH 3
)
2 "Bu H F H OH H H NH 2 3 Ph VI-40- p-I- H H CH 2
CH(CH
3
)
2 "Bu H F H OH H H NH 2 4 Ph VII-40- p-I- H H CH 2 Ph "Bu H F H OH H H NI 2 5 ~Ph VII-40- p-I- H H CH 2 -indol-3- "Bu H F H OH H H NH 2 6 Ph YI VH-40- p-I- H H CH 2
CH
2
SCH
3 'Bu H F H OH H H NH 2 7 Ph VH-40- p-I- * H * "Bu H F H OH H H NH 2 8 Ph *R and R3b joined together by (CH2)3 to form five-membered ring. Table VII-41. N R' R2 R 3 a R 3 b R' R' R' X Y R'R R 9 VII-41-1 CH 3 H H H Bz H F H OH H H NH 2 VI-41-2 CH 3 H H CH 3 Bz H F H OH H H NH 2 VII-41-3 CH3 H H CH(CH 3
)
2 Bz H F H OH H H NH 2 VI-41-4 CH 3 H H CH 2
CH(CH
3
)
2 Bz H F H OH H H NH 2 VI-41-5 CH 3 H H CH 2 Ph Bz H F H OH H H NH 2 VH-41-6 CH 3 H H CH 2 -indol-3-yl Bz H F H OH H H NH 2 VII-41-7 CH 3 H H CH 2
CH
2
SCH
3 Bz H F H OH H H NH2 VII-41.-8 CH 3 * H * Bz H F H OH H H NH 2 *R and Rab joined together by (CH 2
)
3 to form five-membered ring.
Table VII-42. X2 R1 R 2
R
3 a R 3 b R' R' R' X Y R 7
R
8 RP VH-42-1 Et H H H Bz H F H OH H H NE2 VH-42-2 Et H H CH 3 Bz H F H OH H H NH 2 VH-42-3 Et H H CH(CH 3
)
2 Bz H F H OH H H NH 2 VH-42-4 Et H H CH 2
CH(CH
3
)
2 Bz H F H OH H H NH 2 VH-42-5 Et H H CH 2 Ph Bz H F H OH H H NH 2 VH-42-6 Et H H CH 2 -indol-3-yl Bz H F H OH H H NH 2 VH-42-7 Et H H CH 2
CH
2
SCH
3 Bz H F H OH H H NH 2 VH-42-8 Et * H * Bz H F H OH H H NH2 *R2 and R3b joined together by (CH2)3 to form five-membered ring. Table VII-43. X2 R' R2 R 3 a R 3 b R4 R' R 6 X Y R 7
R
8
R
9 VH-43-1 'Pr H H H Bz H F H OH H H NH 2 VH-43-2 'Pr H H CH 3 Bz H F H OH H H NH 2 VH1-43-3 'Pr H H CH(CH 3
)
2 Bz H F H OH H H NH 2 VH1-43-4 'Pr H H CH 2
CH(CH
3
)
2 Bz H F H OH H H NH2 V-43-5 'Pr H H CH 2 Ph Bz H F H OH H H NH2 VI-43-6 'Pr H H CH 2 -indol-3-yl Bz H F H OH H H Ni- 2 VH-43-7 'Pr H H CH 2
CH
2
SCH
3 Bz H F H OH H H NH 2 Vl-43-8 'Pr * H * Bz H F H OH H H NH2
*R
2 and R-" joined together by (CH 2
)
3 to form five-membered ring. 5 Table VII-44. X2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y R 7
R
8
R
9 VII-44-1 'Bu H H H Bz H F H OH H H NH 2 VH-44-2 'Bu H H CH 3 Bz H F H OH -H H NH 2 VH-44-3 'Bu H H CH(CH 3
)
2 Bz H F H OH H H NH 2 V'1-44-4 'Bu H H CH 2
CH(CH
3
)
2 Bz H F H OH H H NH 2 VII-44.-5 'Bu H H CH 2 Ph Bz H F H OH H H NH 2 V1-44-6 'Bu H H CH 2 -indol-3-yl Bz H F H OH H H NH 2 V'-44-7 'Bu H H CH 2
CH
2
SCH
3 Bz H F H OH H H NH 2 VH-44.8 'Bu * H * Bz H F H OH H H NH 2 *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table VII-45. 9 R' R 2 R 3 aRb R R' R 6 X Y R' R' R 9 VU-45-1 Ph H H H Bz H F H OH H H NH 2 V-45-2 Ph H H CH 3 Bz H F H OH H H NH2 VII-45-3 Ph H H CH(CH 3
)
2 Bz H F H OH H H NH 2 VI-45-4 Ph H H CH 2
CH(CH
3
)
2 Bz H F H OH H H NH 2 VI-45-5 Ph H H CH 2 Ph Bz H F H OH H H NH 2 VII-45-6 Ph H H CH 2 -indol-3-yl Bz H F H OH H H NH 2 VI-45-7 Ph H H CH 2
CH
2
SCH
3 Bz H F H OH H H NH2 VII-45-8 Ph * H * Bz H F H OH H H NH2 *R2 and R b joined together by (CH 2
)
3 to form five-membered ring. Table VII-46. X R' R 2 Ra Rb R 4 R R 6 XY R R 8
R
9 VII- p-Me- H H H Bz H F H OH H H NH2 46-1 Ph VII- p-Me- H H CH- 3 Bz H F H OH H H NH 2 46-2 Ph VII- p-Me- H H CH(CH 3
)
2 Bz H F H OH H H NH2 46-3 Ph VII- p-Me- H H CH 2
CH(CH
3
)
2 Bz H F H OH H H NH 2 46-4 Ph VUI- p-Me- H H CH 2 Ph Bz H F H OH H H NH- 2 46-5 Ph VII- p-Me- H H CH 2 -indol-3- Bz H F H OH H H NH 2 46-6 Ph Yl VU- p-Me- H H CH 2
CH
2
SCH
3 Bz H F H OH H H NH 2 46-7 Ph VH- p-Me- * H * Bz H F H OH H H NH 2 46-8 Ph
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table VII-47. S R R 2
R
3 " Rb R 4 R R XY R' R' R VII-47- p-F- H H H Bz H F H OH H H NH 2 Ph VII-47- p-F- H H CH 3 Bz H F H OH H H NH 2 Ph NeD R1 R2 R " RA R' R' R' X Y R7 R8 R9 2 VII-47- p-F- H H CH(CH 3
)
2 Bz H F H OH H H NH 2 3 Ph VII-47- p-F- H H CH 2
CH(CH
3
)
2 Bz H F H OH H H NH 2 4Ph VII-47- p-F- H H CH 2 Ph Bz H F H OH H H NH 2 5 Ph VII-47- p-F- H H CH 2 -indol-3- Bz H F H OH H H NH 2 6 Ph VII-47- p-F- H H CH 2
CH
2
SCH
3 Bz H F H OH H H NH 2 7 Ph VII-47- p-F- * H * Bz H F H OH H H NH 2 Ph R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table VII-48. N2 R' R 2
R
3 a R b R' R' R' X Y R' R' R 9 VII-48- p-Cl- H H H Bz H F H OH H H NH 2 Ph VII-48- p-Cl- H H CH 3 Bz H F H OH H H NH 2 2 Ph VII-48- p-Cl- H H CH(CH 3
)
2 Bz H F H OH H H NH 2 3 Ph VII-48- p-Cl- H H CH 2
CH(CH
3
)
2 Bz H F H OH H H NH 2 4 Ph VII-48- p-Cl- H H CH 2 Ph Bz H F H OH H H NH 2 5 Ph VII-48.- p-Cl- H H CH 2 -indol-3- Bz H F H OH H H NH 2 6 Ph yl VII-48- p-Cl- H H CH 2
CH
2
SCH
3 Bz H F H OH H H NH 2 7 Ph VII-48- p-Cl- * H * Bz H F H OH H H NH 2 8 Ph
*R
2 and R3b joined together by (CH 2
)
3 to form five-membered ring.
,),)C
Table VII-49. N2 R R 2
R
3 a R 3 b R' R' R' X Y R' R' R 9 V-49- p-Br- H H H Bz H F H OH H H NH 2 1 Ph VII-49- p-Br- H H CH 3 Bz H F H OH H H NH 2 2 Ph VII-49- p-Br- H H CH(CH 3
)
2 Bz H F H OH H H NH 2 3 Ph VH-49- p-Br- H H CH 2
CH(CH
3
)
2 Bz H F H OH H H NH- 2 4 Ph VII-49- p-Br- H H CH 2 Ph Bz H F H OH H H NH 2 Ph VII-49- p-Br- H H CH 2 -indol-3- Bz H F H OH H H NH 2 6 Ph Yl VH-49- p-Br- H H CH 2
CH
2
SCH
3 Bz H F H OH H H NH2 7 Ph VII-49- p-Br- * H * Bz H F H OH H H NH 2 8 Ph RT2and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table VII-50. N2 Rl R 2 R3a R 3 b R R R X Y R R' R 9 VII-50- p-I- H H H Bz H F H OH H H NH2 1 Ph VII-50- p-I- H H CH 3 Bz H F H OH H H NH 2 2 Ph VII-50- p-I- H H CH(CH 3
)
2 Bz H F H OH H H NH 2 3 Ph VII-50- p-I- H H CH 2
CH(CH
3
)
2 Bz H F H OH H H NH 2 4 Ph VII-50- p-I- H H CH 2 Ph Bz H F H OH H H NH 2 5 Ph VII-50- p-I- H H CH2-indol-3- Bz H F H OH H H NH 2 6 Ph yl VII-50- p-I- H H CH 2
CH
2
SCH
3 Bz H F H OH H H NH 2 7 Ph VII-50.- p-I- * H * Bz H F H OH H H NH 2 X2 Rl R R3a R 3 b R 4 R' R 6 X y R' R R' 8 Ph *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 0
R
8 NH 'R3b 2 R N N 0R 7 N 0 R3a, N-P- O C0 2
R
4 OR' R5 R6 Y X VIII Table VIII-l. NO R' R 2
R
3 a" R 3 b R 4
R
5
R
6 X Y R' R' VIII-1-1 CH 3 H H H CH 3 H CH 3 OH OH H H VII-1-2 CH 3 H H CH 3
CH
3 H CH 3 OH OH H H VII-1-3 CH 3 H H CH(CH 3
)
2
CH
3 H CH 3 OH OH H H VII-1-4 CH 3 H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 OH OH H H VIII-1-5 CH 3 H H CH 2 Ph CH 3 H CH 3 OH OH H H VII-1-6 CH 3 H H CH 2 -indol-3-yl CH 3 H CH 3 OH OH H H VIII-1--7 CH 3 H H CH 2
CH
2
SCH
3
CH
3 H CH 3 OH OH H H VIII-1-8 CH 3 * H * CH 3 H CH 3 OH OH H H 5 *RTand R 3 b joined together by (CH 2
)
3 to form five-membered ring. 11-7 Table VIII-2. N! RI R 2
R
3 a R 3 b R 4
R
5
R
6 X Y R' R" VIII-2-1 Et H H H CH 3 H CH 3 OH OH H H VHI-2-2 Et H H CH 3
CH
3 H CH 3 OH OH H H VIII-2-3 Et H H CH(CH 3
)
2
CH
3 H CH 3 OH OH H H VIU--2-4 Et H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 OH OH H H VII-.2-5 Et H H CH 2 Ph CH 3 H CH 3 OH OH H H VII-2-6 Et H H CH 2 -indol-3-yl CH 3 H CH 3 OH OH H H VHI-2-7 Et H H CH 2
CH
2
SCH
3
CH
3 H CH 3 OH OH H H VI1-2-8 Et * H * CH 3 H CH 3 OH OH H H *R2 and Rb joined together by (CH 2
)
3 to form five-membered ring. Table VIII-3. X R' R2 R 3 a R 3 b R 4 R' R 6 X Y R 7
R
8 VI1-3-1 'Pr H H H CH 3 H CH 3 OH OH H H VIII-3-2 'Pr H H CH 3
CH
3 H CH 3 OH OH H H VIH-3-3 'Pr H H CH(CH 3
)
2
CH
3 H CH 3 OH OH H H VII-3-4 'Pr H H CH 2
CH(CH
3 )2 CH 3 H CH 3 OH OH H H VIII-3-5 'Pr H H CH 2 Ph CH 3 H CH 3 OH OH H H V'I-3-6 'Pr H H CH 2 -indol-3-yl CH 3 H CH 3 OH OH H H VI'-3-7 'Pr H H CH 2
CH
2
SCH
3
CH
3 H CH 3 OH OH H H VI'-3-8 'Pr * H * CH 3 H CH 3 OH OH H H *R" and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table VIII-4. N R1 R2 R 3 a R 3 b R 4 R' R 6 X Y R' R' VIU-4-1 'Bu H H H CH 3 H CH 3 OH OH H H V'1-4-2 'Bu H H CH 3
CH
3 H CH 3 OH OH H H V'I-4-3 'Bu H H CH(CH 3
)
2
CH
3 H CH 3 OH OH H H VIII-4-4 'Bu H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 OH OH H H VIH-4-5 'Bu H H CH 2 Ph CH 3 H CH 3 OH OH H H VIII-4-6 'Bu H H CH 2 -indol-3-yi CH 3 H CH 3 OH OH H H VII-4-7 'Bu H H CH 2
CH
2
SCH
3
CH
3 H CH 3 OH OH H H VII-4-8 'Bu * H * CH 3 H CH 3 OH OH H H *R' and RIb joined together by (CH 2
)
3 to form five-membered ring.
Table VIII-5. Ne R' R 2
R
3
R
3 b R 4 R' R 6 X Y R' R 8 VIII-5-1 Ph H H H CH 3 H CH 3 OH OH H H VI-5-2 Ph H H CH 3
CH
3 H CH 3 OH OH H H VIII-5-3 Ph H H CH(CH 3
)
2
CH
3 H CH 3 OH OH H H VMI-5-4 Ph H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 OH OH H H VII-5-5 Ph H H CH 2 Ph CH 3 H CH 3 OH OH H H VHI-5-6 Ph H H CH 2 -indol-3-yl CH 3 H CH 3 OH OH H H VII-5-7 Ph H H CH 2
CH
2
SCH
3
CH
3 H CH 3 OH OH H H VI-5-8 Ph * H * CH 3 H CH 3 OH OH H H
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table VIII-6. Ne R R 2 R3a R 3 b R 4 R' R 6 X Y R 7 R' VII-6- p-Me- H H H CH 3 H CH 3 OH OH H H 1Ph VIH-6- p-Me- H H CH 3
CH
3 H CH 3 OH OH H H 2 Ph VIII-6- p-Me- H H CH(CH 3
)
2
CH
3 H CH 3 OH OH H H 3 Ph VIH-6- p-Me- H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 OH OH H H 4 Ph VIII-6- p-Me- H H CH 2 Ph CH 3 H CH 3 OH OH H H 5 Ph VHI-6- p-Me- H H CH 2 -indol-3- CH 3 H CH 3 OH OH H H 6 Ph yl VIII-6- p-Me- H H CH 2
CH
2
SCH
3
CH
3 H CH 3 OH OH H H 7 Ph VHI.-6- p-Me- * H * CH 3 H CH 3 OH OH H H 8 Ph *R'and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table VIII-7. Ne R' R 2 R3a R 3 b R4 R 5
R
6 X Y R 7 R7 VII-7-1 p-F-Ph H H H CH 3 H CH 3 OH OH H H VII-7-2 p-F-Ph H H CH 3
CH
3 H CH 3 OH OH H H Vm-7-3 p-F-Ph H H CH(CH 3
)
2
CH
3 H CH 3 OH OH H H N R1 R 2 Ra Rab R' R' R 6 X Y R 7 R VII-7-4 p-F-Ph H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 OH OH H H VH-7-6 p-F-Ph H H CH 2 Ph CH 3 H CH 3 OH OH H H VII-7-7 p-F-Ph H H CH 2 -indol-3-yl CH 3 H CH 3 OH OH H H VIII-7-8 p-F-Ph H H CH 2
CH
2
SCH
3
CH
3 H CH 3 OH OH H H VII-7-20 p-F-Ph * H * CH 3 H CH 3 OH OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table VIII-8. X2 R' R2 R 3 a R 3 b R' R' R 6 X Y R 7
R
8 VII-8-1 p-Cl-Ph H H H CH 3 H CH 3 OH OH H H VIII-8-2 p-Cl-Ph H H CH 3
CH
3 H CH 3 OH OH H H VI-8-3 p-Cl-Ph H H CH(CH 3
)
2
CH
3 H CH 3 OH OH H H VIL-8-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 OH OH H H V1H-8-5 p-Cl-Ph H H CH 2 Ph CH 3 H CH 3 OH OH H H VIII-8-6 p-Cl-Ph H H CH 2 -indol-3-yl CH 3 H CH 3 OH OH H H VIII-8-7 p-Cl-Ph H H CH 2
CH
2
SCH
3
CH
3 H CH 3 OH OH H H VHI-8-8 p-Cl-Ph * H * CH 3 H CH 3 OH OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table VIII-9. NR R 2 Ra Rab R 4 R' R X Y R' R VIU-9-1 p-Br- H H H CH 3 H CH 3 OH OH H H Ph VHI-9-2 p-Br- H H CH 3
CH
3 H CH 3 OH OH H H Ph VIH-9-3 p-Br- H H CH(CH 3
)
2
CH
3 H CH 3 OH OH H H Ph VIU-9-4 p-Br- H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 OH OH H H Ph VIII-9-6 p-Br- H H CH 2 Ph CH 3 H CH 3 OH OH H H Ph VHI-9-7 p-Br- H H CH 2 -indol-3- CH 3 H CH 3 OH OH H H Ph yl VHI-9-8 p-Br- H H CH 2
CH
2
SCH
3
CH
3 H CH 3 OH OH H H Ph VIH-9- p-Br- * H * CH 3 H CH 3 OH OH H H 20 Ph 5 *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table VIII-10. X2 R2 R 3 a Rb R 4
R
5
R
6 X Y R 7 R VIm-10-1 p-I-Ph H H H CH 3 H CH 3 OH OH H H VI1-10-2 p-I-Ph H H CH 3
CH
3 H CH 3 OH OH H H VIII-10-3 p-I-Ph H H CH(CH 3
)
2
CH
3 H CH 3 OH OH H H VUI-10-4 p-I-Ph H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 OH OH H H VIII-10-5 p-I-Ph H H CH 2 Ph CH 3 H CH 3 OH OH H H VIH-10-6 p-I-Ph H H CH 2 -indol-3-yl CH 3 H CH 3 OH OH H H VIH-10-7 p-I-Ph H H CH 2
CH
2
SCH
3
CH
3 H CH 3 OH OH H H VIII-10-8 p-I-Ph * H * CH 3 H CH 3 OH OH H H
*R
2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table VIII-11. N2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y R 7 R VIn-11-1 CH 3 H H H Et H CH 3 OH OH H H VIHI-11-2 CH 3 H H CH 3 Et H CH 3 OH OH H H VHI-11-3 CH 3 H H CH(CH 3
)
2 Et H CH 3 OH OH H H VHI-11-4 CH 3 H H CH 2
CH(CH
3
)
2 Et H CH 3 OH OH H H VHI-11-5 CH 3 H H CH 2 Ph Et H CH 3 OH OH H H VHI-11-6 CH 3 H H CH 2 -indol-3-yl Et H CH 3 OH OH H H VIH-11-7 CH 3 H H CH 2
CH
2 SCH3 Et H CH 3 OH OH H H VHI-11-8 CH 3 * H * Et H CH 3 OH OH H H *RY and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table VIII-12. N2 RI R2 R3a R 3 b R4 R 5
R
6 X Y R' R VIM-12-1 Et H H H Et H CH 3 OH OH H H VI-12-2 Et H H CH 3 Et H CH 3 OH OH H H VIII-12-3 Et H H CH(CH 3
)
2 Et H CH 3 OH OH H H VHI-12-4 Et H H CH 2
CH(CH
3
)
2 Et H CH 3 OH OH H H VIII-12-5 Et H H CH 2 Ph Et H CH 3 OH OH H H VHI-12-6 Et H H CH 2 -indol-3-yl Et H CH 3 OH OH H H VIII-12-7 Et H H CH 2
CH
2
SCH
3 Et H CH 3 OH OH H H VIII-12-8 Et * H * Et H CH 3 OH OH H H
*R
2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 11 Table VIII-13. X2 R R2 R3a R3b R 4 R' R' X Y R' R' VII-13-1 'Pr H H H Et H CH 3 OH OH H H VIII-13-2 'Pr H H CH 3 Et H CH 3 OH OH H H VII-13-3 'Pr H H CH(CH 3
)
2 Et H CH 3 OH OH H H VII-13-4 'Pr H H CH2CH(CH 3
)
2 Et H CH 3 OH OH H H VIH-13-5 'Pr H H CH 2 Ph Et H CH 3 OH OH H H VIII-13-6 'Pr H H CH 2 -indol-3-yi Et H CH 3 OH OH H H VII-13-7 'Pr H H CH 2
CH
2
SCH
3 Et H CH 3 OH OH H H VII-13-8 'Pr * H * Et H CH 3 OH OH H H
*R
2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table VIII-14. N2 R R Ra R 3 b R 4 R R( X Y R R 8 VHI-14-1 'Bu H H H Et H CH 3 OH OH H H VUI-14-2 'Bu H H CH 3 Et H CH 3 OH OH H H VIII-14-3 'Bu H H CH(CH 3
)
2 Et H CH 3 OH OH H H VHI-14-4 'Bu H H CH 2
CH(CH
3
)
2 Et H CH 3 OH OH H H VIII-14-5 'Bu H H CH 2 Ph Et H CH 3 OH OH H H V11.1-14-6 'Bu H H CH 2 -indol-3-yl Et H CH 3 OH OH H H VI-14-7 'Bu H H CH 2
CH
2
SCH
3 Et H CH 3 OH OH H H VIII-14-8 'Bu * H * Et H CH 3 OH OH H H *R and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table VIII-15. N2 R' R 2
R
3 a R 3 b R4 RT R 6 X Y R' R7 Vm-.15-1 Ph H H H Et H CH 3 OH OH H H VTH-15-2 Ph H H CH 3 Et H CH 3 OH OH H H VIH-15-3 Ph H H CH(CH 3 )2 Et H CH 3 OH OH H H VIII-15-4 Ph H H CH 2
CH(CH
3
)
2 Et H CH 3 OH OH H H VIII-15-5 Ph H H CH 2 Ph Et H CH 3 OH OH H H VIII-15-6 Ph H H CH 2 -indol-3-yl Et H CH 3 OH OH H H VM-15-7 Ph H H CH 2
CH
2
SCH
3 Et H CH 3 OH OH H H VITI-15-8 Ph * H * Et H CH 3 OH OH H H *RTaid R joined together by (CH 2
)
3 to form five-membered ring. -vvII Table VIII-16. N2 R R 2
R
3 a Rib R' R R 6 X Y R R VII-16- p-Me- H H H Et H CH 3 OH OH H H 1 Ph VII-16- p-Me- H H CH 3 Et H CH 3 OH OH H H 2 Ph VM-16- p-Me- H H CH(CH 3
)
2 Et H CH 3 OH OH H H 3 Ph VIII-16- p-Me- H H CH 2
CH(CH
3
)
2 Et H CH 3 OH OH H H 4Ph VIII-16- p-Me- H H CH 2 Ph Et H CH 3 OH OH H H 5 Ph VIII-16- p-Me- H H CH 2 -indol-3- Et H CH 3 OH OH H H 6 Ph YI VH1-16- p-Me- H H CH 2
CH
2
SCH
3 Et H CH 3 OH OH H H 7 Ph VII-16- p-Me- * H * Et H CH 3 OH OH H H 8 Ph
*R
2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table VIII-17. N2 R' R 2 Ria R3b R 4 R' R' X Y R' R 8 VHI-17-1 p-F-Ph H H H Et H CH 3 OH OH H H VM-17-2 p-F-Ph H H CH 3 Et H CH 3 OH OH H H VM-17-3 p-F-Ph H H CH(CH 3
)
2 Et H CH 3 OH OH H H VIII-17-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Et H CH 3 OH OH H H VM-17-5 p-F-Ph H H CH 2 Ph Et H CH 3 OH OH H H Vm-17-6 p-F-Ph H H CH 2 -indol-3-yl Et H CH 3 OH OH H H VM-17-7 p-F-Ph H H CH 2 CH2SCH 3 Et H CH 3 OH OH H H VM-17-8 p-F-Ph * H * Et H CH 3 OH OH H H *RT and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table VIII-18. NR R 2 R aR 3 b R 4 R X Y R'R 8 VM-18-1 p-Cl-Ph H H H Et H CH 3 OH OH H H Vm-18-2 p-Cl-Ph H H CH 3 Et H CH 3 OH OH H H VI-18-3 p-Cl-Ph H H CH(CH 3
)
2 Et H CH 3 OH OH H H N R R 2
R
3 a R 3 b R4 R 5
R
6 X Y R' R' VII-18-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Et H CH 3 OH OH H H VM-18-5 p-Cl-Ph H H CH 2 Ph Et H CH 3 OH OH H H VIH-18-6 p-Cl-Ph H H CH 2 -indol-3-yl Et H CH 3 OH OH H H VHI-18-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Et H CH 3 OH OH H H VII1-18-8 p-Cl-Ph * H * Et H CH 3 OH OH H H
*R
2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table VIII-19. N2 R R 2
R
3 a R 3 b R4 R 5
R
6 X Y R 7 R VUI-19-1 p-Br-Ph H H H Et H CH 3 OH OH H H VUI-19-2 p-Br-Ph H H CH 3 Et H CH 3 OH OH H H VIH-19-3 p-Br-Ph H H CH(CH 3
)
2 Et H CH 3 OH OH H H VIl-19-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Et H CH 3 OH OH H H VMI-19-5 p-Br-Ph H H CH 2 Ph Et H CH 3 OH OH H H VHI-19-6 p-Br-Ph H H CH 2 -indol-3-yl Et H CH 3 OH OH H H VUI-19-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Et H CH 3 OH OH H H VHI-19-8 p-Br-Ph * H * Et H CH 3 OH OH H H *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table VIII-20. N R R 2 Ra Rb R 4 R' R' X Y R' R VM-20-1 p-I-Ph H H H Et H CH 3 OH OH H H VHI.-20-2 p-I-Ph H H CH 3 Et H CH 3 OH OH H H VM-20-3 p-I-Ph H H CH(CH 3
)
2 Et H CH 3 OH OH H H Vm-20-4 p-I-Ph H H CH 2
CH(CH
3 )2 Et H CH 3 OH OH H H VM-20-5 p-I-Ph H H CH 2 Ph Et H CH 3 OH OH H H VHI-20-6 p-I-Ph H H CH 2 -indol-3-yi Et H CH 3 OH OH H H VM-20-7 p-I-Ph H H CH 2
CH
2
SCH
3 Et H CH 3 OH OH H H VIII-20-8 p-I-Ph * H * Et H CH 3 OH OH H H 5 *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table VIII-2 1. N R R 2
R
3 aR 3
R
4 R R 6 X Y R' R VII-21-1 CH 3 H H H 'Pr H CH 3 OH OH H H VIII-21-2 CH3 H H CH 3 'Pr H CH 3 OH OH H H VM-21-3 CH3 H H CH(CH 3
)
2 'Pr H CH3 OH OH H H VIII-21-4 CH 3 H H CH 2
CH(CH
3
)
2 'Pr H CH 3 OH OH H H X2 R' R 2 R3" R-b R 4 R' R 6 X Y R' R' VIII-21-5 CH 3 H H CH 2 Ph 'Pr H CH 3 OH OH H H VIII-21-6 CH 3 H H CIH 2 -indol-3-yl 'Pr H CH 3 OH OH H H VII-21-7 CH 3 H H CH4 2
CH
2
SCH
3 'Pr H CH 3 OH OH H H VIII-21-8 CH 3 * H * 'Pr H CH 3 OH OH H H *R ind R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table VIII-22. NR R 2 RaR 3
R
4 R' R X Y R' R' VIII-22-1 Et H H H 'Pr H CH 3 OH OH H H VII-22-2 Et H H CH 3 'Pr H CH 3 OH OH H H VIII-22-3 Et H H CH(CH 3
)
2 'Pr H CH 3 OH OH H H VIII-22-4 Et H H CH 2
CH(CH
3
)
2 'Pr H CH 3 OH OH H H VIII-22-5 Et H H CH 2 Ph 'Pr H CH 3 OH OH H H VIII-22-6 Et H H CH 2 -indol-3-yl 'Pr H CH 3 OH OH H H VIII-22-7 Et H H CH 2
CH
2
SCH
3 'Pr H CH 3 OH OH H H VIII-22-8 Et * H * 'Pr H CH 3 OH OH H H *R2and Rib joined together by (CH 2
)
3 to form five-membered ring. Table VIII-23. N2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y R 7
R
8 VIII-23-1 'Pr H H H 'Pr H CH 3 OH OH H H VII-23-2 'Pr H H CH 3 'Pr H CH 3 OH OH H H VIII-23-3 'Pr H H CH(CH 3
)
2 'Pr H CH 3 OH OH H H VII-23-4 'Pr H H CH 2
CH(CH
3
)
2 'Pr H CH 3 OH OH H H VIII-23-5 'Pr H H CH 2 Ph 'Pr H CH 3 OH OH H H VIII-23-6 'Pr H H CH 2 -indol-3-yl 'Pr H CH 3 OH OH H H VIII-23-7 'Pr H H CH 2
CH
2
SCH
3 'Pr H CH 3 OH OH H H VIII-23-8 'Pr * H * 'Pr H CH 3 OH OH H H 5 *R" and Rib joined together by (CH 2
)
3 to form five-membered ring. Table VIII-24. X2 R R2 R 3 a R 3 b R4 R 5
R
6 X Y R 7 R VIII-24-1 'Bu H H H 'Pr H CH 3 OH OH H H VIII-24-2 'Bu H H CH 3 'Pr H CH 3 OH OH H H VIII-24-3 'Bu H H CH(CH 3
)
2 Pr H CH 3 OH OH H H VIII-24-4 'Bu H H CH 2
CH(CH
3
)
2 Pr H CH 3 OH OH H H VIII-24-5 'Bu H H CH 2 Ph Pr H CH 3 OH OH H H - 11; N R' R2 R 3 a R 3 b R 4 R' R 6 X Y R' R' VIII--24-6 'Bu H H CH 2 -indol-3-yl 'Pr H CH 3 OH OH H H VIII-24-7 'Bu H H CH 2
CH
2
SCH
3 'Pr H CH 3 OH OH H H VIII..24-8 'Bu * H * 'Pr H CH 3 OH OH H H 7*R'and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table VIII-25. N2 RI R 2
R
3 " R 3 b R 4 R- R 6 X Y R' R' VIII-25-1 Ph H H H 'Pr H CH 3 OH OH H H Vm-25-2 Ph H H CH 3 'Pr H CH 3 OH OH H H VIII-25-3 Ph H H CH(CH 3
)
2 'Pr H CH 3 OH OH H H VIII--25-4 Ph H H CH 2
CH(CH
3
)
2 'Pr H CH 3 OH OH H H VM--25-5 Ph H H CH 2 Ph 'Pr H CH 3 OH OH H H VIII--25-6 Ph H H CH 2 -indol-3-yl 'Pr H CH 3 OH OH H H V'1-25-7 Ph H H CH 2
CH
2
SCH
3 'Pr H CH 3 OH OH H H VM-25-8 Ph * H * 'Pr H CH 3 OH OH H H *R" and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table VIII-26. 2 R R 2 Ra R 3 b R' R' R( X Y R' R' V'1-26- p-Me- H H H 'Pr H CH 3 OH OH H H 1 Ph VIII-.26- p-Me- H H CH 3 'Pr H CH 3 OH OH H H 2 Ph VHI-26- p-Me- H H CH(CH 3
)
2 'Pr H CH 3 OH OH H H 3 Ph V'1-26- p-Me- H H CH 2
CH(CH
3
)
2 'Pr H CH 3 OH OH H H 4 Ph VIII-26- p-Me- H H CH 2 Ph 'Pr H CH 3 OH OH H H 5 Ph V111-26- p-Me- H H CH 2 -indol-3- 'Pr H CH 3 OH OH H H 6 Ph YI VIII-26- p-Me- H H CH 2
CH
2
SCH
3 'Pr H CH 3 OH OH H H 7 Ph V'11-26- p-Me- * H * 'Pr H CH 3 OH OH H H 8 Ph 5 *R iand R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table VIII-27. SR R 2
R
3
R
3 b R 4 R R X Y R' R VMH-27-1 p-F-Ph H H H 'Pr H CH 3 OH OH H H VIH-27-2 p-F-Ph H H CH 3 'Pr H CH 3 OH OH H H VI-27-3 p-F-Ph H H CH(CH 3
)
2 'Pr H CH 3 OH OH H H VH-27-4 p-F-Ph H H CH 2
CH(CH
3
)
2 'Pr H CH 3 OH OH H H VIII-27-5 p-F-Ph H H CH 2 Ph 'Pr H CH 3 OH OH H H VIH-27-6 p-F-Ph H H CH 2 -indol-3-yl 'Pr H CH 3 OH OH H H VII-27-7 p-F-Ph H H CH 2
CH
2
SCH
3 'Pr H CH 3 OH OH H H VIII-27-8 p-F-Ph * H * 'Pr H CH 3 OH OH H H *R2Tand RJb joined together by (CH 2
)
3 to form five-membered ring. Table VIII-28. 2 R R 2
R
3 a Rb R 4 R R X Y R' R VIf-28-1 p-Cl-Ph H H H 'Pr H CH 3 OH OH H H VIH-28-2 p-Cl-Ph H H CH 3 'Pr H CH 3 OH OH H H VII-28-3 p-Cl-Ph H H CH(CH 3
)
2 'Pr H CH 3 OH OH H H VIH-28-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 'Pr H CH 3 OH OH H H VHI-28-5 p-Cl-Ph H H CH 2 Ph 'Pr H CH 3 OH OH H H VIII-28-6 p-Cl-Ph H H CH 2 -indol-3-yl 'Pr H CH 3 OH OH H H VHI-28-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 'Pr H CH 3 OH OH H H VIII-28-8 p-Cl-Ph * H * 'Pr H CH 3 OH OH H H *RTand R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table VIII-29.
SRR
2
R
3 aR Rb R 4 R R 6 X Y R R VIH-29-1 p-Br-Ph H H H 'Pr H CH 3 OH OH H H VI-29-2 p-Br-Ph H H CH 3 'Pr H CH 3 OH OH H H VIH-29-3 p-Br-Ph H H CH(CH 3
)
2 'Pr H CH 3 OH OH H H VHI-29-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 'Pr H CH 3 OH OH H H VIII-29-5 p-Br-Ph H H CH 2 Ph 'Pr H CH 3 OH OH H H VIH-29-6 p-Br-Ph H H CH 2 -indol-3-yl 'Pr H CH 3 OH OH H H V1J-29-7 p-Br-Ph H H CH 2
CH
2
SCH
3 'Pr H CH 3 OH OH H H VIi-29-8 p-Br-Ph * H * 'Pr H CH 3 OH OH H H *R and RJb joined together by (CH 2
)
3 to form five-membered ring.
Table VIII-30. X9 R R 2
R
3 a R 3 b R 4 R' R' X Y R R' VMIH-30-1 p-I-Ph H H H 'Pr H CH 3 OH OH H H V'I.-30-2 p-I-Ph H H CH 3 'Pr H CH 3 OH OH H H VIH-30-3 p-I-Ph H H CH(CH 3
)
2 'Pr H CH 3 OH OH H H VII-30-4 p-I-Ph H H CH 2
CH(CH
3
)
2 'Pr H CH 3 OH OH H H VIH-30-5 p-I-Ph H H CH 2 Ph 'Pr H CH 3 OH OH H H VIH-30-6 p-I-Ph H H CH 2 -indol-3-yl 'Pr H CH 3 OH OH H H VIII-30-7 p-I-Ph H H CH 2
CH
2
SCH
3 'Pr H CH 3 OH OH H H VHI-30-8 p-I-Ph * H * 'Pr H CH 3 OH OH H H *R2 amd R3b joined together by (CH 2
)
3 to form five-membered ring. Table VIII-3 1. N2 R R2 R 3 a R 3 b R 4
R
5
R
6 X Y R' R' VI'-31-1 CH 3 H H H "Bu H CH 3 OH OH H H VII-31-2 CH 3 H H CH 3 "Bu H CH 3 OH OH H H VI'-31-3 CH 3 H H CH(CH 3
)
2 "Bu H CH 3 OH OH H H V'I-31-4 CH 3 H H CH 2
CH(CH
3
)
2 "Bu H CH 3 OH OH H H VIII-31-5 CH 3 H H CH 2 Ph "Bu H CH 3 OH OH H H VIII-31-6 CH 3 H H CH 2 -indol-3-yl "Bu H CH 3 OH OH H H VIH-31-7 CH 3 H H CH 2
CH
2
SCH
3 "Bu H CH 3 OH OH H H VIH-31-8 CH 3 * H * "Bu H CH 3 OH OH H H
*R
2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table VIII-32. N RI R R 3 aR 3 b R 4 R 5
R
6 X Y R' R' VHI-32-1 Et H H H "Bu H CH 3 OH OH H H VIH-32-2 Et H H CH 3 "Bu H CH 3 OH OH H H VIII-32-3 Et H H CH(CH 3
)
2 "Bu H CH 3 OH OH H H VI1-32-4 Et H H CH 2
CH(CH
3
)
2 "Bu H CH 3 OH OH H H VI-32-5 Et H H CH 2 Ph "Bu H CH 3 OH OH H H VIII-32-6 Et H H CH 2 -indol-3-yl "Bu H CH 3 OH OH H H1 V'I-32-7 Et H H CH 2
CH
2
SCH
3 "Bu H CH 3 OH OH H H V'I-32-8 Et * H * "Bu H CH 3 OH OH H H *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. -vI Table VIII-33. N R R 2
R
3 a R 3 . R 4 R' R' X Y R' R VII-33-1 'Pr H H H "Bu H CH 3 OH OH H H VIH-.33-2 'Pr H H CH 3 "Bu H CH 3 OH OH H H VIII--33-3 'Pr H H CH(CH 3
)
2 "Bu H CH 3 OH OH H H VIII-33-4 'Pr H H CH 2
CH(CH
3
)
2 "Bu H CH 3 OH OH H H VI-33-5 'Pr H H CHPh "Bu H CH 3 OH OH H H VIII-33-6 'Pr H H CH 2 -indol-3-yl "Bu H CH 3 OH OH H H VII-33-7 'Pr H H CHCH 2
SCH
3 "Bu H CH 3 OH OH H H VI1-33-8 'Pr * H * "Bu H CH 3 OH OH H H *R'and Rib joined together by (CH 2
)
3 to form five-membered ring. Table VIII-34. N2 R' R2 R 3 a R 3 b R 4
R
5
R
6 X Y R' R' VI1-34-1 'Bu H H H "Bu H CH 3 OH OH H H VI-34-2 'Bu H H CH 3 "Bu H CH 3 OH OH H H VIf-34-3 'Bu H H CH(CH 3
)
2 "Bu H CH 3 OH OH H H VIH-34-4 'Bu H H CH 2
CH(CH
3
)
2 "Bu H CH 3 OH OH H H VIH-34-5 'Bu H H CH 2 Ph "Bu H CH 3 OH OH H H VH-34-6 'Bu H H CH 2 -indol-3-yl "Bu H CH 3 OH OH H H VI1-34-7 'Bu H H CH 2
CH
2
SCH
3 "Bu H CH 3 OH OH H H VIII-34-8 'Bu * H * "Bu H CH 3 OH OH H H *R and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table VIII-35. X2 R' R2 R3a R 3 b R' R' R 6 X Y R R 8 VIII-35-1 Ph H H H "Bu H CH 3 OH OH H H VIII-35-2 Ph H H CH 3 "Bu H CH 3 OH OH H H VI-35-3 Ph H H CH(CH 3
)
2 "Bu H CH 3 OH OH H H VHI-35-4 Ph H H CH 2
CH(CH
3
)
2 "Bu H CH 3 OH OH H H VI-35-5 Ph H H CH 2 Ph "Bu H CH 3 OH OH H H VI-35-6 Ph H H CH 2 -indol-3-yl "Bu H CH 3 OH OH H H VI-35-7 Ph H H CH 2
CH
2
SCH
3 "Bu H CH 3 OH OH H H VIII-35-8 Ph * H * "Bu H CH 3 OH OH H H *R and Rib joined together by (CH 2
)
3 to form five-membered ring.
Table VIII-36. N2 R' R 2
R
3 a R 3 b R 4 R' R' X Y R' R' VIII-36- p-Me- H H H "Bu H CH 3 OH OH H H 1 Ph VI-36- p-Me- H H CH 3 "Bu H CH 3 OH OH H H 2 Ph VI-36- p-Me- H H CH(CH 3
)
2 "Bu H CH 3 OH OH H H 3 Ph VHI-36- p-Me- H H CH 2
CH(CH
3
)
2 "Bu H CH 3 OH OH H H 4Ph VI-36- p-Me- H H CH 2 Ph "Bu H CH 3 OH OH H H 5 Ph VIII-36- p-Me- H H CH 2 -indol-3- "Bu H CH 3 OH OH H H 6 Ph YI VIII-36- p-Me- H H CH 2
CH
2
SCH
3 "Bu H CH 3 OH OH H H 7 Ph VIII-36- p-Me- * H * "Bu H CH 3 OH OH H H 8 Ph *R2and R3b joined together by (CH 2
)
3 to form five-membered ring. Table VIII-37. SR R 2 RaRb R R' R 6 X Y R' R VIII-37-1 p-F-Ph H H H "Bu H CH 3 OH OH H H VHI-37-2 p-F-Ph H H CH 3 "Bu H CH 3 OH OH H H VII-37-3 p-F-Ph H H CH(CH 3
)
2 "Bu H CH 3 OH OH H H VII-37-4 p-F-Ph H H CH 2
CH(CH
3
)
2 "Bu H CH 3 OH OH H H VII-37-5 p-F-Ph H H CH 2 Ph "Bu H CH 3 OH OH H H VII-37-6 p-F-Ph H H CH 2 -indol-3-yl "Bu H CH 3 OH OH H H VII-37-7 p-F-Ph H H CH 2
CH
2
SCH
3 "Bu H CH 3 OH OH H H VII-37-8 p-F-Ph * H * "Bu H CH 3 OH OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table VIII-38. NV R' R 2
R
3 aa R 3 b R 4 R' R 6 X Y R' R VII-38- p-Cl- H H H "Bu H CH 3 OH OH H H I Ph VHI-38- p-Cl- H H CH 3 "Bu H CH 3 OH OH H H Ph X2 R' R 2
R
3 a R 3 b R4 R 5
R
6 X Y R' R' 2 VII-38- p-Cl- H H CH(CH 3
)
2 "Bu H CH 3 OH OH H H 3 Ph VIII-38- p-Cl- H H CH 2
CH(CH
3
)
2 "Bu H CH 3 OH OH H H 4 Ph V111-38- p-Cl- H H CH 2 Ph "Bu H CH 3 OH OH H H 5 Ph V111-38- p-Cl- H H CH 2 -indol-3- "Bu H CH 3 OH OH H H 6 Ph Yl VIII-38- p-Cl- H H CH 2
CH
2
SCH
3 "Bu H CH 3 OH OH H H 7 Ph VIII-38- p-Cl- * H * "Bu H CH 3 OH OH H H 8 Ph *Rand R b joined together by (CH 2
)
3 to form five-membered ring. Table VIII-39.
R
2
R
3 a R 3 b R' R'R 6 X Y R R VIII-39- p-Br- H H H "Bu H CH 3 OH OH H H 1 Ph V111-39- p-Br- H H CH 3 "Bu H CH 3 OH OH H H 2 Ph VIII-39- p-Br- H H CH(CH 3
)
2 "Bu H CH 3 OH OH H H 3 Ph VIII-39- p-Br- H H CH 2
CH(CH
3
)
2 "Bu H CH 3 OH OH H H 4 Ph VIII-39- p-Br- H H CH 2 Ph "Bu H CH 3 OH OH H H 5 Ph VII-39- p-Br- H H CH 2 -indol-3- "Bu H CH 3 OH OH H H 6 Ph VI VIII-39- p-Br- H H CH 2
CH
2
SCH
3 "Bu H CH 3 OH OH H H 7 Ph VIII-39- p-Br- * H * "Bu H CH 3 OH OH H H 8 Ph *RT and Rib joined together by (CH 2
)
3 to form five-membered ring. ')A 1 Table VIII-40. N2 R R2 R 3 a R 3 b R' R 3
R
6 X Y R R8 VI-40-1 p-I-Ph H H H "Bu H CH 3 OH OH H H VIII-40-2 p-I-Ph H H CH 3 "Bu H CH 3 OH OH H H VII-40-3 p-I-Ph H H CH(CH 3
)
2 "Bu H CH 3 OH OH H H VII-40-4 p-I-Ph H H CH 2
CH(CH
3
)
2 "Bu H CH 3 OH OH H H VIII--40-5 p-I-Ph H H CH 2 Ph "Bu H CH 3 OH OH H H VIII-40-6 p-I-Ph H H CH 2 -indol-3-yl "Bu H CH 3 OH OH H H VIII--40-7 p-I-Ph H H CH 2
CH
2
SCH
3 "Bu H CH 3 OH OH H H VIII-40-8 p-I-Ph * H * "Bu H CH 3 OH OH H H *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table VIII-41. N2 R' R2 R3a R 3 b R4 R' R 6 X Y R R VII-41-1 CH 3 H H H Bz H CH 3 OH OH H H VIII-41-2 CH 3 H H CH 3 Bz H CH 3 OH OH H H VIII-41-3 CH 3 H H CH(CH 3
)
2 Bz H CH 3 OH OH H H VII-41-4 CH 3 H H CH 2
CH(CH
3
)
2 Bz H CH 3 OH OH H H VI-41-5 CH 3 H H CH 2 Ph Bz H CH 3 OH OH H H VIII-41-6 CH 3 H H CH 2 -indol-3-yl Bz H CH 3 OH OH H H VII-41-7 CH 3 H H CH 2
CH
2
SCH
3 Bz H CH 3 OH OH H H VIII-41-8 CH 3 * H * Bz H CH 3 OH OH H H *R' and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table VIII-42. X2R' R12 R3a R3b R 4
R
5 R 6 X Y R' R'_ VII-42-1 Et H H H Bz H CH 3 OH OH H H VIII-42-2 Et H H CH 3 Bz H CH 3 OH OH H H VIII-42-3 Et H H CH(CH 3
)
2 Bz H CH 3 OH OH H H VIII-42-4 Et H H CH 2
CH(CH
3
)
2 Bz H CH 3 OH OH H H VIII-42-5 Et H H CH 2 Ph Bz H CH 3 OH OH H H VI-42-6 Et H H CH 2 -indol-3-yl Bz H CH 3 OH OH H H VIII-42-7 Et H H CH 2
CH
2
SCH
3 Bz H CH 3 OH OH H H VII-42-8 Et * H * Bz H CH 3 OH OH H H *R and R3b joined together by (CH 2
)
3 to form five-membered ring.
A)
Table VIII-43. X2 RI R 2
R
3 a RAb R4 R' R' X Y R7 R 8 VIII-43-1 'Pr H H H Bz H CH 3 OH OH H H VIH-43-2 'Pr H H CH 3 Bz H CH 3 OH OH H H VIII-43-3 Pr H H CH(CH 3
)
2 Bz H CH 3 OH OH H H VIII--43-4 'Pr H H CH 2
CH(CH
3
)
2 Bz H CH 3 OH OH H H VUI.-43-5 'Pr H H CH 2 Ph Bz H CH 3 OH OH H H V'I--43-6 'Pr H H CH-indol-3-yl Bz H CH 3 OH OH H H V111-43-7 'Pr H H CH 2
CH
2
SCH
3 Bz H CH 3 OH OH H H VIII-43-8 'Pr * H * Bz H CH 3 OH OH H H *R2ind R3b joined together by (CH 2
)
3 to form five-membered ring. Table VIII-44. N R R R 3
R
3
R
4
R
5 R X Y R' R' VI-44-1 'Bu H H H Bz H CH 3 OH OH H H VII-44-2 'Bu H H CH 3 Bz H CH 3 OH OH H H VIII-44-3 'Bu H H CH(CH 3
)
2 Bz H CH 3 OH OH H H VIII-44-4 'Bu H H CH 2
CH(CH
3
)
2 Bz H CH 3 OH OH H H VIII-44-5 'Bu H H CHPh Bz H CH 3 OH OH H H VIII-44-6 'Bu H H CHr-indol-3-yl Bz H CH 3 OH OH H H VIU-44-7 'Bu H H CH 2
CH
2
SCH
3 Bz H CH 3 OH OH H H VIII-44-8 'Bu * H * Bz H CH 3 OH OH H H
*R
2 and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table VIII-45. N2 R' R 2
R
3
R
3 b R R' R 6 X Y R' R' VII-45-1 Ph H H H Bz H CH 3 OH OH H H VII-45-2 Ph H H CH 3 Bz H CH 3 OH OH H H VUI-45-3 Ph H H CH(CH 3
)
2 Bz H CH 3 OH OH H H VIII-45-4 Ph H H CH 2
CH(CH
3
)
2 Bz H CH 3 OH OH H H VIII-45-5 Ph H H CH 2 Ph Bz H CH 3 OH OH H H V11-45-6 Ph H H CH 2 -indol-3-yl Bz H CH 3 OH OH H H VI1-45-7 Ph H H CH 2
CH
2
SCH
3 Bz H CH 3 OH OH H H VI-45-8 Ph * H * Bz H CH 3 OH OH H H *RT and Rib joined together by (CH 2
)
3 to form five-membered ring.
Table VIII-46. N2 R' R 2
R
3 a Rb R' R R 6 X Y R' 7 R VIH-46- p-Me- H H H Bz H CH 3 OH OH H H 1 Ph V'I-46- p-Me- H H CH 3 Bz H CH 3 OH OH H H 2 Ph VI1-46- p-Me- H H CH(CH 3
)
2 Bz H CH 3 OH OH H H 3 Ph VII-46- p-Me- H H CH 2
CH(CH
3
)
2 Bz H CH 3 OH OH H H 4 Ph VIII-46- p-Me- H H CH 2 Ph Bz H CH 3 OH OH H H 5 Ph V'I-46- p-Me- H H CH 2 -indol-3- Bz H CH 3 OH OH H H 6 Ph Yl VIII-46- p-Me- H H CH 2
CH
2
SCH
3 Bz H CH 3 OH OH H H 7 Ph VII-46- p-Me- * H * Bz H CH 3 OH OH H H 8 Ph
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table VIII-47. N R R 2
R
3 a R 3 b R R' R6 X Y R_' R VIII-47-1 p-F-Ph H H H Bz H CH 3 OH OH H H VIII-47-2 p-F-Ph H H CH 3 Bz H CH 3 OH OH H H VIII-47-3 p-F-Ph H H CH(CH 3
)
2 Bz H CH 3 OH OH H H VI1-47-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Bz H CH 3 OH OH H H VIH-47-5 p-F-Ph H H CH 2 Ph Bz H CH 3 OH OH H H VIII-47-6 p-F-Ph H H CH 2 -indol-3-yl Bz H CH 3 OH OH H H VIII-47-7 p-F-Ph H H CH 2
CH
2
SCH
3 Bz H CH 3 OH OH H H VIII-47-8 p-F-Ph * H * Bz H CH 3 OH OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table VIII-48. N R! R 2 RaR 3 b R 4
R
5
R
6 X Y R 7
R
8 VUI-48-1 p-Cl-Ph H H H Bz H CH 3 OH OH H H V'I-48-2 p-Cl-Ph H H CH 3 Bz H CH 3 OH OH H H VIII-48-3 -p-Cl-Ph H H CH(CH 3
)
2 Bz H CH 3 OH OH H H
')AA
X2 Rl R 2
R
3
R
3 b R4 R 5
R
6 X Y R R VIII-48-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Bz H CH 3 OH OH H H VIII-48-5 p-Cl-Ph H H CH 2 Ph Bz H CH 3 OH OH H H VIH-48-6 p-Cl-Ph H H CH 2 -indol-3-yl Bz H CH 3 OH OH H H VIH-48-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Bz H CH 3 OH OH H H VI-48-8 p-Cl-Ph * H * Bz H CH 3 OH OH H H *R" nd R3b joined together by (CH 2
)
3 to form five-membered ring. Table VIII-49. N2 R' R 2 Ra R R 4 R'R X Y R' R VIII-49-1 p-Br-Ph H H H Bz H CH 3 OH OH H H VII-49-2 p-Br-Ph H H CH 3 Bz H CH 3 OH OH H H VIII-49-3 p-Br-Ph H H CH(CH 3 )2 Bz H CH 3 OH OH H H VIII-49-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Bz H CH 3 OH OH H H VIII-49-5 p-Br-Ph H H CH 2 Ph Bz H CH 3 OH OH H H VIII-49-6 p-Br-Ph H H CH 2 -indol-3-yl Bz H CH 3 OH OH H H VII-49-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Bz H CH 3 OH OH H H VIII-49-8 p-Br-Ph * H * Bz H CH 3 OH OH H H *R and R joined together by (CH 2
)
3 to form five-membered ring. Table VIII-50. N2 R R2 Ra Rb R 4 R' R' X Y R' R V11-50-1 p-I-Ph H H l Bz H CH 3 OH OH H H VIII-50-2 p-I-Ph H H CH 3 Bz H CH 3 OH OH H H VIII-50-3 p-I-Ph H H CH(CH 3
)
2 Bz H CH 3 OH OH H H VIII-50-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Bz H CH 3 OH OH H H VIII-50-5 p-I-Ph H H CH 2 Ph Bz H CH 3 OH OH H H VIH-50-6 p-I-Ph H H CH 2 -indol-3-yl Bz H CH 3 OH OH H H VIII-50-7 p-I-Ph H H CH 2
CH
2
SCH
3 Bz H CH 3 OH OH H H VIII-50-8 p-I-Ph * H * Bz H CH 3 OH OH H H 5 *R and R3b joined together by (CH 2
)
3 to form five-membered ring. ')A C 0
R
8 NH
R
2 0 R3b 7 0P R 7 N 0 R3a N - - -- 0 C0 2
R
4 OR R5 R6 Y X IX Table IX-1. Ne R' R 2 R" R 3 b R 4
R
5 R X Y R' R 8 IX-1-1 CH 3 H H H CH3 H CH 3 F OH H H IX-1-2 CH 3 H H CH 3
CH
3 H CH 3 F OH H H IX-1-3 CH 3 H H CH(CH 3
)
2
CH
3 H CH 3 F OH H H IX-1-4 CH3 H H CH 2
CH(CH
3
)
2 CH3 H CH 3 F OH H H IX-1-5 CH3 H H CH 2 Ph CH 3 H CH 3 F OH H H IX-1-6 CH3 H H CH 2 -indol-3-yl CH 3 H CH3 F OH H H IX-1-7 CH3 H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH H H IX-1-8 CH3 * H * CH 3 H CH 3 F OH H H
*R
2 and RIb joined together by (CH 2
)
3 to form five-membered ring. 5 Table IX-2. Xe RI R 2 Ra R 3 b R 4 R' R 6 X Y R'R 8 IX-2-1 Et H H -H CH 3 H CH 3 F OH H H IX-2-2 Et H H CH 3 CH3 H CH3 F OH H H IX-2-3 Et H H CH(CH 3
)
2 CH3 H CH3 F OH H H IX-2-4 Et H H CH 2
CH(CH
3
)
2
CH
3 H CH3 F OH H H IX-2-5 Et H H CH 2 Ph CH3 H CH 3 F OH H H IX-2-6 Et H H CH 2 -indol-3-yl CH3 H CH3 F OH H H IX-2-7 Et H H CH 2
CH
2
SCH
3 CH3 H CH3 F OH H H IX-2-8 Et * H * CH3 H CH3 F OH H H *R and Rab joined together by (CH 2
)
3 to form five-membered ring.
Table IX-3. 2 R' R 2
R
3 a RSb R 4
R
5
R
6 X Y R R IX-3-1 'Pr H H H CH 3 H CH 3 F OH H H IX-3-2 'Pr H H CH 3
CH
3 H CH 3 F OH H H IX-3-3 'Pr H H CH(CH 3
)
2
CH
3 H CH 3 F OH H H IX-3-4 'Pr H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH H H IX-3-5 'Pr H H CH 2 Ph CH 3 H CH 3 F OH H H IX-3-6 'Pr H H CH 2 -indol-3-yl CH 3 H CH 3 F OH H H IX-3--7 'Pr H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH H H IX-3-8 'Pr * H * CH 3 H CH 3 F OH H H *R2and R3b joined together by (CH 2
)
3 to form five-membered ring. Table IX-4. X2 R' R 2 R3a R 3 b R 4
R
5
R
6 X Y R' R 8 LX-4-1 'Bu H H H CH 3 H CH 3 F OH H H IX-4-2 'Bu H H CH 3
CH
3 H CH 3 F OH H H IX-4-3 'Bu H H CH(CH 3
)
2
CH
3 H CR 3 F OH H H IX-4-4 'Bu H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH H H IX-4-5 'Bu H H CH 2 Ph CH 3 H CH 3 F OH H H IX-4-6 'Bu H H CH 2 -indol-3-yl CH 3 H CH 3 F OH H H IX-4-7 'Bu H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH H H IX-4-8 'Bu * H * CH 3 H CH 3 F OH1 H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table IX-5. N2 R' R 2
R
3 a R 3 b R 4
R
5
R
6 X Y R' R' IX-5-1 Ph H H ~ H CH3 H CH 3 F OH H H IX-5-2 Ph H H CH 3
CH
3 H CH 3 F OH H H IX-5-3 Ph H H CH(CH 3
)
2
CH
3 H CH 3 F OH H H IX-5-4 Ph H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH H H IX-5-5 Ph H H CH 2 Ph CH 3 H CH 3 F OH H H IX-5-6 Ph H H CH 2 -indol-3-yl CH 3 H CH 3 F OH H H IX-5-7 Ph H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH H H IX-5-8 Ph * H * CH 3 H CH 3 F OH H H *R and R.ib joined together by (CH 2
)
3 to form five-membered ring. ')A'7 Table IX-6. N2 R1 R 2
R
3 a R 3 b R 4
R
5
R
6 X Y R' R 8 IX-6-1 p-Me-Ph H H H CH 3 H CH 3 F OH H H IX-6-2 p-Me-Ph H H CH 3
CH
3 H CH 3 F OH H H IX-6-3 p-Me-Ph H H CH(CH 3
)
2
CH
3 H CH 3 F OH H H IX-6-4 p-Me-Ph H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH H H IX-6-5 p-Me-Ph H H CH 2 Ph CH 3 H CH 3 F OH H H IX-6-6 p-Me-Ph H H CH 2 -indol-3-yl CH 3 H CH 3 F OH H H IX-6-7 p-Me-Ph H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH H H IX-6-8 p-Me-Ph * H * CH 3 H CH 3 F OH H H *R' and RIb joined together by (CH 2
)
3 to form five-membered ring. Table IX-7. N2 R' R R 3 aR 3 b R 4 R R X Y R' R IX-7-1 p-F-Ph H H H CH 3 H CH 3 F OH H H IX-7-2 p-F-Ph H H CH 3
CH
3 H CH 3 F OH H H IX-7-3 p-F-Ph H H CH(CH 3
)
2
CH
3 H CH 3 F OH H H IX-7-4 p-F-Ph H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH H H IX-7-6 p-F-Ph H H CH2Ph CH 3 H CH 3 F OH H H IX-7-7 p-F-Ph H H CH 2 -indol-3-yl CH 3 H CH 3 F OH H H IX-7-8 p-F-Ph H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH H H IX-7-20 p-F-Ph * H * CH 3 H CH 3 F OH H H *R and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table IX-8. R' R 2
R
3 " R 31
R
4
R
5 R' X Y R 7 R' IX-8-1 p-Cl-Ph H H H CH 3 H CH 3 F OH H H IX-8-2 p-Cl-Ph H H CH 3
CH
3 H CH 3 F OH H H IX-8-3 p-Cl-Ph H H CH(CH 3
)
2
CH
3 H CH 3 F OH H H IX-8-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH H H IX-8-5 p-Cl-Ph H H CH 2 Ph CH 3 H CH 3 F OH H H IX-8-6 p-Cl-Ph H H CH-indol-3-yl CH 3 H CH 3 F OH H H IX-8-7 p-Cl-Ph H H CH2CH 2
SCH
3
CH
3 H CH 3 F OH H H IX-8-8 p-Cl-Ph * H * CH 3 H CH 3 F OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. ')A 0 Table IX-9. N2 R1 R 2
R
3 a R 3 b R 4
R
5
R
6 X Y R'R 8 IX-9-1 p-Br-Ph H H H CH 3 H CH 3 F OH H H IX-9-2 p-Br-Ph H H CH 3
CH
3 H CH 3 F OH H H IX-9-3 p-Br-Ph H H CH(CH 3
)
2
CH
3 H CH 3 F OH H H IX-9-4 p-Br-Ph H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH H H IX-9-6 p-Br-Ph H H CH 2 Ph CH 3 H CH 3 F OH H H IX-9-7 p-Br-Ph H H CH- 2 -indol-3-yl CH 3 H CH 3 F OH H H IX-9-8 p-Br-Ph H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH14 H H IX-9-20 p-Br-Ph * H * CH 3 H CH 3 F OH H H *R2and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table IX-10. S R R 2 Ra Rab R 4 R' R 6 X Y R 7
R
8 IX-10-1 p-I-Ph H H H CH 3 H CH 3 F OH H H IX-10-2 p-I-Ph H H CH 3
CH
3 H CH 3 F OH H H IX-10-3 p-I-Ph H H CH(CH 3
)
2
CH
3 H CH 3 F OH H H IX-10-4 p-I-Ph H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH H H IX-10--5 p-I-Ph H H CH 2 Ph CH 3 H CH 3 F OH H H IX-10-6 p-I-Ph H H CH 2 -indol-3-yl CH 3 H CH 3 F OH H H IX-10-7 p-I-Ph H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH H H IX-10-8 p-I-Ph * H * CH 3 H CH 3 F OH H H * R and R3" joined together by (CH 2
)
3 to form five-membered ring. 5 Table IX-11. N2 R' R 2 R3a R 3 b R 4 R' R 6 X Y R R 8 IX-11-1 CH 3 H H H Et H CH 3 F OH H H IX-11-2 CH 3 H H CH 3 Et H CH 3 F OH H H IX-11-3 CH 3 H H CH(CH 3
)
2 Et H CH 3 F OH H H IX-11-4 CH 3 H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH H H IX-11-5 CH 3 H H CH 2 Ph Et H CH 3 F OH H H IX-11-6 CH 3 H H CH2-indol-3-yl Et H CH 3 F OH H H IX-11-7 CH 3 H H CH 2
CH
2
SCH
3 Et H CH 3 F OH H H IX-11-8 CH 3 * H * Et H CH 3 F OH H H R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. - AG Table IX-12. N R R R 3 " Rb R' R' R 6 X Y R 7
R
8 IX-12-1 Et H H H Et H CH 3 F OH H H IX-12-2 Et H H CH 3 Et H CH 3 F OH H H IX-12-3 Et H H CH(CH 3
)
2 Et H CH 3 F OH H H IX-12-4 Et H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH H H IX-12-5 Et H H CH 2 Ph Et H CH 3 F OH H H IX-12-6 Et H H CH 2 -indol-3-yl Et H CH 3 F OH H H IX-12-7 Et H H CH 2
CH
2
SCH
3 Et H CH 3 F OH H H IX-12-8 Et * H * Et H CH 3 F OH H H *Yand Rib joined together by (CH 2
)
3 to form five-membered ring. Table IX-13. N2 R' R 2 Raa R 3 b R4 R 5
R
6 X Y R 7
R
8 IX-13-1 'Pr H H H Et H CH 3 F OH H H IX-13-2 'Pr H H CH 3 Et H CH 3 F OH H H LX-13-3 'Pr H H CH(CH 3
)
2 Et H CH 3 F OH H H IX-13-4 'Pr H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH H H LX-13-5 'Pr H H CH 2 Ph Et H CH 3 F OH H H LX-13-6 'Pr H H CH 2 -indol-3-yl Et H CH 3 F OH H H IX-13-7 'Pr H H CH 2
CH
2
SCH
3 Et H CH 3 F OH H H IX-13-8 'Pr * H * Et H CH 3 F OH H H
*R
2 and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table IX-14. N2 R 1 R2 R 3 a R 3 b R 4 R R 6 X Y R' R8 IX-14-1 'Bu H H H Et H CH 3 F OH H H IX-14-2 'Bu H H CH 3 Et H CH 3 F OH H H IX-14-3 'Bu H H CH(CH 3
)
2 Et H CH 3 F OH H H IX-14-4 'Bu H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH H H IX-14-5 'Bu H H CH 2 Ph Et H CH 3 F OH H H IX-14-6 'Bu H H CH 2 -indol-3-yl Et H CH 3 F OH H H IX-14-7 'Bu H H CH2CH 2
SCH
3 Et H CH 3 F OH H H IX-14-8 'Bu * H * Et H CH 3 F OH H H *RTand R 3 " joined together by (CH 2
)
3 to form five-membered ring.
Table IX-15. X2 R' R 2
R
3 a R 3 b R 4
R
5 R' X Y R' R IX-1.5-1 Ph H H H Et H CH 3 F OH H H [X-I 5-2 Ph H H Cl- 3 Et H CH 3 F OH H H IX-15-3 Ph H H CH(CH 3
)
2 Et H CH 3 F OH H H IX-15-4 Ph H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH H H IX-15-5 Ph H H CH 2 Ph Et H CH 3 F OH H H IX-15-6 Ph H H CH 2 -indol-3-yl Et H CH 3 F OH H H IX-15-7 Ph H H CH 2
CH
2
SCH
3 Et H CH 3 F OH H H IX-15-8 Ph * H * Et H CH 3 F OH H H *RFand R"b joined together by (CH 2
)
3 to form five-membered ring. Table IX-16. X R' R 2
R
3 a R 3 b R4 R 5
R
6 X Y R R IX-16-1 p-Me-Ph H H H Et H CH 3 F OH H H IX-16-2 p-Me-Ph H H CH 3 Et H CH 3 F OH H H IX-16-3 p-Me-Ph H H CH(CH 3
)
2 Et H CH 3 F OH H H IX-16-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH H H IX-16-5 p-Me-Ph H H CH 2 Ph Et H CH 3 F OH H H IX-16-6 p-Me-Ph H H CH 2 -indol-3-yl Et H CH 3 F OH H H IX-16-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Et H CH 3 F OH H H IX-16-8 p-Me-Ph * H * Et H CH 3 F OH H H
R
2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table IX-17. Xe R RR 3 R R 4 R' R 6 X Y R R IX-17-1 p-F-Ph H H H Et H CH 3 F OH H H IX-17-2 p-F-Ph H H CH 3 Et H CH 3 F OH H H IX-17-3 p-F-Ph H H CH(CH 3
)
2 Et H CH 3 F OH H H IX-17-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH H H IX-17-5 p-F-Ph H H CH 2 Ph Et H CH 3 F OH H H IX-17-6 p-F-Ph H H CH 2 -indol-3-yl Et H CH 3 F OH H H IX-17-7 p-F-Ph H H CH 2
CH
2
SCH
3 Et H CH 3 F OH H H IX-17-8 p-F-Ph * H * Et H CH 3 F OH H H *R7and RIb joined together by (CH 2
)
3 to form five-membered ring. -C 1 Table IX-18. N2 RT R 2 R 3 a R 3 b R' R' R' X Y R' -R' IX-18-1 p-Cl-Ph H H H Et H CH 3 F OH H H IX-18-2 p-Cl-Ph H H CH 3 Et H CH 3 F OH H H IX-18-3 p-Cl-Ph H H CH(CH 3
)
2 Et H CH 3 F OH H H IX-18-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH H H IX-18-5 p-Cl-Ph H H CH 2 Ph Et H CH 3 F OH H H IX-18-6 p-Cl-Ph H H CH 2 -indol-3-yl Et H CH 3 F OH H H IX-18-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Et H CH 3 F OH H H IX-18-8 p-Cl-Ph * H * Et H CH 3 F OH H H *R and R3b joined together by (CH 2
)
3 to form five-membered ring. Table IX-19.
R
2
R
3 a R 3 b R 4 5 6 X 7 R N2 R' RI Ra b R' R' Ra X Y R R' IX-19-1 p-Br-Ph H H H Et H CH 3 F OH H H IX-19-2 p-Br-Ph H H CH 3 Et H CH 3 F OH H H IX-19-3 p-Br-Ph H H CH(CH 3
)
2 Et H CH 3 F OH H H IX-19-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH H H IX-19-5 p-Br-Ph H H CH 2 Ph Et H CH 3 F OH H H IX-19-6 p-Br-Ph H H CH 2 -indol-3-yl Et H CH 3 F OH H H IX-19-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Et H CH 3 F OH H H IX-19-8 p-Br-Ph * H * Et H CH 3 F OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table IX-20. N2 R R 2 Ra R 3 b R 4 RI R 6 X Y R 7
R
8 IX-20-1 p-I-Ph H H H Et H CH 3 F OH H H IX-20-2 p-I-Ph H H CH 3 Et H CH 3 F OH H H IX-20-3 p-I-Ph H H CH(CH 3
)
2 Et H CH 3 F OH H H IX-20-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH H H IX-20-5 p-I-Ph H H CH 2 Ph Et H CH 3 F OH H H IX-20-6 p-I-Ph H H CH 2 -indol-3-yl Et H CH 3 F OH H H IX-20-7 p-I-Ph H H CH 2
CH
2
SCH
3 Et H CH 3 F OH H H IX-20-8 p-I-Ph * H * Et H CH 3 F OH H H *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. - 252 - Table IX-21. N2 RT R 2 R3a R 3 b R' R' R' .X Y R" R' IX-21-1 CH 3 H H H 'Pr H CH 3 F OH H H IX-21-2 CH 3 H H CH 3 'Pr H CH 3 F OH H H IX-21-3 CH 3 H H CH(CH 3
)
2 'Pr H CH 3 F OH H H IX-21-4 CH 3 H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH H H IX-21-5 CH 3 H H CH 2 Ph 'Pr H CH 3 F OH H H IX-21-6 CH 3 H H CH 2 -indol-3-yl 'Pr H CH 3 F OH H H IX-21-7 CH 3 H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH H H IX-21-8 CH 3 * H * 'Pr H CH 3 F OH H H *R2and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table IX-22. N2 RI R 2
R
3 a R 3 b R 4 R' R' X Y R' R 8 IX-22-1 Et H H H 'Pr H CH 3 F OH H H IX-22-2 Et H H CH 3 'Pr H CH 3 F OH H H IX-22-3 Et H H CH(CH 3
)
2 'Pr H CH 3 F OH H H IX-22-4 Et H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH H H IX-22-5 Et H H CH 2 Ph 'Pr H CH 3 F OH H H IX-22-6 Et H H CH 2 -indol-3-yi 'Pr H CH 3 F OH H H IX-22-7 Et H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH H H IX-22-8 Et * H * 'Pr H CH 3 F OH H H *R2and R b joined together by (CH 2
)
3 to form five-membered ring. 5 Table IX-23. N2 R' R 2
R
3 a Rab R R' R 6 X Y R 7
R
8 IX-23-1 'Pr H H H 'Pr H CH 3 F OH H H IX-23-2 'Pr H H CH 3 'Pr H CH 3 F OH H H IX-23-3 'Pr H H CH(CH 3
)
2 'Pr H CH 3 F OH H H IX-23-4 'Pr H H CH 2
CH(CH
3 )2 'Pr H CH 3 F OH H H IX-23-5 'Pr H H CH 2 Ph 'Pr H CH 3 F OH H H IX-23-6 'Pr H H CH 2 -indol-3-yl 'Pr H CH 3 F OH H H IX-23-7 'Pr H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH H H IX-23-8 'Pr * H * 'Pr H CH 3 F OH H H *R2tand Rib joined together by (CH 2
)
3 to form five-membered ring.
Table IX-24. N2 RT R2 R 3 a R 3 b R4 R 5
R
6 X Y R 7
R
8 IX-24-1 'Bu H H H 'Pr H CH 3 F OH H H IX-24-2 'Bu H H CH 3 'Pr H CH 3 F OH H H IX-24-3 'Bu H H CH(CH 3
)
2 'Pr H CH 3 F OH H H IX-24-4 'Bu H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH H H IX-24-5 'Bu H H CH 2 Ph 'Pr H CH 3 F OH H H IX-24-6 'Bu H H CH 2 -indol-3-yl 'Pr H CH 3 F OH H H IX-24-7 'Bu H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH H H IX-24-8 'Bu * H * 'Pr H CH 3 F OH H H *RT and Rib joined together by (CH 2
)
3 to form five-membered ring. Table IX-25. X2 RI R 2
R
3 a R 3 b R4 R 5
R
6 X Y R' R IX-25-1 Ph H H H 'Pr H CH 3 F OH H H IX-25-2 Ph H H CH 3 'Pr H CH 3 F OH H H IX-25-3 Ph H H CH(CH 3
)
2 'Pr H CH 3 F OH H H IX-25-4 Ph H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH H H IX-25-5 Ph H H CH 2 Ph 'Pr H CH 3 F OH H H IX-25-6 Ph H H CH 2 -indol-3-yl 'Pr H CH 3 F OH H H IX-25-7 Ph H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH H H IX-25-8 Ph * H * 'Pr H CH 3 F OH H H *RTand R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table IX-26. N2 R' R2 R 3 a R 3 b R 4 R' R' X Y R 7 R' IX-26-1 p-Me-Ph H H H 'Pr H CH 3 F OH H H IX-26-2 p-Me-Ph H H CH 3 'Pr H CH 3 F OH H H IX-26-3 p-Me-Ph H H CH(CH 3
)
2 'Pr H CH 3 F OH H H IX-26-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH H H IX-26-5 p-Me-Ph H H CH 2 Ph 'Pr H CH 3 F OH H H IX-26-6 p-Me-Ph H H CH 2 -indol-3-yl 'Pr H CH 3 F OH H H IX-26-7 p-Me-Ph H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH H H IX-26-8 p-Me-Ph * H * 'Pr H CH 3 F OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring.
'ICA
Table IX-27. X R R 2
R
3 a R 3 b R 4 R R X Y R' R' IX-27-1 p-F-Ph H H H 'Pr H CH 3 F OH H H IX-27-2 p-F-Ph H H CH 3 'Pr H CH 3 F OH H H IX-27-3 p-F-Ph H H CH(CH 3
)
2 'Pr H CH 3 F OH H H IX-27-4 p-F-Ph H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH H H IX-27-5 p-F-Ph H H CH 2 Ph 'Pr H CH 3 F OH H H IX-27-6 p-F-Ph H H CH 2 -indol-3-yl 'Pr H CH 3 F OH H H IX-27-7 p-F-Ph H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH H H IX-27-8 p-F-Ph * H * 'Pr H CH 3 F OH H H *R2 and R b joined together by (CH 2
)
3 to form five-membered ring. Table IX-28.
R
2
R
3
R
3 b R' R' R' X Y R' R' IX-28-1 p-Cl-Ph H H H 'Pr H CH 3 F OH H H IX-28-2 p-Cl-Ph H H CH 3 'Pr H CH 3 F OH H H IX-28-3 p-Cl-Ph H H CH(CH 3
)
2 'Pr H CH 3 F OH H H IX-28-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH H H IX-28-5 p-Cl-Ph H H CH 2 Ph 'Pr H CH 3 F OH H H IX-28-6 p-Cl-Ph H H CH 2 -indol-3-yl 'Pr H CH 3 F OH H H IX-28.-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH H H IX-28-8 p-Cl-Ph * H * 'Pr H CH 3 F OH H H
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table IX-29. N2 R1 R 2
R
3 a RJb R 4 R' R 6 X Y R'R 8 IX-29-1 p-Br-Ph H H H 'Pr H CH 3 F OH H H IX-29-2 p-Br-Ph H H CH 3 'Pr H CH 3 F OH H H IX-29-3 p-Br-Ph H H CH(CH 3
)
2 'Pr H CH 3 F OH H H IX-29-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH H H IX-29-5 p-Br-Ph H H CH 2 Ph 'Pr H CH 3 F OH H H IX-29-6 p-Br-Ph H H CH 2 -indol-3-yl 'Pr H CH 3 F OH H H IX-29--7 p-Br-Ph H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH H H IX-29--8 p-Br-Ph * H * 'Pr H CH 3 F OH H H *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table IX-30. X R' R 2 R3a Rsb R 4
R
5 R 6 X Y R' R' IX-30-1 p-I-Ph H H H 'Pr H CH 3 F OH H H IX-30-2 p-I-Ph H H CH 3 'Pr H CH 3 F OH H H IX-30-3 p-I-Ph H H CH(CH 3
)
2 'Pr H CH 3 F OH H H IX-30-4 p-I-Ph H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH H H IX-30-5 p-I-Ph H H CH- 2 Ph 'Pr H CH 3 F OH H H IX-30-6 p-I-Ph H H CH2-indol-3-yl 'Pr H CH 3 F OH H H IX-30-7 p-I-Ph H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH H H IX-30-8 p-I-Ph * H * 'Pr H CH 3 F OH H H R7 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table IX-3 1. 2 R' R R3a 1 3b R14 RRR5 R X Y R' R' IX-31-1 CH 3 H H H "Bu H CH 3 F OH H H IX-31-2 CH 3 H H CH 3 "Bu H CH 3 F OH H H IX-31-3 CH 3 H H CH(CH 3
)
2 "Bu H CH 3 F OH H H IX-31-4 CH 3 H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH H H IX-31-5 CH 3 H H CH 2 Ph "Bu H CH 3 F OH H H IX-31-6 CH 3 H H CH 2 -indol-3-yl "Bu H CH 3 F OH H H IX-31-7 CH 3 H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH H H IX-31-8 CH 3 * H * "Bu H CH 3 F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table IX-32. 2 RI R 2
R
3 a R 3 b R4 R' R 6 X Y R 7 R' IX-32-1 Et H H H "Bu H CH 3 F OH H H IX-32-2 Et H H CH 3 "Bu H CH 3 F OH H H IX-32-3 Et H H CH(CH 3
)
2 "Bu H CH 3 F OH H H IX-32-4 Et H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH H H IX-32-5 Et H H CH 2 Ph "Bu H CH 3 F OH H H IX-32-6 Et H H CH 2 -indol-3-yl "Bu H CH 3 F OH H H IX-32-7 Et H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH H H IX-32-8 Et * H * "Bu H CH 3 F OH H H *R and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table IX-33. N2 R' R 2 R 3a R 3 b R 4 R' R' X Y R' R6 IX-33-1 'Pr H H H "Bu H CH 3 F OH H H IX-33-2 'Pr H H CH 3 "Bu H CH 3 F OH H H IX-33-3 'Pr H H CH(CH 3
)
2 "Bu H CH 3 F OH H H IX-33-4 'Pr H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH H H IX-33-5 'Pr H H CH 2 Ph "Bu H CH 3 F OH H H IX-33-6 'Pr H H CH 2 -indol-3-yl "Bu H CH 3 F OH H H IX-33-7 'Pr H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH H H IX-33-8 'Pr * H * "Bu H CH 3 F OH H H *RTand Rab joined together by (CH 2
)
3 to form five-membered ring. Table IX-34. N2 R R2 RM Ro R' R' R6 X Y R/ R8 IX-34-1 'Bu H H H "Bu H CH 3 F OH H H IX-34-2 'Bu H H CH 3 "Bu H CH 3 F OH H H IX-34-3 'Bu H H CH(CH 3
)
2 "Bu H CH 3 F OH H H IX-34-4 'Bu H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH H H IX-34-5 'Bu H H CH 2 Ph "Bu H CH 3 F OH H H IX-34-6 'Bu H H CH 2 -indol-3-yl "Bu H CH 3 F OH H H IX-34-7 'Bu H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH H H IX-34-8 'Bu * H * "Bu H CH 3 F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table IX-35. N2 R' R2 R 3 a R 3 b R R' R' X Y R' R' IX-35-1 Ph H H H "Bu H CH 3 F OH H H IX-35-2 Ph H H CH 3 "Bu H CH 3 F OH H H IX-35-3 Ph H H CH(CH 3
)
2 "Bu H CH 3 F OH H H IX-35-4 Ph H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH H H IX-35-5 Ph H H CH 2 Ph "Bu H CH 3 F OH H H IX-35-6 Ph H H CH 2 -indol-3-yl "Bu H CH 3 F OH H H IX-35-7 Ph H H CH 2
CH
2
SCH
3 "fBu H CH 3 F OH H H IX-35-8 Ph * H * "Bu H CH 3 F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 'I C'7 Table IX-36. No R R 2
RR
3 b R 4 R R' X Y R' R IX-36-1 p-Me-Ph H H H "Bu H CH 3 F OH H H IX-36-2 p-Me-Ph H H CH 3 "Bu H CH 3 F OH H H IX-36-3 p-Me-Ph H H CH(CH 3
)
2 "Bu H CH 3 F OH H H IX-36-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH H H IX-36-5 p-Me-Ph H H CH 2 Ph "Bu H CH 3 F OH H H IX-36-6 p-Me-Ph H H CH 2 -indol-3-yl "Bu H CH 3 F OH H H IX-36-7 p-Me-Ph H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH H H IX-36-8 p-Me-Ph * H * "Bu H CH 3 F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table IX-37. S R R2 R3a R3b R4 R' R 6 X Y R 7 R' IX-37-1 p-F-Ph H H H "Bu H CH 3 F OH H H IX-37-2 p-F-Ph H H CH 3 "Bu H CH 3 F OH H H IX-37-3 p-F-Ph H H CH(CH 3
)
2 "Bu H CH 3 F OH H H IX-37-4 p-F-Ph H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH H H IX-37-5 p-F-Ph H H CH 2 Ph "Bu H CH 3 F OH H H IX-37-6 p-F-Ph H H CH 2 -indol-3-yl "Bu H CH 3 F OH H H IX-37.-7 p-F-Ph H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH H H IX-37-8 p-F-Ph * H * "Bu H CH 3 F OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table IX-38. X R' R 2 R a R3b R R 5 R6 X Y R R7 R IX-38-1 p-Cl-Ph H H H "Bu H CH 3 F OH H H IX-38--2 p-Cl-Ph H H CH 3 "Bu H CH 3 F OH H H IX-38-3 p-Cl-Ph H H CH(CH3) 2 "Bu H CH 3 F OH H H IX-38-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 'Bu H CH 3 F OH H H IX-38..5 p-Cl-Ph H H CH 2 Ph "Bu H CH 3 F OH H H IX-38-6 p-Cl-Ph H H CH 2 -indol-3-yl "Bu H CH 3 F OH H H IX-38-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH H H IX-38--8 p-Cl-Ph * H * "Bu H CH 3 F OH H H *R and Rib joined together by (CH 2
)
3 to form five-membered ring.
Table IX-39. 2 R R Ra Rab R 4
R
5 R X Y R' R IX-39-1 p-Br-Ph H H H "Bu H CH 3 F OH H H IX-39-2 p-Br-Ph H H CH 3 "Bu H CH 3 F OH H H IX-39-3 p-Br-Ph H H CH(CH 3
)
2 "Bu H CH 3 F OH H H IX-39-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH H H IX-39-5 p-Br-Ph H H CH 2 Ph "Bu H CH 3 F OH H H IX-39-6 p-Br-Ph H H CH 2 -indol-3-yi "Bu H CH 3 F OH H H IX-39-7 p-Br-Ph H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH H H IX-39-8 p-Br-Ph * H * "Bu H CH 3 F OH H H
*R
2 and RJb joined together by (CH 2
)
3 to form five-membered ring. Table IX-40. X2 R' R 2
R
3 a Rab R R 5
R
6 X Y R' R( IX-40-1 p-I-Ph H H H "Bu H CH 3 F OH H H IX-40-2 p-I-Ph H H CH 3 "Bu H CH 3 F OH H H IX-40-3 p-I-Ph H H CH(CH 3
)
2 "Bu H CH 3 F OH H H IX-40-4 p-I-Ph H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH H H IX-40-5 p-I-Ph H H CH 2 Ph "Bu H CH 3 F OH H H IX-40-6 p-I-Ph H H CH 2 -indol-3-yl "Bu H CH 3 F OH H H IX-40-7 p-I-Ph H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH H H IX-40-8 p-I-Ph * H * "Bu H CH3 F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table IX-4 1. X2 R R 2
R
3 a R3b R4 R' R 6 X Y R' R IX-41-1 CH 3 H H H Bz H CH 3 F OH H H IX-41-2 CH 3 H H CH 3 Bz H CH 3 F OH H H IX-41-3 CH 3 H H CH(CH 3
)
2 Bz H CH 3 F OH H H IX-41-4 CH 3 H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH H H IX-41-5 CH 3 H H CH 2 Ph Bz H CH 3 F OH H H IX-41-6 CH 3 H H CH 2 -indol-3-yl Bz H CH 3 F OH H H IX-41-.7 CH 3 H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH H H IX-41-8 CH 3 * H * Bz H CH 3 F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table IX-42. N2 R7 R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7 R7 IX-42-1 Et H H H Bz H CH 3 F OH- H H IX-42-2 Et H H CH 3 Bz H CH 3 F OH H H IX-42-3 Et H H CH(CH 3
)
2 Bz H CH 3 F OH H H IX-42-4 Et H H CH 2
CH(CH
3
)
2 Bz H CH3 F OH H H IX-42-5 Et H H CH 2 Ph Bz H CH 3 F OH H H IX-42-6 Et H H CH 2 -indol-3-yl Bz H CH 3 F OH H H IX-42-7 Et H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH H H IX-42-8 Et * H * Bz H CH 3 F OH H H *R and Rab joined together by (CH 2
)
3 to form five-membered ring. Table IX-43. N2 R' R 2
R
3 a R 3 b R 4
R
5
R
6 X Y R' R' IX-43-1 'Pr H H H Bz H CH 3 F OH H H IX-43-2 'Pr H H CH 3 Bz H CH 3 F OH H IX-43-3 'Pr H H CH(CH 3
)
2 Bz H CH 3 F OH H H LX-43-4 'Pr H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH H H IX-43-5 'Pr H H CH 2 Ph Bz H CH 3 F OH H H IX-43-6 'Pr H H CH 2 -indol-3-yl Bz H CH 3 F OH H H LX-43-7 'Pr H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH H H IX-43-8 'Pr * H * Bz H CH 3 F OH H H 10 *R 2 and R 3b joined together by (CH 2
)
3 to form five-membered ring. Table IX-44. N2 R R2 Ra Rb R4 R3 R' X Y R' R' IX-44-1 'Bu H H H Bz H CH 3 F ,OH H H IX-44-2 'Bu H H CH 3 Bz H CH 3 F OH H H IX-44--3 'Bu H H CH(CH 3
)
2 Bz H CH 3 F OH H H IX-44-4 'Bu H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH H H IX-44..5 'Bu H H CH 2 Ph Bz H CH 3 F OH H H IX-44-6 'Bu H H CH 2 -indol-3-yl Bz H CH 3 F OH H H IX-44--7 'Bu H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH H H IX-44-.8 'Bu * H * Bz H CH 3 F OH H H *R2and R 3b joined together by (CH 2
)
3 to form five-membered ring.
Table IX-45. N2 R R 2
R
3 a R 3 b R 4 R R X Y R' R" IX-45-1 Ph H H H Bz H CH 3 F OH H H IX-45-2 Ph H H CH 3 Bz H CH 3 F OH H H IX-45-3 Ph H H CH(CH 3
)
2 Bz H CH 3 F OH H H IX-45-4 Ph H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH H H IX-45-5 Ph H H CH 2 Ph Bz H CH 3 F OH H H IX-45-6 Ph H H CH 2 -indol-3-yl Bz H CH 3 F OH H H IX-45-7 Ph H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH H H IX-45-8 Ph * H * Bz H CH 3 F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table IX-46. 2 R' R2 R 3 a R 3 b R 4 R' R' X Y R' R' IX-46-1 p-Me-Ph H H H Bz H CH 3 F OH H H IX-46-2 p-Me-Ph H H CH 3 Bz H CH 3 F OH H H IX-46-3 p-Me-Ph H H CH(CH 3
)
2 Bz H CH 3 F OH H H IX-46-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH H H IX-46--5 p-Me-Ph H H CH 2 Ph Bz H CH 3 F OH H H IX-46-.6 p-Me-Ph H H CH 2 -indol-3-yl Bz H CH 3 F OH H H IX-46-.7 p-Me-Ph H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH H H IX-46-8 p-Me-Ph * H * Bz H CH 3 F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table IX-47. N2 R1 R 2 Ra R 3 b R' R' R' X Y R 7 R IX-47-1 p-F-Ph H H H Bz H CH 3 F OH H H IX-47-2 p-F-Ph H H CH 3 Bz H CH 3 F OH H H IX-47-3 p-F-Ph H H CH(CH 3
)
2 Bz H CH 3 F OH H H IX-47-4 p-F-Ph H H CH1 2
CH(CH
3
)
2 Bz H CH 3 F OH H H IX-47-5 p-F-Ph H H CH 2 Ph Bz H CH 3 F OH H H IX-47-6 p-F-Ph H H CH 2 -indol-3-yl Bz H CH 3 F OH H H IX-47-7 p-F-Ph H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH H H IX-47-8 p-F-Ph * H * Bz H CH 3 F OH H H *R and R joined together by (CH 2
)
3 to form five-membered ring. 4I 1 Table IX-48. N2 R' R2 R 3 a R 3 b R4 R 5
R
6 X Y R' R' IX-48-1 p-Cl-Ph H H H Bz H CH 3 F OH H H IX-48-2 p-Cl-Ph H H CH 3 Bz H CH 3 F OH H H IX-48-3 p-Cl-Ph H H CH(CH 3
)
2 Bz H CH 3 F OH H H IX-48-4 p-Cl-Ph H H CH2CH(CH 3 )2 Bz H CH 3 F OH H H IX-48-5 p-Cl-Ph H H CH 2 Ph Bz H CH 3 F OH H H IX-48-6 p-Cl-Ph H H CH 2 -indol-3-yl Bz H CH 3 F OH H H IX-48-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH H H IX-48-8 p-Cl-Ph * H Bz H CH 3 F OH H H *Rand R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table IX-49. X2 R7 R 3
R
3 a R" R 4 R R 6 X Y R' R IX-49-1 p-Br-Ph H H H Bz H CH 3 F OH H H IX-49-2 p-Br-Ph H H CH 3 Bz H CH 3 F OH H H IX-49-3 p-Br-Ph H H CH(CH 3
)
2 Bz H CH 3 F OH H H IX-49-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH H H IX-49-5 p-Br-Ph H H CH 2 Ph Bz H CH 3 F OH H H IX-49-6 p-Br-Ph H H CH 2 -indol-3-yi Bz H CH 3 F OH H H IX-49-7 p-Br-Ph H H CH 2 CH2SCH 3 Bz H CH 3 F OH H H IX-49-8 p-Br-Ph * H * Bz H CH 3 F OH H H
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table IX-50. X R1 R 2 R3aa R 3 b R 4 R' R' X Y R' R' IX-50-1 p-I-Ph H H H Bz H CH 3 F OH H H IX-50-2 p-I-Ph H H CH 3 Bz H CH 3 F OH H H IX-50-3 p-I-Ph H H CH(CH 3
)
2 Bz H CH 3 F OH H H IX-50-4 p-I-Ph H H CH2CH(CH 3
)
2 Bz H CH 3 F OH H H IX-50-5 p-I-Ph H H CH2Ph Bz H CH 3 F OH H H IX-50-6 p-I-Ph H H CF2-indol-3-yl Bz H CH 3 F OH H H IX-50-7 p-I-Ph H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH H H IX-50-8 p-I-Ph H * Bz H CH 3 F OH H H *R2 and R b joined together by (CH 2
)
3 to form five-membered ring.
0 R 8 R2 0 NH R3b 2 R N R3a N-- 0 C0 2
R
4 OR' R6 Y X x Table X- 1. N2 R' R 2
R
3 a R 3 b R' R' R' X Y R R X-1-1 CH 3 H H H CH 3 H F F OH H H X-1-2 CH 3 H H CH 3
CH
3 H F F OH H H X-1-3 CH 3 H H CH(CH 3
)
2
CH
3 H F F OH H H X-1-4 CH 3 H H CH 2
CH(CH
3
)
2
CH
3 H F F OH H H X-1-5 CH 3 H H CH 2 Ph CH 3 H F F OH H H X-1-6 CH 3 H H CH 2 -indol-3-yl CH 3 H F F OH H H X-1-7 CH 3 H H CH 2
CH
2
SCH
3
CH
3 H F F OH H H X-1-8 CH 3 * H * CH 3 H F F OH H H *R7 and R joined together by (CH 2
)
3 to form five-membered ring. 5 Table X-2. N2 RI R 2
R
3 a R 3 b R' R' R 6 X Y R' R' X-2-1 Et H H H CH 3 H F F OH H H X-2-2 Et H H CR 3
CH
3 H F F OH H H X-2-3 Et H H CH(CH 3
)
2
CH
3 H F F OH H H X-2-4 Et H H CH 2
CH(CH
3
)
2
CH
3 H F F OH H H X-2-5 Et H H CH 2 Ph CH 3 H F F OH H H X-2-6 Et H H CH 2 -indol-3-y CH 3 H F F OH H H X-2-7 Et H H CH 2
CH
2
SCH
3
CH
3 H F F OH H H X-2-8 Et* H * CH 3 H F F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table X-3. N2 R R2 Ra R R4 R' R 6 X Y R' R X-3-1 'Pr H H H CH 3 H F F OH H H X-3-2 'Pr H H CH 3
CH
3 H F F OH H H X-3-3 'Pr H H CH(CH 3
)
2
CH
3 H F F OH H H X-3-4 'Pr H H CH 2
CH(CH
3
)
2
CH
3 H F F OH H H X-3-5 'Pr H H CH 2 Ph CH 3 H F F OH H H X-3-6 'Pr H H CH 2 -indol-3-yl CH 3 H F F OH H H X-3-7 'Pr H H CH 2
CH
2
SCH
3
CH
3 H F F OH H H X-3-8 'Pr * H * CH 3 H F F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table X-4. N2 R R2 Ra RIb R' RI R 6 X Y R R' X-4-1 'Bu H H H CH 3 H F F OH H H X-4-2 'Bu H H CH 3
CH
3 H F F OH H H X-4-3 'Bu H H CH(CH 3
)
2
CH
3 H F F OH H H X-4-4 'Bu H H CH 2
CH(CH
3
)
2
CH
3 H F F OH H H X-4-5 'Bu H H CH 2 Ph CH 3 H F F OH H H X-4-6 'Bu H H CH 2 -indol-3-yl CH 3 H F F OH H H X-4-7 'Bu H H CH 2
CH
2
SCH
3
CH
3 H F F OH H H X-4-8 'Bu * H * CH 3 H F F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table X-5. N R R 2
R
3 a R 3 b R4 R R 6 X Y R' R X-5-1 Ph H H H CH 3 H F F OH H H X-5-2 Ph H H CH 3
CH
3 H F F OH H H X-5-3 Ph H H CH(CH 3 )2 CH 3 H F F OH H H X-5-4 Ph H H CH 2
CH(CH
3
)
2
CH
3 H F F OH H H X-5-5 Ph H H CH 2 Ph CH 3 H F F OH H H X-5-6 Ph H H CH 2 -indol-3-yl CH 3 H F F OH H H X-5-7 Ph H H CH 2
CH
2
SCH
3
CH
3 H F F OH H H X-5-8 Ph * H * CH 3 H F F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table X-6. N2 R1 R 2 Ra R 3 b R 4 R' R 6 X Y R 7
R
8 X-6-1 p-Me-Ph H H H CH 3 H F F OH H H X-6-2 p-Me-Ph H H CH 3
CH
3 H F F OH H H X-6-3 p-Me-Ph H H CH(CH 3
)
2
CH
3 H F F OH H H X-6-4 p-Me-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F F OH H H X-6-5 p-Me-Ph H H CH 2 Ph CH 3 H F F OH H H X-6-6 p-Me-Ph H H CH 2 -indol-3-yl CH 3 H F F OH H H X-6-7 p-Me-Ph H H CH 2
CH
2
SCH
3
CH
3 H F F OH H H X-6-8 p-Me-Ph * H * CH 3 H F F OH H H *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table X-7. N R R 2
R
3 Rb R 4 R' R 6 X Y R 7 R' X-7-1 p-F-Ph H H H CH 3 H F F OH H H X-7-2 p-F-Ph H H CH 3
CH
3 H F F OH H H X-7-3 p-F-Ph H H CH(CH 3
)
2
CH
3 H F F OH H H X-7-4 p-F-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F F OH H H X-7-6 p-F-Ph H H CH 2 Ph CH 3 H F F OH H H X-7-7 p-F-Ph H H CH 2 -indol-3-yi CH 3 H F F OH H H X-7-8 p-F-Ph H H CH 2
CH
2
SCH
3
CH
3 H F F OH H H X-7-20 p-F-Ph * H * CH 3 H F F OH H H *R2 and R2 joined together by (CH 2
)
3 to form five-membered ring. 5 Table X-8. N2 R1 R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7
R
8 X-8-1 p-Cl-Ph H H H CH 3 H F F OH H H X-8-2 p-Cl-Ph H H CH 3
CH
3 H F F OH H H X-8-3 p-Cl-Ph H H CH(CH 3
)
2
CH
3 H F F OH H H X-8-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F F OH H H X-8-5 p-Cl-Ph H H CH 2 Ph CH 3 H F F OH H H X-8-6 p-Cl-Ph H H CH 2 -indol-3-yl CH 3 H F F OH H H X-8-7 p-Cl-Ph H H CH 2
CH
2
SCH
3
CH
3 H F F OH H H X-8-8 p-Cl-Ph * H * CH 3 H F F OH H H *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table X-9. X2 R1 R 2 Ra R 3 b R 4 R R' X Y R 7
R
8 X-9-1 p-Br-Ph H H H CH 3 H F F OH H H X-9-2 p-Br-Ph H H CH 3
CH
3 H F F OH H H X-9-3 p-Br-Ph H H CH(CH 3
)
2
CH
3 H F F OH H H X-9-4 p-Br-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F F OH H H X-9-6 p-Br-Ph H H CH 2 Ph CH 3 H F F OH H H X-9-7 p-Br-Ph H H CH 2 -indol-3-yi CH 3 H F F OH H H X-9-8 p-Br-Ph H H CH 2
CH
2
SCH
3
CH
3 H F F OH H H X-9-20 p-Br-Ph * H * CH 3 H F F OH H H
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table X-10. N2 R1 R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7
R
8 X-10-1 p-I-Ph H H H CH 3 H F F OH H H X-10-2 p-I-Ph H H CH 3
CH
3 H F F OH H H X-10-3 p-I-Ph H H CH(CH 3
)
2
CH
3 H F F OH H H X-10-4 p-I-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F F OH H H X-10-5 p-I-Ph H H CH 2 Ph CH 3 H F F OH H H X-10-6 p-I-Ph H H CH 2 -indol-3-yl CH 3 H F F OH H H X-10-7 p-I-Ph H H CH 2
CH
2
SCH
3
CH
3 H F F OH H H X-10-8 p-I-Ph * H * CH 3 H F F OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table X-I1. N2 R1 R 2
R
3 a R 3 b R 4 R' R 6 X Y R' R' X-11-1 CH 3 H H H Et H F F OH H H X-11-2 CH 3 H H CH 3 Et H F F OH H H X-11-3 CH 3 H H CH(CH 3
)
2 Et H F F OH H H X-11-4 CH 3 H H CH 2
CH(CH
3
)
2 Et H F F OH H H X-11-5 CH 3 H H CH 2 Ph Et H F F OH H H X-11-6 CH 3 H H CH 2 -indol-3-yl Et H F F OH H H X-11-7 CH 3 H H CH 2
CH
2
SCH
3 Et H F F OH H H X-11-8 CH 3 * H * Et H F F OH H H *R1 and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table X-12. N2 R' R 2 R3a R 3 b R4 R' R 6 X Y R 7 R' X-12-1 Et H H H Et H F F OH H H X-12-2 Et H H CH 3 Et H F F OH H H X-12-.3 Et H H CH(CH 3
)
2 Et H F F OH H H X-12-4 Et H H CH 2 CIi(CH 3
)
2 Et H F F OH H H X-12-5 Et H H CH 2 Ph Et H F F OH H H X-12-6 Et H H CH 2 -indol-3-yl Et H F F OH H H X-12-7 Et H H CH 2
CH
2
SCH
3 Et H F F OH H H X-12-8 Et * H * Et H F F OH H H R1 and R b joined together by (CH 2
)
3 to form five-membered ring. Table X-13. N2 R' R 2 R3a R 3 b R 4 R' R 6 X Y R' R' X-13-1 'Pr H H H Et H F F OH H H X-13-2 'Pr H H CH 3 Et H F F OH H H X-13-3 'Pr H H CH(CH 3
)
2 Et H F F OH H H X-13-4 'Pr H H CH 2
CH(CH
3 )2 Et H F F OH H H X-13-5 'Pr H H CH 2 Ph Et H F F OH H H X-13-6 'Pr H H CH 2 -indol-3-yl Et H F F OH H H X-13-7 'Pr H H CH 2
CH
2
SCH
3 Et H F F OH H H X-13-8 'Pr * H * Et H F F OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table X-14. N2 R1 R2 R RAb R4 R 5
R
6 X Y R' R 8 3a X-14-1 'Bu H H H Et H F F OH H H X-14-2 'Bu H H CH 3 Et H F F OH H H X-14-3 'Bu H H CH(CH 3
)
2 Et H F F OH H H X-14-4 'Bu H H CH2CH(CH 3
)
2 Et H F F OH H H X-14-5 'Bu H H CH 2 Ph Et H F F OH H H X-14-6 'Bu H H CH 2 -indol-3-yl Et H F F OH H H X-14-7 'Bu H H CH 2
CH
2
SCH
3 Et H F F OH H H X-14-8 'Bu* H* Et H F F OH H H R and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table X-15. X2 R' R2 Ra R 3 b R4 R' R 6 X Y R 7
R
8 X-15-1 Ph H H H Et H F F OH H H X-15-2 Ph H H CH 3 Et H F F OH H H X-15-3 Ph H H CH(CH 3
)
2 Et H F F OH H H X-15-4 Ph H H CH 2
CH(CH
3
)
2 Et H F F OH H H X-15-5 Ph H H CH 2 Ph Et H F F OH H H X-15-6 Ph H H CH 2 -indol-3-yl Et H F F OH H H X-15-7 Ph H H CH 2
CH
2
SCH
3 Et H F F OH H H X-15-8 Ph * H * Et H F F OH H H *R-=and R.3b joined together by (CH 2
)
3 to form five-membered ring. Table X-16. N2 R R 2 R 3 aR 3 b R 4 R' R 6 X Y R' R' X-16-1 p-Me-Ph H H H Et H F F OH H H X-16-2 p-Me-Ph H H CH 3 Et H F F OH H H X-16-3 p-Me-Ph H H CH(CH 3
)
2 Et H F F OH H H X-16-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Et H F F OH H H X-16-5 p-Me-Ph H H CH 2 Ph Et H F F OH H H X-16-6 p-Me-Ph H H CH 2 -indol-3-yl Et H F F OH H H X-16-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Et H F F OH H H X-16-8 p-Me-Ph * H * Et H F F OH H H *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table X-17. N2 R' R 2 R3a R 3 b R' R' R 6 X Y R 7
R
8 X-17-1 p-F-Ph H H H Et H F F OH H H X-17-2 p-F-Ph H H CH 3 Et H F F OH H H X-17-3 p-F-Ph H H CH(CH 3
)
2 Et H F F OH H H X-17-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Et H F F OH H H X-17-5 p-F-Ph H H CH 2 Ph Et H F F OH H H X-17-6 p-F-Ph H H CH 2 -indol-3-yl Et H F F OH H H X-17-7 p-F-Ph H H CH 2
CH
2
SCH
3 Et H F F OH H H X-17-8 p-F-Ph * H * Et H F F OH H H *Rl and Rib joined together by (CH 2
)
3 to form five-membered ring.
Table X-18. X2 R RR 3 a R3b R 4 R' R' X Y R' R" X-18-1 p-Cl-Ph H H H Et H F F OH H H X-18-2 p-Cl-Ph H H CH 3 Et H F F OH H H X-18-3 p-Cl-Ph H H CH(CH 3
)
2 Et H F F OH H H X-18-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Et H F F OH H H X-18-5 p-Cl-Ph H H CH 2 Ph Et H F F OH H H X-18-6 p-Cl-Ph H H CH 2 -indol-3-yl Et H F F OH H H X-18-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Et H F F OH H H X-18-8 p-Cl-Ph * H * Et H F F OH H H
*R
2 and R b joined together by (CH 2
)
3 to form five-membered ring. Table X-19. Xe R R 2
R
3 a R 3 b R R X Y R 7
R
8 X-19-1 p-Br-Ph H H H Et H F F OH H H X-19-2 p-Br-Ph H H CH 3 Et H F F OH H H X-19-3 p-Br-Ph H H CH(CH 3
)
2 Et H F F OH H H X-19-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Et H F F OH H H X-19-5 p-Br-Ph H H CH 2 Ph Et H F F OH H H X-19-6 p-Br-Ph H H CH 2 -indol-3-yl Et H F F OH H H X-19-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Et H F F OH H H X-19-8 p-Br-Ph * H * Et H F F OH H H
*R
2 -and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table X-20. Ne R R 2
R
3 a R 3 b R 4 R' R' X Y R' X-20-1 p-I-Ph H H H Et H F F OH H X-20-2 p-I-Ph H H CH 3 Et H F F OH H X-20-3 p-I-Ph H H CH(CH 3
)
2 Et H F F OH H X-20-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Et H F F OH H X-20-5 p-I-Ph H H CH 2 Ph Et H F F OH H X-20-6 p-I-Ph H H CH 2 -indol-3-yl Et H F F OH H X-20-7 p-I-Ph H H CH 2
CH
2
SCH
3 Et H F F OH H X-20-8 p-I-Ph * H * Et H F F OH H *R and Rib joined together by (CH 2
)
3 to form five-membered ring.
Table X-21. 2 R' R2 R 3 a R 3 b R 4 R' R' X Y R' R' X-21-1 CH 3 HH H 'Pr H F F OH H H X-21-2 CH 3 H H CH 3 'Pr H F F OH H H X-21-3 CH 3 H H CH(CH 3
)
2 Pr H F F OH H H X-21-4 CH 3 H H CH 2
CH(CH
3
)
2 'Pr H F F OH H H X-21-5 CH 3 H H CH 2 Ph 'Pr H F F OH H H X-21-6 CH 3 H H CH 2 -indol-3-yl 'Pr H F F OH H H X-21-7 CH 3 H H CH 2
CH
2
SCH
3 'Pr H F F OH H H X-21-8 CH 3 * H * 'Pr H F F OH H H *R aind R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table X-22. Ng RI R 2
R
3 a R 3 b R' R' R' X Y R R' X-22-1 Et H H H 'Pr H F F OH H H X-22-2 Et H H CH 3 'Pr H F F OH H H X-22-3 Et H H CH(CH 3
)
2 'Pr H F F OH H H X-22-4 Et H H CH 2
CH(CH
3
)
2 'Pr H F F OH H H X-22-5 Et H H CH 2 Ph 'Pr H F F OH H H X-22-6 Et H H CH 2 -indol-3-yl 'Pr H F F OH H H X-22-7 Et H H CH 2
CH
2
SCH
3 'Pr H F F OH H H X-22-8 Et * H * 'Pr H F F OH H H *R and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table X-23. N2 R' R 2
R
3 R R 4 R R X Y R R' X-23-1 'Pr H H H 'Pr H F F OH H H X-23-2 'Pr H H CH 3 'Pr H F F OH H H X-23-3 'Pr H H CH(CH 3
)
2 'Pr H F F OH H H X-23-4 'Pr H H CH 2
CH(CH
3
)
2 'Pr H F F OH H H X-23-5 'Pr H H CH 2 Ph 'Pr H F F OH H H X-23-6 'Pr H H CH 2 -indol-3-yl 'Pr H F F OH H H X-23-7 'Pr H H CH 2
CH
2
SCH
3 'Pr H F F OH H H X-23-8 'Pr * H * 'Pr H F F OH H H *R4 and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table X-24. NR R' R2 R 3 a R 3 b R 4 R' R' X Y R' R' X-24-1 'Bu H H H 'Pr H F F OH H H X-24-2 'Bu H H CH 3 'Pr H F F OH H H X-24-3 'Bu H H CH(CH 3
)
2 'Pr H F F OH H H X-24-4 'Bu H H CH 2
CH(CH
3
)
2 'Pr H F F OH H H X-24-5 'Bu H H CH 2 Ph 'Pr H F F OH H H X-24-6 'Bu H H CH 2 -indol-3-yl 'Pr H F F OH H H X-24-7 'Bu H H CH 2
CH
2
SCH
3 'Pr H F F OH H H X-24-8 'Bu * . H * 'Pr H F F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table X-25. N2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y R 7
R
8 X-25-1 Ph H H H 'Pr H F F OH H H X-25-2 Ph H H CH 3 'Pr H F F OH H H X-25-3 Ph H H CH(CH 3
)
2 'Pr H F F OH H H X-25-4 Ph H H CH 2
CH(CH
3
)
2 'Pr H F F OH H H X-25-5 Ph H H CH 2 Ph 'Pr H F F OH H H X-25-6 Ph H H CH 2 -indol-3-yl 'Pr H F F OH H H X-25-7 Ph H H CH 2
CH
2
SCH
3 'Pr H F F OH H H X-25-8 Ph * H * 'Pr H F F OH H H *RTand Rab joined together by (CH 2
)
3 to form five-membered ring. 5 Table X-26. S RR 2
R
3 a R 3 b R 4 R R XY R R X-26-1 p-Me-Ph H H H 'Pr H F F OH H H X-26-2 p-Me-Ph H H CH 3 'Pr H F F OH H H X-26-3 p-Me-Ph H H CH(CH 3
)
2 'Pr H F F OH H H X-26-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 'Pr H F F OH H H X-26-5 p-Me-Ph H H CH 2 Ph 'Pr H F F OH H H X-26-6 p-Me-Ph H H CH 2 -indol-3-yl 'Pr H F F OH H H X-26-7 p-Me-Ph H H CH 2
CH
2
SCH
3 'Pr H F F OH H H X-26-8 p-Me-Ph * H * 'Pr H F F OH H H *RTand R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table X-27. N2 R1 R2 R3a R 3 R R R 6 X Y R 7 R 8 X-27-1 p-F-Ph H H H 'Pr H F F OH H H X-27-2 p-F-Ph H H CH 3 'Pr H F F OH H H X-27-3 p-F-Ph H -H CH(CH 3
)
2 'Pr H F F OH H H X-27-4 p-F-Ph H H CH 2
CH(CH
3
)
2 'Pr H F F OH H H X-27-5 p-F-Ph H H CH1 2 Ph 'Pr H F F OH H H X-27-6 p-F-Ph H H CH 2 -indol-3-yl 'Pr H F F OH H H X-27-7 p-F-Ph H H CH 2
CH
2
SCH
3 'Pr H F F OH H H X-27-8 p-F-Ph * H * 'Pr H F F OH H H *RZ and R b joined together by (CH 2
)
3 to form five-membered ring. Table X-28.
R
2 R " R 3 b R' R' R 6 X Y R 7
R
8 X-28-1 p-Cl-Ph H H H Pr H F F OH H H X-28-2 p-Cl-Ph H H CH 3 Pr H F F OH H H X-28-3 p-Cl-Ph H H CH(CH 3
)
2 'Pr H F F OH H H X-28-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 'Pr H F F OH H H X-28-5 p-Cl-Ph H H CH 2 Ph 'Pr H F F OH H H X-28-6 p-Cl-Ph H H CH 2 -indol-3-yl 'Pr H F F OH H H X-28-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 'Pr H F F OH H H X-28-8 p-Cl-Ph * H * 'Pr H F F OH H H *R2 and RIb joined together by (CH 2
)
3 to form five-membered ring. 5 Table X-29. N2 R' R2 R 3 a Rb R 4 R' R 6 X Y R' R' X-29-1 p-Br-Ph H H H 'Pr H F F OH H H X-29-2 p-Br-Ph H H CH 3 'Pr H F F OH H H X-29-3 p-Br-Ph H H CH(CH 3
)
2 'Pr H F F OH H H X-29-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 'Pr H F F OH H H X-29-5 p-Br-Ph H H CH 2 Ph 'Pr H F F OH H H X-29-.6 p-Br-Ph H H CH 2 -indol-3-yl 'Pr H F F OH H H X-29-7 p-Br-Ph H H CH 2
CH
2
SCH
3 'Pr H F F OH H H X-29-8 p-Br-Ph * H * 'Pr H F F OH H H *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring.
Table X-30. Xe R R 2
R
3 a R 3 b R 4 R' R 6 X Y R' R' X-30-1 p-I-Ph H H H 'Pr H F F OH H H X-30-2 p-I-Ph H H CH 3 'Pr H F F OH H H X-30-3 p-I-Ph H H CH(CH 3
)
2 'Pr H F F OH H H X-30-4 p-I-Ph H H CH 2
CH(CH
3
)
2 'Pr H F F OH H H X-30-5 p-I-Ph H H CH2Ph 'Pr H F F OH H H X-30-6 p-I-Ph H H CH 2 -indol-3-yl 'Pr H F F OH H H X-30-7 p-I-Ph H H CH 2
CH
2
SCH
3 'Pr H F F OH H H X-30-8 p-I-Ph * H * 'Pr H F F OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table X-31. NO R' R2 R 3 a R 3 b R 4 R' R 6 X Y R'R 8 X-31-1 CH 3 H H H "Bu H F F OH H H X-31-2 CH 3 H H CH 3 "Bu H F F OH H H X-31-3 CH 3 H H CH(CH 3
)
2 "Bu H F F OH H H X-31-4 CH 3 H H CH 2
CH(CH
3
)
2 "Bu H F F OH H H X-31-5 CH 3 H H CH 2 Ph "Bu H F F OH H H X-31-6 CH 3 H H CH 2 -indol-3-yl 'Bu H F F OH H H X-31-7 CH 3 H H CH 2
CH
2
SCH
3 "Bu H F F OH H H X-31-8 CH 3 * H * "Bu H F F OH H H *R and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table X-32. Xe RI R 2 R3a R 3 b R 4 R' R 6 X Y R 7 R' X-32-1 Et H H H "Bu H F F OH H H X-32-2 Et H H CH 3 "Bu H F F OH H H X-32-3 Et H H CH(CH 3
)
2 "Bu H F F OH H H X-32-4 Et H H CH 2
CH(CH
3
)
2 "Bu H F F OH H H X-32-5 Et H H CH 2 Ph "Bu H F F OH H H X-32-6 Et H H CH 2 -indol-3-yl "Bu H F F OH H H X-32-7 Et H H CH 2
CH
2
SCH
3 "Bu H F F OH H H X-32-8 Et * H * "Bu H F F OH H H *R and Rib joined together by (CH 2
)
3 to form five-membered ring.
Table X-33. N R' R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7 R X-33-1 'Pr H H H "Bu H F F OH H H X-33-2 'Pr H H CH 3 "Bu H F F OH H H X-33-3 'Pr H H CH(CH 3
)
2 "Bu H F F OH H H X-33-4 'Pr H H CH 2
CH(CH
3
)
2 "Bu H F F OH H H X-33-5 'Pr H H CH 2 Ph "Bu H F F OH H H X-33-6 'Pr H H CH 2 -indol-3-yI "Bu H F F OH H H X-33-7 'Pr H H CH 2
CH
2
SCH
3 "Bu H F F OH H H X-33-8 'Pr * H * "Bu H F F OH H H *R and Rab joined together by (CH 2
)
3 to form five-membered ring. Table X-34. Ne R' R2 Rsa Rb R4 R' R 6 X Y R' R' X-34-1 'Bu H H H 'Bu H F F OH H H X-34-2 'Bu H H CH 3 "Bu H F F OH H H X-34-3 'Bu H H CH(CH 3
)
2 'Bu H F F OH H H X-34-4 'Bu H H CH 2
CH(CH
3
)
2 "Bu H F F OH H H X-34-5 'Bu H H CH 2 Ph "Bu H F F OH H H X-34-6 'Bu H H CH 2 -indol-3-yl "Bu H F F OH H H X-34-7 'Bu H H CH 2
CH
2
SCH
3 "Bu H F F OH H H X-34-8 'Bu * H * "Bu H F F OH H H *Rand R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table X-35. Ne R' R 2
R
3 a R 3 b R' R' R 6 X Y R 7 R X-35-1. Ph H H H "Bu H F F OH H H X-35-2 Ph H H CH 3 "Bu H F F OH H H X-35-3 Ph H H CH(CH 3
)
2 "Bu H F F OH H H X-35-4 Ph H H CH 2
CH(CH
3
)
2 "Bu H F F OH H H X-35-5 Ph H H CH 2 Ph "Bu H F F OH H H X-35-6 Ph H H CH2-indol-3-yl "Bu H F F OH H H X-35-7 Ph H H CH 2
CH
2
SCH
3 "Bu H F F OH H H X-35-8 Ph * H * "Bu H F F OH H H *R and R3b joined together by (CH 2
)
3 to form five-membered ring.
IIA
Table X-36. X2 R 2 R a R 3 b R' R' R 6 X Y R' R' X-36-1 p-Me-Ph H H H "Bu H F F OH H H X-36-2 p-Me-Ph H H CH 3 "Bu H F F OH H H X-36-3 p-Me-Ph H H CH(CH 3
)
2 "Bu H F F OH H H X-36-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 "Bu H F F OH H H X-36-5 p-Me-Ph H H CH 2 Ph "Bu H F F OH H H X-36-6 p-Me-Ph H H CH 2 -indol-3-yl "Bu H F F OH H H X-36-7 p-Me-Ph H H CH 2
CH
2
SCH
3 "Bu H F F OH H H X-36-8 p-Me-Ph * H * "Bu H F F OH H H *R and Rib joined together by (CH 2
)
3 to form five-membered ring. Table X-37. N2 Rl R 2
R
3 a R 3 b R 4 R' R 6 X Y R RY X-37-1 p-F-Ph H H H "Bu H F F OH H H X-37-2 p-F-Ph H H CH 3 "Bu H F F OH H H X-37-3 p-F-Ph H H CH(CH 3
)
2 "Bu H F F OH H H X-37-4 p-F-Ph H H CH 2
CH(CH
3
)
2 "Bu H F F OH H H X-37-5 p-F-Ph H H CH 2 Ph "Bu H F F OH H H X-37-6 p-F-Ph H H CH 2 -indol-3-yl "Bu H F F OH H H X-37-7 p-F-Ph H H CH 2
CH
2
SCH
3 "Bu H F F OH H H X-37-8 p-F-Ph * H * "Bu H F F OH H H
*R
2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table X-38. N2 Rl R 2
R
3 2 R b R 4 R' R 6 X Y RT RT X-38-1 p-Cl-Ph H H H "Bu H F F OH H H X-38-2 p-Cl-Ph H H CH 3 "Bu H F F OH H H X-38-3 p-Cl-Ph H H CH(CH 3
)
2 "Bu H F F OH H H X-38-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 "Bu H F F OH H H X-38-5 p-Cl-Ph H H CH 2 Ph "Bu H F F OH H H X-38-6 p-Cl-Ph H H CI-1 2 -indol-3-yl "Bu H F F OH H H X-38-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 "Bu H F F OH H H X-38-8 p-Cl-Ph * H * "Bu H F F OH H H *R' and Rib joined together by (CH 2
)
3 to form five-membered ring.
Table X-39. N2 R' R 2
R
3 a R 3 b R 4 R R X Y R' R X-39-1 p-Br-Ph H H H "Bu H F F OH H H X-39-2 p-Br-Ph H H CH 3 "Bu H F F OH H H X-39-3 p-Br-Ph H H CH(CH 3
)
2 "Bu H F F OH H H X-39-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 "Bu H F F OH H H X-39-5 p-Br-Ph H H CH 2 Ph "Bu H F F OH H H X-39-6 p-Br-Ph H H CH 2 -indol-3-yl "Bu H F F OH H H X-39-7 p-Br-Ph H H CH 2
CH
2
SCH
3 "Bu H F F OH H H X-39-8 p-Br-Ph * H * "Bu H F F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table X-40. N R R 2
R
3 a R3b R R R X Y R R X-40-1 p-I-Ph H H H "Bu H F F OH H H X-40-2 p-I-Ph H H CH 3 "Bu H F F OH H H X-40-3 p-I-Ph H H CH(CH 3
)
2 "Bu H F F OH H H X-40-4 p-I-Ph H H CH 2
CH(CH
3
)
2 "Bu H F F OH H H X-40-5 p-I-Ph H H CH 2 Ph "Bu H F F OH H H X-40-6 p-I-Ph H H CH 2 -indol-3-yl "Bu H F F OH H H X-40-7 p-I-Ph H H CH 2
CH
2
SCH
3 "Bu H F F OH H H X-40-8 p-I-Ph * H * "Bu H F F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table X-41. X2 R1 R2 R 3 a R 3 b R4 R' R 6 X Y R 7 RF X-41-1 CH 3 H H H Bz H F F OH H *H X-41-2 CH 3 H H CH 3 Bz H F F OH H H X-41-3 CH 3 H H CH(CH 3
)
2 Bz H F F OH H H X-41-4 CH 3 H H CH 2
CH(CH
3
)
2 Bz H F F OH H H X-41-5 CH 3 H H CH 2 Ph Bz H F F OH H H X-41-6 CH 3 H H CH 2 -indol-3-yl Bz H F F OH H H X-41-7 CH 3 H H CH 2
CH
2
SCH
3 Bz H F F OH H H X-41-8 CH 3 * H * Bz H F F OH H H
*R
2 and Rib joined together by (CH 2
)
3 to form five-membered ring.
Table X-42. N2 R' R 2
R
3 a R 3 b R 4 R' R' X Y R 7
R
8 X-42-1 Et H H H Bz H F F OH H H X-42-2 Et H H CH 3 Bz H F F OH H H X-42-3 Et H H CH(CH 3
)
2 Bz H F F OH H H X-42-4 Et H H CH 2
CH(CH
3
)
2 Bz H F F OH H H X-42-5 Et H H CH 2 Ph Bz H F F OH H H X-42-6 Et H H CH 2 -indol-3-yl Bz H F F OH H H X-42-7 Et H H CH 2
CH
2
SCH
3 Bz H F F OH H H X-42-8 Et * H * Bz H F F OH H H R and RJb joined together by (CH 2
)
3 to form five-membered ring. Table X-43. X2 R' R 2
R
3 a R 3 b R 4 R' R 6 X Y R' R' X-43-1 'Pr H H H Bz H F F OH H H X-43-2 'Pr H H CH 3 Bz H F F OH H A X-43-3 'Pr H H CH(CH 3
)
2 Bz H F F OH H H X-43-4 'Pr H H CH 2
CH(CH
3
)
2 Bz H F F OH H H X-43-5 'Pr H H CH 2 Ph Bz H F F OH H H X-43-6 'Pr H H CH 2 -indol-3-yl Bz H F F OH H H X-43-7 'Pr H H CH 2
CHSCH
3 Bz H F F OH H H X-43-8 'Pr * H * Bz H F F OH H H 10 *R 2 and R joined together by (CH 2
)
3 to form five-membered ring. Table X-44. NV R' R 2
R
3 a R3b R4 R' R 6 X Y R 7 Rs X-44-1 'Bu H H H Bz H F F OH H H X-44-2 'Bu H H CH 3 Bz H F F OH H H X-44-3 'Bu H H CH(CH 3
)
2 Bz H F F OH H H X-44-4 'Bu H H CH 2
CH(CH
3
)
2 Bz H F F OH H H X-44-5 'Bu H H CH 2 Ph Bz H F F OH H H X-44-6 'Bu H H CH 2 -indol-3-yl Bz H F F OH H H X-44-7 'Bu H H CH 2
CH
2
SCH
3 Bz H F F OH H H X-44-8 'Bu * H * Bz H F F OH H H *R2and R 3 b joined together by (CH 2
)
3 to form five-membered ring. -N-7 -7 Table X-45. N2 RI R 2
R
3 a R 3 b R 4 R' R 6 X Y R' R' X-45-1 Ph H H H Bz H F F OH H H X-45-2 Ph H H CH 3 Bz H F F OH H H X-45-3 Ph H H CH(CH 3
)
2 Bz H F F OH H H X-45-4 Ph H H CH 2
CH(CH
3
)
2 Bz H F F OH H H X-45-5 Ph H H CH 2 Ph Bz H F F OH H H X-45-6 Ph H H CH 2 -indol-3-yl Bz H F F OH H H X-45-7 Ph H H CH 2
CH
2
SCH
3 Bz H F F OH H H X-45-8 Ph * H * Bz H F F OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table X-46. N2 Rl R 2
R
3 a R 3 b R4 R' R 6 X Y R 7 RR X-46-1 p-Me-Ph H H H- Bz H F F OH H H X-46-2 p-Me-Ph H H CH 3 Bz H F F OH H H X-46-3 p-Me-Ph H H CH(CH 3
)
2 Bz H F F OH H H X-46-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Bz H F F OH H H X-46-5 p-Me-Ph H H CH 2 Ph Bz H F F OH H H X-46-6 p-Me-Ph H H CH 2 -indol-3-yl Bz H F F OH H H X-46-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Bz H F F OH H H X-46-8 p-Me-Ph * H * Bz H F F OH H H
*RF
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table X-47. N R2R 2
R
3 " Rb R 4 R'R X Y R' R X-47-1 p-F-Ph H H H Bz H F F OH H H X-47-2 p-F-Ph H H CH 3 Bz H F F OH H H X-47-3 p-F-Ph H H CH(CH 3
)
2 Bz H F F OH H H X-47-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Bz H F F OH H H X-47-5 p-F-Ph H H CH 2 Ph Bz H F F OH H H X-47-6 p-F-Ph H H CH 2 -indol-3-yl Bz H F F OH H H X-47-7 p-F-Ph H H CH 2
CH
2
SCH
3 Bz H F F OH H H X-47-8 p-F-Ph * H * Bz H F F OH H H *R and R-b joined together by (CH 2
)
3 to form five-membered ring. Table X-48. N2 Rl R 2
R
3 a R R 4 R R 6 X Y R' R N2 Rl R 2
R
3
R
3 b R' R' R' X Y Ri R X-48-1 p-Cl-Ph H H H Bz H F F OH H H X-48-2 p-Cl-Ph H H CH 3 Bz H F F OH H -H X-48-3 p-Cl-Ph H H CH(CH 3
)
2 Bz H F F OH H H X-48-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Bz H F F OH H H X-48-5 p-Cl-Ph H H CH 2 Ph Bz H F F OH H H X-48-6 p-Cl-Ph H H CH 2 -indol-3-yl Bz H F F OH H H X-48-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Bz H F F OH H H X-48-8 p-Cl-Ph * H * Bz H F F OH H H *R2 and Rob joined together by (CH 2
)
3 to form five-membered ring. Table X-49. N Rl R 2
R
3 a R 3 b R' R' R 6 X Y R R X-49-1 p-Br-Ph H H H Bz H F F OH H H X-49-2 p-Br-Ph H H CH 3 Bz H F F OH H H X-49-3 p-Br-Ph H H CH(CH 3
)
2 Bz H F F OH H H X-49-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Bz H F F OH H H X-49-5 p-Br-Ph H H CH 2 Ph Bz H F F OH H H X-49-6 p-Br-Ph H H CH 2 -indol-3-yl Bz H F F OH H H X-49-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Bz H F F OH H H X-49-8 p-Br-Ph * H * Bz H F F OH H H *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table X-50. N2 R R2 R 3 a R 3 b R 4 R' R' X Y R' R X-50-:1 p-I-Ph H H H Bz H F F OH H H X-50-2 p-I-Ph H H CH 3 Bz H F F OH H H X-50-3 p-I-Ph H H CH(CH 3
)
2 Bz H F F OH H H X-50-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Bz H F F OH H H X-50-5 p-I-Ph H H CH 2 Ph Bz H F F OH H H X-50-6 p-I-Ph H H CH 2 -indol-3-yl Bz H F F OH H H X-50-7 p-I-Ph H H CH 2
CH
2
SCH
3 Bz H F F OH H H X-50-8 p-I-Ph * H * Bz H F F OH H H 5 *R2 and R-b joined together by (CH 2
)
3 to form five-membered ring.
0 R8 NH
R
3 b R 0 R N 0 R3a N - P-O O C0 2
R
4 OR R R6 Y X XI Table XI- 1. N2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y R' R' XI-1-1 CH 3 H H H CH3 H H F OH H H XI-1-2 CH 3 H H CH 3
CH
3 H H F OH H H XI-1-3 CH 3 H H CH(CH 3
)
2
CH
3 H H F OH H H XI-1-4 CH 3 H H CH 2
CH(CH
3
)
2
CH
3 H H F OH H H XI-1-5 CH 3 H H CH 2 Ph CH 3 H H F OH H H XI-1-6 CH 3 H H CH 2 -indol-3-yl CH 3 H H F OH H H XI-1-7 CH 3 H H CH 2
CI
2
SCH
3
CH
3 H H F OH H H XI-1-8 CH 3 * H * CH 3 H H F OH H H *R and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XI-2. N2 RI R 2
R
3 a R 3 b R 4 R' R 6 X Y R' R' XI-2-1 Et H H H CH 3 H H F OH H H XI-2-2 Et H H CH 3
CH
3 H H F OH H H XI-2-3 Et H H CH(CH 3
)
2
CH
3 H H F OH H H XI-2-4 Et H H CH 2
CH(CH
3
)
2
CH
3 H H F OH H H XI-2-5 Et H H CH 2 Ph CH 3 H H F OH H H XI-2-6 Et H H CH 2 -indol-3-yl CH 3 H H F OH H H XI-2-7 Et H H CH 2
CH
2
SCH
3
CH
3 H H F OH H H XI-2-8 Et * H * CH 3 H H F OH H H
R
2 and Ri joined together by (CH 2
)
3 to form five-membered ring.
Table XI-3. NX RI R 2
R
3 a R 3 b R 4 R5 R' X Y R 7
R
8 XI-3-1 'Pr H H H CH 3 H H F OH H H XI-3-2 'Pr H H CH 3
CH
3 H H F OH H H XI-3-3 'Pr H H CH(CH 3
)
2
CH
3 H H F OH H H XI-3-4 'Pr H H CH 2
CH(CH
3
)
2
CH
3 H H F OH H H XI-3-5 'Pr H H CH 2 Ph CH 3 H H F OH H H XI-3-6 'Pr H H CH 2 -indol-3-yl CH 3 H H F OH H H XI-3-7 'Pr H H CH 2
CHSCH
3
CH
3 H H F OH H H XI-3-8 'Pr * H * CH 3 H H F OH H H R2 and Rb joined together by (CH 2
)
3 to form five-membered ring. Table XI-4. N2 R' R 2 R3a R 3b R R ' R R6 X Y R' R' XI-4-1 'Bu H H H CH 3 H H F OH H H XI-4-2 'Bu H H CH 3
CH
3 H H F OH H H XI-4-3 'Bu H H CH(CH 3
)
2
CH
3 H H F OH H H XI-4-4 'Bu H H CH 2
CH(CH
3
)
2
CH
3 H H F OH H H XI-4-5 'Bu H H CH 2 Ph CH 3 H H F OH H H XI-4-6 'Bu H H CH 2 -indol-3-yl CH 3 H H F OH H H XI-4-7 'Bu H H CH 2
CH
2
SCH
3
CH
3 H H F OH H H XI-4-8 'Bu * H * CH 3 H H F OH H H R and R3b joined together by (CH2)3 to form five-membered ring. 5 Table XI-5. N2 R' R 2 R3a R 3 b R 4 R' R6 X Y R' R' XI-5-1 Ph H H H CH 3 H H F OH H H XI-5-2 Ph H H CH 3
CH
3 H H F OH H H XI-5-3 Ph H H CH(CH 3
)
2
CH
3 H H F OH H H XI-5-4 Ph H H CH 2
CH(CH
3
)
2
CH
3 H H F OH H H XI-5-5 Ph H H CH2Ph CH 3 H H F OH H H XI-5-6 Ph H H CH 2 -indol-3-yl CH 3 H H F OH H H XI-5-7 Ph H H CH 2
CH
2
SCH
3
CH
3 H H F OH H H XI-5-8 Ph * H * CH 3 H H F OH H H *R' and R3b joined together by (CH 2
)
3 to form five-membered ring. 101 Table XI-6. N2 R R2 R3a R 3 b R 4 R' R 6 X Y R 7 R 8 XI-6-1 p-Me-Ph H H H CH 3 H H F OH H H XI-6-2 p-Me-Ph H H CH 3
CH
3 H H F OH H H XI-6-3 p-Me-Ph H H CH(CH 3
)
2
CH
3 H H F OH H H XI-6-4 p-Me-Ph H H CH 2
CH(CH
3
)
2
CH
3 H H F OH H H XI-6-5 p-Me-Ph H H CH 2 Ph CH 3 H H F OH H H XI-6-6 p-Me-Ph H H CH 2 -indol-3-yl CH 3 H H F OH H H XI-6-7 p-Me-Ph H H CH 2
CH
2
SCH
3
CH
3 H H F OH H H XI-6-8 p-Me-Ph * H * CH 3 H H F OH H H *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XI-7. N2 Rl R 2
R
3 a Rab R 4 R' R' X Y R 7
R
8 XI-7-1 p-F-Ph H H H CH 3 H H F OH H H XI-7-2 p-F-Ph H H CH 3
CH
3 H H F OH H H XI-7-3 p-F-Ph H H CH(CH 3
)
2
CH
3 H H F OH H H XI-7-4 p-F-Ph H H CH 2
CH(CH
3
)
2
CH
3 H H F OH H H XI-7-6 p-F-Ph H H CH 2 Ph CH 3 H H F OH H H XI-7-7 p-F-Ph H H CH 2 -indol-3-yl CH 3 H H F OH H H XI-7-8 p-F-Ph H H CH 2
CH
2
SCH
3
CH
3 H H F OH H H XI-7-20 p-F-Ph * H * CH 3 H H F OH H H *RTand R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XI-8. N RR 2
R
3 a R 3 b R R' R' X Y R R XI-8-1 p-Cl-Ph H H H CH 3 H H F OH H H XI-8-2 p-Cl-Ph H H CH 3
CH
3 H H F OH H H XI-8-3 p-Cl-Ph H H CH(CH 3
)
2
CH
3 H H F OH H H XI-8-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2
CH
3 H H F OH H H XI-8-5 p-Cl-Ph H H CH 2 Ph CH 3 H H F OH H H XI-8-6 p-Cl-Ph H H CH 2 -indol-3-yi CH 3 H H F OH H H XI-8-7 p-Cl-Ph H H CH 2
CH
2
SCH
3
CH
3 H H F OH H H XI-8-8 p-Cl-Ph * H * CH 3 H H F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. -~ Q'I Table XI-9. N2 R' R 2
R
3 a R 3 b R 4 R' R' X Y R 7
R
8 XI-9-1 p-Br-Ph H H H CH 3 H H F OH H H XI-9-2 p-Br-Ph H H CH 3
CH
3 H H F OH H H XI-9-3 p-Br-Ph H H CH(CH 3
)
2
CH
3 H H F OH H H XI-9-4 p-Br-Ph H H CH 2
CH(CH
3
)
2
CH
3 H H F OH H H XI-9-6 p-Br-Ph H H CH 2 Ph CH 3 H H F OH H H XI-9-7 p-Br-Ph H H CH 2 -indol-3-yl CH 3 H H F OH H H XI-9-8 p-Br-Ph H H CH 2
CH
2
SCH
3
CH
3 H H F OH H H XI-9-20 p-Br-Ph * H * CH 3 H H F OH H H
*R
2 and RJb joined together by (CH 2
)
3 to form five-membered ring. Table XI-10. X2 R R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7
R
8 XI-10-1 p-I-Ph H H H CH 3 H H F OH H H XI-10-2 p-I-Ph H H CH 3
CH
3 H H F OH H H XI-10-3 p-I-Ph H H CH(CH 3
)
2
CH
3 H H F OH H H XI-10-4 p-I-Ph H H CH1 2
CH(CH
3
)
2
CH
3 H H F OH H H XI-10-5 p-I-Ph H H CH 2 Ph CH 3 H H F OH H H XI-10-6 p-I-Ph H H CH 2 -indol-3-yl CH 3 H H F OH H H XI-10-7 p-I-Ph H H CH1 2
CH
2
SCH
3
CH
3 H H F OH H H XI-10-8 p-I-Ph * H * CH 3 H H F OH H H *R2Tand R b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XI-11. X2 R' R2 R 3 a R 3 b R 4 R' R' X Y R 7 R' XI-11-1 CH 3 H H H Et H H F OH H H XI-11-2 CH 3 H H CH 3 Et H H F OH H H XI-11-3 CH 3 H H CH(CH 3
)
2 Et H H F OH H H XI-11-4 CH 3 H H CH 2
CH(CH
3
)
2 Et H H F OH H H XI-11-5 CH 3 H H CH 2 Ph Et H H F OH H H XI-11-6 CH 3 H H CH 2 -indol-3-yi Et H H F OH H H XI-11-7 CH 3 H H CH 2
CH
2
SCH
3 Et H H F OH H H XI-11-8 CH 3 * H * Et H H F OH H H *R2 and Rab joined together by (CH 2
)
3 to form five-membered ring.
Table XI-12. X2 R' R2 R3a R3b R 4 R' R' X Y R' R' XI-12-1 Et H H H Et H H F OH H H XI-12-2 Et H H CH 3 Et H H F OH H H XI-12-3 Et H H CH(CH 3
)
2 Et H H F OH H H XI-12-4 Et H H CH 2
CH(CH
3
)
2 Et H H F OH H H XI-12.-5 Et H H CH 2 Ph Et H H F OH H H XI-12-6 Et H H CH 2 -indol-3-yi Et H H F OH H H XI-12-7 Et H H CH 2
CH
2
SCH
3 Et H H F OH H H XI-12-8 Et* H * Et H H F OH H H *R2Tand R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XI-13. N2 R' R 2
R
3 a R 3 b R 4 R' R' X Y R' R 8 XI-13-1 'Pr H H H Et H H F OH H H XI-13-2 'Pr H H CH 3 Et H H F OH H H XI-13-3 'Pr H H CH(CH 3
)
2 Et H H F OH H H XI-13-4 'Pr H H CH 2
CH(CH
3
)
2 Et H H F OH H H XI-13-5 'Pr H H CH 2 Ph Et H H F OH H H XI-13-6 'Pr H H CH 2 -indol-3-yl Et H H F OH H H XI-13-7 'Pr H H CH 2
CH
2
SCH
3 Et H H F OH H H XI-13-8 'Pr * H * Et H H F OH H H *RTaiid R 3 b joined together by (CH 2
)
3 to form five-membered ing. 5 Table XI-14. N2 R1 R 2 R a R 3 b R 4 R' R 6 X Y R 7
R
8 XI-14-1 'Bu H H H Et H H F OH H H XI-14-2 'Bu H H CH 3 Et H H F OH H H XI-14-3 'Bu H H CH(CH 3
)
2 Et H H F OH H H XI-14-4 'Bu H H CH 2
CH(CH
3
)
2 Et H H F OH H H XI-14-5 'Bu H H CH 2 Ph Et H H F OH H H XI-14-6 'Bu H H CH 2 -indol-3-yl Et H H F OH H H XI-14-7 'Bu H H CH 2
CH
2
SCH
3 Et H H F OH H H XI-14-8 'Bu * H * Et H H F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. I )Q A Table XI-15. Xe RT R2 R 3 a R3b R 4 R' R' X Y R' R' XI-15-1 Ph H H H Et H H F OH H H XI-15-2 Ph H H CH 3 Et H H. F OH H H XI-15-3 Ph H H CH(CH 3
)
2 Et H H F OH H H XI-15-4 Ph H H CH 2
CH(CH
3
)
2 Et H H F OH H H XI-15-5 Ph H H CH 2 Ph Et H H F OH H H XI-15.-6 Ph H H CH 2 -indol-3-yl Et H H F OH H H XI-15..7 Ph H H CH 2
CH
2
SCH
3 Et H H F OH H H XI-15--8 Ph * H * Et H H F OH H H
*R
2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XI-16. X R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7
R
8 XI-16-1 p-Me-Ph H H H Et H H F OH H H XI-16-2 p-Me-Ph H H CH 3 Et H H F OH H H XI-16-3 p-Me-Ph H H CH(CH 3
)
2 Et H H F OH H H XI-16-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Et H H F OH H H XI-16-5 p-Me-Ph H H CH 2 Ph Et H H F OH H H XI-16-6 p-Me-Ph H H CH 2 -indol-3-yl Et H H F OH H H XI-16-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Et H H F OH H H XI-16-8 p-Me-Ph * H * Et H H F OH H H *R2and Ri joined together by (CH 2
)
3 to form five-membered ring. 5 Table XI-17. Xe R R 2
R
3 a R3b R 4 R' R 6 X Y R' R' XI-17-1 p-F-Ph H H H Et H H F OH H H XI-17-2 p-F-Ph H H CH 3 Et H H F OH H H XI-17-3 p-F-Ph H H CH(CH 3
)
2 Et H H F OH H H XI-17-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Et H H F OH H H XI-17-5 p-F-Ph H H CH 2 Ph Et H H F OH H H XI-17-6 p-F-Ph H H CH 2 -indol-3-yl Et H H F OH H H XI-17-7 p-F-Ph H H CH 2
CH
2
SCH
3 Et H H F OH H H XI-17-8 p-F-Ph * H * Et H H F OH H H *R" and RIb joined together by (CH 2
)
3 to form five-membered ring.
Table XI-18. N2 RT R 2
R
3 a R 3 b R 4 R' R' X Y R' R' XI-18-1 p-Cl-Ph H H H Et H H F OH H H XI-18-2 p-Cl-Ph H H CH 3 Et H H F OH H H XI-18-3 p-Cl-Ph H H CH(CH 3
)
2 Et H H F OH H H XI-18-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Et H H F OH H H XI-18-5 p-Cl-Ph H H CH 2 Ph Et H H F OH H H XI-18--6 p-Cl-Ph H H CH 2 -indol-3-yl Et H H F OH H H XI-18--7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Et H H F OH H H XI-18-8 p-Cl-Ph * H * Et H H F OH H H *R and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XI-1 9. 2 R R 2
R
3 a Rb R 4 R' R' X Y R' R XI-19-1 p-Br-Ph H H H Et H H F OH H H XI-19-2 p-Br-Ph H H CH 3 Et H H F OH H H XI-19-3 p-Br-Ph H H CH(CH 3
)
2 Et H H F OH H H XI-19-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Et H H F OH H H XI-19-5 p-Br-Ph H H CH 2 Ph Et H H F OH H H XI-19-6 p-Br-Ph H H CH 2 -indol-3-yl Et H H F OH H H XI-19-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Et H H F OH H H XI-19-8 p-Br-Ph * H * Et H H F OH H H *Riand R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XI-20. N2 R' R2 R 3 a R 3 b R' R' R 6 X Y R'R 8 XI-20-1 p-I-Ph H H H Et H H F OH H H XI-20-2 p-I-Ph H H CH 3 Et H H F OH H H XI-20-3 p-I-Ph H H CH(CH 3
)
2 Et H H F OH H H XI-20-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Et H H F OH H H XI-20-5 p-I-Ph H H CH 2 Ph Et H H F OH H H XI-20-6 p-I-Ph H H CH2-indol-3-yl Et H H F OH H H XI-20-7 p-I-Ph H H CH 2
CH
2
SCH
3 Et H H F OH H H XI-20-8 p-I-Ph * H * Et H H F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 104 Table XI-21. N2 R' R 2
R
3 aRb R R R 6 X Y R' R' XI-21-1 CH 3 H H H 'Pr H H F OH H H XI-21-2 CH 3 H H CH 3 'Pr H H F OH H H XI-21-3 CH 3 H H CH(CH 3
)
2 'Pr H H F OH H H XI-21-4 CH 3 H H CH 2
CH(CH
3
)
2 'Pr H H F OH H H XI-21-5 CH 3 H H CH 2 Ph 'Pr H H F OH H H XI-21-6 CH 3 H H CH 2 -indol-3-yl 'Pr H H F OH H H XI-21-7 CH 3 H H CH 2
CH
2
SCH
3 'Pr H H F OH H H XI-21-8 CH 3 * H * 'Pr H H F OH H H *R aid Rab joined together by (CH 2
)
3 to form five-membered ring. Table XI-22. 2 RI R 2
R
3 a R R' R' X Y R 7
R
8 XI-22-1 Et H H H 'Pr H H F OH H H XI-22-2 Et H H CH 3 'Pr H H F OH H H XI-22-3 Et H H CH(CH 3 )2 'Pr H H F OH H H XI-22-4 Et H H CH 2
CH(CH
3
)
2 'Pr H H F OH H H XI-22-5 Et H H CH 2 Ph 'Pr H H F OH H H XI-22-6 Et H H CH 2 -indol-3-yl 'Pr H H F OH H H XI-22-7 Et H H CH 2
CH
2
SCH
3 'Pr H H F OH H H XI-22-8 Et * H * 'Pr H H F OH H H *R and R joined together by (CH 2
)
3 to form five-membered ring. 5 Table XI-23. N2 R' R2 R 3 a R 3 b R4 R' R' X Y R 7
R
8 XI-23-1 'Pr H H H 'Pr H H F OH H H XI-23-2 'Pr H H CH 3 'Pr H H F OH H H XI-23-3 'Pr H H CH(CH 3
)
2 'Pr H H F OH H H XI-23-4 'Pr H H CH 2
CH(CH
3
)
2 'Pr H H F OH H H XI-23-5 'Pr H H CH 2 Ph 'Pr H H F OH H H XI-23-6 'Pr H H CH 2 -indol-3-yl 'Pr H H F OH H H XI-23-7 'Pr H H CH 2
CH
2
SCH
3 'Pr H H F OH H H XI-23-8 'Pr * H * 'Pr H H F OH H H *R and R b joined together by (CH 2
)
3 to form five-membered ring. '107 Table XI-24. X R' R 2 Ra Rb R R R X Y R' R' XI-24-1 'Bu H H H 'Pr H H F OH H H XI-24-2 'Bu H H CH 3 'Pr H H F OH H H XI-24-3 'Bu H H CH(CH 3
)
2 'Pr H H F OH H H XI-24-4 'Bu H H CH 2
CH(CH
3
)
2 'Pr H H F OH H H XI-24-5 'Bu H H CH 2 Ph 'Pr H H F OH H H XI-24-6 'Bu H H CH 2 -indol-3-yi 'Pr H H F OH H H XI-24-7 'Bu H H CH 2
CH
2
SCH
3 'Pr H H F OH H H XI-24-8 'Bu * H * 'Pr H H F OH H H *R2 and R- 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XI-25. N2 RI R 2
R
3 a R 3 b R4 R'R R X Y R' R" XI-25-1 Ph H H H 'Pr H H F OH H H XI-25-2 Ph H H CH 3 'Pr H H F OH H H XI-25-3 Ph H H CH(CH 3
)
2 'Pr H H F OH H H XI-25-4 Ph H H CH 2
CH(CH
3
)
2 'Pr H H F OH H H XI-25-5 Ph H H CH 2 Ph 'Pr H H F OH H H XI-25-6 Ph H H CH 2 -indol-3-yl 'Pr H H F OH H H XI-25-7 Ph H H CH 2
CH
2
SCH
3 'Pr H H F OH H H XI-25-8 Ph * H * 'Pr H H F. OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XI-26.
NRR
2 Ra Rob R 4 R R 6 X Y R R XI-26-1 p-Me-Ph H H H 'Pr H H F OH H H XI-26-2 p-Me-Ph H H CH 3 'Pr H H F OH H H XI-26-3 p-Me-Ph H H CH(CH 3
)
2 'Pr H H F OH H H XI-26-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 'Pr H H F OH H H XI-26-5 p-Me-Ph H H CH 2 Ph 'Pr H H F OH H H XI-26-6 p-Me-Ph H H CH 2 -indol-3-yl 'Pr H H F OH H H XI-26-7 p-Me-Ph H H CH 2
CH
2
SCH
3 'Pr H H F OH H H XI-26-8 p-Me-Ph * H * 'Pr H H F OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring.
QQ
Table XI-27. 2 R R 2
R
3 a R 3 b R 4 R' R 6 X Y R' R' XI-27-1 p-F-Ph H H H 'Pr H H F OH H H XI-27-2 p-F-Ph H H CH 3 'Pr H H F OH H H XI-27-3 p-F-Ph H H CH(CH 3
)
2 'Pr H H F OH H H XI-27-4 p-F-Ph H H CH 2
CH(CH
3
)
2 'Pr H H F OH H H XI-27-5 p-F-Ph H H CH 2 Ph 'Pr H H F OH H H XI-27-6 p-F-Ph H H CH 2 -indol-3-yl 'Pr H H F OH H H XI-27-7 p-F-Ph H H CH 2
CH
2
SCH
3 'Pr H H F OH H H XI-27-8 p-F-Ph * H * 'Pr H H F OH H H *R2 and R t joined together by (CH 2
)
3 to form five-membered ring. Table XI-28. X2 R R2 R aR 3 b R' R' R 6 X Y R' R 8 XI-28-1 p-Cl-Ph H H H 'Pr H H F OH H H XI-28-2 p-Cl-Ph H H CH 3 'Pr H H F OH H H XI-28-3 p-Cl-Ph H H CH(CH 3
)
2 'Pr H H F OH H H XI-28-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 'Pr H H F OH H H XI-28-5 p-Cl-Ph H H CH 2 Ph 'Pr H H F OH H H XI-28-6 p-Cl-Ph H H CH 2 -indol-3-yl 'Pr H H F OH H H XI-28-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 'Pr H H F OH H H XI-28-8 p-Cl-Ph * H * 'Pr H H F OH H H T3b *R and R joined together by (CH 2
)
3 to form five-membered ring. 5 Table XI-29. N! R1 R 2
R
3 a Rib R' R R R6 X Y R' R' XI-29-1 p-Br-Ph H H H 'Pr H H F OH H H XI-29-2 p-Br-Ph H H CH 3 'Pr H H F OH H H XI-29-3 p-Br-Ph H H CH(CH 3
)
2 'Pr H H F OH H H XI-29-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 'Pr H H F OH H H XI-29-5 p-Br-Ph H H CH 2 Ph 'Pr H H F OH H H XI-29-6 p-Br-Ph H H CH 2 -indol-3-yl 'Pr H H F OH H H XI-29-7 p-Br-Ph H H CH 2
CH
2
SCH
3 'Pr H H F OH H H XI-29-8 p-Br-Ph * H * 'Pr H H F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. - 'QQ Table XI-30. 7 2 3a 3b67 8 S R R 2
R
3 aR Rb R 4 R R XY R' R XI-30-1 p-I-Ph H H H 'Pr H H F OH H H XI-30-2 p-I-Ph H H CI 3 'Pr H H F OH H H XI-30-3 p-I-Ph H H CH(CH 3
)
2 'Pr H H F OH H H XI-30-4 p-I-Ph H H CH 2
CH(CH
3
)
2 'Pr H H F OH H H XI-30-5 p-I-Ph H H CH 2 Ph 'Pr H H F OH H H XI-30-6 p-I-Ph H H CH 2 -indol-3-yl 'Pr H H F OH H H XI-30-7 p-I-Ph H H CH 2
CH
2
SCH
3 'Pr H H F OH H H XI-30-8 p-I-Ph * H * 'Pr H H F OH H H *R2 and R'b joined together by (CH 2
)
3 to form five-membered ring. Table XI-31. X2 R' R2 Ra Rb R4 R' Ra R' R XI-31-1 CH 3 H H H "Bu H H F OH H H XI-31-2 CH 3 H H CH 3 "Bu H H F OH H H XI-31-3 CH 3 H H CH(CH 3
)
2 "Bu H H F OH H H XI-31-4 CH 3 H H CH 2
CH(CH
3
)
2 "Bu H H F OH H H XI-31-5 CH 3 H H CH 2 Ph "Bu H H F OH H H XI-31-6 CH 3 H H CH 2 -indol-3-yl "Bu H H F OH H H XI-31-7 CH 3 H H CH 2
CH
2
SCH
3 "Bu H H F OH H H XI-31-8 CH 3 * H * "Bu H H F OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XI-32. N2 R1 R2 R 3a Rab - R4 R' R 6 X Y R' R' XI-32-1 Et H H H "Bu H H F OH H H XI-32-2 Et H H CH 3 "Bu H H F OH H H XI-32-3 Et H H CH(CH 3
)
2 "Bu H H F OH H H XI-32-4 Et H H CH 2
CH(CH
3
)
2 "Bu H H F OH H H XI-32-5 Et H H CH 2 Ph "Bu H H F OH H H XI-32-6 Et H H CH 2 -indol-3-yl "Bu H H F OH H H XI-32-7 Et H H CH 2
CH
2
SCH
3 "Bu H H F OH H H XI-32-8 Et * H * "Bu H H F OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XI-33. X2 RT R 2
R
3 a R 3 b R 4 R' R 6 X Y R' R' XI-33-1 'Pr H H H "Bu H H F OH H H XI-33-2 'Pr H H CH 3 "Bu H H F OH H H XI-33-3 'Pr H H CH(CH 3
)
2 "Bu H H F OH H H XI-33-4 'Pr H H CH 2
CH(CH
3
)
2 "Bu H H F OH H H XI-33-5 'Pr H H CH 2 Ph "Bu H H F OH H H XI-33-6 'Pr H H CH 2 -indol-3-yl "Bu H H F OH H H XI-33-7 'Pr H H CH 2
CH
2
SCH
3 "Bu H H F OH H H XI-33-8 'Pr * H * "Bu H H F OH H H *R7 and RIb joined together by (CH 2
)
3 to form five-membered ring. Table XI-34. N2 RT R 2
R
3 a R R' R' R 6 X Y R' R' XI-34-1 'Bu H H H "Bu H H F OH H H XI-34-2 'Bu H H CH 3 "Bu H H F OH H H XI-34-3 'Bu H H CH(CH 3
)
2 "Bu H H F OH H H XI-34-4 'Bu H H CH 2
CH(CH
3
)
2 "Bu H H F OH H H XI-34-5 'Bu H H CH 2 Ph "Bu H H F OH H H XI-34-6 'Bu H H CH 2 -indol-3-yl "Bu H H F OH H H XI-34-7 'Bu H H CH 2
CH
2
SCH
3 "Bu H H F OH H H XI-34-8 'Bu * H * "Bu H H F OH H H *R2 and R"' joined together by (CH 2
)
3 to form five-membered ring. 5 Table XI-35. N2 R' R 2
R
3 a R 3 b R' R' R 6 X Y R' R' XI-35-1 Ph H H H "Bu H H F OH H H XI-35-2 Ph H H CH 3 "Bu H H F OH H H XI-35-3 Ph H H CH(CH 3
)
2 "Bu H H F OH H H XI-35-4 Ph H H CH 2
CH(CH
3
)
2 "Bu H H F OH H H XI-35-5 Ph H H CH2Ph "Bu H H F OH H H XI-35-6 Ph H H CH 2 -indol-3-yl "Bu H H F OH H H XI-35-7 Ph H H CH 2
CH
2
SCH
3 "Bu H H F OH H H XI-35-8 Ph * H * "Bu H H F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. (A11 Table XI-36. N2 RT R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7
R
8 XI-36-1 p-Me-Ph H H H "Bu H H F OH H H XI-36-2 p-Me-Ph H H CH 3 "Bu H H F OH H H XI-36-3 p-Me-Ph H H CH(CH 3
)
2 "Bu H H F OH H H XI-36-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 "Bu 1H 1 H F OH H H XI-36-5 p-Me-Ph H H CH 2 Ph "Bu H H F OH H H XI-36-6 p-Me-Ph H H CH 2 -indol-3-yl "Bu H H F OH H H XI-36-7 p-Me-Ph H H CH 2
CH
2
SCH
3 "Bu H H F OH H H XI-36-8 p-Me-Ph * H * "Bu H H F OH H H *R and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XI-37. N2 RT R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7 RI XI-37-1 p-F-Ph H H H "Bu H H F OH H H XI-37-2 p-F-Ph H H CH 3 "Bu H H F OH H H XI-37-3 p-F-Ph H H CH(CH 3
)
2 "Bu H H F OH H H XI-37-4 p-F-Ph H H CH 2
CH(CH
3
)
2 "Bu H H F OH H H XI-37-5 p-F-Ph H H CH 2 Ph "Bu H H F OH H H XI-37-6 p-F-Ph H H CH 2 -indol-3-yl "Bu H H F OH H H XI-37-7 p-F-Ph H H CH 2
CH
2
SCH
3 "Bu H H F OH H H XI-37-8 p-F-Ph * H * "Bu H H F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XI-38. N2 R R 2
R
3 a R b R' R' R 6 X Y R R XI-38-I p-Cl-Ph H H H "Bu H H F OH H H XI-38-2 p-Cl-Ph H H CH 3 "Bu H H F OH H H XI-38-3 p-Cl-Ph H H CH(CH 3
)
2 "Bu H H F OH H H XI-38-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 "Bu H H F OH H H XI-38-5 p-Cl-Ph H H CH 2 Ph "Bu H H F OH H H XI-38-6 p-Cl-Ph H H CH 2 -indol-3-yl "Bu H H F OH H H XI-38-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 "Bu H H F OH H H XI-38-8 p-Cl-Ph * H * "Bu H H F OH H H *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring.
Table XI-39. R2 R 2 R 3 aR 3 b R 4 R' R' X Y R' R XI-39-1 p-Br-Ph H H H "Bu H H F OH H H XI-39-2 p-Br-Ph H H CH 3 "Bu H H F OH H H XI-39-3 p-Br-Ph H H CH(CH 3
)
2 "Bu H H F OH H H XI-39-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 "Bu H H F OH H H XI-39-5 p-Br-Ph H H CH 2 Ph "Bu H H F OH H H XI-39-6 p-Br-Ph H H CH 2 -indol-3-yl "Bu H H F OH H H XI-39-7 p-Br-Ph H H CH 2
CH
2
SCH
3 "Bu H H F OH H H XI-39-8 p-Br-Ph * H * "Bu H H F OH H H *R-and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XI-40. R2 R 2
R
3 a Rb R 4 R' R' X Y R 7 R XI-40-1 p-I-Ph H H H "Bu H H F OH H H XI-40-2 p-I-Ph H H CH 3 "Bu H H F OH H H XI-40-3 p-I-Ph H H CH(CH 3
)
2 "Bu H H F OH H H XI-40-4 p-I-Ph H H CH 2
CH(CH
3
)
2 "Bu H H F OH H H XI-40-5 p-I-Ph H H CH 2 Ph "Bu H H F OH H H XI-40-6 p-I-Ph H H CH,-indol-3-yl "Bu H H F OH H H XI-40-7 p-I-Ph H H CH 2
CH
2 SCH3 "Bu H H F OH H H XI-40-8 p-I-Ph * H * "Bu H H F OH H H *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XI-41. Nf R' R 2
R
3 a R R 4 R' R 6 X Y R' R XI-41-1 CH 3 H H H Bz H H F OH H H XI-41-2 CH 3 H H CH 3 Bz H H F OH H H XI-41-3 CH 3 H H CH(CH 3
)
2 Bz H H F OH H H XI-41-4 CH 3 H H CH 2
CH(CH
3
)
2 Bz H H F OH H H XI-41-5 CH 3 H H CH 2 Ph Bz H H F OH H H XI-41-6 CH 3 H H CH 2 -indol-3-yl Bz H H F OH H H XI-41-7 CH 3 H H CH 2
CH
2
SCH
3 Bz H H F OH H H XI-41-8 CH 3 * H * Bz H H F OH H H *RT and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XI-42. 2__ 3a 3b N2 R R' R R R R' R X Y R' R' XI-42-1 Et H H H Bz H H F OH H H XI-42-2 Et H H CH 3 Bz H H F OH H H XI-42-3 Et H H CH(CH 3
)
2 Bz H H F OH H H XI-42-4 Et H H CH 2
CH(CH
3
)
2 Bz H H F OH H H XI-42-5 Et H H CH 2 Ph Bz H H F OH H H XI-42-6 Et H H CH 2 -indol-3-yl Bz H H F OH H H XI-42-7 Et H H CH 2
CH
2
SCH
3 Bz H H F OH H H XI-42-8 Et * H * Bz H H F OH H H
*R
2 and RJb joined together by (CH 2
)
3 to form five-membered ring. Table XI-43. N2 R' R 2
R
3 aRi R R R 6 X Y R 7
R
8 XI-43-.1 'Pr H H H Bz H H F OH H H XI-43-2 'Pr H H CH 3 Bz H H F OH H A XI-43-3 'Pr H H CH(CH 3
)
2 Bz H H F OH H H XI-43-4 'Pr H H CH 2
CH(CH
3
)
2 Bz H H F OH H H XI-43-5 'Pr H H CH 2 Ph Bz H H F OH H H XI-43-6 'Pr H H CH 2 -indol-3-yl Bz H H F OH H H XI-43-7 'Pr H H CH 2
CH
2 SCH3 Bz H H F OH H H XI-43-8 'Pr * H * Bz H H F OH H H 10 *R 2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XI-44. N2 RT R 2 R3a R 3 A R' R' R 6 X Y R 7 R' XI-44-1 'Bu H 1 H H Bz H H F OH H H XI-44-2 'Bu H H CH 3 Bz H H F OH H H XI-44-3 'Bu H H CH(C1 3
)
2 Bz H H F OH H H XI-44-4 'Bu H H CH 2
CH(CH
3
)
2 Bz H H F OH H H XI-44-5 'Bu H H CH 2 Ph Bz H H F OH H H XI-44-6 'Bu H H CH 2 -indol-3-yl Bz H H F OH H H XI-44-7 'Bu H H CH 2
CH
2
SCH
3 Bz H H F OH H H XI-44-8 'Bu * H * Bz H H F OH H H *RT2and Rab joined together by (CH 2
)
3 to form five-membered ring. o)A Table XI-45. N2 R' R 2 R3a R 3 b R 4 R' R' X Y R' R' XI-45-1 Ph H H H Bz H H F OH H H XI-45-2 Ph H H CH 3 Bz H H F OH H H XI-45-3 Ph H H CH(CH 3
)
2 Bz H H F OH H H XI-45-4 Ph H H CH 2
CH(CH
3
)
2 Bz H H F OH H H XI-45-5 Ph H H CH 2 Ph Bz H H F OH H H XI-45-6 Ph H H CH 2 -indol-3-yi Bz H H F OH H H XI-45-7 Ph H H CH 2
CIH
2
SCH
3 Bz H H F OH H H XI-45.-8 Ph * H * Bz H H F OH H H R and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XI-46. NR' R2 R 3 a Rb R 4 R R X Y R' R' XI-46-1 p-Me-Ph H H H Bz H H F OH H H XI-46-2 p-Me-Ph H H CH 3 Bz H H F OH H H XI-46-3 p-Me-Ph H H CH(CH 3
)
2 Bz H H F OH H H XI-46-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Bz H H F OH H H XI-46-5 p-Me-Ph H H CH 2 Ph Bz H H F OH H H XI-46-6 p-Me-Ph H H CH 2 -indol-3-yl Bz H H F OH H H XI-46-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Bz H H F OH H H XI-46-8 p-Me-Ph * H * Bz H H F OH H H R' and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XI-47. 2 R' R2 RaR6b R 4 R' R 6 X Y R 7
R
8 XI-47-1 p-F-Ph H H H Bz H H F OH H H XI-47-2 p-F-Ph H H CH 3 Bz H H F OH H H XI-47-3 p-F-Ph H H CH(CH 3
)
2 Bz H H F OH H H XI-47-4 p-F-Ph H H CH2CH(CH 3
)
2 Bz H H F OH H H XI-47-5 p-F-Ph H H CH 2 Ph Bz H H F OH H H XI-47-6 p-F-Ph H H CH-indol-3-yl Bz H H F OH H H XI-47-7 p-F-Ph H H CH 2
CH
2
SCH
3 Bz H H F OH H H XI-47-8 p-F-Ph * H * Bz H H F OH H H *RT and R 3b joined together by (CH 2
)
3 to form five-membered ring.
Table XI-48. S R R 2
R
3
R
3
R
4 R R XY R R XI-48-1 p-Cl-Ph H H H Bz H H F OH H H XI-48-2 p-Cl-Ph H H CH 3 Bz H H F OH H H XI-48-3 p-Cl-Ph H H CH(CH 3
)
2 Bz H H F OH H H XI-48-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Bz H H F OH H H XI-48-5 p-Cl-Ph H H CH 2 Ph Bz H H F OH H H XI-48-6 p-Cl-Ph H H CH 2 -indol-3-yl Bz H H F OH H H XI-48-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Bz H H F OH H H XI-48-8 p-Cl-Ph * H * Bz H H F OH H H *R and R joined together by (CH 2
)
3 to form five-membered ring. Table XI-49. 2 R ' R 2
R
3 a R 3 b R4 R' R 6 X Y R 7 R XI-49-1 p-Br-Ph H H H Bz H H F OH H H XI-49-2 p-Br-Ph H H CH 3 Bz H H F OH H H XI-49-3 p-Br-Ph H H CH(CH 3
)
2 Bz H H F OH H H XI-49-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Bz H H F OH H H XI-49-5 p-Br-Ph H H CH 2 Ph Bz H H F OH H H XI-49-6 p-Br-Ph H H CH 2 -indol-3-yl Bz H H F OH H H XI-49-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Bz H H F OH H H XI-49-8 p-Br-Ph * H Bz H H F OH H H *R1 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XI-50. N2 R R 2
R
3 a R 3 b R' R' R' X Y R R' XI-50-1 p-I-Ph H H H Bz H H F OH H H XI-50-2 p-I-Ph H H CH 3 Bz H H F OH H H XI-50-3 p-I-Ph H H CH(CH 3
)
2 Bz H H F OH H H XI-50-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Bz H H F OH H H XI-50-5 p-I-Ph H H CH 2 Ph Bz H H F OH H H XI-50-6 p-I-Ph H H CH 2 -indol-3-yl Bz H H F OH H H XI-50-7 p-I-Ph H H CH 2
CH
2
SCH
3 Bz H H F OH H H XI-50-8 p-I-Ph * H * Bz H H F OH H H *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 104oj 0 R 8
R
2 0 N O R3b 7 0P R 0 R3a, N - P - C0 2
R
4 OR' R5 R 6 Y X XII Table XII-1. N R' R 2
R
3 a R 3
R
4 R' R' X Y R/ Rs XII-1-1 CH 3 H H H CH 3
N
3 F F OH H H XI-1-2 CH 3 H H CH 3
CH
3
N
3 F F OH H H XII-1-3 CH 3 H H CH(CH 3
)
2
CH
3
N
3 F F OH H H XII-1--4 CH 3 H H CH 2
CH(CH
3
)
2
CH
3
N
3 F F OH H H XII-1-5 CH 3 H H CH 2 Ph CH 3
N
3 F F OH H H XI-1-6 CH 3 H H CH 2 -indol-3-yl CH 3
N
3 F F OH H H XII-1-7 CH 3 H H CH 2
CH
2
SCH
3
CH
3
N
3 F F OH H H XIH-1-8 CH 3 * H * CH 3
N
3 F F OH H H
*R
2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XII-2. N! R R 2 Ra R 3 b R' R' R 6 X Y R' R' XII-2-1 Et H H H CH 3
N
3 F F OH H H XII-2-2 Et H H CH 3
CH
3
N
3 F F OH H H XII-2-3 Et H H CH(CH 3
)
2
CH
3
N
3 F F OH H H XII-2-4 Et H H CH 2
CH(CH
3
)
2
CH
3
N
3 F F OH H H XI-2-5 Et H H CH 2 Ph CH 3
N
3 F F OH H H XI-2-6 Et H H CH 2 -indol-3-yl CH 3
N
3 F F OH H H XII-2-7 Et H H CH 2 CH2SCH 3
CH
3
N
3 F F OH H H XII-2-8 Et * H * CH 3
N
3 F F OH H H *R" and R3b joined together by (CH 2
)
3 to form five-membered ring. 'I 7 Table XII-3. N2 R R 2
R
3 a R 3 b R' R' R 6 X Y R 7 R XII-3-1 Pr H H H CH 3
N
3 F F OH H H XII-3-2 'Pr H H CH 3
CH
3
N
3 F F OH H H XI-3-3 'Pr H H CH(CH 3
)
2
CH
3
N
3 F F OH H H XH-3-4 'Pr H H CH 2
CH(CH
3
)
2
CH
3
N
3 F F OH H H XJI-3-5 ' Pr H H CHAP Cl- 3
N
3 F F OH H H XII-3-6 'Pr H H CH 2 -indol-3-yl CH 3
N
3 F F OH H H XII-3-7 'Pr H H CH 2
CH
2
SCH
3
CH
3
N
3 F F OH H H XII-3-8 'Pr * H * CH 3
N
3 F F OH H H *R and R joined together by (CH 2
)
3 to form five-membered ring. Table XII-4. N2 R R 2 Ra Rb R 4 R R 6 X Y R R XII-4-1 'Bu H H H CH 3
N
3 F F OH H H XII-4-2 'Bu H H CH 3
CH
3
N
3 F F OH H H XII-4-3 'Bu H H CH(CH 3
)
2
CH
3
N
3 F F OH H H XII-4-4 'Bu H H CH 2
CH(CH
3
)
2
CH
3
N
3 F F OH H H XII-4-5 'Bu H H CH 2 Ph CH 3
N
3 F F OH H H XII-4-6 'Bu H H CH2-indol-3-yl CH 3
N
3 F F OH H H XII-4-7 'Bu H H CH 2
CH
2
SCH
3
CH
3
N
3 F F OH H H XII-4-8 'Bu * H * CH 3
N
3 F F OH H H *R2 and RIb joined together by (CH 2
)
3 to form five-membered ring. 5 Table XII-5. N2 R' R 2
RR
3 b R' R' R' X Y R 7
R
8 XII-5-1 Ph H H H CH 3
N
3 F F OH H H XII-5-2 Ph H H CH 3
CH
3
N
3 F F OH H H XII-5-3 Ph H H CH(CH 3
)
2
CH
3
N
3 F F OH H H XII-5-4 Ph H H CH 2
CH(CH
3
)
2
CH
3
N
3 F F OH H H XII-5-5 Ph H H CH 2 Ph CH 3
N
3 F F OH H H XII-5-6 Ph H H CH 2 -indol-3-yl CH 3
N
3 F F OH H H XII-5-7 Ph H H CH 2 CH2SCH 3
CH
3
N
3 F F OH H H XII-5-8 Ph * H * CH 3
N
3 F F OH H H *R% and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XII-6. X2 R R 2
R
3 a R b R 4 R' R' X Y R' R' XII-6-1 p-Me-Ph H H H CH 3
N
3 F F OH H H X--6-2 p-Me-Ph H H CH 3
CH
3
N
3 F F OH H H XII-6-3 p-Me-Ph H H CH(CH 3
)
2
CH
3
N
3 F F OH H H XH-6-4 p-Me-Ph H H CH 2
CH(CH
3
)
2
CH
3
N
3 F F OH H H XH-6-5 p-Me-Ph H H CH 2 Ph CH 3
N
3 F F OH H H XII-6-6 p-Me-Ph H H CH 2 -indol-3-yl CH 3
N
3 F F OH H H XH-6-7 p-Me-Ph H H CH 2
CH
2
SCH
3
CH
3
N
3 F F OH H H XH-6-8 p-Me-Ph * H * CH 3
N
3 F F OH H H *R2and R2b joined together by (CH 2
)
3 to form five-membered ring. Table XII-7. X2 R R 3 b aRR R' R X Y R' R' XH-7-1 p-F-Ph H H H CH 3
N
3 F F OH H H XU-7-2 p-F-Ph H H CH 3
CH
3
N
3 F F OH H H XH-7-3 p-F-Ph H H CH(CH 3
)
2
CH
3
N
3 F F OH H H XII-7--4 p-F-Ph H H CH 2
CH(CH
3
)
2
CH
3
N
3 F F OH H H XII-7-6 p-F-Ph H H CH 2 Ph CH 3
N
3 F F OH H H XJI-7-7 p-F-Ph H H CH 2 -indol-3-yl CH 3
N
3 F F OH H H XII-7-8 p-F-Ph H H CH 2
CH
2
SCH
3
CH
3
N
3 F F OH H H XII-7-20 p-F-Ph * H * CH 3
N
3 F F OH H H *R and RA joined together by (CH 2
)
3 to form five-membered ring. 5 Table XII-8. N R' R 2
R
3 a R 3 b R' R 5
R
6 X Y RI R XH-8-1 p-Cl-Ph H H H CH 3
N
3 F F OH H H XH-8-2 p-Cl-Ph H H CH 3
CH
3
N
3 F F OH H H XII-8-3 p-Cl-Ph H H CH(CH 3
)
2
CH
3
N
3 F F OH H H XH-8-4 p-Cl-Ph H H CH 2
CH(CH
3 )2 CH 3
N
3 F F OH H H XH-8-5 p-Cl-Ph H H CH 2 Ph CH 3
N
3 F F OH H H XII-8-6 p-Cl-Ph H H CH 2 -indol-3-yl CH 3
N
3 F F OH H H XII-8-7 p-Cl-Ph H H CH 2
CH
2
SCH
3
CH
3
N
3 F F OH H H XII-8-8 p-Cl-Ph * H * CH 3
N
3 F F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. ,o0 Table XII-9. N R 2
R
3 aR 3 b R 4 R R 6 X Y R' R' XII-9-1 p-Br-Ph H H H CH 3
N
3 F F OH H H XII-9-2 p-Br-Ph H H CH 3
CH
3
N
3 F F OH H H XH-9-3 p-Br-Ph H H CH(CH 3
)
2
CH
3
N
3 F F OH H H XH-9-4 p-Br-Ph H H CH 2
CH(CH
3
)
2
CH
3
N
3 F F OH H H XH-9-6 p-Br-Ph H H CH 2 Ph CH 3
N
3 F F OH H H XI-9-7 p-Br-Ph H H CH 2 -indol-3-yl CH 3
N
3 F F OH H H XH-9-8 p-Br-Ph H H CH 2
CH
2
SCH
3
CH
3
N
3 F F OH H H XH-9-20 p-Br-Ph * H * CH 3
N
3 F F OH H H *R and R joined together by (CH 2
)
3 to form five-membered ring. Table XII-10. N! R1 R 2
R
3 a R 3 b R 4 R' R' X Y R' R' XH-10-1 p-I-Ph H H H CH 3
N
3 F F OH H H XH-10-2 p-I-Ph H H CH 3
CH
3
N
3 F F OH H H XH-10-3 p-I-Ph H H CH(CH 3
)
2
CH
3
N
3 F F OH H H XH-10-4 p-I-Ph H H CH 2
CH(CH
3
)
2
CH
3
N
3 F F OH H H XII-10-5 p-I-Ph H H CH 2 Ph CH 3
N
3 F F OH H H XH-10-6 p-I-Ph H H CH 2 -indol-3-yl CH 3
N
3 F F OH H H XII-10-7 p-I-Ph H H CH 2
CH
2
SCH
3
CH
3
N
3 F F OH H H XII-10-8 p-I-Ph * H * CH 3
N
3 F F OH H H *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XII-11. N RT R2 R 3 a R 3 b R4 R' R 6 X Y R/ R XH-11-1 CH 3 H H H Et N 3 F F OH H H XJI-11-2 CH 3 H H CH 3 Et N 3 F F OH H H XII-11--3 CH 3 H H CH(CH 3
)
2 Et N 3 F F OH H H X11-11--4 CH 3 H H CH 2
CH(CH
3
)
2 Et N 3 F F OH H H XII-11-5 CH 3 H H CH 2 Ph Et N 3 F F OH H H XII-11-6 CH 3 H H CH 2 -indol-3-yl Et N 3 F F OH H H XII-11-7 CH 3 H H CH 2
CH
2
SCH
3 Et N 3 F F OH H H XHI-11-8 CH 3 * H * Et N 3 F F OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XII-12. N2 RI R 2
R
3 a R 3 b R 4 R' R' X Y R 7 R9 XII-12-1 Et H H H Et N 3 F F OH H H XH-12-2 Et H H CH 3 Et N 3 F F OH H H XII-12-3 Et H H CH(CH 3
)
2 Et N 3 F F OH H H XII-12-4 Et H H CH 2
CH(CH
3
)
2 Et N 3 F F OH H H XII-12-5 Et H H CH 2 Ph Et N 3 F F OH H H XII- 12-6 Et H H CH 2 -indol-3-yl Et N 3 F F OH H H XII-12-7 Et H H CH 2
CH
2
SCH
3 Et N 3 F F OH H H XII-12-8 Et * H * Et N 3 F F OH H H *R2 and R" joined together by (CH 2
)
3 to form five-membered ring. Table XII-13. NO R1 R2 R 3 a R 3 b R4 R5 R 6 X Y R 7
R
8 XH-13-1 'Pr H H H Et N 3 F F OH H H XII-13-2 'Pr H H CH 3 Et N 3 F F OH H H XII-13-3 'Pr H H CH(CH 3
)
2 Et N 3 F F OH H H XII-13-4 'Pr H H CH 2
CH(CH
3
)
2 Et N 3 F F OH H H XII-13-5 'Pr H H CH 2 Ph Et N 3 F F OH H H XII-13-6 'Pr H H CH 2 -indol-3-yl Et N 3 F F OH H H XII-13-7 'Pr H H CH 2
CH
2
SCH
3 Et N 3 F F OH H H XII-13-8 'Pr * H * Et N 3 F F OH H H *R1 and Rah joined together by (CH 2
)
3 to form five-membered ring. 5 Table XII-14. X2 R' R2 R R 3 b R 4 R' R' X Y R 7 R' 3a XII- 'Bu H H H Et N F F OH H H 14-1 3 XII- 'Bu H H CH 3 Et N F F OH H H 14-2 3 XII- 'Bu H H CH(CH 3
)
2 Et N F F OH H H 14-3 3 XII- 'Bu H H CH 2
CH(CH
3
)
2 Et N F F OH H H 14-4 3 XII- 'Bu H H CH 2 Ph Et N F F OH H H 14-5 3 1~ Ne R' R 2 R R 3 b R 4 R R' X Y R R 3a XII- 'Bu H H CH 2 -indol-3-yl Et N F F OH H H 14-6 3 XII- 'Bu H H CH 2
CH
2
SCH
3 Et N F F OH H H 14-7 3 XII- 'Bu * H * Et N F F OH H H 14-8 3 *RZ and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XII-15. N2 R' R 2 RaR 3 b R R' RXY R Rs XII-15-1 Ph H H H Et N 3 F F OH H H XII-15-2 Ph H H CH 3 Et N 3 F F OH H H XII-15-3 Ph H H CH(CH 3
)
2 Et N 3 F F OH H H XII-15-4 Ph H H CH 2
CH(CH
3
)
2 Et N 3 F F OH H H XII-15-5 Ph H H CH 2 Ph Et N 3 F F OH H H XII-15-6 Ph H H CH 2 -indol-3-yl Et N 3 F F OH H H XII-15-7 Ph H H CH 2
CH
2
SCH
3 Et N 3 F F OH H H XII-15-8 Ph * H * Et N 3 F F OH H H *R2 and R joined together by (CH 2
)
3 to form five-membered ring. Table XII-16. N! R' R2 R 3 a R 3 b R 4 R' R' X Y R'R 8 XII-16-1 p-Me-Ph H H H Et N 3 F F OH H H XII-16-2 p-Me-Ph H H CH 3 Et N 3 F F OH H H XII-16-3 p-Me-Ph H H CH(CH 3
)
2 Et N 3 F F OH H H XII-16-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Et N 3 F F OH H H XII-16-5 p-Me-Ph H H CH 2 Ph Et N 3 F F OH H H XII-16-6 p-Me-Ph H H CH 2 -indol-3-yl Et N 3 F F OH H H XII-16-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Et N 3 F F OH H H XII-16-8 p-Me-Ph * H * Et N 3 F F OH H H 5 *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XII-17. N R R 2
R
3 a R 3 ) R4 R R 6 X Y R 7
R
8 XII-17-1 p-F-Ph H H H Et N 3 F F OH H H XII-17-2 p-F-Ph H H CH 3 Et N 3 F F OH H H N R R R R 2
R
3 aR 3 b R 4 R R 6 X Y R 7
R
8 XII-17-3 p-F-Ph H H CH(CH 3
)
2 Et N 3 F F OH H H XII-17-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Et N 3 F F OH H H XII-17-5 p-F-Ph H H CH 2 Ph Et N 3 F F OH H H XII-17-6 p-F-Ph H H CH 2 -indol-3-yl Et N 3 F F OH H H XH-17-7 p-F-Ph H H CH 2
CH
2
SCH
3 Et N 3 F F OH H H XU-17-8 p-F-Ph * H * Et N 3 F F OH H H *RTand R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XII-18. N2 R' R 2
R
3 a R3b R 4 R' R 6 X Y R' R' XII-18-1 p-Cl-Ph H H H Et N 3 F F OH H H XII-18-2 p-Cl-Ph H H CH 3 Et N 3 F F OH H H XII-18-3 p-Cl-Ph H H CH(CH 3
)
2 Et N 3 F F OH H H4 XH-18-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Et N 3 F F OH H H XH-18-5 p-Cl-Ph H H CH 2 Ph Et N 3 F F OH H H XII-18-6 p-Cl-Ph H H CH 2 -indol-3-yl Et N 3 F F OH H H XH-18-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Et N 3 F F OH H H XII-18-8 p-Cl-Ph * H * Et N 3 F F OH H H *R2 and RJb joined together by (CH 2
)
3 to form five-membered ring. Table XII-19. X2 Rl R 2
R
3 a R 3 b R 4 R R 6 X Y R7 R 8 XI-19-1 p-Br-Ph H H H Et N 3 F F OH H H XII-19-2 p-Br-Ph H H CH 3 Et N 3 F F OH H H XL-19-3 p-Br-Ph H H CH(CH 3
)
2 Et N 3 F F OH H H XH-19-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Et N 3 F F OH H H XII-19-5 p-Br-Ph H H CH 2 Ph Et N 3 F F OH H H XI-19-6 p-Br-Ph H H CH 2 -indol-3-yl Et N 3 F F OH H H XII-19-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Et N 3 F F OH H H XII-19-8 p-Br-Ph * H * Et N 3 F F OH H H 5 *RT and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XII-20. N2 R R 2
R
3 a R 3 b R 4 R R 6 XY R' XII-20-1 p-I-Ph H H H Et N 3 F F OH H XII-20-2 p-I-Ph H H CH 3 Et N 3 F F OH H XII-20-3 p-I-Ph H H CH(CH 3
)
2 Et N 3 F F OH H N R C R7 R3a R 3 b R4 R' R6 X Y R' XH--20-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Et N 3 F F OH H XII-20-5 p-I-Ph H H CH 2 Ph Et N 3 F F OH H XH-20-6 p-I-Ph H H CH 2 -indol-3-yl Et N 3 F F OH H XH-20-7 p-I-Ph H H CH 2
CH
2
SCH
3 Et N 3 F F OH H XH-20-8 p-I-Ph * H * Et N 3 F F OH H *RTand R3b joined together by (CH 2
)
3 to form five-membered ring. Table XII-2 1. N R R2 R 3 a Rab R' R' R' X Y R R 8 XH-21-1 CH 3 H H H 'Pr N 3 F F OH H H XH-21-2 CH 3 H H CH 3 'Pr N 3 F F OH H H XH-21-3 CH 3 H H CH(CH 3
)
2 'Pr N 3 F F OH H H XH-21-4 CH 3 H H CH 2
CH(CH
3
)
2 'Pr N 3 F F OH H H XH-21-5 CH 3 H H CH2Ph 'Pr N 3 F F OH H H XH-21-6 CH 3 H H CH 2 -indol-3-yl 'Pr N 3 F F OH H H XH-21-7 CH 3 H H CH 2
CH
2
SCH
3 'Pr N 3 F F OH H H XH-21-8 CH 3 * H * 'Pr N 3 F F OH H H *RTand R3b joined together by (CH 2
)
3 to form five-membered ring. Table XII-22. N R R 2 R3a R 3 b R 4
R
5 R' X Y RI R' XH-22-1 Et H H H 'Pr N 3 F F OH H H XH-22-2 Et H H CH 3 'Pr N 3 F F OH H H XH-22-3 Et H H CH(CH 3
)
2 'Pr N 3 F F OH H H XH-22-4 Et H H CH 2 CH(CH3) 2 'Pr N 3 F F OH H H XH-22-5 Et H H CH 2 Ph 'Pr N 3 F F OH H H XH-22-6 Et H H CH 2 -indol-3-yl 'Pr N 3 F F OH H H XH-22-7 Et H H CH 2
CH
2
SCH
3 'Pr N 3 F F OH H H XII-22.-8 Et * H * 'Pr N 3 F F OH H H 5 *R' and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XII-23. N! R R2 R 3 a R 3 b R4 R' R 6 X Y R 7
R
8 XII-23-1 'Pr H H H 'Pr N 3 F F OH H H XII-23-2 'Pr H H CH 3 Pr N 3 F F OH H H XH-23-3 'Pr H H CH(CH 3
)
2 Pr N 3 F F OH H H XH-23-4 'Pr H H CH 2
CH(CH
3
)
2 Pr N 3 F F OH H H I A N RI R 2 Raa R 3 b R 4 R' R' X Y R' R XII-23-5 'Pr H H CH 2 Ph 'Pr N 3 F F OH H H XII-23-6 'Pr H H CH 2 -indol-3-yl 'Pr N 3 F F OH H H XII-23-7 'Pr H H CH 2
CH
2
SCH
3 'Pr N 3 F F OH H H XII-.23-8 'Pr * H * 'Pr N 3 F F OH H H *R7 and R b joined together by (CH 2
)
3 to form five-membered ring. Table XII-24. N2 Rl R 2
R
3 a R 3 b R 4 R R X Y R' R' XII-24-1 'Bu H H H 'Pr N 3 F F OH H H XII-24-2 'Bu H H CH 3 'Pr N 3 F F OH H H XII-24-3 'Bu H H CH(CH 3
)
2 'Pr N 3 F F OH H H XII-24-4 'Bu H H CH 2
CH(CH
3
)
2 'Pr N 3 F F OH H H XII-24-5 'Bu H H CH 2 Ph 'Pr N 3 F F OH H H XI-24-6 'Bu H H CH 2 -indol-3-yl 'Pr N 3 F F OH H H XII-24-7 'Bu H H CH 2
CH
2
SCH
3 'Pr N 3 F F OH H H XII-24-8 'Bu * H * 'Pr N 3 F F OH H H *RTand R 3 b joined together by (CH2)3 to form five-membered ring. Table XII-25. N2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y R' R' XII-25-1 Ph H H H 'Pr N 3 F F OH H H XII-25-2 Ph H H CH 3 'Pr N 3 F F OH H H XII-25-3 Ph H H CH(CH 3
)
2 'Pr N 3 F F OH H H XII-25-4 Ph H H CH 2
CH(CH
3
)
2 'Pr N 3 F F OH H H XII-25-5 Ph H H CH 2 Ph 'Pr N 3 F F OH H H XII-25-6 Ph H H CH 2 -indol-3-yl 'Pr N 3 F F OH H H XII-25-7 Ph H H CH 2
CH
2
SCH
3 'Pr N 3 F F OH H H XII-25-8 Ph * H * 'Pr N 3 F F OH H H 5 *R' and R joined together by (CH 2
)
3 to form five-membered ring. Table XII-26. N2 R' R 2 Ra R 3 b R 4
R
5 R' X Y R 7 R' XII-26-1 p-Me-Ph H H H 'Pr N 3 F F OH H H XII-26-2 p-Me-Ph H H CH 3 'Pr N 3 F F OH H H XII-26-3 p-Me-Ph H H CH(CH 3
)
2 Pr N 3 F F OH H H XII-26-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 'Pr N 3 F F OH H H XII-26-5 p-Me-Ph H H CH 2 Ph 'Pr N 3 F F OH H H N2 Rt R 2 R aRb R 4 R' R 6 X Y R 7
R
8 XII-26-6 p-Me-Ph H H CH 2 -indol-3-yl 'Pr N 3 F F OH H H XII-26-7 p-Me-Ph H H CH 2
CH
2
SCH
3 'Pr N 3 F F OH H H XI--26-8 p-Me-Ph * H * 'Pr N 3 F F OH H H *R and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XII-27. NR' R2 R 3 2 R b R 4 R' R X Y R 7 R' XII-27-1 p-F-Ph H H H 'Pr N 3 F F OH H H XI-27-2 p-F-Ph H H CH 3 'Pr N 3 F F OH H H XI-27-3 p-F-Ph H H CH(CH 3
)
2 'Pr N 3 F F OH H H XII-27-4 p-F-Ph H H CH 2
CH(CH
3
)
2 'Pr N 3 F F OH H H XII-27-5 p-F-Ph H H CH 2 Ph 'Pr N 3 F F OH H H XI-27-6 p-F-Ph H H CH 2 -indol-3-yl 'Pr N 3 F F OH H H XI-27-7 p-F-Ph H H CH 2
CH
2
SCH
3 'Pr N 3 F F OH H H XII-27-8 p-F-Ph * H * 'Pr N 3 F F OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XII-28. S R' R2 R 3 a R 3 b R 4 R' R' X Y R' R' XH-28-1 p-Cl-Ph H H H 'Pr N 3 F F OH H H XII-28-2 p-Cl-Ph H H CH 3 'Pr N 3 F F OH H H XII-28-3 p-Cl-Ph H H CH(CH 3
)
2 'Pr N 3 F F OH H H XI-28-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 'Pr N 3 F F OH H H XII-28-5 p-Cl-Ph H H CH 2 Ph 'Pr N 3 F F OH H H XII-28-6 p-Cl-Ph H H CH 2 -indol-3-yl 'Pr N 3 F F OH H H XII-28-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 'Pr N 3 F F OH H H XI-28-8 p-Cl-Ph * H * 'Pr N 3 F F OH H H 5 *R2-aind R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XII-29. N2 Rl R 2
R
3 a R R 4 RT R' X Y R' R' XII-29-1 p-Br-Ph H H H 'Pr N 3 F F OH H H XII-29-2 p-Br-Ph H H CH 3 'Pr N 3 F F OH H H XII-29-3 p-Br-Ph H H CH(CH 3
)
2 'Pr N 3 F F OH H H XI-29-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 'Pr N 3 F F OH H H XII-29-5 p-Br-Ph H H CH 2 Ph 'Pr N 3 F F OH H H XII-29-6 p-Br-Ph H H CH 2 -indol-3-yi 'Pr N 3 F F OH H H N2 R2 R 3 a R 3 b R 4 R' R' X Y RF R9 XH-29-7 p-Br-Ph H H CH 2
CH
2
SCH
3 'Pr N 3 F F OH H H XH-29-8 p-Br-Ph * H * 'Pr N 3 F F OH H H RTand R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XII-30. X2 R' R 2 R3a R 3 b R 4 R' R' X Y R 7
R
8 XJH-30-1 p-I-Ph H H H 'Pr N 3 F F OH H H XII-30-2 p-I-Ph H H CH 3 'Pr N 3 F F OH H H XII-30-3 p-I-Ph H H CH(CH 3
)
2 'Pr N 3 F F OH H H XI-30-4 p-I-Ph H H CH2CH(CH 3 )2 'Pr N 3 F F OH H H XH-30-5 p-I-Ph H H CH 2 Ph 'Pr N 3 F F OH H H XIH-30-6 p-I-Ph H H CH 2 -indol-3-yl 'Pr N 3 F F OH H H XH-30-7 p-I-Ph H H CH 2
CH
2
SCH
3 Pr N 3 F F OH H H XII-30-8 p-I-Ph * H * Pr N 3 F F OH H H *R" and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XII-3 1. N2 R' R2 R 3 a R 3 b R 4 R' R' X Y R' R' XH-31-1 CH 3 H H H "Bu N 3 F F OH H H XJI-31-2 CH 3 H H CH 3 "Bu N 3 . F F OH H H XH-31-3 CH 3 H H CH(CH 3
)
2 "Bu N 3 F F OH H H XH-31-4 CH 3 H H CH 2
CH(CH
3
)
2 "Bu N 3 F F OH H H XII-31-5 CH 3 H H CH 2 Ph "Bu N 3 F F OH H H XH-31-6 CH 3 H H CH 2 -indol-3-yl "Bu N 3 F F OH H H XH-31-7 CH 3 H H CH 2
CH
2
SCH
3 "Bu N 3 F F OH H H XH-31-8 CH 3 * H * "Bu N 3 F F OH H H 5 *R and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XII-32. X2 R R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7 R8 XH-32-1 Et H H H "Bu N 3 F .F OH H H XH-32-2 Et H H CH 3 'Bu N 3 F F OH H H XII-32-3 Et H H CH(CH 3
)
2 'Bu N 3 F F OH H H XII-32-4 Et H H CH 2
CH(CH
3
)
2 'Bu N 3 F F OH H H XII-32-5 Et H H CH 2 Ph "Bu N 3 F F OH H H XH-32-6 Et H H CH 2 -indol-3-yl "Bu N 3 F F OH H H XH-32-7 Et H H CH 2
CH
2
SCH
3 "Bu N 3 F F OH H H 1) A-7 X2 RI R 2
R
3 a Rb R4 R' R 6 X Y R' R 8 XII-32-8 Et * H * "Bu N 3 F F OH H H * R and R"b joined together by (CH 2
)
3 to form five-membered ring. Table XII-33. X2 R' R2 R 3 a R 3 b R 4 R' R' X Y R' R" XII-33-1 'Pr H H H "Bu N 3 F F OH H H XII-33-2 'Pr H H CH 3 "Bu N 3 F F OH H H XII-33-3 'Pr H H CH(CH 3
)
2 "Bu N 3 F F OH H H XII-33-4 'Pr H H CH 2
CH(CH
3
)
2 "Bu N 3 F F OH H H XII-33-5 'Pr H H CH 2 Ph "Bu N 3 F F OH H H XII-33-6 'Pr H H CH 2 -indol-3-yl "Bu N 3 F F OH H H XII-33-7 'Pr H H CH 2
CH
2
SCH
3 "Bu N 3 F F OH H H XII-33-8 'Pr * H * "Bu N 3 F F OH H H *R and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XII-34. X2 R' R 2
R
3 a R 3 b R 4 R' R' X Y R' R' XI-34-1 'Bu H H H "Bu N 3 F F OH H H XI-34-2 'Bu H H CH 3 "Bu N 3 F F OH H H XII-34-3 'Bu H H CH(CH 3
)
2 "Bu N 3 F F OH H H XII-34-4 'Bu H H CH 2
CH(CH
3
)
2 "Bu N 3 F F OH H H XII-34-5 'Bu H H CH2Ph "Bu N 3 F F OH H H XII-34-6 'Bu H H CH 2 -indol-3-yl "Bu N 3 F F OH H H XII-34-7 'Bu H H CH 2
CH
2
SCH
3 "Bu N 3 F F OH H H XII-34-8 'Bu * H * "Bu N 3 F F OH H H 5 *R and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XII-35. 2 RI R 2
R
3 a R 3 b R '4 R R X Y R' R' XII-35-1 Ph H H H "Bu N 3 F F OH H H XII-35-2 Ph H H CH 3 "Bu N 3 F F OH H H XII-35-3 Ph H H CH(CH 3
)
2 "Bu N 3 F F OH H H XII-35-4 Ph H H CH 2
CH(CH
3
)
2 "Bu N 3 F F OH H H XII-35-5 Ph H H CH 2 Ph "Bu N 3 F F OH H H XII-35-6 Ph H H CH 2 -indol-3-yl "Bu N 3 F F OH H H XII-35-7 Ph H H CH 2
CH
2
SCH
3 "Bu N 3 F F OH H H XII-35-8 Ph * H * "Bu N3 F F OH H H
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XII-36. X2 R R 2
R
3 a R 3 b R 4 R R 6 X Y R' R' XH-36-1 p-Me-Ph H H H "Bu N 3 F F OH H H XII-36-2 p-Me-Ph H H CH 3 "Bu N 3 F F OH H H XH-36-3 p-Me-Ph H H CH(CH 3
)
2 "Bu N 3 F F OH H H XI-36-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 "Bu N 3 F F OH H H XII-36-5 p-Me-Ph H H CH 2 Ph "Bu N 3 F F OH H H XII-36-6 p-Me-Ph H H CH 2 -indol-3-yl "Bu N 3 F F OH H H XH-36-7 p-Me-Ph H H CH 2
CH
2
SCH
3 "Bu N 3 F F OH H H XII-36-8 p-Me-Ph * H * "Bu N 3 F F OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XII-37. XR R 2
R
3 aRi R 4
R
5 R XY R 7
R
8 XH-37-1 p-F-Ph H H H "Bu N 3 F F OH H H XH-37-2 p-F-Ph H H CH 3 "Bu N 3 F F OH H H XII-37-3 p-F-Ph H H C H(CH 3
)
2 "Bu N 3 F F OH H H XII-37-4 p-F-Ph H H CH2CH(CH 3 )2 "Bu N 3 F F OH H H XH-37-5 p-F-Ph H H CH 2 Ph "Bu N 3 F F OH H H XII-37-6 p-F-Ph H H CH 2 -indol-3-yl "Bu N 3 F F OH H H XI-37-7 p-F-Ph H H CH 2
CH
2
SCH
3 "Bu N 3 F F OH H H XH-37-8 p-F-Ph * H * "Bu N 3 F F OH H H 5 *R2 and R 3 0 joined together by (CH 2
)
3 to form five-membered ring. Table XII-38. NX R R 2 R 3b R 4 R R 6 X Y R7 R' XH-38-1 p-Cl-Ph H H H "Bu N 3 F F OH H H XH-38-2 p-Cl-Ph H H CH 3 "Bu N 3 F F OH H H XII-38-3 p-Cl-Ph H H CH(CH 3
)
2 "Bu N 3 F F OH H H XH-38-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 "Bu N 3 F F OH H H XII-38-5 p-Cl-Ph H H CH 2 Ph "Bu N 3 F F OH H H XI-38-6 p-Cl-Ph H H CH 2 -indol-3-yl "Bu N 3 F F OH H H XH-38-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 "Bu N 3 F F OH H H XH-38..8 p-Cl-Ph * H * "Bu N 3 F F OH H H R and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XII-39. S R' R 2
R
3 a Rb 4 R' R X Y R' R XII-39-1 p-Br-Ph H H H "Bu N 3 F F OH H H XII-39-2 p-Br-Ph H H CH 3 "Bu N 3 F F OH H H XII-39-3 p-Br-Ph H H CH(CH 3
)
2 "Bu N 3 F F OH H H XII-39-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 "Bu N 3 F F OH H H XII-39-5 p-Br-Ph H H CH 2 Ph "Bu N 3 F F OH H H XI-39-6 p-Br-Ph H H CH 2 -indol-3-yl "Bu N 3 F F OH H H XII-39-7 p-Br-Ph H H CH 2 CH2SCH 3 "Bu N 3 F F OH H H XII-39-8 p-Br-Ph * H * "Bu N 3 F F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XII-40. N2 R R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7
R
8 XI-40-1 p-I-Ph H H H "Bu N 3 F F OH H H XII-40-2 p-I-Ph H H CH 3 "Bu N 3 F F OH H H XII-40-3 p-I-Ph H H CH(CH 3
)
2 "Bu N 3 F F OH H H XII-40-4 p-I-Ph H H CH 2
CH(CH
3
)
2 "Bu N 3 F F OH H H XII-40-5 p-I-Ph H H CH 2 Ph "Bu N 3 F F OH H H XI-40-6 p-I-Ph H H CH 2 -indol-3-yl "Bu N 3 F F OH H H XI-40.-7 p-I-Ph H H CH 2
CH
2
SCH
3 "Bu N 3 F F OH H H XII-40-8 p-I-Ph * H * "Bu N 3 F F OH H H RT and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XII-41. X2 R' R 2 R aR 3 b R R 3
R
6 X Y R' R' XII-41--1 CH 3 H H H Bz N 3 F F OH H H XI-41-2 CH 3 H H CH 3 Bz N 3 F F OH H H XII-41--3 CH 3 H H CH(CH 3
)
2 Bz N 3 F F OH H H XHI-41-4 CH 3 H H CH 2
CH(CH
3
)
2 Bz N 3 F F OH H H XII-41-5 CH 3 H H CH 2 Ph Bz N 3 F F OH H H XII-41-6 CH 3 H H CH 2 -indol-3-yl Bz N 3 F F OH H H XII-41-7 CH 3 H H CH 2
CH
2
SCH
3 Bz N 3 F F OH H H XII-41-8 CH 3 * H * Bz N 3 F F OH H H *R a R b joined together by (CH 2
)
3 to form five-membered ring. '21 Table XII-42. N2 RI R 2 RaR 3 b R 4 R R X Y R Rs XJI-42-1 Et H H H Bz N 3 F F OH H H XJI-42-2 Et H H CH 3 Bz N 3 F F OH H H XII-42-3 Et H H CH(CH 3
)
2 Bz N 3 F F OH H H XII-42-4 Et H H CH 2
CH(CH
3
)
2 Bz N 3 F F OH H H XU-42-5 Et H H CH 2 Ph Bz N 3 F F OH H H XII-42-6 Et H H CH 2 -indol-3-yl Bz N 3 F F OH H H XII-42-7 Et H H CH 2
CH
2
SCH
3 Bz N 3 F F OH H H XII-42-8 Et * H * Bz N 3 F F OH H H *R2 and Rab joined together by (CH 2
)
3 to form five-membered ring. Table XII-43. N2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y R' R' XII-43-1 'Pr H H H Bz N 3 F F OH H H XII-43-2 'Pr H H CH 3 Bz N 3 F F OH H A XII-43-3 'Pr H H CH(CH 3
)
2 Bz N 3 F F OH H H XII-43-4 'Pr H H CH 2
CH(CH
3
)
2 Bz N 3 F F OH H H XII-43-5 'Pr H H CH 2 Ph Bz N 3 F F OH H H XII-43-6 'Pr H H CH 2 -indol-3-yl Bz N 3 F F OH H H XH-43-7 'Pr H H CH 2
CH
2
SCH
3 Bz N 3 F F OH H H XI-43-8 'Pr * H * Bz N 3 F F OH H H 10 *R 2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XII-44. X2 R R 2
R
3 a R 3 b R 4 R' R' X Y R' R' XII-44-1 'Bu H H H Bz N 3 F F OH H H XII-44-2 'Bu H H CH 3 Bz N 3 F F OH H H XII-44-3 'Bu H H CH(CH 3
)
2 Bz N 3 F F OH H H XU-44-4 'Bu H H CH 2
CH(CH
3
)
2 Bz N 3 F F OH H H XII-44-5 'Bu H H CH 2 Ph Bz N 3 F F OH H H XII-44-6 'Bu H H CH 2 -indol-3-yl Bz N 3 F F OH H H XII-44-7 'Bu H H CH 2
CH
2
SCH
3 Bz N 3 F F OH H H XII-44-8 'Bu * H * Bz N 3 F F OH H H *R2 and Rb joined together by (CH 2
)
3 to form five-membered ring. l11 Table XII-45. X2 R' R 2 R3a R 3 b R 4 R' R 6 X Y R 7 R 8 XII-45-1 Ph H H H Bz N 3 F F OH H H XII-45-2 Ph H H CH 3 Bz N 3 F F OH H H XH-45-3 Ph H H CH(CH 3
)
2 Bz N 3 F F OH H H XII-45-4 Ph H H CH 2
CH(CH
3
)
2 Bz N 3 F F OH H H XII-45-5 Ph H H CH 2 Ph Bz N 3 F F OH H H XII-45-6 Ph H H CH 2 -indol-3-yl Bz N 3 F F OH H H XII-45-7 Ph H H CH 2
CH
2
SCH
3 Bz N 3 F F OH H H XII-45-8 Ph * H * Bz N 3 F F OH H H *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XII-46. X2 R R R3 R 3 b R4 R R6 X Y R R( XII-46-1 p-Me-Ph H H H Bz N 3 F F OH H H XII-46-2 p-Me-Ph H H CH 3 Bz N 3 F F OH H H XI-46-3 p-Me-Ph H H CH(CH 3
)
2 Bz N 3 F F OH H H XII-46-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Bz N 3 F F OH H H XII-46-5 p-Me-Ph H H CH2Ph Bz N 3 F F OH H H XII-46-6 p-Me-Ph H H CH 2 -indol-3-yl Bz N 3 F F OH H H XI-46-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Bz N 3 F F OH H H XII-46-8 p-Me-Ph * H * Bz N 3 F F OH H 1H *RTand R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XII-47. N2 R' R2 R 3 R3b R 4 R R 6 X Y R 7 R XI-47-1 p-F-Ph H H H Bz N 3 F F OH H H XII-47-2 p-F-Ph H H CH 3 Bz N 3 F F OH H H XII-47-3 p-F-Ph H H CH(CH 3
)
2 Bz N 3 F F OH H H XII-47-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Bz N 3 F F OH H H XII-47-.5 p-F-Ph H H CH 2 Ph Bz N 3 F F OH H H XII-47-6 p-F-Ph H H CH 2 -indol-3-yl Bz N 3 F F OH H H XII-47--7 p-F-Ph H H CH 2
CH
2
SCH
3 Bz N 3 F F OH H H XII-47-8 p-F-Ph * H * Bz N 3 F F OH H H *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XII-48. M R1 R 2 R3a R 3 b R 4 R' R' X Y R 7
R
8 XH-48-1 p-Cl-Ph H H H Bz N 3 F F OH H H XII-48-2 p-Cl-Ph H H CH3 Bz N 3 F F OH H H XH-48-3 p-Cl-Ph H H CH(CH 3
)
2 Bz N 3 F F OH H H XH-48-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Hz N 3 F F OH H H XII-48-5 p-Cl-Ph H H CH 2 Ph Bz N 3 F F OH H H XII-48-6 p-Cl-Ph H H CH 2 -indol-3-yl Bz N 3 F F OH H H XH-48-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Bz N 3 F F OH H H XII-48-8 p-Cl-Ph * H * Bz N 3 F F OH H H
*R
2 and R b joined together by (CH 2
)
3 to form five-membered ring. Table XII-49. SR R 2 RaR 3 b R 4 R' R 6 X Y R Rv XII-49-1 p-Br-Ph H H H Bz N 3 F F OH H H XII-49-2 p-Br-Ph H H CH 3 Bz N 3 F F OH H H XII-49-3 p-Br-Ph H H CH(CH 3
)
2 Bz N 3 F F OH H H XH-49-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Bz N 3 F F OH H H XH-49-5 p-Br-Ph H H CH 2 Ph Bz N 3 F F OH H H XH-49--6 p-Br-Ph H H CH 2 -indol-3-yl Bz N 3 F F OH H H XHI-49-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Bz N 3 F F OH H H XII-49--8 p-Br-Ph * H * Bz N 3 F F OH H H *R and Rb joined together by (CH 2
)
3 to form five-membered ring. 5 Table XII-50. 2 R' R 2 Ra R R 4 R' R XY R R XII-50-1 p-I-Ph H H H Bz N 3 F F OH H H XII-50-2 p-I-Ph H H Cl- 3 Bz N 3 F F OH H H XII-50-3 p-I-Ph H H CH(CH 3
)
2 Bz N 3 F F OH H H XH-50-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Bz N 3 F F OH H H XII-50-5 p-I-Ph H H C-I 2 Ph Bz N 3 F F OH H H XI-50-6 p-I-Ph H H CH 2 -indol-3-yl Bz N 3 F F OH H H X1I-50-7 p-I-Ph H H CH 2
CH
2
SCH
3 Bz N 3 F F OH H H XH-50-8 p-I-Ph * H * Bz N 3 F F OH H H *R2 and R t ' joined together by (CH 2
)
3 to form five-membered ring.
0
R
8 NH R3b R OD R3a N0 C0 2
R
4
OR
1 R 6 Y X XIII Table XIII-1. X2 R1 R2 R 3 " R 3 b R 4 R' R 6 X Y R 7
R
8 XII-1-1 CH 3 H H H CH 3
N
3 H F OH H H XIII-1-2 CH 3 H H CH 3
CH
3
N
3 H F OH H H XII-1-3 CH 3 H H CH(CH 3
)
2
CH
3
N
3 H F OH H H XI-1-4 CH 3 H H CH 2
CH(CH
3
)
2
CH
3
N
3 H F OH H H XIII-1-5 CH 3 H H CH 2 Ph CH 3
N
3 H F OH H H XIII-1-6 CH 3 H H CH 2 -indol-3-yl CH 3
N
3 H F OH H H XIII-1-7 CH 3 H H CH 2
CH
2
SCH
3
CH
3
N
3 H F OH H H XIII-1-8 CH 3 * H * CH 3
N
3 H F OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIII-2. RI R 2 RaR 3 b R 4
R'R
6 X Y R' R' XIII-2-1 Et H H H CH 3
N
3 H F OH H H XIII-2-2 Et H H CH 3
CH
3
N
3 H F OH H H XIII-2-3 Et H H CH(CH 3
)
2
CH
3
N
3 H F OH H H XIII-2-4 Et H H CH 2
CH(CH
3
)
2
CH
3
N
3 H F OH H H XII-2-5 Et H H CH 2 Ph CH 3
N
3 H F OH H H XI-2-6 Et H H CH 2 -indol-3-yl CH 3
N
3 H F OH H H XIII-2-7 Et H H CH 2 CH2SCH 3
CH
3
N
3 H F OH H H XIII-2-8 Et * H * CH 3
N
3 H F OH H H *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. '21 A Table XIII-3. N2 R' R12 R 3 R 3 b R 4 R' R' X Y R( R 8 XIJ-3-1 'Pr H H H CH 3
N
3 H F OH H H XII-3-2 Pr H H CH3 CH 3
N
3 H F OH H H XIII-3-3 Pr H H CH(CH 3
)
2
CH
3
N
3 H F OH H H XIII-3-4 'Pr H H CH 2
CH(CH
3
)
2
CH
3
N
3 H F OH H H XIII-3-5 'Pr H H CH 2 Ph CH3 N 3 H F OH H H XIH-3-6 'Pr H H CH 2 -indol-3-yl CH 3
N
3 H F OH H H XIf-3-7 'Pr H H CH 2
CH
2
SCH
3
CH
3
N
3 H F OH H H XIII-3-8 'Pr * H * CH 3
N
3 H F OH H H *R2and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XIII-4. [2 R' R2 R3a R3b R4 R' R6 X Y R( R' XMI-4-1 'Bu H H H CH 3
N
3 H F OH H H XITI-4-2 'Bu H H CH 3
CH
3
N
3 H F OH H H XIH-4-3 'Bu H H CH(CH 3
)
2
CH
3
N
3 H F OH H H XI-4-4 'Bu H H CH 2
CH(CH
3
)
2
CH
3
N
3 H F OH H H Xm-4-5 'Bu H H CH 2 Ph CH 3
N
3 H F OH H H XI-4-6 'Bu H H CH 2 -indol-3-yl CH 3
N
3 H F OH H H XIH-4-7 'Bu H H CH 2
CH
2
SCH
3
CH
3
N
3 H F OH H H XM-4-8 'Bu * H * CH 3
N
3 H F OH H H *R2and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIII-5. N R' R2 R3aRb R4 R R X Y R7 R8 XI-5-1 Ph H H H CH 3
N
3 H F OH H H XIH-5-2 Ph H H CH 3
CH
3
N
3 H F OH H H XI-5-3 Ph H H CH(CH 3
)
2
CH
3
N
3 H F OH H H XIH-5-4 Ph H H CH 2
CH(CH
3
)
2
CH
3
N
3 H F OH H H XIII-5-5 Ph H H CH 2 Ph CH 3
N
3 H F OH H H XI-5-6 Ph H H CH 2 -indol-3-yl CH 3
N
3 H F OH H H XI-5-7 Ph H H CH 2
CH
2
SCH
3
CH
3
N
3 H F OH H H XIII-5-8 Ph * H * CH 3
N
3 H F OH H H *Rand R3b joined together by (CH 2
)
3 to form five-membered ring. '121 C Table XIII-6. N R RR 3 a R 3 b R 4 R' R 6 X Y R' R XIII-6-1 p-Me-Ph H H H CH 3
N
3 H F OH H H XII-6-2 p-Me-Ph H H CH 3
CH
3
N
3 H F OH H H XI-6-3 p-Me-Ph H H CH(CH 3
)
2
CH
3
N
3 H F OH H H XII-6-4 p-Me-Ph H H CH2CH(CH 3
)
2
CH
3
N
3 H F OH H H XIII-6-5 p-Me-Ph H H CH 2 Ph CH 3
N
3 H F OH H H XII-6-6 p-Me-Ph H H CH 2 -indol-3-yl CH 3
N
3 H F OH H H XIH-6-7 p-Me-Ph H H CH 2
CH
2
SCH
3
CH
3
N
3 H F OH H H XIH-6-8 p-Me-Ph * H * CH 3
N
3 H F OH H H *R" and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XIII-7. N2 R' R 2 R3a R 3 b R 4 R' R 6 X Y R 7
R
8 XII1-7--1 p-F-Ph H H H CH 3
N
3 H F OH H H XIII-7-2 p-F-Ph H H CH 3
CH
3
N
3 H F OH H H XIH-7-3 p-F-Ph H H CH(CH 3
)
2
CH
3
N
3 H F OH H H XIII-7-4 p-F-Ph H H CH 2
CH(CH
3
)
2
CH
3
N
3 H F OH H H XIII-7-6 p-F-Ph H H CH 2 Ph CH 3
N
3 H F OH H H XIII-7-7 p-F-Ph H H CH 2 -indol-3-yl CH 3
N
3 H F OH H H XIII-7--8 p-F-Ph H H CH 2
CH
2
SCH
3
CH
3
N
3 H F OH H H XIH-7-20 p-F-Ph * H * CH 3
N
3 H F OH H H *RT and R joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIII-8.
XRR
2
R
3 "R R 4 RR XY R R XIH-8-1 p-Cl-Ph H H H CH 3
N
3 H F OH H H XHI-8-.2 p-Cl-Ph H H CH 3
CH
3
N
3 H F OH H H XIH-8-3 p-Cl-Ph H H CH(CH 3
)
2
CH
3
N
3 H F OH H H XHI-8-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2
CH
3
N
3 H F OH H H XIII-8-5 p-Cl-Ph H H CH 2 Ph CH 3
N
3 H F OH H H XIII-8-6 p-Cl-Ph H H CH 2 -indol-3-yl CH 3
N
3 H F OH H H XII-8-7 p-Cl-Ph H H CH 2
CH
2
SCH
3
CH
3
N
3 H F OH H H XIII-8-8 p-Cl-Ph * H * CH 3
N
3 H F OH H H *RT and Rib joined together by (CH 2
)
3 to form five-membered ring.
Table XIII-9. N2 Rl R 2 Ra R 3 b R 4 R' R' X Y R 7
R
8 XIII-9-1 p-Br-Ph H H H CH 3
N
3 H F OH H H XIII-9-2 p-Br-Ph H H CH 3
CH
3
N
3 H F OH H H XII-9-3 p-Br-Ph H H CH(CH 3
)
2
CH
3
N
3 H F OH H H XIH-9-4 p-Br-Ph H H CH 2
CH(CH
3
)
2
CH
3
N
3 H F OH H H XIH-9-6 p-Br-Ph H H CH 2 Ph CH 3
N
3 H F OH H H XIII-9-7 p-Br-Ph H H CH 2 -indol-3-yl CH 3
N
3 H F OH H H XII-9-8 p-Br-Ph H H CH 2
CH
2
SCH
3
CH
3
N
3 H F OH H H XIII-9-20 p-Br-Ph * H * CH 3
N
3 H F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XIII-10. N2 Rl R 2 R3a R 3 b R 4 R' R 6 X Y R' R' XII-10-1 p-I-Ph H H H CH 3
N
3 H F OH H H XIH-10-2 p-I-Ph H H CH 3
CH
3
N
3 H F OH H H XIII-10-3 p-I-Ph H H CH(CH 3
)
2
CH
3
N
3 H F OH H H XIH-10-4 p-I-Ph H H CH 2
CH(CH
3
)
2
CH
3
N
3 H F OH H H XIII-10-5 p-I-Ph H H CH 2 Ph CH 3
N
3 H F OH H H XIII-10-6 p-I-Ph H H CH 2 -indol-3-yl CH 3 N3 H F OH H H XIH-10-7 p-I-Ph H H CH 2
CH
2
SCH
3
CH
3
N
3 H F OH H H XI1-10-8 p-I-Ph * H * CH 3
N
3 H F OH H H *R and R joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIII-11. JN2 R' R 2
R
3 " R 3 b R 4 R' R' X Y R 7
R
8 XII-11-1 CH 3 H H H Et N 3 H F OH H H XM-11-2 CH 3 H H CH 3 Et N 3 H F OH H H XIII-11-3 CH 3 H H CH(CH 3
)
2 Et N 3 H F OH H H XIH-11-4 CH 3 H H CH 2
CH(CH
3
)
2 Et N 3 H F OH H H XI-11-5 CH 3 H H CH 2 Ph Et N 3 H F OH H H XHI-11-6 CH 3 H H CH 2 -indol-3-yl Et N 3 H F OH H H XIII-11-7 CH 3 H H CH 2
CH
2
SCH
3 Et N 3 H F OH H H XIH-11-8 CH 3 * H * Et N 3 H F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 1 1 7 Table XIII-12. X2 R R2 R 3 a R 3 b R 4 R5 R' X Y I R 8 XIH-12-1 Et H H H Et N 3 H F OH H H XIII-12-2 Et H H CH3 Et N 3 H F OH H H XI-12-3 Et H H CH(CH 3
)
2 Et N 3 H F OH H H XHI-12-4 Et H H CH 2
CH(CH
3
)
2 Et N 3 H F OH H H XIM-12-5 Et H H CH 2 Ph Et N 3 H F OH H H XH-12-6 Et H H CH 2 -indol-3-yl Et N 3 H F OH H H XHI-12-7 Et H H CH 2
CH
2
SCH
3 Et N 3 H F OH H H XIII-12-8 Et * H * Et N3 H F OH H H *RTand Rab joined together by (CH 2
)
3 to form five-membered ring. Table XIII-13. N2 R' R2 R 3 a R 3 b R4 R R 6 X Y R/ R XI-13-1 'Pr H H H Et N 3 H F OH H H XIII-13-2 'Pr H H CH 3 Et N 3 H F OH H H XIH-13-3 'Pr H H CH(CH 3
)
2 Et N 3 H F OH H H XIII-13-4 'Pr H H CH 2
CH(CH
3
)
2 Et N 3 H F OH H H XI-13-5 'Pr H H CH 2 Ph Et N 3 H F OH H H XII-13-6 'Pr H H CH 2 -indol-3-yl Et N 3 H F OH H H XHI-13-7 'Pr H H CH 2
CH
2
SCH
3 Et N 3 H F OH H H XIH-13-8 'Pr * H * Et N 3 H F OH H H *and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIII-14. XR2 R2 RaRSb R41R5 R( X Y R R( XIII-14-1 'Bu H H H Et N 3 H F OH H H XIII-14-2 'Bu H H CH 3 Et N 3 H F OH H H XIH-14-3 'Bu H H CH(CH 3
)
2 Et N 3 H F OH H H XIH-14-4 'Bu H H CH 2
CH(CH
3
)
2 Et N 3 H F OH H H XIII-14-5 'Bu H H CH2Ph Et N 3 H F OH H H XI-14-6 'Bu H H CH-indol-3-yl Et N 3 H F OH H H XIH-14-7 'Bu H H CH 2 CH2SCH 3 Et N 3 H F OH H H XIII-14-8 'Bu * H * Et N 3 H F OH H H *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. 1 0 Table XIII-15. N2 R' R2 R 3 a R 3 b R 4 R' R' X Y R' R' XM-15-1 Ph H H H Et N 3 H F OH H H XIII-15-2 Ph H H CH 3 Et N 3 H F OH H H XM-15-3 Ph H H CH(CH 3
)
2 Et N 3 H F OH H H XIH-15-4 Ph H H CH 2
CH(CH
3
)
2 Et N 3 H F OH H H Xm-15-5 Ph H H CH 2 Ph Et N 3 H F OH H H XIII-15-6 Ph H H CH 2 -indol-3-yl Et N 3 H F OH H H XIm-15-7 Ph H H CH 2
CH
2
SCH
3 Et N 3 H F OH H H XM-15-8 Ph* H * Et N 3 H F OH H H *R7 and R 3 6 joined together by (CH 2
)
3 to form five-membered ring. Table XIII-16. N9 R' R 2 R3a R 3 b R 4 R' R 6 X Y R 7
R
8 XIII-16-1 p-Me-Ph H H H Et N 3 H F OH H H XIII-16-2 p-Me-Ph H H CH 3 Et N 3 H F OH H H XIII-16-3 p-Me-Ph H H CH(CH 3
)
2 Et N 3 H F OH H H XM-16-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Et N 3 H F OH H H Xm-16-5 p-Me-Ph H H CH 2 Ph Et N 3 H F OH H H XI-16-6 p-Me-Ph H H CH 2 -indol-3-yl Et N 3 H F OH H H XII-16-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Et N 3 H F OH H H XIII-16-8 p-Me-Ph * H * Et N 3 H F OH H H *R and R"b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIII-17. N2 Rl R 2
R
3 a Rab R 4 R' R 6 X Y R' R' XIII-17-1 p-F-Ph H H H Et N 3 H F OH H H XM-17-2 p-F-Ph H H CH 3 Et N 3 H F OH H H XJI-17-3 p-F-Ph H H CH(CH 3
)
2 Et N 3 H F OH H H XIH-17-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Et N 3 H F OH H H XIH-17-5 p-F-Ph H H CH 2 Ph Et N 3 H F OH H H XIII-17-6 p-F-Ph H H CH 2 -indol-3-yi Et N 3 H F OH H H XM-17-7 p-F-Ph H H CH 2
CH
2
SCH
3 Et N 3 H F OH H H XM-17-8 p-F-Ph * H * Et N 3 H F OH H H *R and R 3 joined together by (CH 2
)
3 to form five-membered ring. 2 1 O Table XIII-18. N2 Rl R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7
R
8 XII-18-1 p-Cl-Ph H H H Et N 3 H F OH H H XI-18-2 p-Cl-Ph H H CH 3 Et N 3 H F OH H H XIII-18-3 p-Cl-Ph H H CH(CH 3
)
2 Et N 3 H F OH H Hl XII-18-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Et N 3 H F OH H H XLI-18-5 p-Cl-Ph H H CH 2 Ph Et N 3 H F OH H H XII-18-6 p-Cl-Ph H H CH 2 -indol-3-yl Et N 3 H F OH H H XIH-18-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Et N 3 H F OH H H XIII-18-8 p-Cl-Ph * H * Et N 3 H F OH H H *Rand Rdb joined together by (CH 2
)
3 to form five-membered ring. Table XIII-19. N2 RR 3
R
3 Rb R 4 R' R 6 X Y R 7
R
8 XHI-19-1 p-Br-Ph H H H Et N 3 H F OH H H XI1-19-2 p-Br-Ph H H CH 3 Et N 3 H F OH H H XIII-19-3 p-Br-Ph H H CH(CH 3
)
2 Et N 3 H F OH H H XIH-19-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Et N 3 H F OH H H XM-19-5 p-Br-Ph H H CH 2 Ph Et N 3 H F OH H H XIH-19-6 p-Br-Ph H H CH2-indol-3-yl Et N 3 H F OH H H XI-19-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Et N 3 H F OH H H XI1-19-8 p-Br-Ph * H * Et N 3 H F OH H H *R and Rab joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIII-20. N2 Rl R 2
R
3 a R 3 b R 4 R' R' X Y R' R' XIf-20-1 p-I-Ph H H H Et N 3 H F OH H H Xml7-20-2 p-I-Ph H H CH 3 Et N 3 H F OH H H XIII-20-3 p-I-Ph H H CH(CH 3
)
2 Et N 3 H F OH H H XI-20-4 p-I-Ph H H CH 2 CH(CH3) 2 Et N 3 H F OH H H XII1-20-5 p-I-Ph H H CH 2 Ph Et N 3 H F OH H H XIH-20-6 p-I-Ph H H CH 2 -indol-3-yl Et N 3 H F OH H H XHI-20-7 p-I-Ph H H CH 2
CH
2
SCH
3 Et N 3 H F OH H H Xm-20-8 p-I-Ph * H * Et N 3 H F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XIII-21. X2 R' R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7
R
8 XIII-21-1 CH 3 H H H 'Pr N 3 H F OH H H XIII-21-2 CH 3 H H CH- 'Pr N 3 H F OH H H XIII-21-3 CH 3 H H CH(CH 3
)
2 'Pr N 3 H F OH H H XIII-21-4 CH 3 H H CH 2
CH(CH
3
)
2 'Pr N 3 H F OH H H XIII-21-5 CH 3 H H CH 2 Ph 'Pr N 3 H F OH H H XHI-21-6 CH 3 H H CH2-indol-3-yl 'Pr N 3 H F OH H H XIII-21-7 CH 3 H H CH 2
CH
2
SCH
3 'Pr N 3 H F OH H H XIII-21-8 CH 3 * H * 'Pr N 3 H F OH H H
R
2 an d R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XIII-22. N2 RI R 2
R
3 a R 3 b R 4 R R 6 X Y R' R' XIH-22-1 Et H H H 'Pr N 3 H F OH H H XIII-22-2 Et H H CH 3 'Pr N 3 H F OH H H XII-22-3 Et H H CH(CH 3
)
2 'Pr N 3 H F OH H H XIII-22-4 Et H H CH 2
CH(CH
3
)
2 'Pr N 3 H F OH H H XfI-22-5 Et H H CH 2 Ph 'Pr N 3 H F OH H H XI-22-6 Et H H CH 2 -indol-3-yl 'Pr N 3 H F OH H H XIII-22-7 Et H H CH2CH 2
SCH
3 'Pr N 3 H F OH H H XIH-22-8 Et * H * 'Pr N 3 H F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIII-23. N2 R' R 2 R3a R 3 b R 4 R' R' X Y R 7 - R" XIII-23-1 'Pr H H H 'Pr N 3 H F OH H H XM-23-2 'Pr H H CH 3 'Pr N 3 H F OH H H XIII-23-3 'Pr H H CH(CH 3
)
2 'Pr N 3 H F OH H H XIII-23-4 'Pr H H CH 2
CH(CH
3
)
2 'Pr N 3 H F OH H H XHI-23-5 'Pr H H CH 2 Ph 'Pr N 3 H F OH H H XI-23-6 'Pr H H CH 2 -indol-3-yi Pr N 3 H F OH H H XI-23-7 'Pr H H CH 2
CH
2
SCH
3 'Pr N 3 H F OH H H XHI-23-8 'Pr * H * 'Pr N 3 H F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XIII-24. N2 R R 2 R3a R 3 b R 4 R' R X Y R R 29 1 X2 RI R2 R 3 a R 3 b R' R' R' X Y R' R' XIII-24-1 'Bu H H H 'Pr N 3 H F OH H H XJII-24-2 'Bu H H CH 3 'Pr N 3 H F OH H H XII-24-3 'Bu H H CH(CH 3
)
2 'Pr N 3 H F OH H H XUI-24-4 'Bu H H CH 2
CH(CH
3
)
2 'Pr N 3 H F OH H H XIII-24-5 'Bu H H CH 2 Ph 'Pr N 3 H F OH H H XIH-24-6 'Bu H H CH 2 -indol-3-yl 'Pr N 3 H F OH H H XHII-24-7 'Bu H H CH 2
CH
2
SCH
3 'Pr N 3 H F OH H H XJI-24-8 'Bu * H * 'Pr N 3 H F OH H H *Rand R3b joined together by (CH 2
)
3 to form five-membered ring. Table XIII-25. N2 R' R 2 Ra R3b R' R' R' X Y R R( XIH-25-1 Ph H H H 'Pr N 3 H F OH H H XIH-25-2 Ph H H CH 3 'Pr N 3 H F OH H H XIU-25-3 Ph H H CH(CH 3
)
2 'Pr N 3 H F OH H H XIII-25-4 Ph H H CH 2
CH(CH
3
)
2 'Pr N 3 H F OH H H XIH-25-5 Ph H H CH 2 Ph 'Pr N 3 H F OH H H XIH-25-6 Ph H H CH 2 -indol-3-yl 'Pr N 3 H F OH H H XIII-25-7 Ph H H CH 2
CH
2
SCH
3 'Pr N 3 H F OH H H XI-25-8 Ph * H * 'Pr N 3 H F OH H H *R" and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XIII-26. X2 Rl R 2
R
3 a R 3 b R' R' R' X Y R' R' XIH-26-1 p-Me-Ph H H H 'Pr N 3 H F OH H H XIH-26-2 p-Me-Ph H H CH 3 'Pr N 3 H F OH H H XIII-26-3 p-Me-Ph H H CH(CH 3
)
2 'Pr N 3 H F OH H H XIH-26-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 'Pr N 3 H F OH H H XHI-26-5 p-Me-Ph H H CH 2 Ph 'Pr N 3 H F OH H H XIM-26-6 p-Me-Ph H H CH 2 -indol-3-yl 'Pr N 3 H F OH H H XLH-26-7 p-Me-Ph H H CH 2
CH
2
SCH
3 'Pr N 3 H F OH H H XIH-26-8 p-Me-Ph * H * 'Pr N 3 H F OH H H 5 *RT and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XII-27. X Re R 2 R3a R 3 b R4 R' R' X Y R' R' X1II-2'7-1 p-F-Ph H H H 'Pr N 3 H F OH H H XIII-27-2 p-F-Ph H H CH 3 'Pr N 3 H F OH H H XII-27-3 p-F-Ph H H CH(CH 3
)
2 'Pr N 3 H F OH H H XIH-27-4 p-F-Ph H H CH 2
CH(CH
3
)
2 'Pr N 3 H F OH H H XM-27-5 p-F-Ph H H CH 2 Ph 'Pr N 3 H F OH H H XIH-27-6 p-F-Ph H H CH 2 -indol-3-yl 'Pr N 3 H F OH H H XIHI-27-7 p-F-Ph H H CH 2
CH
2
SCH
3 'Pr N 3 H F OH H H XII-27-8 p-F-Ph * H * 'Pr N 3 H F OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XIII-28. Xe R' R 2 R3Ja R 3 b R 4 R' R 6 X Y R' R' XIH-28-1 p-Cl-Ph H H H 'Pr N 3 H F OH H H XHI-28-2 p-Cl-Ph H H CH 3 'Pr N 3 H F OH H H XIII-28-3 p-Cl-Ph H H CH(CH 3
)
2 'Pr N 3 H F OH H H XIII-28-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 'Pr N 3 H F OH H H XIm-28-5 p-Cl-Ph H H CH2Ph 'Pr N 3 H F OH H H XIH-28-6 p-Cl-Ph H H CH 2 -indol-3-yl 'Pr N 3 H F OH H H XIII-28-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 'Pr N 3 H F OH H H XIH-28-8 p-Cl-Ph * H * 'Pr N 3 H F OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIII-29. Xe R' R 2 R 3 a Rab R 4 R' R 6 X Y R 7 R' XIII-29-1 p-Br-Ph H H H 'Pr N 3 H F OH H H XIII-29-2 p-Br-Ph H H CH3 'Pr N 3 H F OH H H XIH-29-3 p-Br-Ph H H CH(CH 3
)
2 'Pr N 3 H F OH H H XIII-29-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 'Pr N 3 H F OH H H XHI-29-5 p-Br-Ph H H CH 2 Ph 'Pr N 3 H F OH H H XIH-29-6 p-Br-Ph H H CH 2 -indol-3-yl 'Pr N 3 H F OH H H XIII-29-7 p-Br-Ph H H CH 2
CH
2
SCH
3 'Pr N 3 H F OH H H XI-29-8 p-Br-Ph * H * 'Pr N 3 H F OH H H
*R
2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XII-30. X R RR 3 Rb R R' R' X Y R R' N2 Ri R 2
R
3 a R3b R 4 R R 6 X Y R' R' XII-30-1 p-I-Ph H H H 'Pr N 3 H F OH H H XII-30-2 p-I-Ph H H CH 3 'Pr N 3 H F OH H H XIII-30-3 p-I-Ph H H CH(CH 3
)
2 'Pr N 3 H F OH H H XIIH-30-4 p-I-Ph H H CH 2
CH(CH
3
)
2 'Pr N 3 H F OH H H XIH-30-5 p-I-Ph H H CH 2 Ph 'Pr N 3 H F OH H H XIII-30-6 p-I-Ph H H CH 2 -indol-3-yl 'Pr N 3 H F OH H H XIII-30-7 p-I-Ph H H CH2CH 2
SCH
3 'Pr N 3 H F OH H H XII-30-8 p-I-Ph * H * 'Pr N 3 H F OH H H *R" and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XIII-3 1. N2 R' R2 R " R 3 b R 4 R' R 6 X Y R' R" XII-31-1 CH 3 H H H "Bu N 3 H F OH H H XIII-31-2 CH 3 H H CH 3 "Bu N 3 H F OH H H XI-31-3 CH 3 H H CH(CH 3
)
2 "Bu N 3 H F OH H H XIII-31-4 CH 3 H H CH 2
CH(CH
3 )2 "Bu N 3 H F OH H H XII-31-5 CH 3 H H CH 2 Ph "Bu N 3 H F OH H H XII-31-6 CH 3 H H CH 2 -indol-3-yl "Bu N 3 H F OH H H XIII-31-7 CH 3 H H CH 2
CH
2
SCH
3 "Bu N 3 H F OH H H XJIII-31-8 CH 3 * H * "Bu N 3 H F OH H H
*R
2 and R joined together by (CH 2
)
3 to form five-membered ring. Table XIII-32. N2 RI R 2
R
3 a R 3 b R' R' R 6 X Y R' R' XIII-32-1 Et H H H "Bu N 3 H F OH H H XIII-32-2 Et H H CH 3 "Bu N 3 H F OH H H XII-32-3 Et H H CH(CH 3
)
2 "Bu N 3 H F OH H H XII-32-4 Et H H CH 2
CH(CH
3
)
2 "Bu N 3 H F OH H H XI-32-5 Et H H CH 2 Ph "Bu N 3 H F OH H H XIII-32-6 Et H H CH 2 -indol-3-yl "Bu N 3 H F OH H H XIII-32-7 Et H H CH 2
CH
2
SCH
3 "Bu N 3 H F OH H H XII-32-8 Et * H * "Bu N 3 H F OH H H 5 *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XIII-33. N2 R' R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7 R8 XIII-33-1 'Pr H H H "Bu N 3 H F OH H H
SA
X2 R' R2 R 3 a R 3 b R 4 R' R' X Y R 7
R
8 XM-33-2 'Pr H H CH 3 "Bu N 3 H F OH H H XIH-33-3 'Pr H H CH(CH 3
)
2 "Bu N 3 H F OH H H XIII-33-4 'Pr H H CH 2
CH(CH
3
)
2 "Bu N 3 H F OH H H XIII-33-5 'Pr H H CH 2 Ph "Bu N 3 H F OH H H XIH-33-6 'Pr H H CH 2 -indol-3-yl "Bu N 3 H F OH H H XII-33-7 'Pr H H CH 2 CH2SCH 3 "Bu N 3 H F OH H H XM-33-8 'Pr * H * "Bu N 3 H F OH H H * R and R"0 joined together by (CH 2
)
3 to form five-membered ring. Table XIII-34. N2 R' R2 RaR 3 b R' R' R 6 X Y R 7 R' Xm-34-1 'Bu H H H "Bu N 3 H F OH H H XII-34-2 'Bu H H CH 3 "Bu N 3 H F OH H H XIII-34-3 'Bu H H CH(CH 3
)
2 "Bu N 3 H F OH H H XM-34-4 'Bu H H CH 2
CH(CH
3
)
2 "Bu N 3 H F OH H H XM-34-5 'Bu H H CH 2 Ph "Bu N 3 H F OH H H XIII-34-6 'Bu H H CH 2 -indol-3-yl "Bu N 3 H F OH H H XIH-34-7 'Bu H H CH 2
CH
2
SCH
3 "Bu N 3 H F OH H H XI-34-8 'Bu * H * "Bu N 3 H F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XIII-35. X2 R' R2 R 3 a R 3 b R 4 R' R' X Y R 7
R
8 XIII-35-1 Ph H H H "Bu N 3 H F OH H H XHI-35-2 Ph H H CH 3 "Bu N 3 H F OH H H XM-35-3 Ph H H CH(CH 3
)
2 "Bu N 3 H F OH H H XIH-35-4 Ph H H CH 2
CH(CH
3
)
2 "Bu N 3 H F OH H H XIH-35-5 Ph H H CH 2 Ph "Bu N 3 H F OH H H XIH-35-6 Ph H H CH 2 -indol-3-yl "Bu N 3 H F OH H H XIII-35-7 Ph H H CH 2
CH
2
SCH
3 "Bu N 3 H F OH H H X11-35-8 Ph * H * "Bu N 3 H F OH H H 5 *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XIII-36. N2 Rl R 2
R
3 a" R 3 b R 4 R' R 6 X Y R 7 RS XI-36--1 p-Me-Ph H H H "Bu N 3 H F OH H H XIII-36-2 p-Me-Ph H H CH 3 "Bu N 3 H F OH H H N RI R 2 R 3a R 3 b R 4 R' R' X Y R 7
R
8 XIH-36-3 p-Me-Ph H H CH(CH 3
)
2 "Bu N 3 H F OH H H XIH-36-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 "Bu N 3 H F OH H H XIH-36-5 p-Me-Ph H H CH 2 Ph "Bu N 3 H F OH H H XIH-36-6 p-Me-Ph H H CH 2 -indol-3-yl "Bu N 3 H F OH H H XIII-36-7 p-Me-Ph H H CH 2
CH
2
SCH
3 "Bu N 3 H F OH H H XIf-36-8 p-Me-Ph * H * "Bu N 3 H F OH H H - *Rand Rab joined together by (CH 2
)
3 to form five-membered ring. Table XIII-37. N R' R 2
R
3 a R 3 b R 4 R' R' X Y R' R 8 XIH-37-1 p-F-Ph H H H "Bu N 3 H F OH H H XIII-37-2 p-F-Ph H H CH 3 "Bu N 3 H F OH H H XI-37-3 p-F-Ph H H CH(CH 3
)
2 "Bu N 3 H F OH H H XIII-37-4 p-F-Ph H H CH 2
CH(CH
3
)
2 "Bu N 3 H F OH H H XIII-37-5 p-F-Ph H H CH 2 Ph "Bu N 3 H F OH H H XIII-37-6 p-F-Ph H H CH 2 -indol-3-yl "Bu N 3 H F OH H H XM-37-7 p-F-Ph H H CH 2
CH
2
SCH
3 "Bu N 3 H F OH H H XIJ-37-8 p-F-Ph * H * "Bu N 3 H F OH H H *R2 and RO joined together by (CH 2
)
3 to form five-membered ring. Table XIII-38. N2 RM R2 R 3 a R 3 b R 4 R' R' X Y R 7
R
8 XIII-38-1 p-Cl-Ph H H H "Bu N 3 H F OH H H XIH-38-2 p-Cl-Ph H H CH 3 "Bu N 3 H F OH H H XH-38-3 p-Cl-Ph H H CH(CH 3
)
2 "Bu N 3 H F OH H H XHI-38-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 "Bu N 3 H F OH H H XIHI-38-5 p-Cl-Ph H H CH 2 Ph "Bu N 3 H F OH H H XII1-38.-6 p-Cl-Ph H H CH 2 -indol-3-yl "Bu N 3 H F OH H H XIH-38-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 "Bu N 3 H F OH H H XIH-38-8 p-Cl-Ph * H * "Bu N 3 H F OH H H 5 *Rand R 3 R joined together by (CH 2
)
3 to form five-membered ring. Table XIII-39. N2 RM R 2 R 3 a R 3 b R 4 R' R' X Y R 7 R' XIH-39-1 p-Br-Ph H H H "Bu N 3 H F OH H H XIH-39-2 p-Br-Ph H H CH 3 "Bu N 3 H F OH H H XHI-39-3 p-Br-Ph H H CH(CH 3
)
2 "Bu N 3 H F OH H H X2 Rl R 2
R
3 a R 3 b R' R R 6 X Y R 7
R
8 XIII-39-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 "Bu N 3 H F OH H H XIH-39-5 p-Br-Ph H H CH 2 Ph "Bu N 3 H F OH H H XIH-39-6 p-Br-Ph H H CH 2 -indol-3-yl "Bu N 3 H F OH H H XIII-39-7 p-Br-Ph H H CH 2
CH
2
SCH
3 "Bu N 3 H F OH H H XIH-39-8 p-Br-Ph * H * "Bu N 3 H F OH H H *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XIII-40. X2 R' R2 R 3 a Rb R 4 R' R 6 X Y R' R' XIII-40-1 p-I-Ph H H H "Bu N 3 H F OH H H XI-40-2 p-I-Ph H H CH 3 "Bu N 3 H F OH H H XIH-40-3 p-I-Ph H H CH(CH 3
)
2 "Bu N 3 H F OH H H XII-40-4 p-I-Ph H H CH 2
CH(CH
3
)
2 "Bu N 3 H F OH H H XIH-40-5 p-I-Ph H H CH 2 Ph "Bu N 3 H F OH H H XIH-40-6 p-I-Ph H H CH 2 -indol-3-yl "Bu N 3 H F OH H H XHI-40-7 p-I-Ph H H CH 2
CH
2
SCH
3 "Bu N 3 H F OH H H XII-40-8 p-I-Ph * H * "Bu N 3 H F OH H H *R and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XIII-41. X2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y R 7
R
8 XIII-41-1 CH 3 H H H Bz N 3 H F OH H H XHI-41-2 CH 3 H H CH 3 Bz N 3 H F OH H H XII-41-3 CH 3 H H CH(CH 3
)
2 Bz N 3 H F OH H H XIII-41-4 CH 3 H H CH 2
CH(CH
3
)
2 Bz N 3 H F OH H H XIH-41-5 CH 3 H H CH 2 Ph Bz N 3 H F OH H H XII-41-6 CH 3 H H CH 2 -indol-3-yl Bz N 3 H F OH H H XIHI-41-7 CH 3 H H CH 2
CH
2
SCH
3 Bz N 3 H F OH H H XIH-41-8 CH 3 * H * Bz N 3 H F OH H H 5 *R 2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XIII-42. X2 RI R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7
R
8 XIII-42-1 Et H H H Bz N 3 H F OH H H XJI-42-2 Et H H CH 3 Bz N 3 H F OH H H XIH-42-3 Et H H CH(CH 3
)
2 Bz N 3 H F OH H H XIH-42-4 Et H H CH 2
CH(CH
3
)
2 Bz N 3 H F OH H H N RI R 2
R
3 a R 3 b R 4 R' R' X Y R 7
R
8 XHI-42-5 Et H H CH 2 Ph Bz N 3 H F OH H H XIH-42-6 Et H H CH 2 -indol-3-yl Bz N 3 H F OH H H XMI-42-7 Et H H CH 2
CH
2
SCH
3 Bz N 3 H F OH H H XIII-42-8 Et * H * Bz N 3 H F OH H H *R2 and Rab joined together by (CH 2
)
3 to form five-membered ring. Table XIII-43. N R' R2 R 3 a R3b R 4 R' R 6 X Y R' R XIH-43-1 'Pr H H H Bz N 3 H F OH H H XI-43-2 'Pr H H CH 3 Bz N 3 H F OH H H XII-43-3 'Pr H H CH(CH 3
)
2 Bz N 3 H F OH H XHI-43-4 'Pr H H CH 2
CH(CH
3
)
2 Bz N 3 H F OH H H XIII-43-5 'Pr H H CH 2 Ph Bz N 3 H F OH H H XIII-43-6 'Pr H H CH 2 -indol-3-yl Bz N 3 H F OH H H XIH-43-7 'Pr H H CH 2
CH
2
SCH
3 Bz N 3 H F OH H H XII-43-8 'Pr * H * Bz N 3 H F OH H H
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 10 Table XIII-44. Ne R' R 2
R
3 a R 3 b R' R' R 6 X Y R' R' XUI-44-1 'Bu H H H Bz N 3 H F OH H H XM-44-2 'Bu H H CH 3 Bz N 3 H F OH H H XI-44-3 'Bu H H CH(CH 3
)
2 Bz N 3 H F OH H H XIII-44-4 'Bu H H CH 2
CH(CH
3
)
2 Bz N 3 H F OH H H XI-44-5 'Bu H H CH 2 Ph Bz N 3 H F OH H H XIH-44-6 'Bu H H CH 2 -indol-3-yl Bz N 3 H F OH H H X1I1-44-7 'Bu H H CH 2
CH
2
SCH
3 Bz N 3 H F OH H H XIII-44-8 'Bu * H * Bz N 3 H F OH H H *RTand R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XIII-45. N R' R2 R 3 a R 3 b R' R' R 6 X Y R' R 8 XIII-45-1 Ph H H H Bz N 3 H F OH H H XM-45-2 Ph H H CH 3 Bz N 3 H F OH H H XIII-45-3 Ph H H CH(CH 3 )2 Bz N 3 H F OH H H X2 R' R2 R 3 a R 3 b R 4 R' R' X Y R' R' XIH-45-4 Ph H H CH 2
CH(CH
3
)
2 Bz N 3 H F OH H H XIII-45-5 Ph H H CH 2 Ph Bz N 3 H F OH H H XJI-45-6 Ph H H CH 2 -indol-3-yl Bz N 3 H F OH H H XHI-45-7 Ph H H CH 2
CH
2 SCH3 Bz N 3 H F OH H H XM-45-8 Ph * H * Bz N 3 H F OH H H *R and R b joined together by (CH 2
)
3 to form five-membered ring. Table XIII-46.
NR
2
R
3
R
3 b R' R' R 6 X Y R' R XIII-46-1 p-Me-Ph H H H Bz N 3 H F OH H H XHI-46-2 p-Me-Ph H H CH 3 Bz N 3 H F OH H H XIII-46-3 p-Me-Ph H H CH(CH 3
)
2 Bz N 3 H F OH H H XILI-46-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Bz N 3 H F OH H H XIII-46-5 p-Me-Ph H H CH 2 Ph Bz N 3 H F OH H H XI-46-6 p-Me-Ph H H CH 2 -indol-3-yl Bz N 3 H F OH H H XM-46-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Bz N 3 H F OH H H Xm-46-8 p-Me-Ph * H * Bz N 3 H F OH H H *R2 and R 3 1 joined together by (CH 2
)
3 to form five-membered ring. Table XIII-47. NO Rl R 2
R
3 a R 3 b R 4 R' R 6 X Y R' R 8 XHI-47-1 p-F-Ph H H H Bz N 3 H F OH H H Xm-47-2 p-F-Ph H H CH 3 Bz N 3 H F OH H H XIH-47-3 p-F-Ph H H CH(CH 3
)
2 Bz N 3 H F OH H H XHI-47-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Bz N 3 H F OH H H Xlf-47-5 p-F-Ph H H CH 2 Ph Bz N 3 H F OH H H XI-47-6 p-F-Ph H H CH 2 -indol-3-yl Bz N 3 H F OH H H Xm-47-7 p-F-Ph H H CH 2
CH
2
SCH
3 Bz N 3 H F OH H H X1-47-8 p-F-Ph* H * Bz N 3 H F OH H H 5 *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XIII-48. X2 R' R2 R 3 a Rb R' R' R 6 X Y R R XUI-48-1 p-Cl-Ph H H H Bz N 3 H F OH H H XIII-48-2 p-Cl-Ph H H CH 3 Bz N 3 H F OH H H XI1-48-3 p-Cl-Ph H H CH(CH 3
)
2 Bz N 3 H F OH H H XM-48-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Bz N 3 H F OH H H Xe R R 2 R3a R 3 b R 4 R' R' X Y RI7 R 8 XM-48-5 p-Cl-Ph H H CH 2 Ph Bz N 3 H F OH H H XM-48-6 p-Cl-Ph H H CH 2 -indol-3-yl Bz N 3 H F OH H H XIII-48-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Bz N 3 H F OH H H XM-48-8 p-Cl-Ph * H * Bz N 3 H F OH H H *R and R~b joined together by (CH 2
)
3 to form five-membered ring. Table XIII-49. N2 Rl R 2
R
3 " R 3 b R 4 R' R' X Y R 7
R
8 XIII-49-1 p-Br-Ph H H H Bz N 3 H F OH H H XIII-49-2 p-Br-Ph H H CH 3 Bz N 3 H F OH H H XII-49-3 p-Br-Ph H H CH(CH 3
)
2 Bz N 3 H F OH H H XIH-49-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Bz N 3 H F OH H H XIII-49-5 p-Br-Ph H H CH 2 Ph Bz N 3 H F OH H H XIII-49-6 p-Br-Ph H H CH 2 -indol-3-yl Bz N 3 H F OH H H XII-49-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Bz N 3 H F OH H H XIII-49-8 p-Br-Ph * H * Bz N 3 H F OH H H *R2 and RJb joined together by (CH 2
)
3 to form five-membered ring. Table XIII-50. Xe R R 2
R
3 a Rb R 4 R' R 6 X Y R 7
R
8 XIII-50-1 p-I-Ph H H H Bz N 3 H F OH H H XM-50-2 p-I-Ph H H CH 3 Bz N 3 H F OH H H XI-50-3 p-I-Ph H H CH(CH 3
)
2 Bz N 3 H F OH H H XIH-50-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Bz N 3 H F OH H H XIH-50-5 p-I-Ph H H CH 2 Ph Bz N 3 H F OH H H XM-50-6 p-I-Ph H H CH 2 -indol-3-yl Bz N 3 H F OH H H XIH-50-7 p-I-Ph H H CH 2
CH
2
SCH
3 Bz N 3 H F OH H H XIII-50-8 p-I-Ph * H * Bz N 3 H F OH H H 5 *R 2 and R-b joined together by (CH 2
)
3 to form five-membered ring. nn 0 NH 0 R3b R2 R3aN-P C0 2
R
4 OR'
R
6 Y X XIV Table XIV-1. X2 R' R2 R 3 a R 3 b R 4 R' R X Y R' R XIV-1-1 CH 3 H H H CH 3
N
3 F H OH H H XIV-1-2 CH 3 H H CH 3
CH
3
N
3 F H OH H H XIV-1-3 CH 3 H H CH(CH 3
)
2
CH
3
N
3 F H OH H H XIV-1-4 CH 3 H H CH2CH(CH 3
)
2
CH
3
N
3 F H OH H H XIV-1-5 CH 3 H H CH 2 Ph CH 3
N
3 F H OH H H XIV-1-6 CH 3 H H CH 2 -indol-3-yl CH 3
N
3 F H OH H H XIV-1-7 CH 3 H H CH 2
CH
2
SCH
3
CH
3
N
3 F H OH H H XIV-1-8 CH 3 * H * CH 3
N
3 F H OH H H *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIV-2. X RI R 2 R Rb R R'R 6 XY RRR 8 XIV-2-1 Et H H H CH 3
N
3 F H OH H H XIV-2-2 Et H H CH 3
CH
3
N
3 F H OH H H XIV-2-.3 Et H H CH(CH 3
)
2
CH
3
N
3 F H OH H H XIV-2-4 Et H H CH 2
CH(CH
3
)
2
CH
3
N
3 F H OH H H XIV-2-5 Et H H CH 2 Ph CH 3
N
3 F H OH H H XIV-2-.6 Et H H CH 2 -indol-3-yl CH 3
N
3 F H OH H H XIV-2-7 Et H H CH 2
CH
2
SCH
3
CH
3
N
3 F H OH H H XIV-2-8 Et * H * CH 3
N
3 F H OH H H *RTand R 3 " joined together by (CH 2
)
3 to form five-membered ring. 2,2 1 Table XIV-3. N2 RI R 2 R a RA R 4 R' R' X Y R 7 R XIV-3-1 'Pr H H H CH 3
N
3 F H OH H H XIV-3-2 'Pr H H CH 3
CH
3
N
3 F H OH H H XIV-3-3 'Pr H H CH(CH 3
)
2
CH
3
N
3 F H OH H H XIV-3-4 'Pr H H CH 2
CH(CH
3
)
2
CH
3
N
3 F H OH H H XIV-3-5 'Pr H H CH 2 Ph CH 3
N
3 F H OH H H XIV-3-6 'Pr H H CH 2 -indol-3-yl CH 3
N
3 F H OH H H XIV-3-7 'Pr H H CH 2
CH
2
SCH
3
CH
3
N
3 F H OH H H XIV-3-8 'Pr * H * CH 3
N
3 F H OH H H *R2 and R b joined together by (CH 2
)
3 to form five-membered ring. Table XIV-4. N R' R2 R 3 a R 3 b R 4 R' R 6 X Y R 7
R
8 XIV-4-1 'Bu H H H CH 3
N
3 F H OH H H XIV-4-2 'Bu H H CH 3
CH
3
N
3 F H OH H H XIV-4-3 'Bu H H CH(CH 3
)
2
CH
3
N
3 F H OH H H XIV-4-4 'Bu H H CH 2
CH(CH
3
)
2
CH
3
N
3 F H OH H H XIV-4-5 'Bu H H CH 2 Ph CH 3
N
3 F H OH H H XIV-4-6 'Bu H H CH 2 -indol-3-yl CH 3
N
3 F H OH H H XIV-4-7 'Bu H H CH 2
CH
2
SCH
3
CH
3
N
3 F H OH H H XV-4-8 'Bu * H * CH 3
N
3 F H OH H H
*R
2 and R b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIV-5. N RI R 2
R
3 a R3b R 4 R' R 6 X Y R 7
R
8 XIV-5-1 Ph H H H CH 3
N
3 F H OH H H XIV-5-2 Ph H H CH 3
CH
3
N
3 F H OH H H XIV-5-3 Ph H H CH(CH 3
)
2
CH
3
N
3 F H OH H H XIV-5-4 Ph H H CH 2
CH(CH
3
)
2
CH
3
N
3 F H OH H H XIV-5-5 Ph H H CH 2 Ph CH 3
N
3 F H OH H H XIV-5-6 Ph H H CH 2 -indol-3-yl CH 3
N
3 F H OH H H XIV-5-7 Ph H H CH 2
CH
2
SCH
3
CH
3
N
3 F H OH H H XIV-5-8 Ph * H * CH 3
N
3 F H OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XIV-6. NV R' R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7
R
8 XIV-6-1 p-Me-Ph H H H CH 3
N
3 F H OH H H XIV-6-2 p-Me-Ph H H CH 3
CH
3
N
3 F H OH H H XIV-6-3 p-Me-Ph H H CH(CH 3
)
2
CH
3
N
3 F H OH H H XIV-6-4 p-Me-Ph H H CH 2
CH(CH
3
)
2
CH
3
N
3 F H OH H H XIV-6-5 p-Me-Ph H H CH 2 Ph CH 3
N
3 F H OH H H XIV-6-6 p-Me-Ph H H CH 2 -indol-3-yl CH 3
N
3 F H OH H H XIV-6-7 p-Me-Ph H H CH 2
CH
2
SCH
3
CH
3
N
3 F H OH H H XIV-6-8 p-Me-Ph * H * CH 3
N
3 F H OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XIV-7. N2 R' R 2
R
3 a R3b R 4 R' R 6 X Y R' R' XIV-7-1 p-F-Ph H H H CH 3
N
3 F H OH H H XIV-7-2 p-F-Ph H H CH 3
CH
3
N
3 F H OH H H XIV-7-3 p-F-Ph H H CH(CH 3
)
2
CH
3
N
3 F H OH H H XIV-7-4 p-F-Ph H H CH 2
CH(CH
3
)
2
CH
3
N
3 F H OH H H XIV-7-6 p-F-Ph H H CH 2 Ph CH 3
N
3 F H OH H H XIV-7-7 p-F-Ph H H CH 2 -indol-3-yl CH 3
N
3 F H OH H H XIV-7-8 p-F-Ph H H CH 2
CH
2
SCH
3
CH
3
N
3 F H OH H H XIV-7-20 p-F-Ph * H * CH 3
N
3 F H OH H H
*R
2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIV-8. X RT R 2 R 3 a R3b R 4 R' R 6 X Y R 7 R' XIV-8-1 p-Cl-Ph H H H CH 3
N
3 F H OH H H XIV-8-2 p-Cl-Ph H H CH 3
CH
3
N
3 F H OH H H XIV-8-3 p-Cl-Ph H H CH(CH 3
)
2
CH
3
N
3 F H OH H H XIV-8-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2
CH
3
N
3 F H OH H H XIV-8-5 p-Cl-Ph H H CH 2 Ph CH 3
N
3 F H OH H H XIV-8-6 p-Cl-Ph H H CH 2 -indol-3-yl CH 3
N
3 F H OH H H XIV-8-7 p-Cl-Ph H H CH 2
CH
2
SCH
3
CH
3
N
3 F H OH H H XIV-8-8 p-Cl-Ph * H * CH 3
N
3 F H OH H H *R an Rib joined together by (CH 2
)
3 to form five-membered ring. 02 11 Table XIV-9.
R
2
R
3 " R 3 b R 4 R' R' X Y R 7
R
8 XIV-9-1 p-Br-Ph H H H CH 3
N
3 F H OH H H XIV-9-2 p-Br-Ph H H CH 3
CH
3
N
3 F H OH H H XIV-9-3 p-Br-Ph H H CH(CH 3
)
2
CH
3
N
3 F H OH H H XIV-9-4 p-Br-Ph H H CH 2
CH(CH
3
)
2
CH
3
N
3 F H OH H H XIV-9-6 p-Br-Ph H H CH 2 Ph CH 3
N
3 F H OH H H XIV-9-7 p-Br-Ph H H CH 2 -indol-3-yl CH 3
N
3 F H OH H H XIV-9-8 p-Br-Ph H H CH 2
CH
2
SCH
3
CH
3
N
3 F H OH H H XIV-9-20 p-Br-Ph * H * CH 3
N
3 F H OH H H *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XIV-10. 2 R R Ra Rb R 4 R' R X Y R R 8 XIV-10-1 p-I-Ph H H H CH 3
N
3 F H OH H H XIV-10-2 p-I-Ph H H CH 3
CH
3
N
3 F H OH H H XIV-10-3 p-I-Ph H H CH(CH 3
)
2
CH
3
N
3 F H OH H H XIV-10-4 p-I-Ph H H CH 2
CH(CH
3
)
2
CH
3
N
3 F H OH H H XIV-10-5 p-I-Ph H H CH 2 Ph CH 3
N
3 F H OH H H XIV-10-6 p-I-Ph H H CH 2 -indol-3-yl CH 3
N
3 F H OH H H XIV-10-7 p-I-Ph H H CH 2
CH
2
SCH
3
CH
3
N
3 F H OH H H XIV-10-8 p-I-Ph * H * CH 3
N
3 F H OH H H
*R
2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIV-11. N2 RI R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7 R 8 XIV-11-1 CH 3 H H H Et N3 F H OH H H XIV-11-2 CH 3 H H CH 3 Et N 3 F H OH H H XIV-11-3 CH 3 H H CH(CH 3
)
2 Et N 3 F H OH H H XIV-11.-4 CH 3 H H CH 2
CH(CH
3
)
2 Et N3 F H OH H H XIV-11--5 CH 3 H H CH 2 Ph Et N 3 F H OH H H XIV-11-6 CH 3 H H CH 2 -indol-3-yl Et N 3 F H OH H H XIV-11.-7 CH 3 H H CH 2
CH
2
SCH
3 Et N 3 F H OH H H XIV-11.-8 CH 3 * H * Et N 3 F H OH H H *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. I I A Table XIV-12. N2 R R 2
R
3 a R 3 b R 4 R R XY RR'R XIV-12-1 Et H H H Et N 3 F H OH H H XIV-12-2 Et H H CH 3 Et N 3 F H OH H H XIV-12-3 Et H H CH(CH 3
)
2 Et N 3 F H OH H H XIV-12-4 Et H H CH 2
CH(CH
3
)
2 Et N 3 F H OH H H XIV-12-5 Et H H CH 2 Ph Et N 3 F H OH H H XIV-12-6 Et H H CH 2 -indol-3-yl Et N 3 F H OH H H XIV-12-7 Et H H CH 2
CH
2
SCH
3 Et N 3 F H OH H H XIV-12-8 Et * H * Et N 3 F H OH H H *R2and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XIV-13. N2 R' R 2
RNR
3 b R 4
R
5
R
6 XY RR'R XIV-13-1 'Pr H H H Et N 3 F H OH H H XIV-13-2 'Pr H H CH 3 Et N 3 F H OH H H XIV-13-3 'Pr H H CH(CH 3
)
2 Et N 3 F H OH H H XIV-13-4 'Pr H H CH 2
CH(CH
3
)
2 Et N 3 F H OH H H XIV-13-5 'Pr H H CH 2 Ph Et N 3 F H OH H H XIV-13-6 'Pr H H CH 2 -indol-3-yl Et N 3 F H OH H H XIV-13-7 'Pr H H CH 2
CH
2
SCH
3 Et N 3 F H OH H H XIV-13-8 'Pr * H * Et N 3 F H OH H H *R and Rb joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIV-14. N2 Rl R 2
R
3 a R 3 b R' R' R' X Y R' R6 XIV-14--1 'Bu H H H Et N 3 F H OH H H XIV-14-2 tBu H H CH 3 Et N 3 F H OH H H XIV-14-3 tBu H H CH(CH 3
)
2 Et N 3 F H OH H H XIV-14-4 tBu H H CH 2
CH(CH
3
)
2 Et N 3 F H OH H H XIV-14..5 'Bu H H CH 2 Ph Et N 3 F H OH H H XIV-14--6 tBu H H CH 2 -indol-3-yl Et N 3 F H OH H H XIV-14-7 'Bu H H CH 2 CH2SCH 3 Et N 3 F H OH H H XIV-14-8 tBu * H * Et N 3 F H OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XIV-15. N2 RI R 2
R
3 a R 3 b R 4 R' R' X Y R' R" XIV-15-1 Ph H H H Et N 3 F H OH H H XIV-15-2 Ph H H CH 3 Et N 3 F H OH H H XIV-15-3 Ph H H CH(CH 3
)
2 Et N 3 F H OH H H XIV-15-4 Ph H H CH 2
CH(CH
3
)
2 Et N 3 F H OH H H XIV-15-5 Ph H H CH 2 Ph Et N 3 F H OH H H XIV-15-6 Ph H H CH 2 -indol-3-yl Et N 3 F H OH H H XIV-15-7 Ph H H CH 2
CH
2
SCH
3 Et N 3 F H OH H H XIV-15-8 Ph * H * Et N 3 F H OH H H *R and R joined together by (CH 2
)
3 to form five-membered ring. Table XIV-16. X2 Rl R 2
R
3 a Rab R 4 R' R 6 X Y R' R' XIV-16-1 p-Me-Ph H H H Et N 3 F H OH H H XIV-16-2 p-Me-Ph H H CH 3 Et N 3 F H OH H H XIV-16-3 p-Me-Ph H H CH(CH 3
)
2 Et N 3 F H OH H H XIV-16-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Et N 3 F H OH H H XIV-16-5 p-Me-Ph H H CH 2 Ph Et N 3 F H OH H H XIV-16-6 p-Me-Ph H H CH 2 -indol-3-yl Et N 3 F H OH H H XIV-16-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Et N 3 F H OH H H XIV-16-8 p-Me-Ph * H * Et N 3 F H OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIV-17. N2 Rl R 2
R
3 a R 3 b R' R' R 6 X Y R 7 R' XIV-17-1 p-F-Ph H H H Et N 3 F H OH H H XIV-17--2 p-F-Ph H H CH 3 Et N 3 F H OH H H XIV-17-3 p-F-Ph H H CH(CH 3
)
2 Et N 3 F H OH H H XIV-17-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Et N 3 F H OH H H XIV-17-5 p-F-Ph H H CH 2 Ph Et N 3 F H OH H H XIV-17-6 p-F-Ph H H CH 2 -indol-3-yl Et N 3 F H OH H H XIV-17-7 p-F-Ph H H CH 2
CH
2
SCH
3 Et N 3 F H OH H H XIV-17-8 p-F-Ph * H * Et N 3 F H OH H H *R nd Rib joined together by (CH 2
)
3 to form five-membered ring.
Table XIV-18. N2 Rl R 2
R
3 aR 3 b R 4 R R X Y R Rr XIV-18-1 p-Cl-Ph H H H Et N 3 F H OH H H XIV-18-2 p-Cl-Ph H H CH 3 Et N 3 F H OH H H XIV-18-3 p-Cl-Ph H H CH(CH 3
)
2 Et N 3 F H OH H H XIV-18-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Et N 3 F H OH H H XIV-18-5 p-Cl-Ph H H CH 2 Ph Et N 3 F H OH H H XIV-18-6 p-Cl-Ph H H CH 2 -indol-3-yl Et N 3 F H OH H H XIV-18-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Et N 3 F H OH H H XIV-18-8 p-Cl-Ph * H * Et N 3 F H OH H H *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XIV-19. N2 Rl R 2 R3a R 3 b R 4 R' R' X Y R' R' XIV-19-1 p-Br-Ph H H H Et N 3 F H OH H H XIV-19-2 p-Br-Ph H H CH 3 Et N 3 F H OH H H XIV-19-3 p-Br-Ph H H CH(CH 3
)
2 Et N 3 F H OH H H XIV-19-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Et N 3 F H OH H H XIV-19-5 p-Br-Ph H H CH 2 Ph Et N 3 F H OH H H XIV-19-6 p-Br-Ph H H CH 2 -indol-3-yl Et N 3 F H OH H H XIV-19-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Et N 3 F H OH H H XIV-19-8 p-Br-Ph * H * Et N 3 F H OH H H
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIV-20. 2 R R 2
RR
3 b R' R' R' X Y R' R XIV-20-1 p-I-Ph H H H Et N 3 F H OH H H XIV-20-2 p-I-Ph H H CH 3 Et N 3 F H OH H H XIV-20-3 p-I-Ph H H CH(CH 3
)
2 Et N 3 F H OH H H XIV-20-4 p-i-Ph H H CH 2
CH(CH
3
)
2 Et N 3 F H OH H H XIV-20-5 p-I-Ph H H CH 2 Ph Et N 3 F H OH H H XIV-20-6 p-I-Ph H H CH 2 -indol-3-yl Et N 3 F H OH H H XIV-20-7 p-I-Ph H H CH 2
CH
2
SCH
3 Et N 3 F H OH H H XIV-20-8 p-I-Ph * H * Et N 3 F H OH H H *R and R2b joined together by (CH 2
)
3 to form five-membered ring. I 1 7 Table XIV-2 1. N2 R' R 2
R
3 a R~b R 4
R
5
R
6 X Y R 7
R
8 XIV-21-1 CH 3 H H H 'Pr N 3 F H OH H H XIV-21-2 CH 3 H H CH 3 'Pr N 3 F H OH H H XIV-21-3 CH 3 H H CH(CH 3
)
2 'Pr N 3 F H OH H H XIV-21-4 CH 3 H H CH 2
CH(CH
3
)
2 'Pr N 3 F H OH H H XIV-21-5 CH 3 H H CH 2 Ph 'Pr N 3 F H OH H H XIV-21-6 CH 3 H H CH 2 -indol-3-yl 'Pr N 3 F H OH H H XIV-21-7 CH 3 H H CH 2
CH
2
SCH
3 'Pr N 3 F H OH H H XIV-21-8 CH 3 * H * 'Pr N 3 F H OH H H *RT and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XIV-22. N2 RI R 2
R
3 a R 3 b R 4 R R XY R R XIV-22-1 Et H H H 'Pr N 3 F H OH H H XIV-22-2 Et H H CH 3 'Pr N 3 F H OH H H XIV-22-3 Et H H CH(CH 3
)
2 'Pr N 3 F H OH H H XIV-22-4 Et H H CH 2
CH(CH
3
)
2 'Pr N 3 F H OH H H XIV-22-5 Et H H CH 2 Ph 'Pr N 3 F H OH H H XIV-22-6 Et H H CH 2 -indol-3-yl 'Pr N 3 F H OH H H XIV-22-7 Et H H CH2CH 2
SCH
3 'Pr N 3 F H OH H H XIV-22-8 Et * H * 'Pr N 3 F H OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIV-23. N2 R R 2
R
3 " R 3 b R' R' R' X Y RI R' XIV-23-1 Pr H H H 'Pr N 3 F H OH H H XIV-23-2 'Pr H H CH 3 'Pr N 3 F H OH H H XIV-23-3 'Pr H H CH(CH 3
)
2 'Pr N 3 F H OH H H XIV-23-4 'Pr H H CH2CH(CH 3
)
2 'Pr N 3 F H OH H H XIV-23-5 'Pr H H CH 2 PII 'Pr N 3 F H OH H H XIV-23-6 'Pr H H CH 2 -indol-3-yl 'Pr N 3 F H OH H H XIV-23-7 'Pr H H CH 2
CH
2
SCH
3 'Pr N 3 F H OH H H XIV-23-8 'Pr * H * Pr N 3 F H OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 11O Table XIV-24. N2 RI R 2
R
3 a R 3 b R 4 R R X Y R R 8 XIV-24-1 'Bu H H H 'Pr N 3 F H OH H H XIV-24-2 'Bu H H CH 3 'Pr N 3 F H OH H H XIV-24-3 'Bu H H CH(CH 3
)
2 'Pr N 3 F H OH H H XIV-24-4 'Bu H H CH 2
CH(CH
3
)
2 'Pr N 3 F H OH H H XIV-24-5 'Bu H H CH 2 Ph 'Pr N 3 F H OH H H XIV-24-6 'Bu H H CH 2 -indol-3-yl 'Pr N 3 F H OH H H XIV-24-7 'Bu H H CH 2
CH
2
SCH
3 Pr N 3 F H OH H H XIV-24-8 'Bu * H * 'Pr N 3 F H OH H H *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XIV-25. X R' R2 R 3a R 3 b R'R' R R6 X Y R7 R 8 XIV-25-1 Ph H H H 'Pr N 3 F H OH H H XIV-25-2 Ph H H CH 3 'Pr N 3 F H OH H H XIV-25-3 Ph H H CH(CH 3
)
2 'Pr N 3 F H OH H H XIV-25-4 Ph H H CH 2
CH(CH
3
)
2 'Pr N 3 F H OH H H XIV-25-5 Ph H H CH 2 Ph 'Pr N 3 F H OH H H XIV-25-6 Ph H H CH 2 -indol-3-yl 'Pr N 3 F H OH H H XIV-25-7 Ph H H CH 2
CH
2
SCH
3 'Pr N 3 F H OH H H XIV-25-8 Ph * H * Pr N 3 F H OH H H
*R
2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIV-26. Xe R' R2 R 3 a R 3 b R' R 5
R
6 X Y R 7 RF XIV-26-1 p-Me-Ph H H H 'Pr N 3 F H OH H H XIV-26-2 p-Me-Ph H H CH 3 'Pr N 3 F H OH H H XIV-26-3 p-Me-Ph H H CH(CH 3
)
2 'Pr N 3 F H OH H H XIV-26-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 'Pr N 3 F H OH H H XIV-26-5 p-Me-Ph H H CH 2 Ph 'Pr N 3 F H OH H H XIV-26-6 p-Me-Ph H H CH2-indol-3-yl 'Pr N 3 F H OH H H XIV-26.-7 p-Me-Ph H H CH 2
CH
2
SCH
3 'Pr N 3 F H OH H H XIV-26-8 p-Me-Ph * H * 'Pr N 3 F H OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XIV-27. NJ2 R 2 RN R 3 b R 4 R' R X Y R R 8 XIV-27-1 p-F-Ph H H H 'Pr N 3 F H OH H H XIV-27-2 p-F-Ph H H CH 3 'Pr N 3 F H OH H H XIV-27-3 p-F-Ph H H CH(CH 3
)
2 'Pr N 3 F H OH H H XIV-27-4 p-F-Ph H H CH 2
CH(CH
3
)
2 'Pr N 3 F H OH H H XIV-27-5 p-F-Ph H H CH 2 Ph 'Pr N 3 F H OH H H XIV-27-6 p-F-Ph H H CH 2 -indol-3-yl 'Pr N 3 F H OH H H XIV-27-7 p-F-Ph H H CH 2
CH
2
SCH
3 'Pr N 3 F H OH H H XIV-27-8 p-F-Ph * H * 'Pr N 3 F H OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XIV-28. N Rl R 2
R
3 a REb R4 R 5
R
6 X Y R Rs XIV-28-1 p-Cl-Ph H H H 'Pr N 3 F H OH H H XIV-28-2 p-Cl-Ph H H CH 3 'Pr N 3 F H OH H H XIV-28-3 p-Cl-Ph H H CH(CH 3
)
2 'Pr N 3 F H OH H H XIV-28-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 'Pr N 3 F H OH H H XIV-28-5 p-Cl-Ph H H CH 2 Ph 'Pr N 3 F H OH H H XIV-28-6 p-Cl-Ph H H CH 2 -indol-3-yl 'Pr N 3 F H OH H H XIV-28-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 'Pr N 3 F H OH H H XIV-28-8 p-Cl-Ph * H * 'Pr N 3 F H OH H H *R2 anl R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIV-29. N2 Rl R 2 R3a R 3 b R 4 R' R 6 X Y R' R' XIV-29-1 p-Br-Ph H H H 'Pr N 3 F H OH H H XIV-29.-2 p-Br-Ph H H CH 3 'Pr N 3 F H OH H H XIV-29-3 p-Br-Ph H H CH(CH 3
)
2 'Pr N 3 F H OH H H XIV-29-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 'Pr N 3 F H OH H H XIV-29..5 p-Br-Ph H H CH 2 Ph 'Pr N 3 F H OH H H XIV-29-6 p-Br-Ph H H CH 2 -indol-3-yl 'Pr N 3 F H OH H H XIV-29--7 p-Br-Ph H H CH 2
CH
2
SCH
3 'Pr N 3 F H OH H H XIV-29-8 p-Br-Ph * H * Pr N 3 F H OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. )A 1 Table XIV-30. N2 RI R2 R 3 a R3b R 4 R' R 6 X Y R' R' XIV-30-1 p-I-Ph H H H 'Pr N 3 F H OH H H XIV-30-2 p-I-Ph H H CH 3 'Pr N 3 F H OH H H XIV-30-3 p-I-Ph H H CH(CH 3
)
2 'Pr N 3 F H OH H H XIV-30-4 p-I-Ph H H CIH 2
CH(CH
3
)
2 'Pr N 3 F H OH H H XIV-30-5 p-I-Ph H H CH 2 Ph 'Pr N 3 F H OH H H XIV-30-6 p-I-Ph H H CH 2 -indol-3-yl 'Pr N 3 F H OH H H XIV-30-7 p-I-Ph H H CH 2
CH
2
SCH
3 'Pr N 3 F H OH H H XIV-30-8 p-I-Ph * H * 'Pr N 3 F H OH H H *Rla7nd R~b joined together by (CH 2
)
3 to form five-membered ring. Table XIV-3 1. N2 R' R 2 Ra Rb R 4 R R XY R' R XIV-31-1 CH 3 H H H "Bu N 3 F H OH H H XIV-31-2 CH 3 H H CH 3 "Bu N 3 F H OH H H XIV-31-3 CH 3 H H CH(CH 3
)
2 "Bu N 3 F H OH H H XIV-31-4 CH 3 H H CH 2
CH(CH
3
)
2 "Bu N 3 F H OH H H XIV-31-5 CH 3 H H CH 2 Ph "Bu N 3 F H OH H H XIV-31-6 CH 3 H H CH 2 -indol-3-yl "Bu N 3 F H OH H H XIV-31-7 CH 3 H H CH 2
CH
2
SCH
3 "Bu N 3 F H OH H H XIV-31-8 CH 3 * H * "Bu N 3 F H OH H H *RTand R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIV-32. N R' R 2 R 3 a R 3 b R 4 R' R 6 X Y R 7
R
8 XIV-32-1 Et H H H "Bu N 3 F H OH H H XIV-32-2 Et H H CH 3 "Bu N 3 F H OH H H XIV-32-3 Et H H CH(CH 3
)
2 "Bu N 3 F H OH H H XIV-32-4 Et H H CH 2
CH(CH
3
)
2 "Bu N 3 F H OH H H XIV-32-5 Et H H CH 2 Ph "Bu N3 F H OH H H XIV-32-6 Et H H CH 2 -indol-3-yI "Bu N 3 F H OH H H XIV-32-7 Et H H CH 2
CH
2
SCH
3 "Bu N 3 F H OH H H XIV-32-8 Et * H * "Bu N 3 F H OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. ')A 1 Table XIV-33. X R' R 2 RaR 3 b R 4 R R X Y R' R XIV-33-1 'Pr H H H "Bu N 3 F H OH H H XIV-33-2 'Pr H H CH 3 "Bu N 3 F H OH H H XIV-33-3 'Pr H H CH(CH 3
)
2 "Bu N 3 F H OH H H XIV-33-4 'Pr H H CH 2
CH(CH
3
)
2 "Bu N 3 F H OH H H XIV-33-5 'Pr H H CH 2 Ph "Bu N 3 F H OH H H XIV-33-6 'Pr H H CH 2 -indol-3-yl "Bu N 3 F H OH H H XIV-33-7 'Pr H H CH2CH 2
SCH
3 "Bu N 3 F H OH H H XIV-33-8 'Pr * H * "Bu N 3 F H OH H H RT and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XIV-34. X R' R 2 R3a R 3 b R 4 R' R 6 X Y R' R' XIV-34-1 'Bu H H H "Bu N 3 F H OH H H XIV-34-2 'Bu H H CH 3 "Bu N 3 F H OH H H XIV-34-3 'Bu H H CH(CH 3
)
2 "Bu N 3 F H OH H H XIV-34-4 'Bu H H CH 2
CH(CH
3
)
2 "Bu N 3 F H OH H H XIV-34-5 'Bu H H CH 2 Ph "Bu N 3 F H OH H H XIV-34-6 'Bu H H CH 2 -indol-3-yl "Bu N 3 F H OH H H XIV-34-7 'Bu H H CH 2
CH
2
SCH
3 "Bu N 3 F H OH H H XIV-34-8 'Bu * H * "Bu N 3 F H OH H H *R and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIV-35. N2 R' R 2
R
3 a R 3 b R 4 R' R7 X Y R 7
R
8 XIV-35-1 Ph H H H "Bu N 3 F H OH H H XIV-35-2 Ph H H CH 3 "Bu N 3 F H OH H H XV-35-3 Ph H H CH(CH 3
)
2 "Bu N 3 F H OH H H XIV-35-4 Ph H H CH 2
CH(CH
3
)
2 "Bu N 3 F H OH H H XIV-35-5 Ph H H CH 2 Ph "Bu N 3 F H OH H H XIV-35-6 Ph H H CH 2 -indol-3-yI "Bu N 3 F H OH H H XIV-35-7 Ph H H CH 2
CH
2
SCH
3 "Bu N 3 F H OH H H XIV-35-8 Ph * H * "Bu N 3 F H OH H H *RT and R3b joined together by (CH 2
)
3 to form five-membered ring. I"4Al Table XIV-36. N2 Rl R2 R 4 R' R' X Y R' R XIV-36-1 p-Me-Ph H H H "Bu N 3 F H OH H H XIV-36-2 p-Me-Ph H H CH 3 "Bu N 3 F H OH H H XIV-36-3 p-Me-Ph H H CH(CH 3
)
2 "Bu N 3 F H OH H H XIV-36-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 "Bu N 3 F H OH H H XIV-36-5 p-Me-Ph H H CH 2 Ph "Bu N 3 F H OH H H XIV-36-6 p-Me-Ph H H CH 2 -indol-3-yl "Bu N 3 F H OH H H XIV-36-7 p-Me-Ph H H CH 2
CH
2
SCH
3 "Bu N 3 F H OH H H XIV-36-8 p-Me-Ph * H * "Bu N 3 F H OH H H *R2 and R joined together by (CH 2
)
3 to form five-membered ring. Table XIV-37. X2 R R 2 R"3a R 3b R'4 R' R' X Y R' R' XIV-37-1 p-F-Ph H H H "Bu N 3 F H OH H H XIV-37-2 p-F-Ph H H CH 3 "Bu N 3 F H OH H H XIV-37-3 p-F-Ph H H CH(CH 3
)
2 "Bu N 3 F H OH H H XIV-37-4 p-F-Ph H H CH 2
CH(CH
3
)
2 "Bu N 3 F H OH H H XIV-37-5 p-F-Ph H H CH 2 Ph "Bu N 3 F H OH H Hl XIV-37-6 p-F-Ph H H CH 2 -indol-3-yl "Bu N 3 F H OH H H XIV-37-7 p-F-Ph H H CH 2
CH
2
SCH
3 "Bu N 3 F H OH H H XIV-37-8 p-F-Ph * H * "Bu N 3 F H OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIV-38. X RI RI2 Rp3a R3b RH RH R X Y R R XIV-38-1 p-Cl-Ph H H H "Bu N 3 F H OH H H XIV-38-2 p-Cl-Ph H H CH 3 "Bu N 3 F H OH H H XIV-38-3 p-Cl-Ph H H CH(CH 3
)
2 "Bu N 3 F H OH H H XIV-38-4 p-Cl-Ph H H CH 2 CH(CH3)2 "Bu N 3 F H OH H H XIV-38-5 p-Cl-Ph H H CH 2 Ph "Bu N 3 F H OH H H XIV-38-6 p-Cl-Ph H H CH2-indol-3-yl "Bu N3 F H OH H H XIV-38-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 "Bu N 3 F H OH H H XIV-38-8 p-Cl-Ph * H * "Bu N 3 F H OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XIV-39. N2 RI R 2
R
3 aRb 4 R' R X Y R R' I A I NO R R 2
R
3 a R 3 b R 4 R' R' X Y R 7
R
8 XIV-39-1 p-Br-Ph H H H "Bu N 3 F H OH H H XIV-39-2 p-Br-Ph H H CH 3 "Bu N 3 F H OH H H XIV-39-3 p-Br-Ph H H CH(CH 3
)
2 "Bu N 3 F H OH H H XIV-39-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 "Bu N 3 F H OH H H XIV-39-5 p-Br-Ph H H CH 2 Ph "Bu N 3 F H OH H H XIV-39-6 p-Br-Ph H H CH 2 -indol-3-yl "Bu N 3 F H OH H H XIV-39-7 p-Br-Ph H H CH 2
CH
2
SCH
3 "Bu N 3 F H OH H H XIV-39-8 p-Br-Ph * H * "Bu N 3 F H OH H H *R nd Rab joined together by (CH 2
)
3 to form five-membered ring. Table XIV-40. X R' R 2
R
3 a R 3 b R 4 R' R XY R XIV-40-1 p-I-Ph H H H "Bu N 3 F H OH H H XIV-40-2 p-I-Ph H H CH 3 "Bu N 3 F H OH H H XIV-40-3 p-I-Ph H H CH(CH 3
)
2 "Bu N 3 F H OH H H XIV-40-4 p-I-Ph H H CH 2
CH(CH
3
)
2 "Bu N 3 F H OH H H XIV-40-5 p-I-Ph H H CH 2 Ph "Bu N 3 F H OH H H XIV-40-6 p-I-Ph H H CH 2 -indol-3-yl "Bu N 3 F H OH H H XIV-40-7 p-I-Ph H H CH 2
CH
2
SCH
3 "Bu N 3 F H OH H H XIV-40-8 p-I-Ph * H * "Bu N 3 F H OH H H *R7 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XIV-41. X2 R' R 2
R
3 a R 3 b R 4 R' R) X Y R' R' XIV-41-1 CH 3 H H H Bz N 3 F H OH H H XIV-41-2 CH 3 H H CH 3 Bz N 3 F H OH H H XIV-41-3 CH 3 H H CH(CH 3
)
2 Bz N 3 F H OH H H XIV-41-4 CH 3 H H CH 2
CH(CH
3
)
2 Bz N 3 F H OH H H XIV-41-5 CH 3 H H CH 2 Ph Bz N 3 F H OH H H XIIV-41-6 CH 3 H H CH 2 -indol-3-yl Bz N 3 F H OH H H XIV-41-7 CH 3 H H CH 2
CH
2
SCH
3 Bz N 3 F H OH H H XIV-41-8 CH 3 * H * Bz N 3 F H OH H H 5 *R and R3b joined together by (CH 2
)
3 to form five-membered ring. ' A A Table XIV-42. X R R RE3 Rtb R 4 R 3 R X y R R XIV-42-1 Et H H H Bz N 3 F H OH H H XIV-42-2 Et H H CH 3 Bz N 3 F H OH H H XIV-42-3 Et H H CH(CH 3
)
2 Bz N 3 F H OH H H XIV-42-4 Et H H CH2CH(CH3)2 Bz N 3 F H OH H H XIV-42-5 Et H H CH 2 Ph Bz N 3 F H OH H H XIV-42-6 Et H H CH 2 -indol-3-yl Bz N 3 F H OH H H XIV-42-7 Et H H CH2CH2SCH3 Bz N 3 F H OH H H XIV-42-8 Et * H *Bz N3 F H OH H H *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XIV-43. N2 R' R 2 R 3a R 3b R 4 R' R' X Y R 7 R 8 XIV-43.-1 'Pr H H H Bz N 3 F H OH H H XIV-43.-2 'Pr H H CH 3 Bz N 3 F H OH H A XIV-43-3 'Pr H H CH(CH 3
)
2 Bz N 7 F H OH H H XIV-43-4 'Pr H H CH2CH(CH 3
)
2 Bz N 3 F H OH H H XIV-43-5 'Pr H H CH 2 Ph Bz N 3 F H OH H H XIV-43-6 'Pr H H CH 2 -indol-3-yl Bz N 3 F H OH H H XIV-43-7 'Pr H H CH 2
CH
2
SCH
3 Bz N 3 F H OH H H XIV-43-8 'Pr * H * Bz N 3 F H OH H H 10 *R 2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XIV-44. X2 R' R 2 R(a R R R 4 R R6 X Y R R, XIV-44-1 'Bu H H H Bz N 3 F H OH H H XIV-44..2 'Bu H H CH 3 Bz N 3 F H OH H H XIV-44..3 'Bu H H CH(CH 3
)
2 Bz N 3 F H OH H H XIV-44-4 'Bu H H CH 2
CH(CH
3
)
2 Bz N 3 F H OH H H XIV-44-5 'Bu H H CH 2 Ph Bz N 3 F H OH H H XIV-44-6 'Bu H H CH 2 -indol-3-yl Bz N 3 F H OH H H XIV-44-7 Bu H H CH 2
CH
2
SCH
3 Bz N 3 F H OH H H XIV-44--8 'Bu * H * Bz N 3 F H OH H H *RT and R 3 b joined together by (CH 2
)
3 to form five-membered ring. A C Table XIV-45. N2 RI R 2
R
3 a R 3 b .R 4 R' R' X Y R/ R 8 XIV-45-1 Ph H H H Bz N 3 F H OH H H XIV-45-2 Ph H H CH 3 Bz N 3 F H OH H H XIV-45-3 Ph H H CH(CH 3
)
2 Bz N 3 F H OH H H XIV-45-4 Ph H H CH 2
CH(CH
3
)
2 Bz N 3 F H OH H H XIV-45-5 Ph H H CH 2 Ph Bz N 3 F H OH H H XIV-45-6 Ph H H CH 2 -indol-3-yl Bz N 3 F H OH H H XIV-45-7 Ph H H CH 2
CH
2
SCH
3 Bz N 3 F H OH H H XIV-45-8 Ph * H * Bz N 3 F H OH H H *R and Rb joined together by (CH 2
)
3 to form five-membered ring. Table XIV-46. X2 R' R 2 R3a R A R 4 R' R 6 X Y R 7
R
8 XIV-46-1 p-Me-Ph H H H Bz N 3 F H OH H H XIV-46-2 p-Me-Ph H H CH 3 Bz N 3 F H OH H H XIV-46.-3 p-Me-Ph H H CH(CH 3
)
2 Bz N 3 F H OH H H XIV-46-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Bz N 3 F H OH H H XIV-46-5 p-Me-Ph H H CH 2 Ph Bz N 3 F H OH H H XIV-46.-6 p-Me-Ph H H CH 2 -indol-3-yl Bz N 3 F H OH H H XIV-46-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Bz N 3 F H OH H H XIV-46-8 p-Me-Ph * H * Bz N 3 F H OH H H *R and R joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIV-47. X2 R' R 2
R
3 a R'b R 4 R' R 6 X Y R 7
R
8 XIV-47-1 p-F-Ph H H H Bz N 3 F H OH H H XIV-47-2 p-F-Ph H H CH 3 Bz N 3 F H OH H H XIV-47--3 p-F-Ph H H CH(CH 3
)
2 Bz N 3 F H OH H H XIV-47-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Bz N 3 F H OH H H XIV-47-5 p-F-Ph H H CH 2 Ph Bz N 3 F H OH H H XIV-47-.6 p-F-Ph H H C1 2 -indol-3-yl Bz N 3 F H OH H H XIV-47-7 p-F-Ph H H CH 2
CH
2
SCH
3 Bz N 3 F H OH H H XIV-47-8 p-F-Ph * H * Bz N 3 F H OH H H and R 3 joined together by (CH 2
)
3 to form five-membered ring.
Table XIV-48. N2 R! R 2 R3a R3b R' R' R' X Y R 7
R
8 XIV-48-1 p-Cl-Ph H H H Bz N 3 F H OH H H XIV-48-2 p-Cl-Ph H H CH 3 Bz N 3 F H OH H H XIV-48-3 p-Cl-Ph H H CH(CH 3
)
2 Bz N 3 F H OH H H XIV-48-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Bz N 3 F H OH H H XIV-48-5 p-Cl-Ph H H CH 2 Ph Bz N 3 F H OH H H XIV-48-6 p-Cl-Ph H H CH 2 -indol-3-yl Bz N 3 F H OH H H XIV-48-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Bz N 3 F H OH H H XIV-48-8 p-Cl-Ph * H * Bz N 3 F H OH H H *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XIV-49. N! R' R2 R 3 a R 3 b R 4 R' R 6 X Y R 7
R
8 XIV-49-1 p-Br-Ph H H H Bz N 3 F H OH H H XIV-49-2 p-Br-Ph H H CH 3 Bz N 3 F H OH H H XIV-49-3 p-Br-Ph H H CH(CH 3
)
2 Bz N 3 F H OH H H XIV-49-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Bz N 3 F H OH H H XIV-49-5 p-Br-Ph H H CH 2 Ph Bz N 3 F H OH H H XIV-49-6 p-Br-Ph H H CH 2 -indol-3-yl Bz N 3 F H OH H H XIV-49-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Bz N 3 F H OH H H XIV-49-8 p-Br-Ph * H * Bz N 3 F H OH H H *Rl and R joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIV-50. N! R R 2
R
3 a R 3 b R 4 R R 6 X Y R 7
R
8 XIV-50-1 p-I-Ph H H H Bz N 3 F H OH H H XIV-50-2 p-I-Ph H H CH 3 Bz N 3 F H OH H H XIV-50-3 p-I-Ph H H CH(CH 3
)
2 Bz N 3 F H OH H H XIV-50-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Bz N 3 F H OH H H XIV-50-5 p-I-Ph H H CH 2 Ph Bz N 3 F H OH H H XIV-50-6 p-I-Ph H H CH 2 -indol-3-yl Bz N 3 F H OH H H XIV-50-7 p-I-Ph H H CH 2
CH
2
SCH
3 Bz N 3 F H OH H H XIV-50-8 p-I-Ph * H * Bz N 3 F H OH H H *R and R joined together by (CH 2
)
3 to form five-membered ring.
0 NH
R
3 b R2 0 7 NR N 0 R3a N -- P-O O C0 2
R
4 OR R Y X xv Table XV-1. X2 Rk7 R' R 3 a R 3 b R 4 R' R 6 X Y R' R' XV-1-1 CH 3 H H H CH 3 F F H OH H H XV-1-2 CH 3 H H CH 3
CH
3 F F H OH H H XV-1-3 CH 3 H H CH(CH 3
)
2
CH
3 F F H OH H H XV-1-4 CH 3 H H CH 2
CH(CH
3
)
2
CH
3 F F H OH H H XV-1-5 CH 3 H H CH 2 Ph CH 3 F F H OH H H XV-1-6 CH 3 H H CH 2 -indol-3-yl CH 3 F F H OH H H XV-1-7 CH 3 H H CH2CH 2
SCH
3
CH
3 F F H OH H H XV-1-8 CH 3 * H * CH 3 F F H OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XV-2. N2 R R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7 R' XV-2-1 Et H H H CH 3 F F H OH H H XV-2-2 Et H H CH 3
CH
3 F F H OH H H XV-2-3 Et H H CH(CH 3
)
2
CH
3 F F H OH H H XV-2-4 Et H H CH 2
CH(CH
3
)
2
CH
3 F F H OH H H XV-2-5 Et H H CH 2 Ph CH 3 F F H OH H H XV-2-6 Et H H CH 2 -indol-3-yl CH 3 F F H OH H H XV-2-7 Et H H CH 2
CH
2
SCH
3
CH
3 F F H OH H H XV-2-8 Et * H * CH 3 F F H OH H H *R and R'b joined together by (CH 2
)
3 to form five-membered ring. A O Table XV-3. M R' R 2
R
3 aR 3 b R R R X Y R' R XV-3-1 'Pr H H H CH 3 F F H OH H H XV-3-2 'Pr H H CH 3
CH
3 F F H OH H H XV-3-3 'Pr H H CH(CH 3
)
2
CH
3 F F H OH H H XV-3-4 'Pr H H CH 2
CH(CH
3 )2 CH 3 F F H OH H H XV-3-5 'Pr H H CH 2 Ph CH 3 F F H OH H H XV-3-6 'Pr H H CH 2 -indol-3-yl CH 3 F F H OH H H XV-3-7 'Pr H H CH 2 Ci 2
SCH
3
CH
3 F F H OH H H XV-3-8 'Pr * H * CH 3 F F H OH H H R and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XV-4. X RT R 2
R
3
R
3 b R' R'R 6 XY RR 8 XV-4-1 'Bu H H H CH 3 F F H OH H H XV-4-2 'Bu H H CH 3
CH
3 F F H OH H H XV-4-3 'Bu H H CH(CH 3
)
2
CH
3 F F H OH H H XV-4-4 'Bu H H CH 2
CH(CH
3
)
2
CH
3 F F H OH H H XV-4-5 'Bu H H CH 2 Ph CH 3 F F H OH H H XV-4-6 'Bu H H CH 2 -indol-3-yl CH 3 F F H OH H H XV-4-7 'Bu H H CH 2 CH2SCH 3
CH
3 F F H OH H H XV-4-8 'Bu * H * CH 3 F F H OH H H *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIV-5. 2 RI R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7
R
8 XV-5-1 Ph H H H CH 3 F F H OH H H XV-5-2 Ph H H CH 3
CH
3 F F H OH H H XV-5-3 Ph H H CH(CH 3
)
2
CH
3 F F H OH H H XV-5-4 Ph H H CH 2
CH(CH
3
)
2
CH
3 F F H OH H H XV-5-5 Ph H H CH 2 Ph CH 3 F F H OH H H XV-5-6 Ph H H CH 2 -indol-3-y CH 3 F F H OH H H XV-5-7 Ph H H CH 2
CH
2
SCH
3
CH
3 F F H OH H H XV-5-8 Ph H H CH CH 3 F F H OH H H *R7 and R3b joined together by (CH 2
)
3 to form five-membered ring. I A Table XV-6.
R
2 R3a Rb R 4
R
6 Xy R 7 RR XV-6-1 p-Me-Ph H H H CH 3 F F H OH H H XV-6-2 p-Me-Ph H H CH 3
CH
3 F F H OH H H XV-6-3 p-Me-Ph H H CH(CH 3
)
2
CH
3 F F H OH H H XV-6-4 p-Me-Ph H H CH 2
CH(CH
3
)
2
CH
3 F F H OH H H XV-6-5 p-Me-Ph H H CH 2 Ph CH 3 F F H OH H H XV-6-6 p-Me-Ph H H CH 2 -indol-3-yl CH 3 F F H OH H H XV-6-7 p-Me-Ph H H CH 2
CH
2
SCH
3
CH
3 F F H OH H H XV-6-8 p-Me-Ph * H * CH 3 F F H OH H H
*R
2 and RIb joined together by (CH 2
)
3 to form five-membered ring. Table XV-7. N2 R1 R 2 Ra Rab R4 R' R 6 X Y R 7
R
8 XV-7-1 p-F-Ph H H H CH 3 F F H OH H H XV-7-2 p-F-Ph H H CH 3
CH
3 F F H OH H H XV-7-3 p-F-Ph H H CH(CH 3
)
2
CH
3 F F H OH H H XV-7-4 p-F-Ph H H CH 2
CH(CH
3
)
2
CH
3 F F H OH H H XV-7-6 p-F-Ph H H CH 2 Ph CH 3 F F H OH H H XV-7-7 p-F-Ph H H CH 2 -indol-3-yl CH 3 F F H OH H H XV-7-8 p-F-Ph H H CH 2
CH
2
SCH
3
CH
3 F F H OH H H XV-7-20 p-F-Ph * H * CH 3 F F H OH H H *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XV-8. N2 R' R2 R3a R 3 b R 4 R' R' X Y R' R 8 XV-8-1 p-Cl-Ph H H H CH 3 F F H OH H H XV-8-2 p-Cl-Ph H H CH 3
CH
3 F F H OH H H XV-8-3 p-Cl-Ph H H CH(CH 3
)
2
CH
3 F F H OH H H XV-8-4 p-Cl-Ph H H CH2CH(CH3) 2
CH
3 F F H OH H H XV-8-5 p-Cl-Ph H H CH2Ph CH 3 F F H OH H H XV-8-6 p-Cl-Ph H H CH2-indol-3-yl CH 3 F F H OH H H XV-8-7 p-Cl-Ph H H CH 2
CH
2
SCH
3
CH
3 F F H OH H H XV-8-8 p-Cl-Ph * H * CH 3 F F H OH H H *R and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XV-9. X2 R' R 2 R3a R 3 b R 4 Ri R' X Y R 7 R 8 XV-9-1 p-Br-Ph H H H CH 3 F F H OH H H XV-9-2 p-Br-Ph H H CH 3
CH
3 F F H OH H H XV-9-3 p-Br-Ph H H CH(CH 3
)
2
CH
3 F F H OH H H XV-9-4 p-Br-Ph H H CH 2
CH(CH
3
)
2
CH
3 F F H OH H H XV-9-6 p-Br-Ph H H CH 2 Ph CH 3 F F H OH H H XV-9-7 p-Br-Ph H H CH 2 -indol-3-yI CH 3 F F H OH H H XV-9-8 p-Br-Ph H H CH 2
CH
2
SCH
3
CH
3 F F H OH H H XV-9-20 p-Br-Ph * H * CH 3 F F H OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XV-10. X R R Ra R R4 R R XY R XV-10-1 p-I-Ph H H H CH 3 F F H OH H H XV-10-2 p-I-Ph H H CH 3
CH
3 F F H OH H H XV-10-3 p-I-Ph H H CH(CH 3
)
2
CH
3 F F H OH H H XV-10-4 p-I-Ph H H CH 2
CH(CH
3
)
2
CH
3 F F H OH H H XV-10-5 p-I-Ph H H CH 2 Ph CH 3 F F H OH H H XV-10-6 p-I-Ph H H CH 2 -indol-3-yl CH 3 F F H OH H H XV-10-7 p-I-Ph H H CH 2
CH
2
SCH
3
CH
3 F F H OH H H XV-10-8 p-I-Ph * H * CH 3 F F H OH H H * R and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XV-I 1. N2 R1 R2 R3aRb R 4 R' R' X Y R' R XV-11-1 CH 3 H H H Et F F H OH H H XV-11-2 CH 3 H H CH 3 Et F F H OH H H XV-11-3 CH 3 H H CH(CH 3 )2 Et F F H OH H H XV-11-4 CH 3 H H CH 2
CH(CH
3
)
2 Et F F H OH H H XV-11-5 CH 3 H H CH 2 Ph Et F F H OH H H XV-11-6 CH 3 H H CH2-indol-3-yi Et F F H OH H H XV-11-7 CH 3 H H CH 2
CH
2
SCH
3 Et F F H OH H H XV-11-8 CH 3 * H * Et F F H OH H H *R2 and Rub joined together by (CH 2
)
3 to form five-membered ring.
Table XV-12. 2 RI R 2
R
3 a R 3 b R 4 R R 6 X Y R' R' XV-12-1 Et H H H Et F F H OH H H XV-12-2 Et H H CH 3 Et F F H OH H H XV-12-3 Et H H CH(CH 3
)
2 Et F F H OH H H XV-12-4 Et H H CH 2 CH(CH3) 2 Et F F H OH H H XV-12-5 Et H H CH 2 Ph Et F F H OH H H XV-12-6 Et H H CH 2 -indol-3-yl Et F F H OH H H XV-12-7 Et H H CH 2 CH2SCH 3 Et F F H OH H H XV-12-8 Et * H * Et F F H OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XV-13. 2 R' R2 R 3 a R 3 b R' R' R' X Y R' R XV-13-1 'Pr H H H Et F F H OH H H XV-13-2 'Pr H H CH 3 Et F F H OH H H XV-13-3 'Pr H H CH(CH 3
)
2 Et F F H OH H H XV-13-4 'Pr H H CH 2
CH(CH
3
)
2 Et F F H OH H H XV-13-5 'Pr H H CH 2 Ph Et F F H OH H H XV-13-6 'Pr H H CH 2 -indol-3-yl Et F F H OH H H XV-13-7 'Pr H H CH 2
CH
2
SCH
3 Et F F H OH H H XV-13-8 'Pr * H * Et F F H OH H H *R and R b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XV-14. X2 R R 2 R 3a R 3 b R4 R' R 6 X Y R* R8 XV-14-1 'Bu H H H Et F F H OH H H XV-14-2 'Bu H H CH 3 Et F F H OH H H XV-14-3 'Bu H H CH(CH 3
)
2 Et F F H OH H H XV-14-4 'Bu H H CH 2
CH(CH
3
)
2 Et F F H OH H H XV-14-5 'Bu H H CH 2 Ph Et F F H OH H H XV-14-6 'Bu H H CH 2 -indol-3-yl Et F F H OH H H XV-14-7 'Bu H H CH 2
CH
2
SCH
3 Et F F H OH H H XV-14-8 'Bu * H * Et F F H OH H H *Rl and Ro joined together by (CH 2
)
3 to form five-membered ring.
Table XV-15. N2 R' R 2
R
3 a R 3 b R 4 R' R' X Y R R XV-15-1 Ph H H H Et F F H OH H H XV-15-2 Ph H H CH 3 Et F F H OH H H XV-15-3 Ph H H CH(CH 3
)
2 Et F F H OH H H XV-15-4 Ph H H CH 2
CH(CH
3 )2 Et F F H OH H H XV-15-5 Ph H H CH 2 Ph Et F F H OH H H XV-15-6 Ph H H CH 2 -indol-3-yl Et F F H OH H H XV-15-7 Ph H H CH 2
CH
2
SCH
3 Et F F H OH H H XV-15-8 Ph * H * Et F F H OH H H *R and Rdb joined together by (CH 2
)
3 to form five-membered ring. Table XV-16. N2 R R 2
R
3
R
3 b R4 R R 6 X Y R' R' XV-16-1 p-Me-Ph H H H Et F F H OH H H XV-16-2 p-Me-Ph H H CH 3 Et F F H OH H H XV-16-3 p-Me-Ph H H CH(CH 3
)
2 Et F F H OH H H XV-16-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Et F F H OH H H XV-16-5 p-Me-Ph H H CH 2 Ph Et F F H OH H H XV-16-6 p-Me-Ph H H CH 2 -indol-3-yl Et F F H OH H H XV-16-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Et F F H OH H H XV-16-8 p-Me-Ph * H * Et F F H OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XV-17. N2 RK R 2 R3a R 3 b R 4 R' R 6 X Y R 7
R
8 XV-17-1 p-F-Ph H H H Et F F H OH H H XV-17-2 p-F-Ph H H CH 3 Et F F H OH H H XV-17-3 p-F-Ph H H CH(CH 3
)
2 Et F F H OH H H XV-17-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Et F F H OH H H XV-17-5 p-F-Ph H H CH 2 Ph Et F F H OH H H XV-17-6 p-F-Ph H H CH 2 -indol-3-yl Et F F H OH H H XV-17-7 p-F-Ph H H CH 2
CH
2
SCH
3 Et F F H OH H H XV-17-8 p-F-Ph * H * Et F F H OH H H *R' and R 3 " joined together by (CH 2
)
3 to form five-membered ring.
Table XV-18. N2 RI R 2
R
3 a R 3 b R R' R' X Y R' R XV-18-1 p-Cl-Ph H H H Et F F H OH H H XV-18-2 p-Cl-Ph H H CH 3 Et F F H OH H H XV-18-3 p-Cl-Ph H H CH(CH 3
)
2 Et F F H OH H H XV-18-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Et F F H OH H H XV-18-5 p-Cl-Ph H H CH 2 Ph Et F F H OH H H XV-18-6 p-Cl-Ph H H CH 2 -indol-3-yl Et F F H OH H H XV-18-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Et F F H OH H H XV-18-8 -p-Cl-Ph * H * Et F F H OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XV-19. N2 R1 R 2 R3a REb R 4 R' R 6 X Y R R 8 XV-19-1 p-Br-Ph H H H Et F F H OH H H XV-19-2 p-Br-Ph H H CH 3 Et F F H OH H H XV-19-3 p-Br-Ph H H CH(CH 3
)
2 Et F F H OH H H XV-19-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Et F F H OH H H XV-19-5 p-Br-Ph H H CH 2 Ph Et F F H OH H H XV-19-6 p-Br-Ph H H CH 2 -indol-3-yl Et F F H OH H H XV-19-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Et F F H OH H H XV-19-8 p-Br-Ph * H * Et F F H OH H H *Rland R36 joined together by (CH 2
)
3 to form five-membered ring. 5 Table XV-20. N2 R' R2 R 3 a R 3 R4 R' R' X Y R 7 R XV-20-1 p-I-Ph H H H Et F F H OH H H XV-20-2 p-I-Ph H H ClH 3 Et F F H OH H H XV-20-.3 p-I-Ph H H CH(CH 3
)
2 Et F F H OH H H XV-20-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Et F F H OH H H XV-20-5 p-I-Ph H H CH 2 Ph Et F F H OH H H XV-20-6 p-I-Ph H H CH 2 -indol-3-yl Et F F H OH H H XV-20-.7 p-I-Ph H H CH 2
CH
2
SCH
3 Et F F H OH H H XV-20-.8 p-I-Ph * H * Et F F H OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XV-21. N2 R1 R2 R R R 4 R' R' X Y R R" XV-21-1 CH 3 H H H 'Pr F F H OH H H XV-21-2 CH 3 H H CH 3 'Pr F F H OH H H XV-21-3 CH 3 H H CH(CH 3
)
2 'Pr F F H OH H H XV-21-4 CH 3 H H CH 2
C.H(CH
3
)
2 'Pr F F H OH H H XV-21-5 CH 3 H H CH 2 PII 'Pr F F H OH H H XV-21-6 CH 3 H H CH 2 -indol-3-yl 'Pr F F H OH H H XV-21-7 CH 3 H H CH 2
CH
2
SCH
3 'Pr F F H OH H H XV-21-8 CH 3 * H * 'Pr F F H OH H H R -and R b joined together by (CH 2
)
3 to form five-membered ring. Table XV-22. N2 R1 R 2
R
3 a R 3 b R 4 R' R 6 X Y R/ R 8 XV-22-t Et H H H Pr F F H OH H H XV-22-2 Et H H CH 3 'Pr F F H OH H H XV-22-3 Et H H CH(CH 3
)
2 Pr F F H OH H H XV-22-4 Et H H CH 2
CH(CH
3
)
2 Pr F F H OH H H XV-22-5 Et H H CH 2 Ph Pr F F H OH H H XV-22-6 Et H H CH 2 -indol-3-yl Pr F F H OH H H XV-22-7 Et H H CH 2
CH
2
SCH
3 'Pr F F H OH H H XV-22-8 Et * H * Pr F F H OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XV-23. N2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y R' R' XV-23-1 'Pr H H H 'Pr F F H OH H H XV-23-2 'Pr H H CH 3 Pr F F H OH H H XV-23-3 'Pr H H CH(CH 3
)
2 Pr F F H OH H H XV-23-4 'Pr H H CH 2
CH(CH
3 )2 Pr F F H OH H H XV-23-5 'Pr H H CH 2 Ph Pr F F H OH H H XV-23-6 'Pr H H CH 2 -indol-3-yl 'Pr F F H OH H H XV-23-7 'Pr H H CH 2
CH
2
SCH
3 Pr F F H OH H H XV-23-8 'Pr * H * Pr F F H OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XV-24. N2 R1 R 2 R" R 3 b R4 R' R 6 X Y R 7
R
8 XV-24-1 'Bu H H H 'Pr F F H OH H H XV-24-2 'Bu H H CH 3 'Pr F F H OH H H XV-24-3 'Bu H H CH(CH 3
)
2 'Pr F F H OH H H XV-24-4 'Bu H H CH 2
CH(CH
3
)
2 'Pr F F H OH H H XV-24-5 'Bu H H CH 2 Ph 'Pr F F H OH H H XV-24-6 'Bu H H CH 2 -indol-3-yl 'Pr F F H OH H H XV-24-7 'Bu H H CH 2
CH
2
SCH
3 'Pr F F H OH H H XV-24-8 'Bu * H * 'Pr F F H OH H H R2and R" joined together by (CH 2
)
3 to form five-membered ring. Table XV-25. N9 R' R2 R 3 a R b R 4 R' R 6 X Y R' R' XV-25-1 Ph H H H 'Pr F F H OH H H XV-25-2 Ph H H CH 3 'Pr F F H OH H H XV-25-3 Ph H H CH(CH 3
)
2 'Pr F F H OH H H XV-25-4 Ph H H CH 2
CH(CH
3
)
2 'Pr F F H OH H H XV-25-5 Ph H H CH 2 Ph 'Pr F F H OH H H XV-25-6 Ph H H CH 2 -indol-3-yl 'Pr F F H OH H H XV-25-7 Ph H H CH 2
CH
2
SCH
3 'Pr F F H OH H H XV-25-8 Ph * H * 'Pr F F H OH H H *R2 and R 3 'b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XV-26. N R' R 2
R
3 a R 3 b R' R' R 6 X Y R 7
R
8 XV-26-1 p-Me-Ph H H H 'Pr F F H OH H H XV-26-2 p-Me-Ph H H CH 3 'Pr F F H OH H H XV-26-3 p-Me-Ph H H CH(CH 3
)
2 'Pr F F H OH H H XV-26-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 'Pr F F H OH H H XV-26-5 p-Me-Ph H H CH 2 Ph 'Pr F F H OH H H XV-26-6 p-Me-Ph H H CH 2 -indol-3-yl 'Pr F F H OH H H XV-26-7 p-Me-Ph H H CH 2
CH
2
SCH
3 'Pr F F H OH H H XV-26-8 p-Me-Ph * H * 'Pr F F H OH H H *RT-and Rdb joined together by (CH 2
)
3 to form five-membered ring.
Table XV-27. N2 R' R2 R 3 a R 3 b R 4 R' R' X Y R' R' XV-27-1 p-F-Ph H H H 'Pr F F H OH H H XV-27-2 p-F-Ph H H CH 3 'Pr F F H OH H H XV-27-3 p-F-Ph H H CH(CH 3
)
2 'Pr F F H OH H H XV-27-4 p-F-Ph H H CH 2
CH(CH
3
)
2 'Pr F F H OH H H XV-27-5 p-F-Ph H H CH 2 Ph 'Pr F F H OH H H XV-27-6 p-F-Ph H H CH2-indol-3-yl 'Pr F F H OH H H XV-27-7 p-F-Ph H H CH 2
CH
2
SCH
3 'Pr F F H OH H H XV-27-8 p-F-Ph * H * 'Pr F F H OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XV-28. X2 R1 R 2 Ra R3b R 4 R' R' X Y R R 8 XV-28-1 p-Cl-Ph H H H 'Pr F F H OH H H XV-28-2 p-Cl-Ph H H CH 3 'Pr F F H OH H H XV-28-3 p-Cl-Ph H H CH(CH 3
)
2 'Pr F F H OH H H XV-28-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 'Pr F F H OH H H XV-28-5 p-Cl-Ph H H CH 2 Ph 'Pr F F H OH H H XV-28-6 p-Cl-Ph H H CH 2 -indol-3-yl 'Pr F F H OH H H XV-28-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 'Pr F F H OH H H XV-28-8 p-Cl-Ph * H * 'Pr F F H OH H H *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XV-29. N2 R R 2 R R 3 b R 4 R' R' X Y R' R XV-29-1 p-Br-Ph H H H 'Pr F F H OH H H XV-29-2 p-Br-Ph H H CH 3 'Pr F F H OH H H XV-29-3 p-Br-Ph H H CH(CH 3
)
2 'Pr F F H OH H H XV-29-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 'Pr F F H OH H H XV-29-5 p-Br-Ph H H CH 2 Ph 'Pr F F H OH H H XV-29-6 p-Br-Ph H H CH 2 -indol-3-y 'Pr F F H OH H H XV-29-7 p-Br-Ph H H CH 2
CH
2
SCH
3 'Pr F F H OH H H XV-29-8 p-Br-Ph H H * 2 'Pr F F H OH H H *R and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XV-30. N R' R2 R 3 a R 3 b R4 R- R' X Y R' R' XV-30-1 p-I-Ph H H H 'Pr F F H OH H H XV-30-2 p-I-Ph H H CH 3 'Pr F F H OH H H XV-30-3 p-I-Ph H H CH(CH 3
)
2 'Pr F F H OH H H XV-30-4 p-I-Ph H H CH 2
CH(CH
3
)
2 'Pr F F H OH H H XV-30-5 p-I-Ph H H CH 2 Ph 'Pr F F H OH H H XV-30-6 p-I-Ph H H CH 2 -indol-3-yl 'Pr F F H OH H H XV-30-7 p-I-Ph H H CH 2
CH
2
SCH
3 'Pr F F H OH H H XV-30-8 p-I-Ph * H * 'Pr F F H OH H H *R2and R b joined together by (CH 2
)
3 to form five-membered ring. Table XV-31. Ne R' R 2 R3" Rsb R4 R' R 6 X Y R 7 R( XV-31-1 CH 3 H H H "Bu F F H OH H H XV-31-2 CH 3 H H CH 3 "Bu F F H OH H H XV-31-3 CH 3 H H CH(CH 3
)
2 "Bu F F H OH H H XV-31-4 CH 3 H H CH 2
CH(CH
3
)
2 "Bu F F H OH H H XV-31-5 CH 3 H H CH 2 Ph "Bu F F H OH H H XV-31-6 CH 3 H H CH 2 -indol-3-yl "Bu F F H OH H H XV-31-7 CH 3 H H CH 2
CH
2
SCH
3 "Bu F F H OH H H XV-31-8 CH 3 * H * "Bu F F H OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XV-32. X R' R2 R 3 " R3b R 4 R' R 6 X Y R R' XV-32-1 Et H H H "Bu F F H OH H H XV-32-2 Et H H CH 3 "Bu F F H OH H H XV-32-3 Et H H CH(CH 3
)
2 "Bu F F H OH H H XV-32-4 Et H H CH 2
CH(CH
3
)
2 "Bu F F H OH H H XV-32-5 Et H H CH 2 Ph "Bu F F H OH H H XV-32-6 Et H H CH 2 -indol-3-yl "Bu F F H OH H H XV-32-7 Et H H CH 2
CH
2
SCH
3 "Bu F F H OH H H XV-32-8 Et * H * "Bu F F H OH H H *R2 and R b joined together by (CH 2
)
3 to form five-membered ring. ~1 Q Table XV-33. N2 R' R2 R3a R 3b R 4 R' R' X Y R' R' XV-33-1 'Pr H H H "Bu F F H OH H H XV-33-2 'Pr H H CH 3 "Bu F F H OH H H XV-33-3 'Pr H H CH(CH 3
)
2 "Bu F F H OH H H XV-33-4 'Pr H H CH 2
CH(CH
3
)
2 "Bu F F H OH H H XV-33-5 'Pr H H CH 2 Ph "Bu F F H OH H H XV-33-6 'Pr H H CH 2 -indol-3-yl "Bu F F H OH H H XV-33-7 'Pr H H CH 2
CH
2
SCH
3 "Bu F F H OH H H XV-33-8 'Pr * H * "Bu F F H OH H H *R" and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XV-34. N2 R 1
R
2 R3a R 3 b R 4 R' R 6 X Y R' R' XV-34-1 'Bu H H H "Bu F F H OH H H XV-34-2 'Bu H H CH 3 "Bu F F H OH H H XV-34-3 'Bu H H CH(CH 3
)
2 "Bu F F H OH H H XV-34-4 'Bu H H CH 2
CH(CH
3
)
2 "Bu F F H OH H H XV-34-5 'Bu H H CH 2 Ph "Bu F F H OH H H XV-34-6 'Bu H H CH 2 -indol-3-yl "Bu F F H OH H H XV-34-7 'Bu H H CH 2
CH
2
SCH
3 "Bu F F H OH H H XV-34-8 'Bu * H * "Bu F F H OH H H *R2 and RJ joined together by (CH2)3 to form five-membered ring. 5 Table XV-35. N2 R1 R 2 R 3a R3b R 4 R' R' X Y R' R' XV-35-1 Ph H H H "Bu F F H OH H H XV-35-2 Ph H H CH 3 "Bu F F H OH H H XV-35-3 Ph H H CH(CH 3
)
2 "Bu F F H OH H H XV-35-4 Ph H H CH 2
CH(CH
3
)
2 "Bu F F H OH H H XV-35-5 Ph H H CH 2 Ph "Bu F F H OH H H XV-35-6 Ph H H CH 2 -indol-3-yl "Bu F F H OH H H XV-35-7 Ph H H CH 2
CH
2
SCH
3 "Bu F F H OH H H XV-35-8 Ph * H * "Bu F F H OH H H R andi R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XV-36. N2 R R 2 RaR 3 b R 4 R R X Y R"R 8 XV-36-1 p-Me-Ph H H H "Bu F F H OH H H XV-36-2 p-Me-Ph H H CH 3 "Bu F F H OH H H XV-36-3 p-Me-Ph H H CH(CH 3
)
2 "Bu F F H OH H H XV-36-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 "Bu F F H OH H H XV-36-5 p-Me-Ph H H CH 2 Ph "Bu F F H OH H H XV-36-6 p-Me-Ph H H CH 2 -indol-3-yl "Bu F F H OH H H XV-36-7 p-Me-Ph H H CH 2
CH
2
SCH
3 "Bu F F H OH H H XV-36-8 p-Me-Ph * H * "Bu F F H OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XV-37. N2 R' R 2
R
3 a R 3 b R 4 R' R' X Y R 7
R
8 XV-37-1 p-F-Ph H H H "Bu F F H OH H H XV-37-2 p-F-Ph H H CH 3 "Bu F F H OH H H XV-37-3 p-F-Ph H H CH(CH 3
)
2 "Bu F F H OH H H XV-37-4 p-F-Ph H H CH 2
CH(CH
3
)
2 "Bu F F H OH H H XV-37-5 p-F-Ph H H CH 2 Ph "Bu F F H OH H H XV-37-6 p-F-Ph H H CH 2 -indol-3-yl "Bu F F H OH H H XV-37-7 p-F-Ph H H CH 2
CH
2
SCH
3 "Bu F F H OH H H XV-37-8 p-F-Ph * H * "Bu F F H OH H H *R2 and Rab joined together by (CH 2
)
3 to form five-membered ring. 5 Table XV-38. N R R R R R' R' R X Y R R XV-38-1 p-Cl-Ph H H H "Bu F F H OH H H XV-38-2 p-Cl-Ph H H CH 3 "Bu F F H OH H H XV-38-3 p-Cl-Ph H H CH(CH 3
)
2 "Bu F F H OH H H XV-38-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 "Bu F F H OH H H XV-38-5 p-Cl-Ph H H CH 2 Ph "Bu F F H OH H H XV-38-6 p-Cl-Ph H H CH 2 -indol-3-yl "Bu F F H OH H H XV-38-7 p-Cl-Ph H H CH1 2
CH
2
SCH
3 "Bu F F H OH H H XV-38-8 p-Cl-Ph * H * "Bu F F H OH H H i*R2and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XV-39. 2 R R 2 Ra Rab R 4 R' R' X Y R( R' XV-39-1 p-Br-Ph H H H "Bu F F H OH H H XV-39-2 p-Br-Ph H H CH 3 "Bu F F H OH H H XV-39-3 p-Br-Ph H H CH(CH 3
)
2 "Bu F F H OH H H XV-39-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 "Bu F F H OH H H XV-39-5 p-Br-Ph H H CH 2 Ph "Bu F F H OH H H XV-39-6 p-Br-Ph H H CH 2 -indol-3-yl "Bu F F H OH H H XV-39-7 p-Br-Ph H H CH 2
CH
2
SCH
3 "Bu F F H OH H H XV-39-8 p-Br-Ph * H * "Bu F F H OH H H *R7 and Rb joined together by (CH 2
)
3 to form five-membered ring. Table XV-40. X2 R1 R 2 Ra RIb R' R' R' X Y R 7 R" XV-40-1 p-I-Ph H H H "Bu F F H OH H H XV-40-2 p-I-Ph H H CH 3 "Bu F F H OH H H XV-40-3 p-I-Ph H H CH(CH 3
)
2 "Bu F F H OH H H XV-40-4 p-I-Ph H H CH 2
CH(CH
3
)
2 "Bu F F H OH H H XV-40-5 p-I-Ph H H CH 2 Ph "Bu F F H OH H H XV-40-6 p-I-Ph H H CH 2 -indol-3-yl "Bu F F H OH H H XV-40-7 p-I-Ph H H CH 2
CH
2
SCH
3 "Bu F F H OH H H XV-40-8 p-I-Ph * H * "Bu F F H OH H H *R and R 3 b joined together by (CH 2
)
3 toform five-membered ring. 5 Table XN-4 1. N R R 2
R
3 a R 3 b R 4 R' R( X Y R 7 R XV-41- CH 3 H H H Bz F F H OH H H XV-41-2 CH 3 H H CH 3 Bz F F H OH H H XV-41-3 CH 3 H H CH(CH 3
)
2 Bz F F H OH H H XV-41-4 CH 3 H H CH 2
CH(CH
3 )2 Bz F F H OH H H XV-41-5 CH 3 H H CH 2 Ph Bz F F H OH H H XV-41-6 CH 3 H H CH 2 -indol-3-yl Bz F F H OH H H XV-41-7 CH 3 H H CH 2
CH
2 SCH3 Bz F F H OH H H XV-41-8 CH 3 * H * Bz F F H OH H H *R2 and R tb joined together by (CH 2
)
3 to form five-membered ring. 2~I Table XV-42. N2 R R 2
R
3 a R 3 b R 4 R' R' X Y R 7
R
8 XV-42-1 Et H H H Bz F F H OH H H XV-42-2 Et H H CH 3 Bz F F H OH H H XV-42-3 Et H H CH(CH 3
)
2 Bz F F H OH H H XV-42-4 Et H H CH 2
CH(CH
3
)
2 Bz F F H OH H H XV-42-5 Et H H CH 2 Ph Bz F F H OH H H XV-42-6 Et H H CH 2 -indol-3-yl Bz F F H OH H H XV-42-7 Et H H CH 2
CH
2
SCH
3 Bz F F H OH H H XV-42-8 Et * H * Bz F F H OH H H
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XV-43. X R' R 2 Ra R A R 4 R' R 6 XY R' R' XV-43-1 'Pr H H H Bz F F H OH H H XV-43-2 'Pr H H CH 3 Bz F F H OH H XV-43-3 'Pr H H CH(CH 3
)
2 Bz F F H OH H H XV-43-4 'Pr H H CH2CH(CH 3
)
2 Bz F F H OH H H XV-43-5 'Pr H H CH 2 Ph Bz F F H OH H H XV-43-6 'Pr H H CH 2 -indol-3-yl Bz F F H OH H H XV-43-7 'Pr H H CH 2
CH
2
SCH
3 Bz F F H OH H H XV-43-8 'Pr * H * Bz F F H OH H H 10 *R 2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XV-44. Xe R' R 2
R
3 a R R 4 R R 6 X Y R R' XV-44-1 'Bu H H H Bz F F H OH H H XV-44-2 'Bu H H CH 3 Bz F F H OH H H XV-44-3 'Bu H H CH(CH 3
)
2 Bz F F H OH H H XV-44-4 'Bu H H CH 2
CH(CH
3
)
2 Bz F F H OH H H XV-44-5 'Bu H H CH 2 Ph Bz F F H OH H H XV-44-6 'Bu H H CH 2 -indol-3-yl Bz F F H OH H H XV-44-7 'Bu H H CH 2
CH
2
SCH
3 Bz F F H OH H H XV-44-8 'Bu * H * Bz F F H OH H H R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XV-45. NV R R 2 R aR 3 b R 4 R' R' X Y R' R' XV-45-1 Ph H H H Bz F F H OH H H XV-45-2 Ph H H CH 3 Bz F F H OH H H XV-45-3 Ph H H CH(CH 3
)
2 Bz F F H OH H H XV-45-4 Ph H H CH 2
CH(CH
3
)
2 Bz F F H OH H H XV-45-5 Ph H H CH 2 Ph Bz F F H OH H H XV-45-6 Ph H H CH 2 -indol-3-yl Bz F F H OH H H XV-45-7 Ph H H CH 2
CH
2
SCH
3 Bz F F H OH H H XV-45-8 Ph * H * Bz F F H OH H H *R2 and RIb joined together by (CH 2
)
3 to form five-membered ring. Table XV-46. N2 R' R 2
R
3 a R 3 b4 R 5
R
6 X Y R 7
R
8 XV-46-1 p-Me-Ph H H H Bz F F H OH H H XV-46-2 p-Me-Ph H H CH 3 Bz F F H OH H H XV-46-3 p-Me-Ph H H CH(CH 3
)
2 Bz F F H OH H H XV-46-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Bz F F H OH H H XV-46-5 p-Me-Ph H H CH 2 Ph Bz F F H OH H H XV-46-6 p-Me-Ph H H CH 2 -indol-3-yl Bz F F H OH H H XV-46-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Bz F F H OH H H XV-46-8 p-Me-Ph * H * Bz F F H OH H H *R' and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XV-47. 2 R R 2
R
3 a R 3 b R 4 R R 6 X Y R 7
R
8 XV-47-1 p-F-Ph H H H Bz F F H OH H H XV-47-2 p-F-Ph H H CH 3 Bz F F H OH H H XV-47-3 p-F-Ph H H CH(CH 3
)
2 Bz F F H OH H H XV-47-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Bz F F H OH H H XV-47-5 p-F-Ph H H CH 2 Ph Bz F F H OH H H XV-47-6 p-F-Ph H H CH 2 -indol-3-yl Bz F F H OH H H XV-47-7 p-F-Ph H H CH 2
CH
2
SCH
3 Bz F F H OH H H XV-47-8 p-F-Ph * H * Bz F F H OH H H
*R
2 and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XV-48. N2 R1 R2 Raa R b RR 4 R R X Y R' R' XV-48-1 p-Cl-Ph H H H Bz F F H OH H H XV-48-2 p-Cl-Ph H H CH 3 Bz F F H OH H H XV-48-3 p-Cl-Ph H H CH(CH 3
)
2 Bz F F H OH H H XV-48-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Bz F F H OH H H XV-48-5 p-Cl-Ph H H CH 2 Ph Bz F F H OH H H XV-48-6 p-Cl-Ph H H CH 2 -indol-3-yl Bz F F H OH H H XV-48-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 -Bz F F H OH H H XV-48-8 p-Cl-Ph * H * Bz F F H OH H H
*R
2 and R"b joined together by (CH 2
)
3 to form five-membered ring. Table XV-49. N R R 2
R
3 a R 3 b R 4 R R 6 X Y R 7
R
8 XV-49-1 p-Br-Ph H H H Bz F F H OH H H XV-49-2 p-Br-Ph H H CH 3 Bz F F H OH H H XV-49-3 p-Br-Ph H H CH(CH 3
)
2 Bz F F H OH H H XV-49-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Bz F F H OH H H XV-49-5 p-Br-Ph H H CH 2 Ph Bz F F H OH H H XV-49-6 p-Br-Ph H H CH 2 -indol-3-yl Bz F F H OH H H XV-49-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Bz F F H OH H H XV-49-8 p-Br-Ph * H * Bz F F H OH H H *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XV-50. Ne R' R2 R 3 " R 3 b R 4 R( R x Y R' R' XV-50-1 p-I-Ph H H H Bz F F H OH H H XV-50-2 p-I-Ph H H CH 3 Bz F F H OH H H XV-50-3 p-I-Ph H H CH(CH 3
)
2 Bz F F H OH H H XV-50-4 p-l-Ph H H CH 2
CH(CH
3
)
2 Bz F F H OH H H XV-50-5 p-I-Ph H H CH 2 Ph Bz F F H OH H H XV-50-6 p-I-Ph H H CH 2 -indol-3-yl Bz F F H OH H H XV-50-7 p-I-Ph H H CH 2
CH
2
SCH
3 Bz F F H OH H H XV-50-8 p-I-Ph * H * Bz F F H OH H H *RTand R tb joined together by (CH 2
)
3 to form five-membered ring.
0
R
8 NH
R
3 0 R 7 N 0 R3N P -O C0 2
R
4 OR RR6 Y x XVI Table XVI- 1. 2 R R 2 Ra R 3 b R4 R' R' X Y R' R XVI-1-1 CH 3 H H H CH 3 F F F OH H H XVI-1-2 CH 3 H H CH 3
CH
3 F F F OH H H XVI-1-3 CH 3 H H CH(CH 3
)
2
CH
3 F F F OH H H XVI-1-4 CH 3 H H CH 2
CH(CH
3
)
2
CH
3 F F F OH H H XVI-1-5 CH 3 H H CH 2 Ph CH 3 F F F OH H H XVI-1-6 CH 3 H H CH 2 -indol-3-yI CH 3 F F F OH H H XVI-1-7 CH 3 H H CH 2
CH
2
SCH
3
CH
3 F F F OH H H XVI-1-8 CH 3 * H * CH 3 F F F OH H H *R and R3b joined together by (CH 2
)
3 to. form five-membered ring. 5 Table XVI-2. X R R2 R3a R3b R4 R R6 X Y R7 R XVI-2-1 Et H H H CH 3 F F F OH H H XVI-2-2 Et H H CH 3
CH
3 F F F OH H H XVI-2-3 Et H H CH(CH 3
)
2
CH
3 F F F OH H H XVI-2-4 Et H H CH 2 CH(CH3)2 CH 3 F F F OH H H XVI-2-5 Et H H CH 2 Ph CH 3 F F F OH H H XVI-2-6 Et H H CH 2 -indol-3-y CH 3 F F F OH H H XVI-2-7 Et H H CH2CH2SCH3 CH 3 F F F OH H H XVI-2-8 Et * H erCH3 F F F OH H H *R7 and R 3b joined together by (CH2)3 to form five-membered ring.
Table XVI-3. X R' R2 R 3 a R 3 b R 4 R' R' X Y R 7
R
8 XVI-3-1 'Pr H H H CH 3 F F F OH H H XVI-3-2 'Pr H H CH 3
CH
3 F F F OH H H XVI-3-3 'Pr H . H CH(CH 3
)
2
CH
3 F F F OH H H XVI-3-4 'Pr H H CH 2
CH(CH
3
)
2
CH
3 F F F OH H H XVI-3-5 'Pr H H CH 2 Ph CH 3 F F F OH H H XVI-3-6 'Pr H H CH 2 -indol-3-yl CH 3 F F F OH H H XVI-3-7 'Pr H H CH 2
CH
2
SCH
3
CH
3 F F F OH H H XVI-3-8 'Pr * H * CH 3 F F F OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XVI-4. X2 R' R2 R3a Rb R4 R' R' X Y R 7
R
8 XVI-4-1 'Bu H H H CH 3 F F F OH H H XVI-4-2 'Bu H H CH 3
CH
3 F F F OH H H XVI-4-3 'Bu H H CH(CH 3
)
2
CH
3 F F F OH H H XVI-4-4 'Bu H H CH 2
CH(CH
3
)
2
CH
3 F F F OH H H XVI-4-5 'Bu H H CH 2 Ph CH 3 F F F OH H H XVI-4-6 'Bu H H CH 2 -indol-3-yl CH 3 F F F OH H H XVI-4-7 'Bu H H CH 2
CH
2
SCH
3
CH
3 F F F OH H H XVI-4-8 'Bu * H * CH 3 F F F OH H H *R7 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVI-5. X2 RT R2 R 3 a R 3 b R 4 Ri R' X Y R 7
R
8 XVI-5-1 Ph H H H CH 3 F F F OH H H XVI-5-2 Ph H H CH 3
CH
3 F F F OH H H XVI-5-3 Ph H H CH(CH 3
)
2
CH
3 F F F OH H H XVI-5-4 Ph H H CH 2
CH(CH
3
)
2
CH
3 F F F OH H H XVI-5-5 Ph H H CH 2 Ph CH 3 F F F OH H H XVI-5-6 Ph H H CH 2 -indol-3-yl CH 3 F F F OH H H XVI-5-7 Ph H H CH 2
CH
2
SCH
3
CH
3 F F F OH H H XVI-5-8 Ph * H * CH 3 F F F OH H H *RI and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XVI-6. N2 R' R 2 R3a R 3 b R 4 R' R 6 X Y R/ R 8 XVI-6-1 p-Me-Ph H H H CH 3 F F F OH H H XVI-6-2 p-Me-Ph H H CH 3
CH
3 F F F OH H H XVI-6-3 p-Me-Ph H H CH(CH 3
)
2
CH
3 F F F OH H H XVI-6-4 p-Me-Ph H H CH 2
CH(CH
3
)
2
CH
3 F F F OH H H XVI-6-5 p-Me-Ph H H CH 2 Ph CH 3 F F F OH H H XVI-6-6 p-Me-Ph H H CH 2 -indol-3-yl CH 3 F F F OH H H XVI-6-7 p-Me-Ph H H CH 2
CH
2
SCH
3
CH
3 F F F OH H H XVI-6-8 p-Me-Ph * H * CH 3 F F F OH H H *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XVI-7. N2 R R 2 R 3a R 3 b R 4 R' R 6 X Y R' R' XVI-7-1 p-F-Ph H H H CH 3 F F F OH H H XVI-7-2 p-F-Ph H H CH 3
CH
3 F F F OH H H XVI-7-3 p-F-Ph H H CH(CH 3
)
2
CH
3 F F F OH H H XVI-7-4 p-F-Ph H H CH 2
CH(CH
3
)
2
CH
3 F F F OH H H XVI-7-6 p-F-Ph H H CH 2 Ph CH 3 F F F OH H H XVI-7-7 p-F-Ph H H CH 2 -indol-3-yl CH 3 F F F OH H H XVI-7-8 p-F-Ph H H CH 2
CH
2
SCH
3
CH
3 F F F OH H H XVI-7-20 p-F-Ph * H * CH 3 F F F OH H H *Rrand R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVI-8. N2 R' R2 R aRI R4 R5 R 6 X Y R R' XVI-8-1 p-Cl-Ph H H H CH 3 F F F OH H H XVI-8-2 p-Cl-Ph H H CH 3
CH
3 F F F OH H H XVI-8-3 p-Cl-Ph H H CH(CH 3
)
2
CH
3 F F F OH H H XVI-8-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2
CH
3 F F F OH H H XVI-8-5 p-Cl-Ph H H CH 2 Ph CH 3 F F F OH H H XVI-8-6 p-Cl-Ph H H C1 2 -indol-3-yl CH 3 F F F OH H H XVI-8-7 p-Cl-Ph H H CH 2
CH
2
SCH
3
CH
3 F F F OH H H XVI-8-8 p-Cl-Ph * H * CH 3 F F F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XVI-9. N2 R' R 2 RN Rb R 4 R R XY R' R' XVI-9-1 p-Br-Ph H H H CH 3 F F F OH H H XVI-9-2 p-Br-Ph H H CH 3
CH
3 F F F OH H H XVI-9-3 p-Br-Ph H H CH(CH 3
)
2
CH
3 F F F OH H H XVI-9-4 p-Br-Ph H H CH 2
CH(CH
3
)
2
CH
3 F F F OH H H XVI-9-6 p-Br-Ph H H CH 2 Ph CH 3 F F F OH H H XVI-9-7 p-Br-Ph H H CH 2 -indol-3-yl CH 3 F F F OH H H XVI-9-8 p-Br-Ph H H CH 2
CH
2
SCH
3
CH
3 F F F OH H H XVI-9-20 p-Br-Ph * H * CH 3 F F F OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XVI-10. 2 R R 2 R Rb R 4 R' R X Y R R 8 XVI-10-1 p-I-Ph H H H CH 3 F F F OH H H XVI-10-2 p-I-Ph H H CH 3
CH
3 F F F OH H H XVI-10-3 p-I-Ph H H CH(CH 3
)
2
CH
3 F F F OH H H XVI-10-4 p-I-Ph H H CH 2
CH(CH
3
)
2
CH
3 F F F OH H H XVI-10-5 p-I-Ph H H CH 2 Ph CH 3 F F F OH H H XVI-10-6 p-I-Ph H H CH 2 -indol-3-yl CH 3 F F F OH H H XVI-10-7 p-I-Ph H H CH 2
CH
2
SCH
3
CH
3 F F F OH H H XVI-10-8 p-I-Ph * H * CH 3 F F F OH H H *R and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVI-11. N9 R R 2 R R 3 b R 4 R' R 6 X Y R 7
R
8 XVI-11-1 CH 3 H H H Et F F F OH H H XVI-11-2 CH 3 H H CH 3 Et F F F OH H H XVI-11 -3 CH 3 H H CH(CH 3
)
2 Et F F F OH H H XVI-11-4 CH 3 H H CH 2
CH(CH
3
)
2 Et F F F OH H H XVI-11--5 CH 3 H H CH 2 Ph Et F F F OH H H XVI-11-6 CH 3 H H CH 2 -indol-3-yl Et F F F OH H H XVI-11--7 CH 3 H H CH 2
CH
2
SCH
3 Et F F F OH H H XVI-11-8 CH 3 * H * Et F F F OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 12{c0 Table XVI-12. RI R 2
R
3 aR R R 4
R
5
R
6 XY R 7
R
8 XVI-12-1 Et H H H Et F F F OH H H XVI-12-2 Et H H CH 3 Et F F F OH H H XVI-12-3 Et H H CH(C4 3
)
2 Et F F F OH H H XVI-12-4 Et H H CH 2
CH(CH
3
)
2 Et F F F OH H H XVI-12-5 Et H H CH 2 Ph Et F F F OH H H XVI-12-6 Et H H CH 2 -indol-3-yl Et F F F OH H H XVI-12-7 Et H H CH 2
CH
2
SCH
3 Et F F F OH H H XVI-12-8 Et * H * Et F F F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XVI-13. X2 R' R2 R 3 a R 3 b R 4 R' R' X Y R 7
R
8 XVI-13-1 'Pr H H H Et F F F OH H H XVI-13-2 'Pr H H CH 3 Et F F F OH H H XVI-13-3 'Pr H H CH(CH 3
)
2 Et F F F OH H H XVI-13-4 'Pr H H CH 2
CH(CH
3
)
2 Et F F F OH H H XVI-13-5 'Pr H H CH 2 Ph Et F F F OH H H XVI-13-6 'Pr H H CH 2 -indol-3-yl Et F F F OH H H XVI-13-7 'Pr H H CH 2
CH
2
SCH
3 Et F F F OH H H XVI-13-8 'Pr * H * Et F F F OH H H *R and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVI-14. N2 Rl R 2 Ra Rab R R' R 6 X Y R R XVI-14.1 'Bu H H H Et F F F OH H H XVI-14-2 'Bu H H CH 3 Et F F F OH H H XVI-14-3 'Bu H H CH(CH3) 2 Et F F F OH H H XVI-14-4 'Bu H H CH 2
CH(CH
3
)
2 Et F F F OH H H XVI-14-5 'Bu H H CH 2 Ph Et F F F OH H H XVI-14-6 'Bu H H CH 2 -indol-3-yl Et F F F OH H H XVI-14-7 'Bu H H CH 2 CH2SCH 3 Et F F F OH H H XVI-14-8 'Bu * H * Et F F F OH H H *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XVI-15. N2 R' R 2
R
3 a Rb R 4
R
5 R X Y R' R XVI-15-1 Ph H H H Et F F F OH H H XVI-15-2 Ph H H CH 3 Et F F F OH H H XVI-15-3 Ph H H CH(CH 3
)
2 Et F F F OH H H XVI-15-4 Ph H H CH 2
CH(CH
3
)
2 Et F F F OH H H XVI-15-5 Ph H H CH 2 Ph Et F F F OH H H XVI-15-6 Ph H H CH 2 -indol-3-yl Et F F F OH H H XVI-15-7 Ph H H CH 2
CH
2
SCH
3 Et F F F OH H H XVI-15-8 Ph * H * Et F F F OH H H
*R
2 and R b joined together by (CH 2
)
3 to form five-membered ring. Table XVI- 16. X2 Rl R 2
R
3 a R A R4 R 5
R
6 X Y R 7
R
8 XVI-16--1 p-Me-Ph H H H Et F F F OH H H XVI-16-2 p-Me-Ph H H CH 3 Et F F F OH H H XVI-16-3 p-Me-Ph H H CH(CH 3
)
2 Et F F F OH H H XVI-16-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Et F F F OH H H XVI-16-5 p-Me-Ph H H CH 2 Ph Et F F F OH H H XVI-16-6 p-Me-Ph H H CH 2 -indol-3-yl Et F F F OH H H XVI-16-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Et F F F OH H H XVI-16-8 p-Me-Ph * H * Et F F F OH H H R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVI-17. N2 R' R 2
R
3 " R 3 b R 4 R' R 6 X Y R' R 8 XVI-17-1 p-F-Ph H H H Et F F F OH H H XVI-17-2 p-F-Ph H H CH 3 Et F F F OH H H XVI-17-3 p-F-Ph H H CH(CH 3
)
2 Et F F F OH H H XVI-17-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Et F F F OH H H XVI-17-5 p-F-Ph H H CH 2 Ph Et F F F OH H H XVI-17-6 p-F-Ph H H CH2-indol-3-yl Et F F F OH H H XVI-17-7 p-F-Ph H H CH2CH 2
SCH
3 Et F F F OH H H XVI-17-8 p-F-Ph * H * Et F F F OH H H *R and Rab joined together by (CH 2
)
3 to form five-membered ring.
Table XVI-18. X2 Rl R 2
R
3 a Rb R 4 R R X Y R R 8 XVI-18-1 p-Cl-Ph H H H Et F F F OH H H XVI-18-2 p-Cl-Ph H H CH 3 Et F F F OH H H XVI-18-3 p-Cl-Ph H H CH(CH 3
)
2 Et F F F OH H H XVI-18-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Et F F F OH H H XVI-18-5 p-Cl-Ph H H CH 2 Ph Et F F F OH H H XVI-18-6 p-Cl-Ph H H CH 2 -indol-3-yl Et F F F OH H H XVI-18-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Et F F F OH H H XVI-18-8 p-Cl-Ph * H * Et F F F OH H H R7 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XVI-19. XP Rl R 2
R
3 a R b R' R' R' X Y R' R' XVI-19-1 p-Br-Ph H H H Et F F F OH H H XVI-19-2 p-Br-Ph H H CH 3 Et F F F OH H H XVI-19-3 p-Br-Ph H H CH(CH 3
)
2 Et F F F OH H H XVI-19-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Et F F F OH H H XVI-19-5 p-Br-Ph H H CH 2 Ph Et F F F OH H H XVI-19-6 p-Br-Ph H H CH 2 -indol-3-yl Et F F F OH H H XVI-19-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Ft F F F OH H H XVI-19-8 p-Br-Ph * H * Et F F F OH H H *R2 and R b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVI-20. X2 Rl R 2 R3a R 3 b R 4 R' R' X Y RF XVI-20-1 p-I-Ph H H H Et F F F OH H XVI-20-2 p-I-Ph H H CH 3 Et F F F OH H XVI-20--3 p-I-Ph H H CH(CH 3
)
2 Et F F F OH H XVI-20-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Et F F F OH H XVI-20-5 p-I-Ph H H CH 2 Ph Et F F F OH H XVI-20--6 p-I-Ph H H CH 2 -indol-3-yl Et F F F OH H XVI-20-7 p-I-Ph H H CH1 2
CH
2
SCH
3 Et F F F OH H XVI-20--8 p-I-Ph * H * Et F F F OH H *R" and R 3 b joined together by (CH 2
)
3 to form five-membered ring. '71 Table XVI-2 1. X2 R' R2 R3a R 3 b R 4 R' R' X Y R 7R78 XVI-21-1 CH 3 H H H Pr F F F OH H H XVI-21-2 CH 3 H H CH 3 'Pr F F F OH H H XVI-21-3 CH 3 H H CH(CH 3
)
2 Pr F F F OH H H XVI-21-4 CH 3 H H CH 2
CH(CH
3
)
2 Pr F F F OH H H XVI-21-5 CH 3 H H CH 2 Ph Pr F F F OH H H XVI-21-6 CH 3 H H CH 2 -indol-3-yl Pr F F F OH H H XVI-21-7 CH 3 H H CH 2
CH
2
SCH
3 Pr F F F OH H H XVI-21-8 CH 3 * H * Pr F F F OH H H R and R~b joined together by (CH 2
)
3 to form five-membered ring. Table XVI-22. X RI R 2
R
3 a R 3 b R R R 6 X Y R' R XVI-22-1 Et H H H 'Pr F F F OH H H XVI-22-2 Et H H CH 3 'Pr F F F OH H H XVI-22-3 Et H H CH(CH 3
)
2 'Pr F F F OH H H XVI-22.-4 Et H H CH 2
CH(CH
3
)
2 'Pr F F F OH H H XVI-22-5 Et H H CH 2 Ph 'Pr F F F OH H H XVI-22-6 Et H H CH 2 -indol-3-yl 'Pr F F F OH H H XVI-22-7 Et H H CH 2
CH
2
SCH
3 'Pr F F F OH H H XVI-22-8 Et * H * 'Pr F F F OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVI-23. X2 R' R2 Raa R3b R4 R' R' X Y R7 R 8 XVI-23-1 'Pr H H H 'Pr F F F OH H H XVI-23-.2 'Pr H H CH 3 'Pr F F F OH H H XVI-23-3 'Pr H H CH(CH 3
)
2 'Pr F F F OH H H XVI-23-4 'Pr H H CH 2
CIH(CH
3 )2 'Pr F F F OH H H XVI-23-5 'Pr H H CH 2 Ph 'Pr F F F OH H H XVI-23-6 'Pr H H CH 2 -indol-3-yl 'Pr F F F OH H H XVI-23-7 'Pr H H CH 2
CF
2
SCH
3 'Pr F F F OH H H XVI-23-8 'Pr * H * 'Pr F F F OH H H *Rland R 3 o joined together by (CH 2
)
3 to form five-membered ring.
Table XVI-24. X R' R 2
R
3 aR R 4 R R X Y R R 8 XVI-24-1 'Bu H H H 'Pr F F F OH H H XVI-24-2 'Bu H H CH 3 'Pr F F F OH H H XVI-24-3 'Bu H H CH(CH 3
)
2 'Pr F F F OH H H XVI-24-4 'Bu H H CH 2
CH(CH
3
)
2 'Pr F F F OH H H XVI-24-5 'Bu H H CH 2 Ph 'Pr F F F OH H H XVI-24-6 'Bu H H CH 2 -indol-3-yl 'Pr F F F OH H H XVI-24-7 'Bu H H CH 2
CH
2
SCH
3 'Pr F F F OH H H XVI-24-8 tBu * H * 'Pr F F F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XVI-25. X2 R' R 2
R
3 Rb R 4 R R X Y R 7 Rs XVI-25-1 Ph H H H 'Pr F F F OH H H XVI-25-2 Ph H H CH 3 'Pr F F F OH H H XVI-25-3 Ph H H CH(CH 3
)
2 'Pr F F F OH H H XVI-25-4 Ph H H CH 2
CH(CH
3
)
2 'Pr F F F OH H H XVI-25-5 Ph H H CH 2 Ph 'Pr F F F OH H H XVI-25-6 Ph H H CH 2 -indol-3-yl 'Pr F F F OH H H XVI-25-7 Ph H H CH 2
CH
2
SCH
3 'Pr F F F OH H H XVI-25-8 Ph * H * 'Pr F F F OH H H *R2 and RJb joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVI-26. X2 R R 2
R
3 a R 3 b R4 R' R 6 X Y R R 8 XVI-26-.1 p-Me-Ph H H H 'Pr F F F OH H H XVI-26-2 p-Me-Ph H H CH 3 'Pr F F F OH H H XVI-26-.3 p-Me-Ph H H CH(CH 3
)
2 'Pr F F F OH H H XVI-26-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 'Pr F F F OH H H XVI-26-5 p-Me-Ph H H CH 2 Ph 'Pr F F F OH H H XVI-26-6 p-Me-Ph H H CH 2 -indol-3-yl 'Pr F F F OH H H XVI-26-7 p-Me-Ph H H CH 2
CH
2
SCH
3 'Pr F F F OH H H XVI-26-8 p-Me-Ph * H * 'Pr F F F OH H H *R7 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 1 72 Table XVI-27. 2 R R 2
R
3 " R R 4 R' R X Y R R' XVI-27-1 p-F-Ph H H H 'Pr F F F OH H H XVI-27-2 p-F-Ph H H CH 3 'Pr F F F OH H H XVI-27-3 p-F-Ph H H CH(CH 3
)
2 'Pr F F F OH H H XVI-27-4 p-F-Ph H H CH 2
CH(CH
3
)
2 'Pr F F F OH H H XVI-27-5 p-F-Ph H H CH 2 Ph 'Pr F F F OH H H XVI-27-6 p-F-Ph H H CH 2 -indol-3-yl 'Pr F F F OH H H XVI-27-7 p-F-Ph H H CH 2
CH
2
SCH
3 Pr F F F OH H H XVI-27-8 p-F-Ph * H * 'Pr F F F OH H H *R and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XVI-28. N2 Rl R 2 R3a R3b R 4 R' R' X Y R 7 R XVI-28-1 p-Cl-Ph H H H 'Pr F F F OH H H XVI-28-2 p-Cl-Ph H H CH 3 'Pr F F F OH H H XVI-28-3 p-Cl-Ph H H CH(CH 3
)
2 'Pr F F F OH H H XVI-28.-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 'Pr F F F OH H H XVI-28-5 p-Cl-Ph H H CH 2 Ph 'Pr F F F OH H H XVI-28-6 p-Cl-Ph H H CH 2 -indol-3-yl 'Pr F F F OH H H XVI-28-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 'Pr F F F OH H H XVI-28-8 p-Cl-Ph * H * 'Pr F F F OH H H *R" and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVI-29. N2 Rl R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7 R' XVI-29-1 p-Br-Ph H H H 'Pr F F F OH H H XVI-29-.2 p-Br-Ph H H CH 3 'Pr F F F OH H H XVI-29-3 p-Br-Ph H H CH(CH 3
)
2 'Pr F F F OH H H XVI-29-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 'Pr F F F OH H H XVI-29-5 p-Br-Ph H H CH 2 Ph 'Pr F F F OH H H XVI-29-6 p-Br-Ph H H CH 2 -indol-3-yl 'Pr F F F OH H H XVI-29-7 p-Br-Ph H H CH 2
CH
2
SCH
3 'Pr F F F OH H H XVI-29-8 p-Br-Ph * H * 'Pr F F F OH H H *R and Rib joined together by (CH 2
)
3 to form five-membered ring. '2'7A Table XVI-30. N2 R R2 R 3 " R 3 b R' R' R' X Y R' R' XVI-30-1 p-I-Ph H H H 'Pr F F F OH H H XVI-30-2 p-I-Ph H H CH 3 'Pr F F F OH H H XVI-30-3 p-I-Ph H H CH(CH 3
)
2 'Pr F F F OH H H XVI-30-4 p-I-Ph H H CH 2
CH(CH
3
)
2 'Pr F F F OH H H XVI-30-5 p-I-Ph H H CH 2 Ph 'Pr F F F OH H H XVI-30-6 p-I-Ph H H CH 2 -indol-3-yl 'Pr F F F OH H H XVI-30-7 p-I-Ph H H CH 2
CH
2
SCH
3 'Pr F F F OH H H XVI-30-8 p-I-Ph * H * 'Pr F F F OH H H
*R
2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XVI-3 1. X2 R' R2 R 3 a R 3 b R4 R' R 6 X Y R' R' XVI-31- CH 3 H H H "Bu F F F OH H H XVI-31-2 CH 3 H H CH 3 "Bu F F F OH H H XVI-31-3 CH 3 H H CH(CH 3
)
2 "Bu F F F OH H H XVI-31-4 CH3 H H CH 2
CH(CH
3
)
2 "Bu F F F OH H H XVI-31-5 CH 3 H H CH 2 Ph "Bu F F F OH H H XVI-31-6 CH 3 H H CH 2 -indol-3-yl "Bu F F F OH H H XVI-31-7 CH 3 H H CH 2
CH
2
SCH
3 "Bu F F F OH H H XVI-31-8 CH 3 * H * "Bu F F F OH H H *R2 and RJb joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVI-32. X2 Rl R 2
R
3 a R 3 b R' R' R X Y R' R' XVI-32-1 Et H H H "Bu F F F OH H H XVI-32-2 Et H H CH 3 "Bu F F F OH H H XVI-32-3 Et H H CH(CH 3
)
2 "Bu F F F OH H H XVI-32-4 Et H H CH 2
CH(CH
3
)
2 "Bu F F F OH H H XVI-32-5 Et H H CH 2 Ph "Bu F F F OH H H XVI-32-6 Et H H CH 2 -indol-3-yl "Bu F F F OH H H XVI-32-7 Et H H CH 2
CH
2
SCH
3 "Bu F F F OH H H XVI-32-8 Et * H * "Bu F F F OH H H R and R t ' joined together by (CH 2
)
3 to form five-membered ring.
Table XVI-33. N9 R R 2
R
3 a R 3 b R' R' R' X Y R' R XVI-33-1 'Pr H H H "Bu F F F OH H H XVI-33-2 'Pr H H CH 3 "Bu F F F OH H H XVI-33-3 'Pr H H CH(CH 3
)
2 "Bu F F F OH H H XVI-33-4 'Pr H H CH 2
CH(CH
3
)
2 "Bu F F F OH H H XVI-33-5 'Pr H H CH 2 Ph "Bu F F F OH H H XVI-33-6 'Pr H H CH 2 -indol-3-yl "Bu F F F OH H H XVI-33-7 'Pr H H CH 2
CH
2
SCH
3 "Bu F F F OH H H XVI-33-8 'Pr* H * "Bu F F F OH H H *RZand Rob joined together by (CH 2
)
3 to form five-membered ring. Table XVI-34. N R R 2 Ra Rb R 4 R' R XY R R XVI-34-1 'Bu H H H "Bu F F F OH H H XVI-34-2 'Bu H H CH 3 "Bu F F F OH H H XVI-34-3 'Bu H H CH(CH 3
)
2 "Bu F F F OH H H XVI-34.-4 'Bu H H CH 2
CH(CH
3
)
2 "Bu F F F OH H H XVI-34-5 'Bu H H CH 2 Ph "Bu F F F OH H H XVI-34-6 'Bu H H CH 2 -indol-3-yl "Bu F F F OH H H XVI-34-7 'Bu H H CH 2
CH
2
SCH
3 "Bu F F F OH H H XVI-34.-8 'Bu * H * "Bu F F F OH H H R and R.b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVI-35. X RI R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7
R
8 XVI-35-1 Ph H H H "Bu F F F OH H H XVI-35-.2 Ph H H CH 3 "Bu F F F OH H H XVI-35-3 Ph H H CH(CH 3
)
2 "Bu F F F OH H H XVI-35--4 Ph H H CH 2
CH(CH
3
)
2 "Bu F F F OH H H XVI-35-5 Ph H H CH 2 Ph "Bu F F F OH H H XVI-35-.6 Ph H H CH 2 -indol-3-yl "Bu F F F OH H H XVI-35-.7 Ph H H CH 2
CH
2
SCH
3 "Bu F F F OH H H XVI-35-8 Ph * H * "Bu F F F OH H H *RTand R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XVI-36. X Rl R 2
R
3 a R3b R' R' R 6 X Y R' R' XVI-36-1 p-Me-Ph H H H "Bu F F F OH H H XVI-36-2 p-Me-Ph H H CH 3 "Bu F F F OH H H XVI-36-3 p-Me-Ph H H CH(CH 3 )2 "Bu F F F OH H H XVI-36-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 "Bu F F F OH H H XVI-36-5 p-Me-Ph H H CH 2 Ph "Bu F F F OH H H XVI-36-6 p-Me-Ph H H CH 2 -indol-3-yl "Bu F F F OH H H XVI-36-7 p-Me-Ph H H CH 2
CH
2
SCH
3 "Bu F F F OH H H XVI-36-8 p-Me-Ph * H * "Bu F F F OH H H
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XVI-37. X2 R' R 2
R
3 a Rb R R R X Y R'R 8 XVI-37-1 p-F-Ph H H H "Bu F F F OH H H XVI-37-2 p-F-Ph H H CH 3 "Bu F F F OH H H XVI-37-3 p-F-Ph H H CH(CH 3
)
2 "Bu F F F OH H H XVI-37-4 p-F-Ph H H CH 2
CH(CH
3
)
2 "Bu F F F OH H H XVI-37-5 p-F-Ph H H CH 2 Ph "Bu F F F OH H H XVI-37-6 p-F-Ph H H CH 2 -indol-3-yl "Bu F F F OH H H XVI-37-7 p-F-Ph H H CH 2
CH
2
SCH
3 "Bu F F F OH H H XVI-37-8 p-F-Ph * H * "Bu F F F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVI-38. X2 R' R2 RaR 3 b R 4 R' R 6 X Y R' R XVI-38-1 p-Cl-Ph H H H "Bu F F F OH H H XVI-38-.2 p-Cl-Ph H H CH 3 "Bu F F F OH H H XVI-38-3 p-Cl-Ph H H CH(CH 3
)
2 "Bu F F F OH H H XVI-38-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 "Bu F F F OH H H XVI-38-.5 p-Cl-Ph H H CH 2 Ph "Bu F F F OH H Fl XVI-38-6 p-Cl-Ph H H CH 2 -indol-3-yl "Bu F F F OH H H XVI-38-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 "Bu F F F OH H H XVI-38-8 p-Cl-Ph * H * "Bu F F F OH H H *R and Rib joined together by (CH 2
)
3 to form five-membered ring. 'II 7 Table XVI-39. 2 Rl R 2
R
3 a R 3 b R 4 R' R' X Y R? R 8 XVI-39-1 p-Br-Ph H H H "Bu F F F OH H H XVI-39-2 p-Br-Ph H H CH 3 "Bu F F F OH H H XVI-39-3 p-Br-Ph H H CH(CH 3
)
2 "Bu F F F OH H H XVI-39-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 "Bu F F F OH H H XVI-39-5 p-Br-Ph H H CH 2 Ph "Bu F F F OH H H XVI-39-6 p-Br-Ph H H CH 2 -indol-3-yl "Bu F F F OH H H XVI-39-7 p-Br-Ph H H CH 2
CH
2
SCH
3 "Bu F F F OH H H XVI-39-8 p-Br-Ph * H * "Bu F F F OH H H
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XVI-40. X Rl R 2 R a R 3 b R 4 R' R 6 X Y R/ Rs XVI-40-1 p-I-Ph H H H "Bu F F F OH H H XVI-40-2 p-I-Ph H H CH 3 "Bu F F F OH H H XVI-40-3 p-I-Ph H H CH(CH 3
)
2 'Bu F F F OH H H XVI-40-4 p-I-Ph H H CH 2
CH(CH
3
)
2 'Bu F F F OH H H XVI-40-5 p-I-Ph H H CH 2 Ph "Bu F F F OH H H XVI-40-6 p-I-Ph H H CH 2 -indol-3-yl 'Bu F F F OH H H XVI-40-7 p-I-Ph H H CH 2
CH
2
SCH
3 'Bu F F F OH H H XVI-40-8 p-I-Ph * H * 'Bu F F F OH H H *Rnd Rb joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVI-41. MR R 2
R
3 a R 3 b R 4 R' R X Y R' R 8 XVI-41-1 CH 3 H H H Bz F F F OH H H XVI-41.-2 CH 3 H H CH 3 Bz F F F OH H H XVI-41-3 CH 3 H H CH(CH 3
)
2 Bz F F F OH H H XVI-41-4 CH 3 H H CH 2
CH(CH
3
)
2 Bz F F F OH H H XVI-41.5 CH 3 H H CH 2 Ph Bz F F F OH H H XVI-41-6 CH 3 H H CH 2 -indol-3-yl Bz F F F OH H H XVI-41--7 CH 3 H H CH 2
CH
2
SCH
3 Bz F F F OH H H XVI-41-8 CH 3 * H * Bz F F F OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XVI-42. X RI R 2
R
3 a R A R 4 R' R' X Y R' R' XVI-42-1 Et H H H Bz F F F OH H H XVI-42-2 Et H H CH 3 Bz F F F OH H H XVI-42-3 Et H H CH(CH 3
)
2 Bz F F F OH H H XVI-42-4 Et H H CH 2
CH(CH
3
)
2 Bz F F F OH H H XVI-42-5 Et H H CH 2 Ph Bz F F F OH H H XVI-42-6 Et H H CH 2 -indol-3-yl Bz F F F OH H H XVI-42-7 Et H H CH 2
CH
2
SCH
3 Bz F F F OH H H XVI-42-8 Et * H * Bz F F F OH H H *R' and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XVI-43. 2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y R7 R 8 XVI-43.-1 'Pr H H H Bz F F F OH H H XVI-43-2 'Pr H H CH 3 Bz F F F OH H XVI-43.-3 'Pr H H CH(CH 3
)
2 Bz F F F OH H H XVI-43-4 'Pr H H CH 2
CH(CH
3
)
2 Bz F F F OH H H XVI-43.-5 'Pr H H CH 2 Ph Bz F F F OH H H XVI-43-6 'Pr H H CH 2 -indol-3-yl Bz F F F OH H H XVI-43--7 'Pr H H CH 2
CH
2
SCH
3 Bz F F F OH H H XVI-43-8 'Pr * H * Bz F F F OH H H 10 *R 2 and R joined together by (CH 2
)
3 to form five-membered ring. Table XVI-44. 2 R' R 2
R
3 a R 3 b R 4 R( R( X Y R 7 Rs XVI-44-1 'Bu H H H Bz F F F OH H H XVI-44-2 'Bu H H CH 3 Bz F F F OH H H XVI-44-3 'Bu H H CH(CH 3
)
2 Bz F F F OH H H XVI-44-4 'Bu H H CH 2
CH(CH
3
)
2 Bz F F F OH H H XVI-44-5 'Bu H H CH 2 Ph Bz F F F OH H H XVI-44-6 'Bu H H CH 2 -indol-3-yl Bz F F F OH H H XVI-44-7 'Bu H H CH 2
CH
2
SCH
3 Bz F F F OH H H XVI-44-8 'Bu * H * Bz F F F OH H H *R2 and R 3 " joined together by (CH 2
)
3 to form five-membered ring. I ' Table XVI-45. N2 R' R2 R 3 a R 3 b R 4 R' R' X Y R 7
R
8 XVII-45-1 Ph H H H Bz F F F OH H H XVII-45-2 Ph H H CH 3 Bz F F F OH H H XVII-45-3 Ph H H CH(CH 3
)
2 Bz F F F OH H H XVII-45-4 Ph H H CH 2
CH(CH
3
)
2 Bz F F F OH H H XVII-45-5 Ph H H CH 2 Ph Bz F F F OH H H XVII-45-6 Ph H H CH 2 -indol-3-yl Bz F F F OH H H XVII-45-7 Ph H H CH 2
CH
2
SCH
3 Bz F F F OH H H XVII-45-8 Ph * H * Bz F F F OH H H R7 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XVI-46. N2 Rl R 2
R
3 " Rab R 4 R' R 6 X Y R' R XVII-46-1 p-Me-Ph H H H Bz F F F OH H H XVII-46-2 p-Me-Ph H H CH 3 Bz F F F OH H H XVII-46-3 p-Me-Ph H H CH(CH 3
)
2 Bz F F F OH H H XVII-46-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Bz F F F OH H H XVII-46-5 p-Me-Ph H H CH 2 Ph Bz F F F OH H H XVII-46-6 p-Me-Ph H H CH 2 -indol-3-yl Bz F F F OH H H XVII-46-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Bz F F F OH H H XVII-46-8 p-Me-Ph * H * Bz F F F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVI-47. N2 RI R2 Ria R 3 b R 4
R
5
R
6 X Y R' R' XVII-47-1 p-F-Ph H H H Bz F F F OH H H XVII-47-2 p-F-Ph H H CH 3 Bz F F F OH H H XVII-47-3 p-F-Ph H H CH(CH 3
)
2 Bz F F F OH H H XVII-47-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Bz F F F OH H H XVII-47-5 p-F-Ph H H CH 2 Ph Bz F F F OH H H XVII-47-6 p-F-Ph H H CH 2 -indol-3-yl Bz F F F OH H H XVII-47-7 p-F-Ph H H CH 2
CH
2
SCH
3 Bz F F F OH H H XVII-47-8 p-F-Ph * H * Bz F F F OH H H *R and Rb joined together by (CH 2
)
3 to form five-membered ring. '1 on Table XVI-48. X2 R R 2
R
3 a R 3 b R 4 R' R' X Y R7 R 8 XVII-48-1 p-Cl-Ph H H H Bz F F F OH H H XVII-48-2 p-Cl-Ph H H CH 3 Bz F F F OH H H XVII-48-3 p-Cl-Ph H H CH(CH 3
)
2 Bz F F F OH H H XVII-48-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Bz F F F OH H H XVII-48-5 p-Cl-Ph H H CH 2 Ph Bz F F F OH H H XVII-48-6 p-Cl-Ph H H CH 2 -indol-3-yl Bz F F F OH H H XVII-48-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Bz F F F OH H H XVII-48-8 p-Cl-Ph * H * Bz F F F OH H H *R and R joined together by (CH 2
)
3 to form five-membered ring. Table XVI-49. X R R 2 R a R 3 b R' R' R 6 X Y R' R' XVII-49-1 p-Br-Ph H H H Bz F F F OH H H XVII-49-2 p-Br-Ph H H CH 3 Bz F F F OH H H XVII-49-3 p-Br-Ph H H CH(CH 3 )2 Bz F F F OH H H XVII-49-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Bz F F F OH H H XVII-49-5 p-Br-Ph H H CH 2 Ph Bz F F F OH H H XVII-49-6 p-Br-Ph H H CH 2 -indol-3-yl Bz F F F OH H H XVII-49-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Bz F F F OH H H XVII-49-8 p-Br-Ph * H * Bz F F F OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVI-50. SR R 2
R
3 a R 3 b R 4 R R'XY R R XVII-50-1 p-I-Ph H H H Bz F F F OH H H XVII-50-2 p-I-Ph H H CH 3 Bz F F F OH H H XVII-50-3 p-I-Ph H H CH(CH 3
)
2 Bz F F F OH H H XVII-50-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Bz F F F OH H H XVII-50-5 p-I-Ph H H CH 2 Ph Bz F F F OH H H XVII-50-6 p-I-Ph H H CH 2 -indol-3-yl Bz F F F OH H H XVII-50-7 p-I-Ph H H CH 2
CH
2
SCH
3 Bz F F F OH H H XVII-50-8 p-I-Ph * H * Bz F F F OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 101 0
R
8 R2 0NH R2O R3b R N P0R7 N O R3a N- -0
CO
2
R
4 OR R R 6 Y X XVHI Table XVII- 1. X2 R' R 2
R
3 Rb R 4 R R X Y R R' XVII-1-1 CH 3 H H H CH 3 F H F OH H H XVII-1-2 CH 3 H H CH 3
CH
3 F H F OH H H XVII-1-3 CH 3 H H CH(CH 3
)
2
CH
3 F H F OH H H XVII-1-4 CH 3 H H CH 2
CH(CH
3
)
2
CH
3 F H F OH H H XVII-1-5 CH 3 H H CH 2 Ph CH 3 F H F OH H H XVII-1-.6 CH 3 H H CH 2 -indol-3-yl CH 3 F H F OH H H XVII-1-7 CH 3 H H CH 2
CH
2
SCH
3
CH
3 F H F OH H H XVII-1-8 CH 3 * H * CH 3 F H F OH H H * R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XVII-2. X2 RI R 2 R3a R3b R 4 R' R 6 X Y R' R" XVII-2-1 Et H H H CH 3 F H F OH H H XVII-2-2 Et H H CH 3
CH
3 F H F OH H H XVII-2-3 Et H H CH(CH 3
)
2
CH
3 F H F OH H H XVII-2-4 Et H H CH 2
CH(CH
3
)
2
CH
3 F H F OH H H XVII-2-5 Et H H CH 2 Ph CH 3 F H F OH H H XVII-2-6 Et H H CH 2 -indol-3-yl CH 3 F H F OH H H XVH-2-7 Et H H CH 2
CH
2
SCH
3
CH
3 F H F OH H H XVII-2-8 Et * H * CH 3 F H F OH H H 5 *R2 and R36 joined together by (CH 2
)
3 to form five-membered ring.
Table XVII-3. N2 R' R 2 R a R R 4 R R 6 X Y R R 8 XVII-3-1 Pr H H H CH 3 F H F OH H H XVII-3-2 'Pr H H CH 3
CH
3 F H F OH H H XVII-3-3 'Pr H H CH(CH 3
)
2
CH
3 F H F OH H H XVII-3-4 'Pr H H CHCH(CH 3
)
2
CH
3 F H F OH H H XVII-3-5 'Pr H H CH 2 Ph CH 3 F H F OH H H XVII-3-6 'Pr H H CH 2 -indol-3-yl CH 3 F H F OH H H XVII-3-7 'Pr H H CH 2
CH
2
SCH
3
CH
3 F H F OH H H XVII-3-8 'Pr * H * CH 3 F H F OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XVII-4. N! R R 2
R
3 a R 3 b R R R X Y R' R' XVII-4--1 'Bu H H H CH 3 F H F OH H H XVII-4-2 'Bu H H CH 3
CH
3 F H F OH H H XVH-4-.3 'Bu H H CH(CH 3
)
2
CH
3 F H F OH H H XVII-4-4 'Bu H H CH 2
CH(CH
3
)
2
CH
3 F H F OH H H XVII-4-5 'Bu H H CH 2 Ph CH 3 F H F OH H H XVII-4-6 'Bu H H CH 2 -indol-3-yl CH 3 F H F OH H H XVII-4-7 'Bu H H CH 2
C:H
2
SCH
3
CH
3 F H F OH H H XVII-4-8 'Bu * H * CH 3 F H F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVII-5. N! R' R2 R 3 a R 3 b R' R' R' X Y R' R" XVH-5-1 Ph H H H CH 3 F H F OH H H XVII-5-2 Ph H H CH 3
CH
3 F H F OH H H XVII-5-3 Ph H H CH(CH 3
)
2
CH
3 F H F OH H H XVII-5-4 Ph H H CH 2
CH(CH
3
)
2
CH
3 F H F OH H H XVH-5-5 Ph H H CH 2 Ph CH 3 F H F OH H H XVII-5-6 Ph H H CH2-indol-3-yl CH 3 F H F OH H H XVII-5-7 Ph H H CH 2
CH
2
SCH
3
CH
3 F H F OH H H XVH-5-8 Ph * H * CH 3 F H F OH H H *Riand R~b joined together by (CH 2
)
3 to form five-membered ring. I202 Table XVII-6. N2 R' R 2 Raa RSb R 4 R' R' X Y R'R 8 XVII-6-1 p-Me-Ph H H H CH 3 F H F OH H H XVH-6-2 p-Me-Ph H H CH 3
CH
3 F H F OH H H XVII-6-3 p-Me-Ph H H CH(CH 3
)
2
CH
3 F H F OH H H XVH-6-4 p-Me-Ph H H CH 2
CH(CH
3
)
2
CH
3 F H F OH H H XVII-6-5 p-Me-Ph H H CH 2 Ph CH 3 F H F OH H H XVII-6-6 p-Me-Ph H H CH 2 -indol-3-yl CH 3 F H F OH H H XVII-6-7 p-Me-Ph H H CH 2
CH
2
SCH
3
CH
3 F H F OH H H XVII-6-8 p-Me-Ph * H * CH 3 F H F OH H H *R and Rdb joined together by (CH 2
)
3 to form five-membered ring. Table XVII-7. N! R R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7 R' XVI-7-1 p-F-Ph H H H CH 3 F H F OH H H XVII-7-2 p-F-Ph H H CH 3
CH
3 F H F OH H H XVII-7-3 p-F-Ph H H CH(CH 3
)
2
CH
3 F H F OH H H XVII-7-4 p-F-Ph H H CH 2
CH(CH
3
)
2
CH
3 F H F OH H H XVH-7-6 p-F-Ph H H CH 2 Ph CH 3 F H F OH H H XVII-7-7 p-F-Ph H H CH 2 -indol-3-yl CH 3 F H F OH H H XVH-7-8 p-F-Ph H H CH 2
CH
2
SCH
3
CH
3 F H F OH H H XVH-7-.20 p-F-Ph * H * CH 3 F H F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVII-8. N R' R 2
R
3 a R 3 b R4 R' R XY R R 8 XVII-8-1 p-Cl-Ph H H H CH 3 F H F OH H H XVI-8-2 p-Cl-Ph H H CH 3
CH
3 F H F OH H H XVI-8-3 p-Cl-Ph H H CH(CH 3
)
2
CH
3 F H F OH H H XVII-8-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2
CH
3 F H F OH H H XVII-8-5 p-Cl-Ph H H CH 2 Ph CH 3 F H F OH H H XVH-8-6 p-Cl-Ph H H CH 2 -indol-3-yl CH 3 F H F OH H H XVII-8-7 p-Cl-Ph H H CH 2
CH
2
SCH
3
CH
3 F H F OH H H XVII-8-8 p-Cl-Ph * H * CH 3 F H F OH H H *RT and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 1 QA Table XVII-9. M2 R' R 2
R
3 a Rb R 4 R R X Y R' R XVII-9-- p-Br-Ph H H H CH 3 F H F OH H H XVH-9-2 p-Br-Ph H H CH 3
CH
3 F H F OH H H XVII-9-3 p-Br-Ph H H CH(CH 3
)
2
CH
3 F H F OH H H XVII-9-4 p-Br-Ph H H CH 2
CH(CH
3
)
2
CH
3 F H F OH H H XVII-9-6 p-Br-Ph H H CH 2 Ph CH 3 F H F OH H H XVH-9-.7 p-Br-Ph H H CH 2 -indol-3-yl CH 3 F H F OH H H XVH-9-8 p-Br-Ph H H CH 2
CH
2
SCH
3
CH
3 F H F OH H H XVI-9-.20 p-Br-Ph * H * CR 3 F H F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XVII-10. X2 R R 2
R
3 a R 3 b R 4 R' R 6 X Y R' R 8 XVH-10-1 p-I-Ph H H H CH 3 F H F OH H H XVII-10-2 p-I-Ph H H CH 3
CH
3 F H F OH H H XVII-10-3 p-I-Ph H H CH(CH 3
)
2
CH
3 F H F OH H H XVII-10-4 p-I-Ph H H CH2CH(CH 3
)
2
CH
3 F H F OH H H XVH-10-5 p-I-Ph H H CH2Ph CH 3 F H F OH H H XVH-10-6 p-I-Ph H H CH 2 -indol-3-yl CH 3 F H F OH H H XVH-10-7 p-I-Ph H H CH 2
CH
2
SCH
3
CH
3 F H F OH H H XVII-10-8 p-I-Ph * H * CH 3 F H F OH H H *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVII-ll1. M2 R R 2 R 3 a R 3 b R 4 R' R 6 X Y R' R' XVII-11-1 CH 3 H H H Et F H F OH H H XVH-11-2 CH 3 H H CH 3 Et F H F OH H H XVII-11-3 CH 3 H H CH(CH 3
)
2 Et F H F OH H H XVH-11-4 CH 3 H H CH 2
CH(CH
3
)
2 Et F H F OH H H XVH-11-5 CH 3 H H CH 2 Ph Et F H F OH H H XVII-11-6 CH 3 H H CH 2 -indol-3-yl Et F H F OH H H XVII-11-7 CH 3 H H CH 2
CH
2
SCH
3 Et F H F OH H H XVH-11-8 CH 3 * H * Et F H F OH H H *RTand Rab joined together by (CH 2
)
3 to form five-membered ring.
Table XVII-12. X RI R2 R3a R3b R 4 R' R' X Y R' R' XVII-12-1 Et H H H Et F H F OH H H XVH-12-2 Et H H CH 3 Et F H F OH H H XVII-12-3 Et H H CH(CH 3
)
2 Et F H F OH H H XVI-12-4 Et H H CH 2
CH(CH
3
)
2 Et F H F OH H H XVH-12-5 Et H H CH 2 Ph Et F H F OH H H XVH-12-6 Et H H CH 2 -indol-3-yl Et F H F OH H H XVH-12-7 Et H H CH 2
CH
2
SCH
3 Et F H F OH H H XVII-12-8 Et * H * Et F H F OH H H RT and R.3b joined together by (CH 2
)
3 to form five-membered ring. Table XVII-13. X R' R2 R3a R3b R 4 R5 R' X Y R 7
R
8 XVII-13-1 'Pr H H H Et F H F OH H H XVII-13-2 'Pr H H CH 3 Et F H F OH H H XVII-13-3 'Pr H H CH(CH 3
)
2 Et F H F OH H H XVI-13-4 'r H H CH 2
CH(CH
3
)
2 Ft F H F OH H H XVII-13-5 'Pr H H CH 2 Ph Ft F H F OH H H XVII-13-6 'Pr H H CH 2 -indol-3-yI Et F H F OH H H XVII-13-7 'Pr H H CH 2
CH
2
SCH
3 Et F H F OH H H XVII-13-8 Pr * H * Et F H F OH H H *R2 and Rlb joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVII-14. X Rl R 2 Ria R3b R 4 R' R 6 X Y R 7 R' XV-14-1 'Bu H H H Et F H F OH H H XVII-14-2 'Bu H H CH 3 Et F H F OH H H XVII-14-3 'Bu H H CH(CH 3
)
2 Et F H F OH H H XVII-14-4 'Bu H H CH 2
CH(CH
3
)
2 Et F H F OH H H XVII-14-5 'Bu H H CH 2 Ph Et F H F OH H H XVH-14-6 'Bu H H CH2-indol-3-yl Et F H F OH H H XVII-14-7 'Bu H H CH 2
CH
2
SCH
3 Et F H F OH H H XVII-14-8 'Bu * H * Et F H F OH H H R7 and R3b joined together by (CH 2
)
3 to form five-membered ring. 04Q Table XVII-15. 2R R 2 RN Rab R 4 R' R 6 X Y R R XVII-15-1 Ph H H H Et F H F OH H H XVU-15-2 Ph H H CH 3 Et F H F OH H H XVII-15-3 Ph H H CH(CH 3
)
2 Et F H F OH H H XVII-15-4 Ph H H CH 2
CH(CH
3
)
2 Et F H F OH H H XVI-15-5 Ph H H CH 2 Ph Et F H F OH H H XVII-15-6 Ph H H CH2-indol-3-yl Et F H F OH H H XVII-15-7 Ph H H CH 2
CH
2
SCH
3 Et F H F OH H H XVI-15-8 Ph * H * Et F H F OH H H *R and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XVIl-16. N2 R R2 Ra Rb R 4 R R XY R 7
R
8 XVII-16-1 p-Me-Ph H H H Et F H F OH H H XVH-16-2 p-Me-Ph H H CH 3 Et F H F OH H H XVII-16-3 p-Me-Ph H H CH(CH 3
)
2 Et F H F OH H H XVH-16-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Et F H F OH H H XVII-16-5 p-Me-Ph H H CH 2 Ph Et F H F OH H H XVH-16-6 p-Me-Ph H H CH 2 -indol-3-yl Et F H F OH H H XVH-16-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Et F H F OH H H XVH- 16-8 p-Me-Ph * H * Et F H F OH H H
*R
2 and R-b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVII-17. N2 R R 2
R
3 a Rib R 4 R' R 6 X Y R 7 R' XVH-17-1 p-F-Ph H H H Et F H F OH H H XVII-17-2 p-F-Ph H H CH 3 Et F H F OH H H XVII-17-3 p-F-Ph H H CH(CH 3
)
2 Et F H F OH H H XVH-17-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Et F H F OH H H XVII-17-5 p-F-Ph H H CH 2 Ph Et F H F OH H H XVII-17-6 p-F-Ph H H CH 2 -indol-3-yl Et F H F OH H H XVH-17-7 p-F-Ph H H CH 2
CH
2
SCH
3 Et F H F OH H H XVII-17-8 p-F-Ph * H * Et F H F OH H H Rand R 36 joined together by (CH 2
)
3 to form five-membered ring. '0 '7 Table XVII-18. N - Rl R 2
R
3 a Rib R' R' R' X Y R 7
R
8 XVH-18-1 p-Cl-Ph H H H Et F H F OH H H XVH-18-2 p-Cl-Ph H H CH 3 Et F H F OH H H XVII-18-3 p-Cl-Ph H H CH(CH 3
)
2 Et F H F OH H H XVII-18-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Et F H F OH H H XVH-18-5 p-Cl-Ph H H CH 2 Ph Et F H F OH H H XVH-18-6 p-Cl-Ph H H CH 2 -indol-3-yi Et F H F OH H H XVH-18-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Et F H F OH H H XVII-18-8 p-Cl-Ph * H * Et F H F OH H H *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XVII-19. X2 R' R 2
R
3 a R 3 b R' R' R 6 X Y Ri R" XVII-19-1 p-Br-Ph H H H Et F H F OH H H XVII-19-2 p-Br-Ph H H CH 3 Et F H F OH H H XVII-19-3 p-Br-Ph H H CH(CH 3
)
2 Et F H F OH H H XVII-19-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Et F H F OH H H XVH-19-5 p-Br-Ph H H CH 2 Ph Et F H F OH H H XVH-19-6 p-Br-Ph H H CH 2 -indol-3-yl Et F H F OH H H XVII-19-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Et F H F OH H H XVII-19-8 p-Br-Ph * H * Et F H F OH H H
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVII-20. N R' R2 R 3 a Rab R 4 R' R' X Y R' R' XVII-20-1 p-I-Ph H H H Et F H F OH H H XVH-20-2 p-I-Ph H H CH 3 Et F H F OH H H XVII-20-3 p-I-Ph H H CH(CH 3
)
2 Et F H F OH H H XVH-20-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Et F H F OH H H XVII-20-5 p-I-Ph H H CH 2 Ph Et F H F OH H H XVII-20-6 p-I-Ph H H CH 2 -indol-3-yl Et F H F OH H H XVII-20-7 p-I-Ph H H CH 2
CH
2
SCH
3 Et F H F OH H H XVII-20-8 p-I-Ph * H * Et F H F OH H H *RTand R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XVII-21. X2 R' R2 R 3 a R 3 b R 4 R' R' X Y R' R' XVH-21-1 CH 3 H H H 'Pr F H F OH H H XVH-21-2 CH 3 H H CH 3 'Pr F H F OH H H XVII-21-3 CH 3 H H CH(CH 3 )2 'Pr F H F OH H H XVII-21-4 CH 3 H H CH2CH(CH 3
)
2 'Pr F H F OH H H XVII-21-5 CH 3 H H CH 2 Ph 'Pr F H F OH H H XVH-21-6 CH 3 H H CH 2 -indol-3-yl Pr F H F OH H H XVII-21-7 CH 3 H H CH 2
CH
2
SCH
3 'Pr F H F OH H H XVII-21-8 CH 3 * H * 'Pr F H F OH H H *R and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XVII-22. N2 R' R 2
R
3 a" R 3 b R' R' R 6 X Y R' R 8 XVH-22-1 Et H H H 'Pr F H F OH H H XVII-22-2 Et H H CH 3 'Pr F H F OH H H XVII-22-3 Et H H CH(CH 3
)
2 'Pr F H F OH H H XVII-22-4 Et H H CH 2
CH(CH
3
)
2 'Pr F H F OH H H XVH-22-5 Et H H CH 2 Ph 'Pr F H F OH H H XVII-22-6 Et H H CH 2 -indol-3-yl 'Pr F H F OH H H XVII-22-7 Et H H CH 2
CH
2
SCH
3 'Pr F H F OH H H XVH-22-8 Et * H * 'Pr F H F OH H H R and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVII-23. N2 R R2 R 3 a R 3 b R 4 R' R 6 X Y R 7
R
8 XVII-23-1 Pr H H H 'Pr F H F OH H H XVH-23-2 'Pr H H CH 3 'Pr F H F OH H H XVII-23-3 Pr H H CH(CH 3
)
2 'Pr F H F OH H H XVII-23-4 'Pr H H CH2CH(CH 3
)
2 'Pr F H F OH H H XVII-23-5 'Pr H H CH 2 Ph 'Pr F H F OH H H XVH-23-6 'Pr H H CH 2 -indol-3-yl 'Pr F H F OH H H XVII-23-7 'Pr H H CH 2
CH
2
SCH
3 'Pr F H F OH H H XVII-23-8 Pr * H * 'Pr F H F OH H H R7 and Rib joined together by (CH 2
)
3 to form five-membered ring.
Table XVII-24. M R' R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7
R
8 XVII-24-1 'Bu H H H Pr F H F OH H H XVH-24-2 'Bu H H CH 3 Pr F H F OH H H XVII-24-3 'Bu H H CH(CH 3
)
2 'Pr F H F OH H H XVH-24-4 'Bu H H CH 2
CH(CH
3
)
2 'Pr F H F OH H H XVII-24-5 'Bu H H CH 2 Ph Pr F H F OH H H XVII-24-6 'Bu H H CH 2 -indol-3-yl 'Pr F H F OH H H XVII-24-7 'Bu H H CH 2
CH
2
SCH
3 Pr F H F OH H H XVII-24-8 'Bu * H * Pr F H F OH H H *Ra R joined together by (CH 2
)
3 to form five-membered ring. Table XVII-25. 2 RI R 2 R3a R A R4 R' R 6 X Y R7 R 8 XVH-25-1 Ph H H H 'Pr F H F OH H H XVH-25-2 Ph H H CH 3 'Pr F H F OH H H XVII-25-3 Ph H H CH(CH 3
)
2 'Pr F H F OH H H XVH-25-4 Ph H H CH 2
CH(CH
3
)
2 'Pr F H F OH H H XVII-25-5 Ph H H CH 2 Ph 'Pr F H F OH H H XVH-25-6 Ph H H CH 2 -indol-3-yl 'Pr F H F OH H H XVII-25-7 Ph H H CH 2
CH
2
SCH
3 'Pr F H F OH H H XVH-25-8 Ph * H * 'Pr F H F OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVII-26. 2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y R 7
R
8 XVH-26-1 p-Me-Ph H H H 'Pr F H F OH H H XVH-26-2 p-Me-Ph H H CH 3 'Pr F H F OH H H XVII-26-3 p-Me-Ph H H CH(CH 3
)
2 'Pr F H F OH H H XVH-26-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 'Pr F H F OH H H XVII-26-5 p-Me-Ph H H CH 2 Ph 'Pr F H F OH H H XVI-26-6 p-Me-Ph H H CH 2 -indol-3-yl 'Pr F H F OH H H XVTI-26-7 p-Me-Ph H H CH 2
CH
2
SCH
3 'Pr F H F OH H H XVH-26-8 p-Me-Ph * H * 'Pr F H F OH H H *R and R-t joined together by (CH 2
)
3 to form five-membered ring.
Table XVII-27. Xe R R 2 R " R b R' R' R 6 X Y R 7 RI XVH-27-1 p-F-Ph H H H 'Pr F H F OH H H XVII-27-2 p-F-Ph H H CH 3 'Pr F H F OH H H XVH-27-3 p-F-Ph H H CH(CH 3
)
2 'Pr F H F OH H H XVH-27-4 p-F-Ph H H CH 2
CH(CH
3
)
2 'Pr F H F OH H H XVII-27-5 p-F-Ph H H CH 2 Ph 'Pr F H F OH H H XVH-27-6 p-F-Ph H H CH 2 -indol-3-yl 'Pr F H F OH H H XVII-27-7 p-F-Ph H H CH 2
CH
2
SCH
3 'Pr F H F OH H H XVII-27-8 p-F-Ph * H * 'Pr F H F OH H H
*R
2 and R-b joined together by (CH 2
)
3 to form five-membered ring. Table XVII-28. Xe R R 2
R
3 Rib R 4 R R( X Y R 7
R
8 XVII-28-1 p-Cl-Ph H H H 'Pr F H F OH H H XVII-28-2 p-Cl-Ph H H CH 3 'Pr F H F OH H H1 XVII-28-3 p-Cl-Ph H H CH(CH 3
)
2 'Pr F H F OH H H XVH-28-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 'Pr F H F OH H H XVH-28-5 p-Cl-Ph H H CH 2 Ph 'Pr F H F OH H H XVH-28-6 p-Cl-Ph H H CH 2 -indol-3-yl 'Pr F H F OH H H XVII-28-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 'Pr F H F OH H H XVII-28-8 p-Cl-Ph * H * 'Pr F H F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVII-29. X R' R 2
R
3 a Rb R' R' R' X Y R 7
R
8 XVII-29-1 p-Br-Ph H H H 'Pr F H F OH H H XVII-29-2 p-Br-Ph H H CH 3 'Pr F H F OH H H XVII-29-3 p-Br-Ph H H CH(CH 3
)
2 'Pr F H F OH H H XVII-29-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 'Pr F H F OH H H XVII-29-5 p-Br-Ph H H CH 2 Ph 'Pr F H F OH H H XVII-29-6 p-Br-Ph H H CH 2 -indol-3-yl 'Pr F H F OH H H XVII-29-7 p-Br-Ph H H CH 2
CH
2
SCH
3 'Pr F H F OH H H XVII-29-8 p-Br-Ph * H * 'Pr F H F OH H H *RT2and R3 joined together by (CH 2
)
3 to form five-membered ring. 201 Table XVII-30. N2 R' R2 R 3 a R 3 b R 4 R' R' X Y R 7
R
8 XVII-30-1 p-I-Ph H H l 'Pr F H F OH H H XVII-30-2 p-I-Ph H H CH 3 'Pr F H F OH H H XVII-30-3 p-I-Ph H H CH(CH 3
)
2 'Pr F H F OH H H XVII-30-4 p-I-Ph H H CH 2
CH(CH
3
)
2 'Pr F H F OH H H XVI-30-5 p-I-Ph H H CH 2 Ph 'Pr F H F OH H H XVII-30-6 p-I-Ph H H CH 2 -indol-3-yl 'Pr F H F OH H H XVII-30-7 p-I-Ph H H CH 2
CH
2
SCH
3 'Pr F H F OH H H XVII-30-8 p-I-Ph * H * 'Pr F H F OH H H R2 and Rb joined together by (CH 2
)
3 to form five-membered ring. Table XVII-3 1. N2 R' R2 R 3 a Rb R 4 R' R 6 X Y R' R' XVH-31-1 CH 3 H H H "Bu F H F OH H H XVII-31-2 CH- 3 H H CH 3 "Bu F H F OH H H XVII-31-3 CH 3 H H CH(CH 3
)
2 "Bu F H F OH H H XVII-31-4 CH 3 H H CH 2
CH(CH
3
)
2 "Bu F H F OH H H XVII-31-5 CH 3 H H CH 2 Ph "Bu F H F OH H H XVH-31-6 CH 3 H H CH 2 -indol-3-yl "Bu F H F OH H H XVH-31-7 CH 3 H H CH 2
CH
2
SCH
3 "Bu F H F OH H H XVH-31-8 CH 3 * H * "Bu F H F OH H H R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVII-32. 2 RI R 2
R
3 a R 3 b R4 R' R 6 X Y R 7
R
8 XVII-32-1 Et H H H "Bu F H F OH H H XVII-32-2 Et H H CH 3 "Bu F H F OH H H XVII-32-3 Et H H CH(CH 3
)
2 "Bu F H F OH H H XVII-32-4 Et H H CH 2
CH(CH
3
)
2 "Bu F H F OH H H XVII-32-5 Et H H CH 2 Ph "Bu F H F OH H H XVII-32-6 Et H H CH 2 -indol-3-yl "Bu F H F OH H H XVII-32-7 Et H H CH 2
CH
2
SCH
3 "Bu F H F OH H H XVI-32-8 Et * H * "Bu F H F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. In'-) Table XVII-33. N2 R' R 2 R3a R3b R 4 R' R 6 X Y R' R' XVI-33-1 'Pr H H H "Bu F H F OH H H XVH-33-2 'Pr H H CH 3 "Bu F H F OH H H XVII-33-3 'Pr H H CH(CH 3
)
2 "Bu F H F OH H H XVII-33-4 'Pr H H CH 2
CH(CH
3
)
2 "Bu F H F OH H H XVII-33-5 'Pr H H CH 2 Ph "Bu F H F OH H H XVU-33-6 'Pr H H CH2-indol-3-yl "Bu F H F OH H H XVU-33-7 'Pr H H CH 2
CH
2
SCH
3 "Bu F H F OH H H XVII-33-8 'Pr * H * "Bu F H F OH H H *RT and R b joined together by (CH 2
)
3 to form five-membered ring. Table XVII-34. N2 Rl R2 R3a R 3 b R 4 R' R' XY R 7 R XVII-34-1 'Bu H H H "Bu F H F OH H H XVII-34-2 'Bu H H CH 3 'Bu F H F OH H H XVII-34-3 'Bu H H CH(CH 3
)
2 "Bu F H F OH H H XVII-34-4 'Bu H H CH 2
CH(CH
3
)
2 "Bu F H F OH H H XVII-34-5 'Bu H H CH 2 Ph "Bu F H F OH H H XVII-34-6 'Bu H H CH 2 -indol-3-yl nBu F H F OH H H XVU-34-7 'Bu H H CH 2
CH
2
SCH
3 "Bu F H F OH H H XVU-34-8 'Bu * H * "Bu F H F OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVII-35. X2 R' R2 R3a R3b R 4 R' R' X Y R 7
R
8 XVE-35-1 Ph H H H "Bu F H F OH H H XVH-35-2 Ph H H CH 3 "Bu F H F OH H H XVH-35-3 Ph H H CH(CH 3
)
2 "Bu F H F OH H H XVII-35-4 Ph H H CH 2
CH(CH
3
)
2 "Bu F H F OH H H XVII-35-5 Ph H H CH 2 Ph "Bu F H F OH H H XVII-35-6 Ph H H CH 2 -indol-3-yl "Bu F H F OH H H XVH-35-7 Ph H H CH 2
CH
2
SCH
3 "Bu F H F OH H H XVII-35-8 Ph * H * "Bu F H F OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 11 W Table XVII-36. N2 Ri R 2 Rja Rb R 4 R' R X Y R R XVII-36-1 p-Me-Ph H H H "Bu F H F OH H H XVH-36-2 p-Me-Ph H H CH 3 "Bu F H F OH H H XVH-36-3 p-Me-Ph H H CH(CH 3
)
2 "Bu F H F OH H H XVH-36-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 "Bu F H F OH H H XVH-36-5 p-Me-Ph H H CH 2 Ph "Bu F H F OH H H XVII-36-6 p-Me-Ph H H CH 2 -indol-3-yl "Bu F H F OH H H XVII-36-7 p-Me-Ph H H CH 2
CH
2
SCH
3 "Bu F H F OH H H XVII-36-8 p-Me-Ph * H * "Bu F H F OH H H R Tand R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XVII-37. N2 R R 2
R
3 a R 3 b R 4 R' R 6 X Y R7 R 8 XVH-37-1 p-F-Ph H H H "Bu F H F OH H H XVII-37-2 p-F-Ph H H CH 3 "Bu F H F OH H H XVI-37-3 p-F-Ph H H CH(CH 3
)
2 "Bu F H F OH H H XVII-37-4 p-F-Ph H H CH 2
CH(CH
3
)
2 "Bu F H F OH H H XVH-37-5 p-F-Ph H H CH 2 Ph "Bu F H F OH H H XVH-37-6 p-F-Ph H H CH 2 -indol-3-yl "Bu F H F OH H H XVI-37-7 p-F-Ph H H CH 2
CH
2
SCH
3 "Bu F H F OH H H XVI-37-8 p-F-Ph * H * "Bu F H F OH H H *R2 and R 3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVII-38. N2 Rl R 2 Ra R 3 b R 4 R' R' X Y R 7
R
8 XVH-38-1 p-Cl-Ph H H H "Bu F H F OH H H XVH-38-2 p-Cl-Ph H H CH 3 "Bu F H F OH H H XVII-38-3 p-Cl-Ph H H CH(CH 3
)
2 "Bu F H F OH H H XVII-38-4 p-Cl-Ph H H CH 2 CH(CH3) 2 "Bu F H F OH H H XVII-38-5 p-Cl-Ph H H CH 2 Ph "Bu F H F OH H H XVII-38-6 p-Cl-Ph H H CH 2 -indol-3-yl "Bu F H F OH H H XVII-38-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 "Bu F H F OH H H XVII-38-8 p-Cl-Ph * H * "Bu F H F OH H H *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 20,1 Table XVII-39. N2 R R 2 RaR 3 b R 4 R' R' X Y R R 8 XVH-39-1 p-Br-Ph H H H "Bu F H F OH H H XVH-39-2 p-Br-Ph H H CH 3 "Bu F H F OH H H XVH-39-3 p-Br-Ph H H CH(CH 3 )2 "Bu F H F OH H H XVII-39-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 "Bu F H F OH H H XVII-39-5 p-Br-Ph H H CH 2 Ph "Bu F H F OH H H XVII-39-6 p-Br-Ph H H CH 2 -indol-3-yl "Bu F H F OH H H XVII-39-7 p-Br-Ph H H CH 2
CH
2
SCH
3 "Bu F H F OH H H XVII-39-8 p-Br-Ph * H * "Bu F H F OH H H R7 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XVII-40. X2 R' R 2
R
3 a Rab R 4 R' R6 X Y R 7 R 8 XVH-40-1 p-I-Ph H H H "Bu F H F OH H H XVH-40-2 p-I-Ph H H CH 3 "Bu F H F OH H H XVII-40-3 p-I-Ph H H CH(CH 3
)
2 "Bu F H F OH H H XVH-40-4 p-I-Ph H H CH 2
CH(CH
3
)
2 "Bu F H F OH H H XVH-40-5 p-I-Ph H H CH 2 Ph "Bu F H F OH H H XVH-40-6 p-I-Ph H H CH 2 -indol-3-yl "Bu F H F OH H H XVH-40-7 p-I-Ph H H CH 2
CH
2
SCH
3 "Bu F H F OH H H XVII-40-8 p-I-Ph * H * "Bu F H F OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVII-4 1. N2 RI R R 3 a R R 4 R' R' X Y R' R' XVII-41-1 CH 3 H H H Bz F H F OH H H XVII-41-2 CH 3 H H CH 3 Bz F H F OH H H XVH-41-3 CH 3 H H CH(CH 3
)
2 Bz F H F OH H H XVH-41-4 CH 3 H H CH 2
CH(CH
3 )2 Bz F H F OH H H XVII-41-5 CH 3 H H CH 2 Ph Bz F H F OH H H XVII-41-6 CH 3 H H CH 2 -indol-3-yl Bz F H F OH H H XVH-41-7 CH 3 H H CH 2
CH
2
SCH
3 Bz F H F OH H H XVII-41-8 CH 3 * H * Bz F H F OH H H *R2 and R- joined together by (CH 2
)
3 to form five-membered ring.
Table XVII-42. Xel ' R2 R3a R b R 4 RI R' X Y R' R' XVII-42-1 Et H H H Bz F H F OH H H XVII-42-2 Et H H CH 3 Bz F H F OH H H XVH-42-3 Et H H CH(CH 3
)
2 Bz F H F OH H H XVH-42-4 Et H H CH 2
CH(CH
3
)
2 Bz F H F OH H H XVII-42-5 Et H H CH 2 Ph Bz F H F OH H H XVH-42-6 Et H H CH 2 -indol-3-yl Bz F H F OH H H XVH-42-7 Et H H CH 2
CH
2
SCH
3 Bz F H F OH H H XVH-42-8 Et * H * Bz F H F OH H H *R and R 3b joined together by (CH 2
)
3 to form five-membered ring. Table XVII-43. X R' R 2 R 3a R 3b R 4 R' R 6 X Y R7 Rs XVH-43-1 'Pr H H H Bz F H F OH H H XVII-43-2 'Pr H H CH 3 Bz F H F OH H XVII-43-3 'Pr H H CH(CH 3
)
2 Bz F H F OH H H XVH-43-4 'Pr H H CH 2
CH(CH
3
)
2 Bz F H F OH H H XVH-43-5 'Pr H H CH 2 Ph Bz F H F OH H H XVII-43-6 'Pr H H CH 2 -indol-3-yl Bz F H F OH H H XVH-43-7 'Pr H H CH 2
CH
2
SCH
3 Bz F H F OH H H XVII-43-8 'Pr * H * Bz F H F OH H H 10 *R 2 and R 3b joined together by (CH 2
)
3 to form five-membered ring. Table XVII-44. Xe R R 2 R3a RA3b R 4 R' R 6 X Y R' R' XVII-44-1 'Bu H H H Bz F H F OH H H XVII-44-2 'Bu H H CH 3 Bz F H F OH H H XVII-44-3 'Bu H H CH(CH 3
)
2 Bz F H F OH H H XVH-44-4 'Bu H H CH 2
CH(CH
3
)
2 Bz F H F OH H H XVH-44-5 'Bu H H CH 2 Ph Bz F H F OH H H XVH-44-6 'Bu H H CH 2 -indol-3-yl Bz F H F OH H H XVII-44-7 'Bu H H CH 2
CH
2
SCH
3 Bz F H F OH H H XVII-44-8 'Bu * H * Bz F H F OH H H *Rand R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XVII-45. X R R2 R3a R 3 b R 4 R' R6 X Y R 7 R 8 XVH-45-1 Ph H H H Bz F H F OH H H XVII-45-2 Ph H H CH 3 Bz F H F OH H H XVI-45-3 Ph H H CH(CH 3
)
2 Bz F H F OH H H XVII-45-4 Ph H H CH 2
CH(CH
3
)
2 Bz F H F OH H H XVH-45-5 Ph H H CH 2 Ph Bz F H F OH H H XVH-45-6 Ph H H CH 2 -indol-3-yl Bz F H F OH H H XVH-45-7 Ph H H CH 2
CH
2
SCH
3 Bz F H F OH H H XVH-45-8 Ph * H * Bz F H F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XVII-46. X R' R 2 R3a R 3 b R 4 R' R 6 X Y R' R' XVH-46-1 p-Me-Ph H H H Bz F H F OH H H XVII-46-2 p-Me-Ph H H CH 3 Bz F H F OH H H XVII-46-3 p-Me-Ph H H CH(CH 3
)
2 Bz F H F OH H H XVII-46-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Bz F H F OH H H XVH-46-5 p-Me-Ph H H CH 2 Ph Bz F H F OH H H XVH-46-6 p-Me-Ph H H CH 2 -indol-3-yl Bz F H F OH H H XVII-46-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Bz F H F OH H H XVII-46-8 p-Me-Ph * H * Bz F H F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVII-47. X2 R R2 R 3 a R 3 b R 4 R' R 6 X Y R 7 R XVII-47-1 p-F-Ph H H H Bz F H F OH H H XVH-47-2 p-F-Ph H H CH 3 Bz F H F OH H H XVH-47-3 p-F-Ph H H CH(CH 3
)
2 Bz F H F OH H H XVII-47-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Bz F H F OH H H XVH-47-5 p-F-Ph H H CH 2 Ph Bz F H F OH H H XVII-47-6 p-F-Ph H H CH 2 -indol-3-yl Bz F H F OH H H XVII-47-7 p-F-Ph H H CH 2
CH
2
SCH
3 Bz F H F OH H H XVII-47-8 p-F-Ph * H * Bz F H F OH H H *RT and R3 joined together by (CH 2
)
3 to form five-membered ring. I WY7 Table XVII-48. N2 Rt R 2 R3a R 3 b R4 R' R 6 X Y R 7
R
8 XVII-48-1 p-Cl-Ph H H H Bz F H F OH H H XVII-48-2 p-Cl-Ph H H CH 3 Bz F H F OH H H XVII-48-3 p-Cl-Ph H H CH(CH 3
)
2 Bz F H F OH H H XVH-48-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Bz F H F OH H H XVII-48-5 p-Cl-Ph H H CH 2 Ph Bz F H F OH H H XVI-48-6 p-Cl-Ph H H CH 2 -indol-3-yl Bz F H F OH H H XVI-48-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Bz F H F OH H H XVII-48-8 p-Cl-Ph * H * Bz F H F OH H H
*R
2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XVII-49. N2 Rl R 2
R
3 a Rb R' R' R' X Y R 7 R' XVII-49-1 p-Br-Ph H H H Bz F H F OH H H XVII-49-2 p-Br-Ph H H CH 3 Bz F H F OH H H XVH-49-3 p-Br-Ph H H CH(CH 3
)
2 Bz F H F OH H H XVII-49-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Bz F H F OH H H XVI-49-5 p-Br-Ph H H CH 2 Ph Bz F H F OH H H XVII-49-6 p-Br-Ph H H CH 2 -indol-3-yl Bz F H F OH H H XVII-49-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Bz F H F OH H H XVII-49-8 p-Br-Ph * H * Bz F H F OH H H *R" and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVII-50. N2 R R RV" Rb R 4 R R' X Y RR XVII-50-1 p-I-Ph H H H Bz F H F OH H H XVII-50-2 p-I-Ph H H CH 3 Bz F H F OH H H XVII-50-3 p-I-Ph H H CH(CH 3
)
2 Bz F H F OH H H XVI-50-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Bz F H F OH H H XVII-50-5 p-I-Ph H H CH 2 Ph Bz F H F OH H H XVII-50-6 p-I-Ph H H CH 2 -indol-3-yl Bz F H F OH H H XVII-50-7 p-I-Ph H H CH 2
CH
2
SCH
3 Bz F H F OH H H XVH-50-8 p-I-Ph * H * Bz F H F OH H H R and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
0 R 8 NH R3b 2 R7 NO 0P R N' 0 R3a N -- P - O C0 2
R
4 OR' R
R
6 Y x XVIII Table XVIII-1. N2 R' R 2
R
3 " Rab R 4
R
3
R
6 X Y R R XVIII-1-1 CH 3 H H H CH 3
OCH
3 F H OH H H XVHI-1-2 CH 3 H H CH 3
CH
3
OCH
3 F H OH H H XVI-1-3 CH 3 H H CH(CH 3
)
2
CH
3
OCH
3 F H OH H H XVIII-1-4 CH 3 H H CH 2
CH(CH
3
)
2
CH
3
OCH
3 F H OH H H XVIl-1-5 CH 3 H H CH 2 Ph CH 3
OCH
3 F H OH H H XVIII-1-6 CH 3 H H CH 2 -indol-3-yi CH 3
OCH
3 F H OH H H XVIII-1-7 CH 3 H H CH 2
CH
2
SCH
3
CH
3
OCH
3 F H OH H H XVII-1-8 CH 3 * H * CH 3
OCH
3 F H OH H H *R2and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVIII-2. N2 RI R 2
R
3 a R 3 b R 4 R5 R 6 X Y R' R' XVIU-2-1 Et H H H CH 3
OCH
3 F H OH H H XVIII-2-2 Et H H CH 3
CH
3
OCH
3 F H OH H H XVIH-2-3 Et H H CH(CH 3
)
2
CH
3
OCH
3 F H OH H H XVHI-2-4 Et H H CH 2
CH(CH
3
)
2
CH
3
OCH
3 F H OH H H XVI-2-5 Et H H CH 2 Ph CH 3
OCH
3 F H OH H H XVIII-2-6 Et H H CH 2 -indol-3-yl CH 3
OCH
3 F H OH H H XVIII-2-7 Et H H CH 2 CI2SCH 3
CH
3
OCH
3 F H OH H H XVIII-2-8 Et * H * CH 3
OCH
3 F H OH H H *RT and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XVIII-3. N2 R' R2 R 3 a R 3 b R 4 R 5 R' X Y R 7
R
8 XVII-3-1 'Pr H H H CH 3
OCH
3 F H OH H H XVHI-3-2 'Pr H H CH 3
CH
3
OCH
3 F H OH H H XVIII-3-3 'Pr H H CH(CH 3
)
2
CH
3
OCH
3 F H OH H H XVM-3-4 'Pr H H CH 2
CH(CH
3
)
2
CH
3
OCH
3 F H OH H H XVIII-3-5 'Pr H H CH 2 Ph CH 3
OCH
3 F H OH H H XVIII-3-6 'Pr H H CH 2 -indol-3-yl CH 3
OCH
3 F H OH H H XVm-3-7 'Pr H H CH 2 CH2SCH 3
CH
3
OCH
3 F H OH H H XVIII-3-8 'Pr * H * CH 3
OCH
3 F H OH H H
*R
2 and Rab joined together by (CH 2
)
3 to form five-membered ring. Table XVIII-4. N2 R R 2
R
3 a R 3 b R 4 R' R 6 X Y R'R XVIII-4-1 'Bu H H H CH 3
OCH
3 F H OH H H XVIII-4-2 'Bu H H CH3 CH 3
OCH
3 F H OH H H XVIII-4-3 'Bu H H CH(CH 3
)
2
CH
3
OCH
3 F H OH H H XVIII-4-4 'Bu H H CH 2
CH(CH
3
)
2
CH
3
OCH
3 F H OH H H XVIII-4-5 'Bu H H CH 2 Ph CH 3
OCH
3 F H OH H H XVI-4-6 'Bu H H CH 2 -indol-3-yl CH 3
OCH
3 F H OH H H XVIII-4-7 'Bu H H CH 2
CH
2
SCH
3
CH
3
OCH
3 F H OH H H XVIII-4-8 'Bu * H * CH 3
OCH
3 F H OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVIII-5. N2 R' R 2
R
3 aR 3 b R 4
R
5
R
6 XY R7 R 8 XVII-5-1 Ph H H H CH 3
OCH
3 F H OH H H XVIII-5-2 Ph H H CH 3
CH
3
OCH
3 F H OH H H XVIII-5-3 Ph H H CH(CH 3
)
2
CH
3
OCH
3 F H OH H H XVIII-5-4 Ph H H CH 2
CH(CH
3
)
2
CH
3
OCH
3 F H OH H H XVIII-5-5 Ph H H CH 2 Ph CH 3
OCH
3 F H OH H H XVHI-5-6 Ph H H CH 2 -indol-3-yl CH 3
OCH
3 F H OH H H XVIII-5-7 Ph H H CH 2
CH
2
SCH
3
CH
3
OCH
3 F H OH H H XVIII-5-8 Ph * H * CH 3
OCH
3 F H OH H H *R7 and R 3 o joined together by (CH 2
)
3 to form five-membered ring. A AAt Table XVIII-6. Xe R R 2 R R R 4
R
5
R
6 XY R7 R XVIII-6- p-Me- H H H CH 3
OCH
3 F H OH H H Ph XVIII-6- p-Me- H H CH 3
CH
3
OCH
3 F H OH H H 2 Ph XVm-6- p-Me- H H CH(CH 3
)
2
CH
3
OCH
3 F H OH H H 3 Ph XVIII-6- p-Me- H H CH2CH(CH 3 )2 CH 3
OCH
3 F H OH H H 4 Ph XVIII-6- p-Me- H H CH 2 Ph CH 3
OCH
3 F H OH H H 5 Ph XVIII-6- p-Me- H H CH 2 -indol-3- CH 3
OCH
3 F H OH H H 6 Ph yl XVIII-6- p-Me- H H CH 2
CH
2
SCH
3
CH
3
OCH
3 F H OH H H 7 Ph XVI-6- p-Me- * H * CH 3
OCH
3 F H OH H H 8 Ph *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XVIII-7. Xe R R 2 Ra Rb R 4 R R XY R R XVM-7-1 p-F- H H H CH 3
OCH
3 F H OH H H Ph XVI-7-2 p-F- H H CH 3
CH
3
OCH
3 F H OH H H Ph XVM-7-3 p-F- H H CH(CH 3
)
2
CH
3
OCH
3 F H OH H H Ph XVIII-7-4 p-F- H H CH 2
CH(CH
3
)
2
CH
3
OCH
3 F H OH H H Ph XVIII-7-6 p-F- H H CH 2 Ph CH 3
OCH
3 F H OH H H Ph XVM-7-7 p-F- H H CH 2 -indol-3- CH 3
OCH
3 F H OH H H Ph XVIII-7-8 p-F- H H CH 2
CH
2
SCH
3
CH
3
OCH
3 F H OH H H Ph XVMII-7- p-F- * H * CH 3
OCH
3 F H OH H H 20 Ph *R R 3 joined together by (CH 2
)
3 to form five-membered ring. 5 AA1 Table XVIII-8. S R R 2
R
3 a R 3 b R' R' RXY R' R' XVII-8- p-Cl- H H H CH 3
OCH
3 F H OH H H 1 Ph XVIII-8- p-Cl- H H CH 3
CH
3
OCH
3 F H OH H H 2 Ph XVIII-8- p-Cl- H H CH(CH 3
)
2
CH
3
OCH
3 F H OH H H 3 Ph XVII-8- p-Cl- H H CH 2
CH(CH
3
)
2
CH
3
OCH
3 F H OH H H 4 Ph XVIH-8- p-Cl- H H CH 2 Ph CH 3
OCH
3 F H OH H H 5 Ph XVIII-8- p-Cl- H H CH 2 -indol-3- CH 3
OCH
3 F H OH H H 6 Ph XVIII-8- p-Cl- H H CH 2
CH
2
SCH
3
CH
3
OCH
3 F H OH H H 7 Ph XVIII-8- p-Cl- * H * CH 3
OCH
3 F H OH H H 8 Ph
*R
2 and R 3 l joined together by (CH 2
)
3 to form five-membered ring. Table XVIII-9. S R R 2 RaR 3 b R 4 R' R' X Y R' R XVIII-9- p-Br- H H H CH 3
OCH
3 F H OH H H 1 Ph XVHI-9- p-Br- H H CH 3
CH
3
OCH
3 F H OH H H 2 Ph XVIH-9- p-Br- H H CH(CH 3
)
2
CH
3
OCH
3 F H OH H H 3Ph XVIII-9- p-Br- H H CH 2
CH(CH
3
)
2
CH
3
OCH
3 F H OH H H 4 Ph XVHI-9- p-Br- H H CH 2 Ph CH 3
OCH
3 F H OH H H 6 Ph XVIH-9- p-Br- H H CH 2 -indol-3- CH 3
OCH
3 F H OH H H 7 Ph YI XVIII-9- p-Br- H H CH 2
CH
2
SCH
3
CH
3
OCH
3 F H OH H H 8 Ph XVHI-9- p-Br- * H * CH 3
OCH
3 F H OH H H A W) X R R 2 R3a R 3 b R 4
R
5 R' X Y R' R' 20 Ph *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table.XVIII-10. Ne R R 2
R
3 a R 3 b R 4
R
5 R' X Y R 3
R
8 XVII-10- p-I- H H H CH 3
OCH
3 F H OH H H 1 Ph XVII-10- p-I- H H CH 3
CH
3
OCH
3 F H OH H H 2 Ph XVIII-10- p-I- H H CH(CH 3
)
2
CH
3
OCH
3 F H OH H H 3 Ph XVIH-10- p-I- H H CH 2
CH(CH
3
)
2
CH
3
OCH
3 F H OH H H 4 Ph XVIII-10- p-I- H H CH 2 Ph CH 3
OCH
3 F H OH H H 5 Ph XVII-10- p-I- H H CH 2 -indol-3- CH 3
OCH
3 F H OH H H 6 Ph XVIII-10- p-I- H H CH 2
CH
2
SCH
3
CH
3
OCH
3 F H OH H H 7 Ph XVIII-10- p-I- * H * CH 3
OCH
3 F H OH H H 8 Ph *R2 and Rb joined together by (CH 2
)
3 to form five-membered ring. Table XVIII-11. X R' R2 R 3 a R 3 b R4 R 5 R' X Y R 7
R
8 XVIII-11-1 CH 3 H H H Et OCH 3 F H OH H H XVIII-11-2 CH 3 H H CH 3 Et OCH 3 F H OH H H XVIII-11-3 CH 3 H H CH(CH 3
)
2 Et OCH 3 F H OH H H XVIH-11-4 CH 3 H H CH 2
CH(CH
3
)
2 Et OCH 3 F H OH H H XVmI-11-5 CH 3 H H CH2Ph Et OCH 3 F H OH H H XVIII-11-6 CH 3 H H CH 2 -indol-3-yl Et OCH 3 F H OH H H XVII-11-7 CH 3 H H CH2CH 2
SCH
3 Et OCH 3 F H OH H H XVIII-11-8 CH 3 * H * Et OCH 3 F H OH H H 5 *R and. R3b joined together by (CH 2
)
3 to form five-membered ring. A Al2 Table XVIII-12. M RI R 2
R
3 a R 3 b R4 R 5 R' X Y R' R" XVHI-12-1 Et H H H Et OCH 3 F H OH H H XVI-12-2 Et H H CH 3 Et OCH 3 F H OH H H XVHI-12-3 Et H H CH(CH 3
)
2 Et OCH 3 F H OH H H XVI-12-4 Et H H CH 2
CH(CH
3
)
2 Et OCH 3 F H OH H H XVIII-12-5 Et H H CH 2 Ph Et OCH 3 F H OH H H XVIH-12-6 Et H H CH 2 -indol-3-yl Et OCH 3 F H OH H H XVHI-12-7 Et H H CH 2
CH
2
SCH
3 Et OCH 3 F H OH H H XVHI-12-8 Et * H * Et OCH 3 F H OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XVIII-13. 2 R' R 2 R3a R 3 b R 4 R' R 6 X Y R 7
R
8 XVHI-13-1 Pr H H H Et OCH 3 F H OH H H XVHI-13-2 'Pr H H CH 3 Et OCH 3 F H OH H H XVIH-13-3 'Pr H H CH(CH 3
)
2 Et OCH 3 F H OH H H XVIHf-13-4 'Pr H H CHCH(CH 3
)
2 Et OCH 3 F H OH H H XVIII-13-5 'Pr H H CH 2 Ph Et OCH 3 F H OH H H XVIH-13-6 'Pr H H CH 2 -indol-3-yl Et OCH 3 F H OH H H XVIII-13-7 'Pr H H CH 2
CH
2
SCH
3 Et OCH 3 F H OH H H XVIII-13-8 'Pr * H * Et OCH 3 F H OH H H *R2 and R joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVIII-14. X Rl R R 3 a R 3 b R 4 R 5 R' X Y R' R' 2 XVHI-14-1 'Bu H H H Et OCH 3 F H OH H H XVIH-14-2 'Bu H H CH 3 Et OCH 3 F H OH H H XVIII-14-3 'Bu H H CH(CH 3
)
2 Et OCH 3 F H OH H H XVHI-14-4 'Bu H H CH 2
CH(CH
3
)
2 Et OCH 3 F H OH H H XVHI-14-5 'Bu H H CH 2 Ph Et OCH 3 F H OH H H XVIH-14-6 'Bu H H CH 2 -indol-3-yl Et OCH 3 F H OH H H XVI-14-7 'Bu H H CH 2
CH
2
SCH
3 Et OCH 3 F H OH H H XVIH-14-8 'Bu * H * Et OCH 3 F H OH H H *R and R joined together by (CH 2
)
3 to form five-membered ring. A A A Table XVIII-15. RI R 2
R
3 a R 3 b R 4 R R XY R R XVIII-15-1 Ph H H H Et OCH 3 F H OH H H XVHI-15-2 Ph H H CH 3 Et OCH 3 F H OH H H XVIII-15-3 Ph H H CH(CH 3
)
2 Et OCH 3 F H OH H H XVHI-15-4 Ph H H CH 2
CH(CH
3
)
2 Et OCH 3 F H OH H H XVH-15-5 Ph H H CH 2 Ph Et OCH 3 F H OH H H XVIM-15-6 Ph H H CH 2 -indol-3-yl Et OCH 3 F H OH H H XVI-15-7 Ph H H CH 2
CH
2
SCH
3 Et OCH 3 F H OH H H XVIII-15-8 Ph * H * Et OCH 3 F H OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XVIII-16. N2 R2 R 3 a R 3 b R4 R 5
R
6 X Y R' R XVHI-16- p-Me- H H H Et OCH 3 F H OH H H 1 Ph XVIH-16- p-Me- H H CH 3 Et OCH 3 F H OH H H 2 Ph XVIII-16- p-Me- H H CH(CH3) 2 Et OCH 3 F H OH H H 3 Ph XVHI-16- p-Me- H H CH 2
CH(CH
3
)
2 Et OCH 3 F H OH H H 4Ph XVIII-16- p-Me- H H CH 2 Ph Et OCH 3 F H OH H H 5 Ph XVHI-16- p-Me- H H CH 2 -indol-3- Et OCH 3 F H OH H H 6 Ph YI XVIHI-16- p-Me- H H CH 2
CH
2
SCH
3 Et OCH 3 F H OH H H 7 Ph XVIH-16- p-Me- * H * Et OCH 3 F H OH H H 8 Ph *RT and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVIII-17.
N
2 R R2 R 3 a R 3 b R 4
R
5
R
6 X Y R 7
R
8 XVIII-17-1 p-F-Ph H H H Et OCH 3 F H OH H H XVHI-17-2 p-F-Ph H H CH 3 Et OCH 3 F H OH H H XVHI-17-3 p-F-Ph H H CH(CH 3
)
2 Et OCH 3 F H OH H H
AA'C
X2 R2 R 3 a R 3 b R 4 R' R' X Y R7 R 8 XVHI-17-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Et OCH 3 F H OH H H XVM-17-5 p-F-Ph H H CH 2 Ph Et OCH 3 F H OH H H XVHI-17-6 p-F-Ph H H CH 2 -indol-3-yl Et OCH 3 F H OH H H XVHI-17-7 p-F-Ph H H CH 2
CH
2
SCH
3 Et OCH 3 F H OH H H XVM-17-8 p-F-Ph * H * Et OCH 3 F H OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XVIII-18. X Rt RRAaR R' RRX'Y R R XVM-18- p-Cl- H H H Et OCH 3 F H OH H H 1 Ph XVIII-18- p-Cl- H H CH 3 Et OCH 3 F H OH H H 2 Ph XVIII-18- p-Cl- H H CH(CH 3
)
2 Et OCH 3 F H OH H H 3 Ph XVM-18- p-Cl- H H CH 2
CH(CH
3
)
2 Et OCH 3 F H OH H H 4 Ph XVHI-18- p-Cl- H H CH 2 Ph Et OCH 3 F H OH H H 5 Ph XVIm-1.8- p-Cl- H H CH 2 -indol-3- Et OCH 3 F H OH H H 6 Ph Yl XVIII-18- p-Cl- H H CH 2
CH
2
SCH
3 Et OCH 3 F H OH H H 7 Ph XVIII-18- p-Cl- * H * Et OCH 3 F H OH H H 8 Ph *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XVIII-19. X R R 2 R R 3 b R' R' R' X Y R.R 8 XVIII-19- p-Br- H H H Et OCH 3 F H OH H H 1 Ph XVII-19- p-Br- H H CH 3 Et OCH 3 F H OH H H 2 Ph XVIII-19- p-Br- H H CH(CH 3
)
2 Et OCH 3 F H OH H H 3 Ph XVIII-19- p-Br- H H CH2CH(CH 3
)
2 Et OCH 3 F H OH H H Ph A A4~ M R' R2 R 3 a R 3 b R' R' R' XY R 7 R 4 XVIIH-19- p-Br- H H CH 2 Ph Et OCH 3 F H OH H H 5 Ph XVII-19- p-Br- H H CH 2 -indol-3- Et OCH 3 F H OH H H 6 Ph yl XVHI-19- p-Br- H H CH 2
CH
2
SCH
3 Et OCH 3 F H OH H H 7 Ph XVIII-19- p-Br- * H * Et OCH 3 F H OH H H 8 Ph *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XVIII-20. SR R 2 Ra Rb R 4 R R XY R R XVIH-20-1 p-I-Ph H H H Et OCH 3 F H OH H H XVIII-20-2 p-I-Ph H H CH 3 Et OCH 3 F H OH H H XVHI-20-3 p-I-Ph H H CH(CH 3
)
2 Et OCH 3 F H OH H H XVIH-20-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Et OCH 3 F H OH H H XVII-20-5 p-I-Ph H H CH 2 Ph Et OCH 3 F H OH H H XVHI-20-6 p-I-Ph H H CH 2 -indol-3-yl Et OCH 3 F H OH H H XVII-20-7 p-I-Ph H H CH 2
CH
2
SCH
3 Et OCH 3 F H OH H H XVIII-20-8 p-I-Ph * H * Et OCH 3 F H OH H H T*Rl and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XVIII-21. SRt R2 R 3 a R 3 b R 4 R' R( X Y R7 R XVHI-21-1 CH 3 H H H 'Pr OCH 3 F H OH H H XVIII-21-2 CH 3 H H CH 3 'Pr OCH 3 F H OH H H XVIII-21-3 CH 3 H H CH(CH 3
)
2 'Pr OCH 3 F H OH H H XVIII-21-4 CH 3 H H CH 2
CH(CH
3
)
2 'Pr OCH 3 F H OH H H XVIII-21-5 CH 3 H H CH 2 Ph 'Pr OCH 3 F H OH H H XVI-21-6 CH 3 H H CH 2 -indol-3-yl 'Pr OCH 3 F H OH H H XVIII-21-7 CH 3 H H CHCH 2
SCH
3 'Pr OCH 3 F H OH H H XVII-21-8 CH 3 * H * 'Pr OCH 3 F H OH H H 5 *R and Rb joined together by (CH 2
)
3 to form five-membered ring. A (7 Table XVIII-22. X2 RI R 2
R
3 a R 3 b R R R X Y R' R' XVIH-22-1 Et H H H 'Pr OCH 3 F H OH H H XVIII-22-2 Et H H CH 3 'Pr OCH 3 F H OH H H XVIII-22-3 Et H H CH(CH 3
)
2 'Pr OCH 3 F H OH H H XVHI-22-4 Et H H CH 2
CH(CH
3
)
2 'Pr OCH 3 F H OH H H XVIH-22-5 Et H H CH 2 Ph 'Pr OCH 3 F H OH H H XVIII-22-6 Et H H CH 2 -indol-3-yl 'Pr OCH 3 F H OH H H XVHI-22-7 Et H H CH 2
CH
2
SCH
3 'Pr OCH 3 F H OH H H XVIH-22-8 Et * H * 'Pr OCH 3 F H OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XVIII-23. M2 R' R2 R 3 a R 3 b R4 R 5 R' X Y R 7
R
8 XVHI-23-1 'Pr H H H 'Pr OCH 3 F H OH H H XVHI-23-2 'Pr H H CH 3 'Pr OCH 3 F H OH H H XVIII-23-3 'Pr H H CH(CH 3
)
2 'Pr OCH 3 F H OH H H XVIII-23-4 'Pr H H CH 2
CH(CH
3
)
2 'Pr OCH 3 F H OH H H XVIII-23-5 'Pr H H CH 2 Ph 'Pr OCH 3 F H OH H H XVIII-23-6 'Pr H H CH 2 -indol-3-yl 'Pr OCH 3 F H OH H H XVHI-23-7 'Pr H H CH 2
CH
2
SCH
3 'Pr OCH 3 F H OH H H XVIII-23-8 'Pr * H * 'Pr OCH 3 F H OH H H *R and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVIII-24. M R R 2 R3a R 3 b R' R' R' X Y R 7 R' XVHI-24-1 'Bu H H H 'Pr OCH 3 F H OH H H XVIII-24-2 'Bu H H CH 'Pr OCH 3 F H OH H H XVIII-24-3 'Bu H H CH(CH 3
)
2 'Pr OCH 3 F H OH H H XVIII-24-4 'Bu H H CH 2
CH(CH
3
)
2 'Pr OCH 3 F H OH H H XVIH-24-5 'Bu H H CH 2 Ph 'Pr OCH 3 F H OH H H XVIH-24-6 'Bu H H CH 2 -indol-3-yl 'Pr OCH 3 F H OH H H XVIII-24-7 'Bu H H CH 2
CH
2
SCH
3 'Pr OCH 3 F H OH H H XVII-24-8 'Bu * H * 'Pr OCH 3 F H OH H H RT and Rib joined together by (CH 2
)
3 to form five-membered ring. AlQ Table XVIII-25. N2 R R2 R 3 a R 3 b R4 R 5 R' X Y R' R 8 XVMI-25-1 Ph H H H 'Pr OCH 3 F H OH H H XVI-25-2 Ph H H CH3 'Pr OCH 3 F H OH H H XVIII-25-3 Ph H H CH(CH 3
)
2 'Pr OCH 3 F H OH H H XVII-25-4 Ph H H CH 2
CH(CH
3
)
2 'Pr OCH 3 F H OH H H XVIH-25-5 Ph H H CH 2 Ph 'Pr OCH 3 F H OH H H XVHI-25-6 Ph H H CH 2 -indol-3-yl 'Pr OCH 3 F H OH H H XVIH-25-7 Ph H H CH 2
CH
2
SCH
3 'Pr OCH 3 F H OH H H XVIH-25-8 Ph * H * 'Pr OCH 3 F H OH H H *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XVIII-26. N2 Rl R 2
R
3 a R 3 b R 4 R' R' X Y R 7
R
8 XVHI-26- p-Me- H H H 'Pr OCH 3 F H OH H H 1 Ph XVm-26- p-Me- H H CH 3 'Pr OCH 3 F H OH H H 2 Ph XVIII-26- p-Me- H H CH(CH 3
)
2 'Pr OCH 3 F H OH H H 3 Ph XVIII-26- p-Me- H H CH 2
CH(CH
3
)
2 'Pr OCH 3 F H OH H H 4 Ph XVIH-26- p-Me- H H CH 2 Ph 'Pr OCH 3 F H OH H H 5 Ph XVIH-26- p-Me- H H CH 2 -indol-3- 'Pr OCH 3 F H OH H H 6 Ph XVIII-26- p-Me- H H CH 2
CH
2
SCH
3 'Pr OCH 3 F H OH H H 7 Ph XVII-26- p-Me- *. H * 'Pr OCH 3 F H OH H H 8 Ph *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVIII-27. X2 Rl R 2
R
3 a Rb R 4
R
5
R
6 XY R' R' XVIII-27- p-F- H H H 'Pr OCH 3 F H OH H H 1 Ph XVIII-27- p-F- H H CH 3 'Pr OCH 3 F H OH H H Ph
A(AA
N2 Rl R 2
R
3 a R 3 b R 4
R
5 R' X Y R' R' 2 XVIII-27- p-F- H H CH(CH 3
)
2 'Pr OCH 3 F H OH H H 3 Ph XVIII-27- p-F- H H CH 2
CH(CH
3
)
2 'Pr OCH 3 F H OH H H 4 Ph XVII-27- p-F- H H CH 2 Ph 'Pr OCH 3 F H OH H H 5 Ph XVIII-27- p-F- H H CH 2 -indol-3- 'Pr OCH 3 F H OH H H 6 Ph yl XVm-27- p-F- H H CH 2
CH
2
SCH
3 'Pr OCH 3 F H OH H H 7 Ph XVIII-27- p-F- * H * 'Pr OCH 3 F H OH H H 8 Ph *R' and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XVIII-28. N2 RI R 2 RN Rab R R' R 6 XY R' R XVIII-28- p-Cl- H H H 'Pr OCH 3 F H OH H H 1 Ph XVIII-28- p-Cl- H H CH 3 'Pr OCH 3 F H OH H H 2 Ph XVIII-28- p-Cl- H H CH(CH 3
)
2 'Pr OCH 3 F H OH H H 3 Ph XVII-28- p-Cl- H H CH 2
CH(CH
3
)
2 'Pr OCH 3 F H OH H H 4 Ph XVI-28- p-Cl- H H CH 2 Ph 'Pr OCH 3 F H OH H H 5 Ph XVIII-28- p-Cl- H H CH 2 -indol-3- 'Pr OCH 3 F H OH H H 6 Ph yi XVHI-28- p-Cl- H H CH 2
CH
2
SCH
3 'Pr OCH 3 F H OH H H 7 Ph XVIII-28- p-Cl- * H * 'Pr OCH 3 F H OH H H 8 Ph *R and Rdb joined together by (CH 2
)
3 to form five-membered ring. A IlA Table XVIII-29. 2 Rl R 2
R
3 a R 3 b R 4 R' R 6 X Y R' R XVIII-29- p-Br- H H H 'Pr OCH 3 F H OH H H 1 Ph XVIII-29- p-Br- H H CH 3 'Pr OCH 3 F H OH H H 2 Ph XVHI-29- p-Br- H H CH(CH 3
)
2 'Pr OCH 3 F H OH H H 3 Ph XVIII-29- p-Br- H H CH 2
CH(CH
3
)
2 'Pr OCH 3 F H OH H H 4 Ph XVII-29- p-Br- H H CH 2 Ph 'Pr OCH 3 F H OH H H 5 Ph XVHI-29- p-Br- H H CH 2 -indol-3- 'Pr OCH 3 F H OH H H 6 Ph YI XVIII-29- p-Br- H H CH 2
CH
2
SCH
3 'Pr OCH 3 F H OH H H 7 Ph XVI-29- p-Br- * H * 'Pr OCH 3 F H OH H H 8 Ph *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XVIII-30. X R' R 2
R
3 " R ~b R 4 R5 R 6 X Y R' R XVIII-30-1 p-I-Ph H H H 'Pr OCH 3 F H OH H H XVI-30-2 p-I-Ph H H CH 3 'Pr OCH 3 F H OH H H XVIU-30-3 p-I-Ph H H CH(CH 3
)
2 'Pr OCH 3 F H OH H H XVHI-30-4 p-I-Ph H H CH 2
CH(CH
3
)
2 'Pr OCH 3 F H OH H H XVHI-30-5 p-I-Ph H H CH 2 Ph 'Pr OCH 3 F H OH H H XVIII-30-6 p-I-Ph H H CH 2 -indol-3-yl 'Pr OCH 3 F H OH H H XVIII-30-7 p-I-Ph H H CH 2
CH
2
SCH
3 'Pr OCH 3 F H OH H H XVIII-30-8 p-I-Ph * H * 'Pr OCH 3 F H OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XVIII-3 1. 2 R' R2 R 3 a R3b R4 R 5
R
6 X Y R 7
R
8 XVIII-31-1 CH 3 H H H "Bu OCH 3 F H OH H H XVIII-31-2 CH 3 H H CH 3 "Bu OCH 3 F H OH H H XVII-31-3 CH 3 H H CH(CH 3
)
2 "Bu OCH 3 F H OH H H A11 2 R' R 2
R
3 a R 3 b R 4 R' R 6 X Y R 7
R
8 XVIII-31-4 CH 3 H H CH 2
CH(CH
3
)
2 "Bu OCH 3 F H OH H H XVHI-31-5 CH 3 H H CH 2 Ph "Bu OCH 3 F H OH H H XVI-31-6 CH 3 H H CH 2 -indol-3-yl "Bu OCH 3 F H OH H H XVHI-31-7 CH 3 H H CH 2
CH
2
SCH
3 "Bu OCH 3 F H OH H H XVIII-31-8 CH 3 * H * "Bu OCH 3 F H OH H H *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XVIII-32. RI R 2 RaR3b R' R' R 6 X Y R 7
R
8 XVHI-32-1 Et H H H "Bu OCH 3 F H OH H H XVIII-32-2 Et H H CH 3 "Bu OCH 3 F H OH H H XVIH-32-3 Et H H CH(CH 3
)
2 "Bu OCH 3 F H OH H H XVHI-32-4 Et H H CH 2
CH(CH
3
)
2 "Bu OCH 3 F H OH H H XVIII-32-5 Et H H CH 2 Ph "Bu OCH 3 F H OH H H XVII-32-6 Et H H CH 2 -indol-3-yl "Bu OCH 3 F H OH H H XVIH-32-7 Et H H CH 2
CH
2
SCH
3 "Bu OCH 3 F H OH H H XVIH-32-8 Et * H * "Bu OCH 3 F H OH H H *R and R-b joined together by (CH 2
)
3 to form five-membered ring. Table XVIII-33. M R' R2 R 3 a R 3 b R 4 R5 R' X Y R7 R 8 XVIII-33-1 'Pr H H H "Bu OCH 3 F H OH H H XVIII-33-2 'Pr H H CH 3 "Bu OCH 3 F H OH H H XVIH-33-3 'Pr H H CH(CH 3
)
2 "Bu OCH 3 F H OH H H XVII-33-4 'Pr H H CH 2
CH(CH
3
)
2 "Bu OCH 3 F H OH H H XVHI-33-5 'Pr H H CH 2 Ph "Bu OCH 3 F H OH H H XVIII-33-6 'Pr H H CH 2 -indol-3-yl "Bu OCH 3 F H OH H H XVHI-33-7 'Pr H H CH 2
CH
2
SCH
3 "Bu OCH 3 F H OH H H XVHI-33-8 'Pr * H * "Bu OCH 3 F H OH H H 5 *R2and Ri joined together by (CH 2
)
3 to form five-membered ring. Table XVIII-34. 2 R' R 2
R
3 a R 3 b R 4
R
5
R
6 X Y R 7
R
8 XVII-34-1 'Bu H H H "Bu OCH 3 F H OH H H XVHI-34-2 'Bu H H CH 3 "Bu OCH 3 F H OH H H XVII-34-3 'Bu H H CH(CH 3
)
2 "Bu OCH 3 F H OH H H XVUI-34-4 'Bu H H CH 2
CH(CH
3
)
2 "Bu OCH 3 F H OH H H _ A1') X R 1
R
2
R
3 a R 3 b R' R' R' X Y RI R8 XVII-34-5 'Bu H H CH 2 Ph "Bu OCH 3 F H OH H H XVIII-34-6 'Bu H H CH 2 -indol-3-yl "Bu OCH 3 F H OH H H XVIII-34-7 'Bu H H CH 2
CH
2
SCH
3 "Bu OCH 3 F H OH H H XVHI-34-8 'Bu * H * "Bu OCH 3 F H OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XVIII-35. X2 RI R 2
R
3 a R 3 b R' R' R 6 X Y R' R' XVHI-35-1 Ph H H H "Bu OCH 3 F H OH H H XVIII-35-2 Ph H H CH 3 "Bu OCH 3 F H OH H H XVII-35-3 Ph H H CH(CH 3
)
2 "Bu OCH 3 F H OH H H XVHI-35-4 Ph H H CH 2
CH(CH
3
)
2 "Bu OCH 3 F H OH H H XVIII-35-5 Ph H H CH 2 Ph "Bu OCH 3 F H OH H H XVIII-35-6 Ph H H CH 2 -indol-3-yl "Bu OCH 3 F H OH H H XVII-35-7 Ph H H CH 2
CH
2
SCH
3 "Bu OCH 3 F H OH H H XVUI-35-8 Ph * H * "Bu OCH 3 F H OH H H *RT and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XVIII-36. N2 R 3 a R 3 b R4 R 5 R6 X Y R7 R 8 XVHI- p-Me- H H H "Bu OCH 3 F H OH H H 36-1 Ph XVIII- p-Me- H H CH 3 "Bu OCH 3 F H OH H H 36-2 Ph XVHI- p-Me- H H CH(CH 3
)
2 "Bu OCH 3 F H OH H H 36-3 Ph XVII- p-Me- H H CH 2
CH(CH
3
)
2 "Bu OCH 3 F H OH H H 36-4 Ph XVIH- p-Me- H H CH 2 Ph "Bu OCH 3 F H OH H H 36-5 Ph XVIII- p-Me- H H CH 2 -indol-3- "Bu OCH 3 F H OH H H 36-6 Ph yl XVIII- p-Me- H H CH 2
CH
2
SCH
3 "Bu OCH 3 F H OH H H 36-7 Ph XVII- p-Me- * H * "Bu OCH 3 F H OH H H 36-8 Ph SA12
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XVIII-37. X2 R' R 2
R
3 a R 3 b R4 Rs R' X Y R 7
R
8 XVHI-37- p-F- H H H "Bu OCH 3 F H OH H H Ph XVUI-37- p-F- H H CH 3 "Bu OCH 3 F H OH H H 2 Ph XVIH-37- p-F- H H CH(CH 3
)
2 "Bu OCH 3 F H OH H H 3 Ph XVIH-37- p-F- H H CH 2
CH(CH
3
)
2 "Bu OCH 3 F H OH H H 4 Ph XVII-37- p-F- H H CH 2 Ph "Bu OCH 3 F H OH H H 5 Ph XVIH-37- p-F- H H CH 2 -indol-3- "Bu OCH 3 F H OH H H 6 Ph yl XVIII-37- p-F- H H CH 2
CH
2
SCH
3 "Bu OCH 3 F H OH H H 7 Ph XVIII-37- p-F- * H * "Bu OCH 3 F H OH H H 8 Ph *R and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XVIII-38. N2 Rl R 2 R3a R 3 b R 4
R
5 R' X Y R 7 RV XVHI-38- p-Cl- H H H "Bu OCH 3 F H OH H H 1 Ph XVII-38- p-Cl- H H CH 3 "Bu OCH 3 F H OH H H 2 Ph XVII-38- p-Cl- H H CH(CH 3
)
2 "Bu OCH 3 F H OH H H 3 Ph XVIH-38- p-Cl- H H CH 2
CH(CH
3
)
2 "Bu OCH 3 F H OH H H 4 Ph XVIII-38- p-Cl- H H CH 2 Ph "Bu OCH 3 F H OH H H 5 Ph XVIH-38- p-Cl- H H CH 2 -indol-3- "Bu OCH 3 F H OH H H 6 Ph Yl XVIH-38- p-Cl- H H CH 2
CH
2
SCH
3 "Bu OCH 3 F H OH H H Ph A1 A
R
2 RNaR 3b R 4 R5 R 6 X Y R 7
R
8 7 XVIII-38- p-Cl- * H * "Bu OCH 3 F H OH H H 8 Ph *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XVIII-39. X2 R 2
R
3 a R R R
R
5
R
6 X Y R' R XVIII-39- p-Br- H H H "Bu OCH 3 F H OH H H 1 Ph XVII-39- p-Br- H H CH 3 "Bu OCH 3 F H OH H H 2 Ph XVIII-39- p-Br- H H CH(CH 3
)
2 "Bu OCH 3 F H OH H H 3 Ph XVII-39- p-Br- H H CH 2
CH(CH
3
)
2 "Bu OCH 3 F H OH H H 4 Ph XVII-39- p-Br- H H CH 2 Ph "Bu OCH 3 F H OH H H 5 Ph XVIII-39- p-Br- H H CH 2 -indol-3- "Bu OCH 3 F H OH H H 6 Ph YI XVIIH-39- p-Br- H H CH 2
CH
2
SCH
3 "Bu OCH 3 F H OH H H 7 Ph XVIII-39- p-Br- * H * "Bu OCH 3 F H OH H H 8 Ph *R" and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XVIII-40. SR R 2
R
3 aR Rb R 4
R
5 R XY R XVIII-40- p-I- H H H "Bu OCH 3 F H OH H H 1 Ph XVIII-40- p-I- H H CH 3 "Bu OCH 3 F H OH H H 2 Ph XVI-40- p-I- H H CH(CH 3
)
2 "Bu OCH 3 F H OH H H 3 Ph XVIII-40- p-I- H H CH 2
CH(CH
3
)
2 "Bu OCH 3 F H OH H H 4 Ph XVIII-40- p-I- H H CH 2 Ph "Bu OCH 3 F H OH H H Ph A1C X2 Rl R 2
R
3 a R 3 b R 4
R
5
R
6 X Y R 7
R
8 5 XVII-40- p-I- H H CH 2 -indol-3- "Bu OCH 3 F H OH H H 6 Ph YI XVM-40- p-I- H H CH 2
CH
2
SCH
3 "Bu OCH 3 F H OH H H 7 Ph XVIU-40- p-I- * H * "Bu OCH 3 F H OH H H 8 Ph *R' and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XVIII-4 1. X2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y R 7 Rs XVIII-41-1 CH 3 H H H Bz OCH 3 F H OH H H XVIH-41-2 CH 3 H H CH 3 Bz OCH 3 F H OH H H XVMH-41-3 CH 3 H H CH(CH 3
)
2 Bz OCH 3 F H OH H H XVIH-41-4 CH 3 H H CH 2
CH(CH
3 )2 Bz OCH 3 F H OH H H XVIf-41-5 CH 3 H H CH 2 Ph Bz OCH 3 F H OH H H XVI-41-6 CH 3 H H CH 2 -indol-3-yl Bz OCH 3 F H OH H H XVM-41-7 CH 3 H H CH 2
CH
2
SCH
3 Bz OCH 3 F H OH H H XVIII-41-8 CH 3 * H * Bz OCH 3 F H OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XVIII-42. X2 RI R 2
R
3 a R 3 b R' R' R 6 X Y R 7
R
8 XVIII-42-1 Et H H H Bz OCH 3 F H OH H H XVIH-42-2 Et H H CH 3 Bz OCH 3 F H OH H H XVHI-42-3 Et H H CH(CH 3
)
2 Bz OCH 3 F H OH H H XVIH-42-4 Et H H CH 2
CH(CH
3
)
2 Bz OCH 3 F H OH H H XVIII-42-5 Et H H CH 2 Ph Bz OCH 3 F H OH H H XVIII-42-6 Et H H CH 2 -indol-3-yl Bz OCH 3 F H OH H H XVIH-42-7 Et H H CH 2
CH
2
SCH
3 Bz OCH 3 F H OH H H XVIH-42-8 Et * H * Bz OCH 3 F H OH H H 5 *R and Rab joined together by (CH 2
)
3 to form five-membered ring. Table XVIII-43. X2 R R2 R 3 a R 3 b R4 R' R 6 X Y R 7 R7 XVIII-43-1 'Pr H H H Bz OCH 3 F H OH H H XVIII-43-2 'Pr H H CH 3 Bz OCH 3 F H OH H H A 1 4 XVM-43-3 'Pr H H CH(CH 3 )2 Bz OCH 3 F H OH H H XVII-43-4 'Pr H H CH 2
CH(CH
3
)
2 Bz OCH 3 F H OH H H XVIII-43-5 'Pr H H CH2Ph Bz OCH 3 F H OH H H XVIII-43-6 'Pr H H CH 2 -indol-3-yl Bz OCH 3 F H OH H H XVIH-43-7 'Pr H H CH 2
CH
2
SCH
3 Bz OCH 3 F H OH H H XVIII-43-8 'Pr * H * Bz OCH 3 F H OH H H
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XVIII-44. X2 R' R 2 R 3a R3b R4 R5 R X Y R' R' XVHI-44-1 'Bu H H H Bz OCH 3 F H OH H H XVIII-44-2 'Bu H H CH 3 Bz OCH 3 F H OH H H XVHI-44-3 'Bu H H CH(CH 3
)
2 Bz OCH 3 F H OH H H XVIII-44-4 'Bu H H CH2CH(CH 3
)
2 Bz OCH 3 F H OH H H XVIII-44-5 'Bu H H CH2Ph Bz OCH 3 F H OH H H XVHI-44-6 'Bu H H CH 2 -indol-3-yl Bz OCH 3 F H OH H H XVIH-44-7 'Bu H H CH 2
CH
2
SCH
3 Bz OCH 3 F H OH H H XVIII-44-8 'Bu * H * Bz OCH 3 F H OH H H *R" and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XVIII-45. N R R 2 R a R3b R 4 R 5 R6 X Y R7 R 8 XVM-45-1 Ph H H H Bz OCH 3 F H OH H H XVM-45-2 Ph H H CH 3 Bz OCH 3 F H OH H H XVH-45-3 Ph H H CH(CH 3
)
2 Bz OCH 3 F H OH H H XVIII-45-4 Ph H H CH 2
CH(CH
3
)
2 Bz OCH 3 F H OH H H XVII-45-5 Ph H H CH 2 Ph Bz OCH 3 F H OH H H XVHI-45-6 Ph H H CH 2 -indol-3-yl Bz OCH 3 F H OH H H XVM-45-7 Ph H H CH 2
CH
2
SCH
3 Bz OCH 3 F H OH H H XVIII-45-8 Ph * H * Bz OCH 3 F H OH H H 5 *R and R' joined together by (CH 2
)
3 to form five-membered ring. Table XVIII-46. N2 R R2 R3a R3b R4 R 5
R
6 X Y R' R' XVIU-46- p-Me- H H H Bz OCH 3 F H OH H H 1 Ph XVIII-46- p-Me- H H CH 3 Bz OCH 3 F H OH H H 2 Ph A ' N RI R 2
R
3 a R 3 b R4 R 5 R' X Y R' R' XVHI-46- p-Me- H H CH(CH 3
)
2 Bz OCH 3 F H OH H H 3 Ph XVII-46- p-Me- H H CH 2
CH(CH
3
)
2 Bz OCH 3 F H OH H H 4 Ph XVHI-46- p-Me- H H CH 2 Ph Bz OCH 3 F H OH H H 5 Ph XVIU-46- p-Me- H H CH 2 -indol-3- Bz OCH 3 F H OH H H 6 Ph Yl XVUI-46- p-Me- H H CH 2
CH
2
SCH
3 Bz OCH 3 F H OH H H 7 Ph XVIII-46- p-Me- * H * Bz OCH 3 F H OH H H 8 Ph *RT and R 3 h joined together by (CH 2
)
3 to form five-membered ring. Table XVIII-47. N R' R 2 RaR 3
R
4 R' R 6 XY R' R XVIII-47- p-F- H H H- Bz OCH 3 F H OH H H 1 Ph XVII-47- p-F- H H CH 3 Bz OCH 3 F H OH H H 2 Ph XVIL-47- p-F- H H CH(CH 3
)
2 Bz OCH 3 F H OH H H 3 Ph XVIII-47- p-F- H H CH 2
CH(CH
3
)
2 Bz OCH 3 F H OH H H 4 Ph XVIII-47- p-F- H H CH 2 Ph Bz OCH 3 F H OH H H 5 Ph XVHI-47- p-F- H H CH 2 -indol-3- Bz OCH 3 F H OH H H 6 Ph Yl XVIII-47- p-F- H H CH 2
CH
2
SCH
3 Bz OCH 3 F H OH H H 7 Ph XVIII-47- p-F- * H * Bz OCH 3 F H OH H H 8 Ph
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XVIII-48. N2 R R 2
R
3 a R 3 b R 4 R R 6 X Y R 7 R9 A10 X2 R 2
R
3 a R3b R 4 R 5 R' X Y R/ R8 XVIII-48- p-Cl- H H 1H Bz OCH 3 F H OH H H 1 Ph XVIII-48- p-Cl- H H CH 3 Bz OCH 3 F H OH H H 2 Ph XVIII-48- p-Cl- H H CH(CH 3
)
2 Bz OCH 3 F H OH H H 3 Ph XVIII-48- p-Cl- H H CH 2
CH(CH
3
)
2 Bz OCH 3 F H OH H H 4 Ph XVIII-48- p-Cl- H H CH 2 Ph Bz OCH 3 F H OH H H 5 Ph XVI-48- p-Cl- H H CH 2 -indol-3- Bz OCH 3 F H OH H H 6 Ph XVIII-48- p-Cl- H H CH 2
CH
2
SCH
3 Bz OCH 3 F H OH H H 7 Ph XVII-48- p-Cl- * H * Bz OCH 3 F H OH H H 8 Ph *R and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XVIII-49. N2 Rl R2 Ra R 3b R 4 R5 R6 X y R 7- R9 XVIII-49- p-Br- H H H Bz OCH 3 F H OH H H 1 Ph XVIII-49- p-Br- H H CH 3 Bz OCH 3 F H OH H H 2 Ph XVII-49- p-Br- H H CH(CH 3
)
2 Bz OCH 3 F H OH H H 3 Ph XVIH-49- p-Br- H H CH 2
CH(CH
3
)
2 Bz OCH 3 F H OH H H 4 Ph XVIII-49- p-Br- H H CH 2 Ph Bz OCH 3 F H OH H H 5 Ph XVII-49- p-Br- H H CH 2 -indol-3- Bz OCH 3 F H OH H H 6 Ph ),I XVIII-49- p-Br- H H CH 2
CH
2
SCH
3 Bz OCH 3 F H OH H H 7 Ph XVIII-49- p-Br- * H * Bz OCH 3 F H OH H H 8 Ph A 1
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XVIII-50. N R' R2 Ra R 3 b R4 R 5 R' X Y R 7
R
8 XVIII-50-1 p-I-Ph H H H Bz OCH 3 F H OH H H XVIII-50-2 p-I-Ph H H CH 3 Bz OCH 3 F H OH H H XVIII-50-3 p-I-Ph H H CH(CH 3
)
2 Bz OCH 3 F H OH H H XVHI-50-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Bz OCH 3 F H OH H H XVIH-50-5 p-I-Ph H H CH 2 Ph Bz OCH 3 F H OH H H XVIII-50-6 p-I-Ph H H CH 2 -indol-3-yl Bz OCH 3 F H OH H H XVHI-50-7 p-I-Ph H H CH 2
CH
2
SCH
3 Bz OCH 3 F H OH H H XVI-50-8 p-I-Ph * H * Bz OCH 3 F H OH H H *R2 and R b joined together by (CH 2
)
3 to form five-membered ring. 0
R
8 2 O 7 N H RP0 R N 0 C0 2
R
4
OR
1
R
6 Y X xix 5 Table XIX-1. N R1 R2 R 3 a R3b R 4 R R 6 X Y R 7
R
8 XIX-1-1 Cl- 3 H H H Gil 3
OCR
3 F F OH H H XIX-1-2 CH 3 H H H 3
CH
3
OCH
3 F F OH H H XIX-1-3 CH 3 H H CH(CH 3
)
2
CH
3
OCH
3 F F OH H H XIX-1-4 CH 3 H H CH 2
CH(CH
3
)
2
CH
3
OCH
3 F F OH H H XIX-1-5 CH 3 H H CH 2 Ph CH 3
OCH
3 F F OH H H XIX-1-6 CH 3 H H CH 2 -indol-3-yl CH 3
OCH
3 F F OH H H XIX-1-7 CH 3 H H CH 2
CH
2
SCH
3
CH
3
OCH
3 F F OH H H XIX-1-8 CH 3 H H CH CH 3 OCH3 F F OH H H *RTand R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XIX-2. A IM SRI R 2
R
3 a R 3 b R 4
R
5
R
6 X Y R 7
R
8 XIX-2-1 Et H H H CH 3
OCH
3 F F OH H H XIX-2-2 Et H H CH 3
CH
3
OCH
3 F F OH H H XIX-2-3 Et H H CH(CH 3
)
2
CH
3
OCH
3 F F OH H H XIX-2-4 Et H H CH 2
CH(CH
3
)
2
CH
3
OCH
3 F F OH. H H XIX-2-5 Et H H CH 2 Ph CH 3
OCH
3 F F OH H H XIX-2-6 Et H H CH 2 -indol-3-yl CH 3
OCH
3 F F OH H H XIX-2-7 Et H H CH 2
CH
2
SCH
3
CH
3
OCH
3 F F OH H H XIX-2-8 Et * H * CH 3
OCH
3 F F OH H H * -- and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XIX-3. X R' R 2
R
3 a R R 4 R R X Y R' R XIX-3-1 'Pr H H H CH 3
OCH
3 F F OH H H XIX-3-2 'Pr H H CH 3
CH
3
OCH
3 F F OH H H XIX-3-3 'Pr H H CH(CH 3
)
2
CH
3
OCH
3 F F OH H H XIX-3-4 'Pr H H CH 2
CH(CH
3
)
2
CH
3
OCH
3 F F OH H H XIX-3-5 'Pr H H CH2Ph CH 3
OCH
3 F F OH H H XIX-3-6 'Pr H H CH 2 -indol-3-yl CH 3
OCH
3 F F OH H H XIX-3-7 'Pr H H CH 2
CH
2
SCH
3
CH
3
OCH
3 F F OH H H XIX-3-8 'Pr * H * CH 3
OCH
3 F F OH H H *R2 and Rb joined together by (CH 2
)
3 to form five-membered ring. Table XIX-4. 2 R1 R 2
R"R
3 b R 4 R' R 6 XY R R 8 XIX-4-1 'Bu H H H CH 3
OCH
3 F F OH H H XIX-4-2 'Bu H H CH 3
CH
3
OCH
3 F F OH H H XIX-4-3 'Bu H H CH(CH 3
)
2
CH
3
OCH
3 F F OH H H XIX-4-4 'Bu H H CH 2
CH(CH
3
)
2
CH
3
OCR
3 F F OH H H XIX-4-5 'Bu H H CH 2 Ph CH 3
OCH
3 F F OH H H XIX-4-6 'Bu H H CH 2 -indol-3-yl CH 3
OCH
3 F F OH H H XIX-4-7 'Bu H H CH 2
CH
2
SCH
3
CH
3
OCH
3 F F OH H H XIX-4-8 'Bu * H * CH 3
OCH
3 F F OH H H 5 *R 2 and Rdb joined together by (CH 2
)
3 to form five-membered ring. A') I Table XIX-5. X2 RI R 2
R
3 a R 3 b R 4
R
5 R' X Y R 7 RV XIX-5-1 Ph H H H CH 3
OCH
3 F F OH H H XIX-5-2 Ph H H CH 3
CH
3
OCH
3 F F OH H H XIX-5-3 Ph H H CH(CH 3
)
2
CH
3
OCH
3 F F OH H H XIX-5-4 Ph H H CH 2
CH(CH
3
)
2
CH
3
OCH
3 F F OH H H XIX-5-5 Ph H H CH 2 Ph CH 3
OCH
3 F F OH H H XIX-5-6 Ph H H CH 2 -indol-3-yl CH 3
OCH
3 F F OH H H XIX-5-7 Ph H H CH 2
CH
2
SCH
3
CH
3
OCH
3 F F OH H H XIX-5-8 Ph * H * CH 3
OCH
3 F F OH H H
*R
2 and RJb joined together by (CH 2
)
3 to form five-membered ring. Table XIX-6. X2 R' R 2
R
3 a R 3 b R 4 R5 R 6 X Y R' Rs XIX-6- p-Me- H H H CH 3
OCH
3 F F OH H H 1 Ph XIX-6- p-Me- H H CH 3
CH
3
OCH
3 F F OH H H 2 Ph XIX-6- p-Me- H H CH(CH 3
)
2
CH
3
OCH
3 F F OH H H 3 Ph XIX-6- p-Me- H H CH 2
CH(CH
3
)
2
CH
3
OCH
3 F F OH H H 4 Ph XIX-6- p-Me- H H CH 2 Ph CH 3
OCH
3 F F OH H H 5 Ph XIX-6- p-Me- H H CH 2 -indol-3- CH 3
OCH
3 F F OH H H 6 Ph XIX-6- p-Me- H H CH 2
CH
2
SCH
3
CH
3
OCH
3 F F OH H H 7 Ph XIX-6- p-Me- * H * CH 3
OCH
3 F F OH H H 8 Ph *RT and R b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIX-7. X2 R' R 2
R
3 a R 3 b R' R' R 6 X Y R 7R XIX-7-1 p-F-Ph H H H CH 3
OCH
3 F F OH H H XIX-7-2 p-F-Ph H H CH 3
CH
3
OCH
3 F F OH H H XIX-7-3 p-F-Ph H H CH(CH 3
)
2
CH
3
OCH
3 F F OH H H X2 R2 R 3 a R 3 b R 4
R
5 R' X Y R 7
R
8 XIX-7-4 p-F-Ph H H CH 2
CH(CH
3
)
2
CH
3
OCH
3 F F OH H H XIX-7-6 p-F-Ph H H CH 2 Ph CH 3
OCH
3 F F OH H H XIX-7-7 p-F-Ph H H CH 2 -indol-3-yI CH 3
OCH
3 F F OH H H XIX-7-8 p-F-Ph H H CH 2
CH
2
SCH
3
CH
3
OCH
3 F F OH H H XIX-7-20 p-F-Ph * H * CH 3
OCH
3 F F OH H H *R-and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XIX-8. N2 R' R 2
R
3 a R b R 4
R
5
R
6 X Y R 7 R' XIX-8-1 p-Cl-Ph H H H CH 3
OCH
3 F F OH H H XIX-8-2 p-Cl-Ph H H CH 3
CH
3
OCH
3 F F OH H H XIX-8-3 p-Cl-Ph H H CH(CH 3
)
2
CH
3
OCH
3 F F OH H H XIX-8-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2
CH
3
OCH
3 F F OH H H XLX-8-5 p-Cl-Ph H H CH 2 Ph CH 3
OCH
3 F F OH H H XIX-8-6 p-Cl-Ph H H C-1 2 -indol-3-yl CH 3
OCH
3 F F OH H H XIX-8-7 p-Cl-Ph H H CH4 2
CH
2
SCH
3
CH
3
OCH
3 F F OH H H XIX-8-8 p-Cl-Ph * H * CH 3
OCH
3 F F OH H H
*R
2 and R 3 b joined together by (CH2) 3 to form five-membered ring. Table XIX-9. N R R R 3 Rb R R 5 R' X Y R" R 8 XIX-9-1 p-Br- H H H CH 3
OCH
3 F F OH H H Ph XIX-9-2 p-Br- H H CH 3
CH
3 OCH3 F F OH H H Ph XIX-9-3 p-Br- H H CH(CH 3
)
2
CH
3
OCH
3 F F OH H H Ph XIX-9-4 p-Br- H H CH 2
CH(CH
3
)
2
CH
3
OCH
3 F F OH H H Ph XIX-9-6 p-Br- H H CH 2 Ph CH 3
OCH
3 F F OH H H Ph XIX-9-7 p-Br- H H CH 2 -indol-3- CH 3
OCH
3 F F OH H H Ph yl XIX-9-8 p-Br- H H CH 2
CH
2
SCH
3
CH
3
OCH
3 F F OH H H Ph XIX-9- p-Br- * H * CH 3
OCH
3 F F OH H H 20 Ph 5 *Rl and Rib joined together by (CH 2
)
3 to form five-membered ring. A 1)) Table XIX-10. N2 R1 R 2
R
3 a R 3 b R 4 R' R 6 X Y R R XIX-10-1 p-I-Ph H H H CH 3
OCH
3 F F OH H H XIX-10-2 p-I-Ph H H CH 3
CH
3
OCH
3 F F OH H H XIX-10-3 p-I-Ph H H CH(CH 3
)
2
CH
3
OCH
3 F F OH H H XIX-10-4 p-I-Ph H H CH 2
CH(CH
3
)
2
CH
3
OCH
3 F F OH H H XIX-10-5 p-I-Ph H H CIH 2 Ph CH 3
OCH
3 F F OH H H XIX-10-6 p-I-Ph H H CH 2 -indol-3-yl CH 3
OCH
3 F F OH H H XIX-10-7 p-I-Ph H H CH 2
CH
2
SCH
3
CH
3
OCH
3 F F OH H H XIX-10-8 p-I-Ph * H * CH 3
OCH
3 F F OH H H *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XIX-11. N2 R[ R2 R3a R 3 b R4 R 5
R
6 X Y R 7 R XIX-11-1 CH 3 H H H Et OCH 3 F F OH H H XIX-11-2 CH 3 H H CH 3 Et OCH 3 F F OH H H XIX-11-3 CH 3 H H CH(CH 3
)
2 Et OCH 3 F F OH H H XIX-11-4 CH 3 H H CH 2
CH(CH
3
)
2 Et OCH 3 F F OH H H XIX-11-5 CH 3 H H CH 2 Ph Et OCH 3 F F OH H H XIX-11-6 CH 3 H H CH 2 -indol-3-yl Et OCH 3 F F OH H H XIX-11-7 CH 3 H H CH 2
CH
2
SCH
3 Et OCH 3 F F OH H H XIX-11-8 CH 3 * H * Et OCH 3 F F OH H H *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIX-12. X2 R' R2 R 3 a R 3 b R 4
R
5 R' X Y R R 8 XIX-12-1 Et H H H Et OCH 3 F F OH H H XIX-12-2 Et H H CH 3 Et OCH 3 F F OH H H XIX-12-3 Et H H CH(CH 3
)
2 Et OCH 3 F F OH H H XIX-12-4 Et H H CH 2
CH(CH
3
)
2 Et OCH 3 F F OH H H XIX-12-5 Et H H CH 2 Ph Et OCH 3 F F OH H H XIX-12-6 Et H H CH 2 -indol-3-yi Et OCH 3 F F OH H H XIX-12-.7 Et H H CH 2
CH
2
SCH
3 Et OCH 3 F F OH H H XIX-12-8 Et * H * Et OCH 3 F F OH H H *RTand R3b joined together by (CH 2
)
3 to form five-membered ring.
A'IA
Table XIX-13. SR R 2
R
3 a Rb R 4 R R' X Y R R XIX-13-1 'Pr H H H Et OCH3 F F OH H H XIX-13.-2 'Pr H H CH 3 Et OCH 3 F F OH H H XIX-13-3 'Pr H H CH(CH- 3
)
2 Et OCH 3 F F OH H H XIX-13-4 'Pr H H CH 2
CH(CH
3
)
2 Et OCH 3 F F OH H H XIX-13-5 'Pr H H CH 2 Ph Et OCH 3 F F OH H H XLX-13-6 'Pr H H CH 2 -indol-3-yl Et OCH 3 F F OH H H XIX-13.-7 'Pr H H CH 2
CH
2
SCH
3 Et OCH 3 F F OH H H XIX-13-8 'Pr * H * Et OCH 3 F F OH H H *R and R joined together by (CH 2
)
3 to form five-membered ring. Table XIX-14. N2 R R 2 Ra b R 4 R' R 6 X Y R R 8 XIX-14--I 'Bu H H H Et OCH 3 F F OH H H XIX-14-2 'Bu H H CH 3 Et OCH 3 F F OH H H XIX-14-3 'Bu H H CH(CH 3
)
2 Et OCH 3 F F OH H H XIX-14-4 'Bu H H CH 2
CH(CH
3
)
2 Et OCH 3 F F OH H H XIX-14-5 'Bu H H CH 2 Ph Et OCH 3 F F OH H H XIX-14-6 'Bu H H CH 2 -indol-3-yl Et OCH 3 F F OH H H XIX-14-7 'Bu H H CH 2
CH
2
SCH
3 Et OCH 3 F F OH H H XIX-14-8 'Bu * H * Et OCH 3 F . F OH H H
*
2 and R 3 ' joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIX-15. RI R 2 R aR 3 b R' R' R 6 X Y R 7 R XIX-15-1 Ph H H H Et OCH 3 F F OH H H XIX-15-2 Ph H H CH 3 Et OCH3 F F OH H H XLX-15-3 Ph H H CH(CH 3
)
2 Et OCH3 F F OH H H XLX-15-4 Ph H H CH 2
CH(CH
3
)
2 Et OCH 3 F F OH H H XIX-15-5 Ph H H CH 2 Ph Et OCH3 F F OH H H XIX-15-6 Ph H H CH 2 -indol-3-y1 Et OCH 3 F F OH H H XIX-15-7 Ph H H CH 2
CH
2
SCH
3 Et OCH 3 F F OH H H XIX-15-8 Ph * H * Et OCH 3 F F OH H H *Rl and R joined together by (CH 2
)
3 to form five-membered ring.
Table XIX-16. N2 R R 2
R
3
R
3 b R 4 R' R' X Y R' R XIX-16- p-Me- H H H Et OCH 3 F F OH H H 1 Ph XIX-16- p-Me- H H CH 3 Et OCH 3 F F OH H H 2 Ph XIX-16- p-Me- H H CH(CH 3
)
2 Et OCH 3 F F OH H H 3 Ph XIX-16- p-Me- H H CH 2
CH(CH
3
)
2 Et OCH 3 F F OH H H 4 Ph XIX-16.- p-Me- H H CH 2 Ph Et OCH 3 F F OH H H 5 Ph XIX-16- p-Me- H H CH 2 -indol-3- Et OCH 3 F F OH H H 6 Ph YI XIX-16- p-Me- H H CH 2
CH
2
SCH
3 Et OCH 3 F F OH H H 7 Ph XIX-16- p-Me- * H * Et OCH 3 F F OH H H 8 Ph * R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XIX-17. N2 Rl R 2 Ria Rb R4 R 5 R' X Y R'R 8 XIX-17--1 p-F-Ph H H H Et OCH 3 F F OH H H XIX-17-2 p-F-Ph H H CH 3 Et OCH 3 F F OH H H XIX-17-.3 p-F-Ph H H CH(CH 3
)
2 Et OCH 3 F F OH H H XIX-17-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Et OCH3 F F OH H H XIX-17-5 p-F-Ph H H CH 2 Ph Et OCH 3 F F OH H H XIX-17-6 p-F-Ph H H CH 2 -indol-3-yl Et OCH 3 F F OH H H XIX-17-7 p-F-Ph H H CH 2
CH
2
SCH
3 Et OCH 3 F F OH H H XIX-17-8 p-F-Ph * H * Et OCH 3 F F OH H H Rl and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIX-18. N2 Rl R 2
R
3 " R 3 b R 4 R{ R 6 X Y R' R 8 XIX-18-1 p-Cl-Ph H H H Et OCH 3 F F OH H H XIX-18-2 p-Cl-Ph H H CH 3 Et OCH 3 F F OH H H XIX-18-3 p-Cl-Ph H H CH(CH 3
)
2 Et OCH 3 F F OH H H X2 Rl R 2 . Ra R b R4 R 5
R
6 X Y R7 RR XIX-18-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Et OCH 3 F F OH H H XIX-18-5 p-Cl-Ph H H CH 2 Ph Et OCH 3 F F OH H H XIX-18-6 p-Cl-Ph H H CH 2 -indol-3-yl Et OCH 3 F F OH H H XIX-18-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Et OCH 3 F F OH H H XIX-18-8 p-Cl-Ph * H * Et OCH 3 F F OH H H
*R
2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XIX-19. N2 R 2 Ri Rb R 4 R' R, X Y R' R XIX-19-1 p-Br-Ph H H H Et OCH 3 F F OH H H XIX-19--2 p-Br-Ph H H CH 3 Et OCH 3 F F OH H H XLX-19-3 p-Br-Ph H H CH(CH 3
)
2 Et OCH 3 F F OH H H XIX-19--4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Et OCH 3 F F OH H H XIX-19-5 p-Br-Ph H H CH 2 Ph Et OCH 3 F F OH H H XIX-19-6 p-Br-Ph H H CH 2 -indol-3-yl Et OCH 3 F F OH H H XIX-19-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Et OCH 3 F F OH H H XIX-19-8 p-Br-Ph * H * Et OCH 3 F F OH H H *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XIX-20. N2 Rl R 2
R
3 a R31 R 4 R' R' X Y R 7 XIX-20--1 p-I-Ph H H H Et OCH 3 F F OH H XIX-20-2 p-I-Ph H H CH 3 Et OCH 3 F F OH H XIX-20-3 p-I-Ph H H CH(CH 3
)
2 Et OCH 3 F F OH H XIX-20-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Et OCH 3 F F OH H XIX-20-5 p-I-Ph H H CH 2 Ph Et OCH 3 F F OH H XIX-20-6 p-I-Ph H H CH 2 -indol-3-yl Et OCH 3 F F OH H XIX-20-7 p-l-Ph H H CH 2
CH
2
SCH
3 Et OCH 3 F F OH H XIX-20-8 p-I-Ph * H * Et OCH 3 F F OH H 5 *Rrand Rjb joined together by (CH 2
)
3 to form five-membered ring. Table XIX-21. N2 R' R 2 Ra R 3 b R4 R 5
R
6 X Y R 7
R
8 XIX-21-1 CH 3 H H H 'Pr OCH 3 F F OH H H XIX-21-2 CH 3 H H CH 3 'Pr OCH 3 F F OH H H XIX-21-3 CH 3 H H CH(CH 3
)
2 'Pr OCH 3 F F OH H H XIX-21-4 CH 3 H H CH 2
CH(CH
3
)
2 'Pr OCH 3 F F OH H H A')7 N9 R' R2 R 3 a R 3 b R 4 R' R' X Y R 7 R XIX-21-5 CH 3 H H CH 2 Ph 'Pr OCH 3 F F OH H H XIX-21-6 CH 3 H H CH 2 -indol-3-yl 'Pr OCH 3 F F OH H H XIX-21-7 CH 3 H H CH 2
CH
2
SCH
3 'Pr OCH 3 F F OH H H XIX-21-8 CH 3 * H * 'Pr OCH 3 F F OH H H
*R
2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XIX-22. N2 RI R 2
R
3 a R 3 b R' R' R 6 X Y R 7
R
8 XIX-22-1 Et H H H 'Pr OCH 3 F F OH H H XIX-22-2 Et H H CH 3 'Pr OCH 3 F F OH H H XIX-22-3 Et H H CH(CH 3 )2 'Pr OCH 3 F F OH H H XIX-22-4 Et H H CH 2
CH(CH
3
)
2 'Pr OCH 3 F F OH H H XIX-22.-5 Et H H CH 2 Ph 'Pr OCH 3 F F OH H H XIX-22.-6 Et H H CH 2 -indol-3-yl 'Pr OCH 3 F F OH H H XIX-22-7 Et H H CH 2
CH
2
SCH
3 'Pr OCH 3 F F OH H H XIX-22.-8 Et * H * 'Pr OCH 3 F F OH H H *R2 and R-b joined together by (CH 2
)
3 to form five-membered ring. Table XIX-23. N2 R' R 2
R
3 aRb R 4 R R X Y R' R XIX-23-1 'Pr H H H Pr OCH 3 F F OH H H XIX-23-.2 'Pr H H CH 3 Pr OCH 3 F F OH H H XIX-23-3 'Pr H H CH(CH 3
)
2 Pr OCH 3 F F OH H H XIX-23-4 'Pr H H CH 2
CH(CH
3
)
2 Pr OCH 3 F F OH H H XIX-23--5 'Pr H H CH 2 Ph Pr OCH 3 F F OH H H XIX-23-6 'Pr H H CH 2 -indol-3-yl Pr OCH 3 F F OH H H XIX-23--7 'Pr H H CH 2
CH
2
SCH
3 Pr OCH 3 F F OH H H XIX-23-8 'Pr * H * Pr OCH 3 F F OH H H 5 *R' and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XIX-24. N R' R 2 Rla R 3 b R 4
R
5
R
6 X Y R 7
R
8 XIX-24-1 'Bu H H H 'Pr OCH 3 F F OH H H XIX-24-2 'Bu H H CH 3 'Pr OCH 3 F F OH H H XIX-24-3 'Bu H H CH(CH 3
)
2 'Pr OCH 3 F F OH H H XIX-24-4 'Bu H H CH 2
CH(CH
3
)
2 'Pr OCH 3 F F OH H H XIX-24-5 'Bu H H CH 2 Ph 'Pr OCH 3 F F OH H H A ') X R' R 2
R
3 a Rb R 4 R R X Y R' R XIX-24-6 'Bu H H CH 2 -indol-3-yl 'Pr OCH 3 F F OH H H XIX-24-7 'Bu H H CH 2
CH
2
SCH
3 'Pr OCH 3 F F OH H H XIX-24-8 'Bu * H * 'Pr OCH 3 F F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XIX-25. M R' R 2
R
3 " R 3 b R 4 R' R' X Y R 7 R 8 XIX-25-1 Ph H H H 'Pr OCH 3 F F OH H H XIX-25-2 Ph H H CH 3 'Pr OCH 3 F F OH H H XIX-25-3 Ph H H CH(CH 3
)
2 'Pr OCH 3 F F OH H H XIX-25-4 Ph H H CH 2
CH(CH
3
)
2 'Pr OCH 3 F F OH H H XIX-25-5 Ph H H CH 2 Ph 'Pr OCH 3 F F OH H H XIX-25-6 Ph H H CH 2 -indol-3-yl 'Pr OCH 3 F F OH H H XIX-25-7 Ph H H CH 2
CH
2
SCH
3 'Pr OCH 3 F F OH H H XIX-25-8 Ph * H * 'Pr OCH 3 F F OH H H *R2 and R b joined together by (CH 2
)
3 to form five-membered ring. Table XIX-26. X R' R 2 Ra R R 4 R' R 6 XY R R XIX-26- p-Me- H H H 'Pr OCH 3 F F OH H H Ph XIX-26-. p-Me- H H CH 3 'Pr OCH 3 F F OH H H 2 Ph XIX-26-. p-Me- H H CH(CH 3
)
2 'Pr OCH 3 F F OH H H 3 Ph XIX-26- p-Me- H H CH 2
CH(CH
3
)
2 'Pr OCH 3 F F OH H H 4 Ph XIX-26- p-Me- H H CH 2 Ph 'Pr OCH 3 F F OH H H 5 Ph XIX-26- p-Me- H H CH 2 -indol-3- 'Pr OCH 3 F F OH H H 6 Ph yl XIX-26- p-Me- H H CH 2
CH
2
SCH
3 'Pr OCH 3 F F OH H H 7 Ph XIX-26- p-Me- * H * 'Pr OCH 3 F F OH H H 8 Ph 5 *Rland R 3 joined together by (CH 2
)
3 to form five-membered ring. A'ln Table XIX-27. X2 R 2
R
3 a R 3 b R 4 R R X Y R R XIX-27-1 p-F-Ph H H H 'Pr OCH 3 F F OH H H XIX-27-2 p-F-Ph H H CH 3 'Pr OCH 3 F F OH H H XIX-27-3 p-F-Ph H H CH(CH 3
)
2 'Pr OCH 3 F F OH H H XIX-27-4 p-F-Ph H H CH 2
CH(CH
3
)
2 'Pr OCH 3 F F OH H H XIX-27-5 p-F-Ph H H CH 2 Ph 'Pr OCH 3 F F OH H H XIX-27-6 p-F-Ph H H CH 2 -indol-3-yl 'Pr OCH 3 F F OH H H XIX-27-7 p-F-Ph H H CH 2
CH
2
SCH
3 'Pr OCH 3 F F OH H H XIX-27-8 p-F-Ph * H * 'Pr OCH 3 F F OH H H *Rand R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XIX-28.
R
2
R
3
R
3
R
4 R' R' X Y R' R 8 XIX-28-1 p-Cl-Ph H H H 'Pr OCH 3 F F OH H H XIX-28-2 p-Cl-Ph H H CH 3 'Pr OCH 3 F F OH H H XIX-28-3 p-Cl-Ph H H CH(CH 3
)
2 'Pr OCH 3 F F OH H H XIX-28-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 'Pr OCH 3 F F OH H H XIX-28-5 p-Cl-Ph H H CH 2 Ph 'Pr OCH 3 F F OH H H XIX-28-6 p-Cl-Ph H H CH 2 -indol-3-yl 'Pr OCH 3 F F OH H H XIX-28-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 'Pr OCH 3 F F OH H H XIX-28-8 p-Cl-Ph * H * 'Pr OCH 3 F F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIX-29. 2 R' R 2 R" R 3
R
4 R' R 6 X Y R' R XIX-29-1 p-Br-Ph H H H 'Pr OCH 3 F F OH H H XIX-29--2 p-Br-Ph H H CH 3 'Pr OCH 3 F F OH H H XIX-29-3 p-Br-Ph H H CH(CH 3
)
2 'Pr OCH 3 F F OH H H XIX-29-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 'Pr OCH 3 F F OH H H XIX-29--5 p-Br-Ph H H CH 2 Ph 'Pr OCH 3 F F OH H H XIX-29-6 p-Br-Ph H H CH 2 -indol-3-yl 'Pr OCH 3 F F OH H H XIX-29-7 p-Br-Ph H H CH 2
CH
2
SCH
3 'Pr OCH 3 F F OH H H XIX-29-8 p-Br-Ph * H * 'Pr OCH 3 F F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. A -) Table XIX-30. 2 R R 2
R
3 a Rb R 4 R R' X Y R R XIX-30-1 p-I-Ph H H H 'Pr OCH 3 F F OH H H XIX-30-2 p-I-Ph H H CH 3 'Pr OCH 3 F F OH H H XIX-30-3 p-I-Ph H H CH(CH 3
)
2 'Pr OCH 3 F F OH H H XIX-30-4 p-I-Ph H H CH 2
CH(CH
3
)
2 'Pr OCH 3 F F OH H H XIX-30-5 p-I-Ph H H CH 2 Ph 'Pr OCH 3 F F OH H H XIX-30-6 p-I-Ph H H CH 2 -indol-3-yl 'Pr OCH 3 F F OH H H XIX-30-7 p-I-Ph H H CH 2
CH
2
SCH
3 'Pr OCH 3 F F OH H H XIX-30-8 p-I-Ph * H * 'Pr OCH 3 F F OH H H *R and Rdb joined together by (CH 2
)
3 to form five-membered ring. Table XIX-3 1. N2 RI R2 R 3 a R 3 b R' R' R 6 X Y R 7
R
8 XIX-31--1 CH 3 H H H "Bu OCH 3 F F OH H H XIX-31-2 CH 3 H H CH 3 "Bu OCH 3 F F OH H H XIX-31.3 CH 3 H H CH(CH 3
)
2 "Bu OCH 3 F F OH H H XIX-31-4 CH 3 H H CH 2
C.H(CH
3
)
2 "Bu OCH 3 F F OH H H XIX-31-5 CH 3 H H CH 2 Ph "Bu OCH 3 F F OH H H XIX-31-.6 CH 3 H H CH 2 -indol-3-yl "Bu OCH 3 F F OH H H XIX-31-7 CH 3 H H CH 2
CH
2
SCH
3 "Bu OCH 3 F F OH H H XIX-31-8 CH 3 * H * "Bu OCH 3 F F OH H H *Ri and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIX-32. X2 R' R 2
R
3 a R3b R4 R 5 R' X Y R 7 R 8 XIX-32-1 Et H H H "Bu OCH 3 F F OH H H XIX-32-2 Et H H CH 3 "Bu OCH 3 F F OH H H XIX-32-3 Et H H CH(CH 3
)
2 "Bu OCH 3 F F OH H H XIX-32-4 Et H H CH 2
CH(CH
3
)
2 "Bu OCH 3 F F OH H H XIX-32-5 Et H H CH 2 Ph "Bu OCH 3 F F OH H H XIX-32-6 Et H H CH 2 -indol-3-yl "Bu OCH 3 F F OH H H XIX-32-7 Et H H CH 2
CH
2
SCH
3 "Bu OCH 3 F F OH H H XIX-32-8 Et * H * "Bu OCH 3 F F OH H H *Rand R~b joined together by (CH 2
)
3 to form five-membered ring. A') 1 Table XIX-33. X2 Rt R 2 Ra RR R4 R 5 R" X Y R' R' XIX-33-1 'Pr H H H "Bu OCH 3 F F OH H H XIX-33-2 'Pr H H CH 3 "Bu OCH 3 F F OH H H XIX-33-3 'Pr H H CH(CH 3
)
2 "Bu OCH 3 F F OH H H XIX-33-4 'Pr H H CH 2
CH(CH
3
)
2 "Bu OCH 3 F F OH H H XIX-33-5 'Pr H H CH 2 Ph "Bu OCH 3 F F OH H H XIX-33-6 'Pr H H CH 2 -indol-3-yl "Bu OCH 3 F F OH H H XIX-33-7 'Pr H H CH 2
CH
2
SCH
3 "Bu OCH 3 F F OH H H XIX-33-8 'Pr * H * "Bu OCH 3 F F OH H H *Raind R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XIX-34. X2 R' R 2
R
3 a R3b R 4 R' R6 X Y R 7 R 8 XIX-34--1 'Bu H H H "Bu OCH 3 F F OH H H XIX-34-2 'Bu H H CH 3 "Bu OCH 3 F F OH H H XIX-34--3 'Bu H H CH(CH 3
)
2 "Bu OCH 3 F F OH H H XIX-34-4 'Bu H H CH 2
CH(CH
3
)
2 "Bu OCH 3 F F OH H H XIX-34-5 'Bu H H CHPh "Bu OCH 3 F F OH H H XIX-34-6 'Bu H H CH 2 -indol-3-yl "Bu OCH 3 F F OH H H XIX-34-7 'Bu H H CH 2
CH
2
SCH
3 "Bu OCH 3 F F OH H H XIX-34-8 tBu * H * "Bu OCH 3 F F OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIX-35. X2 R R 2 R aR3b R' R' R 6 X Y R 7
R
8 XIX-35-1 Ph H H H "Bu OCH 3 F F OH H H XIX-35-2 Ph H H CH 3 "Bu OCH 3 F F OH H H XIX-35-3 Ph H H CH(CH 3
)
2 "Bu OCH 3 F F OH H H XIX-35-4 Ph H H CH 2
CH(CH
3
)
2 "Bu OCH 3 F F OH H H XIX-35-5 Ph H H CH2Ph "Bu OCH 3 F F OH H H XIX-35-6 Ph H H CH 2 -indol-3-yl "Bu OCH 3 F F OH H H XIX-35-7 Ph H H CH 2
CH-
2
SCH
3 "Bu OCH 3 F F OH H H XIX-35-8 Ph * H * "Bu OCH 3 F F OH H H *R R 3 b joined together by (CH 2
)
3 to form five-membered ring. A I2) Table XIX-36. N2 R' R 2
R
3 a R 3 b R' R' R 6 X Y R 7
R
8 XIX-36- p-Me- H H H "Bu OCH 3 F F OH H H 1 Ph XIX-36- p-Me- H H CH 3 "Bu OCH 3 F F OH H H 2 Ph XIX-36- p-Me- H H CH(CH 3
)
2 "Bu OCH 3 F F OH H H 3 Ph XIX-36- p-Me- H H CH 2
CH(CH
3 )2 "Bu OCH 3 F F OH H H 4 Ph XIX-36- p-Me- H H C:H 2 Ph "Bu OCH 3 F F OH H H 5 Ph XIX-36- p-Me- H H CH 2 -indol-3- "Bu OCH 3 F F OH H H 6 Ph Y1 XIX-36- p-Me- H H CH 2
CH
2
SCH
3 "Bu OCH 3 F F OH H H 7 Ph XIX-36- p-Me- * H * "Bu OCH 3 F F OH H H Ph *R and R' joined together by (CH 2
)
3 to form five-membered ring. Table XIX-37.
SR
2
R
3 aR R 4 R R X Y R' R XIX-37-1 p-F-Ph H H H "Bu OCH 3 F F OH H H XIX-37-2 p-F-Ph H H CH 3 "Bu OCH 3 F F OH H H XIX-37-3 p-F-Ph H H CH(CH 3
)
2 "Bu OCH 3 F F OH H H XIX-37-4 p-F-Ph H H CH 2
CH(CH
3
)
2 "Bu OCH 3 F F OH H H XIX-37-5 p-F-Ph H H CH 2 Ph "Bu OCH 3 F F OH H H XIX-37-6 p-F-Ph H H CH 2 -indol-3-yl "Bu OCH 3 F F OH H H XIX-37-7 p-F-Ph H H CH 2
CH
2
SCH
3 "Bu OCH 3 F F OH H H XIX-37-8 p-F-Ph * H * "Bu OCH 3 F F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIX-38. N2 R 1
R
2 R3a R 3 b R 4 R 5 R 6 X Y R R7 R8 XIX-38- p-Cl- H H H "Bu OCH 3 F F OH H H 1 Ph XIX-38- p-Cl- H H CH 3 "Bu OCH 3 F F OH H H Ph A 'I X2 R' R 2
R
3 a R b R 4
R
5 R' X Y R 7
R
8 2 XIX-38- p-Cl- H H CH(CH 3
)
2 "Bu OCH 3 F F OH H H 3 Ph XIX-38- p-Cl- H H CH 2
CH(CH
3
)
2 "Bu OCH 3 F F OH H H 4 Ph XIX-38- p-Cl- H H CH 2 Ph "Bu OCH 3 F F OH H H 5 Ph XIX-38- p-Cl- H H CH 2 -indol-3- "Bu OCH 3 F F OH H H 6 Ph XIX-38- p-Cl- H H CH 2
CH
2
SCH
3 "Bu OCH 3 F F OH H H 7 Ph XIX-38- p-Cl- * H * "Bu OCH 3 F F OH H H 8 Ph *Rland R b joined together by (CH 2
)
3 to form five-membered ring. Table XIX-39. S R R 2
R
3 a R R R
R
5 RXY R 7 R XIX-39- p-Br- H H H "Bu OCH 3 F F OH H H 1 Ph XIX-39- p-Br- H H CH 3 "Bu OCH 3 F F OH H H 2 Ph XIX-39- p-Br- H H CH(CH 3
)
2 "Bu OCH 3 F F OH H H 3 Ph XIX-39-- p-Br- H H CH 2
CH(CH
3
)
2 "Bu OCH 3 F F OH H H 4 Ph XIX-39- p-Br- H H CH 2 Ph "Bu OCH 3 F F OH H H 5 Ph XIX-39- p-Br- H H CH 2 -indol-3- "Bu OCH 3 F F OH H H 6 Ph XIX-39- p-Br- H H CH 2
CH
2
SCH
3 "Bu OCH 3 F F OH H H 7 Ph XIX-39- p-Br- * H * "Bu OCH 3 F F OH H H 8 Ph *R and R joined together by (CH 2
)
3 to form five-membered ring.
Table XIX-40. N R R 2
R
3 a R 3 b R 4 R R' X Y R' R XIX-40-1 p-I-Ph H H H "Bu OCH 3 F F OH H H XIX-40-2 p-I-Ph H H CH 3 "Bu OCH 3 F F OH H H XIX-40-3 p-I-Ph H H CH(CH 3
)
2 "Bu OCH 3 F F OH H H XIX-40-4 p-I-Ph H H CH 2
CH(CH
3
)
2 "Bu OCH 3 F F OH H H XIX-40-5 p-I-Ph H H CH 2 Ph "Bu OCH 3 F F OH H H XIX-40-6 p-I-Ph H H CH 2 -indol-3-yl "Bu OCH 3 F F OH H H XIX-40-7 p-I-Ph H H CH 2
CH
2
SCH
3 "Bu OCH 3 F F OH H H XIX-40-8 p-I-Ph * H * "Bu OCH 3 F F OH H H *R and R 3 " joined together by (CH 2
)
3 to form five-membered ring. Table XIX-41. N! R' R 2 R a Rab R 4
R
5
R
6 X Y R 7
R
8 XIX-41-1 CH 3 H H H Bz OCH 3 F F OH H H XIX-41-2 CH 3 H H CH 3 Bz OCH 3 F F OH H H XIX-41-3 CH 3 H H CH(CH 3
)
2 Bz OCH 3 F F OH H H XIX-41-4 CH 3 H H CH 2
CH(CH
3
)
2 Bz OCH 3 F F OH H H XIX-41-5 CH 3 H H CH 2 Ph Bz OCH 3 F F OH H H XIX-41-6 CH 3 H H CH 2 -indol-3-yl Bz OCH 3 F F OH H H XIX-41-7 CH 3 H H CH 2
CH
2
SCH
3 Bz OCH 3 F F OH H H XIX-41-8 CH 3 * H * Bz OCH 3 F F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIX-42. N RI R 2
R
3 a R 3 b R 4
R
5 R X Y R R' XIX-42-1 Et H H H Bz OCH 3 F F OH H H XIX-42-.2 Et H H CH 3 Bz OCH 3 F F OH H H XIX-42-3 Et H H CH(CH 3
)
2 Bz OCH 3 F F OH H H XIX-42-4 Et H H CH 2
CH(CH
3
)
2 Bz OCH 3 F F OH H H XIX-42-5 Et H H CH 2 Ph Bz OCH 3 F F OH H H XIX-42-6 Et H H CH 2 -indol-3-yl Bz OCH 3 F F OH H H XIX-42-7 Et H H CH 2
CH
2
SCH
3 Bz OCH 3 F F OH H H XIX-42-8 Et * H * Bz OCH 3 F F OH H H R and Rdb joined together by (CH 2
)
3 to form five-membered ring.
Table XIX-43. N2 R R 2
R
3 a R A R 4 R' R' X Y R 7
R
8 XIX-43-1 'Pr H H H Bz OCH 3 F F OH H H XIX-43-2 'Pr H H CH 3 Bz OCH 3 F F OH H H XIX-43-3 'Pr H H CH(CH 3
)
2 Bz OCH 3 F F OH H H XIX-43-4 'Pr H H CH 2
CH(CH
3
)
2 Bz OCH 3 F F OH H H XIX-43-5 'Pr H H CH 2 Ph Bz OCH 3 F F OH H H XIX-43-6 'Pr H H CH 2 -indol-3-yl Bz OCH 3 F F OH H H XIX-43-7 'Pr H H CH 2
CH
2
SCH
3 Bz OCH 3 F F OH H H XIX-43-8 'Pr * H * Bz OCH 3 F F OH H H *R" and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XIX-44. X2 R' R2 R 3 a R 3 b R' R' R' X Y R 7
R
8 XIX-44.-1 'Bu H H H Bz OCH 3 F F OH H H XIX-44-2 'Bu H H CH 3 Bz OCH 3 F F OH H H XIX-44.3 'Bu H H CH(CH 3
)
2 Bz OCH 3 F F OH H H XIX-44-4 'Bu H H CH 2
CH(CH
3
)
2 Bz OCH 3 F F OH H H XIX-44-5 'Bu H H CH 2 Ph Bz OCH 3 F F OH H H XIX-44-6 'Bu H H CH 2 -indol-3-yl Bz OCH 3 F F OH H H XIX-44-7 'Bu H H CH 2
CH
2
SCH
3 Bz OCH 3 F F OH H H XIX-44-8 'Bu * H * Bz OCH 3 F F OH H H
*R
2 and Rab joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIX-45. N2 R' R 2
R
3 " R 3 A R4 R' R' X Y R 7
R
8 XIX-45-1 Ph H H H Bz OCH 3 F F OH H H XIX-45-2 Ph H H CH 3 Bz OCH 3 F F OH H H XIX-45-3 Ph H H CH(CH 3
)
2 Bz OCH 3 F F OH H H XIX-45-4 Ph H H CH 2
CH(CH
3
)
2 Bz OCH 3 F F OH H H XIX-45-5 Ph H H CH 2 Ph Bz OCH 3 F F OH H H XIX-45-6 Ph H H CH 2 -indol-3-yl Bz OCH 3 F F OH H H XIX-45-7 Ph H H CH 2
CH
2
SCH
3 Bz OCH 3 F F OH H H XIX-45-8 Ph * H * Bz OCH 3 F F OH H H *R and Rb joined together by (CH 2
)
3 to form five-membered ring. A 02f, Table XIX-46. N2 R R R R R 4 R' 6 X Y R R XIX-46- p-Me- H H H Bz OCH 3 F F OH H H 1 Ph XIX-46- p-Me- H H CH 3 Bz OCH 3 F F OH H H 2 Ph XIX-46- p-Me- H H CH(CH 3
)
2 Bz OCH 3 F F OH H H 3 Ph XIX-46- p-Me- H H CH 2
CH(CH
3
)
2 Bz OCH 3 F F OH H H 4 Ph XIX-46- p-Me- H H CH 2 Ph Bz OCH 3 F F OH H H 5 Ph XIX-46- p-Me- H H CH 2 -indol-3- Bz OCH 3 F F OH H H 6 Ph VI XIX-46- p-Me- H H CH 2
CH
2
SCH
3 Bz OCH 3 F F OH H H 7 Ph XIX-46- p-Me- * H * Bz OCH 3 F F OH H H 8 Ph *R7 and R.'b joined together by (CH 2
)
3 to form five-membered ring. Table XIX-47. X2 R' R2 R 3 a Rob R4 R' R 6 X Y RR 8 XIX-47-1 p-F-Ph H H H Bz OCH 3 F F OH H H XIX-47--2 p-F-Ph H H CH 3 Bz OCH 3 F F OH H H XIX-47-3 p-F-Ph H H CH(CH 3
)
2 Bz OCH 3 F F OH H H XIX-47-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Bz OCH3 F F OH H H XIX-47-5 p-F-Ph H H CH 2 Ph Bz OCH 3 F F OH H H XIX-47-6 p-F-Ph H H C1 2 -indol-3-yl Bz OCH 3 F F OH H H XIX-47-7 p-F-Ph H H CH 2
CH
2
SCH
3 Bz OCH 3 F F OH H H XIX-47-8 p-F-Ph * H * Bz OCH 3 F F OH H H *RTand R lb joined together by (CH 2
)
3 to form five-membered ring. 5 Table XIX-48. SR R 2 RaRb R4R R R 6 XY R' R XIX-48-1 p-Cl-Ph H H H Bz OCH 3 F F OH H H XIX-48-2 p-Cl-Ph H H CH 3 Bz OCH 3 F F OH H H XIX-48-3 p-Cl-Ph H H CH(CH 3
)
2 Bz OCH 3 F F OH H H A 1 '7 N9 Rl R 2 R3" RAb R 4 R 5 R X Y R' R' XIX-48-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Bz OCH 3 F F OH H H XIX-48-5 p-Cl-Ph H H CH 2 Ph Bz OCH 3 F F OH H H XIX-48-6 p-Cl-Ph H H CH 2 -indol-3-yl Bz OCH 3 F F OH H H XIX-48-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Bz OCH 3 F F OH H H XIX-48-8 p-Cl-Ph * H * Bz OCH 3 F F OH H H
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XIX-49. N Rl R 2 R R 3 b R 4
R
5
R
6 X Y R' R 8 XIX-49-1 p-Br-Ph H H H Bz OCH 3 F F OH H H XIX-49-2 p-Br-Ph H H CH 3 Bz OCH 3 F F OH H H XIX-49-3 p-Br-Ph H H CH(CH 3
)
2 Bz OCH 3 F F OH H H XIX-49-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Bz OCH 3 F F OH H H XIX-49-5 p-Br-Ph H H CH 2 Ph Bz OCH 3 F F OH H H XIX-49-6 p-Br-Ph H H CH 2 -indol-3-yl Bz OCH 3 F F OH H H XIX-49-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Bz OCH 3 F F OH H H XIX-49-8 p-Br-Ph * H * Bz OCH 3 F F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XIX-50. N2 R R 2 Ra R" R 4 R' R 6 X Y R' R' XIX-50--1 p-I-Ph H H H Bz OCH 3 F F OH H H XIX-50-2 p-I-Ph H H CH 3 Bz OCH 3 F F OH H H XIX-50-.3 p-I-Ph H H CH(CH 3
)
2 Bz OCH 3 F F OH H H XIX-50-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Bz OCH 3 F F OH H H XIX-50--5 p-I-Ph H H CH 2 Ph Bz OCH 3 F F OH H H XIX-50-6 p-I-Ph H H CH 2 -indol-3-yl Bz OCH 3 F F OH H H XIX-50-7 p-I-Ph H H CF 2
CH
2
SCH
3 Bz OCH 3 F F OH H H XIX-50-8 p-I-Ph * H * Bz OCH 3 F F OH H H 5 *R and R3b joined together by (CH 2
)
3 to form five-membered ring. A I Q 0
R
8 NH R3b R O || R7 N O
R
3 a N-P-O O C0 2
R
4
OR
1 R6 Y X xx Table XX-1. N2 R R 2 RaRab R4 R' R' X Y R R' XX-1-1 CH 3 H H H CH 3
OCH
3 H F OH H H XX-1-2 CH 3 H H CH 3
CH
3
OCH
3 H F OH H H XX-1-3 CH 3 H H CH(CH 3
)
2
CH
3
OCH
3 H F OH H H XX-1-4 CH 3 H H CH 2
CH(CH
3
)
2
CH
3
OCH
3 H F OH H H XX-1-5 CH 3 H H CH 2 Ph CH 3
OCH
3 H F OH H H XX-1-6 CH 3 H H CH 2 -indol-3-yl CH 3
OCH
3 H F OH H H XX-1-7 CH 3 H H CH 2
CH
2 SCH3 CH 3
OCH
3 H F OH H H XX-1-8 CH 3 * H * CH3 OCH 3 H F OH H H *R2 and R b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XX-2. N2 R1 R 2
R
3 a R 3 b R 4 RI5 R' X Y R 7
R
8 XX-2-1 Et H H H CH 3
OCH
3 H F OH H H XX-2-2 Et H H CH 3
CH
3
OCH
3 H F OH H H XX-2-3 Et H H CH(CH 3 )2 CH 3
OCH
3 H F OH H H XX-2-4 Et H H CH 2
CH(CH
3
)
2
CH
3
OCH
3 H F OH H H XX-2-5 Et H H CH 2 Ph CH 3
OCH
3 H F OH H H XX-2-6 Et H H CH 2 -indol-3-yl CH 3
OCH
3 H F OH H H XX-2-7 Et H H CH 2
CH
2
SCH
3
CH
3
OCH
3 H F OH H H XX-2-8 Et * H * CH 3
OCH
3 H F OH H H *R7 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. A "I(' Table XX-3. 2 R R
R
R
3 ' R 3 b R 4
R
5 R' X Y R' R 8 XX-3-1 'Pr H H H CH 3
OCH
3 H F OH H H XX-3-2 'Pr H H CH 3
CH
3
OCH
3 H F OH H H XX-3-3 'Pr H H CH(CH 3
)
2
CH
3
OCH
3 H F OH H H XX-3-4 'Pr H H CH 2
CH(CH
3
)
2
CH
3
OCH
3 H F OH H H XX-3-5 'Pr H H CH 2 Ph CH 3
OCH
3 H F OH H H XX-3-6 'Pr H H CH 2 -indol-3-yl CH 3
OCH
3 H F OH H H XX-3-7 'Pr H H CH 2
CH
2
SCH
3
CH
3
OCH
3 H F OH H H XX-3-8 'Pr * H * CH3 OCH 3 H F OH H H *R and R' joined together by (CH 2
)
3 to form five-membered ring. Table XX-4. X2 R' R 2 Ra Rb R 4 R' R' X Y R 7
R
8 XX-4-1 'Bu H H H CH 3
OCH
3 H F OH H H XX-4-2 'Bu H H CH 3
CH
3
OCH
3 H F OH H H XX-4-3 'Bu H H CH(CH 3
)
2
CH
3
OCH
3 H F OH H H XX-4-4 'Bu H H CH 2
CH(CH
3
)
2
CH
3
OCH
3 H F OH H H XX-4-5 'Bu H H CH 2 Ph CH 3
OCH
3 H F OH H H XX-4-6 'Bu H H CH 2 -indol-3-yl CH 3
OCH
3 H F OH H H XX-4-7 'Bu H H CH 2 CH2SCH 3
CH
3
OCH
3 H F OH H H XX-4-8 'Bu * H * CH 3
OCH
3 H F OH H H *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XX-5. N2 R' R2 R3a R 3 b R 4 R' RT X Y R 7
R
8 XX-5-1 Ph H H H CH 3
OCH
3 H F OH H H XX-5-2 Ph H H CH 3 CH3 OCH 3 H F OH H H XX-5-3 Ph H H CH(CH 3
)
2
CH
3
OCH
3 H F OH H H XX-5-4 Ph H H CH 2
CH(CH
3
)
2
CH
3
OCH
3 H F OH H H XX-5-5 Ph H H CH 2 Ph CH 3
OCH
3 H F OH H H XX-5-6 Ph H H CH 2 -indol-3-yl CH 3
OCH
3 H F OH H H XX-5-7 Ph H H CH 2
CH
2
SCH
3 CH3 OCH 3 H F OH H H XX-5-8 Ph * H * CH 3
OCH
3 H F OH H H
*R
2 7and R3b joined together by (CH 2
)
3 to form five-membered ring.
AAA~
Table XX-6. S RR 2
R
3
R
3 b R 4 R' R' X Y R' R XX-6-1 p-Me-Ph H H H CH 3
OCH
3 H F OH H H XX-6-2 p-Me-Ph H H CH 3
CH
3
OCH
3 H F OH H H XX-6-3 p-Me-Ph H H CH(CH 3
)
2
CH
3
OCH
3 H F OH H H XX-6-4 p-Me-Ph H H CH 2
CH(CH
3
)
2
CH
3
OCH
3 H F OH H H XX-6-5 p-Me-Ph H H C.H 2 Ph CH 3
OCH
3 H F OH H H XX-6-6 p-Me-Ph H H CH 2 -indol-3-yl CH 3
OCH
3 H F OH H H XX-6-7 p-Me-Ph H H CH 2 CH2SCH 3
CH
3
OCH
3 H F OH H H XX-6-8 p-Me-Ph * H * CH 3
OCH
3 H F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XX-7. N2 R- R 2 Ra Rb R 4 R) R 6 XY R' R XX-7-1 p-F-Ph H H H CH 3
OCH
3 H F OH H H XX-7-2 p-F-Ph H H CH 3
CH
3
OCH
3 H F OH H H XX-7-3 p-F-Ph H H CH(CH 3
)
2
CH
3
OCH
3 H F OH H H XX-7-4 p-F-Ph H H CH 2
CH(CH
3
)
2
CH
3
OCH
3 H F OH H H XX-7-6 p-F-Ph H H CH2Ph CH 3
OCH
3 H F OH H H XX-7-7 p-F-Ph H H CH 2 -indol-3-yl CH 3
OCH
3 H F OH H H XX-7-8 p-F-Ph H H CH 2
CH
2
SCH
3
CH
3
OCH
3 H F OH H H XX-7-20 p-F-Ph * H * CH 3
OCH
3 H F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XX-8. N2 R' R2 R 3 a R A R4 R' R6 X Y R 7
R
8 XX-8-1 p-Cl-Ph H H H CH 3
OCH
3 H F OH H H XX-8-2 p-Cl-Ph H H CH 3
CH
3
OCH
3 H F OH H H XX-8-3 p-Cl-Ph H H CH(CH 3
)
2
CH
3
OCH
3 H F OH H H XX-8-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2
CH
3
OCH
3 H F OH H H XX-8-5 p-Cl-Ph H H CH 2 Ph CH 3
OCH
3 H F OH H H XX-8-6 p-Cl-Ph H H CH 2 -indol-3-yl CH 3
OCH
3 H F OH H H XX-8-7 p-Cl-Ph H H CH2CH 2
SCH
3
CH
3
OCH
3 H F OH H H XX-8-8 p-Cl-Ph * H * CH 3
OCH
3 H F OH H H *R and Rib joined together by (CH 2
)
3 to form five-membered ring. AA 1 Table XX-9. N R R 2 Ra Rb R 4
R
5 R X Y R R XX-9-1 p-Br- H H H CH 3
OCH
3 H F OH H H Ph XX-9-2 p-Br- H H CH 3
CH
3
OCH
3 H F OH H H Ph XX-9-3 p-Br- H H CH(CH 3
)
2
CH
3
OCH
3 H F OH H H Ph XX-9-4 p-Br- H H CH 2
CH(CH
3
)
2
CH
3
OCH
3 H F OH H H Ph XX-9-6 p-Br- H H CH 2 Ph CH 3
OCH
3 H F OH H H Ph XX-9-7 p-Br- H H CH 2 -indol-3-yl CH 3
OCH
3 H F OH H H Ph XX-9-8 p-Br- H H CH 2
CH
2
SCH
3
CH
3
OCH
3 H F OH H H Ph XX-9- p-Br- * H * CH 3
OCH
3 H F OH H H 20 Ph *R-and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XX-10. S R' R 2 RaRb R R 5 R' X Y R R XX-10-1 p-I-Ph H H H CH 3
OCH
3 H F OH H H XX-10-2 p-I-Ph H H CH 3
CH
3
OCH
3 H F OH H H XX-10-3 p-I-Ph H H CH(CH 3
)
2
CH
3
OCH
3 H F OH H H XX-10-4 p-I-Ph H H CH 2
CH(CH
3
)
2
CH
3
OCH
3 H F OH H H XX-10-5 p-I-Ph H H CH2Ph CH 3
OCH
3 H F OH H H XX-10-6 p-I-Ph H H CH2-indol-3-yl CH 3
OCH
3 H F OH H H XX-10-7 p-I-Ph H H CH 2
CH
2
SCH
3
CH
3
OCH
3 H F OH H H XX-10-8 p-I-Ph * H * CH 3
OCH
3 H F OH H H *R" and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XX-11. X2 R' R 2 RMRab R 4 R' RXY R' R XX-11-1 CH 3 H H H Et OCH 3 H F OH H H XX-11-2 CH 3 H H CH 3 Et OCH 3 H F OH H H XX-11-3 CH 3 H H CH(CH 3
)
2 Et OCH 3 H F OH H H XX-11-4 CH 3 H H CH 2
CH(CH
3
)
2 Et OCH 3 H F OH H H XX-11-5 CH 3 H H CH 2 Ph Et OCH 3 H F OH H H XX-11-6 CH 3 H H CH 2 -indol-3-yl Et OCH 3 H F OH H H XX-11-7 CH 3 H H CH 2
CH
2
SCH
3 Et OCH 3 H F OH H H A A 1) X2 R' R2 R3a R 3 b R4 R 5 R' X Y R 7
R
8 XX-11-8 CH 3 * H * Et OCH 3 H F OH H H *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XX-12. X2 R' R 2
R
3 a R 3 b R 4
R
5 R' X Y RI R' XX-12-1 Et H H H Et OCH3 H F OH H H XX-12-2 Et H H CH 3 Et OCH 3 H F OH H H XX-12-3 Et H H CH(CH 3
)
2 Et OCH 3 H F OH H H XX-12-4 Et H H CH 2
CH(CH
3
)
2 Et OCH 3 H F OH H H XX-12-5 Et H H CH 2 Ph Et OCH 3 H F OH H H XX-12-6 Et H H CH 2 -indol-3-yl Et OCH 3 H F OH H H XX-12-7 Et H H CH 2
CHSCH
3 Et OCH 3 H F OH H H XX-12-8 Et * H * Et OCH 3 H F OH H H *R" and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XX-13. N2 R' R 2
R
3 a R 3 b R 4
R
5
R
6 X Y R' R' XX-13-1 'Pr H H H Et OCH 3 H F OH H H XX-13-2 'Pr H H CH 3 Et 0GW3 H F OH H H XX-13-3 'Pr H H CH(CH 3
)
2 Et OCH 3 H F OH H H XX-13-4 'Pr H H CH 2
CH(CH
3
)
2 Et OCH 3 H F OH H H XX-13-5 'Pr H H CH 2 Ph Et OCH 3 H F OH H H XX-13-6 'Pr H H CH 2 -indol-3-yi Et OCH 3 H F OH H H XX-13-7 'Pr H H CH 2
CH
2
SCH
3 Et OCH 3 H F OH H H XX-13-8 'Pr * H CH Et OCH 3 H F OH H H 5 *R and R 3b joined together by (CH 2
)
3 to form five-membered ring. A Al2 Table XX-14. N2 R1 R 2
R
3 a R 3 b R' R' R 6 X Y R 7 Ra XX-14-1 'Bu H H H Et OCH 3 H F OH H H XX-14-2 'Bu H H CH 3 Et OCH 3 H F OH H H XX-14-3 'Bu H H CH(CH 3
)
2 Et OCH 3 H F OH H H XX-14-4 'Bu H H CH 2
CH(CH
3
)
2 Et OCH 3 H F OH H H XX-14-5 'Bu H H CH 2 Ph Et OCH 3 H F OH H H XX-14-6 'Bu H H CH 2 -indol-3-yl Et OCH 3 H F OH H H XX-14-7 'Bu H H CH 2
CH
2
SCH
3 Et OCH 3 H F OH H H XX-14-8 'Bu * H * Et OCH 3 H F OH H H *R2 and RIb joined together by (CH 2
)
3 to form five-membered ring. Table XX-15. N R1 R2 R 3a R 3 b R 4
R
5 R' X Y R7 R 8 XX-15-1 Ph H H H Et OCH3 H F OH H H XX-15-2 Ph H H CH 3 Et OCH 3 H F OH H H XX-15-3 Ph H H CH(CH 3
)
2 Et OCH 3 H F OH H H XX-15-4 Ph H H CH 2
CH(CH
3
)
2 Et OCH 3 H F OH H H XX-15-5 Ph H H CH 2 Ph Et OCH 3 H F OH H H XX-15-6 Ph H H CH 2 -indol-3-yl Et OCH 3 H F OH H H XX-15-7 Ph H H CH 2
CH
2
SCH
3 Et OCH 3 H F OH H H XX-15-8 Ph * H * Et OCH 3 H F OH H H *R1 and R 1 joined together by (CH 2
)
3 to form five-membered ring. 5 Table XX-16. 2 RI R2 R 3 a R 3 b R 4
R
5
R
6 X Y R 7
R
8 XX-16-1 p-Me-Ph H H H Et OCH 3 H F OH H H XX-16-2 p-Me-Ph H H CH 3 Et OCH 3 H F OH H H XX-16-3 p-Me-Ph H H CH(CH 3
)
2 Et OCH 3 H F OH H H XX-16-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Et OCH 3 H F OH H H XX-16-5 p-Me-Ph H H CH 2 Ph Et OCH 3 H F OH H H XX-16-6 p-Me-Ph H H CH 2 -indol-3-yl Et OCH 3 H F OH H H XX-16- 7 p-Me-Ph H H CH 2
CH
2
SCH
3 Et OCH 3 H F OH H H XX-16-8 p-Me-Ph * H * Et OCH 3 H F OH H H *R' and Rib joined together by (CH 2
)
3 to form five-membered ring.
AAA
Table XX-17. X2 R' R 2 R3a R 3 b R' R' R 6 X Y R 7 R' XX-17-1 p-F-Ph H H H Et OCH 3 H F OH H H XX-17-2 p-F-Ph H H CH 3 Et OCH 3 H F OH H H XX-17-3 p-F-Ph H H CH(CH 3
)
2 Et OCH 3 H F OH H H XX-17-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Et OCH 3 H F OH H H XX-17-5 p-F-Ph H H CH 2 Ph Et OCH 3 H F OH H H XX-17-6 p-F-Ph H H CH 2 -indol-3-yl Et OCH 3 H F OH H H4 XX-17-7 p-F-Ph H H CH 2
CH
2
SCH
3 Et OCH 3 H F OH H H XX-17-8 p-F-Ph * H * Et OCH 3 H F OH H H
R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XX-18. N2 Rl R 2 R3a R3b R' R' R6 X Y R' R XX-18-1 p-Cl-Ph H H H Et OCH 3 H F OH H H XX-18-2 p-Cl-Ph H H CH 3 Et OCH 3 H F OH H H XX-18-3 p-Cl-Ph H H CH(CH 3
)
2 Ft OCH 3 H F OH H H XX-18-4 p-Cl-Ph H H CI 2
CH(CH
3
)
2 Et OCH 3 H F OH H H XX-18-5 p-Cl-Ph H H CH 2 Ph Et OCH 3 H F OH H H XX-18-6 p-Cl-Ph H H CH 2 -indol-3-y Et OCH 3 H F OH H H XX-18-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Et OCH 3 H F OH H H XX-18-8 p-Cl-Ph * H CH Et OCH 3 H F OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XX-19. N2 Rl R 2
R
3 a Rib R' R' R 6 X Y R' R 8 XX-19-1 p-Br-Ph H H H Et OCH 3 H F OH H H XX-19-2 p-Br-Ph H H CH 3 Et OCH 3 H F OH H H XX-19-3 p-Br-Ph H H CH(CH 3
)
2 Et OCH 3 H F OH H H XX-19-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Et OCH 3 H F OH H H XX-19-5 p-Br-Ph H H CH 2 Ph Et OCH 3 H F OH H H XX-19-6 p-Br-Ph H H CH 2 -indol-3-yl Et OCH 3 H F OH H H XX-19-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Et OCH 3 H F OH H H XX-19-8 p-Br-Ph H H CH Et OCH 3 H F OH H H
*R-
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. A A Table XX-20. X R' R 2 R a R 3 b R R R' X Y R' R' XX-20-1 p-I-Ph H H H Et OCH 3 H F OH H H XX-20-2 p-I-Ph H H CH 3 Et OCH 3 H F OH H H XX-20-3 p-I-Ph H H CH(CH 3
)
2 Et OCH 3 H F OH H H XX-20-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Et OCH 3 H F OH H H XX-20-5 p-I-Ph H H CH 2 Ph Et OCH 3 H F OH H H XX-20-6 p-I-Ph H H CH 2 -indol-3-yl Et OCH 3 H F OH H H XX-20-7 p-I-Ph H H CH 2
CH
2
SCH
3 Et OCH 3 H F OH H H XX-20-8 p-I-Ph * H * Et OCH 3 H F OH H H *iR2 and R 3 6 joined together by (CH 2
)
3 to form five-membered ring. Table XX-2 1. X R' R 2
R
3 a R R 4 R' R' X Y R 7
R
8 XX-21-1 CH 3 H H H 'Pr OCH 3 H F OH H H XX-21-2 CH 3 H H CH 3 'Pr OCH 3 H F OH H H XX-21-3 CH 3 H H CH(CH 3
)
2 'Pr OCH 3 H F OH H H XX-21-4 CH 3 H H CH 2
CH(CH
3
)
2 'Pr OCH 3 H F OH H H XX-21-5 CH 3 H H CH2Ph 'Pr OCH 3 H F OH H H XX-21-6 CH 3 H H CH 2 -indol-3-yl 'Pr OCH 3 H F OH H H XX-21-7 CH 3 H H CH2CH2SCH 3 'Pr OCH 3 H F OH H H XX-21-8 CH 3 * H * 'Pr OCH 3 H F OH H H
*R
2 and R-b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XX-22. 2 R' R 2
R
3 a R 3 b R 4 R' R' X Y R 7
R
8 XX-22-1 Et H H H 'Pr OCH 3 H F OH H H XX-22-2 Et H H CH 3 Pr OCH 3 H F OH H H XX-22-3 Et H H CH(CH 3
)
2 'Pr OCH 3 H F OH H H XX-22-4 Et H H CH 2
CH(CH
3
)
2 Pr OCH 3 H F OH H H XX-22-5 Et H H CH 2 Ph 'Pr OCH 3 H F OH H H XX-22-6 Et H H CH 2 -indol-3-yl 'Pr OCH 3 H F OH H H XX-22-7 Et H H CH 2
CH
2
SCH
3 'Pr OCH 3 H F OH H H XX-22-8 Et * H * Pr OCH 3 H F OH H H *RT2and Rb joined together by (CH 2
)
3 to form five-membered ring. - AAA Table XX-23. N2 R' R2 R3a R3b R 4 R' R 6 X Y R 7
R
8 XX-23-1 'Pr H H H 'Pr OCH 3 H F OH H H XX-23-2 'Pr H H CH 3 'Pr OCH 3 H F OH H H XX-23-.3 'Pr H H CH(CH 3
)
2 'Pr OCH 3 H F OH H H XX-23-4 'Pr H H CH 2
CH(CH
3
)
2 'Pr OCH 3 H F OH H H XX-23-5 'Pr H H CHPh 'Pr OCH 3 H F OH H H XX-23-6 'Pr H H CH 2 -indol-3-yl 'Pr OCH 3 H F OH H H XX-23-7 'Pr H H CH 2
CH
2
SCH
3 'Pr OCH 3 H F OH H H XX-23-8 'Pr * H * 'Pr OCH 3 H F OH H H *R and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XX-24. N2 R' R2 R a R3b R 4 R5 R 6 X Y R 7
R
8 XX-24-1 'Bu H H H 'Pr OCH 3 H F OH H H XX-24-2 'Bu H H CH 3 'Pr OCH 3 H F OH H H XX-24-3 'Bu H H CH(CH 3
)
2 'Pr OCH 3 H F OH H H XX-24-4 'Bu H H CH 2
CH(CH
3
)
2 'Pr OCH 3 H F OH H H XX-24-5 'Bu H H CH 2 Ph 'Pr OCH 3 H F OH H H XX-24-6 'Bu H H CH2-indol-3-yl 'Pr OCH 3 H F OH H H XX-24-7 'Bu H H CH 2
CH
2
SCH
3 'Pr OCH 3 H F OH H H XX-24-8 'Bu * H * 'Pr OCH 3 H F OH H H *R and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XX-25. N2 R' R 2 R3a R3b R' R5 R 6 X Y R 7
R
8 XX-25-1 Ph H H H 'Pr OCH 3 H F OH H H XX-25-2 Ph H H CH 3 'Pr OCH 3 H F OH H H XX-25-3 Ph H H CH(CH 3
)
2 'Pr OCH 3 H F OH H H XX-25-4 Ph H H CH 2
CH(CH
3
)
2 'Pr OCH 3 H F OH H H XX-25-5 Ph H H CH 2 Ph 'Pr OCH 3 H F OH H H XX-25-6 Ph H H CH 2 -indol-3-yl 'Pr OCH 3 H F OH H H XX-25-7 Ph H H CH 2
CH
2
SCH
3 'Pr OCH 3 H F OH H H XX-25-8 Ph * H * 'Pr OCH 3 H F OH H H
*R
2 and R3b joined together by (CH 2
)
3 to form five-membered ring. A A '7 Table XX-26. N2 R1 R 2
R
3 aR 3 b R R' R XY R' R XX-26-1 p-Me-Ph H H H 'Pr OCH 3 H F OH H H XX-26-2 p-Me-Ph H H CH 3 'Pr OCH 3 H F OH H H XX-26-3 p-Me-Ph H H CH(CH 3
)
2 'Pr OCH 3 H F OH H H XX-26-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 'Pr OCH 3 H F OH H H XX-26-5 p-Me-Ph H H CH 2 Ph 'Pr OCH 3 H F OH H H XX-26-6 p-Me-Ph H H CH 2 -indol-3-yl 'Pr OCH 3 H F OH H H XX-26-7 p-Me-Ph H H CH 2
CH
2
SCH
3 'Pr OCH 3 H F OH H H XX-26-8 p-Me-Ph * H * 'Pr OCH 3 H F OH H H *RTand Rb joined together by (CH 2
)
3 to form five-membered ring. Table XX-27. N2 R R 2
R
3 a R 3 b R4 R 5
R
6 X Y R 7
R
8 XX-27-1 p-F-Ph H H H 'Pr OCH 3 H F OH H H XX-27-2 p-F-Ph H H CH 3 'Pr OCH 3 H F OH H H XX-27-3 p-F-Ph H H CH(CH 3
)
2 'Pr OCH 3 H F OH H H XX-27-4 p-F-Ph H H CH 2
CH(CH
3
)
2 'Pr OCH 3 H F OH H H XX-27-5 p-F-Ph. H H CH2Ph 'Pr OCH 3 H F OH H 1H XX-27-6 p-F-Ph H H CH2-indol-3-yl 'Pr OCH 3 H F OH H H XX-27-7 p-F-Ph H H CH 2
CH
2
SCH
3 'Pr OCH 3 H F OH H H XX-27-8 p-F-Ph * H * 'Pr OCH 3 H F OH H H *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XX-28. N2 R1 R2 R 3a R 3 b R 4 R' R' X Y R7 R 8 XX-28-1 p-Cl-Ph H H H 'Pr OCH 3 H F OH H H XX-28-2 p-Cl-Ph H H CH 3 'Pr OCH 3 H F OH H H XX-28-3 p-Cl-Ph H H CH(CH 3
)
2 'Pr OCH 3 H F OH H H XX-28-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 'Pr OCH 3 H F OH H H XX-28-5 p-Cl-Ph H H CH 2 Ph 'Pr OCH 3 H F OH H H XX-28-6 p-Cl-Ph H H CH2-indol-3-yl 'Pr OCH 3 H F OH H H XX-28-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 'Pr OCH 3 H F OH H H XX-28-8 p-Cl-Ph * H * 'Pr OCH 3 H F OH H H *R and R 3 1 joined together by (CH 2
)
3 to form five-membered ring.
-AAQ
Table XX-29. NV R' R2 R 3 a R 3 b R4 R 5
R
6 X Y R 7
R
8 XX-29-1 p-Br-Ph H H H 'Pr OCH 3 H F OH H H XX-29-2 p-Br-Ph H H CH 3 'Pr OCH 3 H F OH H H XX-29-3 p-Br-Ph H H CH(CH 3
)
2 'Pr OCH 3 H F OH H H XX-29-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 'Pr OCH 3 H F OH H H XX-29-5 p-Br-Ph H H CH 2 Ph 'Pr OCH 3 H F OH H H XX-29-6 p-Br-Ph H H CH 2 -indol-3-yl 'Pr OCH 3 H F OH H H XX-29-7 p-Br-Ph H H CH 2
CH
2
SCH
3 'Pr OCH 3 H F OH H H XX-29-8 p-Br-Ph * H * 'Pr OCH 3 H F OH H H *R2 and R b joined together by (CH 2
)
3 to form five-membered ring. Table XX-30. N2 R' R2 R 3 a R 3 b R' R' R 6 X Y R 7
R
8 XX-30-1 p-I-Ph H H H 'Pr OCH 3 H F OH H H XX-30-2 p-I-Ph H H CH 3 'Pr OCH 3 H F OH H H XX-30-3 p-I-Ph H H CH(CH 3
)
2 'Pr OCH 3 H F OH H H XX-30-4 p-I-Ph H H CH 2
CH(CH
3
)
2 'Pr OCH 3 H F OH H F XX-30-5 p-I-Ph H H CH 2 Ph 'Pr OCH 3 H F OH H H XX-30-6 p-I-Ph H H CH 2 -indol-3-yl 'Pr OCH 3 H F OH H H XX-30-7 p-I-Ph H H CH 2
CH
2
SCH
3 'Pr OCH 3 H F OH H H XX-30-8 p-I-Ph * H * 'Pr OCH 3 H F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XX-3 1. N2 R' R 2
R
3 a R 3 b R. R' R 6 X Y R' R' XX-31-1 CH 3 H H H "Bu OCH 3 H F OH H H XX-31-2 CH 3 H H CH 3 "Bu OCH 3 H F OH H H XX-31-3 CH 3 H H CH(CH3) 2 "Bu OCH 3 H F OH H H XX-31-4 CH 3 H H CH 2
CH(CH
3
)
2 "Bu OCH 3 H F OH H H XX-31-5 CH 3 H H CH 2 Ph "Bu OCH 3 H F OH H H XX-31-6 CH 3 H H CH 2 -indol-3-yl "Bu OCH 3 H F OH H H XX-31-7 CH 3 H H CH 2
CH
2
SCH
3 "Bu OCH 3 H F OH H H XX-31-8 CH 3 * H * "Bu OCH 3 H F OH H H *R7 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. _ AAG Table XX-32. N2 R1 R2 R 3a R 3 b R' R5 R' X Y R 7 R8 XX-32-1 Et H H H "Bu OCH 3 H F OH H H XX-32-2 Et H H CH 3 "Bu OCH 3 H F OH H H XX-32-3 Et H H CH(CH 3
)
2 "Bu OCH 3 H F OH H H XX-32-4 Et H H CH 2
CH(CH
3
)
2 "Bu OCH 3 H F OH H H XX-32-5 Et H H CH 2 Ph "Bu OCH 3 H F OH H H XX-32-6 Et H H CH 2 -indol-3-yl "Bu OCH 3 H F OH H H XX-32-7 Et H H CH 2
CHSCH
3 "Bu OCH 3 H F OH H H XX-32-8 Et * H * "Bu OCH 3 H F OH H H *RT and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XX-33. X2 R' R2 R3 Ra3b R 4 R' R X Y R' R' XX-33-1 'Pr H H H "Bu OCH 3 H F OH H H XX-33-2 'Pr H H CH 3 "Bu OCH 3 H F OH H H XX-33-3 'Pr H H CH(CH 3 )2 "Bu OCH 3 H F OH H H XX-33-4 'Pr H H CH 2
CH(CH
3
)
2 "Bu OCH 3 H F OH H H XX-33-5 'Pr H H CH 2 Ph "Bu OCH 3 H F OH H H XX-33-6 'Pr H H CH 2 -indol-3-yl "Bu OCH 3 H F OH H H XX-33-7 'Pr H H CH 2
CH
2
SCH
3 "Bu OCH 3 H F OH H H XX-33-8 'Pr * H * "Bu OCH 3 H F OH H H *RTand R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XX-34. N2 R R2 R3a R3b R 4
R
5 R' X Y R' 7 R XX-34-1 'Bu H H H "Bu OCH 3 H F OH H H XX-34-2 'Bu H H CH 3 "Bu OCH 3 H F OH H H XX-34-3 'Bu H H CH(CH 3
)
2 "Bu OCH 3 H F OH H H XX-34-4 'Bu H H CH 2
CH(CH
3
)
2 "Bu OCH 3 H F OH H H XX-34-5 'Bu H H CH 2 Ph "Bu OCH 3 H F OH H H XX-34-6 'Bu H H CH 2 -indol-3-yl "Bu OCH 3 H F OH H H XX-34-7 'Bu H H CH 2 CH2SCH 3 "Bu OCH 3 H F OH H H XX-34-8 'Bu * H * "Bu OCH 3 H F OH H H *RR2 ad R3b joined together by (CH 2
)
3 to form five-membered ring. Table XX-35. X2 R' R2 R 3a R3b R 4 R 5 R' X Y R 7
R
8 -ArI) NS R 1 R2 R 3 a Rb R 4 R' R' X Y R 7 R XX-35-1 Ph H H H "Bu OCH 3 H F OH H H XX-35-2 Ph H H CH 3 "Bu OCH 3 H F OH H H XX-35-3 Ph H H CH(CH 3
)
2 "Bu OCH 3 H F OH H H XX-35-4 Ph H H CH 2
CH(CH
3
)
2 "Bu OCH 3 H F OH H H XX-35-5 Ph H H CH 2 Ph "Bu OCH 3 H F OH H H XX-35-6 Ph H H CH 2 -indol-3-yI "Bu OCH 3 H F OH H H XX-35-7 Ph H H CH 2
CH
2
SCH
3 "Bu OCH 3 H F OH H H XX-35-8 Ph * H * "Bu OCH 3 H F OH H H *7 and R b joined together by (CH 2
)
3 to form five-membered ring. Table XX-36. N2 R' R 2
R
3 a R 3 b R 4
R
5 R' X Y R 7
R
8 XX-36- p-Me- H H H "Bu OCH 3 H F OH H H Ph XX-36- p-Me- H H CH 3 "Bu OCH 3 H F OH H H 2 Ph XX-36- p-Me- H H CH(CH 3
)
2 "Bu OCH 3 H F OH H H 3 Ph XX-36- p-Me- H H CH 2
CH(CH
3
)
2 "Bu OCH 3 H F OH H H 4Ph XX-36- p-Me- H H CH 2 Ph "Bu OCH 3 H F OH H H 5 Ph XX-36- p-Me- H H CH2-indol-3- "Bu OCH 3 H F OH H H 6 Ph Yl XX-36- p-Me- H H CH2CH 2
SCH
3 "Bu OCH 3 H F OH H H 7 Ph XX-36- p-Me- * H * "Bu OCH 3 H F OH H H 8 Ph *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XX-37. NS R1 R 2
R
3 a R 3 b R 4 R R 6 X Y R 7 R XX-37-1 p-F-Ph H H H "Bu OCH 3 H F OH H H XX-37-2 p-F-Ph H H CH 3 "Bu OCH 3 H F OH H H XX-37-3 p-F-Ph H H CH(CH 3
)
2 "Bu OCH 3 H F OH H H XX-37-4 p-F-Ph H H CH2CH(CH 3
)
2 "Bu OCH 3 H F OH H H AC1 N9 Rl R 2
R
3 a R 31
R
4 R' R' X Y R 7
R
8 XX-37-5 p-F-Ph H H CH1 2 Ph "Bu OCH 3 H F OH H H XX-37-6 p-F-Ph H H CH 2 -indol-3-yl "Bu OCH 3 H F OH H H XX-37-7 p-F-Ph H H CH 2
CH
2
SCH
3 "Bu OCH 3 H F OH H H XX-37-8 p-F-Ph * H * "Bu OCH 3 H F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XX-38. X2 R R 2
R
3 a R 3
R
4 R R X Y R' R XX-38-1 p-Cl-Ph H H H "Bu OCH 3 H F OH H H XX-38-2 p-Cl-Ph H H CH 3 "Bu OCH 3 H F OH H H XX-38-3 p-Cl-Ph H H CH(CH 3
)
2 "Bu OCH 3 H F OH H H XX-38-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 "Bu OCH 3 H F OH H H XX-38-5 p-Cl-Ph H H CH 2 Ph "Bu OCH 3 H F OH H H XX-38-6 p-Cl-Ph H H CH 2 -indol-3-yl "Bu OCH 3 H F OH H H XX-38-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 "Bu OCH 3 H F OH H H XX-38-8 p-Cl-Ph * H * "Bu OCH 3 H F OH H H *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XX-39. X2 R' R2 R 3 a Rb R4 R 3 R' X Y R 7 R XX-39-1 p-Br-Ph H H H "Bu OCH 3 H F OH H H XX-39-2 p-Br-Ph H H CH 3 "Bu OCH 3 H F OH H H XX-39-3 p-Br-Ph H H CH(CH 3
)
2 "Bu OCH 3 H F OH H H XX-39-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 "Bu OCH 3 H F OH H H XX-39-5 p-Br-Ph H H CH 2 Ph "Bu OCH 3 H F OH H H XX-39-6 p-Br-Ph H H CH 2 -indol-3-yl "Bu OCH 3 H F OH H H XX-39-7 p-Br-Ph H H CH 2
CH
2
SCH
3 "Bu OCH 3 H F OH H H XX-39-8 p-Br-Ph * H * "Bu OCH 3 H F OH H H 5 *RTand R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XX-40. X2 R R 2
R
3 aR R 4 R R' X Y R R XX-40-1 p-I-Ph H H H "Bu OCH 3 H F OH H H XX-40-2 p-I-Ph H H CH 3 'Bu OCH 3 H F OH H H1 XX-40-3 p-I-Ph H H CH(CH 3
)
2 "Bu OCH 3 H F OH H H XX-40-4 p-I-Ph H H CH 2
CH(CH
3
)
2 "Bu OCH 3 H F OH H H XX-40-5 p-I-Ph H H CH 2 Ph "Bu OCH 3 H F OH H H X A " HO XR R 2 Ra Rab PR R' R XY R' R' XX-40-6 p-I-Ph H H CH-indol-3-yl "Bu OCH 3 H F OH H H XX-40-7 p-I-Ph H H CH 2
CH
2
SCH
3 "Bu OCH 3 H F OH H H XX-40-8 p-I-Ph * H * "Bu OCH 3 H F OH H H *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XX-4 1. 2 R' R2 2
R
3 a R 3 b R 4
R
5 R' X Y R 7
R
8 XX-41-1 CH 3 H H H Bz OCH 3 H F OH H H XX-41-2 CH 3 H H CH 3 Bz OCH 3 H F OH H H XX-41-3 CH 3 H H CH(CH 3
)
2 Bz OCH 3 H F OH H H XX-41-4 CH 3 H H CH 2
CH(CH
3
)
2 Bz OCH 3 H F OH H H XX-41-5 CH 3 H H CH 2 Ph Bz OCH 3 H F OH H H XX-41-6 CH 3 H H CH 2 -indol-3-yl Bz OCH 3 H F OH H H XX-41-7 CH 3 H H CH 2
CH
2
SCH
3 Bz OCH 3 H F OH H H XX-41-8 CH 3 * H * Bz OCH 3 H F OH H H *R2 and R36 joined together by (CH 2
)
3 to form five-membered ring. Table XX-42. X2 RI R 2
R
3 a RA R 4 R' R' X Y R 7
R
8 XX-42-1 Et H H H Bz OCH3 H F OH H H XX-42-2 Et H H CH 3 Bz OCH 3 H F OH H H XX-42-3 Et H H CH(CHI) 2 Bz OCH H F OH H H XX-42-4 Et H H CH 2
CH(CH
3
)
2 Bz OCH 3 H F OH H H XX-42-5 Et H H CH 2 Ph Bz OCH 3 H F OH H H XX-42-6 Et H H CH 2 -indol-3-yl Bz OCH 3 H F OH H H XX-42-7 Et H H CH 2
CH
2
SCH
3 Bz OCH 3 H F OH H H XX-42-8 Et * H * Bz OCH 3 H F OH H H 5 *Rland R 3 joined together by (CH 2
)
3 to form five-membered ring. Table XX-43. X2 R' R 2
R
3 a Rb R 4 R R' X Y R R 8 XX-43-1 'Pr H H H Bz OCH 3 H F OH H H XX-43-2 'Pr H H CH 3 Bz OCH 3 H F OH H H XX-43-3 'Pr H H CH(CH 3
)
2 Bz OCH 3 H F OH H H XX-43-4 'Pr H H CH 2
CH(CH
3
)
2 Bz OCH 3 H F OH H H XX-43-5 'Pr H H CH 2 Ph Bz OCH 3 H F OH H H XX-43-6 'Pr H H CH 2 -indol-3-yl Bz OCH 3 H F OH H H XX-43-7 'Pr H H CH 2
CH
2
SCH
3 Bz OCH 3 H F OH H H XX-43-8 'Pr * H * Bz OCH 3 H F OH H H *RT and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XX-44. N9 R' R 2 R3a R 3 b R 4 R 5 R' X Y R 7
R
8 XX-44-1 'Bu H H H Bz OCH 3 H F OH H H XX-44-2 'Bu H H CH 3 Bz OCH 3 H F OH H H XX-44-3 'Bu H H CH(CH 3
)
2 Bz OCH 3 H F OH H H XX-44-4 'Bu H H CH 2
CH(CH
3
)
2 Bz OCH 3 H F OH H H XX-44-5 'Bu H H CH 2 Ph Bz OCH 3 H F OH H H XX-44-6 'Bu H H CH 2 -indol-3-yl Bz OCH 3 H F OH H H XX-44-7 'Bu H H CH 2
CH
2 SCH3 Bz OCH 3 H F OH H H XX-44-8 'Bu * H * Bz OCH 3 H F OH H H *R2 and R b joined together by (CH 2
)
3 to form five-membered ring. Table XX-45. N9 RI R 2
R
3 a R 3 b R 4 R' R' X Y R7 R 8 XX-45-1 Ph H H H Bz OCH 3 H F OH H H XX-45-2 Ph H H CH 3 Bz OCH 3 H F OH H H XX-45-3 Ph H. H CH(CH 3
)
2 Bz OCH 3 H F OH H H XX-45-4 Ph H H CH 2
CH(CH
3
)
2 Bz OCH 3 H F OH H H XX-45-5 Ph H H CH 2 Ph Bz OCH 3 H F OH H H XX-45-6 Ph H H CH 2 -indol-3-yl Bz OCH 3 H F OH H H XX-45-7 Ph H H CH 2 CH2SCH 3 Bz OCH 3 H F OH H H XX-45-8 Ph * H * Bz OCH 3 H F OH H H 5 *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. A IZA Table XX-46. X R' R 2
R
3 a R 3 b R' R' R' X Y R' R XX-46-1 p-Me-Ph H H H Bz OCH 3 H F OH H H XX-46-2 p-Me-Ph H H CH 3 Bz OCH 3 H F OH H H XX-46-3 p-Me-Ph H H CH(CH 3
)
2 Bz OCH 3 H F OH H H XX-46-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Bz OCH 3 H F OH H H XX-46-5 p-Me-Ph H H CH 2 Ph Bz OCH 3 H F OH H H XX-46-6 p-Me-Ph H H CH 2 -indol-3-yl Bz OCH 3 H F OH H H XX-46-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Bz OCH 3 H F OH H H XX-46-8 p-Me-Ph * H * Bz OCH 3 H F OH H H Rand Rb joined together by (CH 2
)
3 to form five-membered ring. Table XX-47. X R' R 2 R3a R 3 b R' R' R 6 X Y R 7
R
8 XX-47-I p-F-Ph H H H Bz OCH 3 H F OH H H XX-47-2 p-F-Ph H H CH 3 Bz OCH 3 H F OH H H XX-47-3 p-F-Ph H H CH(CH 3
)
2 Bz OCH 3 H F OH H H XX-47-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Bz OCH 3 H F OH H H XX-47-5 p-F-Ph H H CH 2 Ph Bz OCH 3 H F OH H H XX-47-6 p-F-Ph H H CH 2 -indol-3-yl Bz OCH 3 H F OH H H XX-47-7 p-F-Ph H H CH 2
CH
2
SCH
3 Bz OCH 3 H F OH H H XX-47-8 p-F-Ph * H * Bz OCH 3 H F OH H H *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XX-48. M R. 2 R aR R 4 R R' X Y R7 R' XX-48-1 p-Cl-Ph H H H Bz OCH 3 H F OH H H XX-48-2 p-Cl-Ph H H CH 3 Bz OCH 3 H F OH H H XX-48-3 p-Cl-Ph H H CHI(CH 3
)
2 Bz OCH 3 H F OH H H XX-48-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Bz OCH 3 H F OH H H XX-48-5 p-Cl-Ph H H CH 2 Ph Bz OCH 3 H F OH H H XX-48-6 p-Cl-Ph H H CH 2 -indol-3-yl Bz OCH 3 H F OH H H XX-48-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Bz OCH 3 H F OH H H XX-48-8 p-Cl-Ph * H * Bz OCH 3 H F OH H H *R nd R'b joined together by (CH 2
)
3 to form five-membered ring.
Table XX-49. SR R 2 Ra Rb R 4 R R XY R R XX-49-1 p-Br-Ph H H H Bz OCH 3 H F OH H H XX-49-2 p-Br-Ph H H CH 3 Bz OCH 3 H F OH H H XX-49-3 p-Br-Ph H H CH(CH 3
)
2 Bz OCH 3 H F OH H H XX-49-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Bz OCH 3 H F OH H H XX-49-5 p-Br-Ph H H CH 2 Ph Bz OCH 3 H F OH H H XX-49-6 p-Br-Ph H H CH 2 -indol-3-yl Bz OCH 3 H F OH H H XX-49-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Bz OCH 3 H F OH H H XX-49-8 p-Br-Ph * H * Bz OCH 3 H F OH H H *R anid R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XX-50. 2 R1 R 2 R 3a R 3 b R 4 R R' X Y R' R' XX-50-1 p-I-Ph H H H Bz OCH 3 H F OH H H XX-50-2 p-I-Ph H H CH 3 Bz OCH 3 H F OH H H XX-50-3 p-I-Ph H H CH(CH3) 2 Bz OCH 3 H F OH H H XX-50-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Bz OCH 3 H F OH H H XX-50-5 p-I-Ph H H CH 2 Ph Bz OCH 3 H F OH H H XX-50-6 p-I-Ph H H CH 2 -indol-3-yl Bz OCH 3 H F OH H H XX-50-7 p-I-Ph H H CH 2
CH
2
SCH
3 Bz OCH 3 H F OH H H XX-50-8 p-I-Ph * H * Bz OCH 3 H F OH H H
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 N R3b R2 O N R3a O N C0 2
R
4
OR
1 R'
R
6
NH
2 Y X XXI 10 _A IA Table XXI- 1. N2 R' R2 R 3 a R A R 4 R' R' X Y XXI-1-1 CH 3 H H H CH 3 H CH 3 F OH XXI-1-2 CH 3 H H CH 3
CH
3 H CH 3 F OH XXI-1-3 CH 3 H H CH(CH 3
)
2
CH
3 H CH 3 F OH XXI-1-4 CH 3 H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH XXI-1-5 CH 3 H H CH 2 Ph CH 3 H CH 3 F OH XXI-1-6 CH 3 H H CH 2 -indol-3-yl CH 3 H CH 3 F OH XXI-1-7 CH 3 H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH XXI-1-8 CH 3 * H * CH 3 H CH 3 F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXI-2. N R' R 2 R 3 a R 3 b R 4
R
5
R
6 X Y XXI-2-1. Et H H H CH 3 H CH 3 F OH XXI-2-2 Et H H CH 3
CH
3 H CH 3 F OH XXI-2-3 Et H H CH(CH 3 )2 CH 3 H CH 3 F OH XXI-2-4 Et H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH XXI-2-5 Et H H CH 2 Ph CH 3 H CH 3 F OH XXI-2-6 Et H H CH 2 -indol-3-yl CH 3 H CH 3 F OH XXI-2-7 Et H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH XXI-2-8 Et * H * CH 3 H CH 3 F QH *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXI-3. N! R' R 2
R
3 " R 3 b R 4
R
5
R
6 X Y XXI-3-1 'Pr H H H CH 3 H CH 3 F OH XXI-3-2 'Pr H H CH 3
CH
3 H CH 3 F OH XXI-3-3 'Pr H H CH(CH 3
)
2
CH
3 H CH 3 F OR XXI-3-4 'Pr H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH XXI-3-5 'Pr H H CH 2 Ph CH 3 H CH 3 F OH XXI-3-6 'Pr H H CH2-indol-3-yI CH 3 H CH 3 F OH XXI-3-7 'Pr H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH XXI-3-8 'Pr * H * CH 3 H CH 3 F OH *R and R joined together by (CH 2
)
3 to form five-membered ring. -A ,7 Table XXI-4. N2 R' R 2 R3a R 3 b R 4 RI R 6 X Y XXI-4-1 'Bu H H H CH 3 H CH 3 F OH XXI-4-2 'Bu H H CH 3
CH
3 H CH 3 F OH XXI-4-3 'Bu H H CH(CH 3
)
2
CH
3 H CH 3 F OH XXI-4-4 'Bu H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH XXI-4-5 'Bu H H CH 2 Ph CH 3 H CH 3 F OH XXI-4-6 'Bu H H CH 2 -indol-3-yl CH 3 H CH 3 F OH XXI-4-7 'Bu H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH XXI-4-8 'Bu * H * CH 3 H CH 3 F OH
*R
2 and R"' joined together by (CH 2
)
3 to form five-membered ring. Table XXI-5. N2 R' R2 R 3 a R 3 b R' R' R' X Y XXI-5-1 Ph H H H CH 3 H CH 3 F OH XXI-5-2 Ph H H CH 3
CH
3 H CH 3 F OH XXI-5-3 Ph H H CH(CH 3
)
2
CH
3 H CH 3 F OH XXI-5-4 Ph H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH XXI-5-5 Ph H H CH 2 Ph CH 3 H CH 3 F OH XXI-5-6 Ph H H CH 2 -indol-3-yl CH 3 H CH 3 F OH XXI-5-7 Ph H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH XXI-5-8 Ph * H * CH 3 H CH 3 F OH *RT and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXI-6. N2 RT R 2 R3a R 3 b R 4 R 5 R 6 x Y XXI-6-1 p-Me-Ph H H H CH 3 H CH 3 F OH XXI-6-2 p-Me-Ph H H CH 3
CH
3 H CH 3 F OH XXI-6-3 p-Me-Ph H H CH(CH 3
)
2
CH
3 H CH 3 F OH XXI-6-4 p-Me-Ph H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH XXI-6-5 p-Me-Ph H H CH 2 Ph CH 3 H CH 3 F OH XXI-6-6 p-Me-Ph H H CH 2 -indol-3-yl CH 3 -,H CH 3 F OH XXI-6-7 p-Me-Ph H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH XXI-6-8 p-Me-Ph * H * CH 3 H CH 3 F OH *Rr and Rb joined together by (CH 2
)
3 to form five-membered ring.
-A;Q
Table XXI-7. N2 R1 R 2
R
3 a R 3 b R 4 R' R' X Y XXI-7-1 p-F-Ph H H H CH 3 H CH 3 F OH XXI-7-2 p-F-Ph H H CH 3
CH
3 H CH 3 F OH XXI-7-3 p-F-Ph H H CH(CH 3
)
2
CH
3 H CH 3 F OH XXI-7-4 p-F-Ph H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH XXI-7-6 p-F-Ph H H CH 2 Ph CH 3 H CH 3 F OH XXI-7-7 p-F-Ph H H CH 2 -indol-3-yl CH 3 H CH 3 F OH XXI-7-8 p-F-Ph H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH XXI-7-20 p-F-Ph * H * CH 3 H CH 3 F OH *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXI-8. N2 R1 R 2
R
3 a Rab R 4
R
5
R
6 X Y XXI-8-1 p-Cl-Ph H H H CH 3 H CH 3 F OH XXI-8-2 p-Cl-Ph H H CH 3
CH
3 H CH 3 F OH XXI-8-3 p-Cl-Ph H H CH(CH 3
)
2
CH
3 H CH 3 F OH XXI-8-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH XXI-8-5 p-Cl-Ph H H CH2Ph CH 3 H CH 3 F OH XXI-8-6 p-Cl-Ph H H CH 2 -indol-3-yl CH 3 H CH 3 F OH XXI-8-7 p-Cl-Ph H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH XXI-8-8 p-Cl-Ph * H * CH 3 H CH 3 F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXI-9. X2 R1 R 2 Ria Rab R 4 R' R6 X y XXI-9-1 p-Br-Ph H H H CH 3 H CH 3 F OH XXI-9-2 p-Br-Ph H H CH 3
CH
3 H CH 3 F OH XXI-9-3 p-Br-Ph H H CH(CH 3
)
2
CH
3 H CH 3 F OH XXI-9-4 p-Br-Ph H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH XXI-9-6 p-Br-Ph H H CH 2 Ph CH 3 H CH 3 F OH XXI-9-7 p-Br-Ph H H CH 2 -indol-3-yl CH 3 H CH 3 F OH XXI-9-8 p-Br-Ph H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH XXI-9-20 p-Br-Ph * H * CH 3 H CH 3 F OH *R and Rab joined together by (CH 2
)
3 to form five-membered ring. A rO Table XXI-10. NOR R 2 Ra" Rib R4 R 5 R x Y XXI-10-1 p-I-Ph H H H CH 3 H CH 3 F OH XXI 10-2 p-I-Ph H H CH 3
CH
3 H CH 3 F OH XXI-10-3 p-I-Ph H H CH(CH 3
)
2
CH
3 H CH 3 F OH XXI-10-4 p-I-Ph H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH XXI-10-5 p-I-Ph H H CH 2 Ph CH 3 H CH 3 F OH XXI-10-6 p-I-Ph H H CH 2 -indol-3-yl CH 3 H CH 3 F OH XXI-10-7 p-I-Ph H H CH2CH 2
SCH
3
CH
3 H CH 3 F OH XXI-10-8 p-I-Ph * H * CH 3 H CH 3 F OH *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XXI- 11. N2 R' R 2 R3a R 3 b R 4 R' R 6 X Y XXI-11- CH 3 H H H Et H CH 3 F OH XXI-11-2 CH 3 H H CH 3 Et H CH 3 F OH XXI-11--3 CH 3 H H CH(CH 3
)
2 Et H CH 3 F OH XXI-11-4 CH 3 H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH XXI-1-5 CH 3 H H CH 2 Ph Et H CH 3 F OH XXI-11-6 CH 3 H H CH 2 -indol-3-yl Et H CH 3 F OH XXI-11-7 CH 3 H H CH 2
CH
2
SCH
3 Et H CH 3 F OH XXI-11-8 CH 3 * H * Et H CH 3 F OH *R" and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXI-12.
R
1 R 32 R 3 a R
(
b R 4 R R6 X Y XXI-12-1 Et H H H Et H CH 3 F OH XXI-12-2 Et H H CH 3 Et H CH 3 F OH XXI-12-3 Et H H CH(CH 3
)
2 Et H CH 3 F OH XXI-12-4 Et H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH XXI-12-5 Et H H CH 2 Ph Et H CH 3 F OH XXI-12-6 Et H H CH 2 -indol-3-yl Et H CH 3 F OH XXI-12-7 Et H H CH 2
CH
2
SCH
3 Et H CH 3 F OH XXI-12-8 Et * H * Et H CH 3 F OH *R and Rib joined together by (CH 2
)
3 to form five-membered ring. A 4AI Table XXI-13. NV R I R 2 R R 3 a R R'R' X Y XXI-13-1 'Pr H H H Et H CH 3 F OH XXI-13-2 'Pr H H CH 3 Et H CH 3 F OH XXI-13-3 'Pr H H CH(CH 3
)
2 Et H CH 3 F OH XXI-13.-4 'Pr H H CH 2 CIi(CH 3
)
2 Et H CH 3 F OH XXI-13-5 'Pr H H CH 2 Ph Et H CH 3 F OH XXI-13..6 'Pr H H CH 2 -indol-3-yl Et H CH 3 F OH XXI-13-7 'Pr H H CH 2
CH
2
SCH
3 Et H CH 3 F OH XXI-13-8 'Pr * H * Et H CH 3 F OH *R2 and RIb joined together by (CH 2
)
3 to form five-membered ring. Table XXI-14. N2 R R 2
R
3 a R 3 b R 4 RI R 6 x Y XXI-14-1 'Bu H H H Et H CH 3 F OH XXI-14--2 'Bu H H CH 3 Et H CH 3 F OH XXI-14-3 'Bu H H CH(CH 3 )2 Et H CH 3 F OH XXI-14-4 'Bu H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH XXI-14-5 'Bu H H CH 2 Ph Et H CH 3 F OH XXI-14-6 'Bu H H CH 2 -indol-3-yl Et H CH 3 F OH XXI-14-7 'Bu H H CH 2
CH
2
SCH
3 Et H CH 3 F OH XXI-14-8 'Bu * H * Et H CH 3 F OH *R1 and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXI-15. N2 R' R2 R la RI3b R 4 R' R 6 X y XXI-15-1 Ph H H H Et H CH 3 F OH XXI-15-2 Ph H H CH 3 Et H CH 3 F OH XXI-15-3 Ph H H CH(CH 3
)
2 Et H CH 3 F OH XXI-15-4 Ph H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH XXI-15-5 Ph H H CH 2 Ph Et H CH 3 F OH XXI-15-6 Ph H H CH 2 -indol-3-yl Et H CH 3 F OH XXI-15-7 Ph H H CH 2 CH2SCH 3 Et H CH 3 F OH XXI-15-8 Ph * H * Et H CH 3 F OH *R7 and R3b joined together by (CH 2
)
3 to form five-membered ring. A A 1 Table XXI-16. N2 R R 2 R3a R 3 b R 4 R' R6 X Y XXI-16-1 p-Me-Ph H H H Et H CH 3 F OH XXI-16-2 p-Me-Ph H H CH 3 Et H CH 3 F OH XXI-16-3 p-Me-Ph H H CH(CH 3
)
2 Et H CH 3 F OH XXI-16-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH XXI-16.-5 p-Me-Ph H H CH 2 Ph Et H CH 3 F OH XXI-16-6 p-Me-Ph H H CH 2 -indol-3-yl Et H CH 3 F OH XXI-16-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Et H CH 3 F OH XXI-16-8 p-Me-Ph * H * Et H CH 3 F OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXI-17. X2 R 4
R
5 R X Y XXI-17--1 p-F-Ph H H H Et H CH 3 F OH XXI-17-2 p-F-Ph H H CH 3 Et H CH 3 F OH XXI-17-3 p-F-Ph H H CH(CH 3
)
2 Et H CH 3 F OH XXI-17-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH XXI-17-5 p-F-Ph H H CH 2 Ph Et H CH 3 F OH XXI-17-6 p-F-Ph H H CH 2 -indol-3-yl Et H CH 3 F OH XXI-17-7 p-F-Ph H H CH 2
CH
2
SCH
3 Et H CH 3 F OH XXI-17-8 p-F-Ph * H * Et H CH 3 F OH *RTand R 3 " joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXI-18. SRI R2 R3a R3b R 4 R R X Y XXI-18-1 p-Cl-Ph H H H Et H CH 3 F OH XXI-18-2 p-Cl-Ph H H CH 3 Et H CH 3 F OH XXI-18-3 p-Cl-Ph H H CH(CH 3
)
2 Et H CH 3 F OH XXI-18-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH XXI-18-5 p-Cl-Ph H H CH 2 Ph Et H CH 3 F OH XXI-18-6 p-Cl-Ph H H CH 2 -indol-3-yl Et H CH 3 F OH XXI-18-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Et H CH 3 F OH XXI-18-8 p-Cl-Ph * H * Et H CH 3 F OH *R1 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XXI-19. X. Rl R 2
R
3 a R 3 b R4 R 5
R
6 X Y XXI-19-1 p-Br-Ph H H H Et H CH 3 F OH XXI-19-2 p-Br-Ph H H CH 3 Et H CH 3 F OH XXI-19-3 p-Br-Ph H H CH(CH 3
)
2 Et H CH 3 F OH XXI-19-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH XXI-19-5 p-Br-Ph H H CH 2 Ph Et H CH 3 F OH XXI-19-6 p-Br-Ph H H CH 2 -indol-3-yl Et H CH 3 F OH XXI-19-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Et H CH 3 F OH XXI-19-8 p-Br-Ph * H * Et H CH 3 F OH *R2 and R"b joined together by (CH 2
)
3 to form five-membered ring. Table XXI-20. N2 Rl R 2
R
3 a Rb R 4 R' R' X Y XXI-20-- p-I-Ph H H H Et H CH 3 F OH XXI-20-2 p-I-Ph H H CH 3 Et H CH 3 F OH XXI-20--3 p-I-Ph H H CH(CH 3
)
2 Et H CH 3 F OH XXI-20-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH XXI-20-5 p-I-Ph H H CH 2 Ph Et H CH 3 F OH XXI-20-6 p-I-Ph H H CH 2 -indol-3-yl Et H CH 3 F OH XXI-20-7 p-I-Ph H H CH 2
CH
2
SCH
3 Et H CH 3 F OH XXI-20-8 p-I-Ph * H * Et H CH 3 F OH *R2 and Rb joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXI-2 1. N2 R R2 R 3 a R3b R 4 R' R' X Y XXI-21-1 CH 3 H H H 'Pr H CH 3 F OH XXI-21-2 CH 3 H H CH 3 'Pr H CH 3 F OH XXI-21-3 CH 3 H H CH(CH 3
)
2 'Pr H CH 3 F OH XXI-21-4 CH 3 H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH XXI-21-5 CH 3 H H CH 2 Ph 'Pr H CH 3 F OH XXI-21-6 CH 3 H H CH 2 -indol-3-yl 'Pr H CH 3 F OH XXI-21-7 CH 3 H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH XXI-21-8 CH 3 * H * 'Pr H CH 3 F OH *R nd Rib joined together by (CH 2
)
3 to form five-membered ring.
Table XXI-22. N2 RI R 2
R
3 a R 3 b R 4 R' R' X Y XXI-22-1 Et H H H 'Pr H CH 3 F OH XXI-22-2 Et H H CH 3 'Pr H CH 3 F OH XXI-22-3 Et H H CH(CH 3
)
2 'Pr H CH 3 F OH XXI-22-4 Et H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH XXI-22-5 Et H H CH 2 Ph 'Pr H CH 3 F OH XXI-22-6 Et H H CH 2 -indol-3-yl 'Pr H CH 3 F OH XXI-22-7 Et H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH XXI-22-8 Et * H * 'Pr H CH 3 F OH *RT and R b joined together by (CH 2
)
3 to form five-membered ring. Table XXI-23. N2 R R2 R 3 a R 3 b R 4 R' R' X Y XXI-23-1 'Pr H H H 'Pr H CH 3 F OH XXI-23-.2 'Pr H H CH 3 'Pr H CH 3 F OH XXI-23-3 'Pr H H CH(CH 3
)
2 'Pr H CH 3 F OH XXI-23-4 'Pr H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH XXI-23-5 'Pr H H CH 2 Ph 'Pr H CH 3 F OH XXI-23-6 'Pr H H CH 2 -indol-3-yl 'Pr H CH 3 F OH XXI-23-7 'Pr H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH XXI-23-8 'Pr * H * 'Pr H CH 3 F OH *R2 and R3b joined together by (CH2)3 to form five-membered ring. 5 Table XXI-24. NV R R 2
R
3 a R 3 b R 4 R' R 6 X Y XXI-24-1 'Bu H H H 'Pr H CH 3 F OH XXI-24-2 'Bu H H CH 3 'Pr H CH 3 F OH XXI-24-3 'Bu H H CH(CH 3
)
2 'Pr H CH 3 F OH XXI-24-4 'Bu H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH XXI-24-5 'Bu H H CH 2 Ph 'Pr H CH 3 F OH XXI-24-6 'Bu H H CH 2 -indol-3-yl 'Pr H CH 3 F OH XXI-24-7 'Bu H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH XXI-24-8 'Bu * H * 'Pr H CH 3 F OH R and R 3 tb joined together by (CH 2
)
3 to form five-membered ring. AC A Table XXI-25. RI R 2
R
3 a R 3 b R 4 R' R 6 X Y XXI-25-1 Ph H H H 'Pr H CH 3 F OH XXI-25-2 Ph H H CH 3 'Pr H CH 3 F OH XXI-25-3 Ph H H CH(CH 3
)
2 'Pr H CH 3 F OH XXI-25-4 Ph H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH XXI-25-5 Ph H H CH 2 Ph 'Pr H CH 3 F OH XXI-25-6 Ph H H CH2-indol-3-yl 'Pr H CH 3 F OH XXI-25-7 Ph H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH XXI-25-8 Ph * H * 'Pr H CH 3 F OH *R2 and R"b joined together by (CH 2
)
3 to form five-iriembered ring. Table XXI-26. X2 R' R 2
R
3 " R 3 b R 4
R
5
R
6 X Y XXI-26--1 p-Me-Ph H H H 'Pr H CH 3 F OH XXI-26-2 p-Me-Ph H H CH 3 'Pr H CH 3 F OH XXI-26--3 p-Me-Ph H H CH(CH 3
)
2 'Pr H CH 3 F OH XXI-26-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH XXI-26-5 p-Me-Ph H H CH 2 Ph 'Pr H CH 3 F OH XXI-26-6 p-Me-Ph H H CH 2 -indol-3-yl 'Pr H CH 3 F OH XXI-26-7 p-Me-Ph H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH XXI-26-8 p-Me-Ph * H * 'Pr H CH 3 F OH *RTand R b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXI-27. X2 R R 2
R
3 a R 3 b R4 R 5
R
6 X Y XXI-27-1 p-F-Ph H H H 'Pr H CH 3 F OH XXI-27-2 p-F-Ph H H CH 3 'Pr H CH 3 F OH XXI-27-3 p-F-Ph H H CH(CH 3
)
2 'Pr H CH 3 F OH XXI-27-4 p-F-Ph H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH XXI-27-5 p-F-Ph H H CH 2 Ph 'Pr H CH 3 F OH XXI-27-6 p-F-Ph H H CH 2 -indol-3-yl 'Pr H CH 3 F OH XXI-27-7 p-F-Ph H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH XXI-27-8 p-F-Ph * H * 'Pr H CH 3 F OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. A AC C Table XXI-28. N R' R 2 R3a Rib R 4
R
5
R
6 X Y XXI-28-1 p-Cl-Ph H H H 'Pr H CH 3 F OH XXI-28-2 p-Cl-Ph H H CH 3 'Pr H CH 3 F OH XXI-28.-3 p-Cl-Ph H H CH(CH 3
)
2 'Pr H CH 3 F OH XXI-28-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH XXI-28-5 p-Cl-Ph H H CH 2 Ph 'Pr H CH 3 F OH XXI-28--6 p-Cl-Ph H H CH 2 -indol-3-yl 'Pr H CH 3 F OH XXI-28-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH XXI-28-8 p-Cl-Ph * H * 'Pr H CH 3 F OH *R" and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXI-29. X R' R 2 Ria R3b R4 R 5
R
6 X Y XXI-29-1 p-Br-Ph H H H 'Pr H CH 3 F OH XXI-29-2 p-Br-Ph H H CH 3 'Pr H CH 3 F OH XXI-29-.3 p-Br-Ph H H CH(CH 3
)
2 'Pr H CH 3 F OH XXI-29-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH XXI-29-5 p-Br-Ph H H CH 2 Ph 'Pr H CH 3 F OH XXI-29-6 p-Br-Ph H H CH 2 -indol-3-yl 'Pr H CH 3 F OH XXI-29-7 p-Br-Ph H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH XXI-29-8 p-Br-Ph * H * 'Pr H CH 3 F OH *R and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXI-30. X R' R 2 Ra R3b R4 R 5
R
6 X Y XXI-30-1 p-I-Ph H H H 'Pr H CH 3 F OH XXI-30-2 p-I-Ph H H CH 3 'Pr H CH 3 F OH XXI-30-3 p-I-Ph H H CH(CH 3
)
2 'Pr H CH 3 F OH XXI-30-4 p-I-Ph H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH XXI-30-5 p-I-Ph H H CH 2 Ph 'Pr H CH 3 F OH XXI-30-6 p-I-Ph H H CH 2 -indol-3-yi 'Pr H CH 3 F OH XXI-30-7 p-I-Ph H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH XXI-30-8 p-I-Ph * H * 'Pr H CH 3 F OH *R_2and R3b joined together by (CH 2
)
3 to form five-membered ring. A 44~ Table XXI-3 1. NR 2 R(3a R R3b R 4 R R x Y XXI-31.-1 CH 3 H H H "Bu H CH 3 F OH XXI-31-2 CH 3 H H CH 3 "Bu H CH 3 F OH XXI-31.-3 CH 3 H H CH(CH 3
)
2 "Bu H CH 3 F OH XXI-31--4 CH 3 H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH XXI-31--5 CH 3 H H CH 2 Ph "Bu H CH 3 F OH XXI-31..6 CH 3 H H CH 2 -indol-3-yl "Bu H CH 3 F OH XXI-31-7 CH 3 H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH XXI-31--8 CH 3 * H * "Bu H CH 3 F OH *R- and R b joined together by (CH 2
)
3 to form five-membered ring. Table XXI-32. NR R22 R3a 3b R4 RR R R X Y XXI-32--1 Et H H H "Bu H CH 3 F OH XXI-32-2 Et H H CH 3 "Bu H CH 3 F OH XXI-32-.3 Et H H CH(CH 3
)
2 "Bu H CH 3 F OH XXI-32-4 Et H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH XXI-32-5 Et H H CH 2 Ph "Bu H CH 3 F OH XXI-32-6 Et H H CH 2 -indol-3-yl "Bu H CH 3 F OH XXI-32-7 Et H H CH2CH 2
SCH
3 "Bu H CH 3 F OH XXI-32-8 Et * H * "Bu H Cl 3 F OH *R and R 3 " joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXI-33. N2 R' R 2 R3a R3b R 4 R5 R6 X Y XXI-33-1 'Pr H H H "Bu H CH3 F OH XXI-33-2 'Pr H H CH 3 "Bu H CH 3 F OH XXI-33-3 'Pr H H CH(CH 3
)
2 "Bu H CH 3 F OH XXI-33-4 'Pr H H CH2CH(CH 3
)
2 "Bu H CH 3 F OH XXI-33-5 'Pr H H CH 2 Ph "Bu H CH 3 F OH XXI-33-6 'Pr H H CH 2 -indol-3-yl "Bu H CH 3 F OH XXI-33-7 'Pr H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH XXI-33-8 'Pr * H * "Bu H CH 3 F OH *RTand R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XXI-34. N2 Rl R2 R 3 a R 3 b R 4 R' R' X Y XXI-34-1 'Bu H H H "Bu H CH 3 F OH XXI-34-2 'Bu H H CH 3 'Bu H CH 3 F OH XXI-34-3 'Bu H H CH(CH 3
)
2 "Bu H CH 3 F OH XXI-34-4 'Bu H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH XXI-34-5 'Bu H H CH 2 Ph "Bu H CH 3 F OH XXI-34-6 'Bu H H CH 2 -indol-3-yl "Bu H CH 3 F OH XXI-34-7 'Bu H H CH2CH 2
SCH
3 "Bu H CH 3 F OH XXI-34-8 'Bu * H * "Bu H CH 3 F OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXI-35. X2 R' R 2 Ra Rb R 4 R R X Y XXI-35--1 Ph H H H "Bu H CH 3 F OH XXI-35-2 Ph H H CH 3 "Bu H CH 3 F OH XXI-35-3 Ph H H CH(CH 3
)
2 "Bu H CH 3 F OH XXI-35-4 Ph H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH XXI-35-5 Ph H H CH 2 Ph "Bu H CH 3 F OH XXI-35-6 Ph H H CH 2 -indol-3-yl "Bu H CH 3 F OH XXI-35-7 Ph H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH XXI-35-8 Ph * H * -Bu H CH 3 F OH *R2Tand R b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXI-36. N2 R I R 2
R
3 a R 3 b R 4
R
5
R
6 X Y XXI-36-1 p-Me-Ph H H H "Bu H CH 3 F OH XXI-36-2 p-Me-Ph H H CH 3 "Bu H CH 3 F OH XXI-36-3 p-Me-Ph H H CH(CH 3
)
2 "Bu H CH 3 F OH XXI-36-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH XXI-36-5 p-Me-Ph H H CH 2 Ph "Bu H CH 3 F OH XXI-36-6 p-Me-Ph H H CH 2 -indol-3-yl "Bu H CH 3 F OH XXI-36-7 p-Me-Ph H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH XXI-36-8 p-Me-Ph * H * "Bu H CH 3 F OH *R7 and R3b joined together by (CH 2
)
3 to form five-membered ring. - AAQ Table XXI-37. X2 R R 2 RN Rob R 4 R' R 6 XY XXI-37-1 p-F-Ph H H H "Bu H CH 3 F OH XXI-37-2 p-F-Ph H H CH 3 "Bu H CH 3 F OH XXI-37-3 p-F-Ph H H CH(CH 3
)
2 "Bu H CH 3 F OH XXI-37-4 p-F-Ph H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH XXI-37-5 p-F-Ph H H CH 2 Ph "Bu H CH 3 F OH XXI-37-6 p-F-Ph H H CH 2 -indol-3-yl "Bu H CH 3 F OH XXI-37-7 p-F-Ph H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH XXI-37-8 p-F-Ph * H * "Bu H CH 3 F OH
*R
2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XXI-38. N2 Rl R 2 Ra R 3 b R4 R 5
R
6 X Y XXI-38--1 p-Cl-Ph H H H "Bu H CH 3 F OH XXI-38-2 p-Cl-Ph H H CH 3 "Bu H CH 3 F OH XXI-38-3 p-Cl-Ph H H CH(CH 3
)
2 "Bu H CH 3 F OH XXI-38-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH XXI-38-.5 p-Cl-Ph H H CH 2 Ph "Bu H CH 3 F OH XXI-38-6 p-Cl-Ph H H CH 2 -indol-3-yl "Bu H CH 3 F OH XXI-38-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH XXI-38-8 p-Cl-Ph * H * "Bu H CH 3 F OH *R and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXI-39. X2 R' R2 Ra R 3 b R 4 R' R 6 X Y XXI-39-1 p-Br-Ph H H Hl "Bu H CH 3 F OH XXI-39-2 p-Br-Ph H H CH 3 "Bu H CH 3 F OH XXI-39-3 p-Br-Ph H H CH(CH 3
)
2 "Bu H CH 3 F OH XXI-39-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH XXI-39-5 p-Br-Ph H H CH 2 Ph "Bu H CH 3 F OH XXI-39-6 p-Br-Ph H H CH 2 -indol-3-yl "Bu H CH 3 F OH XXI-39-7 p-Br-Ph H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH XXI-39-8 p-Br-Ph * H * "Bu H CH 3 F OH *R and Rb joined together by (CH 2
)
3 to form five-membered ring. A 4 0O Table XXI-40. N2 Rl R 2 Rja R 3 b R 4 R' R' X Y XXI-40-1 p-I-Ph H H H "Bu H CH 3 F OH XXI-40-2 p-I-Ph H H CH 3 "Bu H CH 3 F OH XXI-40-3 p-I-Ph H H CH(CH 3
)
2 "Bu H CH 3 F OH XXI-40-4 p-I-Ph H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH XXI-40-5 p-I-Ph H H CH2Ph "Bu H CH 3 F OH XXI-40-6 p-I-Ph H H CH 2 -indol-3-yl "Bu H CH 3 F OH XXI-40-7. p-I-Ph H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH XXI-40--8 p-I-Ph * H * "Bu H CH 3 F OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXI-41. N2 R' R 2
R
3 aR R 4
R
5 R X Y XXI-41--1 CH 3 H H H Bz H CH 3 F OH XXI-41-2 CH 3 H H CH 3 Bz H CH 3 F OH XXI-41--3 CH 3 H H CH(CH 3
)
2 Bz H CH 3 F OH XXI-41-4 CH 3 H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH XXI-41-5 CH 3 H H CH 2 Ph Bz H CH 3 F OH XXI-41-6 CH 3 H H CH 2 -indol-3-yl Bz H CH 3 F OH XXI-41-7 CH 3 H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH XXI-41-8 CH 3 * H * Bz H CH 3 F OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXI-42. N2 R' R R 3 a Rb R' R' R 6 X Y XXI-42-1 Et H H H Bz H CH 3 F OH XXI-42-2 Et H H CH 3 Bz H CH 3 F OH XXI-42-3 Et H H CH(CH 3
)
2 Bz H CH 3 F OH XXI-42-4 Et H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH XXI-42-5 Et H H CH 2 Ph Bz H CH 3 F OH XXI-42-6 Et H H CH 2 -indol-3-yl Bz H CH 3 F OH XXI-42-7 Et H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH XXI-42-8 Et * H * Bz H CH 3 F OH *R2 and R 3 1 b joined together by (CH 2
)
3 to form five-membered ring. A '7A Table XXI-43. X R' R 2 R3a R 3 b R 4 R 5
R
6 x Y XXI-43-1 'Pr H H H Bz H CH 3 F OH XXI-43--2 'Pr H H CH 3 Bz H CH 3 F OH XXI-43-3 'Pr H H CH(CH 3
)
2 Bz H CH 3 F OH XXI-43-4 'Pr H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH XXI-43..5 'Pr H H CH 2 Ph Bz H CH 3 F Ogi XXI-43-6 'Pr H H CH 2 -indol-3-yl Bz H CH 3 F OH XXI-43..7 'Pr H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH XXI-43-8 'Pr * H * Bz H CH 3 F OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXI-44. N! R' R2 Ra Rb R 4
R
5 RI X Y XXI-44-1 'Bu H H H Bz H CH 3 F OH XXI-44-2 'Bu H H CH 3 Bz H CH 3 F OH XXI-44-3 'Bu H H CH(CH 3
)
2 Bz H CH 3 F OH XXI-44-4 'Bu H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH XXI-44-5 'Bu H H CH 2 Ph Bz H CH 3 F OH XXI-44-6 'Bu H H CH 2 -indol-3-yl Bz H CH 3 F OH XXI-44-7 'Bu H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH XXI-44-8 'Bu * H * Bz H CH 3 F OH 10 *R and R3 joined together by (CH 2
)
3 to form five-membered ring. Table XXI-45. ! R' R2 R 3 a R 3 b R 4
R
5
R
6 X Y XXI-45-1 Ph H H H Bz H CH 3 F OH XXI-45-2 Ph H H CH 3 Bz H CH 3 F OH XXI-45-3 Ph H H CH(CH 3
)
2 Bz H CH 3 F OH XXI-45-4 Ph H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH XXI-45-5 Ph H H CH 2 Ph Bz H CH 3 F OH XXI-45-6 Ph H H CH 2 -indol-3-yl Bz H CH 3 F OH XXI-45-7 Ph H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH XXI-45-8 Ph * H * Bz H CH 3 F OH R7 -and Rb joined together by (CH 2
)
3 to form five-membered ring. A A71 Table XXI-46.
R
2
R
3 a R 3 b R 4 R R XY XXI-46-1 p-Me-Ph H H H Bz H CH 3 F OH XXI-46-2 p-Me-Ph H H CH 3 Bz H CH 3 F OH XXI-46-3 p-Me-Ph H H CH(CH 3
)
2 Bz H CH 3 F OH XXI-46-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH XXI-46-5 p-Me-Ph H H CH 2 Ph Bz H CH 3 F OH XXI-46-.6 p-Me-Ph H H CH 2 -indol-3-yl Bz H CH 3 F OH XXI-46-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH XXI-46-8 p-Me-Ph * H * Bz H CH 3 F OH *R2 and R joined together by (CH 2
)
3 to form five-membered ring. Table XXI-47. N2 Rl R 2
R
3 " R3b R 4 RI5 R 6 X Y XXI-47-1 p-F-Ph H H H Bz H CH 3 F OH XXI-47-2 p-F-Ph H H CH4 3 Bz H CH 3 F OH XXI-47-3 p-F-Ph H H CH(CH 3
)
2 Bz H CH 3 F OH XXI-47-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH XXI-47-5 p-F-Ph H H CH2Ph Bz H CH 3 F OH XXI-47-6 p-F-Ph H H CH2-indol-3-yl Bz H CH 3 F OH XXI-47-7 p-F-Ph H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH XXI-47-8 p-F-Ph * H * Bz H CH 3 F OH *R and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXI-48. X2 R' R2 R3a R b R 4 R' R' X Y XXI-48-1 p-Cl-Ph H H H Bz H CH 3 F OH XXI-48-2 p-Cl-Ph H H CH 3 Bz H CH 3 F OH XXI-48-3 p-Cl-Ph H H CH(CH 3
)
2 Bz H CH 3 F OH XXI-48-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH XXI-48-5 p-Cl-Ph H H CH 2 Ph Bz H CH 3 F OH XXI-48-6 p-Cl-Ph H H CH 2 -indol-3-yl Bz H CH 3 F OH XXI-48-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH XXI-48-8 p-Cl-Ph * H * Bz H CH 3 F OH *R and R3b joined together by (CH 2
)
3 to form five-membered ring. A A'71 Table XXI-49. N2 R' R2 R 3 a R3b R 4 R' R 6 X Y XXI-49-1 p-Br-Ph H H H Bz H CH 3 F OH XXI-49-2 p-Br-Ph H H CH 3 Bz H CH 3 F OH XXI-49-3 p-Br-Ph H H CH(CH 3
)
2 Bz H CH 3 F OH XXI-49-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH XXI-49-5 p-Br-Ph H H CH 2 Ph Bz H CH 3 F OH XXI-49-6 p-Br-Ph H H CH 2 -indol-3-yl Bz H CH 3 F OH XXI-49-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH XXI-49-8 p-Br-Ph * H * Bz H CH 3 F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXI-50. N2 Rl R 2
R
3 a R 31 ) R' R 5
R
6 X Y XXI-50--1 p-I-Ph H H H Bz H CH 3 F OH XXI-50-2 p-I-Ph H H CH 3 Bz H CH 3 F OH XXI-50-3 p-I-Ph H H CI(CH 3
)
2 Bz H CH 3 F OH XXI-50-4 p-I-Ph H H CH-I 2
CH(CH
3
)
2 Bz H CH 3 F OH XXI-50-5 p-I-Ph H H CH 2 Ph Bz H CH 3 F OH XXI-50-6 p-I-Ph H H CH 2 -indol-3-yl Bz H CH 3 F OH XXI-50-7 p-I-Ph H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH XXI-50-8 p-I-Ph * H * Bz H CH 3 F OH *Rl and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 N R3b R 2 O / N R-3a -- O N C0 2
R
4
OR
1 RR6
NH
2 Y X XXII 10 A A'71 Table XXII- 1. N9 R' R2 R 3 a R 3 b R 4 R' R 6 X Y XXII-1-1 CH 3 H H H CH 3 H F H OH XXII-1-.2 CH 3 H H CH 3
CH
3 H F H OH XXII-1-3 CH 3 H H CH(CH 3
)
2
CH
3 H F H OH XXII-1-4 CH 3 H H CH 2
CH(CH
3
)
2
CH
3 H F H OH XXII-1-5 CH 3 H H CH 2 Ph CH 3 H F H OH XXII-1-6 CH 3 H H CH 2 -indol-3-yl CH 3 H F H OH XXII-1-7 CH 3 H H CH 2
CH
2
SCH
3
CH
3 H F H OH XXI-1-8 CH 3 * H * CH 3 H F H OH *R2 and R"' joined together by (CH 2
)
3 to form five-membered ring. Table XXII-2. N9 RI R R 3 a Rb R4 R' R 6 X y XXII-2-1 Et H H H CH 3 H F H OH XXII-2-2 Et H H CH 3
CH
3 H F H OH XXII-2-3 Et H H CH(CH 3
)
2
CH
3 H F H OH XXII-2-4 Et H H CH 2
CH(CH
3
)
2
CH
3 H F H OH XXII-2-5 Et H H CH 2 Ph CH 3 H F H OH XXII-2-6 Et H H CH 2 -indol-3-yl CH 3 H F H OH XXII-2-7 Et H H CH 2
CH
2
SCH
3
CH
3 H F H OH XXII-2-8 Et * H * CH 3 H F H OH *R and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXII-3. N9 R' R2 R 3 a R 3 b R 4 R' R 6 X Y XXII-3-1 'Pr H H H CH 3 H F H OH XXII-3-2 'Pr H H CH 3
CH
3 H F H OH XXII-3-3 'Pr H H CH(CH 3
)
2
CH
3 H F H OH XXII-3-4 'Pr H H CH 2
CH(CH
3
)
2
CH
3 H F H OH XXII-3-5 'Pr H H CH 2 Ph CH 3 H F H OH XXII-3-6 'Pr H H CH 2 -indol-3-yl CH 3 H F H OH XXII-3-7 'Pr H H CH 2
CH
2
SCH
3
CH
3 H F H OH XXII-3-8 'Pr * H * CH 3 H F H OH *R and R 3 joined together by (CH 2
)
3 to form five-membered ring. A '7A Table XXII-4. N2 R' R2 R3a R3b R' R' R' X Y XXII-4--1 'Bu H H H CH3 H F H OH XXII-4-2 'Bu H H CH 3
CH
3 H F H OH XXII-4-3 'Bu H H CH(CH3)2 CH 3 H F H OH XXII-4-4 'Bu H H CH 2
CH(CH
3
)
2
CH
3 H F H OH XXII-4-5 'Bu H H CH 2 Ph CH 3 H F H OH XXII-4-.6 'Bu H H CH 2 -indol-3-yl CH 3 H F H OH XXII-4--7 'Bu H H CH 2
CH
2
SCH
3
CH
3 H F H OH XXH-4-.8 'Bu * H * CH 3 H F H OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXII-5. N2 RI R 2
R
3 a R 3 b R 4 R' R' X Y XXII-5-1 Ph H H H CH 3 H F H OH XXI-5-2 Ph H H CH 3
CH
3 H F H OH XXII-5-3 Ph H H CH(CH- 3
)
2
CH
3 H F H OH XXII-5-4 Ph H H CH 2
CH(CH
3
)
2
CH
3 H F H OH XXII-5-5 Ph H H CH 2 Ph CH 3 H F H OH XXII-5-6 Ph H H CH 2 -indol-3-yl CH 3 H F H OH XXII-5-7 Ph H H CH 2
CH
2
SCH
3
CH
3 H F H OH XXII-5-8 Ph * H * CH 3 H F H OH *R and R joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXII-6. N R! R2 R 3 aR 3 b R 4 R' R' X Y XXH-6-1 p-Me-Ph H H H CH 3 H F H OH XXII-6-2 p-Me-Ph H H CH 3
CH
3 H F H OH XXII-6-3 p-Me-Ph H H CH(CH 3
)
2
CH
3 H F H OH XXII-6-4 p-Me-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F H OH XXII-6-5 p-Me-Ph H H CH 2 Ph CH 3 H F H OH XXII-6-6 p-Me-Ph H H CH 2 -indol-3-yl CH 3 H F H OH XXH-6-7 p-Me-Ph H H CH 2
CH
2
SCH
3
CH
3 H F H OH XXII-6-8 p-Me-Ph * H * CH 3 H F H OH *R and R b joined together by (CH 2
)
3 to form five-membered ring. A '7 4 Table XXII-7. X Re R2 R 3 a R 3 b R 4 R' R' X Y XXH-7-1 p-F-Ph H H H CH 3 H F H OH XXfH-7-2 p-F-Ph H H CH 3
CH
3 H F H OH XXfl-7-.3 p-F-Ph H H CH(CH 3
)
2
CH
3 H F H OH XXII-7-4 p-F-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F H OH XXfl-7-6 p-F-Ph H H CH 2 Ph CH 3 H F H OH XXLI-7-7 p-F-Ph H H CH 2 -indol-3-yl CH 3 H F H OH XXI-7-8 p-F-Ph H H CH 2
CH
2
SCH
3
CH
3 H F H OH XXH-7-20 p-F-Ph * H * CH 3 H F H OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXII-8. X Rl R 2
R
3 a R 3 b R 4 R' R' X Y XXH-8-1 p-CL-Ph H H H CH 3 H F H OH XXII-8-2 p-Cl-Ph H H CH 3
CH
3 H F H OH XXII-8-3 p-Cl-Ph H H CH(CH 3
)
2
CH
3 H F H OH XXIH-8-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F H OH XXII-8-5 p-Cl-Ph H H CH 2 Ph CH 3 H F H OH XXII-8-6 p-Cl-Ph H H CH 2 -indol-3-yl CH 3 H F H OH XXII-8-7 p-Cl-Ph H H CH 2
CH
2
SCH
3
CH
3 H F H OH XXII-8-8 p-Cl-Ph * H * CH 3 H F H OH 2 3b *RF and R joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXII-9. X R R2 R"R 3 b R' R' R' X Y XXII-9-1 p-Br-Ph H H H CH 3 H F H OH XXIH-9-2 p-Br-Ph H H CH 3
CH
3 H F H OH XXII-9-3 p-Br-Ph H H CH(CH 3
)
2
CH
3 H F H OH XXII-9-4 p-Br-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F H OH XXH-9-6 p-Br-Ph H H CH 2 Ph CH 3 H F H OH XXII-9-7 p-Br-Ph H H CH 2 -indol-3-yl CH 3 H F H OH XXII-9-8 p-Br-Ph H H CH 2
CH
2
SCH
3
CH
3 H F H OH XXII-9-20 p-Br-Ph * H * CH 3 H F H OH *R and Rab joined together by (CH 2
)
3 to form five-membered ring. A '7KZ Table XXII-10. N9 Rl R 2
R
3 a R 3 b R 4 R' R' X Y XXII-10-1 p-I-Ph H H H CH 3 H F H OH XXH-10-2 p-I-Ph H H CH 3
CH
3 H F H OH XXII-10-3 p-I-Ph H H CH(CH 3
)
2
CH
3 H F H OH XXH-10-4 p-I-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F H OH XXII-10-5 p-I-Ph H H CH 2 Ph CH 3 H F H OH XXII-10-6 p-I-Ph H H CH 2 -indol-3-yl CH 3 H F H OH XXH-10-7 p-I-Ph H H CH 2
CH
2
SCH
3
CH
3 H F H OH XXII-10-8 p-I-Ph * H * CH 3 H F H OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXII- 11. N2 R R2 R 3 a R 3 b R4 R' R X Y XXII-1-1 CH 3 H H H Et H F H OH XXII-11-2 CH 3 H H CH 3 Et H F H OH XXU-11-3 CH 3 H H CH(CH 3
)
2 Et H F H OH XXII-11-4 CH 3 H H CH 2
CH(CH
3
)
2 Et H F H OH XXH-11-5 CH 3 H H CH 2 Ph Et H F H OH XXII-11-6 CH 3 H H CH 2 -indol-3-yl Et H F H OH XXH-1-7 CH 3 H H CH 2
CH
2
SCH
3 Et H F H OH XXH-11-8 CH 3 * H * Et H F H OH *Ra R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXII-12. N2 R R 2 R 3a R 3b R 4 R' R 6 X y XXI-12-1 Et H H H Et H F H OH XXII-12-2 Et H H CH 3 Et H F H OH XXH-12-3 Et H H CH(CH 3
)
2 Et H F H OH XXII-12-4 Et H H CH 2
CH(CH
3
)
2 Et H F H OH XXII-12-5 Et H H CH 2 Ph Et H F H OH XXH-12-6 Et H H CH 2 -indol-3-yl Et H F H OH XXH-12-7 Et H H CH2CH 2
SCH
3 Et H F H OH XXII-12-8 Et * H * Et H F H OH *R2 and R joined together by (CH 2
)
3 to form five-membered ring. A '7'7 Table XXII-13. X R' R 2 R3a R 3 b R 4 R' R' X Y XXII-13-1 'Pr H H H Et H F H OH XXH-13-2 'Pr H H CH 3 Et H F H OH XXII-13-3 'Pr H H CH(CH 3
)
2 Et H F H OH XXII-13-4 'Pr H H CH 2
CH(CH
3
)
2 Et H F H OH XXII-13-5 'Pr H H CH 2 Ph Et H F H OH XXII-13-6 'Pr H H CH 2 -indol-3-yl Et H F H OH XXII-13-7 'Pr H H CH 2
CH
2
SCH
3 Et H F H OH XXII-13-8 'Pr * H * Et H F H OH *RT and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXII-14. X R R 2
R
3 a R 3 b R' R' R 6 X Y XXH-14-1 'Bu H H H Et H F H OH XXII-14-2 'Bu H H CH 3 Et H F H OH XXII-14-3 'Bu H H CH(CH 3
)
2 Et H F H OH XXII-14-4 'Bu H H CH 2
CH(CH
3
)
2 Et H F H OH XXH-14-5 'Bu H H CH 2 Ph Et H F H OH XXH-14-6 'Bu H H CH 2 -indol-3-yl Et H F H OH XXH-14-7 'Bu H H CH 2
CH
2
SCH
3 Et H F H OH XXII-14-8 'Bu * H * Et H F H OH *R" and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXII-15. Xe R' R 2
R
3 "Rb R 4 R'R X Y XXII-15-1 Ph H H H Et H F H OH XXHI-15-2 Ph H H CH 3 Et H F H OH XXII-15-3 Ph H H CH(CH 3
)
2 Et H F H OH XXII-15-4 Ph H H CH 2
CH(CH
3
)
2 Et H F H OH XXII-15-5 Ph H H CH 2 Ph Et H F H OH XXII-15-6 Ph H H CH 2 -indol-3-yl Et H F H OH XXH-15-7 Ph H H CH 2
CH
2
SCH
3 Et H F H OH XXII-15-8 Ph * H * Et H F H OH *RTand R 3b joined together by (CH 2
)
3 to form five-membered ring. A IQ Table XXII-16. N2 Rl R 2
R
3 a R 3 b R 4 R' R 6 X Y XXH-16-1 p-Me-Ph H H H Et H F H OH XXH-16-2 p-Me-Ph H H CH 3 Et H F H OH XXII-16-3 p-Me-Ph H H CH(CH 3
)
2 Et H F H OH XXH-16-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Et H F H OH XXH-16-5 p-Me-Ph H H CH 2 Ph Et H F H OH XXII-16-6 p-Me-Ph H H CH 2 -indol-3-yl Et H F H OH XXII-16-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Et H F H OH XXH-16-8 p-Me-Ph * H * Et H F H OH
*R
2 and R b joined together by (CH 2
)
3 to form five-membered ring. Table XXII-17. N2 Rl R 2
R
3 a R 3 b R 4 R' R 6 X Y XXH-17-1 p-F-Ph H H H Et H F H OH XXH-17-2 p-F-Ph H H CH 3 Et H F H OH XXII-1 7 -3 p-F-Ph H H CH(CH 3
)
2 Et H F H OH XXII-17-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Et H F H OH XXH-17-5 p-F-Ph H H CH 2 Ph Et H F H OH XXII-17-6 p-F-Ph H H CH 2 -indol-3-yl Et H F H OH XXII-17-7 p-F-Ph H H CH 2
CH
2
SCH
3 Et H F H OH XXII-17-8 p-F-Ph * H * Et H F H OH *R2 and Rb joined together by (CH2)3 to form five-membered ring. 5 Table XXII-18. N2 Rl R 2
R
3 a R 3 b R 4 R' R 6 X Y XXH-18-1 p-Cl-Ph H H H Et H F H OH XXII-18-2 p-Cl-Ph H H CH 3 Et H F H OH XXII-18-3 p-Cl-Ph H H CH(CH 3
)
2 Et H F H OH XXH-18-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Et H F H OH XXII-18-5 p-Cl-Ph H H CH 2 Ph Et H F H OH XXII-18-6 p-Cl-Ph H H CH 2 -indol-3-yl Et H F H OH XXH-18-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Et H F H OH XXH-18-8 p-Cl-Ph * H * Et H F H OH T*R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. A'70 Table XXII-19. Xe R' R2 R 3 a R3b R' R' R 6 X Y XXII-19-1 p-Br-Ph H H H Et H F H OH XXII-19-2 p-Br-Ph H H CH 3 Et H F H OH XXH-19-3 p-Br-Ph H H CH(CH 3
)
2 Et H F H OH XXII-19-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Et H F H OH XXH-19-5 p-Br-Ph H H CH 2 Ph Et H F H OH XXI-19-6 p-Br-Ph H H CH 2 -indol-3-yl Et H F H OH XXII-19-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Et H F H OH XXII-19-8 p-Br-Ph * H * Et H F H OH *R' and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXII-20. X R R2 R aR 3 b R4 R' R' X Y XXII-20-1 p-I-Ph H H H Et H F H OH XXH-20-2 p-I-Ph H H CH 3 Et H F H OH XXH-20-3 p-I-Ph H H CH(CH 3
)
2 Et H F H OH XXII-20-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Et H F H OH XXH-20-5 p-I-Ph H H CH 2 Ph Et H F H OH XXII-20-6 p-I-Ph H H CH 2 -indol-3-yl Et H F H OH XXH-20-7 p-I-Ph H H CH 2
CH
2
SCH
3 Et H F H OH XXII-20-8 p-I-Ph * H * Et H F H OH *R and R" joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXII-2 1. X R 1 R2 R 3 a R 3 b R' R' R' X Y XXH-21-1 CH 3 H H H 'Pr H F H OH XXH-21-2 CH 3 H H CH 3 'Pr H F H OH XXII-21-3 CH 3 H H CH(CH 3
)
2 'Pr H F H OH XXI-21-4 CH 3 H H CH 2
CH(CH
3
)
2 'Pr H F H OH XXII-21-5 CH3 H H CH 2 Ph 'Pr H F H OH XXH-21-6 CH 3 H H CH 2 -indol-3-yl 'Pr H F H OH XXH-21-7 CH 3 H H CH 2
CH
2
SCH
3 'Pr H F H OH XXII-21-8 CH 3 * H * 'Pr H F H OH *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. A QA Table XXII-22. N2 Rl R 2
R
3 a R 3 b R 4 R' R 6 X Y XXII-22-1 Et H H H 'Pr H F H OH XXII-22-2 Et H H CH 3 'Pr H F H OH XXII-22-3 Et H H CH(CH 3
)
2 'Pr H F H OH XXII-22-4 Et H H CH2CH(CH 3
)
2 'Pr H F H OH XXII-22-5 Et H H CH 2 Ph 'Pr H F H OH XXII-22-6 Et H H CH 2 -indol-3-yl 'Pr H F H OH XXII-22-7 Et H H CH 2
CH
2
SCH
3 'Pr H F H OH XXI-22-8 Et * H * 'Pr H F H OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXII-23. N2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y XXII-23-1 'Pr H H H 'Pr H F H OH XXII-23-2 'Pr H H CH 3 'Pr H F H OH XXII-23-3 'Pr H H CH(CH 3
)
2 'Pr H F H OH XXII-23-4 'Pr H H CH 2
CH(CH
3
)
2 'Pr H F H OH XXII-23-5 'Pr H H CH 2 Ph 'Pr H F H OH XXII-23-6 'Pr H H CH 2 -indol-3-yl 'Pr H F H OH XXII-23-7 'Pr H H CH 2
CH
2
SCH
3 'Pr H F H OH XXII-23-8 'Pr * H * 'Pr H F H OH *R and R 3 " joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXII-24. N2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y XXII-24-1 'Bu H H H 'Pr H F H OH XXII-24-2 'Bu H H CH 3 'Pr H F H OH XXII-24-3 'Bu H H CH(CH 3
)
2 'Pr H F H OH XXII-24-4 'Bu H H CH2CH(CH 3
)
2 'Pr H F H OH XXII-24-5 'Bu H H CH 2 Ph 'Pr H F H OH XXII-24-6 'Bu H H CH2-indol-3-yl 'Pr H F H OH XXII-24-7 'Bu H H CH 2
CH
2
SCH
3 'Pr H F H OH XXII-24-8 'Bu * H * 'Pr H F H OH *R and R3b joined together by (CH 2
)
3 to form five-membered ring. A01 Table XXII-25. N2 RI R 2
R
3 a R 3 b R 4 R' R 6 X Y XXII-25-1 Ph H H H 'Pr H F H OH XXII-25-2 Ph H H CH 3 'Pr H F H OH XXII-25-3 Ph H H CH(CH 3
)
2 'Pr H F H OH XXI-25-4 Ph H H CH 2
CH(CH
3
)
2 'Pr H F H OH XXII-25-5 Ph H H CH 2 Ph 'Pr H F H OH XXII-25-6 Ph H H CH 2 -indol-3-yl 'Pr H F H OH XXII-25-7 Ph H H CH 2
CH
2
SCH
3 'Pr H F H OH XXU-25-8 Ph * H * 'Pr H F H OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXII-26. N2 R1 R 2
R
3 a R 3 b R' R' R' X Y XXH-26-1 p-Me-Ph H H H 'Pr H F H OH XXII-26-2 p-Me-Ph H H CH 3 'Pr H F H OH XXII-26-3 p-Me-Ph H H CH(CH 3
)
2 'Pr H F H OH XXH-26-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 'Pr H F H OH XXII-26-5 p-Me-Ph H H CH2Ph 'Pr H F H OH XXH-26-6 p-Me-Ph H H CH 2 -indol-3-yl 'Pr H F H OH XXH-26-7 p-Me-Ph H H CH 2
CH
2
SCH
3 'Pr H F H OH XXII-26-8 p-Me-Ph * H * 'Pr H F H OH R and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXII-27. SR R 2
R
3 Rb R' R' R 6 X Y XXH-27-1 p-F-Ph H H H 'Pr H F H OH XXH-27-2 p-F-Ph H H CH 3 'Pr H F H OH XXH-27-3 p-F-Ph H H CH(CH 3
)
2 'Pr H F H OH XXH-27-4 p-F-Ph H H CH 2
CH(CH
3
)
2 'Pr H F H OH XXII-27-5 p-F-Ph H H CH 2 Ph 'Pr H F H OH XXII-27-6 p-F-Ph H H CH 2 -indol-3-yl 'Pr H F H OH XXII-27-7 p-F-Ph H H CH 2
CH
2
SCH
3 'Pr H F H OH XXH-27-8 p-F-Ph * H * 'Pr H F H OH R and R3b joined together by (CH 2
)
3 to form five-membered ring. _ A Q) Table XXII-28. X2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y XXII-28-1 p-Cl-Ph H H H 'Pr H F H OH XXII-28-2 p-Cl-Ph H H CH 3 'Pr H F H OH XXH-28-3 p-Cl-Ph H H CH(CH 3
)
2 'Pr H F H OH XXII-28-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 'Pr H F H OH XXH-28-5 p-Cl-Ph H H CH 2 Ph 'Pr H F H OH XXH-28-6 p-Cl-Ph H H CH 2 -indol-3-yl 'Pr H F H OH XXII-28-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 'Pr H F H OH XXH-28-8 p-Cl-Ph * H * 'Pr H F H OH *R2 and R.3b joined together by (CH 2
)
3 to form five-membered ring. Table XXII-29. N2 Rl R 2
R
3 a R 3 b R4 R' R 6 X Y XXH-29-1 p-Br-Ph H H H 'Pr H F H OH XXII-29-2 p-Br-Ph H H CH 3 'Pr H F H OH XXH-29-3 p-Br-Ph H H CH(CH 3
)
2 'Pr H F H OH XXH-29-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 'Pr H F H OH XXH-29-5 p-Br-Ph H H CH 2 Ph 'Pr H F H OH XXH-29-6 p-Br-Ph H H CH 2 -indol-3-yl 'Pr H F H OH XXII-29-7 p-Br-Ph H H CH 2
CH
2
SCH
3 'Pr H F H OH XXII-29-8 p-Br-Ph * H * 'Pr H F H OH RTand Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXII-30. N2 R' R2 R3a R 3b R 4 R' R 6 X y XXII-30-1 p-I-Ph H H H 'Pr H F H OH XXII-30-2 p-I-Ph H H CH 3 'Pr H F H OH XXII-30-3 p-I-Ph H H CH(CH 3
)
2 'Pr H F H OH XXH-30-4 p-I-Ph H H CH 2
CH(CH
3
)
2 'Pr H F H OH XXH-30-5 p-I-Ph H H CH 2 Ph 'Pr H F H OH XXI-30-6 p-I-Ph H H CH 2 -indol-3-yl 'Pr H F H OH XXII-30-7 p-I-Ph H H CH 2 CH2SCH 3 'Pr H F H OH XXII-30-8 p-I-Ph * H * 'Pr H F H OH *R nd Rib joined together by (CH 2
)
3 to form five-membered ring. A AQI Table XXII-3 1. NV R' R 2 R Rb R 4 R R X Y XXII-31-1 CH 3 H H H "Bu H F H OH XXII-31-2 CH 3 H H CH 3 "Bu H F H OH XXII-31-3 CH 3 H H CH(CH 3
)
2 "Bu H F H OH XXII-31-4 CH 3 H H CH 2
CH(CH
3
)
2 "Bu H F H OH XXII-31-5 CH 3 H H CH 2 Ph "Bu H F H OH XXII-31-6 CH 3 H H CH 2 -indol-3-yl "Bu H F H OH XXII-31-7 CH 3 H H CH 2
CH
2
SCH
3 "Bu H F H OH XXII-31-8 CH 3 * H * "Bu H F H OH *R2and Rab joined together by (CH 2
)
3 to form five-membered ring. Table XXII-32. X2 R' R 2 R 3 aa R b R 4 R' R 6 X y XXII-32-1 Et H H H "Bu H F H OH XXII-32-2 Et H H CH 3 "Bu H F H OH XXI-32-3 Et H H CH(CH 3
)
2 "Bu H F H OH XXII-32-4 Et H H CH 2
CH(CH
3
)
2 "Bu H F H OH XXII-32-5 Et H H CH 2 Ph "Bu H F H OH XXI-32-6 Et H H CH 2 -indol-3-yl "Bu H F H OH XXI-32-7 Et H H CH 2
CH
2
SCH
3 "Bu H F H OH XXII-32-8 Et * H * "Bu H F H OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXII-33. X2 R' R2 R 3 a R 3 b R 4 R' R X Y XXII-33-1 'Pr H H H "Bu H F H OH XXII-33-2 'Pr H H CH 3 "Bu H F H OH XXII-33-3 'Pr H H CH(CH 3
)
2 "Bu H F H OH XXII-33-4 'Pr H H CH 2
CH(CH
3
)
2 "Bu H F H OH XXII-33-5 'Pr H H CH 2 Ph "Bu H F H OH XXII-33-6 'Pr H H CH 2 -indol-3-yl "Bu H F H OH XXII-33-7 'Pr H H CH 2
CH
2
SCH
3 "Bu H F H OH XXII-33-8 'Pr * H * "Bu H F H OH *R2 and R 3b joined together by (CH 2
)
3 to form five-membered ring. AO A Table XXII-34. X2 R1 R2 R 3 a R 3 b R R R X Y XXH-34-1 'Bu H H H "Bu H F H OH XXH-34-2 'Bu H H CH 3 "Bu H F H OH XXII-34-3 'Bu H H CH(CH 3
)
2 "Bu H F H OH XXII-34-4 'Bu H H CH 2
CH(CH
3
)
2 "Bu H F H OH XXII-34-5 'Bu H H CH 2 1Ph "Bu H F H OH XXII-34-6 'Bu H H CH 2 -indol-3-yl "Bu H F H OH XXH-34-7 'Bu H H CH 2
CH
2
SCH
3 "Bu H F H OH XXII-34-8 'Bu * H * "Bu H F H OH *R and R b joined together by (CH 2
)
3 to form five-membered ring. Table XXII-35. N2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y XXH-35-1 Ph H H H "Bu H F H OH XXH-35-2 Ph H H CH 3 "Bu H F H OH XXH-35-3 Ph H H CH(CH 3
)
2 "Bu H F H OH XXH-35-4 Ph H H CH 2
CH(CH
3
)
2 "Bu H F H OH XXII-35-5 Ph H H CH2Ph "Bu H F H OH XXH-35-6 Ph H H CH 2 -indol-3-yl "Bu H F H OH XXII-35-7 Ph H H CH 2
CH
2
SCH
3 "Bu H F H OH XXH-35-8 Ph * H * "Bu H F H OH *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXII-36. R2 RRaR 3 b R 4 R R 6 X Y XXH-36-1 p-Me-Ph H H H "Bu H F H OH XXII-36-2 p-Me-Ph H H CH 3 "Bu H F H OH XXII-36-3 p-Me-Ph H H CH(CH 3
)
2 "Bu H F H OH XXII-36-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 "Bu H F H OH XXII-36-5 p-Me-Ph H H CH 2 Ph "Bu H F H OH XXH-36-6 p-Me-Ph H H CH 2 -indol-3-yl "Bu H F H OH XXH-36-7 p-Me-Ph H H CH 2
CH
2
SCH
3 "Bu H F H OH XXII-36-8 p-Me-Ph * H * "Bu H F H OH *R and Rab joined together by (CH 2
)
3 to form five-membered ring.
,IOC
Table XXII-37. N2 R' R2 R3a R3b R' R' R' X Y XXI-37-1 p-F-Ph H H H "Bu H F H OH XXI-37-2 p-F-Ph H H CH 3 "Bu H F H OH XXH-377-3 p-F-Ph H H CH(CH 3
)
2 "Bu H F H OH XXII-37-4 p-F-Ph H H CH 2
CH(CH
3
)
2 "Bu H F H OH XXII.-37-5 p-F-Ph H H CH 2 Ph "Bu H F H OH XXII-37-6 p-F-Ph H H CH 2 -indol-3-yl "Bu H F H OH XXII-37-7 p-F-Ph H H CH 2
CH
2
SCH
3 "Bu H F H OH XXII-37-8 p-F-Ph * H * "Bu H F H OH *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XXII-38. N2 Rl R 2 R3a R3b R 4 R' R 6 X Y XXII-38-1 p-Cl-Ph H H H "Bu H F H OH XXII-38-2 p-Cl-Ph H H CH 3 'Bu H F H OH XXII-38-3 p-Cl-Ph H H CH(CH 3
)
2 "Bu H F H OH XXII-38-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 'Bu H F H OH XXII-38-5 p-Cl-Ph H H CH 2 Ph 'Bu H F H OH XXII-38-6 p-Cl-Ph H H CH2-indol-3-yl "Bu H F H OH XXII-38-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 "Bu H F H OH XXII-38-8 p-Cl-Ph * H * "Bu H F H OH * and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXII-39. N2 Rl R 2
R
3 a R3b R 4 R' R 6 X Y XXII-39-1 p-Br-Ph H H H "Bu H F H OH XXII-39-2 p-Br-Ph H H CH 3 "Bu H F H OH XXII-39-3 p-Br-Ph H H CH(CH 3
)
2 "Bu H F H OH XXH-39-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 "Bu H F H OH XXH-39-5 p-Br-Ph H H CH 2 Ph "Bu H F H OH XXII-39-6 p-Br-Ph H H CH2-indol-3-yl "Bu H F H OH XXH-39-7 p-Br-Ph H H CH 2
CH
2
SCH
3 "Bu H F H OH XXI-39-8 p-Br-Ph * H * "Bu H F H OH R and R3b joined together by (CH 2
)
3 to form five-membered ring. A04 Table XXII-40. X2 Rl R 2
R
3 a R"' R' R' R' X : Y XXIH-40-1 p-I-Ph H H H " Bu H F H OH XXH-40-2 p-I-Ph H H CH 3 "Bu H F H OH XXH-40-3 p-I-Ph H H CH(CH 3
)
2 "Bu H F H OH XXH-40-4 p-I-Ph H H CH 2
CH(CH
3
)
2 "Bu H F H OH XXII-40-5 p-I-Ph H H CH 2 Ph "Bu H F H OH XXH-40-6 p-I-Ph H H CH 2 -indol-3-yl "Bu H F H OH XXH-40-7 p-I-Ph H H CH 2
CH
2
SCH
3 "Bu H F H OH XXJI-40-8 p-I-Ph * H * "Bu H F H OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXII-41. N2 R' R2 R 3 a R 3 b R 4 R' R' X Y XXH-41-1 CH 3 H H H Bz H F H OH XXII-41-2 CH 3 H H CH 3 Bz H F H OH XXfE-41-3 CH 3 H H CH(CH 3
)
2 Bz H F H OH XXH-41-4 CH 3 H H CH 2
CH(CH
3
)
2 Bz H F H OH XXH-41-5 CH 3 H H CH 2 Ph Bz H F H OH XXII-41-6 CH 3 H H CH 2 -indol-3-yl Bz H F H OH XXH-41-7 CH 3 H H CH 2 CH2SCH 3 Bz H F H OH XXH-41-8 CH 3 * H * Bz H F H OH *RTand R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXII-42. N2 RI R 2
R
3 a R 3 b R4 R' R 6 X Y XXII-42-1 Et H H H Bz H F H OH XXH-42-2 Et H H CH 3 Bz H F H OH XXH-42-3 Et H H CH(CH 3
)
2 Bz H F H OH XXIH-42-4 Et H H CH 2
CH(CH
3
)
2 Bz H F H OH XXII-42-5 Et H H CH 2 Ph Bz H F H OH XXH-42-6 Et H H CH 2 -indol-3-yl Bz H F H OH XXH-42-7 Et H H CH 2
CH
2
SCH
3 Bz H F H OH XXII-42-8 Et * H * Bz H F H OH *R and Rib joined together by (CH 2
)
3 to form five-membered ring. A Q17 Table XXII-43.
N
2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y XXJI-43-1 'Pr H H H Bz H F H OH XXII-43-2 'Pr H H CH 3 Bz H F H OH XXII-43-3 'Pr H H CH(CH 3
)
2 Bz H F H OH XXII-43-4 'Pr H H CH 2
CH(CH
3
)
2 Bz H F H OH XXII-43-5 'Pr H H CH 2 Ph Bz H F H Ogi XXH-43-6 'Pr H H CH 2 -indol-3-yl Bz H F H OH XXH-43-7 'Pr H H CH 2
CH
2
SCH
3 Bz H F H OH XXII-43-8 'Pr * H * Bz H F H OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXII-44. N2 R' R2 R 3 a R 3 b R 4 R' R' X Y XXII-44-1 'Bu H H H Bz H F H OH XXH-44-2 'Bu H H CH 3 Bz H F H OH XXH-44-3 'Bu H H CH(CH 3
)
2 Bz H F H OH XXI-44-4 'Bu H H CH 2
CH(CH
3
)
2 Bz H F H OH XXII-44-5 'Bu H H CH 2 Ph Bz H F H OH XXII-44-6 'Bu H H CH 2 -indol-3-yl Bz H F H OH XXU-44-7 'Bu H H CH 2
CH
2
SCH
3 Bz H F H OH XXI-44-8 'Bu * H * Bz H F H OH 10 *RTand Rib joined together by (CH 2
)
3 to form five-membered ring. Table XXII-45. X2 R' R2 R 3 a R 3 b R 4 R R 6 X Y XXII-45-1 Ph H H H Bz H F H OH XXH-45-2 Ph H H CH 3 Bz H F H OH XXH-45-3 Ph H H CH(CH 3
)
2 Bz H F H OH XXH-45-4 Ph H H CH 2
CH(CH
3
)
2 Bz H F H OH XXH-45-5 Ph H H CH 2 Ph Bz H F H OH XXH-45-6 Ph H H CH 2 -indol-3-yl Bz H F H OH XXH-45-7 Ph H H CH 2
CH
2
SCH
3 Bz H F H OH XXII-45-8 Ph * H * Bz H F H OH *R and Rib joined together by (CH 2
)
3 to form five-membered ring.
AQQ
Table XXII-46. N2 R R 2
R
3 a R 3 b R 4 R' R' X Y XXH-46-1 p-Me-Ph H H H Bz H F H OH XXII-46-2 p-Me-Ph H H CH 3 Bz H F H OH XXII-46-3 p-Me-Ph H H CH(CH 3
)
2 Bz H F H OH XXH-46-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Bz H F H OH XXH-46-5 p-Me-Ph H H CH 2 Ph Bz H F H OH XXH-46-6 p-Me-Ph H H CH 2 -indol-3-yI Bz H F H OH XXH-46-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Bz H F H OH XXII-46-8 p-Me-Ph * H * Bz H F H OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXII-47. X2 R R 2
R
3 a R 3 b R 4 R' R' X Y XXII-47-1 p-F-Ph H H H Bz H F H OH XXII-47-2 p-F-Ph H H CH 3 Bz H F H OH XXI-47-3 p-F-Ph H H C:H(CH 3
)
2 Bz H F H OH XXII-47-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Bz H F H OH XXII-47-5 p-F-Ph H H CH 2 Ph Bz H F H OH XXIJ-47-6 p-F-Ph H H CH 2 -indol-3-yl Bz H F H OH XXII-47-7 p-F-Ph H H CH 2
CH
2
SCH
3 Bz H F H OH XXH-47-8 p-F-Ph * H * Bz H F H OH *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXII-48. N R R 2
R
3 a R Rb R' R 6 X Y XXH-48-1 p-Cl-Ph H H H Bz H F H OH XXH-48-2 p-Cl-Ph H H CH 3 Bz H F H OH XXII-48-3 p-Cl-Ph H H CH(CH 3
)
2 Bz H F H OH XXII-48-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Bz H F H OH XXII-48-5 p-Cl-Ph H H CH 2 Ph Bz H F H OH XXII-48-6 p-Cl-Ph H H CH 2 -indol-3-yl Bz H F H OH XXH-48-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Bz H F H OH XXII-48-8 p-Cl-Ph * H * Bz H F H OH R7and R3b joined together by (CH 2
)
3 to form five-membered ring. A 0( Table XXII-49. N2 R I R 2
R
3 a R 3 b R 4 R' R' X Y XXI-49-1 p-Br-Ph H H H Bz H F H OH XXII-49-2 p-Br-Ph H H CH 3 Bz H F H OH XXII-49-3 p-Br-Ph H H CH(CH 3
)
2 Bz H F H OH XXII-49-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Bz H F H OH XXII-49-5 p-Br-Ph H H CH 2 Ph Bz H F H OH XXII-49-6 p-Br-Ph H H CH 2 -indol-3-yl Bz H F H OH XXII-49-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Bz H F H OH XXII-49-8 p-Br-Ph * H * Bz H F H OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXII-50. X2 R 2 R a R R R R X Y XXII-50-1 p-I-Ph H H H Bz H F H OH XXII-50-2 p-I-Ph H H CH 3 Bz H F H OH XXII-50-3 p-I-Ph H H CH(CH 3
)
2 Bz H F H OH XXII-50-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Bz H F H OH XXII-50-5 p-I-Ph H H CH 2 Ph Bz H F H OH XXII-50-6 p-I-Ph H H CH 2 -indol-3-yl Bz H F H OH XXII-50-7 p-I-Ph H H CH 2
CH
2
SCH
3 Bz H F H OH XXI-50-8 p-I-Ph * H * Bz H F H OH *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 N R3b R2 O N R3a 0 - N N N C0 2
R
4 OR R5 R 6
NH
2 Y x XXIII Table XXIII-1. X2 R' R 2
R
3 a R 3 b R 4 ' R R6 X y XXII-1--1 CH 3 H H H CH 3 H F F OH A A .N R' R 2 R 3a R 3 b R 4 R' R' X Y XXIH-1-2 CH 3 H H CH 3
CH
3 H F F OH XXIH-1-3 CH 3 H H CH(CH 3
)
2
CH
3 H F F OH XXH-1-4 CH 3 H H CH 2
CH(CH
3
)
2
CH
3 H F F OH XXII-1-5 CH 3 H H CH 2 Ph CH 3 H F F OH XXIII-1-6 CH 3 H H CH 2 -indol-3-yl CH 3 H F F OH XXM-1-7 CH 3 H H CH 2
CH
2
SCH
3
CH
3 H F F OH XXM-1-8 CH 3 * H * CH3 H F F OH *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XXIII-2. N2 RI R 2
R
3 a R 3 b R 4 R' R 6 X Y XXIII-2-1 Et H H H CH 3 H F F OH XXIII-2-2 Et H H CH 3
CH
3 H F F OH XXII-2-3 Et H H CH(CH 3
)
2
CH
3 H F F OH XXIH-2-4 Et H H CH2CH(CH 3 )2 CH 3 H F F OH XXIII-2-5 Et H H CH 2 Ph CH 3 H F F OH XXIII-2-6 Et H H CH 2 -indol-3-yl CH 3 H F F OH XXIH-2-7 Et H H CH 2 CH2SCH 3
CH
3 H F F OH XXIH-2-8 Et * H * CH 3 H F F OH *R2 and Ri3 joined together by (CH 2
)
3 to form five-membered ring. Table XXIII-3. N2 R' R2 R 3 a R 3 b R' R' R' X Y XXII-3-1 'Pr H H H CH 3 H F F OH XXIII-3-2 'Pr H H CH 3
CH
3 H F F OH XXIII-3-3 'Pr H H CH(CH 3
)
2
CH
3 H F F OH XXI-3-4 'Pr H H CH2CH(CH 3
)
2
CH
3 H F F OH XXIII-3-5 'Pr H H CH2Ph CH 3 H F F OH XXIII-3-6 'Pr H H CH 2 -indol-3-yl CH 3 H F F OH XXII-3-7 'Pr H H CH2CH 2
SCH
3
CH
3 H F F OH XXIII-3-8 'Pr * H * CH 3 H F F OH 5 *R1 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXIII-4. X2 R RR 3 a R 3 b R 4 R' R 6 X Y XXIII-41 'Bu H H H CH 3 H F F OH XXMI-4-2 'Bu H H CH 3
CH
3 H F F OH AO1 X2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y XXIII-4-3 'Bu H H CH(CH 3
)
2
CH
3 H F F OH XXIm-4-4 'Bu H H CH 2
CH(CH
3
)
2
CH
3 H F F OH XXIII-4-5 'Bu H H CH 2 Ph CH 3 H F F OH XXJII-4-6 'Bu H H CH 2 -indol-3-yl CH 3 H F F OH XXIII-4-7 'Bu H H CH 2
CH
2
SCH
3
CH
3 H F F OH XXIH-4-8 'Bu * H * CH 3 H F F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXIII-5. X2 R' R 2 R 3 a R 3 b R' RI R X Y XXIH-5-1 Ph H H H CH 3 H F F OH XXIII-5-2 Ph H H CH 3
CH
3 H F F OH XXII-5-3 Ph H H CH(CH 3
)
2
CH
3 H F F OH XXIII-5-4 Ph H H CH 2
CH(CH
3
)
2
CH
3 H F F OH XXII-5-5 Ph H H CH2Ph CH 3 H F F OH XXIII-5-6 Ph H H CH 2 -indol-3-yl CH 3 H F F OH XXIH-5-7 Ph H H CH 2
CH
2
SCH
3
CH
3 H F F OH XXIH-5-8 Ph * H * CH 3 H F F OH *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXIII-6. N2 RI R 2
R
3 a R 3 b R4 R' R 6 X Y XXIH-6-1 p-Me-Ph H H H CH 3 H F F OH XXIM-6-2 p-Me-Ph H H CH 3
CH
3 H F F OH XXIII-6-3 p-Me-Ph H H CH(CH 3
)
2
CH
3 H F F OH XXIH-6-4 p-Me-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F F OH XXM-6-5 p-Me-Ph H H CH 2 Ph CH 3 H F F OH XXIII-6-6 p-Me-Ph H H CH 2 -indol-3-yl CH 3 H F F OH XXIII-6-7 p-Me-Ph H H CH 2
CH
2
SCH
3
CH
3 H F F OH XXHI-6-8 p-Me-Ph * H * CH 3 H F F OH 5 *Ra Rab joined together by (CH 2
)
3 to form five-membered ring. Table XXIII-7. N R R2 R3 a R 3b R4 R R 6 X Y XXIH-7--1 p-F-Ph H H H CH 3 H F F OH XXIM-7-2 p-F-Ph H H CH 3
CH
3 H F F OH XXm-7.-3 p-F-Ph H H CH(CH 3
)
2
CH
3 H F F OH A 01) N2 Rl R 2 R3a Rb R R' R" X Y XXHI-7-4 p-F-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F F OH XXM-7-6 p-F-Ph H H CH 2 Ph CH 3 H F F OH XXIH-7-7 p-F-Ph H H CH 2 -indol-3-yl CH 3 H F F OH XXM-7-8 p-F-Ph H H CH 2
CH
2
SCH
3
CH
3 H F F OH XXIII-7-20 p-F-Ph * H * CH 3 H F F OH *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XXIII-8. N2 R R 2
R
3 a R3b R 4 R R 6 X Y XXm-8-1 p-Cl-Ph H H H CH 3 H F F OH XXIII-8-2 p-Cl-Ph H H CH 3
CH
3 H F F OH XXIII-8-3 p-Cl-Ph H H CH(CH 3
)
2
CH
3 H F F OH XXII-8-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F F OH XXM-8-5 p-Cl-Ph H H CH 2 Ph CH 3 H F F OH XXIH-8-6 p-Cl-Ph H H CH 2 -indol-3-yl CH 3 H F F OH XXJ-8-7 p-Cl-Ph H H CH 2
CH
2
SCH
3
CH
3 H F F OH XXM-8-8 p-Cl-Ph * H * CH 3 H F F OH *Rand. Rib joined together by (CH 2
)
3 to form five-membered ring. Table XXIII-9. N Rl R 2
R
3 a Rib R 4 R' R X Y XXIH-9-1 p-Br-Ph H H H CH 3 H F F OH XXM-9-2 p-Br-Ph H H CH 3
CH
3 H F F OH XXm-9-3 p-Br-Ph H H CH(CH 3
)
2
CH
3 H F F OH XXIII-9-4 p-Br-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F F OH XXJH-9-6 p-Br-Ph H H CH 2 Ph CH 3 H F F OH XXIH-9-7 p-Br-Ph H H CH 2 -indol-3-yl CH 3 H F F OH XXIm-9-8 p-Br-Ph H H CH 2
CH
2
SCH
3
CH
3 H F F OH XXIH-9-20 p-Br-Ph * H * CH 3 H F F OH 5 *R' and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XXIII-10. N Rl R2 R 3a R3b R' R 5 R' X Y XXM-10-1 p-I-Ph H H H CH 3 H F F OH XXM-10-2 p-I-Ph H H CH 3
CH
3 H F F OH XXIII-10-3 p-I-Ph H H CH(CH 3
)
2
CH
3 H F F OH XXIII-10-4 p-I-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F F OH
-AGI
Ne Rl R2 R 3 a R 3 b R 4 R' R' XY XXIH-10-5 p-I-Ph H H CH 2 Ph CH 3 H F F OH XXHI-10-6 p-I-Ph H H CH 2 -indol-3-yl CH 3 H F F OH XXIH-10-7 p-I-Ph H H CH 2
CH
2
SCH
3
CH
3 H F F OH XXHI-10-8 p-I-Ph * H * CH 3 H F F OH *Rand R b joined together by (CH 2
)
3 to form five-membered ring. Table XXIII- 11. X R' R 2 R3a R 3 b R 4 R' R 6 X Y XXIII-11-1 CH 3 H H H Et H F F OH XXIH-11-2 CH 3 H H CH 3 Et H F F OH XXHI-11-3 CH 3 H H CH(CH 3
)
2 Et H F F OH XXLH-11-4 CH 3 H H CH 2
CH(CH
3
)
2 Et H F F OH XXIH-11-5 CH 3 H H CH 2 Ph Et H F F OH XXIII-11-6 CH 3 H H CH 2 -indol-3-yl Et H F F OH XXIH-11-7 CH 3 H H CH 2
CH
2
SCH
3 Et H F F OH XXII-11-8 CH 3 * H * Et H F F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXIII-12. Xe RI R 2
R
3 a R 3 b R 4 R' R 6 X Y XXI-12-1 Et H H H Et H F F OH XXIH-12-2 Et H H CH 3 Et H F F OH XXI-12-3 Et H H CH(CH 3
)
2 Et H F F OH XXI-12-4 Et H H CH 2
CH(CH
3
)
2 Et H F F OH XXI-12-5 Et H H CH 2 Ph Et H F F OH XXIH-12-6 Et H H CH 2 -indol-3-yl Et H F F OH XXIII-12-7 Et H H CH 2
CH
2
SCH
3 Et H F F OH XXIII-12-8 Et * H * Et H F F OH 5 *R and R joined together by (CH 2
)
3 to form five-membered ring. Table XXIII-13. X R' R2 R 3 a R A R4 R 5 R' X Y XXIH-13-1 'Pr H H H Et H F F OH XXIH-13-2 'Pr H H CH 3 Et H F F OH XXIII-13-3 'Pr H H CH(CH 3
)
2 Et H F F OH XXIH-13-4 'Pr H H CH 2
CH(CH
3
)
2 Et H F F OH XXIII-13-5 'Pr H H CH 2 Ph Et H F F OH
ACIA
X2 R' R2 R 3 a R 3 b R' R R 6 X Y XXHI-13-6 'Pr H H CH 2 -indol-3-yl Et H F F OH XXIII-13-7 'Pr H H CH 2
CH
2
SCH
3 Et H F F OH XXI-13-8 'Pr * H * Et H F F OH *R and R.
3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXIII-14. N2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y XXI-14-1 'Bu H H H Et H F F OH XXIII-14-2 'Bu H H CH 3 Et H F F OH XXIII- 14-3 'Bu H H CH(CH 3
)
2 Et H F F OH XXIII-14-4 'Bu H H CH 2
CH(CH
3
)
2 Et H F F OH XXIII-14-5 'Bu H H CH 2 Ph Et H F F OH XXIII-14-6 'Bu H H CH 2 -indol-3-yl Et H F F OH XXI-14-7 'Bu H H CH 2
CH
2
SCH
3 Et H F F OH XXHI-14-8 'Bu * H * Et H F F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXIII-15. N2 R' R2 R3a R3b R 4 R' R 6 X Y XXIII-15-1 Ph H H H Et H F F OH XXIII-15-2 Ph H H CH 3 Et H F F OH XXM-15-3 Ph H H CH(CH 3
)
2 Et H F F OH XXIII-15-4 Ph H H CH 2
CH(CH
3
)
2 Et H F F OH XXIH-15-5 Ph H H CH 2 Ph Et H F F OH XXHI-15-6 Ph H H CH 2 -indol-3-yl Et H F F OH XXIH-15-7 Ph H H CH 2
CH
2
SCH
3 Et H F F OH XXIII-15-8 Ph * H * Et H F F OH 5 *RIand R 3 " joined together by (CH 2
)
3 to form five-membered ring. Table XXIII-16. N2 R I R 2
R
3 a R 3 b R 4 R' R 6 X Y XXIII-16-1 p-Me-Ph H H H Et H F F OH XXI-16-2 p-Me-Ph H H CH 3 Et H F F OH XXIH-16-3 p-Me-Ph H H CH(CH 3
)
2 Et H F F OH XXHI-16-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Et H F F OH XXIH-16-5 p-Me-Ph H H CH 2 Ph Et H F F OH XXHI-16-6 p-Me-Ph H H CH 2 -indol-3-yl Et H F F OH
AOAZ
N9 Rt R 2 R 3a R 3 b R' R' R 6 X Y XXIII-16-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Et H F F OH XXIII-16-8 p-Me-Ph * H * Et H F F OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXIII- 17. X2 R2 R 3 a R 3 b R R' R' X Y XXIII-17-1 p-F-Ph H H H Et H F F OH XXIII-17-2 p-F-Ph H H CH 3 Et H F F OH XXIII-17-3 p-F-Ph H H CH(CH 3
)
2 Et H F F OH XXIII-17-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Et H F F OH XXIII-17-5 p-F-Ph H H CH 2 Ph Et H F F OH XXIII-17-6 p-F-Ph H H CH 2 -indol-3-yl Et H F F OH XXIII-17-7 p-F-Ph H H CH 2
CH
2
SCH
3 Et H F F OH XXIII-17-8 p-F-Ph * H * Et H F F OH *R2 and Rb joined together by (CH 2
)
3 to form five-membered ring. Table XXIII-18. N2 Rl R 2
R
3 a R 3 b R4 RI R' X Y XXIII-18-1 p-Cl-Ph H H H Et H F F OH XXIII-18-2 p-Cl-Ph H H CH 3 Et H F F OH XXII-18-3 p-Cl-Ph H H CH(CH 3
)
2 Et H F F OH XXIII-18-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Et H F F OH XXIII-18-5 p-Cl-Ph H H CH 2 Ph Et H F F OH XXIH-18-6 p-Cl-Ph H H CH 2 -indol-3-yl Et H F F OH XXIII-18-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Et H F F OH XXIII-18-8 p-Cl-Ph * H * Et H F F OH 5 RTand R" joined together by (CH 2
)
3 to form five-membered ring. AQ 04 Table XXIII-19. N2 R R2 R3a R3b R4 R' R' X Y XXIH-19-1 p-Br-Ph H H H Et H F F OH XXIU-19-2 p-Br-Ph H H CH 3 Et H F F OH XXIH-1.9-3 p-Br-Ph H H CH(CH 3
)
2 Et H F F OH XXIH-19-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Et H F F OH XXHI-19-5 p-Br-Ph H H CH 2 Ph Et H F F OH XXIII-19-6 p-Br-Ph H H CH 2 -indol-3-yl Et H F F OH XXIHI-19-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Et H F F OH XXIII-19-8 p-Br-Ph * H * Et H F F OH *R2 and R 3 joined together by (CH 2
)
3 to form five-membered ring. Table XXIII-20. X2 R' 2Ra ~ R R R Ra-X Y XXHI-20-1 p-I-Ph H H H Et H F F OH XXIH-20-2 p-I-Ph H H CH 3 Et H F F OH XXM-20-3 p-I-Ph H H CH(CH 3
)
2 Et H F F OH XXII-20-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Et H F F OH XXHI-20-5 p-I-Ph H H CH 2 Ph Et H F F OH XXHI-20-6 p-I-Ph H H CH 2 -indol-3-yl Et H F F OH XXIII-20-7 p-I-Ph H H CH 2
CH
2
SCH
3 Et H F F OH XXIH-20-8 p-I-Ph * H * Et H F F OH *R and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXIII-21. N2 R' R2 R 3 a R 3 b R' R' R 6 X Y XXIII-21-1 CH 3 H H H 'Pr H F F OH XXI-21-2 CH 3 H H CH3 'Pr H F F OH XXIH-21-3 CH 3 H H CH(CH 3
)
2 'Pr H F F OH XXIM-21-4 CH 3 H H CH 2
CH(CH
3
)
2 'Pr H F F OH XXIH-21-5 CH 3 H H CH 2 Ph 'Pr H F F OH XXIH-21-6 CH 3 H H CH 2 -indol-3-yl 'Pr H F F OH XXIH-21-7 CH 3 H H CH 2
CH
2
SCH
3 'Pr H F F OH XXIII-21-8 CH 3 * H * 'Pr H F F OH R2and R 3 b joined together by (CH 2
)
3 to form five-membered ring. A 0'7 Table XXIII-22. N2 RI R 2
R
3 a R 3 b R 4 R' R' X Y XXIH-22-1 Et H H H 'Pr H F F OH XXIH-22-2 Et H H CH 3 'Pr H F F OH XXIII-22-3 Et H H CH(CH 3
)
2 'Pr H F F OH XXHI-22-4 Et H H CH 2
CH(CH
3
)
2 'Pr H F F 01 XXHII-22-5 Et H H CH 2 Ph 'Pr H F F OH XXIH-22-6 Et H H CH 2 -indol-3-yl 'Pr H F F OH XXIII-22-7 Et H H CH 2
CH
2
SCH
3 'Pr H F F OH XXII-22-8 Et * H * 'Pr H F F OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXIII-23. N R' R'RaRb R 4 RR XY XXIII-23-1 'Pr H H H 'Pr H F F OH XXHI-23-2 'Pr H H CH 3 'Pr H F F OH XXII-23-3 'Pr H H CH(CH 3
)
2 'Pr H F F OH XXIII-23-4 'Pr H H CH 2
CH(CH
3
)
2 'Pr H F F OH XXII-23-5 'Pr H H CH 2 Ph 'Pr H F F OH XXHI-23-6 'Pr H H CH 2 -indol-3-yl 'Pr H F F OH XXIH-23-7 'Pr H H CH 2
CH
2
SCH
3 'Pr H F F OH XXIII-23-8 'Pr * H * 'Pr H F F OH *Rl and R joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXIII-24. N R' R2 R3a Rb R 4 R' R 6 X Y XXIH-24-1 'Bu H H H 'Pr H F F OH XXLI-24-2 'Bu H H CH 3 'Pr H F F OH XXIII-24-3 'Bu H H CH(CH 3
)
2 'Pr H F F OH XXIII-24-4 'Bu H H CH 2
CH(CH
3 )2 'Pr H F F OH XXII-24-5 'Bu H H CH 2 Ph 'Pr H F F OH XXIII-24-6 'Bu H H CH 2 -indol-3-yl 'Pr H F F OH XXHI-24-7 'Bu H H CH 2
CH
2
SCH
3 'Pr H F F OH XXIII-24-8 'Bu * H * 'Pr H F F OH *R and Rib joined together by (CH 2
)
3 to form five-membered ring.
-AQQ
Table XXIII-25. N2 R I R 2
R
3 a R b R 4 R' R' X Y XXIII-25-1 Ph H H H 'Pr H F F OH XXIU-25-2 Ph H H CH 3 'Pr H F F OH XXIII-25-3 Ph H H CH(CH 3
)
2 'Pr H F F OH XXIH-25-4 Ph H H CH 2
CH(CH
3
)
2 'Pr H F F OH XXHI-25-5 Ph H H CH 2 Ph 'Pr H F F OH XXIH-25-6 Ph H H CH 2 -indol-3-yl 'Pr H F F OH XXHI-25-7 Ph H H CH 2
CH
2
SCH
3 'Pr H F F OH XXIII-25-8 Ph * H * 'Pr H F F OH *R7 and Rt joined together by (CH 2
)
3 to form five-membered ring. Table XXIII-26.
R
2
R
3
R
3 b R 4 R' R 6 X Y XXIH-26-1 p-Me-Ph H H H 'Pr H F F OH XXHI-26-2 p-Me-Ph H H CH 3 'Pr H F F OH XXIII-26-3 p-Me-Ph H H CH(CH 3
)
2 'Pr H F F OH XXIII-26-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 'Pr H F F OH XXIH-26-5 p-Me-Ph H H CH 2 Ph 'Pr H F F OH XXIM-26-6 p-Me-Ph H H CH 2 -indol-3-yl 'Pr H F F OH XXIII-26-7 p-Me-Ph H H CH 2
CH
2
SCH
3 'Pr H F F OH XXIII-26-8 p-Me-Ph * H * 'Pr H F F OH *Rl and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXIII-27. N2 Rl R 2 Ra R 3 b R' R' R 6 X Y XXIH-27-1 p-F-Ph H H H 'Pr H F F OH XXIH-27-2 p-F-Ph H H CH 3 'Pr H F F OH XXIM-27-3 p-F-Ph H H CH(CH 3
)
2 'Pr H F F OH XXIH-27-4 p-F-Ph H H CH 2
CH(CH
3
)
2 'Pr H F F OH XXIH-27-5 p-F-Ph H H CH 2 Ph 'Pr H F F OH XXIH-27-6 p-F-Ph H H CH 2 -indol-3-yl 'Pr H F F OH XXIII-27-7 p-F-Ph H H CH 2
CH
2
SCH
3 'Pr H F F OH XXIH-27-8 p-F-Ph * H * 'Pr H F F OH R7 and R 3 joined together by (CH 2
)
3 to form five-membered ring.
AOO
Table XXIII-28. X Rl R 2
R
3 a R 3 b R' R' R' X Y XXIH-28-1 p-Cl-Ph H H H 'Pr H F F OH XXm-28-2 p-Cl-Ph H H CH 3 'Pr H F F OH XXIII-28-3 p-Cl-Ph H H CH(CH 3
)
2 'Pr H F F OH XXIII-28-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 'Pr H F F OH XXIm-28-5 p-Cl-Ph H H CH 2 Ph 'Pr H F F OH XXIm-28-6 p-Cl-Ph H H CH 2 -indol-3-yl 'Pr H F F OH XXI-28-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 'Pr H F F OH XXIII-28-8 p-Cl-Ph * H * 'Pr H F F OH *R7 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXIII-29. N2 R 2
R
3 " R3b R 4 R' R' X Y XXM-29-1 p-Br-Ph H H H 'Pr H F F OH XXIm-29-2 p-Br-Ph H H CH 3 'Pr H F F OH XXIII-29-3 p-Br-Ph H H CH(CH 3
)
2 'Pr H F F OH XXI-29-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 'Pr H F F OH XXII-29-5 p-Br-Ph H H CH 2 Ph 'Pr H F F OH XXIH-29-6 p-Br-Ph H H CH 2 -indol-3-yl 'Pr H F F OH XXIII-29-7 p-Br-Ph H H CH 2
CH
2
SCH
3 'Pr H F F OH XXM-29-8 p-Br-Ph * H * 'Pr H F F OH *R and R~b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXIII-30. N2 R f R 2 R 3 " R 3 b R 4 RI R 6 X Y XXM-30-1 p-I-Ph H H H 'Pr H F F OH XXM-30-2 p-I-Ph H H CH 3 'Pr H F F OH XXIII-30-3 p-I-Ph H H CH(CH 3
)
2 Pr H F F OH XXM-30-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Pr H F F OH XXIH-30-5 p-l-Ph H H CH 2 Ph Pr H F F OH XXm-30-6 p-I-Ph H H CH 2 -indol-3-yl Pr H F F OH XXm-30-7 p-I-Ph H H CH 2
CH
2
SCH
3 Pr H F F OH XXIII-30-8 p-I-Ph * H * Pr H F F OH *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XXIII-3 1. N2 R' R 2
R
3 aRb R 4 R R X Y XXIM-31-1 CH 3 H H H "Bu H F F OH XXIM-31-2 CH 3 H H CH 3 "Bu H F F OH XXIH-31-3 CH 3 H H CH(CH 3
)
2 "Bu H F F OH XXIM-31-4 CH 3 H H CH 2
CH(CH
3
)
2 "Bu H F F OH XXI-31-5 CH 3 H H CH 2 Ph "Bu H F F OH XXIH-31-6 CH 3 H H CH 2 -indol-3-yl "Bu H F F OH XXHI-31-7 CH 3 H H CH 2
CH
2
SCH
3 "Bu H F F OH XXM-31-8 CH 3 * H * "Bu H F F OH *RTand R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXIII-32. N2 R' R2 R3a R b R' R' R' X Y XXIII-32-1 Et H H H "Bu H F F OH XXHI-32-2 Et H H CH 3 "Bu H F F OH XXIH-32-3 Et H H CH(CH 3
)
2 "Bu H F F OH XXIH-32-4 Et H H CH 2
CH(CH
3
)
2 "Bu H F F OH XXIH-32-5 Et H H CH 2 Ph "Bu H F F OH XXI-32-6 Et H H CH 2 -indol-3-yl "Bu H F F OH XXII-32-7 Et H H CH 2
CH
2
SCH
3 "Bu H F F OH XXIH-32-8 Et * H * "Bu H F F OH *R' and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXIII-33. N2 Rl R2 R 3 a R 3 b R' R 5 R' X Y XXIH-33-1 'Pr H H H "Bu H F F OH XXIH-33-2 'Pr H H CH 3 "Bu H F F OH XXIH-33-3 'Pr H H CH(CH 3
)
2 "Bu H F F OH XXIH-33-4 'Pr H H CH 2
CH(CH
3
)
2 "Bu H F F OH XXIII-33-5 'Pr H H CH 2 Ph "Bu H F F OH XXIH-33-6 'Pr H H CH 2 -indol-3-yl "Bu H F F OH XXIH-33-7 'Pr H H CH 2
CH
2
SCH
3 "Bu H F F OH XXIII-33-8 'Pr * H * Bu H F F OH *R and R joined together by (CH 2
)
3 to form five-membered ring. C/r1 Table XXIII-34. N2 R' R 2
R
3 aR 3 b R R R X Y XXIH-34-1 'Bu H H H "Bu H F F OH XXJH-34-2 'Bu H H CH 3 "Bu H F F OH XXIH-34-3 'Bu H H CH(CH 3
)
2 "Bu H F F OH XXII-34-4 'Bu H H CH 2
CH(CH
3
)
2 "Bu H F F OH XXM-34-5 'Bu H H CH 2 Ph "Bu H F F OH XXI-34-6 'Bu H H CH 2 -indol-3-yl "Bu H F F OH XXM-34-7 'Bu H H CH 2
CH
2
SCH
3 " Bu H F F OH XXM-34-8 'Bu * H * "Bu H F F OH *R2and R b joined together by (CH 2
)
3 to form five-membered ring. Table XXIII-35. N2 RI R 2
R
3 a R 3 b R 4 R' R' X Y XXIJI-35-1 Ph H H H "Bu H F F OH XXIH-35-2 Ph H H CH 3 "Bu H F F OH XXm-35-3 Ph H H CH(CH 3
)
2 "Bu H F F OH XXM-354 Ph H H CH 2
CH(CH
3
)
2 "Bu H F F OH XX11-35-5 Ph H H CH 2 Ph "Bu H F F OH XXM-35-6 Ph H H CH 2 -indol-3-yl "Bu H F F OH XXIH-35-7 Ph H H CH 2
CH
2
SCH
3 "Bu H F F OH XXM-35-8 Ph * H * "Bu H F F OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXIII-36. N R R 2
R
3 a R 3 b R 4 R' R 6 X Y XXIf-36-1 p-Me-Ph H H H "Bu H F F OH XXIII-36-2 p-Me-Ph H H CH 3 "Bu H F F OH XXIII-36-3 p-Me-Ph H H CH(CH 3
)
2 "Bu H F F OH XXM-36-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 "Bu H F F OH XXIII-36-5 p-Me-Ph H H CH 2 Ph "Bu H F F OH XXm-36-6 p-Me-Ph H H CH 2 -indol-3-yl "Bu H F F OH XXIII-36-7 p-Me-Ph H H CH 2
CH
2
SCH
3 "Bu H F F OH XXIII-36-8 p-Me-Ph * H * "Bu H F F OH *R and R3b joined together by (CH 2
)
3 to form five-membered ring. - 502 - Table XXIII-37. N2 R' R 2 Raa R 3 b R 4 R' R 6 X Y XXIf-37-1 p-F-Ph H H H "Bu H F F OH XXIJ-37-2 p-F-Ph H H CH 3 "Bu H F F OH XXIH-37-3 p-F-Ph H H CH(CH 3
)
2 "Bu H F F OH XXIII-37-4 p-F-Ph H H CH 2
CH(CH
3
)
2 "Bu H F F OH XXHI-37-5 p-F-Ph H H CH 2 Ph "Bu H F F OH XXIH-37-6 p-F-Ph H H CH 2 -indol-3-yl "Bu H F F OH XXI-37-7 p-F-Ph H H CH 2
CH
2
SCH
3 "Bu H F F OH XXIL-37-8 p-F-Ph * H * "Bu H F F OH *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XXIII-38. N2 R R 2 Ra R 3 b R 4 R' R' X Y XXIII-38-1 p-Cl-Ph H H H "Bu H F F OH XXIH-38-2 p-Cl-Ph H H CH 3 "Bu H F F OH XXI-38-3 p-Cl-Ph H H CH(CH 3
)
2 "Bu H F F OH XXI-38-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 "Bu H F F OH XXIII-38-5 p-Cl-Ph H H CH 2 Ph "Bu H F F OH XXIH-38-6 p-Cl-Ph H H CH 2 -indol-3-yl "Bu H F F OH XXIII-38-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 "Bu H F F OH XXMI-38-8 p-Cl-Ph * H * "Bu H F F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXIII-39. N2 R' R 2
R
3 a R 3 b R' R' R' X Y XXIII-39-1 p-Br-Ph H H H "Bu H F F OH XXIII-39-2 p-Br-Ph H H CH 3 "Bu H F F OH XXIII-39-3 p-Br-Ph H H CH(CH 3
)
2 "Bu H F F OH XXIII-39-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 "Bu H F F OH XXI-39-5 p-Br-Ph H H CH 2 Ph "Bu H F F OH XXIII-39-6 p-Br-Ph H H CH 2 -indol-3-yl "Bu H F F OH XXIH-39-7 p-Br-Ph H H CH 2
CH
2
SCH
3 "Bu H F F OH XXIU-39-8 p-Br-Ph * H * "Bu H F F OH *RTand Rab joined together by (CH 2
)
3 to form five-membered ring.
Table XXIII-40. X2 Rl R 2 R3a R3b R 4 R' R 6 X Y XXIH-40-1 p-I-Ph H H H "Bu H F F OH XXIH-40-2 p-I-Ph H H CH 3 "Bu H F F OH XXI-40-3 p-I-Ph H H CH(CH 3
)
2 "Bu H F F OH XXIH-40-4 p-I-Ph H H CH 2
CH(CH
3
)
2 "Bu H F F OH XXIH-40-5 p-I-Ph H H CH 2 Ph "Bu H F F OH XXIH-40-6 p-I-Ph H H CH 2 -indol-3-yl "Bu H F F OH XXIH-40-7 p-I-Ph H H CH 2
CH
2
SCH
3 "Bu H F F OH XXIH-40-8 p-I-Ph * H * "Bu H F F OH Rn Ra b joined together by (CH 2
)
3 to form five-membered ring. Table XXIII-41. N2 R' R2 R 3 a Rb R' R 5
R
6 X Y XX1I-41-1 CH 3 H H H Bz H F F OH XXIH-41-2 CH 3 H H CH 3 Bz H F F OH XXII-41-3 CH 3 H H CH(CH 3
)
2 Bz H F F OH XXIII-41-4 CH 3 H H CH 2
CH(CH
3
)
2 Bz H F F OH XXIII-41-5 CH 3 H H CH 2 Ph Bz H F F OH XXIII-41-6 CH 3 H H CH 2 -indol-3-yl Bz H F F OH XXIII-41-7 CH 3 H H CH 2
CH
2
SCH
3 Bz H F F OH XXIH-41-8 CH 3 * H * Bz H F F OH *R" and Rb joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXIII-42. N2 RI R 2 R3a R3b R 4 R' R 6 X Y XXIII-42-1 Et H H H Bz H F F OH XXIH-42-2 Et H H CH 3 Bz H F F OH XXIII-42-3 Et H H CH(CH 3
)
2 Bz H F F OH XXIII-42-4 Et H H CH 2
CH(CH
3 )2 Bz H F F OH XXIH-42-5 Et H H CH 2 Ph Bz H F F OH XXI-42-6 Et H H CH 2 -indol-3-yl Bz H F F OH XXII-42-7 Et H H CH 2
CH
2
SCH
3 Bz H F F OH XXHI-42-8 Et * H * Bz H F F OH *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring.
Table XXIII-43. X2 R' R2 R 3 a R 3 b R 4 R R' X Y XXII-43-1 'Pr H H H Bz H F F OH XXIII-43-2 'Pr H H CH 3 Bz H F F OH XXIII-43-3 'Pr H H CH(CH 3
)
2 Bz H F F OH XXIf-43-4 'Pr H H CH 2
CH(CH
3
)
2 Bz H F F OH XXIH-43-5 'Pr H H CH 2 Ph Bz H F F Ogi XXI-43-6 'Pr H H CH 2 -indol-3-yl Bz H F F OH XXIH-43-7 'Pr H H CH 2
CH
2
SCH
3 Bz H F F OH XXIH-43-8 'Pr * H * Bz H F F OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXIII-44. N2 R' R2 R 3 a R 3 b R' R' R 6 X Y XXIH-44-1 'Bu H H H Bz H F F OH XXII-44-2 'Bu H H CH 3 Bz H F F OH XXIH-44-3 'Bu H H CH(CH 3
)
2 Bz H F F OH XXIII-44-4 'Bu H H CH 2
CH(CH
3
)
2 Bz H F F OH XXIH-44-5 'Bu H H CH 2 Ph Bz H F F OH XXIII-44-6 'Bu H H CH 2 -indol-3-yl Bz H F F OH XXIH-44-7 'Bu H H CH 2
CH
2
SCH
3 Bz H F F OH XXIII-44-8 'Bu * H * Bz H F F OH 10 *R7 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXIII-45. NR IR 2 RaR 3 R4 R' R' X Y XXI-45-1 Ph H H H Bz H F F OH XXI-45-2 Ph H H CH 3 .Bz H F F OH XXIH-45-3 Ph H H CH(CH 3
)
2 Bz H F F OH XXIII-45-4 Ph H H CH 2
CH(CH
3
)
2 Bz H F F OH XXIH-45-5 Ph H H CH 2 Ph Bz H F F OH XXIH-45-6 Ph H H CH 2 -indol-3-yl Bz H F F OH XXHI-45-7 Ph H H CH 2
CH
2
SCH
3 Bz H F F OH XXIII-45-8 Ph * H * Bz H F F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XXIII-46. N Rl R 2
R
3 a R 3 b R 4 R' R 6 X Y XXIII-46-1 p-Me-Ph H H H Bz H F F OH XXHI-46-2 p-Me-Ph H H CH 3 Bz H F F OH XXIH-46-3 p-Me-Ph H H CH(CH 3
)
2 Bz H F F OH XXIH-46-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Bz H F F OH XXIH-46-5 p-Me-Ph H H CH 2 Ph Bz H F F OH XXM-46-6 p-Me-Ph H H CH 2 -indol-3-yl Bz H F F OH XXHI-46-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Bz H F F OH XXIII-46-8 p-Me-Ph * H * Bz H F F OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXIII-47. N2 R' R2 R 3 a R 3 b RI R' R 6 X Y XXIH-47-1 p-F-Ph H H H Bz H F F OH XXIII-47-2 p-F-Ph H H CH 3 Bz H F F OH XXM-47-3 p-F-Ph H H CH(CH 3
)
2 Bz H F F OH XXIII-47-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Bz H F F OH XXIII-47-5 p-F-Ph H H CH 2 Ph Bz H F F OH XXLI-47-6 p-F-Ph H H CH 2 -indol-3-yl Bz H F F OH XXII-47-7 p-F-Ph H H CH 2
CH
2
SCH
3 Bz H F F OH XXHI-47-8 p-F-Ph * H * Bz H F F OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXIII-48. N2 Rl R 2
R
3 a R 3 b R' R' R XY XXII-48-1 p-Cl-Ph H H H Bz H F F OH XXm-48-2 p-Cl-Ph H H CH 3 Bz H F F OH XXIm-48-3 p-Cl-Ph H H CH(CH 3
)
2 Bz H F F OH XXIII-48-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Bz H F F OH XXM-48-5 p-Cl-Ph H H CH 2 Ph Bz H F F OH XXM-48-6 p-Cl-Ph H H CH 2 -indol-3-yl Bz H F F OH XXM-48-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Bz H F F OH XXLI-48-8 p-Cl-Ph * H * Bz H F F OH *RT and R 3 b joined together by (CH 2
)
3 to form five-membered ring. -l 1) A Table XXIII-49. N2 RK R 2
R
3 a R3b R 4 R' R' X Y XXI-49-1 p-Br-Ph H H H Bz H F F OH XXIH-49-2 p-Br-Ph H H CH 3 Bz H F F OH XXIH-49-3 p-Br-Ph H H CH(CH 3
)
2 Bz H F F OH XXI-49-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Bz H F F OH XXI-49-5 p-Br-Ph H H CH 2 Ph Bz H F F OH XXI-49-6 p-Br-Ph H H CH 2 -indol-3-yl Bz H F F OH XXIH-49-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Bz H F F OH XXIII-49-8 p-Br-Ph * H * Bz H F F OH *R and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXIII-50. 2 R R 2
R
3
R
3 a R3b R4 R' R 6 X Y XXI-50-1 p-I-Ph H H H Bz H F F OH XXIII-50-2 p-I-Ph H H CH 3 Bz H F F OH XXLI-50-3 p-I-Ph H H CH(CH 3
)
2 Bz H F F OH XXI[-50-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Bz H F F OH XXIH-50-5 p-I-Ph H H CH 2 Ph Bz H F F OH XXIM-50-6 p-I-Ph H H CH 2 -indol-3-yl Bz H F F OH XXI-50-7 p-I-Ph H H CH 2
CH
2
SCH
3 Bz H F F OH XXIII-50-8 p-I-Ph * H * Bz H F F OH *R and Rb joined together by (CH 2
)
3 to form five-membered ring. 5 R3b R2 N N 1N 11 0 N R3a -- -- O ON N NN C0 2
R
4 OR R5\
NH
2 Y X XMV Table XXIV- 1. N2 R R 2 R R 3 b R 4
R'R
6 XY XXIV-1-1 CH 3 H H H CH 3 H H F OH C A7 N2 R' R2 R 3 a R 3 b R 4 R' R 6 X y XXIV-1-2 CH 3 H H CH 3
CH
3 H H F OH XXIV-1-3 CH 3 H H CH(CH 3
)
2
CH
3 H H F OH XXIV-1-4 CH 3 H H CH 2 CH(CH3) 2
CH
3 H H F OH XXIV-1-5 CH 3 H H CH 2 Ph CH 3 H H F OH XXIV-1-6 CH 3 H H CH 2 -indol-3-yl CH 3 H H F OH XXIV-1-7 CH 3 H H CH 2
CH
2
SCH
3
CH
3 H H F OH XXIV-1-8 CH 3 * H * CH 3 H H F OH *RT and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXIV-2. N2 RI R 2
R
3 a R 3 b R 4 R R 6 X Y XXIV-2-1 Et H H H CH 3 H H F OH XXIV-2-2 Et H H CH 3
CH
3 H H F OH XXIV-2-3 Et H H CH(CH 3
)
2
CH
3 H H F OH XXIV-2-4 Et H H CH 2
CH(CH
3
)
2
CH
3 H H F OH XXIV-2-5 Et H H CH 2 Ph CH 3 H H F OH XXIV-2-6 Et H H CH 2 -indol-3-yl CH 3 H H F OH XXIV-2-7 Et H H CH 2
CH
2
SCH
3
CH
3 H H F OH XXIV-2-8 Et * H * CH 3 H H F QH T*R2and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXIV-3. N2 R' R2 R 3 a R 3 b R 4 R' R' X Y XXIV-3-1 'Pr H H H CH 3 H H F OH XXIV-3-2 'Pr H H CH 3
CH
3 H H F OH XXIV-3-3 'Pr H H CH(CH 3
)
2
CH
3 H H F OH XXIV-3-4 'Pr H H CH 2
CH(CH
3
)
2
CH
3 H H F OH XXIV-3-5 'Pr H H CH 2 Ph CH 3 H H F OH XXIV-3-6 'Pr H H CH 2 -indol-3-yl CH 3 H H F OH XXIV-3-7 'Pr H H CH 2
CH
2
SCH
3
CH
3 H H F OH XXIV-3-8 'Pr * H * CH 3 H H F OH 5 *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXIV-4. R R 2
R
3 aR 3 b R 4 R' R X Y XXIV-4-1 'Bu H H H CH3 H H F OH XXIV-4-2 'Bu H H CH3 CH 3 H H F OH
HCIA
3 X R R 2
R
3 a R 3 b R 4 R' R' X Y XXIV-4-3 'Bu H H CH(CH 3
)
2
CH
3 H H F OH XXIV-4-4 'Bu H H CH 2
CH(CH
3
)
2
CH
3 H H F OH XXIV-4-5 'Bu H H CH 2 Ph CH 3 H H F OH XXIV-4-6 'Bu H H CH 2 -indol-3-yl CH 3 H H F OH XXIV-4-7 'Bu H H CH 2
CH
2
SCH
3
CH
3 H H F OH XXIV-4-8 'Bu * H * CH 3 H H F OH *R2 and 13b joined together by (CH 2
)
3 to form five-membered ring. Table XXIV-5. X R' R 2
R
3 a R 3 b R 4 R' R' X Y XXIV-5-1 Ph H H H CH4 3 H H F OH XXIV-5-2 Ph H H CH 3
CH
3 H H F OH XXIV-5-3 Ph H H CH(CH 3
)
2
CH
3 H H F OH XXIV-5-4 Ph H H CH 2
CH(CH
3
)
2
CH
3 H H F OH XXIV-5-5 Ph H H CH 2 Ph CH 3 H H F OH XXIV-5-6 Ph H H CH 2 -indol-3-yl CH 3 H H F OH XXIV-5-7 Ph H H CH 2
CH
2
SCH
3
CH
3 H H F OH XXIV-5-8 Ph * H * CH 3 H H F OH *Rland R~b joined together by (CH 2
)
3 to form five-membered ring. Table XXIV-6. X R R 2
R
3 a R 3 b R' R' R' X Y XXIV-6-1 p-Me-Ph H H H CH 3 H H F OH XXIV-6-2 p-Me-Ph H H CH 3
CH
3 H H F OH XXIV-6-3 p-Me-Ph H H CH(CH 3
)
2
CH
3 H H F OH XXIV-6-4 p-Me-Ph H H CH 2
CH(CH
3
)
2
CH
3 H H F OH XXIV-6-5 p-Me-Ph H H CH 2 Ph CH 3 H H F OH XXIV-6-6 p-Me-Ph H H CH 2 -indol-3-yl CH 3 H H F OH XXIV-6-7 p-Me-Ph H H CH 2
CH
2
SCH
3
CH
3 H H F OH XXIV-6-8 p-Me-Ph * H * CH 3 H H F OH 5 *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXIV-7. X Rl R2 R 3 a R 3 b R 4 R' R' X Y XXIV-7--1 p-F-Ph H H H CH 3 H H F OH XXIV-7-2 p-F-Ph H H CH 3
CH
3 H H F OH XXIV-7-3 p-F-Ph H H CH(CH 3
)
2
CH
3 H H F OH X2 R R 2 R3a R 3 b R 4 R' R' X Y XXIV-7-4 p-F-Ph H H CH 2
CH(CH
3
)
2
CH
3 H H F OH XXIV-7-6 p-F-Ph H H CH 2 Ph CH 3 H H F OH XXIV-7-7 p-F-Ph H H CH 2 -indol-3-yl CH 3 H H F OH XXIV-7-8 p-F-Ph H H CH 2
CH
2
SCH
3
CH
3 H H F OH XXIV-7-20 p-F-Ph * H * CH 3 H H F OH
*R
2 and RJb joined together by (CH 2
)
3 to form five-membered ring. Table XXIV-8. N2 Rl R 2
R
3 a R 3 b R 4 R' R 6 X Y XXIV-8-1 p-Cl-Ph H H H CH 3 H H F OH XXIV-8-2 p-Cl-Ph H H CH 3
CH
3 H H F OH XXIV-8-3 p-Cl-Ph H H CH(CH 3
)
2
CH
3 H H F OH XXIV-8-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2
CH
3 H H F OH XXIV-8-5 p-Cl-Ph H H CH 2 Ph CH 3 H H F OH XXIV-8-6 p-Cl-Ph H H CH 2 -indol-3-yl CH 3 H H F OH XXIV-8-7 p-Cl-Ph H H CH 2
CH
2
SCH
3
CH
3 H H F OH XXIV-8-8 p-Cl-Ph * H * CH 3 H H F OH *R and R joined together by (CH 2
)
3 to form five-membered ring. Table XXIV-9. N2 R R 2
R
3 a R3b R 4 R' R 6 X y XXIV-9-1 p-Br-Ph H H H CH 3 H H F OH XXIV-9-2 p-Br-Ph H H CH 3
CH
3 H H F OH XXIV-9-3 p-Br-Ph H H CH(CH 3
)
2
CH
3 H H F OH XXIV-9-4 p-Br-Ph H H CH 2
CH(CH
3
)
2
CH
3 H H F OH XXIV-9-6 p-Br-Ph H H CH 2 Ph CH 3 H H F OH XXIV-9-7 p-Br-Ph H H CH 2 -indol-3-yl CH 3 H H F OH XXIV-9-8 p-Br-Ph H H CH2CH 2
SCH
3
CH
3 H H F OH XXIV-9-20 p-Br-Ph * H * CH 3 H H F OH 5 *R and R~b joined together by (CH 2
)
3 to form five-membered ring. Table XXIV-10. N2 R R2 R3a R3b R4 R' R' X Y XXIV-10-1 p-I-Ph H H H CH 3 H H F OH XXIV-10-2 p-I-Ph H H CH 3
CH
3 H H F OH XXIV-10-3 p-I-Ph H H CH(CH 3
)
2
CH
3 H H F OH XXIV-10-4 p-I-Ph H H CH 2
CH(CH
3
)
2
CH
3 H H F OH C1 A X R' R 2
R
3 a R 3 b R 4
R'R
6 X Y XXIV-10-5 p-I-Ph H H CH 2 Ph CH 3 H H F OH XXIV-10-6 p-I-Ph H H CH 2 -indol-3-yl CH 3 H H F OH XXIV-10-7 p-I-Ph H H CH 2
CH
2
SCH
3
CH
3 H H F OH XXIV-10-8 p-I-Ph * H * CH 3 H H F OH *RT and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXIV-11. X R' R2 R 3 a R 3 b R' RI R' X Y XXIV-11-1 CH 3 H H H Et H H F OH XXIV-11-2 CH 3 H H CH 3 Et H H F OH XXIV-11-3 CH 3 H H CH(CH 3
)
2 Et H H F OH XXIV-11-4 CH 3 H H CHCH(CH 3
)
2 Et H H F OH XXIV-11-5 CH 3 H H CH 2 Ph Et H H F OH XXIV-11-6 CH 3 H H CH2-indol-3-yl Et H H F OH XXIV-11-7 CH 3 H H CHCH 2
SCH
3 Et H H F OH XXIV-11-8 CH 3 * H * Et H H F OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXIV-12. Xe R R 2
R
3 a R 3 ) R 4 R' R' X Y XXIV-12-1 Et H H H Et H H F OH XXIV-12-2 Et H H CH 3 Et H H F OH XXIV-12-3 Et H H CH(CH 3
)
2 Et H H F OH XXIV-12-4 Et H H CH 2
CH(CH
3
)
2 Et H H F OH XXIV-12-5 Et H H CH 2 Ph Et H H F OH XXIV-12-6 Et H H CH 2 -indol-3-yl Et H H F OH XXIV-12-7 Et H H CH 2
CH
2
SCH
3 Et H H F OH XXIV-12-8 Et* H * Et H H F OH 5 *Rland Rb joined together by (CH 2
)
3 to form five-membered ring. Table XXIV-13. X R R2 R 3 " R 3 b R 4 R' R' X Y XXIV-13-1 'Pr H H H Et H H F OH XXIV-13-2 'Pr H H CH 3 Et H H F OH XXIV-13-3 'Pr H H CH(CH 3
)
2 Et H H F OH XXIV-13-4 'Pr H H CH 2
CH(CH
3
)
2 Et H H F OH XXIV-13-5 'Pr H H CH2Ph Et H H F OH _ C 1 X2 R' R 2
R
3 " R 3 b R 4 R' R' X Y XXIV-13-6 'Pr H H CH 2 -indol-3-yl Et H H F OH XXIV-13-7 'Pr H H CH 2
CH
2
SCH
3 Et H H F OH XXIV-13-8 'Pr * H * Et H H F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXIV-14. N2 R' R 2
R
3 a R b R 4 R' R X Y XXIV-14-1 'Bu H H H Et H H F OH XXIV-14-2 'Bu H H CH 3 Et H H F OH XXIV-14-3 'Bu H H CH(CH 3
)
2 Et H H F OH XXIV-14-4 'Bu H H CH 2
CH(CH
3
)
2 Et H H F OH XXIV-14-5 'Bu H H CH 2 Ph Et H H F OH XXIV-14-6 'Bu H H CH 2 -indol-3-yl Et H H F OH XXIV-14-7 'Bu H H CH 2
CH
2
SCH
3 Et H H F OH XXIV-14-8 'Bu * H * Et H H F OH *r and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXIV-15. N2 RI R 2
R
3 a R 3 b R 4 R' R 6 X Y XXIV-15-1 Ph H H H Et H H F OH XXIV-15-2 Ph H H CH 3 Et H H F OH XXIV-15-3 Ph H H CH(CH 3
)
2 Et H H F OH XXIV-15-4 Ph H H CH 2
CH(CH
3
)
2 Et H H F OH XXIV-15-5 Ph H H CH 2 Ph Et H H F OH XXIYV-15-6 Ph H H CH 2 -indol-3-yl Et H H F OH XXIV-15-7 Ph H H CH 2
CH
2
SCH
3 Et H H F OH XXIV-15-8 Ph * H * Et H H F OH 5 nd R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXIV-16. N2 R R2 R 3 a R 3 b R 4 R' R 6 X Y XXIV-16-1 p-Me-Ph H H H Et H H F OH XXIV-16-2 p-Me-Ph H H CH 3 Et H H F OH XXIV-16-3 p-Me-Ph H H CH(CH 3
)
2 Et H H F OH XXIV-16-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Et H H F OH XXIV-16-5 p-Me-Ph H H CH 2 Ph Et H H F OH XXIV-16-6 p-Me-Ph H H CH 2 -indol-3-yl Et H H F OH - 51') - N2 R' R2 R 3 a R 3 b R 4 R'R X Y XXIV-16-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Et H H F OH XXIV-16-8 p-Me-Ph * H * Et H H F OH *R and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXIV-17. X Rl R2 R 3a R 3 b R' R' R 6 X Y XXIV-17-1 p-F-Ph H H H Et H H F OH XXIV-17-2 p-F-Ph H H CH 3 Et H H F OH XXIV-17-3 p-F-Ph H H CH(CH 3
)
2 Et H H F OH XXIV-17-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Et H H F OH XXIV-17-5 p-F-Ph H H CH 2 Ph Et H H F OH XXIV-17-6 p-F-Ph H H CH 2 -indol-3-yl Et H H F OH XXIV-17-7 p-F-Ph H H CH 2
CH
2
SCH
3 Et H H F OH XXIV-17-8 p-F-Ph * H * Et H H F OH *R2 and R 3 6 joined together by (CH 2
)
3 to form five-membered ring. Table XXIV-18. SR R RaRb R R R 6 X Y XXIV-18-1 p-Cl-Ph H H H Et H H F OH XXIV-18-2 p-Cl-Ph H H CH 3 Et H H F OH XXIV-18-3 p-Cl-Ph H H CH(CH 3
)
2 Et H H F OH XXIV-18-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Et H H F OH XXIV-18-5 p-Cl-Ph H H CH 2 Ph Et H H F OH XXIV-18-6 p-Cl-Ph H H CH 2 -indol-3-yl Et H H F OH XXIV-18-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Et H H F OH XXIV-18-8 p-Cl-Ph * H * Et H H F OH 5 T*R2and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XXIV-19. N2 R 2
R
3 Rib R 4 R' R' X Y XXIV-19-1 p-Br-Ph H H H Et H H F OH XXIV-19-2 p-Br-Ph H H CH 3 Et H H F OH XXIV-19-3 p-Br-Ph H H CH(CH 3
)
2 Et H H F OH XXIV-19-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Et H H F OH XXIV-19-5 p-Br-Ph H H CH 2 Ph Et H H F OH XXIV-19-6 p-Br-Ph H H CH 2 -indol-3-yl Et H H F OH XXIV-19-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Et H H F OH Cz1'l2 N Rl R 2 R 3 a R 3 b R R' R 6 X Y XXIV-19-8 p-Br-Ph H * Et H H F OH *R and R 3 ' joined together by (CH 2
)
3 to form five-membered ring. Table XXIV-20. N2 Rl R 2
R
3 a R 3 b R4 R' R' X Y XXIV-20-1 p-I-Ph H H H Et H H F OH XXIV-20-2 p-I-Ph H H CH 3 Et H H F OH XXIV-20-3 p-I-Ph H H CH(CH 3
)
2 Et H H F OH XXIV-20-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Et H H F OH XXIV-20-5 p-I-Ph H H CH 2 Ph Et H H F OH XXIV-20-6 p-I-Ph H H CH 2 -indol-3-yl Et H H F OH XXIV-20-7 p-I-Ph H H CH 2
CH
2
SCH
3 Et H H F OH XXIV-20-8 p-I-Ph * H * Et H H F OH * R and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XXIV-2 1. N2 Rl R 2
R
3 a R 3 b R 4 R' R 6 X Y XXIV-21-1 CH 3 H H H 'Pr H H F OH XXIV-21-2 CH 3 H H CH 3 'Pr H H F OH XXIV-21-3 CH 3 H H CH(CH 3
)
2 'Pr H H F OH XXIV-21-4 CH 3 H H CH 2
CH(CH
3
)
2 'Pr H H F OH XXIV-21-5 CH 3 H H CH 2 Ph 'Pr H H F OH XXIV-21-6 CH 3 H H CH 2 -indol-3-yl 'Pr H H F OH XXIV-21-7 CH 3 H H CH 2
CH
2
SCH
3 'Pr H H F OH XXIV-21-8 CH 3 * H * 'Pr. H H F OH 5 *Rland Rb joined together by (CH 2
)
3 to form five-membered ring. Table XXIV-22. N2 RI R 2
R
3 a R 3 b R 4
R
5
R
6 X Y XXIV-22-1 Et H H H 'Pr H H F OH XXIV-22-2 Et H H CH 3 'Pr H H F OH XXIV-22-3 Et H H CH(CH 3
)
2 'Pr H H F OH XXIV-22-4 Et H H CH 2
CH(CH
3
)
2 'Pr H H F OH XXIV-22-5 Et H H CH 2 Ph 'Pr H H F OH XXIV-22-6 Et H H CH 2 -indol-3-yl 'Pr H H F OH XXIV-22-7 Et H H CH 2
CH
2
SCH
3 'Pr H H F OH XXIV-22-8 Et * H * 'Pr H H F OH C 1A
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXIV-23. 2 NR' R2 R 3 a R 3 b R 4 R R 6 X Y XXIV-23-1 'Pr H H H 'Pr H H F OH XXIV-23-2 'Pr H H CH4 3 'Pr H H F OH XXIV-23-3 'Pr H H CH(CH 3
)
2 'Pr H H F OH XXIV-23-4 'Pr H H CH 2
CH(CH
3
)
2 'Pr H H F OH XXIV-23-5 'Pr H H CH 2 Ph 'Pr H H F OH XXIV-23-6 'Pr H H CH 2 -indol-3-yl 'Pr H H F OH XXIV-23-7 'Pr H H CH 2
CH
2
SCH
3 'Pr H H F OH XXIV-23-8 'Pr * H * 'Pr H H F OH *R2 and R 3 " joined together by (CH 2
)
3 to form five-membered ring. Table XXIV-24. X2 R 1 R2 R 3 a R 3 b R4 R' R 6 X Y XXIV-24-1 'Bu H H H 'Pr H H F OH XXIV-24-2 'Bu H H CH 3 'Pr H H F OH XXIV-24-3 'Bu H H CH(CH 3
)
2 'Pr H H F OH XXIV-24-4 'Bu H H CH 2
CH(CH
3
)
2 'Pr H H F OH XXIV-24-5 'Bu H H CH 2 Ph 'Pr H H F OH XXIV-24-6 'Bu H H CH 2 -indol-3-yl 'Pr H H F OH XXIV-24-7 'Bu H H CH 2
CH
2
SCH
3 'Pr H H F OH XXIV-24-8 'Bu * H * 'Pr H H F OH 5 *R 2 and R"b joined together by (CH 2
)
3 to form five-membered ring. Table XXIV-25. X2 R R2 R 3 a R 3 b R 4 Rs R 6 X Y XXIV-25-1 Ph H H H 'Pr H H F OH XXIV-25-2 Ph H H CH 3 'Pr H H F OH XXIV-25-3 Ph H H CH(CH 3
)
2 'Pr H H F OH XXIV-25-4 Ph H H CH 2
CH(CH
3
)
2 'Pr H H F OH XXIV-25-5 Ph H H CH 2 Ph 'Pr H H F OH XXIV-25-6 Ph H H CH 2 -indol-3-yl 'Pr H H F OH XXIV-25-7 Ph H H CH 2
CH
2
SCH
3 'Pr H H F OH XXIV-25-8 Ph * H * 'Pr H H F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XXIV-26. X2 R R2 Ria R R 4 R' R 6 XY XXIV-26-1 p-Me-Ph H H H 'Pr H H F OH XXIV-26-2 p-Me-Ph H H CH 3 'Pr H H F OH XXIV-26-3 p-Me-Ph H H CH(CH 3
)
2 'Pr H H F OH XXIV-26-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 'Pr H H F OH XXIV-26-5 p-Me-Ph H H CH 2 Ph 'Pr H H F OH XXIV-26-6 p-Me-Ph H H CH 2 -indol-3-yl 'Pr H H F OH XXIV-26-7 p-Me-Ph H H CH 2
CH
2
SCH
3 'Pr H H F OH XXIV-26-8 p-Me-Ph * H * 'Pr H H F OH *R and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XXIV-27. X2 R' R 2
R
3 a R b R R' R 6 X Y XXIV-27-1 p-F-Ph H H H 'Pr H H F OH XXIV-27-2 p-F-Ph H H CH 3 'Pr H H F OH XXIV-27-3 p-F-Ph H H CH(CH 3
)
2 'Pr H H F OH XXIV-27-4 p-F-Ph H H CH 2
CH(CH
3
)
2 'Pr H H F OH XXIV-27-5 p-F-Ph H H CH 2 Ph 'Pr H H F OH XXIV-27-6 p-F-Ph H H CH 2 -indol-3-yl 'Pr H H F OH XXIV-27-7 p-F-Ph H H CH 2
CH
2
SCH
3 'Pr H H F OH XXIV-27-8 p-F-Ph * H * 'Pr H H F OH *R and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXIV-28. X R R2 1 Ra R3b R4 R' R 6 X Y XXIV-28-1 p-Cl-Ph H H H 'Pr H H F OH XXIV-28-2 p-Cl-Ph H H CH 3 'Pr H H F OH XXIV-28-3 p-Cl-Ph H H CH(CH 3
)
2 'Pr H H F OH XXIV-28-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 'Pr H H F OH XXIV-28-5 p-Cl-Ph H H CH 2 Ph 'Pr H H F OH XXIV-28-6 p-Cl-Ph H H CH2-indol-3-yl 'Pr H H F OH XXIV-28-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 'Pr H H F OH XXIV-28-8 p-Cl-Ph * H * 'Pr H H F OH *Ran Ra b joined together by (CH 2
)
3 to form five-membered ring. _C1 A Table XXIV-29. N2 R' R2 R 3 " R 3b R'4 R ' R X Y XXIV-29-1 p-Br-Ph H H H 'Pr H H F OH XXIV-29-2 p-Br-Ph H H CH 3 'Pr H H F OH XXIV-29-3 p-Br-Ph H H CH(CH 3
)
2 'Pr H H F OH XXIV-29-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 'Pr H H F OH XXIV-29-5 p-Br-Ph H H CH 2 Ph 'Pr H H F OH XXIV-29-6 p-Br-Ph H H CH 2 -indol-3-yl 'Pr H H F OH XXIV-29-7 p-Br-Ph H H CH 2
CH
2
SCH
3 'Pr H H F OH XXIV-29-8 p-Br-Ph * H * 'Pr H H F OH
*R
2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXIV-30. N2 Rl R2 R 3 a R 3 b R 4 R' R 6 X Y XXIV-30-1 p-I-Ph H H H Pr H H F OH XXIV-30-2 p-I-Ph H H CH 3 Pr H H F OH XXIYV-30-3 p-I-Ph H H CH(CH 3
)
2 'Pr H H F OH XXIV-30-4 p-I-Ph H H CH 2
CH(CH
3
)
2 'Pr H H F OH XXIV-30-5 p-I-Ph H H CH 2 Ph 'Pr H H F OH XXIV-30-6 p-I-Ph H H CH 2 -indol-3-yl 'Pr H H F OH XXIV-30-7 p-I-Ph H H CH 2
CH
2
SCH
3 'Pr H H F OH XXIV-30-8 p-I-Ph * H * 'Pr H H F OH *R and Rab joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXIV-31. N2 R R R 3 a R 3 b R 4 R' R 6 X Y XXIV-31-1 CH 3 H H H "Bu H H F OH XXIV-31-2 CH 3 H H CH 3 "Bu H H F OH XXIV-31-3 CH 3 H H CH(CH 3
)
2 "Bu H H F OH XXIV-31-4 CH 3 H H CH 2
CH(CH
3
)
2 "Bu H H F OH XXIV-31-5 CH 3 H H CH 2 Ph "Bu H H F OH XXIV-31-6 CH 3 H H CH 2 -indol-3-yl "Bu H H F OH XXIV-31-7 CH 3 H H CH2CH 2
SCH
3 "Bu H H F OH XXIV-31-8 CH 3 * H * "Bu H H F OH nd Rib joined together by (CH 2
)
3 to form five-membered ring. CZ1 '7 Table XXIV-32. N2 RI R 2
R
3 a R b R4 R' R 6 X Y XXIV-32-1 Et H H H "Bu H H F OH XXIV-32-2 Et H H CH 3 "Bu H H F OH XXIV-32-3 Et H H CH(CH 3
)
2 "Bu H H F OH XXIV-32-4 Et H- H CH 2
CH(CH
3
)
2 "Bu H H F OH XXIV-32-5 Et H H CH 2 Ph "Bu H H F OH XXIV-32-6 Et H H CH 2 -indol-3-yl "Bu H H F OH XXIV-32-7 Et H H CH 2
CH
2
SCH
3 "Bu H H F OH XXIV-32-8 Et * H * "Bu H H F OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXIV-33. N2 R' R 2
R
3 a R3b R 4 R' R 6 X Y XXIV-33-1 'Pr H H H "Bu H H F OH XXIV-33-2 'Pr H H CH 3 "Bu H H F OH XXIV-33-3 'Pr H H CH(CH 3
)
2 "Bu H H F OH XXIV-33-4 'Pr H H CH 2
CH(CH
3
)
2 "Bu H H F OH XXIV-33-5 'Pr H H CH 2 Ph "Bu H H F OH XXIV-33-6 'Pr H H CH 2 -indol-3-yl "Bu H H F OH XXIV-33-7 'Pr H H CH 2
CH
2
SCH
3 "Bu H H F OH XXIV-33-8 'Pr * H * "Bu H H F OH
*R
2 and R b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXIV-34. N! R' R2 R3a R3b R' R 6 X Y XXIV-34-1 'Bu H H H "Bu H H F OH XXIV-34-2 'Bu H H CH 3 "Bu H H F OH XXIV-34-3 'Bu H H CH(CH 3
)
2 "Bu H H F OH XXIV-34-4 'Bu H H CH 2
CH(CH
3
)
2 "Bu H H F OH XXIV-34-5 'Bu H H CH 2 Ph "Bu H H F OH XXIV-34-6 'Bu H H CH2-indol-3-yI "Bu H H F OH XXIV-34-7 'Bu H H CH 2
CH
2
SCH
3 "Bu H H F OH XXIV-34-8 'Bu * H * "Bu H H F OH *R and R-b joined together by (CH 2
)
3 to form five-membered ring. _ C1Q Table XXIV-35. X2 R R 2 Ra R 3 b R 4 R' R' X Y XXIV-35-1 Ph H H H "Bu H H F OH XXIV-35-2 Ph H H CH 3 "Bu H H F OH XXIV-35-3 Ph H H CH(CH 3
)
2 "Bu H H F OH XXIV-35-4 Ph H H CH 2
CH(CH
3
)
2 "Bu H H F OH XXIV-35-5 Ph H H CH 2 Ph "Bu H H F OH XXIV-35-6 Ph H H CH 2 -indol-3-yl "Bu H H F OH XXIV-35-7 Ph H H CH 2
CH
2
SCH
3 "Bu H H F OH XXIV-35-8 Ph * H * "Bu H H F OH *R and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXIV-36. N2 R R 2
R
3 a R 3 b R 4 R' R 6 X Y XXIV-36-1 p-Me-Ph H H H "Bu H H F OH XXIV-36-2 p-Me-Ph H H CH 3 "Bu H H F OH XXIV-36-3 p-Me-Ph H H CH(CH 3
)
2 "Bu H H F OH XXIV-36-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 "Bu H H F OH XXIV-36-5 p-Me-Ph H H CH 2 Ph "Bu H H F OH XXIV-36-6 p-Me-Ph H H CH 2 -indol-3-yl "Bu H H F OH XXIV-36-7 p-Me-Ph H H CH 2
CH
2
SCH
3 "Bu H H F OH XXIV-36-8 p-Me-Ph * H * "Bu H H F OH *RTand R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXIV-37. N2 R R 2
R
3 a R 3 b R 4 R' R' X Y XXIV-37-1 p-F-Ph H H H "Bu H H F OH XXIV-37-2 p-F-Ph H H CH 3 "Bu H H F OH XXIV-37-3 p-F-Ph H H CH(CH 3 )2 "Bu H H F OH XXIV-37-4 p-F-Ph H H CH 2
CH(CH
3
)
2 "Bu H H F OH XXIV-37-5 p-F-Ph H H CH 2 Ph "Bu H H F OH XXIV-37-6 p-F-Ph H H CH 2 -indol-3-yl "Bu H H F OH XXIV-37-7 p-F-Ph H H CH 2
CH
2
SCH
3 "Bu H H F OH XXIV-37-8 p-F-Ph * H * "Bu H H F OH
*R
2 and R3b joined together by (CH 2
)
3 to form five-membered ring. _ C10 Table XXIV-38. N2 R' R R R R 4 R R X Y XXIV-38-1 p-Cl-Ph H H H "Bu H H F OH XXIV-38-2 p-Cl-Ph H H CH 3 "Bu H H F OH XXIV-38-3 p-Cl-Ph H H CH(CH 3
)
2 "Bu H H F OH XXIV-38-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 "Bu H H F OH XXIV-38-5 p-Cl-Ph H H CH 2 Ph "Bu H H F OH XXIV-38-6 p-Cl-Ph H H CH 2 -indol-3-yl "Bu H H F OH XXIV-38-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 "Bu H H F OH XXIV-38-8 p-Cl-Ph * H * "Bu H H F OH *R2 and R 3 bjoined together by (CH 2
)
3 to form five-membered ring. Table XXIV-39. NO Rl R 2
R
3 a R 3 b R 4 R' R' X Y XXIV-39-1 p-Br-Ph H H H "Bu H H F OH XXIV-39-2 p-Br-Ph H H CH 3 "Bu H H F OH XXIV-39-3 p-Br-Ph H H CH(CH 3
)
2 "Bu H H F OH XXIV-39-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 "Bu H H F OH XXIV-39-5 p-Br-Ph H H CH 2 Ph "Bu H H F OH XXIV-39-6 p-Br-Ph H H CH 2 -indol-3-yl "Bu H H F OH XXIV-39-7 p-Br-Ph H H CH 2
CH
2
SCH
3 "Bu H H F OH XXIV-39-8 p-Br-Ph * H * 'Bu H H F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXIV-40. X2 R 2 Ra Rb R 4
R'R
6 XY XXIV-40-1 p-I-Ph H H H "Bu H H F OH XXIV-40-2 p-I-Ph H H CH 3 "Bu H H F OH XXIV-40-3 p-I-Ph H H CH(CH 3
)
2 "Bu H H F OH XXIV-40-4 p-I-Ph H H CH 2
CH(CH
3
)
2 "Bu H H F OH XXIV-40-5 p-I-Ph H H CH 2 Ph "Bu H H F OH XXIV-40-6 p-I-Ph H H CH 2 -indol-3-yl "Bu H H F OH XXIV-40-7 p-I-Ph H H CH 2
CH
2
SCH
3 "Bu H H F OH XXIV-40-8 p-I-Ph * H * "Bu H H F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XXIV-4 1. NR R 2 Ra Rb R 4
R
5
R
6 XY XXIV-41-1 CH 3 H H H Bz H H F OH XXIV-41-2 CH 3 H H CH 3 Bz H H F OH XXIV-41-3 CH 3 H H CH(CH 3
)
2 Bz H H F OH XXIV-41-4 CH 3 H H CH 2
CH(CH
3
)
2 Bz H H F OH XXIV-41-5 CH 3 H H CH2Ph Bz H H F OH XXIV-41-6 CH 3 H H CH 2 -indol-3-yl Bz H H F OH XXIV-41-7 CH 3 H H CH2CH 2
SCH
3 Bz H H F OH XXIV-41-8 CH 3 * H * Bz H H F OH *R2 and RJb joined together by (CH 2
)
3 to form five-membered ring. Table XiXIV-42. X2 RI R 2
R
3 a R 3 b R4 R' R' X Y XXIV-42-1 Et H H H Bz H H F OH XXIV-42-2 Et H H CH 3 Bz H H F OH XXIV-42-3 Et H H CH(CH 3
)
2 Bz H H F OH XXIV-42-4 Et H H CH 2
CH(CH
3
)
2 Bz H H F OH XXIV-42-5 Et H H CH 2 Ph Bz H H F OH XXIV-42-6 Et H H CH 2 -indol-3-yl Bz H H F OH XXIV-42-7 Et H H CH 2
CH
2
SCH
3 Bz H H F OH XXIV-42-8 Et * H * Bz H H F OH *RT and R 1 joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXIV-43. N2 R R2 Ra R 3 b R' R' R 6 X Y XXIV-43-1 'Pr H H H Bz H H F OH XXIV-43-2 'Pr H H CH 3 Bz H H F OH XXIV-43-3 'Pr H H CH(CH 3
)
2 Bz H H F OH XXIV-43-4 'Pr H H CH 2
CH(CH
3
)
2 Bz H H F OH XXIV-43-5 'Pr H H CH 2 Ph Bz H H F OH XXIV-43-6 'Pr H H CH 2 -indol-3-yl Bz H H F OH XXIV-43-7 'Pr H H CH 2
CH
2
SCH
3 Bz H H F d(W XXIV-43-8 'Pr * H * Bz H H F OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. _<1 1 Table XXIV-44. N2 R' R2 R3a R 3 b R' R' R' X Y XXIV-44-1 'Bu H H H Bz H H F OH XXIV-44-2 'Bu H H CH 3 Bz H H F OH XXIV-44-3 'Bu H H CH(CH 3
)
2 Bz H H F OH XXIV-44-4 'Bu H H CH 2
CH(CH
3
)
2 Bz H H F OH XXIV-44-5 'Bu H H CH 2 Ph Bz H H F OH XXIV-44-6 'Bu H H CH 2 -indol-3-yl Bz H H F OH XXIV-44-7 'Bu H H CH 2
CH
2
SCH
3 Bz H H F OH XXIV-44-8 'Bu * H * Bz H H F OH *Riand Rib joined together by (CH 2
)
3 to form five-membered ring. Table XXIV-45. N2 R R 2
R
3 aRb R R R 6 XY XXIV-45-1 Ph H H H Bz H H F OH XXIV-45-2 Ph H H CH 3 Bz H H F OH XXIV-45-3 Ph H H CH(CH 3
)
2 Bz H H F OH XXIV-45-4 Ph H H CH 2
CH(CH
3
)
2 Bz H H F OH XXIV-45-5 Ph H H CH 2 Ph Bz H H F OH XXIV-45-6 Ph H H CH 2 -indol-3-yl Bz H H F OH XXIV-45-7 Ph H H CH 2
CH
2
SCH
3 Bz H H F OH XXIV-45-8 Ph * H * Bz H H F OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXIV-46. X2 Rl R 2
R
3 a R 3 b R 4
R
5
R
6 X Y XXIV-46-1 p-Me-Ph H H H Bz H H F OH XXIV-46-2 p-Me-Ph H H CH 3 Bz H H F OH XXIV-46-3 p-Me-Ph H H CH(CH 3
)
2 Bz H H F OH XXIV-46-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Bz H H F OH XXIV-46-5 p-Me-Ph H H CH 2 Ph Bz H H F OH XXIV-46-6 p-Me-Ph H H CH 2 -indol-3-yl Bz H H F OH XXIV-46-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Bz H H F OH XXIV-46-8 p-Me-Ph * H * Bz H H F OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XXIV-47. X2 Rl R 2
R
3
R
3 b R R' R 6 X Y XXIV-47-1 p-F-Ph H H H Bz H H F OH XXIV-47-2 p-F-Ph H H CH 3 Bz H H F OH XXIV-47-3 p-F-Ph H H CH(CH 3
)
2 Bz H H F OH XXIV-47-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Bz H H F OH XXIV-47-5 p-F-Ph H H CH 2 Ph Bz H H F OH XXIV-47-6 p-F-Ph H H CH 2 -indol-3-yl Bz H H F OH XXIV-47-7 p-F-Ph H H CH 2
CH
2
SCH
3 Bz H H F OH XXIV-47-8 p-F-Ph * H * Bz H H F OH *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXIV-48. X2 R' R 2 Ra RE R 4 R' R 6 X Y XXIV-48-1 p-Cl-Ph H H H Bz H H F OH XXIV-48-2 p-Cl-Ph H H CH 3 Bz H H F OH XXIV-48-3 p-Cl-Ph H H CH(CH 3
)
2 Bz H H F OH XXIV-48-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Bz H H F OH XXIV-48-5 p-Cl-Ph H H CH 2 Ph Bz H H F OH XXIV-48-6 p-Cl-Ph H H CH 2 -indol-3-yl Bz H H F OH XXIV-48-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Bz H H F OH XXJEV-48-8 p-Cl-Ph * H *Bz H H F OH 2 3b* *Rl and R joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXIV-49. N2 R R 2
R
3 a Rb R 4 R' R' X Y XXIV-49-1 p-Br-Ph H H H Bz H H F OH XXIV-49-2 p-Br-Ph H H CH 3 Bz H H F OH XXIV-49-3 p-Br-Ph H H CH(CH 3
)
2 Bz H H F OH XXIV-49-4 p-Br-Ph H H CH2CH(CH 3
)
2 Bz H H F OH XXIV-49-5 p-Br-Ph H H CH 2 Ph Bz H H F OH XXIV-49-6 p-Br-Ph H H CH 2 -indol-3-yl Bz H H F OH XXIV-49-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Bz H H F OH XXIV-49-8 p-Br-Ph * H * Bz H H F OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XXIV-50. X2 R R 2 R Rab R 4 R' R 6 X Y XXIV-50-1 p-I-Ph H H H Bz H H F OH XXIV-50-2 p-I-Ph H H CH 3 Bz H H F OH XXIV-50-3 p-I-Ph H H CH(CH 3
)
2 Bz H H F OH XXJV-50-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Bz H H F OH XXIV-50-5 p-I-Ph H H CH 2 Ph Bz H H F OH XXIV-50-6 p-I-Ph H H CH 2 -indol-3-yl Bz H H F OH XXIV-50-7 p-I-Ph H H CH 2
CH
2
SCH
3 Bz H H F OH XXIV-50-8 p-I-Ph * H * Bz H H F OH *R2 and R b joined together by (CH 2
)
3 to form five-membered ring. 5 Rh R 2 O N R3a N
-
O NN C0 2
R
4
OR
1
R
5
R
6
NH
2 Y X XXv Table XXV-1. N2 R R 2 R3a R 3 b R 4 R' R 6 X Y XXV-1-1 CH 3 H H H CH 3 H CH 3 F OH XXV-1-2 CH 3 H H CH 3
CH
3 H CH 3 F OH XXV-1-3 CH 3 H H CH(CH 3
)
2
CH
3 H CH 3 F OH XXV-1-4 CH 3 H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH XXV-1-5 CH 3 H H CH 2 Ph CH 3 H CH 3 F OH XXV-1-6 CH 3 H H CH 2 -indol-3-yl CH 3 H CH 3 F OH XXV-1-7 CH 3 H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH XXV-1-8 CH 3 * H * CH 3 H CH 3 F OH *RI and Rib joined together by (CH 2
)
3 to form five-membered ring. 10 Table XXV-2. N2 RI R 2
R
3 a R 3 b R 4 R' R 6 X Y XXV-2-1 Et H H H CH 3 H CH 3 F OH XXV-2-2 Et H H CH 3
CH
3 H CH 3 F OH XXV-2-3 Et H H CH(CH 3
)
2
CH
3 H CH 3 F OH XXV-2-4 Et H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH XXV-2-5 Et H H CH 2 Ph CH 3 H CH 3 F OH XXV-2-6 Et H H CH 2 -indol-3-yl CH 3 H CH 3 F OH XXV-2-7 Et H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH XXV-2-8 Et * H * CH 3 H CH 3 F OH *Rand R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXV-3. N2 R1 R2 R3a R 3 b R 4 R 5 R 6 x Y XXV-3-1 'Pr H H H CH 3 H CH3 F OH XXV-3-2 'Pr H H CH 3
CH
3 H CH 3 F OH XXV-3-3 'Pr H H CH(CH 3
)
2
CH
3 H CH 3 F OH XXV-3-4 'Pr H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH XXV-3-5 'Pr H H CH 2 Ph CH 3 H CH 3 F OH XXV-3-6 'Pr H H CH 2 -indol-3-yl CH 3 H CH 3 F OH XXV-3-7 'Pr H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH XXV-3-8 'Pr * H * CH 3 H CH 3 F OH *RT and R 3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXV-4. N2 R1 R2 R a R 3 b R4 R5 R 6 X Y XXV-4-1 'Bu H H H CH 3 H CH 3 F OH XXV-4-2 'Bu H H CH 3
CH
3 H CH 3 F OH XXV-4-3 'Bu H H CH(CH 3
)
2
CH
3 H CH 3 F OH XXV-4-4 'Bu H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH XXV-4-5 'Bu H H CH 2 Ph CH 3 H CH 3 F OH XXV-4-6 'Bu H H CH2-indol-3-yl CH 3 H CH 3 F OH XXV-4-7 'Bu H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH XXV-4-8 'Bu * H * CH 3 H CH 3 F OH *R and Rdb joined together by (CH 2
)
3 to form five-membered ring.
Table XXV-5. Xe R' R2 R3a R3b R 4 R' R' X Y XXV-5-1 Ph H H H CH 3 H CH 3 F OH XXV-5-2 Ph H H CH 3
CH
3 H CH 3 F OH XXV-5-3 Ph H H CH(CH 3
)
2
CH
3 H CH 3 F OH XXV-5-4 Ph H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH XXV-5-5 Ph H H CH 2 Ph CH 3 H CH 3 F OH XXV-5-6 Ph H H CH 2 -indol-3-yl CH 3 H CH 3 F OH XXV-5-7 Ph H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH XXV-5-8 Ph * H * CH 3 H CH 3 F OH *R2and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXV-6. Xe R' R 2 Ra R 3 b R 4
R
5
R
6 X Y XXV-6-1 p-Me-Ph H H H CH 3 H CH 3 F OH XXV-6-2 p-Me-Ph H H CH 3
CH
3 H CH 3 F OH XXV-6-3 p-Me-Ph H H CH(CH 3
)
2
CH
3 H CH 3 F OH XXV-6-.4 p-Me-Ph H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH XXV-6-5 p-Me-Ph H H CH 2 Ph CH 3 H CH 3 F OH XXV-6-6 p-Me-Ph H H CH 2 -indol-3-yl CH 3 H CH 3 F OH XXV-6-7 p-Me-Ph H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH XXV-6-8 p-Me-Ph H * CH 3 H CH 3 F OH R and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXV-7. X R R 2
R
3 a R 3 b R 4
R
5
R
6 X Y XXV-7-1 p-F-Ph H H H CH 3 H CH 3 F OH XXV-7-2 p-F-Ph H H CH 3
CH
3 H CH 3 F OH XXV-7-3 p-F-Ph H H CH(CH 3
)
2
CH
3 H CH 3 F OH XXV-7-4 p-F-Ph H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH XXV-7.-6 p-F-Ph H H CH 2 Ph CH 3 H CH 3 F OH XXV-7-7 p-F-Ph H H CH 2 -indol-3-yl CH 3 H CH 3 F OH XXV-7-8 p-F-Ph H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH XXV-7-20 p-F-Ph * H * CH 3 H CH 3 F OH *R and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XXV-8. X RI R2 R 3 a R 3 b R R R 6 X Y XXV-8-1 p-Cl-Ph H H H CH 3 H CH 3 F OH XXV-8-2 p-Cl-Ph H H CH 3
CH
3 H CH 3 F OH XXV-8-3 p-Cl-Ph H H CH(CH 3
)
2
CH
3 H CH 3 F OH XXV-8-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH XXV-8-5 p-Cl-Ph H H CH 2 Ph CH 3 H CH 3 F OH XXV-8-6 p-Cl-Ph H H CH 2 -indol-3-yl CH 3 H CH 3 F OH XXV-8-7 p-Cl-Ph H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH XXV-8-8 p-Cl-Ph * H * CH 3 H CH 3 F OH *RTand R 3 " joined together by (CH 2
)
3 to form five-membered ring. Table XXV-9. X R R 2
R
3 a R 3 b R' R' R 6 X Y XXV-9-1 p-Br-Ph H H H CH 3 H CH 3 F OH XXV-9-2 p-Br-Ph H H CH 3
CH
3 H CH 3 F OH XXV-9-3 p-Br-Ph H H CH(CH 3
)
2
CH
3 H CH 3 F OH XXV-9-.4 p-Br-Ph H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH XXV-9-6 p-Br-Ph H H CH 2 Ph CH 3 H CH 3 F OH XXV-9-7 p-Br-Ph H H CH 2 -indol-3-yl CH 3 H CH 3 F OH XXV-9-8 p-Br-Ph H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH XXV-9-.20 p-Br-Ph * H * CH 3 H CH 3 F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXV-10. Xe R' R2 R 3 a R 3
R
4 R R 6 X Y XXV-10-1 p-I-Ph H H H CH 3 H CH 3 F OH XXV-10-2 p-I-Ph H H CH 3
CH
3 H CH 3 F OH XXV-10-3 p-I-Ph H H CH(CH 3
)
2
CH
3 H CH 3 F OH XXV-10-4 p-I-Ph H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH XXV-10-5 p-I-Ph H, H CH 2 Ph CH 3 H CH 3 F OH XXV-10-6 p-I-Ph H H CH 2 -indol-3-yl CH 3 H CH 3 F OH XXV-10-7 p-I-Ph H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH XXV-10-8 p-I-Ph * H * CH 3 H CH 3 F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XXV-11. N2 R' R 2
R
3 a R 3 b R4 R 5
R
6 X Y XXV-11-1 CH 3 H H H Et H CH 3 F OH XXV-11-2 CH 3 H H CH 3 Et H CH 3 F OH XXV-11-3 CH 3 H H CH(CH 3
)
2 Et H CH 3 F OH XXV-11-4 CH 3 H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH XXV-11-5 CH 3 H H CH 2 Ph Et H CH 3 F OH XXV-11-6 CH 3 H H CH 2 -indol-3-yl Et H CH 3 F OH XXV-11-7 CH 3 H H CH 2
CH
2
SCH
3 Et H CH 3 F OH XXV-11-8 CH 3 * H * Et H CH 3 F OH R-and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXV-12. N2 RI R R 3 a R 3 b R 4 R R' X Y XXV-12-1 Et H H H Et H CH 3 F OH XXV-12-2 Et H H CH 3 Et H CH 3 F OH XXV-12-3 Et H H CH(CH 3
)
2 Et H CH 3 F OH XXV-12-4 Et H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH XXV-12-5 Et H H CH 2 Ph Et H CH 3 F OH XXV-12-6 Et H H C1 2 -indol-3-yl Et H CH 3 F OH XXV-12-7 Et H H CH 2
CH
2
SCH
3 Et H CH 3 F OH XXV-12-8 Et * H * Et H CH 3 F OH *R2and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXV-13. N2 R 1 R2 R 3 a R 3 b R 4 R5 R 6 X Y XXV-13-1 'Pr H H H Et H CH 3 F OH XXV-13-2 'Pr H H CH 3 Et H CH 3 F OH XXV-13-3 'Pr H H CH(CH 3
)
2 Et H CH 3 F OH XXV-13-4 'Pr H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH XXV-13-5 'Pr H H CH 2 Ph Et H CH 3 F OH XXV-13-6 'Pr H H CH 2 -indol-3-yl Et H CH 3 F OH XXV-13-7 'Pr H H CH 2
CH
2
SCH
3 Et H CH 3 F OH XXV-13-8 'Pr * H * Et H CH 3 F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XXV-14. N2 R' R 2 R a Rab R' R' R 6 X Y XXV-14-1 'Bu H H H Et H CH 3 F OH XXV-14-2 'Bu H H CH 3 Et H CH 3 F OH XXV-14-3 'Bu H H CH(CH 3
)
2 Et H CH 3 F OH XXV-14-4 'Bu H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH XXV-14-5 'Bu H H CH 2 Ph Et H CH 3 F OH XXV-14-6 'Bu H H CH 2 -indol-3-yl Et H CH 3 F OH XXV-14-7 'Bu H H CH 2
CH
2
SCH
3 Et H CH 3 F OH XXV-14-8 'Bu * H * Et H CH 3 F OH *R and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XXV-15. N2 RI R 2
R
3 a R 3 b R4 R 5
R
6 X Y XXV-15-1 Ph H H H Et H CH 3 F OH XXV-15-2 Ph H H CH 3 Et H CH 3 F OH XXV-15-3 Ph H H CH(CH 3
)
2 Et H CH 3 F OH XXV-15-4 Ph H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH XXV-15-5 Ph H H CH 2 Ph Et H CH 3 F OH XXV-15-6 Ph H H CH 2 -indol-3-yl Et H CH 3 F OH XXV-15-7 Ph H H CH 2
CH
2
SCH
3 Et H CH 3 F OH XXV-15-8 Ph * H * Et H CH 3 F OH *RTand Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXV-16. N2 Rl R 2 R3a R 3 b R 4 R' R' X Y XXV-16-1 p-Me-Ph H H H Et H CH 3 F OH XXV-16-2 p-Me-Ph H H CH 3 Et H CH 3 F OH XXV-16-3 p-Me-Ph H H CH(CH 3
)
2 Et H CH 3 F OH XXV-16-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH XXV-16-5 p-Me-Ph H H CH 2 Ph Et H CH 3 F OH XXV-16-6 p-Me-Ph H H CH 2 -indol-3-yl Et H CH 3 F OH XXV-16-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Et H CH 3 F OH XXV-16-8 p-Me-Ph * H * Et H CH 3 F OH *R and Rib joined together by (CH 2
)
3 to form five-membered ring.
Table XXV-17. N2 R2 R 3 a R R 4 R' R' X Y XXV-17-1 p-F-Ph H H- H Et H CH 3 F OH XXV-17-2 p-F-Ph H H CH 3 Et H CH 3 F OH XXV-17-3 p-F-Ph H H CH(CH 3
)
2 Et H CH 3 F OH XXV-17-4 p-F-Ph H H CH 2
CH(CH
3 )2 Et H CH 3 F OH XXV-17-5 p-F-Ph H H CH 2 Ph Et H CH 3 F OH XXV-17-6 p-F-Ph H H CH 2 -indol-3-yi Et H CH 3 F OH XXV-17-7 p-F-Ph H H CH 2
CH
2
SCH
3 Et H CH 3 F OH XXV-17-8 p-F-Ph * H * Et H CH 3 F OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXV-18. N2 R' R 2
R
3 a R 3 b R' R' R 6 X Y XXV-18-1 p-Cl-Ph H H H Et H CH 3 F OH XXV-18-2 p-Cl-Ph H H CH 3 Et H CH 3 F OH XXV-18-3 p-Cl-Ph H H CH(CH 3
)
2 Et H CH 3 F OH XXV-18-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH XXV-18-5 p-Cl-Ph H H CH 2 Ph Et H CH 3 F OH XXV-18-6 p-Cl-Ph H H CH 2 -indol-3-yl Et H CH 3 F OH XXV-18-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Et H CH 3 F OH XXV-18-8 p-Cl-Ph * H * Et H CH 3 F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXV-19. X2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y XXV-19-1 p-Br-Ph H H H Et H CH 3 F OH XXV-19-2 p-Br-Ph H H CH 3 Et H CH 3 F OH XXV-19-3 p-Br-Ph H H CH(CH 3
)
2 Et H CH 3 F OH XXV-19-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH XXV-19-5 p-Br-Ph H H CH 2 Ph Et H CH 3 F OH XXV-19-6 p-Br-Ph H H CH 2 -indol-3-yl Et H CH 3 F OH XXV-19-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Et H CH 3 F OH XXV-19-8 p-Br-Ph * H * Et H CH 3 F OH *R7 and RIb joined together by (CH 2
)
3 to form five-membered ring. c 2 () Table XXV-20. N2 R R 2
R
3 a Rb R 4 R R' X Y XXV-20-1 p-I-Ph H H H Et H CH 3 F OH XXV-20-2 p-I-Ph H H CH 3 Et H CH 3 F OH XXV-20-3 p-I-Ph H H CH(CH 3
)
2 Et H CH 3 -F OH XXV-20-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH XXV-20-5 p-I-Ph H H CH 2 Ph Et H CH 3 F OH XXV-20-6 p-I-Ph H H CH 2 -indol-3-yl Et H CH 3 F OH XXV-20-7 p-I-Ph H H CH 2
CH
2
SCH
3 Et H CH 3 F OH XXV-20-8 p-I-Ph * H * Et H CH 3 F OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXV-21. X2 R' R 2
R
3 a R 3 b R R 5
R
6 XY XXV-21-1 CH 3 H H H 'Pr H CH 3 F OH XXV-21-2 CH 3 H H CH 3 'Pr H CH 3 F OH XXV-21-3 CH 3 H H CH(CH 3
)
2 'Pr H CH 3 F OH XXV-21-4 CH 3 H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH XXV-21-5 CH 3 H H CH 2 Ph 'Pr H CH 3 F OH XXV-21-6 CH 3 H H CH 2 -indol-3-yl 'Pr H CH 3 F OH XXV-21-7 CH 3 H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH XXV-21-8 CH 3 * H * 'Pr H CH 3 F OH R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXV-22. N2 RI R 2
R
3 " R,b R 4 R' R 6 X Y XXV-22-1 Et H H H 'Pr H CH 3 F OH XXV-22-2 Et H H CH 3 'Pr H CH 3 F OH XXV-22-3 Et H H CH(CH 3
)
2 'Pr H CH 3 F OH XXV-22-4 Et H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH XXV-22-5 Et H H CH 2 Ph 'Pr H CH 3 F OH XXV-22-6 Et H H CH 2 -indol-3-yl 'Pr H CH 3 F OH XXV-22-7 Et H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH XXV-22-8 Et * H * 'Pr H CH 3 F OH *RTand R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XXV-23. N! R' R2 R 3 a R 3 b R4 R' RF X Y XXV-23-1 'Pr H H H 'Pr H CH 3 F OH XXV-23-2 'Pr H H CH 3 'Pr H CH 3 F OH XXV-23-3 'Pr H H CH(CH 3
)
2 'Pr H CH 3 F OH XXV-23-4 'Pr H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH XXV-23-5 'Pr H H CH 2 Ph 'Pr H CH 3 F OH XXV-23-6 'Pr H H CH 2 -indol-3-yl 'Pr H CH 3 F OH XXV-23-7 'Pr H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH XXV-23-8 'Pr * H * 'Pr H CH 3 F OH *RZ and RIb joined together by (CH 2
)
3 to form five-membered ring. Table XXV-24. 2 R R 2
R
3 aR R' R' R 6 X Y XXV-24-1 'Bu H H H 'Pr H CH 3 F OH XXV-24-2 'Bu H H CH 3 'Pr H CH 3 F OH XXV-24-3 'Bu H H CH(CH 3
)
2 'Pr H CH 3 F OH XXV-24-4 'Bu H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH XXV-24-5 'Bu H H CH 2 Ph 'Pr H CH 3 F OH XXV-24-6 'Bu H H CH 2 -indol-3-yl 'Pr H CH 3 F OH XXV-24-7 'Bu H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH XXV-24-8 'Bu * H * 'Pr H CH 3 F OH *R and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXV-25. N! R1 R 2 R3a R3b R4 R 5
R
6 X Y XXV-25-1 Ph H H H 'Pr H CH 3 F OH XXV-25-2 Ph H H CH 3 'Pr H CH 3 F OH XXV-25-3 Ph H H CH(CH 3
)
2 'Pr H CH 3 F OH XXV-25-4 Ph H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH XXV-25-5 Ph H H CH 2 Ph 'Pr H CH 3 F OH XXV-25-6 Ph H H CH 2 -indol-3-yl 'Pr H CH 3 F OH XXV-25-7 Ph H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH XXV-25-8 Ph * H * 'Pr H CH 3 F OH *RTand Rib joined together by (CH 2
)
3 to form five-membered ring.
Table XXV-26. X2 Rl R 2
R
3 a R 3 b R' R' R 6 X Y XXV-26-1 p-Me-Ph H H H 'Pr H CH 3 F OH XXV-26-2 p-Me-Ph H H CH 3 'Pr H CH 3 F OH XXV-26-3 p-Me-Ph H H CH(CH 3
)
2 'Pr H CH 3 F OH XXV-26-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH XXV-26-5 p-Me-Ph H H CH 2 Ph 'Pr H CH 3 F OH XXV-26-6 p-Me-Ph H H CH 2 -indol-3-yl 'Pr H CH 3 F OH XXV-26-7 p-Me-Ph H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH XXV-26-8 p-Me-Ph * H * 'Pr H CH 3 F OH
*R
2 and R"' joined together by (CH 2
)
3 to form five-membered ring. Table XXV-27. NR R 2 R aR 3 b R 4 R7 R X Y XXV-27-1 p-F-Ph H H H 'Pr H CH 3 F OH XXV-27-2 p-F-Ph H H CH 3 'Pr H CH 3 F OH XXV-27-3 p-F-Ph H H CH(CH 3
)
2 'Pr H CH 3 F OH XXV-27-4 p-F-Ph H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH XXV-27-5 p-F-Ph H H CH 2 Ph 'Pr H CH 3 F OH XXV-27-6 p-F-Ph H H CH 2 -indol-3-yl 'Pr H CH 3 F OH XXV-27-7 p-F-Ph H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH XXV-27-8 p-F-Ph * H * 'Pr H CH 3 F OH
*R
2 and Rab joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXV-28. X2 Rl R 2
R
3 a R 3 b R4 R 5
R
6 X Y XXV-28-1 p-Cl-Ph H H H 'Pr H CH 3 F OH XXV-28-2 p-Cl-Ph H H CH 3 'Pr H CH 3 F OH XXV-28-3 p-Cl-Ph H H CH(CH 3
)
2 'Pr H CH 3 F OH XXV-28-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH XXV-28-5 p-Cl-Ph H H CH 2 Ph 'Pr H CH 3 F OH XXV-28-6 p-Cl-Ph H H CH 2 -indol-3-yl 'Pr H CH 3 F OH XXV-28-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH XXV-28-8 p-Cl-Ph * H * 'Pr H CH 3 F OH *R and Rib joined together by (CH 2
)
3 to form five-membered ring.
Table XXV-29. N2 Rl R 2
R
3 a R 3 b R' R' R' X Y XXV-29-1 p-Br-Ph H H H 'Pr H CH 3 F OH XXV-29-2 p-Br-Ph H H CH 3 'Pr H CH 3 F OH XXV-29-3 p-Br-Ph H H CH(CH 3
)
2 'Pr H CH 3 F OH XXV-29-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH XXV-29-5 p-Br-Ph H H CH 2 Ph 'Pr H CH 3 F OH XXV-29-6 p-Br-Ph H H CH 2 -indol-3-yl 'Pr H CH 3 F OH XXV-29-7 p-Br-Ph H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH XXV-29-8 p-Br-Ph * H * 'Pr H CH 3 F OH
*R
2 and RJb joined together by (CH 2
)
3 to form five-membered ring. Table XXV-30. N2 Rl R 2
R
3 a R 3 b R 4
R
5
R
6 X Y XXV-30-1 p-l-Ph H H H 'Pr H CH 3 F OH XXV-30-2 p-I-Ph H H CH 3 'Pr H CH 3 F OH XXV-30-3 p-I-Ph H H CH(CH 3
)
2 'Pr H CH 3 F OH XXV-30-4 p-I-Ph H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH XXV-30-5 p-I-Ph H H CH 2 Ph 'Pr H CH 3 F OH XXV-30-6 p-I-Ph H H CH 2 -indol-3-yl 'Pr H CH 3 F OH XXV-30-7 p-I-Ph H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH XXV-30-8 p-I-Ph * H * 'Pr H CH 3 F OH
*R
2 and R joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXV-31. N2 R' R2 R 3 a R 3 b R 4
R
5
R
6 X Y XXV-31-1 CH 3 H H H "Bu H CH 3 F OH XXV-31-2 CH 3 H H CH 3 "Bu H CH 3 F OH XXV-31-3 CH 3 H H CH(CH 3
)
2 "Bu H CH 3 F OH XXV-31-4 CH 3 H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH XXV-31-5 CH 3 H H CH 2 Ph "Bu H CH 3 F OH XXV-31-6 CH 3 H H CH 2 -indol-3-yl "Bu H CH 3 F OH XXV-31-7 CH 3 H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH XXV-31-8 CH 3 * H * "Bu H CH 3 F OH *RTand R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XXV-32. X2 R R R 3b R 4
R
5
R
6 X Y XXV-32-1 Et H H H "Bu H CH 3 F OH XXV-32-2 Et H H CH 3 "Bu H CH 3 F OH XXV-32-3 Et H H CH(CH 3
)
2 "Bu H CH 3 F OH XXV-32-4 Et H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH XXV-32-5 Et H H CH 2 Ph "Bu H CH 3 F OH XXV-32-6 Et H H CH 2 -indol-3-yl "Bu H CH 3 F OH XXV-32-7 Et H H CH 2 CH2SCH 3 "Bu H CH 3 F OH XXV-32-8 Et * H * "Bu H CH 3 F OH *R' and R3 joined together by (CH 2
)
3 to form five-membered ring. Table XXV-33. X2 R' R 2
R
3 a R 3 b R 4 R' R' X Y XXV-33-1 'Pr H H H "Bu H CH 3 F OH XXV-33-2 'Pr H H CH 3 "Bu H CH 3 F OH XXV-33-3 'Pr H H CH(CH 3
)
2 "Bu H CH 3 F OH XXV-33-4 'Pr H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH XXV-33-5 'Pr H H CH 2 Ph "Bu H CH 3 F OH XXV-33-6 'Pr H H CH 2 -indol-3-yl "Bu H CH 3 F OH XXV-33-7 'Pr H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH XXV-33-8 'Pr * H * "Bu H CH 3 F OH *R7 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXV-34. X2 R' R 2
R
3 a R 3 b R' R' R 6 X Y XXV-34-1 'Bu H H H "Bu H CH 3 F OH XXV-34-2 'Bu H H CH 3 "Bu H CH 3 F OH XXV-34-3 'Bu H H CH(CH 3
)
2 "Bu H CH 3 F OH XXV-34-4 'Bu H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH XXV-34-5 'Bu H H CH 2 Ph "Bu H CH 3 F OH XXV-34-6 'Bu H H CH 2 -indol-3-yl "Bu H CH 3 F OH XXV-34-7 'Bu H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH XXV-34-8 'Bu * H * 'Bu H CH 3 F OH *R and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XXV-35. NX R' R 2 R-a R 3 b R 4 R' R' X Y XXV-35-1 Ph H H H "Bu H CH 3 F OH XXV-35-2 Ph H H CH 3 "Bu H CH 3 F OH XXV-35-3 Ph H H CH(CH 3
)
2 "Bu H CH 3 F OH XXV-35-4 Ph H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH XXV-35-5 Ph H H CH 2 Ph "Bu H CH 3 F OH XXV-35-6 Ph H H CH 2 -indol-3-yl "Bu H CH 3 F OH XXV-35-7 Ph H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH XXV-35-8 Ph * H * "Bu H CH 3 F OH *R' and RJb joined together by (CH 2
)
3 to form five-membered ring. Table XXV-36. Xe R R 2
R
3 aR R 4 R' R X Y XXV-36-1 p-Me-Ph H H H "Bu H CH 3 F OH XXV-36-2 p-Me-Ph H H CH 3 "Bu H CH 3 F OH XXV-36-3 p-Me-Ph H H CH(CH 3
)
2 "Bu H CH 3 F OH XXV-36-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH XXV-36-5 p-Me-Ph H H CH 2 Ph "Bu H CH 3 F OH XXV-36-6 p-Me-Ph H H CH 2 -indol-3-yl "Bu H CH 3 F OH XXV-36-7 p-Me-Ph H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH XXV-36-8 p-Me-Ph * H * "Bu H CH 3 F OH *R and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXV-37. Ne R R 2
R
3 a R 3 b R 4
R
5
R
6 X Y XXV-37-1 p-F-Ph H H H "Bu H CH 3 F OH XXV-37-2 p-F-Ph H H CH 3 "Bu H CH 3 F OH XXV-37-3 p-F-Ph H H CH(CH 3
)
2 "Bu H CH 3 F OH XXV-37-4 p-F-Ph H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH XXV-37-5 p-F-Ph H H CH 2 Ph "Bu H CH 3 F - OH XXV-37-6 p-F-Ph H H CH 2 -indol-3-yl "Bu H CH 3 F OH XXV-37-7 p-F-Ph H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH XXV-37-8 p-F-Ph * H * "Bu H CH 3 F OH *R and Rib joined together by (CH 2
)
3 to form five-membered ring.
Table XXV-38. N2 R R 2 Raa R 3 b R 4
R
5
R
6 X Y XXV-38-1 p-Cl-Ph H H H "Bu H CH 3 F OH XXV-38-2 p-Cl-Ph H H CH 3 "Bu H CH 3 F OH XXV-38-3 p-Cl-Ph H H CH(CH 3
)
2 "Bu H CH 3 F OH XXV-38-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH XXV-38-5 p-Cl-Ph H H CH 2 Ph "Bu H CH 3 F OH XXV-38-6 p-Cl-Ph H H CH 2 -indol-3-yl "Bu H CH 3 F OH XXV-38-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH XXV-38-8 p-Cl-Ph * H * "Bu H CH 3 F OH
*R
2 and Rb joined together by (CH 2
)
3 to form five-membered ring. Table XXV-39. N2 R' R 2
R
3 a R b R' R' R X Y XXV-39-1 p-Br-Ph H H H "Bu H CH 3 F OH XXV-39-2 p-Br-Ph H H CH 3 "Bu H CH 3 F OH XXV-39-3 p-Br-Ph H H CH(CH 3
)
2 "Bu H CH 3 F OH XXV-39-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH XXV-39-5 p-Br-Ph H H CH 2 Ph "Bu H CH 3 F OH XXV-39-6 p-Br-Ph H H CH 2 -indol-3-yl "Bu H CH 3 F OH XXV-39-7 p-Br-Ph H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH XXV-39-8 p-Br-Ph * H * "Bu H CH 3 F OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXV-40. SR R 2 Ra Rb R 4 R' R 6 X Y XXV-40-1 p-I-Ph H H H "Bu H CH 3 F OH XXV-40-2 p-I-Ph H H CH 3 "Bu H CH 3 F OH XXV-40-3 p-I-Ph H H CH(CH 3
)
2 "Bu H CH 3 F OH XXV-40-4 p-I-Ph H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH XXV-40-5 p-I-Ph H H CH 2 Ph "Bu H CH 3 F OH XXV-40-6 p-I-Ph H H CH 2 -indol-3-yl "Bu H CH 3 F OH XXV-40-7 p-I-Ph H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH XXV-40-8 p-I-Ph * H * "Bu H CH 3 F OH
*R
7 and RJb joined together by (CH 2
)
3 to form five-membered ring.
Table XXV-41. N2 R' R 2
R
3 a R 3 b R 4
R
5 ' R X Y XXV-41-1 CH 3 H H H Bz H CH 3 F OH XXV-41-2 CH 3 H H CH 3 Bz H CH 3 F OH XXV-41-3 CH 3 H H CH(CH 3
)
2 Bz H CH 3 F OH XXV-41-4 CH 3 H H CH2CH(CH 3
)
2 Bz H CH 3 F OH XXV-41-5 CH 3 H H CH 2 Ph Bz H CH 3 F OH XXV-41-6 CH 3 H H CH 2 -indol-3-yl Bz H CH 3 F OH XXV-41-7 CH 3 H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH XXV-41-8 CH 3 * H * Bz H CH 3 F OH
*R
2 and R 3 6 joined together by (CH 2
)
3 to form five-membered ring. Table XXV-42. N2 R I R 2
R
3 a R 3 b R 4 R' R' X Y XXV-42-1 Et H H H Bz H CH 3 F OH XXV-42-2 Et H H CH 3 Bz H CH 3 F OH XXV-42-3 Et H H CH(CH 3
)
2 Bz H CH 3 F OH XXV-42-4 Et H H CH 2
CH(CH
3 )2 Bz H CH 3 F OH XXV-42-5 Et H H CH 2 Ph Bz H CH 3 F OH XXV-42-6 Et H H CH 2 -indol-3-yl Bz H CH 3 F OH XXV-42-7 Et H H CH 2
CH
2 SCH3 Bz H CH 3 F OH XXV-42-8 Et * H * Bz H CH 3 F OH *Rl and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXV-43. N2 R' R 2
R
3 a R 3 b R 4 R' R' X -Y XXV-43-1 'Pr H H H Bz H CH 3 F OH XXV-43-2 'Pr H H CH 3 Bz H CH 3 F OH XXV-43-3 'Pr H H CH(CH 3
)
2 Bz H CH 3 F OH XXV-43-4 'Pr H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH XXV-43-5 'Pr H H CH 2 Ph Bz H CH 3 F OH XXV-43-6 'Pr H H CH 2 -indol-3-yl Bz H CH 3 F OH XXV-43-7 'Pr H H CH 2
CH
2
SCH
3 Bz H CH 3 F (I XXV-43-8 'Pr * H * Bz H CH 3 F OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XXV-44. N? R R2 R 3 a R 3 b R 4 R R 6 X Y XXV-44-1 'Bu H H H Bz H CH 3 F OH XXV-44-2 'Bu H H CH 3 Bz H CH 3 F OH XXV-44-3 'Bu H H CH(CH 3
)
2 Bz H CH 3 F OH XXV-44-4 'Bu H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH XXV-44-5 'Bu H H CH 2 Ph Bz H CH 3 F OH XXV-44-6 'Bu H H CH 2 -indol-3-yl Bz H CH 3 F OH XXV-44-7 'Bu H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH XXV-44-8 'Bu * H * Bz H CH 3 F OH
*R
2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXV-45. SRI R 2 Ra R 3 b R R' R XY XXV-45-1 Ph H H H Bz H CH 3 F OH XXV-45-2 Ph H H CH 3 Bz H CH 3 F OH XXV-45-3 Ph H H CH(CH 3
)
2 Bz H CH 3 F OH XXV-45-4 Ph H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH XXV-45-5 Ph H H CH 2 Ph Bz H CH 3 F OH XXV-45-6 Ph H H CH 2 -indol-3-yl Bz H CH 3 F OH XXV-45-7 Ph H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH XXV-45-8 Ph * H * Bz H CH 3 F OH
*R
2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXV-46. X2 Rl R 2 R a Rab R 4 R' R 6 X Y XXV-46-1 p-Me-Ph H H H Bz H CH 3 F OH XXV-46-2 p-Me-Ph H H CH 3 Bz H CH 3 F OH XXV-46-3 p-Me-Ph H H CH(CH 3
)
2 Bz H CH 3 F OH XXV-46-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH XXV-46-5 p-Me-Ph H H CH 2 Ph Bz H CH 3 F OH XXV-46-6 p-Me-Ph H H CH 2 -indol-3-yl Bz H CH 3 F OH XXV-46-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH XXV-46-8 p-Me-Ph * H * Bz H CH 3 F OH *R and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XXV-47. NR R 2 RaRb R' R' R' X Y XXV-47-1 p-F-Ph H H H Bz H CH 3 F OH XXV-47-2 p-F-Ph H H CH 3 Bz H CH 3 F OH XXV-47-3 p-F-Ph H H CH(CH 3
)
2 Bz H CH 3 F OH XXV-47-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Bz H -* CH 3 F OH XXV-47-5 p-F-Ph H H CH 2 Ph Bz H CH 3 F OH XXV-47-6 p-F-Ph H H CH 2 -indol-3-yl Bz H CH 3 F OH XXV-47-7 p-F-Ph H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH XXV-47-8 p-F-Ph * H * Bz H CH 3 F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXV-48. X2 Rl R 2
R
3 " R 3 b R 4
R
5
R
6 X Y XXV-48-1 p-Cl-Ph H H H Bz H CH 3 F OH XXV-48-2 p-Cl-Ph H H CH 3 Bz H CH 3 F OH XXV-48-3 p-Cl-Ph H H CH(CH 3
)
2 Bz H CH 3 F OH XXV-48-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH XXV-48-5 p-Cl-Ph H H CH 2 Ph Bz H CH 3 F OH XXV-48-6 .p-Cl-Ph H H CH 2 -indol-3-yl Bz H CH 3 F OH XXV-48-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH XXV-48-8 p-Cl-Ph * H * Bz H CH 3 F OH *RY and R3b joined together by (CH2)3 to form five-membered ring. 5 Table XXV-49. N2 Rl R 2
R
3 a R 3 b R 4
R
5
R
6 X Y XXV-49-1 p-Br-Ph H H H Bz H CH 3 F OH XXV-49-2 p-Br-Ph H H CH 3 Bz H CH 3 F OH XXV-49-3 p-Br-Ph H H CH(CH 3 )2 Bz H CH 3 F OH XXV-49-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH XXV-49-5 p-Br-Ph H H CH 2 Ph Bz H CH 3 F OH XXV-49-6 p-Br-Ph H H. CH 2 -indol-3-yl Bz H CH 3 F OH XXV-49-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH XXV-49-8 p-Br-Ph * H * Bz H CH 3 F OH *Rrand R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XXV-50. NR R 2 R aR 3 b R 4
RR
6 X Y XXV-50-1 p-I-Ph H H H Bz H CH 3 F OH XXV-50-2 p-I-Ph H H CH 3 Bz H CH 3 F OH XXV-50-3 p-I-Ph H H CH(CH 3
)
2 Bz H CH 3 F OH XXV-50-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH XXV-50-5 p-I-Ph H H CH 2 Ph Bz H CH 3 F OH XXV-50-6 p-I-Ph H H CH 2 -indol-3-yl Bz H CH 3 F OH XXV-50-7 p-I-Ph H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH XXV-50-8 p-I-Ph * H * Bz H CH 3 F OH *R" and R.3b joined together by (CH 2
)
3 to form five-membered ring. R2 N N R3a -- -- -0 C0 2
R
4 ORI R 5 R6
NH
2 Y X 5 XXVI Table XXVI-1. N2 R R2 R 3 a R 3 b R 4 R' R' X Y XXVI-1-1 CH 3 H H H CH 3 H F H OH XXVI-1-2 CH 3 H H CH 3
CH
3 H F H OH XXVI-1-3 CH 3 H H CH(CH 3
)
2
CH
3 H F H OH XXVI- 1-4 CH 3 H H CH 2
CH(CH
3
)
2
CH
3 H F H OH XXVI-1-5 CH 3 H H CH 2 Ph CH 3 H F H OH XXVI-1-6 CH 3 H H CH 2 -indol-3-yl CH 3 H F H OH XXVI-1-7 CH 3 H H CH 2
CH
2
SCH
3
CH
3 H F H OH XXVI-1-8 CH 3 * H * CH 3 H F H OH *R and Rb joined together by (CH 2
)
3 to form five-membered ring. 10 _ ;A 1 Table XXVI-2. X R R 2 Ra REb R 4 R' R 6 X Y XXVI-2-1 Et H H H CH 3 H F H OH XXVI-2-2 Ft H H CH 3
CH
3 H F H OH XXVI-2-3 Et H H CH(CH 3
)
2
CH
3 H F H OH XXVI-2-4 Et H H CH 2
CH(CH
3
)
2
CH
3 H F H OH XXVI-2-5 Et H H CH 2 Ph CH 3 H F H OH XXVI-2-6 Et H H CH 2 -indol-3-yl CH 3 H F H OH XXVI-2-7 Et H H CH 2
CH
2
SCH
3
CH
3 H F H OH XXVI-2-8 Et * H * CH 3 H F H OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXVI-3. X RI R 2 Ra R 3 b RT R 5 R XY XXVI-3-1 'Pr H H H CH 3 H F H OH XXVI-3-2 'Pr H H CH 3
CH
3 H F H OH XXVI-3-3 'Pr H H CH(CH 3
)
2
CH
3 H F H OH XXVI-3-4 'Pr H H CH 2
CH(CH
3
)
2
CH
3 H F H OH XXVI-3-5 'Pr H H CH 2 Ph CH 3 H F H OH XXVI-3-6 'Pr H H CH 2 -indol-3-yl CH 3 H F H OH XXVI-3-7 'Pr H H CH 2
CH
2
SCH
3
CH
3 H F H OH XXVI-3-8 'Pr * H * CH 3 H F H OH *R and R"b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVI-4. X R' R 2
R
3 a R b R' R' R 6 X Y XXVI-4-1 'Bu H H H CH 3 H F H OH XXVI-4-2 'Bu H H CH 3
CH
3 H F H OH XXVI-4-3 'Bu H H CH(CH 3
)
2
CH
3 H F H OH XXVI-4-4 'Bu H H CH 2
CH(CH
3
)
2
CH
3 H F H OH XXVI-4-5 'Bu H H CH 2 Ph CH 3 H F H OH XXVI-4-6 'Bu H H CH 2 -indol-3-yl CH 3 H F H OH XXVI-4-7 'Bu H H CH 2
CH
2
SCH
3
CH
3 H F H OH XXVI-4-8 'Bu * H * CH 3 H F H OH *RT and Rib joined together by (CH 2
)
3 to form five-membered ring.
~A)
Table XXVI-5. N2 RI R 2 R3a R 3 b R 4 R' R' X Y XXVI-5-1 Ph H H H CH 3 H F H OH XXVI-5-2 Ph H H CH 3
CH
3 H F H OH XXVI-5-3 Ph H H CH(CH 3
)
2
CH
3 H F H OH XXVI-5-4 Ph H H CH 2
CH(CH
3
)
2
CH
3 H F H OH XXVI-5-5 Ph H H CH 2 Ph CH 3 H F H OH XXVI-5-6 Ph H H CH 2 -indol-3-yl CH 3 H F H OH XXVI-5-7 Ph H H CH 2
CH
2
SCH
3
CH
3 H F H OH XXVI-5-8 Ph * H * CH 3 H F H OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXVI-6. N2 Rl R 2 RV" R3b R 4 R' R' X Y XXVI-6-1 p-Me-Ph H H H CH 3 H F H OH XXVI-6-2 p-Me-Ph H H CH 3
CH
3 H F H OH XXVI-6-3 p-Me-Ph H H CH(CH 3
)
2
CH
3 H F H OH XXVI-6-4 p-Me-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F H OH XXVI-6-5 p-Me-Ph H H CH 2 Ph CH 3 H F H OH XXVI-6-6 p-Me-Ph H H CH 2 -indol-3-yl CH 3 H F H OH XXVI-6-7 p-Me-Ph H H CH 2
CH
2
SCH
3
CH
3 H F H OH XXVI-6-8 p-Me-Ph * H * CH 3 H F H OH *RT and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVI-7. N2 Rl R 2 Ra R 3 b R 4 R' R 6 X Y XXVI-7-1 p-F-Ph H H H CH 3 H F H OH XXVI-7-2 p-F-Ph H H CH 3
CH
3 H F H OH XXVI-7-3 p-F-Ph H H CH(CH 3
)
2
CH
3 H F H OH XXVI-7-4 p-F-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F H OH XXVI-7-6 p-F-Ph H H CH 2 Ph CH 3 H F H OH XXVI-7-7 p-F-Ph H H CH 2 -indol-3-yl CH 3 H F H OH XXVI-7-8 p-F-Ph H H CH 2
CH
2
SCH
3
CH
3 H F H OH XXVI-7-20 p-F-Ph * H * CH 3 H F H OH R and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XXVI-8. N2 Rl R 2 RJa Rb R 4 R' R' X Y XXVI-8-1 p-Cl-Ph H H H CH 3 H F H OH XXVI-8-2 p-Cl-Ph H H CH 3
CH
3 H F H OH XXVI-8-3 p-Cl-Ph H H CH(CH 3
)
2
CH
3 H F H OH XXVI-8-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F H OH XXVI-8-5 p-Cl-Ph H H CH 2 Ph CH 3 H F H OH XXVI-8-6 p-Cl-Ph H H CH 2 -indol-3-yl CH 3 H F H OH XXVI-8-7 p-Cl-Ph H H CH 2
CH
2
SCH
3
CH
3 H F H OH XXVI-8-8 p-Cl-Ph * H * CH 3 H F H OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXVI-9. R2 R 2
R
3 a R 3 b R 4 R' R 6 X Y XXVI-9-1 p-Br-Ph H H H CH 3 H F H OH XXVI-9-2 p-Br-Ph H H CH 3
CH
3 H F H OH XXVI-9-3 p-Br-Ph H H CH(CH 3
)
2
CH
3 H F H OH XXVI-9-4 p-Br-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F H OH XXVI-9-6 p-Br-Ph H H CH 2 Ph CH 3 H F H OH XXVI-9-7 p-Br-Ph H H CH 2 -indol-3-yl CH 3 H F H OH XXVI-9-8 p-Br-Ph H H CH 2
CH
2
SCH
3
CH
3 H F H OH XXVI-9-20 p-Br-Ph * H * CH 3 H F H OH *R' and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVI-10. N2 Rl R 2
R
3 a R 3 b R 4 R' R 6 X Y XXVI-10-1 p-I-Ph H H H CH 3 H F H OH XXVI-10-2 p-I-Ph H H CH 3
CH
3 H F H OH XXVI-10-3 p-I-Ph H H CH(CH 3
)
2
CH
3 H F H OH XXVI-10-4 p-I-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F H OH XXVI-10-5 p-I-Ph H H CH 2 Ph CH 3 H F H OH XXVI-10-6 p-I-Ph H H CH 2 -indol-3-yl CH 3 H F H OH XXVI-10-7 p-I-Ph H H CH 2
CH
2
SCH
3
CH
3 H F H OH XXVI-10-8 p-I-Ph * H * CH 3 H F H OH *RTand R b joined together by (CH 2
)
3 to form five-membered ring. - AA Table XXVI-11. N2 R R 2
R
3 a R 3 b R 4 R' R' X Y XXVI-11-1 CH 3 H H H Et H F H OH XXVI-11-2 CH 3 H H CH 3 Et H F H OH XXVI-11-3 CH 3 H H CH(CH 3
)
2 Et H F H OH XXVI-11-4 CH 3 H H CH 2
CH(CH
3
)
2 Et H F H OH XXVI-11-5 CH 3 H H CH 2 Ph Et H F H OH XXVI-11-6 CH 3 H H CH 2 -indol-3-yl Et H F H OH XXVI-11-7 CH 3 H H CH 2
CH
2
SCH
3 Et H F H OH XXVI-11-8 CH 3 * H * Et H F H OH *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXVI-12. N2 Rl R 2
R
3 a R3b R' R' R 6 X Y XXVI-12-1 Et H H H Et H F H OH XXVI-12-2 Et H H CH 3 Et H F H OH XXVI-12-3 Et H H CH(CH 3
)
2 Et H F H OH XXVI-12-4 Et H H CH 2
CH(CH
3
)
2 Et H F H OH XXVI-12-5 Et H H CH 2 Ph Et H F H OH XXVI-12-6 Et H H CH 2 -indol-3-yl Et H F H OH XXVI-12-7 Et H H CH 2
CH
2
SCH
3 Et H F H OH XXVI-12-8 Et * H * Et H F H OH *R2 and RJb joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVI-13. N2 R' R2 R 3 a R 3 b R4 R' R 6 X Y XXVI-13-1 'Pr H H H Et H F H OH XXVI-13-2 'Pr H H CH 3 Et H F H OH XXVI-13-3 'Pr H H CH(CH 3
)
2 Et H F H OH XXVI- 13-4 'Pr H H CH 2
CH(CH
3
)
2 Et H F H OH XXVI-13-5 'Pr H H CH 2 Ph Et H F H OH XXVI-13-6 'Pr H H CH 2 -indol-3-yl Et H F H OH XXVI- 13-7 'Pr H H CH 2
CH
2
SCH
3 Et H F H OH XXVI-13-8 'Pr * H * Et H F H OH *R2 and R-b joined together by (CH 2
)
3 to form five-membered ring.
CC
Table XXVI-14. X2 R R 2 Ra R R 4 R' R X Y XXVI-14-1 'Bu H H H Et H F H OH XXVI-14-2 'Bu H H CH 3 Et H F H OH XXVI-14-3 'Bu H H CH(CH 3
)
2 Et H F H OH XXVI-14-4 'Bu H H CH 2
CH(CH
3
)
2 Et H F H OH XXVI-14-5 'Bu H H CH 2 Ph Et H F H OH XXVI-14-6 'Bu H H CH2-indol-3-yl Et H F H OH XXVI-14-7 'Bu H H CH2CH 2
SCH
3 Et H F H OH XXVI-14-8 'Bu * H * Et H F H OH *R and Rb joined together by (CH 2
)
3 to form five-membered ring. Table XXVI-15. N2 R' R Ria Rb R R R X Y XXVI-15-1 Ph H H H Et H F H OH XXVI-15-2 Ph H H CH 3 Et H F H OH XXVI-15-3 Ph H H CH(CH 3
)
2 Et H F H OH XXVI-15-4 Ph H H CH 2
CH(CH
3
)
2 Et H F H OH XXVI-15-5 Ph H H CH 2 Ph Et H F H OH XXVI-15-6 Ph H H CH2-indol-3-yl Et H F H OH XXVI-15-7 Ph H H CH 2
CH
2
SCH
3 Et H F H OH XXVI-15-8 Ph * H * Et H F H OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVI-16. N2 Rl R 2 RJa R3b R4 R 5
R
6 X Y XXVI-16-1 p-Me-Ph H H H Et H F H OH XXVI-16-2 p-Me-Ph H H CH 3 Et H F H OH XXVI-16-3 p-Me-Ph H H CH(CH 3
)
2 Et H F H OH XXVI-16-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Et H F H OH XXVI-16-5 p-Me-Ph H H CH 2 Ph Et H F H OH XXVI-16-6 p-Me-Ph H H CH2-indol-3-yl Et H F H OH XXVI-16-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Et H F H OH XXVI-16-8 p-Me-Ph * H * Et H F H OH
*R
2 and R3b joined together by (CH 2
)
3 to form five-membered ring. r AA Table XXVI-17. X2 R' R 2 R a R 3 b R 4 R' R' X Y XXVI-17-1 p-F-Ph H H H Et H F H OH XXVI-17-2 p-F-Ph H H CH 3 Et H F H OH XXVI-17-3 p-F-Ph H H CH(CH 3
)
2 Et H F H OH XXVI-17-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Et H F H OH XXVI-17-5 p-F-Ph H H CH 2 Ph Et H F H OH XXVI-17-6 p-F-Ph H H CH 2 -indol-3-yl Et H F H OH XXVI-17-7 p-F-Ph H H CH 2
CH
2
SCH
3 Et H F H OH XXVI-17-8 p-F-Ph * H * Et H F H OH * R2 and R"b joined together by (CH 2
)
3 to form five-membered ring. Table XXVI-18. X2 Rl R2 R 3 a R 3 b R R' R 6 X Y XXVI-18-1 p-Cl-Ph H H H Et H F H OH XXVI-18-2 p-Cl-Ph H H CH 3 Et H F H OH XXVI-18-3 p-Cl-Ph H H CH(CH 3
)
2 Et H F H OH XXVI-18-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Et H F H OH XXVI-18-5 p-Cl-Ph H H CH 2 Ph Et H F H OH XXVI-18-6 p-Cl-Ph H H CH 2 -indol-3-yl Et H F H OH XXVI-18-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Et H F H OH XXVI-18-8 p-Cl-Ph * H * Et H F H OH *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVI-19. N2 Rl R 2
R
3 a R 3 b R 4 R' R 6 X Y XXVI-19-1 p-Br-Ph H H H Et H F H OH XXVI-19-2 p-Br-Ph H H CH 3 Et H F H OH XXVI-19-3 p-Br-Ph H H CH(CH 3
)
2 Et H F H OH XXVI-19-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Et H F H OH XXVI-19-5 p-Br-Ph H H CH 2 Ph Et H F H OH XXVI-19-6 p-Br-Ph H H CH 2 -indol-3-yl Et H F H OH XXVI-19-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Et H F H OH XXVI-19-8 p-Br-Ph * H * Et H F H OH *R and Rib joined together by (CH 2
)
3 to form five-membered ring. C A 7 Table XXVI-20. Ne R R 2 RaR 3 b R 4 R' R' X Y XXVI-20-1 p-I-Ph H H H Et H F H OH XXVI-20-2 p-I-Ph H H CH 3 Et H F H OH XXVI-20-3 p-I-Ph H H CH(CH 3
)
2 Et H F H OH XXVI-20-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Et H F H OH XXVI-20-5 p-I-Ph H H CH 2 Ph Et H F H OH XXVI-20-6 p-I-Ph H H CH 2 -indol-3-yl Et H F H OH XXVI-20-7 p-I-Ph H H CH 2
CH
2
SCH
3 Et H F H OH XXVI-20-8 p-I-Ph * H * Et H F H OH Rlaind R"b joined together by (CH 2
)
3 to form five-membered ring. Table XXVI-2 1. Xe R' R2 R 3 a R 3 b R4 R' R 6 X Y XXVI-21-1 CH 3 H H H Pr H F H OH XXVI-21-2 CH 3 H H CH 3 Pr H F H OH XXVI-21-3 CH 3 H H CH(CH 3
)
2 'Pr H F H OH XXVI-21-4 CH 3 H H CH 2
CH(CH
3
)
2 'Pr H F H OH XXVI-21-5 CH 3 H H CH 2 Ph 'Pr H F H OH XXVI-21-6 CH 3 H H CH 2 -indol-3-yl 'Pr H F H OH XXVI-21-7 CH 3 H H CH 2
CH
2
SCH
3 Pr H F H OH XXVI-21-8 CH 3 * H * Pr H F H OH *Ri and Rb joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVI-22. Xe R' R 2
R
3 a R 3 b R4 R 5 R, X Y XXVI-22-1 Et H H H 'Pr H F H OH XXVI-22-2 Et H H CH 3 'Pr H F H OH XXVI-22-3 Et H H CH(CH 3
)
2 'Pr H F H OH XXVI-22-4 Et H H CH 2
CH(CH
3
)
2 'Pr H F H OH XXVI-22-5 Et H H CH 2 Ph Pr H F H OH XXVI-22-6 Et H H CH 2 -indol-3-yl 'Pr H F H OH XXVI-22-7 Et H H CH 2
CH
2
SCH
3 'Pr H F H OH XXVI-22-8 Et * H * 'Pr H F H OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring.
AO
Table XXVI-23. X2 R' R2 R 3 a R 3 b R 4 R R X Y XXVI-23-1 'Pr H H H 'Pr H F H OH XXVI-23-2 'Pr H H CH 3 'Pr H F H OH XXVI-23-3 'Pr H H CH(CH 3
)
2 'Pr H F H OH XXVI-23-4 'Pr H H CH 2
CH(CH
3
)
2 'Pr H F H OH XXVI-23-5 'Pr H H CH 2 Ph 'Pr H F H OH XXVI-23-6 'Pr H H CH 2 -indol-3-yl 'Pr H F H OH XXVI-23-7 'Pr H H CH 2 CH2SCH 3 'Pr H F H OH XXVI-23-8 'Pr * H * 'Pr H F H OH *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXVI-24. N2 R R 2
R
3 a R 3 b R' R' R' X Y XXVI-24-1 'Bu H H H 'Pr H F H OH XXVI-24-2 'Bu H H CH 3 'Pr H F H OH XXVI-24-3 'Bu H H CH(CH 3
)
2 'Pr H F H OH XXVI-24-4 'Bu H H CH 2
CH(CH
3
)
2 'Pr H F H OH XXVI-24-5 'Bu H H CH 2 Ph 'Pr H F H OH XXVI-24-6 'Bni H H CH 2 -indol-3-yl 'Pr H F H OH XXVI-24-7 'Bu H H CH 2
CH
2
SCH
3 'Pr H F H OH XXVI-24-8 'Bu * H * 'Pr H F H OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVI-25. X2 R' R 2
R
3 a R 3 b R' R' R X Y XXVI-25-1 Ph H H H 'Pr H F H OH XXVI-25-2 Ph H H CH 3 'Pr H F H OH XXVI-25-3 Ph H H CH(CH 3
)
2 'Pr H F H OH XXVI-25-4 Ph H H CH 2
CH(CH
3
)
2 'Pr H F H OH XXVI-25-5 Ph H H CH 2 Ph 'Pr H F H OH XXVI-25-6 Ph H H CH 2 -indol-3-yl 'Pr H F H OH XXVI-25-7 Ph H H CH 2
CH
2
SCH
3 'Pr H F H OH XXVI-25-'8 Ph * H * 'Pr H F H OH *RW and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
CAO
Table XXVI-26. X Rl R 2
R
3 a R 3 b R 4 R' R 6 X Y XXVI-26-1 p-Me-Ph H H H 'Pr H F H OH XXVI-26-2 p-Me-Ph H H CH 3 'Pr H F H OH XXVI-26-3 p-Me-Ph H H CH(CH 3
)
2 'Pr H F H OH XXVI-26-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 'Pr H F H OH XXVI-26-5 p-Me-Ph H H CH 2 Ph 'Pr H F H OH XXVI-26-6 p-Me-Ph H H CH 2 -indol-3-yl 'Pr H F H OH XXVI-26-7 p-Me-Ph H H CH 2
CH
2
SCH
3 'Pr H F H OH XXVI-26-8 p-Me-Ph * H * 'Pr H F H OH *RT and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XXVI-27. X2 Rl R 2
R
3 a R 3 b R 4 R' R' X Y XXVI-27-1 p-F-Ph H H H 'Pr H F H OH XXVI-27-2 p-F-Ph H H CH 3 'Pr H F H OH XXVI-27-3 p-F-Ph H H CH(CH 3
)
2 'Pr H F H OH XXVI-27-4 p-F-Ph H H CH 2
CH(CH
3
)
2 'Pr H F H OH XXVI-27-5 p-F-Ph H H CH 2 Ph 'Pr H F H OH XXVI-27-6 p-F-Ph H H CH 2 -indol-3-yl 'Pr H F H OH XXVI-27-7 p-F-Ph H H CH 2
CH
2
SCH
3 'Pr H F H OH XXVI-27-8 p-F-Ph * H * 'Pr H F H OH *RTand R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVI-28. X2 Rl R 2
R
3 a R 3 b R 4 R' R' X Y XXVI-28-1 p-Cl-Ph H H H 'Pr H F H OH XXVI-28-2 p-Cl-Ph H H CH 3 'Pr H F H OH XXVI-28-3 p-Cl-Ph H H CH(CH 3
)
2 'Pr H F H OH XXVI-28-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 'Pr H F H OH XXVI-28-5 p-Cl-Ph H H CH 2 Ph 'Pr H F H OH XXVI-28-6 p-Cl-Ph H H CH 2 -indol-3-yl 'Pr H F H OH XXVI-28-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 'Pr H F H OH XXVI-28-8 p-Cl-Ph * H * 'Pr H F H OH *R27and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XXVI-29. X R' R 2 R Rb R 4 R R X Y XXVI-29-1 p-Br-Ph H H H 'Pr H F H OH XXVI-29-2 p-Br-Ph H H CH 3 'Pr H F H OH XXVI-29-3 p-Br-Ph H H CH(CH 3
)
2 'Pr H F H OH XXVI-29-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 'Pr H F H OH XXVI-29-5 p-Br-Ph H H CH 2 Ph 'Pr H F H OH XXVI-29-6 p-Br-Ph H H CH 2 -indol-3-yl 'Pr H F H OH XXVI-29-7 p-Br-Ph H H CH 2
CH
2
SCH
3 'Pr H F H OH XXVI-29-8 p-Br-Ph * H * 'Pr H F H OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXVI-30. X2 R I R 2 R3a R 3 b R 4 R' R 6 X Y XXVI-30-1 p-I-Ph H H H 'Pr H F H OH XXVI-30-2 p-I-Ph H H CH 3 'Pr H F H OH XXVI-30-3 p-I-Ph H H CH(CH 3
)
2 'Pr H F H OH XXVI-30-4 p-I-Ph H H CH 2
CH(CH
3
)
2 'Pr H F H OH XXVI-30-5 p-I-Ph H H CH 2 Ph 'Pr H F H OH XXVI-30-6 p-I-Ph H H CH 2 -indol-3-yl 'Pr H F H OH XXVI-30-7 p-I-Ph H H CH 2
CH
2
SCH
3 'Pr H F H OH XXVI-30-8 p-I-Ph * H * 'Pr H F H OH *R2 and RJb joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVI-3 1. 2 R' R2 R 3 a R 3 b R' R' R' X Y XXVI-31-1 CH 3 H H H "Bu H F H OH XXVI-31-2 CH 3 H H CH 3 "Bu H F H OH XXVI-31-3 CH 3 H H CH(CH 3
)
2 "Bu H F H OH XXVI-31-4 CH 3 H H CH 2
CH(CH
3
)
2 "Bu H F H OH XXVI-31-5 CH 3 H H CH 2 Ph "Bu H F H OH XXVI-31-6 CH 3 H H CH 2 -indol-3-yl "Bu H F H OH XXVI-31-7 CH 3 H H CH 2
CH
2
SCH
3 "Bu H F H OH XXVI-31-8 CH 3 * H * "Bu H F H OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XXVI-32. X2 RI R R.
3 a R 3 b R 4 R' R' X Y XXVI-32-1 Et H H H "Bu H F H OH XXVI-32-2 Et H H CH 3 "Bu H F -1 OH XXVI-32-3 Et H H CH(CH 3
)
2 "Bu H F H OH XXVI-32-4 Et H H CH 2
CH(CH
3
)
2 "Bu H F H OH XXVI-32-5 Et H H CH 2 Ph "Bu H F H OH XXVI-32-6 Et H H CH 2 -indol-3-yl "Bu H F H OH XXVI-32-7 Et H H CH 2
CH
2
SCH
3 "Bu H F H OH XXVI-32-8 Et * H * "Bu H F H OH *R and R b joined together by (CH 2
)
3 to form five-membered ring. Table XXVI-33. N2 R' R 2 Raa R 3 b R' R' R 6 X Y XXVI-33-1 'Pr H H H "Bu H F H OH XXVI-33-2 'Pr H H CH 3 "Bu H F H OH XXVI-33-3 'Pr H H CH(CH 3
)
2 "Bu H F H OH XXVI-33-4 'Pr H H CH2CH(CH 3
)
2 "Bu H F H OH XXVI-33-5 'Pr H H CH 2 Ph "Bu H F H OH XXVI-33-6 'Pr H H CH 2 -indol-3-yl "Bu H F H OH XXVI-33-7 'Pr H H CH 2
CH
2
SCH
3 "Bu H F H OH XXVI-33-8 'Pr * H * "Bu H F H OH *R and R 3 joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVI-34. N2 R' R2 R 3 a R 3 b R 4 R R 6 X Y XXVI-34-1 'Bu H H H "Bu H F H OH XXVI-34-2 'Bu H H CH3 "Bu H F H OH XXVI-34-3 'Bu H H CH(CH 3
)
2 "Bu H F H OH XXVI-34-4 'Bu H H CH 2
CH(CH
3
)
2 "Bu H F H OH XXVI-34-5 'Bu H H CH 2 Ph "Bu H F H OH XXVI-34-6 'Bu H H CH 2 -indol-3-yl "Bu H F H OH XXVI-34-7 'Bu H H CH 2
CH
2
SCH
3 "Bu H F H OH XXVI-34-8 'Bu * H * "Bu H F H OH *RTand R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XXVI-35. X2 R' R 2
R
3 a R 3 b R R' R 6 X Y XXVI-35-1 Ph H H H "Bu H F H OH XXVI-35-2 Ph H H CH 3 "Bu H F H OH XXVI-35-3 Ph H H CH(CH 3
)
2 "Bu H F H OH XXVI-35-4 Ph H H CH 2
CH(CH
3
)
2 "Bu H F H OH XXVI-35-5 Ph H H CH 2 Ph "Bu H F H OH XXVI-35-6 Ph H H CH 2 -indol-3-yl "Bu H F H OH XXVI-35-7 Ph H H CH 2
CH
2
SCH
3 "Bu H F H OH XXVI-35-8 Ph * H * "Bu H F H OH *Rand R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXVI-36. N R R 2 R 3 aR 3 b R 4 R' R 6 X Y XXVI-36-1 p-Me-Ph H H H "Bu H F H OH XXVI-36-2 p-Me-Ph H H CH 3 "Bu H F H OH XXVI-36-3 p-Me-Ph H H CH(CH 3
)
2 "Bu H F H OH XXVI-36-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 "Bu H F H OH XXVI-36-5 p-Me-Ph H H CH2Ph "Bu H F H OH XXVI-36-6 p-Me-Ph H H CH 2 -indol-3-yl "Bu H F H OH XXVI-36-7 p-Me-Ph H H CH 2
CH
2
SCH
3 "Bu H F H OH XXVI-36-8 p-Me-Ph * H * "Bu H F H OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVI-37. SR R 2 R 3 aR 3 b R R' R 6 X Y XXVI-37-1 p-F-Ph H H H "Bu H F H OH XXVI-37-2 p-F-Ph H H CH 3 "Bu H F H OH XXVI-37-3 p-F-Ph H H CH(CH 3
)
2 "Bu H F H OH XXVI-37-4 p-F-Ph H H CH 2
CH(CH
3
)
2 "Bu H F H OH XXVI-37-5 p-F-Ph H H CH 2 Ph "Bu H F H OH XXVI-37-6 p-F-Ph H H CH 2 -indol-3-yl "Bu H F H OH XXVI-37-7 p-F-Ph H H CH 2
CH
2
SCH
3 "Bu H F H OH XXVI-37-8 p-F-Ph * H * "Bu H F H OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XXVI-38. X2 R 2
R
3 a R 3 b R R' R 6 X Y XXVI-38-1 p-Cl-Ph H H H "Bu H F H OH XXVI-38-2 p-Cl-Ph H H CH 3 "Bu H F H OH XXVI-38-3 p-Cl-Ph H H CH(CH 3
)
2 "Bu H F H OH XXVI-38-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 "Bu H F H OH XXVI-38-5 p-Cl-Ph H H CH 2 Ph "Bu H F H OH XXVI-38-6 p-Cl-Ph H H CH 2 -indol-3-yl "Bu H F H OH XXVI-38-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 "Bu H F H OH XXVI-38-8 p-Cl-Ph * H * "Bu H F H OH
*R
2 and R b joined together by (CH 2
)
3 to form five-membered ring. Table XXVI-39. X2 Rl R 2
R
3 a R 3 b R 4 R' R 6 X Y XXVI-39-1 p-Br-Ph H H H "Bu H F H OH XXVI-39-2 p-Br-Ph H H CH 3 "Bu H F H OH XXVI-39-3 p-Br-Ph H H CH(CH 3
)
2 "Bu H F H OH XXVI-39-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 "Bu H F H OH XXVI-39-5 p-Br-Ph H H CH 2 Ph "Bu H F H OH XXVI-39-6 p-Br-Ph H H CH 2 -indol-3-yl "Bu H F H OH XXVI-39-7 p-Br-Ph H H CH 2
CH
2
SCH
3 "Bu H F H OH XXVI-39-8 p-Br-Ph * H * "Bu H F H OH *R" and RJb joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVI-40. N2 R I R 2
R
3 a R 3 b R R R 6 X Y XXVI-40-1 p-I-Ph H H H "Bu H F H OH XXVI-40-2 p-I-Ph H H CH 3 "Bu H F H OH XXVI-40-3 p-I-Ph H H CH(CH 3
)
2 "Bu H F H OH XXVI-40-4 p-I-Ph H H CH 2
CH(CH
3
)
2 "Bu H F H OH XXVI-40-5 p-I-Ph H H CH 2 Ph "Bu H F H OH XXVI-40-6 p-I-Ph H H CH 2 -indol-3-yl "Bu H F H OH XXVI-40-7 p-I-Ph H H CH 2
CH
2
SCH
3 "Bu H F H OH XXVI-40-8 p-I-Ph * H * "Bu H F H OH *R" and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XXVI-41. X2 R R2 R 3 a R 3 b R R R' X Y XXVI-41-1 CH 3 H H H Bz H F H OH XXVI-41-2 CH 3 H H CH3 Bz H F H OH XXVI-41-3 CH 3 H H CH(CH 3
)
2 Bz H F H OH XXVI-41-4 CH 3 H H CH 2
CH(CH
3
)
2 Bz H F H OH XXVI-41-5 CH 3 H H CH 2 Ph Bz H F H OH XXVI-41-6 CH 3 H H CH 2 -indol-3-yl Bz H F H OH XXVI-41-7 CH 3 . H H CH 2
CH
2
SCH
3 Bz H F H OH XXVI-41-8 CH 3 * H * Bz H F H OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXVI-42. N2 RI R 2
R
3 a R 3 b R4 R' R' X Y XXVI-42-1 Et H H H Bz H F H OH XXVI-42-2 Et H H CH 3 Bz H F H OH XXVI-42-3 Et H H CH(CH 3
)
2 Bz H F H OH XXVI-42-4 Et H H CH 2
CH(CH
3
)
2 Bz H F H OH XXVI-42-5 Et H H CH 2 Ph Bz H F H OH XXVI-42-6 Et H H CH 2 -indol-3-yl Bz H F H OH XXVI-42-7 Et H H CH 2
CH
2
SCH
3 Bz H F H OH XXVI-42-8 Et * H * Bz H F H OH *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVI-43. N2 R' R2 R3a R 3 b R 4 R' R' X Y XXVI-43-1 'Pr H H H Bz H F H OH XXVI-43-2 'Pr H H CH 3 Bz H F H OH XXVI-43-3 'Pr H H CH(CH 3
)
2 Bz H F H OH XXVI-43-4 'Pr H H CH 2
CH(CH
3
)
2 Bz H F H OH XXVI-43-5 'Pr H H CH 2 Ph Bz H F H OH XXVI-43-6 'Pr H H CH 2 -indol-3-yl Bz H F H OH XXVI-43-7 'Pr H H CH 2
CH
2
SCH
3 Bz H F H dA XXVI-43-8 'Pr * H * Bz H F H OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. ccc Table XXVI-44. N2 R R 2
R
3 a R 3 b R 4 R' R' X Y XXVI-44-1 'Bu H H H Bz H F H OH XXVI-44-2 'Bu H H CH 3 Bz H F H OH XXVI-44-3 'Bu H H CH(CH 3
)
2 Bz H F H OH XXVI-44-4 'Bu H H CH 2
CH(CH
3
)
2 Bz H F H OH XXVI-44-5 'Bu H H CH 2 Ph Bz H F H OH XXVI-44-6 'Bu H H CH 2 -indol-3-yl Bz H F H OH XXVI-44-7 'Bu H H CH 2
CH
2
SCH
3 Bz H F H OH XXVI-44-8 'Bu * H * Bz H F H OH *Ri'and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXVI-45. R' R 2
R
3 a R 3 b R 4 R' R' X Y XXVI-45-1 Ph H H H Bz H F H OH XXVI-45-2 Ph H H CH 3 Bz H F H OH XXVI-45-3 Ph H H CH(CH 3
)
2 Bz H F H OH XXVI-45-4 Ph H H CH 2
CH(CH
3
)
2 Bz H F H OH XXVI-45-5 Ph H H CH 2 Ph Bz H F H OH XXVI-45-6 Ph H H CH 2 -indol-3-yl Bz H F H OH XXVI-45-7 Ph H H CH 2
CH
2
SCH
3 Bz H F H OH XXVI-45-8 Ph * H * Bz H F H OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVI-46. 2 R R 2
R
3 a R 3 b R 4 R' R 6 X Y XXVI-46-1 p-Me-Ph H H H Bz H F H OH XXVI-46-2 p-Me-Ph H H CH 3 Bz H F H OH XXVI-46-3 p-Me-Ph H H CH(CH 3
)
2 Bz H F H OH XXVI-46-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Bz H F H OH XXVI-46-5 p-Me-Ph H H CH 2 Ph Bz H F H OH XXVI-46-6 p-Me-Ph H H CH 2 -indol-3-yl Bz H F H OH XXVI-46-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Bz H F H OH XXVI-46-8 p-Me-Ph * H * Bz H F H OH *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XXVI-47. N2 Rl R 2 R3a R3b R' R' R 6 X Y XXVI-47-1 p-F-Ph H H H Bz H F H OH XXVI-47-2 p-F-Ph H H CH 3 Bz H F H OH XXVI-47-3 p-F-Ph H H CH(CH 3
)
2 Bz H F H OH XXVI-47-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Bz H F H OH XXVI-47-5 p-F-Ph H H CH 2 Ph Bz H F H OH XXVI-47-6 p-F-Ph H H CH 2 -indol-3-yl Bz H F H OH XXVI-47-7 p-F-Ph H H CH 2
CH
2
SCH
3 Bz H F H OH XXVI-47-8 p-F-Ph * H * Bz H F H OH *R and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XXVI-48. X2 R' R 2
R
3 a R 3 b R 4 R' R 6 X Y XXVI-48-1 p-Cl-Ph H H H Bz H F H OH XXVI-48-2 p-Cl-Ph H H CH 3 Bz H F H OH XXVI-48-3 p-Cl-Ph H H CH(CH 3
)
2 Bz H F H OH XXVI-48-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Bz H F H OH XXVI-48-5 p-Cl-Ph H H CH 2 Ph Bz H F H OH XXVI-48-6 p-Cl-Ph H H CH 2 -indol-3-yl Bz H F H OH XXVI-48-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Bz H F H OH XXVI-48-8 p-Cl-Ph * H * Bz H F H OH *R and Rb joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVI-49. N2 Rl R 2 R3a R 3 b R4 R' R 6 X Y XXVI-49-1 p-Br-Ph H H H Bz H F H OH XXVI-49-2 p-Br-Ph H H CH 3 Bz H F H OH XXVI-49-3 p-Br-Ph H H CH(CH3) 2 Bz H F H OH XXVI-49-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Bz H F H OH XXVI-49-5 p-Br-Ph H H CH 2 Ph Bz H F H OH XXVI-49-6 p-Br-Ph H H CH 2 -indol-3-yl Bz H F H OH XXVI-49-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Bz H F H OH XXVI-49-8 p-Br-Ph * H * Bz H F H OH *Rad Ran joined together by (CH 2
)
3 to form five-membered ring.
Table XXVI-50. NR' R R 3 aR R1(R R' R 6 X Y XXVI-50-1 p-I-Ph H H H Bz H F H OH XXVI-50-2 p-I-Ph H H CH 3 Bz H F H OH XXVI-50-3 p-I-Ph H H CH(CH 3
)
2 Bz H F H OH XXVI-50-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Bz H F H OH XXVI-50-5 p-I-Ph H H CH 2 Ph Bz H F H OH XXVI-50-6 p-I-Ph H H CH 2 -indol-3-yl Bz H F H OH XXVI-50-7 p-I-Ph H H CH 2
CH
2
SCH
3 Bz H F H OH XXVI-50-8 p-I-Ph * H * Bz H F H OH *R2 and R b joined together by (CH 2
)
3 to form five-membered ring. R2 0 N R3a --- --- O O NN N C0 2
R
4 OR' Rs
R
6
NH
2 Y X 5 XXVII Table XXVII-1. N R' R2 R 3 a R 3 b R 4 R' R 6 X Y XXVII-1-1 CH 3 H H H CH 3 H F F OH XXVII-1-2 CH 3 H H CH 3
CH
3 H F F OH XXVII-1-3 CH 3 H H CH(CH 3
)
2
CH
3 H F F OH XXVII-1-4 CH 3 H H CH 2
CH(CH
3
)
2
CH
3 H F F OH XXVH-1-5 CH 3 H H CH 2 Ph CH 3 H F F OH XXVU-1-6 CH 3 H H CH 2 -indol-3-yl CH 3 H F F OH XXVII-1-7 CH 3 H H CH1 2
CH
2
SCH
3
CH
3 H F F OH XXVU-1-8 CH 3 * H * CH 3 H F F OH R2and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XXVII-2. N2 R' R 2
R
3 " R3b R 4 R' R' X Y XXVII-2-1 Et H H H CH 3 H F F OH XXVH-2-2 Et H H CH 3
CH
3 H F F OH XXVII..2-3 Et H H CH(CH 3
)
2
CH
3 H F F OH XXVII..2-4 Et H H CH 2
CH(CH
3
)
2
CH
3 H F F OH XXVII..2-5 Et H H CH 2 Ph CH 3 H F F OH XXVH-2-6 Et H H CH 2 -indol-3-yl CH 3 H F F OH XXVH-2-7 Et H H CH 2
CH
2
SCH
3
CH
3 H F F OH XXVH-2-8 Et * H * CH 3 H F F OH *R2 and Rab joined together by (CH 2
)
3 to form five-membered ring. Table XXVII-3. X2 R' R 2
R
3 3 R 3 b R 4 R' R 6 X Y XXVII-3-1 'Pr H H H CH 3 H F F OH XXVII-3-2 'Pr H H CH 3
CH
3 H F F OH XXVII-3-3 'Pr H H CH(CH 3
)
2
CH
3 H F F OH XXVII-3-4 'Pr H H CH 2
CH(CH
3 )2 CH 3 H F F OH XXVII-3-5 'Pr H H CH 2 Ph CH 3 H F F OH XXVH-3-6 'Pr H H CH 2 -indol-3-yl CH 3 H F F OH XXVII-3-7 'Pr H H CH 2
CH
2
SCH
3
CH
3 H F F OH XXVH-3-8 'Pr * H * CH 3 H F F OH *R2 and R b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVII-4. NO R' R2 R 3 a R 3 b R R 6 X Y XXVII-4-1 'Bu H H H CH 3 H F F OH XXVH-4-2 'Bu H H CH 3
CH
3 H F F OH XXVH-4-3 'Bu H H CH(CH 3
)
2
CH
3 H F F OH XXVH-4-4 'Bu H H CH 2
CH(CH
3
)
2
CH
3 H F F OH XXVII-4-5 'Bu H H CHPh CH 3 H F F OH XXVH-4-6 'Bu H H CH2-indol-3-yi CH 3 H F F OH XXVH-4-7 'Bu H H CH 2
CH
2
SCH
3
CH
3 H F F OH XXVII-4-8 'Bu * H * CH 3 H F F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XXVII-5. N2 R' R2 R 3 a R3b R' R' R' X Y XXV-.5-1 Ph H H H CH 3 H F F OH XXVII-5-2 Ph H H CH 3
CH
3 H F F OH XXVII-5-3 Ph H H CH(CH 3
)
2
CH
3 H F F OH XXVII-5-4 Ph H H CH 2
CH(CH
3
)
2
CH
3 H F F OH XXVII--5-5 Ph H H CH 2 Ph CH 3 H F F OH XXVI-5-6 Ph H H CH 2 -indol-3-yl CH 3 H F F OH XXVII-5-7 Ph H H CH 2
CH
2
SCH
3
CH
3 H F F OH XXVII-5-8 Ph * H * CH 3 H F F OH
*R
2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XXVII-6. N RR 2
R
3 Rb R 4 R' R XY XXVI-6-1 p-Me-Ph H H H CH 3 H F F OH XXVH-6-2 p-Me-Ph H H CH 3
CH
3 H F F OH XXVH-6-3 p-Me-Ph H H CH(CH 3
)
2
CH
3 H F F OH XXVII-6-4 p-Me-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F F OH XXVH-6-5 p-Me-Ph H H CH 2 Ph CH 3 H F F OH XXVII-6-6 p-Me-Ph H H CH 2 -indol-3-yl CH 3 H F F OH XXVH-6-7 p-Me-Ph H H CH 2
CH
2
SCH
3
CH
3 H F F OH XXVH-6-8 p-Me-Ph * H * CH 3 H F F OH *R and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVII-7. N2 Rl R 2 R3a R 3 b R' R' R 6 X Y XXVII.-7-1 p-F-Ph H H H CH 3 H F F OH XXVH-7-2 p-F-Ph H H CH 3
CH
3 H F F OH XXVII.-7-3 p-F-Ph H H CH(CH 3
)
2
CH
3 H F F OH XXVII-7-4 p-F-Ph H H CH2CH(CH 3
)
2
CH
3 H F F OH XXVII-7-6 p-F-Ph H H CH2Ph CH 3 H F F OH XXVH-7-7 p-F-Ph H H CH 2 -indol-3-yl CH 3 H F F OH XXVII-7-8 p-F-Ph H H CH 2
CH
2
SCH
3
CH
3 H F F OH XXVII-7-20 p-F-Ph * H * CH 3 H F F OH *R and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XXVII-8. N R RR R 3 b R' R' R XY XXVH..8-1 p-Cl-Ph H H H CH 3 H F F OH XXVH-8-2 p-Cl-Ph H H CH 3
CH
3 H F F OH XXVH-8-3 p-Cl-Ph H H CH(CH 3
)
2
CH
3 H F F OH XXVH-.8-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F F OH XXVH-8-5 p-Cl-Ph H H CH 2 Ph CH 3 H F F OH XXVI-8-6 p-Cl-Ph H H CH 2 -indol-3-yl CH 3 H F F OH XXVII-8-7 p-Cl-Ph H H CH 2
CH
2
SCH
3
CH
3 H F F OH XXVII-8-8 p-Cl-Ph * H * CH 3 H F F OH *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXVII-9. N2 R! R2 R 3 a Rb R 4 R' R' X Y XXVII-9-1 p-Br-Ph H H H CH 3 H F F OH XXVH.-9-2 p-Br-Ph H H CH 3
CH
3 H F F OH XXVH-9-3 p-Br-Ph H H CH(CH 3
)
2
CH
3 H F F OH XXVI-9-4 p-Br-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F F OH XXVH-9-6 p-Br-Ph H H CH 2 Ph CH 3 H F F OH XXVII-9-7 p-Br-Ph H H CH 2 -indol-3-yl CH 3 H F F OH XXVII-9-8 p-Br-Ph H H CH 2
CH
2
SCH
3
CH
3 H F F OH XXVII-9-20 p-Br-Ph * H * CH 3 H F F OH *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVII-10. N! R' R 2 R3a R 3 b R' R' R' X Y XXVI-10-1 p-I-Ph H H H CH 3 H F F OH XXVII-10-2 p-I-Ph H H CH 3
CH
3 H F F OH XXVH-10-3 p-I-Ph H H CH(CH 3
)
2
CH
3 H F F OH XXVII-10-4 p-I-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F F OH XXVII-10-5 p-I-Ph H H CH 2 Ph CH 3 H F F OH XXVII-10-6 p-I-Ph H H CH 2 -indol-3-yl CH 3 H F F OH XXVH-10-7 p-I-Ph H H CH 2
CH
2
SCH
3
CH
3 H F F OH XXVH-10-8 p-I-Ph * H * CH 3 H F F OH *R and Rdb joined together by (CH 2
)
3 to form five-membered ring.
Table XXVII- 11. N R R 2
R
3 a R 3 b R 4 R' R' X Y XXVII-11-1 CH 3 H H H Et H F F OH XXVII-11-2 CH 3 H H CH 3 Et H F F OH XXVI-11-3 CH 3 H H CH(CH 3
)
2 Et H F F OH XXVT--11-4 CH 3 H H CH 2
CH(CH
3
)
2 Et H F F OH XXVH--11-5 CH 3 H H CH 2 Ph Et H F F OH XXVII--11-6 CH 3 H H CH 2 -indol-3-yl Et H F F OH XXVH-.11-7 CH 3 H H CH 2
CH
2
SCH
3 Et H F F OH XXVH--11-8 CH 3 * H * Et H F F OH *R and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXVII-12. N RI R 2
R
3 a R 3 b R 4 R' R 6 X Y XXVH-12-1 Et H H H Et H F F OH XXVH-12-2 Et H H CH 3 Et H F F OH XXV-12-3 Et H H CH(CH 3
)
2 Et H F F OH XXVH-12-4 Et H H CH 2
CH(CH
3
)
2 Et H F F OH XXVH-12-5 Et H H CH 2 Ph Et H F F OH XXVII-12-6 Et H H CH 2 -indol-3-yl Et H F F OH XXV-12-7 Et H H CH 2
CH
2
SCH
3 Et H F F OH XXVH-12-8 Et * H * Et H F F OH *R and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVII-13. N R' R 2 Ria R 3 b R4 R' R 6 X Y XXVII-13-1 'Pr H H H Et H F F OH XXVH-13-2 'Pr H H CH 3 Et H F F OH XXVII-13-3 'Pr H H CH(CH 3
)
2 Et H F F OH XXVII-13-4 'Pr H H CH 2
CH(CH
3
)
2 Et H F F OH XXVH-13-5 'Pr H H CH 2 Ph Et H F F OH XXVH-13-6 'Pr H H CH 2 -indol-3-yl Et H F F OH XXVH-13-7 'Pr H H CH 2
CH
2
SCH
3 Et H F F OH XXVH-13-8 'Pr * H * Et H F F OH *R2 and R b joined together by (CH 2
)
3 to form five-membered ring.
Table XXVII-14. N2 R R2 R (a Rab R' R5 R' X Y XXVII-14-1 'Bu H H H Et H F F OH XXVII-14-2 'Bu H H CH 3 Et H F F OH XXVII-14-3 'Bu H H CH(CH 3
)
2 Et H F F OH XXVII-14-4 'Bu H H CH 2
CH(CH
3
)
2 Et H F F OH XXVI-14-5 'Bu H H CH 2 Ph Et H F F OH XXVII-14-6 'Bu H H CH 2 -indol-3-yl Et H F F OH XXVII-14-7 'Bu H H CH 2
CH
2
SCH
3 Et H F F OH XXVH-14-8 'Bu * H * Et H F F OH *R and Rb joined together by (CH 2
)
3 to form five-membered ring. Table XXVII-15. X2 RI R2 R 3 a R3b R' R' R' X Y XXVII-15-1 Ph H H H Et H F F OH XXV-.15-2 Ph H H CH 3 Et H F F OH XXV-.15-3 Ph H H CH(CH 3
)
2 Et H F F OH XXV-.15-4 Ph H H CH 2
CH(CH
3
)
2 Et H F F OH XXV-.15-5 Ph H H CH2Ph Et H F F OH XXVH-15-6 Ph H H CH 2 -indol-3-yl Et H F F OH XXVII-15-7 Ph H H CH 2
CH
2
SCH
3 Et H F F OH XXVH-15-8 Ph * H * Et H F F OH *RT and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVII-16. N2 R' R 2 RV R b R' R' R 6 X Y XXVII-16-1 p-Me-Ph H H H Et H F F OH XXVI-16-2 p-Me-Ph H H CH 3 Et H F F OH XXVH-16-3 p-Me-Ph H H CH(CH 3
)
2 Et H F F OH XXVII-16-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Et H F F OH XXVH-.16-5 p-Me-Ph H H CH 2 Ph Et H F F OH XXVII--16-6 p-Me-Ph H H CH 2 -indol-3-yl Et H F F OH XXVII-16-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Et H F F OH XXVII--16-8 p-Me-Ph * H * Et H F F OH *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring.
Table XXVII-17. N2 Rl R 2
R
3 a R 3 b R' R' R' X Y XXVII-17-1 p-F-Ph H H H Et H F F OH XXVH-17-2 p-F-Ph H H CH 3 Et H F F OH XXVII-17-3 p-F-Ph H H CH(CH 3
)
2 Et H F F OH XXVII-17-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Et H F F OH XXVI-17-5 p-F-Ph H H CH 2 Ph Et H F F OH XXVH-17-6 p-F-Ph H H CH 2 -indol-3-yl Et H F F OH XXVII-17-7 p-F-Ph H H CH 2
CH
2
SCH
3 Et H F F OH XXVII-17-8 p-F-Ph * H * Et H F F OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXVII-18. N2 Rl R 2
R
3 a R 3 b R4 R' R 6 X Y XXVH-18-1 p-Cl-Ph H H H Et H F F OH XXVII-18-2 p-Cl-Ph H H CH 3 Et H F F OH XXVH-18-3 p-Cl-Ph H H CH(CH 3
)
2 Et H F F OH XXVH-18-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Et H F F OH XXVH-18-5 p-Cl-Ph H H CH 2 Ph Et H F F OH XXVII-18-6 p-Cl-Ph H H CH 2 -indol-3-yl Et H F F OH XXVH-18-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Et H F F OH XXVII-18-8 p-Cl-Ph * H * Et H F F OH *R and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVII-19. NX{2 R 2
R
3 a R 3 b R 4 R' R 6 X Y XXVH-19-1 p-Br-Ph H H H Et H F F OH XXVH-19-2 p-Br-Ph H H CH 3 Et H F F OH XXVH-19-3 p-Br-Ph H H CH(CH 3
)
2 Et H F F OH XXVH-19-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Et H F F OH XXVH-19-5 p-Br-Ph H H CH 2 Ph Et H F F OH XXVII-19-6 p-Br-Ph H H CH 2 -indol-3-yl Et H F F OH XXVH-19-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Et H F F OH XXVII-19-8 p-Br-Ph * H * Et H F F OH *R and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XXVII-20. N R R R a Rb R' R' R' X Y XXVH-20-1 p-I-Ph H H H Et H F F OH XXVH-20-2 p-I-Ph H H CH 3 Et H F F OH XXVII-20-3 p-I-Ph H H CH(CH 3
)
2 Et H F F OH XXVII-20-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Et H F F OH XXVII-20-5 p-I-Ph H H CH 2 Ph Et H F F OH XXVII-20-6 p-I-Ph H H CH 2 -indol-3-yl Et H F F OH XXVI-20-7 p-I-Ph H H CH 2
CH
2
SCH
3 Et H F F OH XXVII-.20-8 p-I-Ph * H * Et H F F OH *R and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXVII-21. Xe R R 2
R
3 a R 3 b R4 R' R 6 X Y XXVH--21-1 CH 3 H H H 'Pr H F F OH XXVII-21-2 CH 3 H H CH 3 'Pr H F F OH XXVII.-21-3 CH 3 H H CH(CH 3
)
2 'Pr H F F OH XXVII-21-4 CH 3 H H CH 2
CH(CH
3
)
2 'Pr H F F OH XXVH-21-5 CH 3 H H CH 2 Ph 'Pr H F F OH XXVH-21-6 CH 3 H H CH 2 -indol-3-yl 'Pr H F F OH XXVH-21-7 CH 3 H H CH 2
CH
2
SCH
3 'Pr H F F OH XXVH-21-8 CH 3 * H * 'Pr H F F OH *R- and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVII-22. X R' R 2
R
3 a R 3 b R 4 R' R 6 X Y XXVH-22-1 Et H H H 'Pr H F F OH XXVH-22-2 Et H H CH 3 'Pr H F F OH XXVII-22-3 Et H H CH(CH 3
)
2 'Pr H F F OH XXVII-22-4 Et H H CH 2
CH(CH
3
)
2 'Pr H F F OH XXVH-22-5 Et H H CH 2 Ph 'Pr H F F OH XXVH-22-6 Et H H CH 2 -indol-3-yl 'Pr H F F OH XXVH-22-7 Et H H CH 2
CH
2
SCH
3 'Pr H F F OR XXVH-22-8 Et * H * 'Pr H F F OH *i2and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XXVII-23. N2 RI R 2
R
3 a R 3 b R' R' R' X Y XXVII-23-1 'Pr H H H 'Pr H F F OH XXVII-23-2 'Pr H H CH 3 'Pr H F F OH XXVII-23-3 'Pr H H CH(CH 3
)
2 'Pr H F F OH XXVII-23-4 'Pr H H CH 2
CH(CH
3
)
2 'Pr H F F OH XXVII-23-5 'Pr H H CH 2 Ph 'Pr H F F OH XXVII-23-6 'Pr H H CH 2 -indol-3-yl 'Pr H F F OH XXVH-23-7 'Pr H H CH 2
CH
2
SCH
3 'Pr H F F OH XXVII-23-8 'Pr * H * 'Pr H F F OH *R and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XXVII-24. N2 R' R 2
R
3 a R 3
R
4 R' R 6 X Y XXVII-24-1 'Bu H H H 'Pr H F F OH XXVII-24-2 'Bu H H CH 3 'Pr H F F OH XXVII-24-3 'Bu H H CH(CH 3
)
2 'Pr H F F OH XXVII-24-4 'Bu H H CH 2
CH(CH
3
)
2 'Pr H F F OH XXVII-24-5 'Bu H H CH1 2 Ph 'Pr H F F OH XXVI-24-6 'Bu H H CH 2 -indol-3-yl 'Pr H F F OH XXVII-24-7 'Bu H H CH 2
CH
2
SCH
3 'Pr H F F OH XXVII-24-8 'Bu * H * 'Pr H F F OH *RT and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVII-25. N Rl R 2
R
3 a R 3 b R4 R' R 6 X Y XXVH-25-1 Ph H H H 'Pr H F F OH XXVII-25-2 Ph H H CH 3 'Pr H F F OH XXVU-25-3 Ph H H CH(CH 3
)
2 'Pr H F F OH XXVH-25-4 Ph H H CH 2
CH(CH
3
)
2 'Pr H F F OH XXVI-25-5 Ph H H CH 2 Ph 'Pr H F F OH XXVII-25-6 Ph H H CH 2 -indol-3-yi 'Pr H F F OH XXVII-25-7 Ph H H CH 2
CH
2
SCH
3 'Pr H F F OH XXVI-25-8 Ph * H * 'Pr H F F OH *R and Rib joined together by (CH 2
)
3 to form five-membered ring.
Table XXVII-26.
-RR
2 R~a Rb R 4 R' R' X Y XXVH.-26-1 p-Me-Ph H H H 'Pr H F F OH XXVI-26-2 p-Me-Ph H H CH 3 'Pr H F F OH XXVII-26-3 p-Me-Ph H H CH(CH 3
)
2 'Pr H F F OH XXVH.-26-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 'Pr H F F OH XXVII.-26-5 p-Me-Ph H H CH 2 Ph 'Pr H F F OH XXVII.-26-6 p-Me-Ph H H CH 2 -indol-3-yl 'Pr H F F OH XXVII.-26-7 p-Me-Ph H H CH 2
CH
2
SCH
3 'Pr H F F OH XXVII-26-8 p-Me-Ph * H * 'Pr H F F OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXVII-27. N9 Rl R 2
R
3 a R 3 b R' R' R' X Y XXVII-27-1 p-F-Ph H H H 'Pr H F F OH XXVII-27-2 p-F-Ph H H CH 3 'Pr H F F OH XXVII-27-3 p-F-Ph H H CH(CH 3
)
2 'Pr H F F OH XXVII-27-4 p-F-Ph H H CH 2
CH(CH
3
)
2 'Pr H F F OH XXVII-27-5 p-F-Ph H H CH 2 Ph 'Pr H F F OH XXVII-27-6 p-F-Ph H H CH 2 -indol-3-yl 'Pr H F F OH XXVII.-27-7 p-F-Ph H H CH 2
CH
2
SCH
3 'Pr H F F OH XXVII-27-8 p-F-Ph * H * 'Pr H F F OH *R and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVII-28. N2 Rl R 2 Ra R 3 b R 4
R'
5 R' X Y XXVH-28-1 p-Cl-Ph H H H 'Pr H F F OH XXVII.-28-2 p-Cl-Ph H H CH 3 'Pr H F F OH XXVII.-28-3 p-Cl-Ph H H CH(CH 3
)
2 'Pr H F F OH XXVII-28-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 'Pr H F F OH XXVII-28-5 p-Cl-Ph H H CH 2 Ph 'Pr H F F OH XXVH-28-6 p-Cl-Ph H H CH 2 -indol-3-yl 'Pr H F F OH XXVII.-28-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 'Pr H F F OH XXVII-28-8 p-Cl-Ph * H * 'Pr H F F OH *R and R3b joined together by (CH 2
)
3 to form five-membered ring. ",'7 Table XXVII-29. N2 R R 2 R3a Rb R 4 R' R' X Y XXVII-29-1 p-Br-Ph H H H 'Pr H F F OH XXVII-29-2 p-Br-Ph H H CH 3 'Pr H F F OH XXVH-29-3 p-Br-Ph H H CH(CH 3
)
2 'Pr H F F OH XXVH-29-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 'Pr H F F OH XXVII-29-5 p-Br-Ph H H CH 2 Ph 'Pr H F F OH XXVI.-29-6 p-Br-Ph H H CH 2 -indol-3-yl 'Pr H F F OH XXVH-29-7 p-Br-Ph H H CH 2
CH
2
SCH
3 'Pr H F F OH XXVH-29-8 p-Br-Ph * H * 'Pr H F F OH *RW and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXVII-30. N2 R R 2 Ra R3b R 4 R' R' X Y XXVU-30-1 p-I-Ph H H H 'Pr H F F OH XXVII-30-2 p-I-Ph H H CH 3 'Pr H F F OH XXVH-30-3 p-I-Ph H H CH(CH 3
)
2 'Pr H F F OH XXVH-30-4 p-I-Ph H H CH 2
CH(CH
3
)
2 'Pr H F F OH XXVII-30-5 p-I-Ph H H CH 2 Ph 'Pr H F F OH XXVH-30-6 p-I-Ph H H CH 2 -indol-3-yl 'Pr H F F OH XXVH-30-7 p-I-Ph H H CH 2
CH
2
SCH
3 'Pr H F F OH XXVH-30-8 p-I-Ph * H * 'Pr H F F OH *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVII-3 1. N! R' R 2
R
3 a R 3 b R 4 R'R X Y XXVH-31-1 CH 3 H H H "Bu H F F OH XXVII-31-2 CH 3 H H CH 3 "Bu H F F OH XXVD-31-3 CH 3 H H CH(CH 3
)
2 "Bu H F F OH XXVII-31-4 CH 3 H H CH 2
CH(CH
3
)
2 "Bu H F F OH XXVU-31-5 CH 3 H H CH 2 Ph "Bu H F F OH XXVII-31-6 CH 3 H H CH 2 -indol-3-yl "Bu H F F OH XXVH-31-7 CH 3 H H CH 2
CH
2
SCH
3 "Bu H F F OH XXVI-31-8 CH 3 * H * "Bu H F F OH nd Rb joined together by (CH 2
)
3 to form five-membered ring.
Table XXVII-32. XRI R 2
R
3 a R 3 b R 4 R' R X Y XXVH-32-1 Et H H H "Bu H F F OH XXVH.-32-2 Et H H CH 3 "Bu H F F OH XXVH-32-3 Et H H CH(CH 3
)
2 "Bu H F F OH XXVII-32-4 Et H H CH 2
CH(CH
3
)
2 "Bu H F F OH XXVH-32-5 Et H H CH2Ph "Bu H F F OH XXVH-32-6 Et H H CH 2 -indol-3-yl "Bu H F F OH XXVH-32-7 Et H H CH2CH 2
SCH
3 "Bu H F F OH XXVH-32-8 Et * H * "Bu H F F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXVII-33. N2 R' R 2
R
3 a R 3 b R R R 6 X Y XXVII-33-1 'Pr H H H "Bu H F F OH XXVII-33-2 'Pr H H CH 3 "Bu H F F OH XXVH-33-3 'Pr H H CH(CH 3
)
2 "Bu H F F OH XXVH-33-4 'Pr H H CH 2
CH(CH
3
)
2 "Bu H F F OH XXVH-33-5 'Pr H H CH 2 Ph "Bu H F F OH XXVH-33-6 'Pr H H ' CH 2 -indol-3-yi "Bu H F F OH XXVU-33-7 'Pr H H CH 2
CH
2
SCH
3 "Bu H F F OH XXVI-33-8 'Pr * H * "Bu H F F OH
*R
2 and R'l joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVII-34. X2 R' R 2
R
3 a R3b R4 R' R 6 X Y XXVU-34-1 'Bu H H H "Bu H F F OH XXVH-34-2 'Bu H H CH 3 "Bu H F F OH XXVII-34-3 'Bu H H CH(CH 3
)
2 "Bu H F F OH XXVII-34-4 'Bu H H CH 2
CH(CH
3
)
2 "Bu H F F OH XXVUI-34-5 'Bu H H CH 2 Ph "Bu H F F OH XXVIIJ-34-6 'Bu H H CH 2 -indol-3-yl "Bu H F F OH XXVUI-34-7 'Bu H H CH 2
CH
2
SCH
3 "Bu H F F OH XXVTI-34-8 'Bu * H * "Bu H F F OH *R and R 3 " joined together by (CH 2
)
3 to form five-membered ring.
C"A
Table XXVII-35. N2 R 1
R
2
R
3 a R 3 b R 4 R R X Y XXVI-35-1 Ph H H H "Bu H F F OH XXVI-35-2 Ph H H CH 3 "Bu H F F OH XXVII-35-3 Ph H H CH(CH 3
)
2 "Bu H F F OH XXVI-35-4 Ph H H CH 2
CH(CH
3
)
2 "Bu H F F OH XXVII-35-5 Ph H H CH 2 Ph "Bu H F F OH XXVH-35-6 Ph H H CH 2 -indol-3-yl "Bu H F F OH XXVII-35-7 Ph H H CH 2
CH
2
SCH
3 "Bu H F F OH XXVH-35-8 Ph * H * "Bu H F F OH
*R
2 and R-b joined together by (CH 2
)
3 to form five-membered ring. Table XXVII-36. N2 R' R 2
R
3 a R 3 b R 4 R' R 6 X Y XXVII..36-1 p-Me-Ph H H H "Bu H F F OH XXVI..36-2 p-Me-Ph H H CH 3 "Bu H F F OH XXVH--36-3 p-Me-Ph H H CH(CH 3
)
2 "Bu H F F OH XXVH-36-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 "Bu H F F OH XXVII-36-5 p-Me-Ph H H CH 2 Ph "Bu H F F OH XXVI-36-6 p-Me-Ph H H CH 2 -indol-3-yl "Bu H F F OH XXVH-36-7 p-Me-Ph H H CH 2
CH
2
SCH
3 "Bu H F F OH XXVII-36-8 p-Me-Ph * H * "Bu H F F OH *R and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVII-37. N2 Rl R 2
R
3 a R 3 b R 4 R' R' X Y XXVH-37-1 p-F-Ph H H H "Bu H F F OH XXVII-37-2 p-F-Ph H H CH 3 "Bu H F F OH XXVII-37-3 p-F-Ph H H CH(CH 3
)
2 'Bu H F F OH XXVH-37-4 p-F-Ph H H CH 2
CH(CH
3
)
2 "Bu H F F OH XXVH-37-5 p-F-Ph H H CH 2 Ph 'Bu H F F OH XXVII.-37-6 p-F-Ph H H CH 2 -indol-3-yl "Bu H F F OH XXVH.-37-7 p-F-Ph H H CH 2
CH
2
SCH
3 "Bu H F F OH XXVII-37-8 p-F-Ph * H * "Bu H F F OH *RT and R.3b joined together by (CH 2
)
3 to form five-membered ring.
Table XXVII-38. N2 R R R R R 4 R' R XY XXVH-38-1 p-Cl-Ph H H H "Bu H F F OH XXVII-38-2 p-Cl-Ph H H CH 3 "Bu H F F OH XXVI-38-3 p-Cl-Ph H H CH(CH 3
)
2 "Bu H F F OH XXVII-38-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 "Bu H F F OH XXVH-38-5 p-Cl-Ph H H CH 2 Ph "Bu H F F OH XXVH-38-6 p-Cl-Ph H H CH 2 -indol-3-yl "Bu H F F OH XXVH-38-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 "Bu H F F OH XXVII-38-8 p-Cl-Ph * H * "Bu H F F OH *RW and R joined together by (CH2)3 to form five-membered ring. Table XXVII-39. N2 R 2 Ra R 3 b R' R' R XY XXVII-39-1 p-Br-Ph H H H "Bu H F F OH XXVII-39-2 p-Br-Ph H H CH 3 "Bu H F F OH XXVH-39-3 p-Br-Ph H H CH(CH 3
)
2 "Bu H F F OH XXVH-39-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 "Bu H F F OH XXVII-39-5 p-Br-Ph H H CH 2 Ph "Bu H F F OH XXVII-39-6 p-Br-Ph H H CH 2 -indol-3-yl "Bu H F F OH XXVH-39-7 p-Br-Ph H H CH 2
CH
2
SCH
3 "Bu H F F OH XXVII-39-8 p-Br-Ph * H * "Bu H F F OH
*R
2 and Rb joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVII-40. N R R 2 RaR 3 b R 4
R
5
R
6 XY XXVII-40-1 p-I-Ph H H H "Bu H F F OH XXVI-40-2 p-I-Ph H H CH 3 "Bu H F F OH XXVH-40-3 p-I-Ph H H CH(CH 3
)
2 "Bu H F F OH XXVI-40-4 p-I-Ph H H CH 2
CH(CH
3
)
2 "Bu H F F OH XXVI-40-5 p-I-Ph H H CH 2 Ph "Bu H F F OH XXVII-40-6 p-I-Ph H H CH 2 -indol-3-yl "Bu H F F OH XXVI-40-7 p-I-Ph H H CH 2
CH
2
SCH
3 "Bu H F F OH XXVI-40-8 p-I-Ph * H * "Bu H F F OH *R7and R"b joined together by (CH 2
)
3 to form five-membered ring. I 7 1 Table XXVII-41. X2 R R2 R 3 a R3b R' R' R' X Y XXVH..41-1 CH 3 H H H Bz H F F OH XXVH-41-2 CH 3 H H CH 3 Bz H F F OH XXVII-41-3 CH 3 H H CH(CH 3
)
2 Bz H F F OH XXVII-41-4 CH 3 H H CH 2
CH(CH
3
)
2 Bz H F F OH XXVH-41-5 CH 3 H H CH 2 Ph Bz H F F OH XXVI-41-6 CH 3 H H CH 2 -indol-3-yl Bz H F F OH XXVII-41-7 CH 3 H H CH 2
CH
2
SCH
3 Bz H F F OH XXVH-41-8 CH 3 * H * Bz H F F OH *R2 and Rab joined together by (CH 2
)
3 to form five-membered ring. Table XXVII-42. 2 RI R 2
R
3 a R 3 b R4 R' R 6 X Y XXVII-42-1 Et H H H Bz H F F OH XXVH-42-2 Et H H CH 3 Bz H F F OH XXVII-42-3 Et H H CH(CH 3
)
2 Bz H F F OH XXVH-42-4 Et H H CH 2
CH(CH
3
)
2 Bz H F F OH XXVII-42-5 Et H H CH 2 Ph Bz H F F OH XXVII-42-6 Et H H CH 2 -indol-3-yl Bz H F F OH XXVH-42-7 Et H H CH 2
CH
2
SCH
3 Bz H F F OH XXVI-42-8 Et * H * Bz H F F OH *RTand R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVII-43. X R' R 2
R
3 " R R 4 R' R 6 X Y XXVII-43-1 'Pr H H H Bz H F F OH XXVU-43-2 'Pr H H CH- 3 Bz H F F OH XXVII-43-3 'Pr H H CH(CH 3
)
2 Bz H F F OH XXVII-43-4 'Pr H H CH 2
CH(CH
3
)
2 Bz H F F OH XXVJ-43-5 'Pr H H CH 2 Ph Bz H F F OH XXVII-43-6 'Pr H H CH 2 -indol-3-yl Bz H F F OH XXVI-43-7 'Pr H H CH 2
CH
2
SCH
3 Bz H F F (AI XXVII-43-8 'Pr * H * Bz H F F OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XXVII-44. N2 R R2 R 3 a R) R' R' R' X Y XXVII-44-1 'Bu H H H Bz H F F OH XXVII-44-2 'Bu H H CH 3 Bz H F F OH XXVH.44-3 'Bu H H CH(CH 3
)
2 Bz H F F OH XXVII-44-4 'Bu H H CH 2
CH(CH
3
)
2 Bz H F F OH XXVII-44-5 'Bu H H CH 2 Ph Bz H F F OH XXVHI..44-6 'Bu H H CH 2 -indol-3-yl Bz H F F OH XXVII-44-7 'Bu H H CH 2
CH
2
SCH
3 Bz H F F OH XXVII-44-8 'Bu * H * Bz H F F OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXVII-45. N2 R R2 R 3 a R 3 b R 4 R' R 6 X Y XXVII-45-1 Ph H H H Bz H F F OH XXVI.45-2 Ph H H CH 3 Bz H F F OH XXVII-45-3 Ph H H CH(CH 3
)
2 Bz H F F OH XXVH-45-4 Ph H H CH 2
CH(CH
3
)
2 Bz H F F OH XXVII-45-5 Ph H H CH 2 Ph Bz H F F OH XXVII-45-6 Ph H H CH 2 -indol-3-yl Bz H F F OH XXVH-45-7 Ph H H CH 2
CH
2
SCH
3 Bz H F F OH XXVII-45-8 Ph * H * Bz H F F OH *R2 and RJb joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVII-46. X2 R2 Ra Rb R 4 R' R X Y XXVII-46-1 p-Me-Ph H H H Bz H F F OH XXVII-46-2 p-Me-Ph H H CH 3 Bz H F F OH XXVII-46-3 p-Me-Ph H H CH(CH 3
)
2 Bz H F F OH XXVII-46-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Bz H F F OH XXVII-46-5 p-Me-Ph H H CH 2 Ph Bz H F F OH XXVII-46-6 p-Me-Ph H H CH 2 -indol-3-yl Bz H F F OH XXVII-46-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Bz H F F OH XXVII-46-8 p-Me-Ph * H * Bz H F F OH *R and Rib joined together by (CH 2
)
3 to form five-membered ring.
Table XXVII-47. N R R 2
R
3 a R 3 b R 4 R' R' X Y XXVH-47-1 p-F-Ph H H H Bz H F F OH XXVH-47-2 p-F-Ph H H CH 3 Bz H F F OH XXVII-47-3 p-F-Ph H H CH(CH 3
)
2 Bz H F F OH XXVH-47-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Bz H F F OH XXVH-47-5 p-F-Ph H H CH 2 Ph Bz H F F OH XXVH-47-6 p-F-Ph H H CH 2 -indol-3-yl Bz H F F OH XXVH-47-7 p-F-Ph H H CH 2
CH
2
SCH
3 Bz H F F OH XXVII-47-8 p-F-Ph * H * Bz H F F OH * Wand R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXVII-48. N R! R2 R 3 a R 3 b R 4 R' R 6 X Y XXVII-48-1 p-Cl-Ph H H H Bz H F F OH XXVII-48-2 p-Cl-Ph H H CH 3 Bz H F F OH XXVII-48-3 p-Cl-Ph H H CH(CH 3
)
2 Bz H F F OH XXVH-48-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Bz H F F OH XXVH-48-5 p-Cl-Ph H H CH 2 Ph Bz H F F OH XXVH-48-6 p-Cl-Ph H H CH 2 -indol-3-yl Bz H F F OH XXVH-48-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Bz H F F OH XXVII-48-8 p-Cl-Ph * H * Bz H F F OH *RT and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVII-49. X2 R' R 2
R
3 a Rb R 4 R' R 6 X Y XXVII-49-1 p-Br-Ph H H H Bz H F F OH XXVII-49-2 p-Br-Ph H H CH 3 Bz H F F OH XXVII-49-3 p-Br-Ph H H CH(CH 3
)
2 Bz H F F OH XXVH-49-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Bz H F F OH XXVH-49-5 p-Br-Ph H H CH 2 Ph Bz H F F OH XXVII-49-6 p-Br-Ph H H CH 2 -indol-3-yl Bz H F F OH XXVI-49-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Bz H F F OH XXVII-49-8 p-Br-Ph * H * Bz H F F OH *R and Rb joined together by (CH 2
)
3 to form five-membered ring. r '"A Table XXVII-50. N R' R 2 RJa R 3 b R 4 R' R' X Y XXVII-50-1 p-I-Ph H H H Bz H F F OH XXVII-50-2 p-I-Ph H H CH 3 Bz H F F OH XXVH-50-3 p-I-Ph H H CH(CH 3
)
2 Bz H F F OH XXVH-50-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Bz H F F OH XXVH-50-5 p-I-Ph H H CH 2 Ph Bz H F F OH XXVII-50-6 p-I-Ph H H CH 2 -indol-3-yl Bz H F F OH XXVII-50-7 p-I-Ph H H CH 2
CH
2
SCH
3 Bz H F F OH XXVII-50-8 p-I-Ph * H * Bz H F F OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. R2 N N R3a O O NN N
CO
2
R
4 OR R 5 R6
NH
2 Y X 5 XXVIII Table XXVIII-1. N! R' R2 R 3 a Rb R 4
R
5
R
6 X Y XXVIII-1-1 CH 3 H H H CH 3 H H F OH XXVHI-1-2 CH 3 H H CH 3
CH
3 H H F OH XXVII-1-3 CH 3 H H CH(CH 3
)
2
CH
3 H H F OH XXVHI-1-4 CH 3 H H CH 2
CH(CH
3
)
2
CH
3 H H F OH XXVHI-1-5 CH 3 H H CH 2 Ph CH 3 H H F OH XXVIII-1-6 CH 3 H H CH 2 -indol-3-yl CH 3 H H F OH XXVIII-1-7 CH 3 H H CH 2
CH
2
SCH
3
CH
3 H H F OH XXVIII-1-8 CH 3 * H * CH 3 H H F OH *R7iaTnd R-b joined together by (CH 2
)
3 to form five-membered ring.
Table XXVIII-2. N2 RI R 2
R
3 a R 3 b R4 R' R' X Y XXVIHI-2-1 Et H H H CH 3 H H F OH XXVILI-2-2 Et H H CH 3
CH
3 H H F OH XXVIH-2-3 Et H H CH(CH 3
)
2
CH
3 H H F OH XXVIl-2-4 Et H H CH 2
CH(CH
3
)
2
CH
3 H H F OH XXVIII-2-5 Et H H CH 2 Ph CH 3 H H F OH XXVIJH-2-6 Et H H CH2-indol-3-yl CH 3 H H F OH XXVIII-2-7 Et H H CH 2
CH
2
SCH
3
CH
3 H H F OH XXVIII-2-8 Et * H * CH 3 H H F OH * R and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XXVIII-3. N2 R R2 Rja R b R' R' R' X Y XXVIII-3-1 'Pr H H H CH 3 H H F OH XXVII-3-2 'Pr H H CH 3
CH
3 H H F OH XXVHI-3-3 'Pr H H CH(CH 3
)
2
CH
3 H H F OH XXVIII-3-4 'Pr H H CH 2
CH(CH
3
)
2
CH
3 H H F OH XXVHI-3-5 'Pr H H CH 2 Ph CH 3 H H F OH XXVUI-3-6 'Pr H H CH 2 -indol-3-yl CH 3 H H F OH XXVIII-3-7 'Pr H H CH 2
CH
2
SCH
3
CH
3 H H F OH XXVHI-3-8 'Pr * H * CH 3 H H F OH
*R
2 and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVIII-4. X R' R 2
R
3 a R 3 b R 4 R' R' X Y XXVI-4-1 'Bu H H H CH 3 H H F OH XXVUI-4-2 'Bu H H CH 3
CH
3 H H F OH XXVUI-4-3 'Bu H H CH(CH 3
)
2
CH
3 H H F OH XXVHI-4-4 'Bu H H CH 2
CH(CH
3
)
2
CH
3 H H F OH XXVUI-4-5 'Bu H H CH 2 Ph CH 3 H H F OH XXVII-4-6 'Bu H H CH 2 -indol-3-yi CH 3 H H F OH XXVIII-4-7 'Bu H H CH 2
CH
2
SCH
3
CH
3 H H F OH XXVIII-4-8 'Bu * H * CH 3 H H F OH
*R
2 and Rib joined together by (CH2) 3 to form five-membered ring.
Table XXVIII-5. N2 RI R 2 Ra R 3 b R4 R 5 R X Y XXVIII-5-1 Ph H H H CH 3 H H F OH XXVM-5-2 Ph H H CH 3
CH
3 H H F OH XXVm-5-3 Ph H H CH(CH 3
)
2
CH
3 H H F OH XXVIn-5-4 Ph H H CH 2
CH(CH
3
)
2
CH
3 H H F OH XXVm-5-5 Ph H H CH 2 Ph CH 3 H H F OH XXVII-5-6 Ph H H CH 2 -indol-3-yl CH 3 H H F OH XXVm-5-7 Ph H H CHCH 2
SCH
3
CH
3 H H F OH XXVM-5-8 Ph * H * CH 3 H H F OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXVIII-6. N2 Rl R 2
R
3 a R 3 b R 4 R' R 6 X Y XXVIH-6-1 p-Me-Ph H H H CH 3 H H F OH XXVM-6-2 p-Me-Ph H H CH 3
CH
3 H H F OH XXVM-6-3 p-Me-Ph H H CH(CH 3
)
2
CH
3 H H F OH XXVII-6-4 p-Me-Ph H H CH 2
CH(CH
3
)
2
CH
3 H H F OH XXVIII-6-5 p-Me-Ph H H CH 2 Ph CH 3 H H F OH XXVUU-6-6 p-Me-Ph H H CH 2 -indol-3-yl CH 3 H H F OH XXVM-6-7 p-Me-Ph H H CH 2
CH
2
SCH
3
CH
3 H H F OH XXVII-6-8 p-Me-Ph * H * CH 3 H H F OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVIII-7. X2 Ri R 2
R
3 a R3b R' R 5
R
6 X Y XXVHI-7-1 p-F-Ph H H H CH 3 H H F OH XXVM-7-2 p-F-Ph H H CH 3
CH
3 H H F OH XXVM-7-3 p-F-Ph H H CH(CH 3
)
2
CH
3 H H F OH XXVUI-7-4 p-F-Ph H H CH 2
CH(CH
3
)
2
CH
3 H H F OH XXVIII-7-6 p-F-Ph H H CH 2 Ph CH 3 H H F OH XXVIH-7-7 p-F-Ph H H CH 2 -indol-3-yl CH 3 H H F OH XXVM-7-8 p-F-Ph H H CH 2
CH
2
SCH
3
CH
3 H H F OH XXVM-7-20 p-F-Ph * H * CH 3 H H F OH *R i and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XXVIII-8.
NRR
2 Ra Rab R' R' R' X Y XXVIII-8-1 p-Cl-Ph H H H CH 3 H H F OH XXVUI-8-2 p-Cl-Ph H H CH 3
CH
3 H H F OH XXVIII-8-3 p-Cl-Ph H H CH(CH 3
)
2
CH
3 H H F OH XXVUI-8-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2
CH
3 H H F OH XXVUI-8-5 p-Cl-Ph H H CH 2 Ph CH 3 H H F OH XXVIII-8-6 p-Cl-Ph H H CH 2 -indol-3-yl CH 3 H H F OH XXVUI-8-7 p-Cl-Ph H H CH 2
CH
2
SCH
3
CH
3 H H F OH XXVUI-8-8 p-Cl-Ph * H * CH 3 H H F OH
R
2 and Rb joined together by (CH 2
)
3 to form five-membered ring. Table XXVIII-9. N2 Rl R 2
R
3 a R 3 b R' R' R 6 X Y XXVUI-9-1 p-Br-Ph H H H CH 3 H H F OH XXVUI-9-2 p-Br-Ph H H CH 3
CH
3 H H F OH XXVUI-9-3 p-Br-Ph H H CH(CH 3
)
2
CH
3 H H F OH XXVHI-9-4 p-Br-Ph H H CH 2
CH(CH
3
)
2
CH
3 H H F OH XXVUI-9-6 p-Br-Ph H H CH2Ph CH 3 H H F OH XXVUI-9-7 p-Br-Ph H H CH 2 -indol-3-yl CH 3 H H F OH XXVII-9-8 p-Br-Ph H H CH 2
CH
2
SCH
3
CH
3 H H F OH XXVHI-9-20 p-Br-Ph * H * CH 3 H H F OH *Rand R.
3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVIII-10. N2 Rl R 2
R
3 a R-b R 4
R
5
R
6 X Y XXVHI-10-1 p-I-Ph H H H CH 3 H H F OH XXVUI-10-2 p-I-Ph H H CH 3
CH
3 H H F OH XXVHI-10-3 p-I-Ph H H CH(CH 3
)
2
CH
3 H H F OH XXVHI-10-4 p-I-Ph H H CH 2
CH(CH
3
)
2
CH
3 H H F OH XXVHI-10-5 p-I-Ph H H CH 2 Ph CH 3 H H F OH XXVHI-10-6 p-I-Ph H H CH2-indol-3-yl CH 3 H H F OH XXVUI-10-7 p-I-Ph H H CH 2
CH
2
SCH
3
CH
3 H H F OH XXVHI-10-8 p-I-Ph * H * CH 3 H H F OH *R and R3b joined together by (CH 2
)
3 to form five-membered ring. r7Q Table XXVIII-11. N R' R 2
R
3 a R 3 b R 4 R R X Y XXVII-11-1 CH 3 H H H Et H H F OH XXVIlI-11-2 CH 3 H H CH 3 Et H H F OH XXVIJI-11-3 CH 3 H H CH(CH 3
)
2 Et H H F OH XXVDI-11-4 CH 3 H H CH 2
CH(CH
3
)
2 Et H H F OH XXVIII-11-5 CH 3 H H CH 2 Ph Et H H F OH XXVIfl-11-6 CH 3 H H CH 2 -indol-3-yl Et H H F OH XXVIII-11-7 CH 3 H H CH 2
CH
2
SCH
3 Et H H F OH XXVII-11-8 CH 3 * H * Et H H F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXVIII-12. N2 RI R 2
R
3 aR Rb R 4 R XY XXVMI-12-1 Et H H H Et H H F OH XXVIJI-12-2 Et H H CI 3 Et H H F OH XXVIII-12-3 Et H H CHI(CH 3
)
2 Et H H F OH XXVDI-12-4 Et H H CH 2
CH(CH
3
)
2 Et H H F OH XXVIII-12-5 Et H H CH1 2 Ph Et H H F OH XXVIII-12-6 Et H H CH 2 -indol-3-yl Et H H F OH XXVM-12-7 Et H H CH 2
CH
2
SCH
3 Et H H F OH XXV-II-12-8 Et * H * Et H H F OH *R" and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVIII-13. XN R' R2 R 3 a R 3 b R 4 R' R 6 X Y XXVIII-13-1 'Pr H H H Et H H F OH XXVIII-13-2 'Pr H H CH 3 Et H H F OH XXVIII-13-3 'Pr H H CH(CH 3
)
2 Et H H F OH XXVIII-13-4 'Pr H H CH 2
CH(CH
3
)
2 Et H H F OH XXVIII-13-5 'Pr H H CH 2 Ph Et H H F OH XXVIII-13-6 'Pr H H CH 2 -indol-3-yl Et H H F OH XXVIII-13-7 'Pr H H CH 2
CH
2
SCH
3 Et H H F OH XXVIII-13-8 'Pr * H * Et H H F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XXVIII-14. N2 R' R 2 Ra Rb R 4 R' R 6 X Y XXVI-14-1 'Bu H H H Et H H F OH XXVHI-14-2 'Bu H H CH 3 Et H H F OH XXVIH-14-3 'Bu H H CH(CH 3
)
2 Et H H F OH XXVIM-14-4 'Bu H H CH 2
CH(CH
3
)
2 Et H H F OH XXVUI-14-5 'Bu H H CH 2 Ph Et H H F OH XXVI-14-6 'Bu H H CH 2 -indol-3-yl Et H H F OH XXVIII-14-7 'Bu H H CH 2
CH
2
SCH
3 Et H H F OH XXVHI-14-8 'Bu * H * Et H H F OH
*R
2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXVIII-15. X2 R' Ri R3a R3b R 4 R' R 6 X Y XXVIH-15-1 Ph H H H Et H H F OH XXVII-15-2 Ph H H CH 3 Et H H F OH XXVIII-15-3 Ph H H CH(CH 3
)
2 Et H H F OH XXVIH-15-4 Ph H H CH 2
CH(CH
3
)
2 Et H H F OH XXVIH-15-5 Ph H H CH 2 Ph Et H H F OH XXVI-15-6 Ph H H CH2-indol-3-yl Et H H F OH XXVII-15-7 Ph H H CH 2
CH
2
SCH
3 Et H H F OH XXVII-15-8 Ph * H * Et H H F OH *R7 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVIII-16. N2 R' R 2 R 3a R3b R 4 R 5 R 6 X Y XXVI-16-1 p-Me-Ph H H H Et H H F OH XXVIH-16-2 p-Me-Ph H H CH 3 Et H H F OH XXVI-16-3 p-Me-Ph H H CH(CH 3
)
2 Et H H F OH XXVIM-16-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Et H H F OH XXVIM-16-5 p-Me-Ph H H CH 2 Ph Et H H F OH XXVIH-16-6 p-Me-Ph H H CH2-indol-3-yl Et H H F OH XXVII-16-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Et H H F OH XXVI[-16-8 p-Me-Ph * H * Et H H F OH *RT and Rab joined together by (CH 2
)
3 to form five-membered ring. C"Ol Table XXVIII-17. N2 Rl R 2 R R 3 b R' R' R' X Y XXVI-17-1 p-F-Ph H H H Et H H F OH XXVIII-17-2 p-F-Ph H H CH 3 Et H H F OH XXVIII-17-3 p-F-Ph H H CH(CH 3
)
2 Et H H F OH XXVII-17-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Et H H F OH XXVIII-17-5 p-F-Ph H H CH 2 Ph Et H H F OH XXVIII-17-6 p-F-Ph H H CH 2 -indol-3-yl Et H H F OH XXVIII-17-7 p-F-Ph H H CH 2
CH
2
SCH
3 Et H H F OH XXVIH-17-8 p-F-Ph * H * Et H H F OH *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXVIII-18. N2 Rl R 2
R
3 a Rb R 4 R R 6 X Y XXVIII-18-1 p-Cl-Ph H H H Et H H F OH XXVHI-18-2 p-Cl-Ph H H CH 3 Et H H F OH XXVIII-18-3 p-Cl-Ph H H CH(CH 3
)
2 Et H H F OH XXVIII-18-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Et H H F OH XXVIII-18-5 p-Cl-Ph H H CH 2 Ph Et H H F OH XXVHI-18-6 p-Cl-Ph H H CH 2 -indol-3-yl Et H H F OH XXVII-18-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Et H H F OH XXVHI-18-8 p-Cl-Ph * H * Et H H F OH *RT and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVIII-19. N2 Rl R 2
R
3 a RA R 4 R' R 6 X Y XXVIII-19-1 p-Br-Ph H H H Et H H F OH XXVIII-19-2 p-Br-Ph H H CH 3 Et H H F OH XXVII-19-3 p-Br-Ph H H CH(CH 3
)
2 Et H H F OH XXVI[I-19-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Et H H F OH XXVIH-19-5 p-Br-Ph H H CH 2 Ph Et H H F OH XXVIm-19-6 p-Br-Ph H H CH 2 -indol-3-yl Et H H F OH XXVIH-19-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Et H H F OH XXVIM-19-8 p-Br-Ph * H * Et H H F OH *R2and R 3 b joined together by (CH 2
)
3 to form five-membered ring. C01 Table XXVIII-20. X R R 2
R
3 a R 3 b R 4 R' R 6 X Y XXVIII-20-1 p-I-Ph H H H Et H H F OH XXVIII-20-2 p-I-Ph H H CH 3 Et H H F OH XXVIII-20-3 p-I-Ph H H CH(CH 3
)
2 Et H H F OH XXVIII-20-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Et H H F OH XXVIII-20-5 p-I-Ph H H CH 2 Ph Et H H F OH XXVfI-20-6 p-I-Ph H H CH 2 -indol-3-yl Et H H F OH XXVJII-20-7 p-I-Ph H H CH 2
CH
2
SCH
3 Et H H F OH XXVfIl-20-8 p-I-Ph * H * Et H H F OH *RT and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXVIII-2 1. N2 R' R2 R 3 a R 3 b R4 R' R' X Y XXVII-21-1 CH 3 H H H 'Pr H H F OH XXVIJ[-21-2 CH 3 H H CH 3 'Pr H H F OH XXVIII-21-3 CH 3 H H CH(CH 3
)
2 'Pr H H F OH XXVIL-21-4 CH 3 H H CH 2
CH(CH
3
)
2 'Pr H H F OH XXVHI-21-5 CH 3 H H CH 2 Ph 'Pr H H F OH XXVUI-21-6 CH 3 H H CH 2 -indol-3-yl 'Pr H H F OH XXVIII-21-7 CH 3 H H CH 2
CH
2
SCH
3 'Pr H H F OH XXVIII-21-8 CH 3 * H * 'Pr H H F OH *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVIII-22. X2 RI R 2 R3a R 3 b R 4 R' R' X Y XXVIII-22-1 Et H H H 'Pr H H F OH XXVHI-22-2 Et H H CH1 3 'Pr H H F OH XXVHI-22-3 Et H H CH(CH 3
)
2 'Pr H H F OH XXVIII-22-4 Et H H CH 2
CH(CH
3
)
2 'Pr H H F OH XXVHI-22-5 Et H H CH 2 Ph 'Pr H H F OH XXVIII-22-6 Et H H CH 2 -indol-3-yl 'Pr H H F OH XXVIII-22-7 Et H H CH 2
CH
2
SCH
3 'Pr H H F OH XXVIII-22-8 Et * H * 'Pr H H F OH *RTand R 3 b joined together by (CH 2
)
3 to form five-membered ring. z ~Q I Table XXVIII-23. X2 R' R 2
R
3 a R 3 b R 4 R' R 6 X Y XXVII-23-1 'Pr H H H 'Pr H H F OH XXVII-23-2 'Pr H H CH 3 'Pr H H F OH XXVm-23-3 'Pr H H CH(CH 3
)
2 'Pr H H F OH XXVIII-23-4 'Pr H H CHI 2
CH(CH
3 )2 'Pr H H F OH XXVIII-23-5 'Pr H H CH 2 Ph 'Pr H H F OH XXVIII-23-6 'Pr H H CH 2 -indol-3-yl 'Pr H H F OH XXVII1-23-7 'Pr H H CH 2
CH
2
SCH
3 'Pr H H F OH XXVII[-23-8 'Pr * H * 'Pr H H F OH *R2 and R b joined together by (CH 2
)
3 to form five-membered ring. Table XXVIII-24. N2 R' R2 R 3 a R 3 b R 4 R' R' X Y XXVIII-24-1 'Bu H H H 'Pr H H F OH XXVIII-24-2 'Bu H H CH 3 'Pr H H F OH XXVII-24-3 'Bu H H CH(CH 3
)
2 'Pr H H F OH XXVIII-24-4 'Bu H H CH 2
CH(CH
3
)
2 'Pr H H F OH XXVIII-24-5 'Bu H H CH 2 Ph 'Pr H H F OH XXVH1-24-6 'Bu H H CH 2 -indol-3-yl 'Pr H H F OH XXVIII-24-7 'Bu H H CH 2
CH
2
SCH
3 'Pr H H F OH XXVIII-24-8 'Bu * H * 'Pr H H F OH *R2 and R"b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVIII-25. N2 R' R 2 Ra R 3 b R 4 R' R 6 X Y XXVJI[-25-1 Ph H H H 'Pr H H F OH XXVIII-25-2 Ph H H CH- 3 'Pr H H F OH XXVII[-25-3 Ph H H CH(CH 3
)
2 'Pr H H F OH XXVIm[-25-4 Ph H H CH 2
CH(CH
3
)
2 'Pr H H F OH XXVmI-25-5 Ph H H CH 2 Ph 'Pr H H F OH XXVIII-25-6 Ph H H CH 2 -indol-3-yl 'Pr H H F OH XXVIII-25-7 Ph H H CH12CH 2
SCH
3 'Pr H H F OH XXVIII-25-8 Ph * H * 'Pr H H F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XXVIII-26. N2 R R 2
R
3 a R 3 b R 4 R R 6 X Y XXVIII-26-1 p-Me-Ph H H H 'Pr H H F OH XXVIII-26-2 p-Me-Ph H H CH 3 'Pr H H F OH XXVIII-26-3 p-Me-Ph H H CH(CH 3
)
2 'Pr H H F OH XXVII-26-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 'Pr H H F OH XXVIII-26-5 p-Me-Ph H Hl CH 2 Ph 'Pr H H F OH XXVIII-26-6 p-Me-Ph H H CH 2 -indol-3-yl 'Pr H H F OH XXVHI-26-7 p-Me-Ph H H CH 2
CH
2
SCH
3 'Pr H H F OH XXVIII-26-8 p-Me-Ph * H * 'Pr H H F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXVIII-27. N2 R' R 2
R
3 a R 3 b R' R' R' X Y XXVIII-27-1 p-F-Ph H H H 'Pr H H F OH XXVIII-27-2 p-F-Ph H H CH 3 'Pr H H F OH XXVHI-27-3 p-F-Ph H H CH(CH 3
)
2 'Pr H H F OH XXVIII-27-4 p-F-Ph H H CH 2
CH(CH
3
)
2 'Pr H H F OH XXVIII-27-5 p-F-Ph H H CH 2 Ph 'Pr H H F OH XXVIII-27-6 p-F-Ph H H CH 2 -indol-3-yl 'Pr H H F OH XXVIII-27-7 p-F-Ph H H CH 2
CH
2
SCH
3 'Pr H H F OH XXVIII-27-8 p-F-Ph * H * 'Pr H H F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVIII-28. N! Rl R 2 R3a R 3 b R 4
R
5 R' X Y XXVIII-28-1 p-Cl-Ph H H H 'Pr H H F OH XXVIII-28-2 p-Cl-Ph H H CH 3 'Pr H H F OH XXVIII-28-3 p-Cl-Ph H H CH(CH 3
)
2 'Pr H H F OH XXVIII-28-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 'Pr H H F OH XXVIII-28-5 p-Cl-Ph H H CH 2 Ph 'Pr H H F OH XXVIII-28-6 p-Cl-Ph H H CH 2 -indol-3-yl 'Pr H H F OH XXVIII-28-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 'Pr H H F OH XXVIII-28-8 p-Cl-Ph * H * 'Pr H H F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. /- ~QA Table XXVIII-29. N2 R' R 2
R
3 a R 3
R
4 R R 6 X Y XXVIII-29-1 p-Br-Ph H H H Pr H H F OH XXVUI-29-2 p-Br-Ph H H CH 3 'Pr H H F OH XXVnI-29-3 p-Br-Ph H H CH(CH 3
)
2 'Pr H H F OH XXVUI-29-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 'Pr H H F OH XXVUI-29-5 p-Br-Ph H H CH 2 Ph 'Pr H H F OH XXVIUI-29-6 p-Br-Ph H H CH 2 -indol-3-yl 'Pr H H F OH XXVUI-29-7 p-Br-Ph H H CH 2
CH
2
SCH
3 'Pr H H F OH XXVI-29-8 p-Br-Ph * H * 'Pr H H F OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXVIII-30. N2 Rl R 2
R
3 a R 3 b R 4 R' R 6 X Y XXVHI-30-1 p-I-Ph H H H 'Pr H H F OH XXVHI-30-2 p-I-Ph H H CH 3 'Pr H H F OH XXVIII-30-3 p-I-Ph H H CH(CH 3
)
2 'Pr H H F OH XXVHI-30-4 p-I-Ph H H CH 2
CH(CH
3
)
2 'Pr H H F OH XXVHI-30-5 p-I-Ph H H CH 2 Ph 'Pr H H F OH XXVHI-30-6 p-I-Ph H H CH 2 -indol-3-yl 'Pr H H F OH XXVHI-30-7 p-I-Ph H H CH 2
CH
2
SCH
3 'Pr H H F OH XXVHI-30-8 p-I-Ph * H * 'Pr H H F OH Rand R"b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVIII-31. N2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y XXVIII-31-1 CH 3 H H H "Bu H H F OH XXVII[-31-2 CH 3 H H CH 3 "Bu H H F OH XXVIILI-31-3 CH 3 H H CH(CH 3
)
2 "Bu H H F OH XXVII-31-4 CH 3 H H CH 2
CH(CH
3
)
2 "Bu H H F OH XXVHI-31-5 CH 3 H H CH 2 Ph "Bu H H F OH XXVIU-31-6 CH 3 H H CH 2 -indol-3-yl "Bu H H F OH XXVHI-31-7 CH 3 H H CH 2
CH
2
SCH
3 "Bu H H F OH XXVIU-31-8 CH 3 * H * "Bu H H F OH
*R
2 and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XXVIII-32. N2 RI R 2 Ra Rb R 4 R R X Y XXVIII-32-1 Et H H H "Bu H H F OH XXVIII-32-2 Et H H CH 3 "Bu H H F OH XXVHI-32-3 Et H H CH(CH 3
)
2 "Bu H H F OH XXVIII-32-4 Et H H CH 2
CH(CH
3
)
2 "Bu H H F OH XXVIII-32-5 Et H H CH 2 Ph "Bu H H F OH XXVIII-32-6 Et H H CH 2 -indol-3-yl "Bu H H F OH XXVHI-32-7 Et H H CH 2
CH
2
SCH
3 "Bu H H F OH XXVIII-32-8 Et * H * Bu H H F OH *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XXVIII-33. N2 R' R2 R3a R'b R4 R' R' X Y XXVIII-33-1 'Pr H H H "Bu H H F OH XXVIII-33-2 'Pr H H CH 3 "Bu H H F OH XXVIII-33-3 'Pr H H CH(CH 3
)
2 "Bu H H F OH XXVIII-33-4 'Pr H H CH 2
CH(CH
3
)
2 "Bu H H F OH XXVII-33-5 'Pr H H CH 2 Ph "Bu H H F OH XXVII-33-6 'Pr H H CH 2 -indol-3-yl "Bu H H F OH XXVIII-33-7 'Pr H H CH 2
CH
2
SCH
3 "Bu H H F OH XXVIII-33-8 'Pr * H * "Bu H H F OH R and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVIII-34. N2 R' R 2 R3a R3b R4 R' R 6 X Y XXVII-34-1 'Bu H H H "Bu H H F OH XXVIII-34-2 'Bu H H CH 3 "Bu H H F OH XXVIII-34-3 'Bu H H CH(CH 3
)
2 "Bu H H F OH XXVIII-34-4 'Bu H H CH 2
CH(CH
3
)
2 "Bu H H F OH XXVHI-34-5 'Bu H H CH 2 Ph "Bu H H F OH XXVIII-34-6 'Bu H H CH 2 -indol-3-yl "Bu H H F OH XXVIII-34-7 'Bu H H CH 2
CH
2
SCH
3 "Bu H H F OH XXVIII-34-8 'Bu * H * "Bu H H F OH *RTand R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XXVIII-35. N2 RI R 2
R
3 a Rb R R R 6 X Y XXVIJI-35-1 Ph H H H "Bu H H F OH XXVII-35-2 Ph H H CH 3 "Bu H H F OH XXVIII-35-3 Ph H H CH(CH 3
)
2 "Bu H H F OH XXVII-35-4 Ph H H CH 2
CH(CH
3
)
2 "Bu H H F OH XXVIII-35-5 Ph H H CH 2 Ph "Bu H H F OH XXVItI-35-6 Ph H H CH 2 -indol-3-yl "Bu H H F OH XXVIII-35-7 Ph H H CH 2
CH
2
SCH
3 "Bu H H F OH XXVHI-35-8 Ph * H * "Bu H H F OH *R2 and R.
3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXVIII-36. N2 R R 2
R
3 a R 3 b R 4 R' R 6 X Y XXVIII-36-1 p-Me-Ph H H H "Bu H H F OH XXVHI-36-2 p-Me-Ph H H CH 3 "Bu H H F OH XXVHI-36-3 p-Me-Ph H H CH(CH 3
)
2 "Bu H H F OH XXVHI-36-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 "Bu H H F OH XXVHI-36-5 p-Me-Ph H H CH 2 Ph "Bu H H F OH XXVHI-36-6 p-Me-Ph H H CH 2 -indol-3-yl "Bu H H F OH XXVHI-36-7 p-Me-Ph H H CH 2
CH
2
SCH
3 "Bu H H F OH XXVIII-36-8 p-Me-Ph * H * "Bu H H F OH *Rand R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVIII-37. X2 Rl R 2
R
3 a R 3 b R' R' R 6 X Y XXVIUI-37-1 p-F-Ph H H H "Bu H H F OH XXVIJI-37-2 p-F-Ph H H CH 3 "Bu H H F OH XXVIII-37-3 p-F-Ph H H CH(CH 3
)
2 "Bu H H F OH XXVUI-37-4 p-F-Ph H H CH 2
CH(CH
3
)
2 "Bu H H F OH XXVIII-37-5 p-F-Ph H H CH 2 Ph "Bu H H F OH XXVIII-37-6 p-F-Ph H H CH 2 -indol-3-yl "Bu H H F OH XXVIII-37-7 p-F-Ph H H CH 2
CH
2
SCH
3 "Bu H H F OH XXVIII-37-8 p-F-Ph * H * "Bu H H F OH *RT and Rib joined together by (CH 2
)
3 to form five-membered ring. CQ-7 Table XXVIII-38. N2 Rl R 2
R
3 a R3b R 4 R R X Y XXVII-38-1 p-Cl-Ph H H H "Bu H H F OH XXVIII-38-2 p-Cl-Ph H H CH 3 "Bu H H F OH XXVIII-38-3 p-Cl-Ph H H CH(CH 3
)
2 "Bu H H F OH XXVHI-38-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 "Bu H H F OH XXVHI-38-5 p-Cl-Ph H H CH 2 Ph "Bu H H F OH XXVIII-38-6 p-Cl-Ph H H CH 2 -indol-3-yl "Bu H H F OH XXVIII-38-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 "Bu H H F OH XXVHI-38-8 p-Cl-Ph * H * "Bu H H F OH *R2 and R b joined together by (CH 2
)
3 to form five-membered, ring. Table XXVIII-39. N2 Rl R 2
R
3 a R 3 b R 4 R' R 6 X Y XXVIII-39-1 p-Br-Ph H H H "Bu H H F OH XXVIII-39-2 p-Br-Ph H H CH 3 'Bu H H F OH XXVIII-39-3 p-Br-Ph H H CH(CH 3
)
2 "Bu H H F OH XXVII-39-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 "Bu H H F OH XXVUI-39-5 p-Br-Ph H H CH 2 Ph "Bu H H F OH XXVII-39-6 p-Br-Ph H H CH 2 -indol-3-yl "Bu H H F OH XXVII-39-7 p-Br-Ph H H CH 2 Ci 2
SCH
3 Bu H H F OH XXVIII-39-8 p-Br-Ph H H C H 3 Bu H H F OH RTand Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVIII-40. N2 Rl R 2 Ra R 3 b R 4 R' R' X Y XXVIJI-40-1 p-I-Ph H H H "Bu H H F OH XXVUI-40-2 p-I-Ph H H CH 3 "Bu H H F OH XXVUI-40-3 p-I-Ph H H CH(CH 3
)
2 "Bu H H F OH XXVI-40-4 p-I-Ph H H CH 2
CH(CH
3
)
2 "Bu H H F OH XXVIJI-40-5 p-I-Ph H H CH 2 Ph "Bu H H F OH XXVLII-40-6 p-I-Ph H H CH 2 -indol-3-y "Bu H H F OH XXVDI-40-7 p-I-Ph H H CH 2
CH
2
SCH
3 "Bu H H F OH XXVDII-40-8 p-I-Ph * H CH "Bu H H F OH *R2 and R-b joined together by (CH 2
)
3 to form five-membered ring. Q Q Table XXVIII-41. N R' R 2 Ra Rab R 4 R' R 6 X Y XXVIII-41-1 CH 3 H H H Bz H H F OH XXVIll-41-2 CH 3 H H CH 3 Bz H H F OH XXVIII-41-3 CH 3 H H CH(CH 3
)
2 Bz H H F OH XXVIll-41-4 CH 3 H H CH 2
CH(CH
3
)
2 Bz H H F OH XXVII-41-5 CH 3 H H CH 2 Ph Bz H H F OH XXVI]I-41-6 CH 3 H H CH 2 -indol-3-yl Bz H H F OH XXVIII-41-7 CH 3 H H CH 2
CH
2
SCH
3 Bz H H F OH XXVIII-41-8 CH 3 * H * Bz H H F OH *Rl and R joined together by (CH 2
)
3 to form five-membered ring. Table XXVIII-42. SRI R 2
R
3 a Rb R' R R 6 X Y XXVIII-42-1 Et H H H Bz H H F OH XXVII-42-2 Et H H CH 3 Bz H H F OH XXVIII-42-3 Et H H CH(CH 3
)
2 Bz H H F OH XXVHI-42-4 Et H H CH 2
CH(CH
3
)
2 Bz H H F OH XXVHI-42-5 Et H H CH 2 Ph Bz H H F OH XXVHII-42-6 Et H H CH 2 -indol-3-yl Bz H H F OH XXVIII-42-7 Et H H CH 2
CH
2
SCH
3 Bz H H F OH XXVHI-42-8 Et * H * Bz H H F OH *Rl and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVIII-43. X2 R' R2 Ra R b R 4 R' R 6 X Y XXVIII-43-1 'Pr H H H Bz H H F OH XXVIII-43-2 'Pr H H CH 3 Bz H H F OH XXVIII-43-3 'Pr H H CH(CH 3
)
2 Bz H H F OH XXVHI-43-4 'Pr H H CH 2
CH(CH
3
)
2 Bz H H F OH XXVIII-43-5 'Pr H H CH 2 Ph Bz H H F OH XXVIII-43-6 'Pr H H CH 2 -indol-3-yl Bz H H F OH XXVIII-43-7 'Pr H H CH 2
CH
2
SCH
3 Bz H H F dAI XXVIII-43-8 'Pr * H * Bz H H F OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
IZQO
Table XXVIII-44. N2 R R 2 R.a RIb R 4 R' R' X Y XXVIII-44-1 'Bu H H H Bz H H F OH XXVIII-44-2 'Bu H H CH 3 Bz H H F OH XXVIII-44-3 'Bu H H CH(CH 3
)
2 Bz H H F OH XXVIII-44-4 'Bu H H CH 2
CH(CH
3
)
2 Bz H H F OH XXVIH-44-5 'Bu H H CH 2 Ph Bz H H F OH XXVII-44-6 'Bu H H CH 2 -indol-3-yl Bz H H F OH XXVIH-44-7 'Bu H H CH 2
CH
2
SCH
3 Bz H H F OH XXVIII-44-8 'Bu * H * Bz H H F OH
*R
2 and R joined together by (CH 2
)
3 to form five-membered ring. Table XXVIII-45. N2 RI R 2
R
3 a R3b R 4 R' R 6 X Y XXVIII-45-1 Ph H H H Bz H H F OH XXVIII-45-2 Ph H H CH 3 Bz H H F OH XXVIII-45-3 Ph H H CH(CH 3
)
2 Bz H H F OH XXVHI-45-4 Ph H H CH 2
CH(CH
3
)
2 Bz H H F OH XXVHI-45-5 Ph H H CH 2 Ph Bz H H F OH XXVHI-45-6 Ph H H CH 2 -indol-3-yl Bz H H F OH XXVII-45-7 Ph H H CH 2
CH
2
SCH
3 Bz H H F OH XXVUI-45-8 Ph * H * Bz H H F OH *R7 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVIII-46. N2 R' R 2
R
3 a R 3 b R 4 R' R 6 X Y XXVIi-46-1 p-Me-Ph H H H Bz H H F OH XXVII-46-2 p-Me-Ph H H CH 3 Bz H H F OH XXVIH-46-3 p-Me-Ph H H4 CH(CH 3
)
2 Bz H H F OH XXVIH-46-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Bz H H F OH XXVII-46-5 p-Me-Ph H H CH 2 Ph Bz H H F OH XXVII-46-6 p-Me-Ph H H CH 2 -indol-3-yl Bz H H F OH XXVM-46-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Bz H H F OH XXVIII-46-8 p-Me-Ph * H * Bz H H F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. IcnA Table XXVIII-47. X2 R R2 R 3 a R 3 b R4 R' R' X Y XXVII-47-1 p-F-Ph H H H Bz H H F OH XXVIII-47-2 p-F-Ph H H CH 3 Bz H H F OH XXVIJI-47-3 p-F-Ph H H CH(CH 3
)
2 Bz H H F OH XXVIII-47-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Bz H H F OH XXVII-47-5 p-F-Ph H H CH 2 Ph Bz H H F OH XXVII-47-6 p-F-Ph H H CH 2 -indol-3-yl Bz H H F OH XXVII-47-7 p-F-Ph H H CH 2
CH
2
SCH
3 Bz H H F OH XXVIII-47-8 p-F-Ph * H * Bz H H F OH *R and Rob joined together by (CH 2
)
3 to form five-membered ring. Table XXVIII-48. N2 Rl R 2 Ra R 3 b R 4 R' R 6 X Y XXVIII-48-1 p-Cl-Ph H H H Bz H H F OH XXVIII-48-2 p-Cl-Ph H H CH 3 Bz H H F OH XXVIII-48-3 p-Cl-Ph H H CH(CH 3
)
2 Bz H H F OH XXVII-48-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Bz H H F OH XXVIII-48-5 p-Cl-Ph H H CH 2 Ph Bz H H F OH XXVIII-48-6 p-Cl-Ph H H CH 2 -indol-3-yl Bz H H F OH XXVIII-48-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Bz H H F OH XXVIII-48-8 p-Cl-Ph * H * Bz H H F OH *Rand R b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXVIII-49. N2 Rl R 2
R
3 a R 3 b R 4
R
3
R
6 X Y XXVI]I-49-1 p-Br-Ph H H H Bz H H F OH XXVII-49-2 p-Br-Ph H H CH 3 Bz H H F OH XXVIII-49-3 p-Br-Ph H H CH(CH 3
)
2 Bz H H F OH XXVIII-49-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Bz H H F OH XXVIII-49-5 p-Br-Ph H H CH 2 Ph Bz H H F OH XXVIII-49-6 p-Br-Ph H H CH 2 -indol-3-yl Bz H H F OH XXVUI-49-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Bz H H F OH XXVIII-49-8 p-Br-Ph * H * Bz H H F OH *R2 and Rab joined together by (CH 2
)
3 to form five-membered ring. CZ(1 Table XXVIII-50. N2 Rl R 2
R
3 a R 3 b R 4 R' R' X Y XXVI-50-1 p-I-Ph H H H Bz H H F OH XXVIII-50-2 p-I-Ph H H CH 3 Bz H H F OH XXVIII-50-3 p-I-Ph H H CH(CH 3
)
2 Bz H H F OH XXVIU-50-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Bz H H F OH XXVIU-50-5 p-I-Ph H H CH 2 Ph Bz H H F OH XXVIU-50-6 p-I-Ph H H CH 2 -indol-3-yl Bz H H F OH XXVHI-50-7 p-I-Ph H H CH 2
CH
2
SCH
3 Bz H H F OH XXVII-50-8 p-I-Ph * H * Bz H H F OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 0 N R--b R2 / NH R 3a 0 - O NN C0 2
R
4
OR
1 R5 R6
NH
2 Y X XXIX 5 Table XXIX-1. X2 R' R2 R 3 a R 3 b R' R' R 6 X Y XXIX-1-1 CH 3 H H H CH 3 H CH 3 F OH XXIX-1-2 CH 3 H H CH 3
CH
3 H CH 3 F OH XXIX-1-3 CH 3 H H CH(CH 3
)
2
CH
3 H CH 3 F OH XXIX-1-4 CH 3 H H CHCH(CH 3
)
2
CH
3 H CH 3 F OH XXIX-1-5 CH 3 H H CHPh CH 3 H CH 3 F OH XXIX-1-6 CH 3 H H CH 2 -indol-3-yl CH 3 H CH 3 F OH XXIX-1-7 CH 3 H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH XXIX-1-8 CH 3 * H * CH 3 H CH 3 F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XXIX-2. X RI R 2
R
3 a R 3 b R' R' R 6 X Y XXIX-2-1 Et H H H CH 3 H CH 3 F OH XXIX-2-2 Et H H CH 3
CH
3 H CH 3 F OH XXIX-2-3 Et H H CH(CH 3
)
2
CH
3 H CH 3 F OH XXIX-2-4 Et H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH XXIX-2-5 Et H H CH 2 Ph CH 3 H CH 3 F OH XXIX-2-6 Et H H CH 2 -indol-3-yl CH 3 H CH 3 F OH XXIX-2-7 Et H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH XXIX-2-8 Et * H * CH 3 H CH 3 F OH *Rand R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXIX-3. X2 R' R2 R 3 a R 3 b R 4 R R 6 X Y XXIX-3-1 'Pr H H H CH 3 H CH 3 F OH XXIX-3-2 'Pr H H CH 3
CH
3 H CH 3 F OH XXIX-3-3 'Pr H H CH(CH 3
)
2
CH
3 H CH 3 F OH XXIX-3-4 'Pr H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH XXIX-3-5 'Pr H H CH 2 Ph CH 3 H CH 3 F OH XXIX-3-6 'Pr H H CH 2 -indol-3-yl CH 3 H CH 3 F OH XXIX--3-7 'Pr H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH XXIX--3-8 'Pr * H * CH 3 H CH 3 F OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXIX-4. X2 R' R2 Ra Rl R' R' R 6 X Y XXIX.-4-1 'Bu H H H CH 3 H CH 3 F OH XXIX-4-2 'Bu H H CH 3
CH
3 H CH 3 F OH XXIX-4-3 'Bu H H CH(CH 3
)
2
CH
3 H CH 3 F OH XXIX-4-4 'Bu H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH XXIX-4-5 'Bu H H CH 2 Ph CH 3 H CH 3 F OH XXIX-4-6 'Bu H H CHr 2 -indol-3-yl CH 3 H CH 3 F OH XXIX-4-7 'Bu H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH XXIX-4-8 'Bu * H * CH 3 H CH 3 F OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XXIX-5. X2 RI R 2
R
3 a R 3 b R 4 R' R 6 X Y XXIX-5-1 Ph H H H CH 3 H CH 3 F OH XXIX-5-2 Ph H H CH 3
CH
3 H CH 3 F OH XXIX-5-3 Ph H H CH(CH 3
)
2
CH
3 H CH 3 F OH XXIX-5-4 Ph H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH XXIX-5-5 Ph H H CH 2 Ph CH 3 H CH 3 F OH XXIX-5-6 Ph H H CH 2 -indol-3-yl CH 3 H CH 3 F OH XXIX-5-7 Ph H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH XXIX-5-8 Ph * H * CH 3 H CH 3 F OH
*R
2 and R b joined together by (CH 2
)
3 to form five-membered ring. Table XXIX-6. N R! R R 3 a R 3 b R 4
R
5
R
6 X Y XXIX-6-1 p-Me-Ph H H H CH 3 H CH 3 F OH XXIX-6-2 p-Me-Ph H H CH 3
CH
3 H CH 3 F OH XXIX-6-3 p-Me-Ph H H CH(CH 3
)
2
CH
3 H CH 3 F OH XXIX-6-4 p-Me-Ph H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH XXIX-6-5 p-Me-Ph H H CH 2 Ph CH 3 H CH 3 F OH XXIX--6-6 p-Me-Ph H H CH 2 -indol-3-yl CH 3 H CH 3 F OH XXIX-6-7 p-Me-Ph H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH XXIX-6-8 p-Me-Ph * H * CH 3 H CH 3 F OH *RT and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXIX-7. N2 Rl R 2
R
3 a Rab R' R' R' X Y XXIX--7-1 p-F-Ph H H H CH 3 H CH 3 F OH XXIX-7-2 p-F-Ph H H CH 3
CH
3 H CH 3 F OH XXIX--7-3 p-F-Ph H H CH(CH 3
)
2
CH
3 H CH 3 F OH XXIX-7-4 p-F-Ph H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH XXIX-7-6 p-F-Ph H H CH 2 Ph CH 3 H CH 3 F OH XXIX--7-7 p-F-Ph H H CH 2 -indol-3-yl CH 3 H CH 3 F OH XXIX-7-8 p-F-Ph H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH XXIX-7-20 p-F-Ph * H * CH 3 H CH 3 F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
A
Table XXIX-8. X2 Rl R 2
R
3 a R 3 b R - R' R' X Y XXIX-8-1 p-Cl-Ph H H H CH 3 H CH 3 F OH XXIX-8-2 p-Cl-Ph H H CH 3
CH
3 H CH 3 F OH XXIX-8-3 p-Cl-Ph H H CH(CH 3
)
2
CH
3 H CH 3 F OH XXIX-8-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH XXIX-8-5 p-Cl-Ph H H CH 2 Ph CH 3 H CH 3 F OH XXIX-8-6 p-Cl-Ph H H CH 2 -indol-3-yl CH 3 H CH 3 F OH XXIX-8-7 p-Cl-Ph H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH XXIX-8-8 p-Cl-Ph * H * CH 3 H CH 3 F OH *R' and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXIX-9. X2 Rl R 2
R
3 a R 3 b R 4 R' R' X Y XXIX-9-1 p-Br-Ph H H H CH 3 H CH 3 F OH XXIX-9-2 p-Br-Ph H H CH 3
CH
3 H CH 3 F OH XXIX-9-3 p-Br-Ph H H CH(CH 3
)
2
CH
3 H CH 3 F OH XXIX-9-4 p-Br-Ph H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH XXIX-9-6 p-Br-Ph H H CH 2 Ph CH 3 H CH 3 F OH XXIX-9-7 p-Br-Ph H H CH 2 -indol-3-yl CH 3 H CH 3 F OH XXIX-9-8 p-Br-Ph H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH XXIX-9-20 p-Br-Ph * H * CH 3 H CH 3 F OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXIX-10. N! R R 2
R
3 a R 3 b R 4 R' R 6 X Y XXIX-10-1 p-I-Ph H H H CH 3 H CH 3 F OH XXIX-10-2 p-I-Ph H H CH 3
CH
3 H CH 3 F OH XXIX-10-3 p-I-Ph H H CH(CH 3
)
2
CH
3 H CH 3 F OH XXIX-10-4 p-I-Ph H H CH 2
CH(CH
3
)
2
CH
3 H CH 3 F OH XXIX-10-5 p-I-Ph H H CH 2 Ph CH 3 H CH 3 F OH XXIX-10-6 p-I-Ph H H CH 2 -indol-3-yl CH 3 H CH 3 F OH XXIX-10-7 p-I-Ph H H CH 2
CH
2
SCH
3
CH
3 H CH 3 F OH XXIX-10-8 p-I-Ph * H * CH 3 H CH 3 F OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XXIX- 11. X2 R' R2 R 3 a R 3 b R 4 R' R' X Y XXIX-11-1 CH 3 H H H Et H CH 3 F OH XXIX-11-2 CH 3 H H CH 3 Et H CH 3 F 0H XXIX-11-3 CH 3 H H CH(CH 3
)
2 Et H CH 3 F OH XXIX-11-4 CH 3 H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH XXIX-11-5 CH 3 H H CH 2 Ph Et H CH 3 F OH XXIX-11-6 CH 3 H H CH 2 -indol-3-yl Et H CH 3 F OH XXIX-11-7 CH 3 H H CH 2
CH
2
SCH
3 Et H CH 3 F OH XXIX-11-8 CH 3 * H * Et H CH 3 F OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXIX-12. N2 R' R 2
R
3 a R 3 b R 4 R 5
R
6 X Y XXIX-12-1 Et H H H Et H CH 3 F OH XXIX-.12-2 Et H H CH 3 Et H CH 3 F OH XXIX--12-3 Et H H CH(CH 3
)
2 Et H CH 3 F OH XXIX-12-4 Et H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH XXIX-12-5 Et H H CH 2 Ph Et H CH 3 F OH XXIX-12-6 Et H H CH 2 -indol-3-yl Et H CH 3 F OH XXIX-12-7 Et H H CH 2
CH
2
SCH
3 Et H CH 3 F OH XXIX-12-8 Et * H * Et H CH 3 F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXIX-13. N2 RI R 2
R
3 a R 3 b R' R' R' X Y XXIX-13-1 'Pr H H H Et H CH 3 F OH XXIX-13-2 'Pr H H CH 3 Et H CH 3 F OH XXIX-13-3 'Pr H H CH(CH 3
)
2 Et H CH 3 F OH XXIX-13-4 'Pr H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH XXIX-.13-5 'Pr H H CH 2 Ph Et H CH 3 F OH XXIX..13-6 'Pr H H CH 2 -indol-3-yl Et H CH 3 F OH XXIX..13-7 'Pr H H CH 2
CH
2
SCH
3 Et H CH 3 F OH XXIX-13-8 'Pr * H * Et H CH 3 F OH *R and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XXIX-14. X2 R' R 2
R
3 a R 3 b R4 R5 R 6 X y XXIX-14-1 'Bu H H H Et H CH 3 F OH XXIX-14-2 'Bu H H CH 3 Et H CH 3 F OH XXIX-14-3 'Bu H H CH(CH 3
)
2 Et H CH 3 F OH XXIX-14-4 'Bu H H CH 2
CH(CH
3 ) Et H CH 3 F OH 2 XXIX-14-5 'Bu H H CH 2 Ph Et H CH 3 F OH XXIX-14-6 'Bu H H CH 2 -indol-3- Et H CH 3 F OH yI XXIX--14-7 'Bu H H CH 2
CH
2 SCH Et H CH 3 F OH 3 XXIX-14-8 'Bu * H * Et H CH 3 F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXIX-15. X2 R R 2 Ra Rb R 4 R' R' X Y XXIX-15-1 Ph H H H Et H CH 3 F OH XXIX-15-2 Ph H H CH 3 Et H CH 3 F OH XXIX-15-3 Ph H H CH(CH 3
)
2 Et H CH 3 F OH XXIX-15-4 Ph H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH XXIX-15-5 Ph H H CH 2 Ph Et H CH 3 F OH XXIX-15-6 Ph H H CH 2 -indol-3-yl Et H CH 3 F OH XXIX-15-7 Ph H H CH 2
CH
2
SCH
3 Et H CH 3 F OH XXIX-15-8 Ph * H * Et H CH 3 F OH *RTand R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXIX-16. N2 R R2 Ra R3b R4 R 5 R X Y XXIX-16-1 p-Me-Ph H H H Et H CH 3 F OH XXIX-16-2 p-Me-Ph H H CH 3 Et H CH 3 F OH XXIX-16-3 p-Me-Ph H H CH(CH 3
)
2 Et H CH 3 F OH XXIX-16-4 p-Me-Ph H H CH2CH(CH 3 )2 Et H CH 3 F OH XXIX-16-5 p-Me-Ph H H CH 2 Ph Et H CH 3 F OH XXIX-16-6 p-Me-Ph H H CH 2 -indol-3-yl Et H CH 3 F OH XXLX-16-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Et H CH 3 F OH XXLX-16-8 p-Me-Ph * H * Et H CH 3 F OH *R and R 3 6 joined together by (CH 2
)
3 to form five-membered ring. , o'7 Table XXIX-17. N2 Rl R 2
R
3 a R 3 b R 4 R' R' X Y XXIX-17-1 p-F-Ph H H H Et H CH 3 F OH XXIX-17-2 p-F-Ph H H CH 3 Et H CH 3 F OH XXIX-17-3 p-F-Ph H H CH(CH 3
)
2 Et H CH 3 F OH XXIX-17-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH XXIX-17-5 p-F-Ph H H CH 2 Ph Et H CH 3 F OH XXIX-17-6 p-F-Ph H H CH 2 -indol-3-yl Et H CH 3 F OH XXIX-17-7 p-F-Ph H H CH 2
CH
2
SCH
3 Et H CH 3 F OH XXIX-17-8 p-F-Ph * H * Et H CH 3 F OH *RT and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXIX-18. N R R 2
R
3 a Rb R 4 R' R 6 X y XXIX-18-1 p-Cl-Ph H H H Et H CH 3 F OH XXIX-18-2 p-Cl-Ph H H CH 3 Et H CH 3 F OH XXIX-18-3 p-Cl-Ph H H CH(CH 3
)
2 Et H CH 3 F OH XXIX-18-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH XXIX-18-5 p-Cl-Ph H H CH 2 Ph Et H CH 3 F OH XXIX-18-6 p-Cl-Ph H H CH 2 -indol-3-yl Et H CH 3 F OH XXIX-18-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Et H CH 3 F OH XXIX-18-8 p-Cl-Ph * H * Et H CH 3 F OH *R2 and R b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXIX-19. X2 R R 2
R
3 a R 3 b R 4 R' R 6 X Y XXIX-19-1 p-Br-Ph H H H Et H CH 3 F OH XXIX-19-2 p-Br-Ph H H CH 3 Et H CH 3 F OH XXIX-19-3 p-Br-Ph H H CH(CH 3
)
2 Et H CH 3 F OH XXIX-19-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH XXIX-19-5 p-Br-Ph H H CH 2 Ph Et H CH 3 F OH XXIX-19-6 p-Br-Ph H H CH 2 -indol-3-yl Et H CH 3 F OH XXIX-19-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Et H CH 3 F OH XXIX-19-8 p-Br-Ph * H * Et H CH 3 F OH *R and RJb joined together by (CH 2
)
3 to form five-membered ring. oQQ Table XXIX-20. SR R 2
R
3 a R R 4 R R X Y XXIX-20-1 p-I-Ph H H H Et H CH 3 F OH XXIX-20-2 p-I-Ph H H CH 3 Et H CH 3 F OH XXIX-20-3 p-I-Ph H H CH(CH 3
)
2 Et H CH 3 F OH XXIX-20-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Et H CH 3 F OH XXIX-20-5 p-I-Ph H H CH 2 Ph Et H CH 3 F OH XXIX-20-6 p-I-Ph H H CH 2 -indol-3-yl Et H CH 3 F OH XXIX-20-7 p-I-Ph H H CH 2
CH
2
SCH
3 Et H CH 3 F OH XXIX-20-8 p-I-Ph * H * Et H CH 3 F OH *R an d R b joined together by (CH 2
)
3 to form five-membered ring. Table XXIX-2 1. X2 R' R2 R 3 a Rb R4 R 5
R
6 X Y XXIX-21-1 CH 3 H H H 'Pr H CH 3 F OH XXIX-21-2 CH 3 H H CH 3 'Pr H CH 3 F OH XXIX-21-3 CH 3 H H CH(CH 3
)
2 'Pr H CH 3 F OH XXIX-21-4 CH 3 H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH XXIX-21-5 CH 3 H H CH 2 Ph 'Pr H CH 3 F OH XXIX-21-6 CH 3 H H CH 2 -indol-3-yl 'Pr H CH 3 F OH XXIX-21-7 CH 3 H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH XXIX-21-8 CH 3 * H * 'Pr H CH 3 F OH *R aid R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXIX-22. X2 R R 2
R
3 a R 3 b R' R 5 R' X Y XXIX-22-1 Et H H H 'Pr H CH 3 F OH XXIX-22-2 Et H H CH 3 'Pr H CH 3 F OH XXIX-22-3 Et H H CH(CH 3
)
2 'Pr H CH 3 F OH XXIX-22-4 Et H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH XXIX-22-5 Et H H CH 2 Ph 'Pr H CH 3 F OH XXIX-22-6 Et H H CH 2 -indol-3-yl 'Pr H CH 3 F OH XXIX-22-7 Et H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH XXIX-22-8 Et * H * 'Pr H CH 3 F OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. ~C~n Table XXIX-23. N2 R R 2
R
3 a Rb R' R' R' X Y XXIX-23-1 'Pr H H H 'Pr H CH 3 F OH XXIX-23-2 'Pr H H CH 3 'Pr H CH 3 F OH XXIX-23-3 'Pr H H CH(CH 3
)
2 'Pr H CH 3 F OH XXIX-23-4 'Pr H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH XXIX-23-5 Pr H H CH 2 Ph 'Pr H CH 3 F OH XXIX-23-6 'Pr H H CH 2 -indol-3-yl 'Pr H CH 3 F OH XXIX-23-7 'Pr H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH XXIX-23-8 'Pr * H * 'Pr H CH 3 F OH
*R
2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXIX-24. N2 R R2 R 3 a Rb R' R' R 6 X Y XXIX-24-1 'Bu H H H 'Pr H CH 3 F OH XXIX-24-2 'Bu H H CH 3 'Pr H CH 3 F OH XXIX-24-3 'Bu H H CH(CH 3
)
2 'Pr H CH 3 F OH XXIX-24-4 'Bu H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH XXIX-24-5 'Bu H H CH 2 Ph 'Pr H CH 3 F OH XXIX-24-6 'Bu H H CH 2 -indol-3-yl 'Pr H CH 3 F OH XXIX-24-7 'Bu H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH XXIX-24-8 'Bu * H * 'Pr H CH 3 F OH *Ri and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXIX-25. N2 RI R 2
R
3 a Rb R4 R 5
R
6 X Y XXIX-25-1 Ph H H H 'Pr H CH 3 F OH XXIX-25-2 Ph H H CH 3 'Pr H CH 3 F OH XXIX-25-3 Ph H H CH(CH 3
)
2 'Pr H CH 3 F OH XXIX-25-4 Ph H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH XXIX-25-5 Ph H H CH 2 Ph 'Pr H CH 3 F OH XXIX-25-6 Ph H H CH 2 -indol-3-yl 'Pr H CH 3 F OH XXIX-25-7 Ph H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH XXIX-25-8 Ph * H * 'Pr H CH 3 F OH *RTand Rib joined together by (CH2) 3 to form five-membered ring.
Table XXIX-26. X2 R 2
R
3 a R 3 b Ra R' R 6 X Y XXIX-26-1 p-Me-Ph H H H Pr H CH 3 F OH XXIX-26-2 p-Me-Ph H H CH 3 'Pr H CH 3 F OH XXIX-26-3 p-Me-Ph H H CH(CH 3
)
2 'Pr H CH 3 F OH XXIX-26-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH XXIX-26-5 p-Me-Ph H H CH 2 Ph 'Pr H CH 3 F OH XXIX-26-6 p-Me-Ph H H CH 2 -indol-3-yl 'Pr H CH 3 F OH XXIX-26-7 p-Me-Ph H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH XXIX-26-8 p-Me-Ph * H * 'Pr H CH 3 F OH *Rand R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXIX-27. X2 Rl R 2
R
3 a R 3 b R 4
R
5
R
6 X Y XXIX-27-1 p-F-Ph H H H 'Pr H CH 3 F OH XXIX-27-2 p-F-Ph H H CH 3 'Pr H CH 3 F OH XXIX-27-3 p-F-Ph H H CH(CH 3
)
2 'Pr H CH 3 F OH XXIX-27-4 p-F-Ph H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH XXIX-27-5 p-F-Ph H H CH 2 Ph 'Pr H CH 3 F OH XXIX-27-6 p-F-Ph H H CH 2 -indol-3-yl 'Pr H CH 3 F OH XXIX-27-7 p-F-Ph H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH XXIX-27-8 p-F-Ph * H * 'Pr H CH 3 F OH
*R
2 and Rlb joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXIX-28. N2 Rl R 2
R
3 a R 3 b R4 R 5 R X Y XXIX-28-1 p-Cl-Ph H H H 'Pr H CH 3 F OH XXIX.-28-2 p-Cl-Ph H H CH 3 'Pr H CH 3 F OH XXIX-28-3 p-Cl-Ph H H CH(CH 3
)
2 'Pr H CH 3 F OH XXIX-28-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH XXIX-28-5 p-Cl-Ph H H CH 2 Ph 'Pr H CH 3 F OH XXIX-28-6 p-Cl-Ph H H CH 2 -indol-3-yl 'Pr H CH 3 F OH XXIX-28-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH XXIX-28-8 p-Cl-Ph * H * 'Pr H CH 3 F OH *R2and R3b joined together by (CH 2
)
3 to form five-membered ring. KZA1 Table XXIX-29. Ne Rl R2 Ra R3b R' R' R' X Y XXIX-29-1 p-Br-Ph H H H 'Pr H CH 3 F OH XXIX-29-2 p-Br-Ph H H CH 3 'Pr H CH 3 F OH XXIX-29-3 p-Br-Ph H H CH(CH 3
)
2 'Pr H CH 3 F OH XXIX-29-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH XXIX-29-5 p-Br-Ph H H CH 2 Ph 'Pr H CH 3 F OH XXIX-29-6 p-Br-Ph H H CH 2 -indol-3-yl 'Pr H CH 3 F OH XXIX-29-7 p-Br-Ph H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH XXIX-29-8 p-Br-Ph * H * 'Pr H CH 3 F OH *R and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XXIX-30. X R' R2 Ra R3b R' R' R 6 X Y XXIX-30-1 p-I-Ph H H H 'Pr H CH 3 F OH XXIX-30-2 p-I-Ph H H CH 3 'Pr H CH 3 F OH XXIX-30-3 p-I-Ph H H CH(CH 3
)
2 'Pr H CH 3 F OH XXIX-30-4 p-I-Ph H H CH 2
CH(CH
3
)
2 'Pr H CH 3 F OH XXIX-30-5 p-I-Ph H H CH 2 Ph 'Pr H CH 3 F OH XXIX-30-6 p-I-Ph H H CH 2 -indol-3-yl 'Pr H CH 3 F OH XXIX-30-7 p-I-Ph H H CH 2
CH
2
SCH
3 'Pr H CH 3 F OH XXIX-30-8 p-I-Ph * H * 'Pr H CH 3 F OH *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXIX-3 1. Xe R' R2 R 3 a Rb R 4 R' R 6 X Y XXIX-31-1 CH3 H H H "Bu H CH 3 F OH XXIX-31-2 CH 3 H H CH 3 "Bu H CH 3 F OH XXIX-31-3 CH 3 H H CH(CH 3
)
2 "Bu H CH 3 F OH XXIX-31-4 CH 3 H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH XXIX-31-5 CH 3 H H CH 2 Ph "Bu H CH 3 F OH XXIX-31-6 CH 3 H H CH 2 -indol-3-yl "Bu H CH 3 F OH XXIX-31-7 CH 3 H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH XXIX-31-8 CH 3 * H * "Bu H CH 3 F OH R aiid R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XXIX-32. N R R 2
R
3
R
3 b R 4
R'R
6 XY XXIX-32-1 Et H H H "Bu H CH 3 F OH XXIX-32-2 Et H H CH 3 "Bu H CH 3 F OH XXIX-32-3 Et H H CH(CH 3
)
2 "Bu H CH 3 F OH XXIX-32-4 Et H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH XXIX-32-5 Et H H CH 2 Ph "Bu H CH 3 F OH XXIX-32-6 Et H H CH 2 -indol-3-yl "Bu H CH 3 F OH XXIX-32-7 Et H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH XXIX-32-8 Et * H * "Bu H CH 3 F OH *R2Tand R b joined together by (CH 2
)
3 to form five-membered ring. Table XXIX-33. N R' R 2 RaR 3 b R R R X Y XXIX-33-1 'Pr H H H "Bu H CH 3 F OH XXIX-33-2 'Pr H H CH 3 "Bu H CH 3 F OH XXIX-33-3 'Pr H H CH(CH 3
)
2 "Bu H CH 3 F OH XXIX-33-4 'Pr H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH XXIX-33-5 'Pr H H CH 2 Ph "Bu H CH 3 F OH XXIX-33-6 'Pr H H CH 2 -indol-3-yl "Bu H CH 3 F OH XXIX-33-7 'Pr H H CHCH 2
SCH
3 "Bu H CH 3 F OH XXIX-33-8 'Pr * H * "Bu H CH 3 F OH *R" and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXIX-34. N2 R R2 R 3 a R 3 ) R R' R 6 X Y XXIX-34-1 'Bu H H H "Bu H CH 3 F OH XXIX-34-2 'Bu H H CH 3 "Bu H CH 3 F OH XXIX-.34-3 'Bu H H CH(CH 3
)
2 "Bu H CH 3 F OH XXIX-34-4 'Bu H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH XXIX-34-5 'Bu H H CH 2 Ph "Bu H CH 3 F OH XXIX-34-6 'Bu H H CH2-indol-3-yl "Bu H CH 3 F OH XXIX-34-7 'Bu H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH XXIX-34-8 'Bu * H * "Bu H CH 3 F OH *R and R 3 joined together by (CH 2
)
3 to form five-membered ring.
Table XXIX-35. N R' R 2
R
3 a REb R' R' R' X Y XXIX-35-1 Ph H H H "Bu H CH 3 F OH XXIX-35-2 Ph H H CH 3 "Bu H CH 3 F OH XXIX-35-3 Ph H H CH(CH 3
)
2 "Bu H CH 3 F OH XXIX-35-4 Ph H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH XXIX-35-5 Ph H H CH 2 Ph "Bu H CH 3 F OH XXIX-35-6 Ph H H CH 2 -indol-3-yl "Bu H CH 3 F OH XXIX-35-7 Ph H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH XXIX-35-8 Ph * H * "Bu H CH 3 F OH RTand Rb joined together by (CH 2
)
3 to form five-membered ring. Table XXIX-36. N2 R R2 R 3 a R 3 b R 4 R' R 6 X Y XXIX-36-1 p-Me-Ph H H H "Bu H CH 3 F OH XXIX-36-2 p-Me-Ph H H CH 3 "Bu H CH 3 F OH XXIX-36-3 p-Me-Ph H H CH(CH 3
)
2 "Bu H CH 3 F OH XXIX-36-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH XXIX-36-5 p-Me-Ph H H CH 2 Ph "Bu H CH 3 F OH XXIX-36-6 p-Me-Ph H H CH 2 -indol-3-yI "Bu H CH 3 F OH XXIX-36-7 p-Me-Ph H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH XXIX-36-8 p-Me-Ph * H * "Bu H CH 3 F OH *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXIX-37. X2 Rl R 2
R
3 " R 3 b R 4 R' R 6 X Y XXIX-37-1 p-F-Ph H H H "Bu H CH 3 F OH XXIX-37-2 p-F-Ph H H CH 3 "Bu H CH 3 F OH XXIX-37-3 p-F-Ph H H CH(CH 3
)
2 "Bu H CH 3 F OH XXIX-37-4 p-F-Ph H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH XXIX-37-5 p-F-Ph H H CH 2 Ph "Bu H CH 3 F OH XXIX-.37-6 p-F-Ph H H CH 2 -indol-3-yl "Bu H CH 3 F OH XXIX-37-7 p-F-Ph H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH XXIX-37-8 p-F-Ph * H * "Bu H CH 3 F OH *R' and Rb joined together by (CH 2
)
3 to form five-membered ring.
Table XXIX-38. N RR 2
R
3 aRb R 4 R R 6 X Y XXIX-38-1 p-Cl-Ph H H H "Bu H CH 3 F OH XXIX-38-2 p-Cl-Ph H H CH 3 "Bu H CH 3 F OH XXIX-38-3 p-Cl-Ph H H CH(CH 3
)
2 "Bu H CH 3 F OH XXIX-38-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH XXIX-38-5 p-Cl-Ph H H CH 2 Ph "Bu H CH 3 F OH XXIX-38-6 p-Cl-Ph H H CH 2 -indol-3-yl "Bu H CH 3 F OH XXIX-38-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH XXIX-38-8 p-Cl-Ph * H * "Bu H CH 3 F OH *R and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XXIX-39. N2 Rl R 2
R
3 a R 3 b R 4 R R X Y XXIX-39-1 p-Br-Ph H H H "Bu H CH 3 F OH XXIX-39-2 p-Br-Ph H H CH 3 "Bu H CH 3 F OH XXIX-39-3 p-Br-Ph H H CH(CH 3
)
2 "Bu H CH 3 F OH XXIX-39-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH XXIX-39-5 p-Br-Ph H H CH 2 Ph "Bu H CH 3 F OH XXIX-39-6 p-Br-Ph H H CH 2 -indol-3-yl "Bu H CH 3 F OH XXIX-39-7 p-Br-Ph H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH XXIX-39-8 p-Br-Ph * H * "Bu H CH 3 F OH *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXIX-40. N2 Rl R 2 R3a R 3 b R 4 R' R' X Y XXIX-40-1 p-I-Ph H H H "Bu H CH 3 F OH XXIX-40-2 p-I-Ph H H CH 3 "Bu H CH 3 F OH XXIX-40-3 p-I-Ph H H CH(CH 3
)
2 "Bu H CH 3 F OH XXIX-40-4 p-I-Ph H H CH 2
CH(CH
3
)
2 "Bu H CH 3 F OH XXIX--40-5 p-I-Ph H H CH 2 Ph "Bu H CH 3 F OH XXIX-40-6 p-I-Ph H H CH 2 -indol-3-yl "Bu H CH 3 F OH XXIX-40-7 p-I-Ph H H CH 2
CH
2
SCH
3 "Bu H CH 3 F OH XXIX-40-8 p-I-Ph * H * "Bu H CH 3 F OH *R and Rib joined together by (CH 2
)
3 to form five-membered ring.
Table XXIX-4 1. X R' R2 R 3 a R 3 b R 4 R' R 6 X Y XXIX-41-1 CH 3 H H H Bz H CH 3 F OH XXIX-41-2 CH 3 H H CH 3 Bz H CH 3 F OH XXIX-41-3 CH 3 H H CH(CH 3
)
2 Bz H CH 3 F OH XXIX-41-4 CH 3 H H CH2CH(CH 3
)
2 Bz H CH 3 F OH XXIX-41-5 CH 3 H H CH 2 Ph Bz H CH 3 F OH XXIX-41-6 CH 3 H H CH 2 -indol-3-yl Bz H CH 3 F OH XXIX-41-7 CH 3 H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH XXIX-41-8 CH 3 * H * Bz H CH 3 F OH *RT and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXIX-42. X2 R R 2
R
3 a R 3 b R' R' R 6 X Y XXIX-42-1 Et H H H Bz H CH 3 F OH XXIX-42-2 Et H H CH 3 Bz H CH 3 F OH XXIX-42-3 Et H H CH(CH 3
)
2 Bz H CH 3 F OH XXIX-42-4 Et H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH XXIX-42-5 Et H H CH 2 Ph Bz H CH 3 F OH XXIX-42-6 Et H H CH 2 -indol-3-yl Bz H CH 3 F OH XXIX-42-7 Et H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH XXIX-42-8 Et * H * Bz H CH 3 F OH R2 and RJb joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXIX-43. X2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y XXIX-43-1 Pr H H H Bz H CH 3 F OH XXIX-43-2 'Pr H H CH 3 Bz H CH 3 F OH XXIX-43-3 'Pr H H CH(CH 3
)
2 Bz H CH 3 F OH XXIX-43-4 'Pr H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH XXIX-.43-5 'Pr H H CH 2 Ph Bz H CH 3 F OH XXIX-43-6 'Pr H H CH 2 -indol-3-yl Bz H CH 3 F OH XXIX-43-7 'Pr H H CH 2
CH
2
SCH
3 Bz H CH 3 F (WAI XXIX-43-8 'Pr * H * Bz H CH 3 F OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XXIX-44. N2 R' R 2 R a Rb R 4 R' R' X Y XXIX-44-1 'Bu H H H Bz H CH 3 F OH XXIX-44-2 'Bu H H CH 3 Bz H CH 3 F OH XXIX-44-3 'Bu H H CH(CH 3
)
2 Bz H CH 3 F OH XXIX-44-4 'Bu H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH XXIX-44-5 'Bu H H CH 2 Ph Bz H CH 3 F OH XXIX-44-6 'Bu H H CH 2 -indol-3-yl Bz H CH 3 F OH XXIX-44-7 'Bu H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH XXIX-44-8 'Bu * H * Bz H CH 3 F OH *R' and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXIX-45. RI R 2
R
3 a R3b R4 R 5
R
6 X Y XXIX-45-1 Ph H H H Bz H CH 3 F OH XXIX-45-2 Ph H H CH 3 Bz H CH 3 F OH XXIX-45-3 Ph H H CH(CH 3
)
2 Bz H CH 3 F OH XXIX-45-4 Ph H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH XXIX-45-5 Ph H H CH 2 Ph Bz H CH 3 F OH XXIX-45-6 Ph H H CH 2 -indol-3-yl Bz H CH 3 F OH XXIX-45-7 Ph H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH XXIX-45-8 Ph * H * Bz H CH 3 F OH T 3b *RT and R joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXIX-46. N Rl R 2
R
3 a R 3 b R 4 R R 6 X Y XXIX-46-1 p-Me-Ph H H H Bz H CH 3 F OH XXIX-46-2 p-Me-Ph H H CH 3 Bz H CH 3 F OH XXIX-46-3 p-Me-Ph H H CH(CH 3
)
2 Bz H CH 3 F OH XXIX-46-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH XXIX-46-5 p-Me-Ph H H CH 2 Ph Bz H CH 3 F OH XXIX-46-6 p-Me-Ph H H CH 2 -indol-3-yl Bz H CH 3 F OH XXIX-46-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH XXIX-46-8 p-Me-Ph * H * Bz H CH 3 F OH *R7and Rb joined together by (CH 2
)
3 to form five-membered ring. 4 A7 Table XXIX-47. N2 R' R 2 RaR 3 b R 4
R
5
R
6 X Y XXIX-47-1 p-F-Ph H H H Bz H CH 3 F OH XXIX-47-2 p-F-Ph H H CH 3 Bz H CH 3 F OH XXIX-47-3 p-F-Ph H H CH(CH 3
)
2 Bz H CH 3 F OH XXIX-47-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH XXIX-47-5 p-F-Ph H H CH 2 Ph Bz H CH 3 F OH XXIX-47-6 p-F-Ph H H CH 2 -indol-3-yl Bz H CH 3 F OH XXIX-47-7 p-F-Ph H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH XXIX-47-8 p-F-Ph * H * Bz H CH 3 F OH *R and R b joined together by (CH 2
)
3 to form five-membered ring. Table XXIX-48. N2 Rl R 2
R
3 a Rb R 4 R R 6 X Y XXIX-48-1 p-Cl-Ph H H H Bz H CH 3 F OH XXIX-48-2 p-Cl-Ph H H CH 3 Bz H CH 3 F OH XXIX-48-3 p-Cl-Ph H H CH(CH 3
)
2 Bz H CH 3 F OH XXIX-48-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH XXIX-48-5 p-Cl-Ph H H CH 2 Ph Bz H CH 3 F OH XXIX-48-6 p-Cl-Ph H H CH 2 -indol-3-yl Bz H CH 3 F OH XXIX-48-7 p-Cl-Ph H H CH2CH 2
SCH
3 Bz H CH 3 F OH XXIX-48-8 p-Cl-Ph * H * Bz H CH 3 F OH *R and R36 joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXIX-49. N2 R' R2 R 3 a R 3 b R' R' R 6 X Y XXIX-49-1 p-Br-Ph H H H Bz H CH 3 F OH XXIX-49-2 p-Br-Ph H H CH 3 Bz H CH 3 F OH XXIX-49-3 p-Br-Ph H H CH(CH 3
)
2 Bz H CH 3 F OH XXIX-49-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH XXIX--49-5 p-Br-Ph H H CH 2 Ph Bz H CH 3 F OH XXIX-49-6 p-Br-Ph H H CH 2 -indol-3-yl Bz H CH 3 F OH XXIX-49-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH XXIX-49-8 p-Br-Ph * H * Bz H CH 3 F OH *RT and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XXIX-50. X2 R R 2
R
3 R R 4 R' R' X Y XXIX-50-1 p-I-Ph H H H Bz H CH 3 F OH XXIX-50-2 p-I-Ph H H CH 3 Bz H CH 3 F OH XXIX-50-3 p-I-Ph H H CH(CH 3
)
2 Bz H CH 3 F OH XXIX-50-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Bz H CH 3 F OH XXIX-50-5 p-I-Ph H H CH 2 Ph Bz H CH 3 F OH XXIX-50-6 p-I-Ph H H CH 2 -indol-3-yl Bz H CH 3 F OH XXIX-50-7 p-I-Ph H H CH 2
CH
2
SCH
3 Bz H CH 3 F OH XXIX-50-8 p-I-Ph * H * Bz H CH 3 F OH *R2Tand R 3 b joined together by (CH 2
)
3 to form five-membered ring. 0 N R2 O0N R 3 b O I O N H Ra - N-P 0 N I N C0 2
R
4 OR R
R
6
NH
2 Y X 5 XXX Table XXX-1. N2 R' R 2
R
3 a R 3 b R 4 R' R 6 X y XXX-1-1 CH 3 H H H CH 3 H F H OH XXX-1-2 CH 3 H H CH 3
CH
3 H F H OH XXX-1-3 CH 3 H H CH(CH 3
)
2
CH
3 H F H OH XXX-1-4 CH 3 H H CH2CH(CH 3
)
2
CH
3 H F H OH XXX-1-5 CH 3 H H CH 2 Ph CH 3 H F H OH XXX-1-6 CH 3 H H CH2-indol-3-yl CH 3 H F H OH XXX-1-7 CH 3 H H CH 2
CH
2
SCH
3
CH
3 H F H OH XXX-1-8 CH 3 * H * CH 3 H F H OH *R and Rob joined together by (CH 2
)
3 to form five-membered ring. 10
IZ(AO
Table XXX-2. 2 R' R 2 R3a R 3 b R 4 R' R' X Y XXX-2-1 Et H H H CH 3 H F H OH XXX-2-2 Et H H CH 3
CH
3 H F H OH XXX-2-3 Et H H CH(CH 3
)
2
CH
3 H F H OH XXX-2-4 Et H H CH 2
CH(CH
3
)
2
CH
3 H F H OH XXX-2-5 Et H H CH 2 Ph CH 3 H F H OH XXX-2-6 Et H H CH 2 -indol-3-yl CH 3 H F H OH XXX-2-7 Et H H CH 2
CH
2
SCH
3
CH
3 H F H OH XXX-2-8 Et * H * CH 3 H F H OH *R and R"b joined together by (CH 2
)
3 to form five-membered ring. Table XXX-3. X R' R2 R 3 a R 3 b R4 R' R 6 X Y XXX-3-1 'Pr H H H CH 3 H F H OH XXX-3-2 'Pr H H CH 3
CH
3 H F H OH XXX-3-3 'Pr H H CH(CH 3
)
2
CH
3 H F H OH XXX-3-4 'Pr H H CH 2
CH(CH
3
)
2
CH
3 H F H OH XXX-3-5 'Pr H H CH 2 Ph CH 3 H F H OH XXX-3-6 'Pr H H CH 2 -indol-3-yl CH 3 H F H OH XXX-3-7 'Pr H H CH 2
CH
2
SCH
3
CH
3 H F H OH XXX-3-8 'Pr * H * CH 3 H F H OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXX-4. X R' R2 R 3 a R 3 b R' R' R 6 X Y XXX-4-1 'Bu H H H CH 3 H F H OH XXX-4-2 'Bu H H CH 3
CH
3 H F H OH XXX-4-3 'Bu H H CH(CH 3
)
2
CH
3 H F H OH XXX-4-4 'Bu H H CH 2
CH(CH
3
)
2
CH
3 H F H OH XXX-4-5 'Bu H H CH 2 Ph CH 3 H F H OH XXX-4-6 'Bu H H CH 2 -indol-3-yl CH 3 H F H OH XXX-4-7 'Bu H H CH 2
CH
2
SCH
3
CH
3 H F H OH XXX-4-8 'Bu * H * CH 3 H F H OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 41 A Table XXX-5. M R' R2 R3a R 3 b R 4 R' R 6 X Y XXX-5-1 Ph H H H CH 3 H F H OH XXX-5-2 Ph H H CH 3
CH
3 H F H OH XXX-5-3 Ph H H CH(CH 3
)
2
CH
3 H F H OH XXX-5-4 Ph H H CH 2
CH(CH
3
)
2
CH
3 H F H OH XXX-5-5 Ph H H CH 2 Ph CH 3 H F H OH XXX-5-6 Ph H H CH 2 -indol-3-yl CH 3 H F H OH XXX-5-7 Ph H H CH 2
CH
2
SCH
3
CH
3 H F H OH XXX-5-8 Ph * H * CH 3 H F H OH *RZ and RJb joined together by (CH 2
)
3 to form five-membered ring. Table XXX-6. 2 R' R 2
R
3 a R 3 b R R' R' X Y XXX-6-1 p-Me-Ph H H H CH 3 H F H OH XXX-6-2 p-Me-Ph H H CH 3
CH
3 H F H OH XXX-6-3 p-Me-Ph H H CH(CH 3
)
2
CH
3 H F H OH XXX-6-4 p-Me-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F H OH XXX-6-5 p-Me-Ph H H CH 2 Ph CH 3 H F H OH XXX-6-6 p-Me-Ph H H CH 2 -indol-3-yl CH 3 H F H OH XXX-6-7 p-Me-Ph H H CH 2
CH
2
SCH
3
CH
3 H F H OH XXX-6-8 p-Me-Ph * H * CH 3 H F H OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXX-7. 2 R R2 R3a R3b R4 R' R 6 X Y XXX-7-1 p-F-Ph H H H CH 3 H F H OH XXX-7-2 p-F-Ph H H CH 3
CH
3 H F H OH XXX-7-3 p-F-Ph H H CH(CH 3
)
2
CH
3 H F H OH XXX-7-4 p-F-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F H OH XXX-7-6 p-F-Ph H H CH 2 Ph CH 3 H F H OH XXX-7-7 p-F-Ph H H CH 2 -indol-3-yl CH 3 H F H OH XXX-7-8 p-F-Ph H H CH 2
CH
2
SCH
3
CH
3 H F H OH XXX-7-20 p-F-Ph * H * CH 3 H F H OH *R2 aid R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XXX-8. S R R 2
R
3 aR R 4 R' R' X Y XXX-8-1 p-Cl-Ph H H H CH 3 H F H OH XXX-8-2 p-Cl-Ph H H CH 3
CH
3 H F H OH XXX-8-3 p-Cl-Ph H H CH(CH 3
)
2
CH
3 H F H OH XXX-8-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F H OH XXX-8-5 p-Cl-Ph H H CH 2 Ph CH 3 H F H OH XXX-8-6 p-Cl-Ph H H CH 2 -indol-3-yl CH 3 H F H OH XXX-8-7 p-Cl-Ph H H CH 2
CH
2
SCH
3
CH
3 H F H OH XXX-8-8 p-Cl-Ph * H * CH 3 H F H OH T*Rland Rib joined together by (CH 2
)
3 to form five-membered ring. Table XXX-9. N2 Rl R 2
R
3 " R 3 b R4 R' R 6 X Y XXX-9-1 p-Br-Ph H H H CH 3 H F H OH XXX-9-2 p-Br-Ph H H CH 3
CH
3 H F H OH XXX-9-3 p-Br-Ph H H CH(CH 3
)
2
CH
3 H F H OH XXX-9-4 p-Br-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F H OH XXX-9-6 p-Br-Ph H H CH 2 Ph CH 3 H F H OH XXX-9-7 p-Br-Ph H H CH 2 -indol-3-yl CH 3 H F H OH XXX-9-8 p-Br-Ph H H CH 2
CH
2
SCH
3
CH
3 H F H OH XXX-9-20 p-Br-Ph * H * CH 3 H F H OH R and R-" joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXX-10. N2 RK R 2
R
3 a R 3 b R 4 R' R' X Y XXX-10-1 p-I-Ph H H H CH 3 H F H OH XXX-10-2 p-I-Ph H H CH 3
CH
3 H F H OH XXX-10-3 p-I-Ph H H CH(CH 3
)
2
CH
3 H F H OH XXX-10-4 p-I-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F H OH XXX-10-5 p-I-Ph H H CH 2 Ph CH 3 H F H OH XXX-10-6 p-I-Ph H H CH 2 -indol-3-yl CH 3 H F H OH XXX-10-7 p-I-Ph H H CH 2
CH
2
SCH
3
CH
3 H F H OH XXX-10-8 p-I-Ph * H * CH 3 H F H OH
*R
2 and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XiXX-11. N2 R' R 2
R
3 a R 3 b R' R' R' X Y XXX-11-1 CH 3 H H H Et H F H OH XXX-11-2 CH 3 H H CH 3 Et H F H OH XXX-11-3 CH 3 H H CH(CH 3
)
2 Et H F H OH XXX-11-4 CH 3 H H CH2CH(CH 3
)
2 Et H F H OH XXX-11-5 CH 3 H H CHPh Et H F H OH XXX-11-6 CH 3 H H CH 2 -indol-3-yl Et H F H OH XXX-11-7 CH 3 H H CH 2
CH
2
SCH
3 Et H F H OH XXX-11-8 CH 3 * H * Et H F H OH Rand R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXX-12. N2 RI R 2
R
3 a R 3 b R 4 R' R 6 X Y XXX-12-1 Et H H H Et H F H OH XXX-12-2 Et H H CH 3 Et H F H OH XXX-12-3 Et H H CH(CH 3
)
2 Et H F H OH XXX-12-4 Et H H CH 2
CH(CH
3
)
2 Et H F H OH XXX-12-5 Et H H CH2Ph Et H F H OH XXX-12-6 Et H H CH 2 -indol-3-yl Et H F H OH XXX-12-7 Et H H CH 2
CH
2
SCH
3 Et H F H OH XXX-12-8 Et* H * Et H F H OH *RTand R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXX-13. N2 R' R2 R 3 a RA R4 R' R 6 X Y XXX-13-1 'Pr H H H Et H F H OH XXX-13-2 'Pr H H CH 3 Et H F H OH XXX-13-3 'Pr H H CH(CH 3
)
2 Et H F H OH XXX-13-4 'Pr H H CH 2
CH(CH
3
)
2 Et H F H OH XXX-13-5 'Pr H H CH 2 Ph Et H F H OH XXX-13-6 'Pr H H CH 2 -indol-3-yl Et H F H OH XXX-13-7 'Pr H H CH 2
CH
2
SCH
3 Et H F H OH XXX-13-8 'Pr * H * Et H F H OH *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. - 1 0 _ Table XXX-14. N2 R R 2
R
3 a R 3 b R 4 R' R' X Y XXX-14-1 'Bu H H H Et H F H OH XXX-14-2 'Bu H H CH 3 Et H F H OH XXX-14-3 'Bu H H CH(CH 3
)
2 Et H F H OH XXX-14-4 'Bu H H CH 2
CH(CH
3
)
2 Et H F H OH XXX-14-5 'Bu H H CH 2 Ph Et H F H OH XXX-14-6 'Bu H H CH 2 -indol-3-yl Et H F H OH XXX-14-7 'Bu H H CH 2
CH
2
SCH
3 Et H F H OH XXX-14-8 'Bu * H * Et H F H OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXX-15. X2 RI R 2
R
3 a R 3 b R 4 R' R 6 X Y XXX-15-1 Ph H H H Et H F H OH XXX-15-2 Ph H H CH 3 Et H F H OH XXX-15-3 Ph H H CH(CH 3
)
2 Et H F H OH XXX-15-4 Ph H H CH 2
CH(CH
3
)
2 Et H F H OH XXX-15-5 Ph H H CH 2 Ph Et H F H OH XXX-15-6 Ph H H CH 2 -indol-3-yl Et H F H OH XXX-15-7 Ph H H CH 2
CH
2
SCH
3 Et H F H OH XXX-15-8 Ph * H * Et H F H OH *R and R3b joined together by (CH2)3 to form five-membered ring. 5 Table XXX-16. N2 R' R 2
R
3 a R 3 b R 4 R' R6 X Y XXX-16-1 p-Me-Ph H H H Et H F H OH XXX-16-2 p-Me-Ph H H CH 3 Et H F H OH XXX-16-3 p-Me-Ph H H CH(CH 3
)
2 Et H F H OH XXX-16-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Et H F H OH XXX-16-5 p-Me-Ph H H CH 2 Ph Et H F H OH XXX-16-6 p-Me-Ph H H CH 2 -indol-3-yl Et H F H OH XXX-16-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Et H F H OH XXX-16-8 p-Me-Ph * H * Et H F H OH
*R
2 and RJb joined together by (CH 2
)
3 to form five-membered ring. I A Table XXX-17. N2 R R 2
R
3 a R 3 b R 4 R' R' X Y XXX-17-1 p-F-Ph H H H Et H F H OH XXX-17-2 p-F-Ph H H CH 3 Et H F H OH XXX-17-3 p-F-Ph H H CH(CH 3
)
2 Et H F H OH XXX-17-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Et H F H OH XXX-17-5 p-F-Ph H H CH 2 Ph Et H F H OH XXX-17-6 p-F-Ph H H CH 2 -indol-3-yl Et H F H OH XXX-17-7 p-F-Ph H H CH 2
CH
2
SCH
3 Et H F H OH XXX-17-8 p-F-Ph * H * Et H F H OH *Rrand R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXX-18. N2 R R 2
R
3 a R 3 b R R R 6 X Y XXX-1.8-1 p-Cl-Ph H H H Et H F H OH XXX-18-2 p-Cl-Ph H H CH 3 Et H F H OH XXX-18-3 p-Cl-Ph H H CH(CH 3
)
2 Et H F H OH XXX-18-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Et H F H OH XXX-18-5 p-Cl-Ph H H CH 2 Ph Et H F H OH XXX-18-6 p-Cl-Ph H H CH 2 -indol-3-yl Et H F H OH XXX-18-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Et H F H OH XXX-18-8 p-Cl-Ph * H * Et H F H OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXX-19. N2 R2 R 3 a R 3 b R 4 R' R 6 X Y XXX-19-1 p-Br-Ph H H H Et H F H OH XXX-19-2 p-Br-Ph H H CH 3 Et H F H OH XXX-19-3 p-Br-Ph H H CH(CH 3
)
2 Et H F H OH XXX-19-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Et H F H OH XXX-19-5 p-Br-Ph H H CH 2 Ph Et H F H OH XXX-19-6 p-Br-Ph H H CH 2 -indol-3-yl Et H F H OH XXX-19-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Et H F H OH XXX-19-8 p-Br-Ph * H * Et H F H OH *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 41 C Table XXX-20. X2 R R 2
R
3 a R 3 b R 4 R' R- X Y XXX-20-1 p-I-Ph H H H Et H F H OH XXX-20-2 p-I-Ph H H CH 3 Et H F H OH XXX-20-3 p-I-Ph H H CH(CH 3
)
2 Et H F H OH XXX-20-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Et H F H OH XXX-20-5 p-I-Ph H H CH 2 Ph Et H F H OH XXX-20-6 p-I-Ph H H CH 2 -indol-3-yl Et H F H OH XXX-20-7 p-I-Ph H H CH 2
CH
2
SCH
3 Et H F H OH XXX-20-8 p-I-Ph * H * Et H F H OH *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXX-21. N2 R' R2 R 3 a R 3 b R 4 R' R' X Y XXX-21-1 CH 3 H H H 'Pr H F H OH XXX-21-2 CH 3 H H CH 3 'Pr H F H OH XXX-21-3 CH 3 H H CH(CH 3
)
2 'Pr H F H OH XXX-21-4 CH 3 H H CH 2
CH(CH
3
)
2 'Pr H F H OH XXX-21-5 CH 3 H H CH 2 Ph 'Pr H F H OH XXX-21-6 CH 3 H H CH 2 -indol-3-yl Pr H F H OH XXX-21-7 CH 3 H H CH 2
CH
2
SCH
3 Pr H F H OH XXX-21-8 CH 3 * H * 'Pr H F H OH R and R joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXX-22. N2 RI R 2
R
3 a R 3 b R' R' R' X Y XXX-22-1 Et H H H 'Pr H F H OH XXX-22-2 Et H H CH 3 'Pr H F H OH XXX-22-3 Et H H CH(CH 3
)
2 'Pr H F H OH XXX-22-4 Et H H CH 2
CH(CH
3 )2 'Pr H F H OH XXX-22-5 Et H H CH 2 Ph 'Pr H F H OH XXX-22-6 Et H H CH 2 -indol-3-yl 'Pr H F H OH XXX-22-7 Et H H CH 2
CH
2
SCH
3 'Pr H F H OH XXX-22-8 Et * H * 'Pr H F H OH *Ra 2 and R-b joined together by (CH 2
)
3 to form five-membered ring. l< 1 Table XXX-23. NRIR R aR 3 b R' R' R' X Y XXX-23-1 'Pr H H H 'Pr H F H OH XXX-23-2 'Pr H H CH 3 'Pr H F H OH XXX-23-3 'Pr H H CH(CH 3
)
2 'Pr H F H OH XXX-23-4 'Pr H H CH 2
CH(CH
3
)
2 'Pr H F H OH XXX-23-5 'Pr H H CH 2 Ph 'Pr H F H OH XXX-23-6 'Pr H H CH 2 -indol-3-yl 'Pr H F H OH XXX-23-7 'Pr H H CH 2
CH
2
SCH
3 'Pr H F H OH XXX-23-8 'Pr * H * 'Pr H F H OH
*R
2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XXX-24. N2 R' R2 R 3 a R 3 b R 4 R' R' X Y XXX-24-1 'Bu H H H 'Pr H F H OH XXX-24-2 'Bu H H CH- 'Pr H F H OH XXX-24-3 'Bu H H CH(CH 3
)
2 'Pr H F H OH XXX-24-4 'Bu H H CH 2
CH(CH
3
)
2 'Pr H F H OH XXX-24-5 'Bu H H CH 2 Ph 'Pr H F H OH XXX-24-6 'Bu H H CH 2 -indol-3-yl 'Pr H F H OH XXX-24-7 'Bu H H CH 2
CH
2
SCH
3 'Pr H F H OH XXX-24-8 'Bu * H * 'Pr H F H OH *R2and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXX-25. N2 R R 2 R a R b R 4 R'R X Y XXX-25-1 Ph H H H 'Pr H F H OH XXX-25-2 Ph H H CH 3 'Pr H F H OH XXX-25-3 Ph H H CH(CH 3
)
2 'Pr H F H OH XXX-25-4 Ph H H CH 2
CH(CH
3
)
2 'Pr H F H OH XXX-25-5 Ph H H CH 2 Ph 'Pr H F H OH XXX-25-6 Ph H H CH 2 -indol-3-yl 'Pr H F H OH XXX-25-7 Ph H H CH 2
CH
2
SCH
3 'Pr H F H OH XXX-25-8 Ph * H * 'Pr H F H OH *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. 4 1'7 Table XXX-26. N2 R' R 2 Ra Rlb R' R' R 6 X Y XXX-26-1 p-Me-Ph H H H 'Pr H F H OH XXX-26-2 p-Me-Ph H H CH 3 'Pr H F H OH XXX-26-3 p-Me-Ph H H CH(CH 3
)
2 'Pr H F H OH XXX-26-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 'Pr H F H OH XXX-26-5 p-Me-Ph H H CH 2 Ph 'Pr H F H OH XXX-26-6 p-Me-Ph H H CH 2 -indol-3-yl 'Pr H F H OH XXX-26-7 p-Me-Ph H H CH 2
CH
2
SCH
3 'Pr H F H OH XXX-26-8 p-Me-Ph * H * 'Pr H . F H OH *R7and R b joined together by (CH 2
)
3 to form five-membered ring. Table XXX-27. N2 Rl R 2
R
3 a R 3 b R' R' R 6 X Y XXX-27-1 p-F-Ph H H H 'Pr H F H OH XXX-27-2 p-F-Ph H H CH 3 'Pr H F H OH XXX-27-3 p-F-Ph H H CH(CH 3
)
2 'Pr H F H OH XXX-27-4 p-F-Ph H H CH 2
CH(CH
3
)
2 'Pr H F H OH XXX-27-5 p-F-Ph H H CH 2 Ph 'Pr H F H OH XXX-27-6 p-F-Ph H H CH 2 -indol-3-yl 'Pr H F H OH XXX-27-7 p-F-Ph H H CH 2
CH
2
SCH
3 'Pr H F H OH XXX-27-8 p-F-Ph * H * 'Pr H F H OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXX-28. N R R 2
R
3 aR 3 b R' R' R 6 X Y XXX-28-1 p-Cl-Ph H H H 'Pr H F H OH XXX-28-2 p-Cl-Ph H H CH 3 'Pr H F H OH XXX-28-3 p-Cl-Ph H H CH(CH 3
)
2 'Pr H F H OH XXX-28-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 'Pr H F H OH XXX-28-5 p-Cl-Ph H H CH 2 Ph 'Pr H F H OH XXX-28-6 p-Cl-Ph H H CH 2 -indol-3-yl 'Pr H F H OH XXX-28-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 'Pr H F H OH XXX-28-8 p-Cl-Ph * H * 'Pr H F H OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. A1 Q Table XXX-29. N2 R R2 R 3 a R 3 b R 4 R' R' X Y XXX-29-1 p-Br-Ph H H H 'Pr H F H OH XXX-29-2 p-Br-Ph H H CH 3 'Pr H F H OH XXX-29-3 p-Br-Ph H H CH(CH 3
)
2 'Pr H F H OH XXX-29-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 'Pr H F H OH XXX-29-5 p-Br-Ph H H CH 2 Ph 'Pr H F H OH XXX-29-6 p-Br-Ph H H CH 2 -indol-3-yl 'Pr H F H OH XXX-29-7 p-Br-Ph H H CH 2
CH
2
SCH
3 'Pr H F H OH XXX-29-8 p-Br-Ph * H * 'Pr H F H OH *R and R b joined together by (CH 2
)
3 to form five-membered ring. Table XXX-30. N R R 2 R 3 aR 3 b R 4 R' R' X Y XXX-30-1 p-I-Ph H H H 'Pr H F H OH XXX-30-2 p-I-Ph H H CH 3 'Pr H F H OH XXX-30-3 p-I-Ph H H CH(CH 3
)
2 'Pr H F H OH XXX-30-4 p-I-Ph H H CH 2
CH(CH
3
)
2 'Pr H F H OH XXX-30-5 p-I-Ph H H CH 2 Ph 'Pr H F H OH XXX-30-6 p-I-Ph H H CH 2 -indol-3-yl 'Pr H F H OH XXX-30-7 p-I-Ph H H CH 2
CH
2
SCH
3 'Pr H F H OH XXX-30-8 p-I-Ph * H * 'Pr H F H OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXX-31. N2 R' R2 R 3 a Rb R4 R' R 6 X Y XXX-31-1 CH 3 H H H "Bu H F H OH XXX-31-2 CH 3 H H CH 3 "Bu H F H OH XXX-31-3 CH 3 H H CH(CH 3
)
2 "Bu H F H OH XXX-31-4 CH 3 H H CH 2
CH(CH
3
)
2 "Bu H F H OH XXX-31-5 CH 3 H H CH 2 Ph "Bu H F H OH XXX-31-6 CH 3 H H CH2-indol-3-yl "Bu H F H OH XXX-31-7 CH 3 H H CH 2
CH
2
SCH
3 "Bu H F H OH XXX-31-8 CH 3 * H * "Bu H F H OH *R id Rib joined together by (CH 2
)
3 to form five-membered ring. Al1l Table XXX-32. N2 RI R 2
R
3 a R 3 b R 4 R' R' X Y XXX-32-1 Et H H H 'Bu H F H OH XXX-32-2 Et H H CH 3 "Bu H F H OH XXX-32-3 Et H H CH(CH 3
)
2 "Bu H F H OH XXX-32-4 Et H H CH 2
CH(CH
3
)
2 "Bu H F H OH XXX-32-5 Et H H CH 2 Ph "Bu H F H OH XXX-32-6 Et H H CH 2 -indol-3-yl "Bu H F H OH XXX-32-7 Et H H CH 2
CH
2
SCH
3 "Bu H F H OH XXX-32-8 Et * H * "Bu H F H OH RTand Rib joined together by (CH 2
)
3 to form five-membered ring. Table XXX-33. N2 R' R2 R 3 a R 3 b R R R X Y XXX-33-1 'Pr H H H "Bu H F H OH XXX-33-2 'Pr H H CH 3 "Bu H F H OH XXX-33-3 'Pr H H CH(CH 3
)
2 "Bu H F H OH XXX-33-4 'Pr H H CH 2
CH(CH
3 )2 "Bu H F H OH XXX-33-5 'Pr H H CH 2 Ph "Bu H F H OH XXX-33-6 'Pr H H CH 2 -indol-3-yl "Bu H F H OH XXX-33-7 'Pr H H CH 2
CH
2
SCH
3 "Bu H F H OH XXX-33-8 'Pr * H * "Bu H F H OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXX-34. N2 R R2 R 3 a Rb R 4 R' R 6 X Y XXX-34-1 'Bu H H H "Bu H F H OH XXX-34-2 'Bu H H CH 3 "Bu H F H OH XXX-34-3 'Bu H H CH(CH 3
)
2 "Bu H F H OH XXX-34-4 'Bu H H CH 2
CH(CH
3
)
2 "Bu H F H OH XXX-34-5 'Bu H H CH 2 Ph "Bu H F H OH XXX-34-6 'Bu H H CH 2 -indol-3-yl "Bu H F H OH XXX-34-7 'Bu H H CH 2
CH
2
SCH
3 "Bu H F H OH XXX-34-8 'Bu * H * "Bu H F H OH *R2Tand R-b joined together by (CH 2
)
3 to form five-membered ring.
Table XXX-35. Xe R' R2 Ra R3b R4 R' R 6 X Y XXX-35-1 Ph H H H "Bu H F H OH XXX-35-2 Ph H H CH 3 "Bu H F H OH XXX-35-3 Ph H H CH(CH 3
)
2 "Bu H F H OH XXX-35-4 Ph H H CH 2
CH(CH
3
)
2 "Bu H F H OH XXX-35-5 Ph H H CH 2 Ph "Bu H F H OH XXX-35-6 Ph H H CH 2 -indol-3-yl "Bu H F H OH XXX-35-7 Ph H H CH 2
CH
2
SCH
3 "Bu H F H OH XXX-35-8 Ph * H * "Bu H F H OH *R2and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXX-36. N2 Rl R R 3a R3b R 4 R' R 6 X Y XXX-36-1 p-Me-Ph H H H "Bu H F H OH XXX-36-2 p-Me-Ph H H CH 3 "Bu H F H OH XXX-36-3 p-Me-Ph H H CH(CH 3
)
2 "Bu H F H OH XXX-36-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 "Bu H F H OH XXX-36-5 p-Me-Ph H H CH 2 Ph "Bu H F H OH XXX-36-6 p-Me-Ph H H CH 2 -indol-3-yl "Bu H F H OH XXX-36-7 p-Me-Ph H H CH 2
CH
2
SCH
3 "Bu H F H OH XXX-36-8 p-Me-Ph * H * "Bu H F H OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXX-37. X Re R2 R3 a R3b R4 R' R 6 X Y XXX-37-1 p-F-Ph H H H "Bu H F H OH XXX-37-2 p-F-Ph H H CH 3 "Bu H F H OH XXX-37-3 p-F-Ph H H CH(CH 3
)
2 "Bu H F H OH XXX-37-4 p-F-Ph H H CH 2
CH(CH
3
)
2 "Bu H F H OH XXX-37-5 p-F-Ph H H CH 2 Ph "Bu H F H OH XXX-37-6 p-F-Ph H H CH 2 -indol-3-yl "Bu H F H OH XXX-37-7 p-F-Ph . H H CH 2
CH
2
SCH
3 "Bu H F H OH XXX-37-8 p-F-Ph * H * "Bu H F H OH *R7 2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Al 1 Table XXX-38. X2 Rl R 2
R
3 a R 3 b R 4 R' R 6 X Y XXX-38-1 p-Cl-Ph H H H "Bu H F H OH XXX-38-2 p-Cl-Ph H H CH 3 "Bu H F H OH XXX-38-3 p-Cl-Ph H H CH(CH 3
)
2 "Bu H F H OH XXX-38-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 "Bu H F H OH XXX-38-5 p-Cl-Ph H H CH 2 Ph "Bu H F H OH XXX-38-6 p-Cl-Ph H H CH 2 -indol-3-yl "Bu H F H OH XXX-38-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 "Bu H F H OH XXX-38-8 p-Cl-Ph * H * "Bu H F H OH *R and R b joined together by (CH 2
)
3 to form five-membered ring. Table XXX-39. N2 R2 Ra R3b RW R' R 6 X Y XXX-39-1 p-Br-Ph H H H "Bu H F H OH XXX-39-2 p-Br-Ph H H CH 3 "Bu H F H OH XXX-39-3 p-Br-Ph H H CH(CH 3
)
2 "Bu H F H OH XXX-39-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 "Bu H F H OH XXX-39-5 p-Br-Ph H H CH 2 Ph "Bu H F H OH XXX-39-6 p-Br-Ph H H CH 2 -indol-3-yl "Bu H F H OH XXX-39-7 p-Br-Ph H H CH 2
CH
2
SCH
3 "Bu H F H OH XXX-39-8 p-Br-Ph * H * "Bu H F H OH *R and R 3 b joined together by (CH 2
)
3 to form five-membered ing. 5 Table XXX-40. N2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y XXX-40-1 p-I-Ph H H H "Bu H F H OH XXX-40-2 p-I-Ph H H CH 3 "Bu H F H OH XXX-40-3 p-I-Ph H H CH(CH 3
)
2 "Bu H F H OH XXX-40-4 p-I-Ph H H CH 2
CH(CH
3
)
2 "Bu H F H OH XXX-40-5 p-I-Ph H H CH 2 Ph "Bu H F H OH XXX-40-6 p-I-Ph H H CH 2 -indol-3-yl "Bu H F H OH XXX-40-7 p-I-Ph H H CH 2
CH
2
SCH
3 "Bu H F H OH XXX-40-8 p-I-Ph * H * "Bu H F H OH *RT and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XXX-41. X2 R' R 2
R
3 a R 3 b R R'R XY XXX-41-1 CH 3 H H H Bz H F H OH XXX-41-2 CH 3 H H CH 3 Bz H F H OH XXX-41-3 CH 3 H H CH(CH 3
)
2 Bz H F H OH XXX-41-4 CH 3 H H CH 2
CH(CH
3
)
2 Bz H F H OH XXX-41-5 CH 3 H H CH 2 Ph Bz H F H OH XXX-41-6 CH 3 H H CH 2 -indol-3-yl Bz H F H OH XXX-41-7 CH 3 H H CH 2
CH
2
SCH
3 Bz H F H OH XXX-41-8 CH 3 * H * Bz H F H OH *R and R joined together by (CH 2
)
3 to form five-membered ring. Table XXX-42. X2 Rl R 2
R
3 a R 3 b R 4 R' R 6 X Y XXX-42-1 Et H H H Bz H F H OH XXX-42-2 Et H H CH 3 Bz H F H OH XXX-42-3 Et H H CH(CH 3
)
2 Bz H F H OH XXX-42-4 Et H H CH 2
CH(CH
3
)
2 Bz H F H OH XXX-42-5 Et H H CH 2 Ph Bz H F H OH XXX-42-6 Et H H CH 2 -indol-3-yl Bz H F H OH XXX-42-7 Et H H CH 2
CH
2
SCH
3 Bz H F H OH XXX-42-8 Et * H * Bz H F H OH *R2 and R- 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXX-43. N2 R' R 2
R
3 a R R 4 R R X Y XXX-43-1 'Pr H H H Bz H F H OH XXX-43-2 'Pr H H CH 3 Bz H F H OH XXX-43-3 'Pr H H CH(CH 3
)
2 Bz H F H OH XXX-43-4 'Pr H H CHCH(CH 3
)
2 Bz H F H OH XXX-43-5 'Pr H H CH 2 Ph Bz H F H OH XXX-43-6 'Pr H H CH 2 -indol-3-yl Bz H F H OH XXX-43-7 'Pr H H CH 2
CH
2
SCH
3 Bz H F H dA XXX-43-8 'Pr * H * Bz H F H OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XXX-44. N2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y XXX-44-1 'Bu H H H Bz H F H OH XXX-44-2 'Bu H H CH 3 Bz H F H OH XXX-44-3 'Bu H H CH(CH 3
)
2 Bz H F H OH XXX-44-4 'Bu H H CH 2
CH(CH
3
)
2 Bz H F H OH XXX-44-5 'Bu H H CH 2 Ph Bz H F H OH XXX-44-6 'Bu H H CH 2 -indol-3-yl Bz H F H OH XXX-44-7 'Bu H H CH 2
CH
2
SCH
3 Bz H F H OH XXX-44-8 'Bu* H * Bz H F H OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXX-45. X R' R2 R 3 a R 3 b R 4 R' R 6 X Y XXX-45-1 Ph H H H Bz H F H OH XXX-45-2 Ph H H CH 3 Bz H F H OH XXX-45-3 Ph H H CH(CH 3
)
2 Bz H F H OH XXX-45-4 Ph H H CH 2
CH(CH
3
)
2 Bz H F H OH XXX-45-5 Ph H H CH 2 Ph Bz H F H OH XXX-45-6 Ph H H CH 2 -indol-3-yl Bz H F H OH XXX-45-7 Ph H H CH 2
CH
2
SCH
3 Bz H F H OH XXX-45-8 Ph * H * Bz H F H OH *_Tand R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXX-46. X Re R 2
R
3 a REb R 4 R' R 6 X Y XXX-46-1 p-Me-Ph H H H Bz H F H OH XXX-46-2 p-Me-Ph H H CH 3 Bz H F H OH XXX-46-3 p-Me-Ph H H CH(CH 3
)
2 Bz H F H OH XXX-46-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Bz H F H OH XXX-46-5 p-Me-Ph H H CH 2 Ph Bz H F H OH XXX-46-6 p-Me-Ph H H CH 2 -indol-3-yl Bz H F H OH XXX-46-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Bz H F H OH XXX-46-8 p-Me-Ph * H * Bz H F H OH *R- and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XXX-47. N2 R R 2
R
3 a R 3 b R 4 R' R 6 X Y XXX-47-1 p-F-Ph H H H Bz H F H OH XXX-47-2 p-F-Ph H H CH 3 Bz H F H OH XXX-47-3 p-F-Ph H H CH(CH 3
)
2 Bz H F H OH XXX-47-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Bz H F H OH XXX-47-5 p-F-Ph H H CH 2 Ph Bz H F H OH XXX-47-6 p-F-Ph H H CH 2 -indol-3-yl Bz H F H OH XXX-47-7 p-F-Ph H H CH 2
CH
2
SCH
3 Bz H F H OH XXX-47-8 p-F-Ph * H * Bz H F H OH *R2 and R b joined together by (CH 2
)
3 to form five-membered ring. Table XXX-48. NX R 2
R
3 "R ~b R R R X Y XXX-48-1 p-Cl-Ph H H H Bz H F H OH XXX-48-2 p-Cl-Ph H H CH 3 Bz H F H OH XXX-48-3 p-Cl-Ph H H CH(CH 3
)
2 Bz H F H OH XXX-48-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Bz H F H OH XXX-48-5 p-Cl-Ph H H CH 2 Ph Bz H F H OH XXX-48-6 p-Cl-Ph H H CH 2 -indol-3-yl Bz H F H OH XXX-48-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Bz H F H OH XXX-48-8 p-Cl-Ph * H * Bz H F H OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXX-49. N R R 2
R
3 aR 3 b R 4 R R 6 X Y XXX-49-1 p-Br-Ph H H H Bz H F H OH XXX-49-2 p-Br-Ph H H CH 3 Bz H F H OH XXX-49-3 p-Br-Ph H H CH(CH 3
)
2 Bz H F H OH XXX-49-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Bz H F H OH XXX-49-5 p-Br-Ph H H CH 2 Ph Bz H F H OH XXX-49-6 p-Br-Ph H H CH 2 -indol-3-yl Bz H F H OH XXX-49-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Bz H F H OH XXX-49-8 p-Br-Ph * H * Bz H F H OH *R1 and R3b joined together by (CH 2
)
3 to form five-membered ring. Ic Table XXX-50. X Rl R 2
R
3 a R b R 4 R' R 6 X Y XXX-50-1 p-I-Ph H H H Bz H F H OH XXX-50-2 p-I-Ph H H CH 3 Bz H F H OH XXX-50-3 p-I-Ph H H CH(CH 3
)
2 Bz H F H OH XXX-50-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Bz H F H OH XXX-50-5 p-I-Ph H H CH 2 Ph Bz H F H OH XXX-50-6 p-I-Ph H H CH 2 -indol-3-yl Bz H F H OH XXX-50-7 p-I-Ph H H CH 2
CH
2
SCH
3 Bz H F H OH XXX-50-8 p-I-Ph * H * Bz H F H OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 0 N
R
2 / NH R3 - -b NN N P0 0N N C0 2
R
4 OR R 5 R6
NH
2 Y X 5 XXXI Table XXXI-1. X R' R2 Ra R 3 b R 4 R' R 6 X Y XXXI-1-1 CH 3 H H H CH 3 H F F OH XXXI-1-2 CH 3 H H CH 3
CH
3 H F F OH XXXI-1-3 CH 3 H H CH(CH 3
)
2
CH
3 H F F OH XXXI-1-4 CH 3 H H CH 2
CH(CH
3
)
2
CH
3 H F F OH XXXI-1-5 CH 3 H H CH 2 Ph CH 3 H F F OH XXXI-1-6 CH 3 H H CH 2 -indol-3-yl CH 3 H F F OH XXXI-1-7 CH 3 H H CH 2
CH
2
SCH
3
CH
3 H F F OH XXXI-1-8 CH 3 * H * CH 3 H F F OH *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XXXI-2.
SRIR
2
R
3 aR R' R' R XY XXXI-2-1 Et H H H CH 3 H F F OH XXXI-2-2 Et H H CH 3
CH
3 H F F OH XXXI-2-3 Et H H CH(CH 3
)
2
CH
3 H F F OH XXXI-2-4 Et H H CH 2
CH(CH
3
)
2
CH
3 H F F OH XXXI-2-5 Et H H CH 2 Ph CH 3 H F F OH XXXI-2-6 Et H H CH 2 -indol-3-yl CH 3 H F F OH XXXI-2-7 Et H H CH 2
CH
2
SCH
3
CH
3 H F F OH XXXI-2-8 Et * H * CH 3 H F F OH *Rand R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXXI-3. N2 R R 2
R
3 a R3b R 4 R' R' X Y XXXI-3-1 'Pr H H H CH 3 H F F OH XXXI-3-2 'Pr H H CH 3
CH
3 H F F OH XXXI-3-3 'Pr H H CH(CH3) 2
CH
3 H F F OH XXXI-3-4 'Pr H H CH 2
CH(CH
3
)
2
CH
3 H F F OH XXXI-.3-5 'Pr H H CH 2 Ph CH 3 H F F OH XXXI-3-6 'Pr H H CH 2 -indol-3-yl CH 3 H F F OH XXXI-3-7 'Pr H H CH 2
CH
2
SCH
3
CH
3 H F F OH XXXI-3-8 'Pr * H * CH 3 H F F OH *R" and Rab joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXXI-4. N2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y XXXI-4-1 'Bu H H H CH 3 H F F OH XXXI-4-2 'Bu H H CH 3
CH
3 H F F OH XXXI-4-3 'Bu H H CH(CH 3
)
2
CH
3 H F F OH XXXI-4-4 'Bu H H CH 2
CH(CH
3
)
2
CH
3 H F F OH XXXI-4-5 'Bu H H CHPh CH 3 H F F OH XXXI-4-6 'Bu H H CH2-indol-3-yl CH 3 H F F OH XXXI-4-7 'Bu H H CH 2 CH2SCH 3
CH
3 H F F OH XXXI-4-8 'Bu * H * CH 3 H F F OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 417 Table XXXI-5. N2 RI R 2
R
3 a R 3 b R' R' R 6 X Y XXM-5-1 Ph H H H CH 3 H F F OH XXXI-5-2 Ph H H CH 3
CH
3 H F F OH XXXI-5-3 Ph H H CH(CH 3
)
2
CH
3 H F F OH XXXI-5-4 Ph H H CH 2
CH(CH
3
)
2
CH
3 H F F OH XXXI-5-5 Ph H H CH 2 Ph CH 3 H F F OH XXXI-5-6 Ph H H CH2-indol-3-yl CH 3 H F F OH XXXI-5-7 Ph H H CH 2
CH
2
SCH
3
CH
3 H F F OH XXXI-5-8 Ph * H * CH 3 H F F OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXXI-6. N2 R R 2
R
3 a R 3 b R R R 6 X Y XXXI-6-1 p-Me-Ph H H H CH 3 H F F OH XXXI-6-2 p-Me-Ph H H CH 3
CH
3 H F F OH XXXI-6-3 p-Me-Ph H H CH(CH 3
)
2
CH
3 H F F OH XXXI-6-4 p-Me-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F F OH XXXI-6-5 p-Me-Ph H H CH 2 Ph CH 3 H F F OH XXXI-6-6 p-Me-Ph H H CH 2 -indol-3-yl CH 3 H F F OH XXXI-6-7 p-Me-Ph H H CH 2
CH
2
SCH
3
CH
3 H F F OH XXXI-6-8 p-Me-Ph * H * CH 3 H F F OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXXI-7. NV Rl R 2
R
3 a R 3 b R 4 R' R' X Y XXXI-7-1 p-F-Ph H H H CH 3 H F F OH XXXI-7-2 p-F-Ph H H CH 3
CH
3 H F F OH XXXI--7-3 p-F-Ph H H CH(CH 3
)
2
CH
3 H F F OH XXXI-7-4 p-F-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F F OH XXXI-7-6 p-F-Ph H H CH 2 Ph CH 3 H F F OH XXXI-7-7 p-F-Ph H H CH 2 -indol-3-yl CH 3 H F F OH XXXI-7-8 p-F-Ph H H CH 2
CH
2
SCH
3
CH
3 H F F OH XXXI-7-20 p-F-Ph * H * CH 3 H F F OH RT and R3b joined together by (CH 2
)
3 to form five-membered ring. 4~1 Q Table XXXI-8.
R
2
R
3 a Rb R 4 R' R 6 XY XXXI-8-1 p-Cl-Ph H H H CH 3 H F F OH XXXI-8-2 p-Cl-Ph H H CH 3
CH
3 H F F OH XXXI-8-3 p-Cl-Ph H H CH(CH 3
)
2
CH
3 H F F OH XXXI-8-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F F OH XXXI-8-5 p-Cl-Ph H H CH 2 Ph CH 3 H F F OH XXXI-8-6 p-Cl-Ph H H CH 2 -indol-3-yl CH 3 H F F OH XXXI-8-7 p-Cl-Ph H H CH 2
CH
2
SCH
3
CH
3 H F F OH XXXI-8-8 p-Cl-Ph * H * CH 3 H F F OH
*R
2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XXXI-9. N2 R' R2 R 3 a R3b R 4 R' R 6 X Y XXXI-9-1 p-Br-Ph H H H CH 3 H F F OH XXXI-9-2 p-Br-Ph H H CH 3
CH
3 H F F OH XXXI-.9-3 p-Br-Ph H H CH(CH 3
)
2
CH
3 H F F OH XXXI-9-4 p-Br-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F F OH XXXI-9-6 p-Br-Ph H H CH 2 Ph CH 3 H F F OH XXXI-9-7 p-Br-Ph H H CH 2 -indol-3-yl CH 3 H F F OH XXXI-9-8 p-Br-Ph H H CH 2
CH
2
SCH
3
CH
3 H F F OH XXXI-9-20 p-Br-Ph * H * CH 3 H F F OH *R and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXXI-10. X2 R2 R 3 a R 3 b R 4 RK R X Y XXXI-10-1 p-I-Ph H H H CH 3 H F F OH XXXI-10-2 p-I-Ph H H CH 3
CH
3 H F F OH XXXI-10-3 p-I-Ph H H CH(CH 3
)
2
CH
3 H F F OH XXXI-10-4 p-I-Ph H H CH 2
CH(CH
3
)
2
CH
3 H F F OH XXXI-10-5 p-I-Ph H H CH 2 Ph CH 3 H F F OH XXXI-10-6 p-I-Ph H H CH 2 -indol-3-yl CH 3 H F F OH XXXI-10-7 p-I-Ph H H CH 2
CH
2
SCH
3
CH
3 H F F OH XXXI-10-8 p-I-Ph * H * CH 3 H F F OH *R and R"b joined together by (CH 2
)
3 to form five-membered ring.
Table XXXI- 11. N2 R' R2 R 3 a R R 4 R' R' X Y XXXI-11-1 CH 3 H H H Et H F F OH XXM-11-2 CH 3 H H CH 3 Et H F F OH XXXI-11-3 CH 3 H H CH(CH 3
)
2 Et H F F OH XXXI-11-4 CH 3 H H CH 2
CH(CH
3
)
2 Et H F F OH XXXI-11-5 CH 3 H H CH 2 Ph Et H F F OH XXXI-11-6 CH 3 H H CH 2 -indol-3-yl Et H F F OH XXXI-11-7 CH 3 H H CH 2
CH
2
SCH
3 Et H F F OH XXXI-11-8 CH 3 * H * Et H F F OH *RT and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XXXI-12. N2 RI R 2
R
3 a R3b R 4 R' R' X Y XXXI-12-1 Et H H H Et H F F OH XXXI-12-2 Et H H CH 3 Et H F F OH XXXI-12-3 Et H H CH(CH 3
)
2 Et H F F OH XXXI-12-4 Et H H CH 2
CH(CH
3
)
2 Et H F F OH XXXI-.12-5 Et H H CH 2 Ph Et H F F OH XXXI-12-6 Et H H CH 2 -indol-3-yl Et H F F OH XXXI-12-7 Et H H CH 2 CH2SCH 3 Et H F F OH XXXI-12-8 Et * H Et H F F OH *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXXI-13. X2 Rl R 2
R
3 a R3b R 4 R' R' X Y XXXI-13-1 'Pr H H H Et H F F OH XXXI-13-2 'Pr H H CH 3 Et H F F OH XXXI-13-3 'Pr H H CH(CH 3
)
2 Et H F F OH XXXI-13-4 'Pr H H CH 2
CH(CH
3
)
2 Et H F F OH XXXI-13-5 'Pr H H CH 2 Ph Et H F F OH XXXI-13-6 'Pr H H CH 2 -indol-3-yl Et H F F OH XXXI-13-7 'Pr H H CH 2
CH
2
SCH
3 Et H F F OH XXXI-13-8 'Pr * H * Et H F F OH *R and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XXXI-14. X2 R R2 R 3 a R3b R4 R' R' X Y XXXI-14-1 'Bu H H H Et H F F 01H XXXI-14-2 'Bu H H CH 3 Et H F F OH XXXI-14-3 'Bu H H CH(CH 3
)
2 Et H F F OH XXXI-14-4 'Bu H H CH 2
CH(CH
3
)
2 Et H F F OH XXXI-14-5 'Bu H H CH 2 Ph Et H F F OH XXXI-14-6 'Bu H H CH 2 -indol-3-yl Et H F F OH XXXI-14-7 'Bu H H CH 2
CH
2
SCH
3 Et H F F OH XXXI-14-8 'Bu * H * Et H F F OH *R a-nd R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXXI-15. N Rt R 2
R
3 a R 3 b R 4 R' R 6 X Y XXXI-15-1 Ph H H H Et H F F OH XXXI-15-2 Ph H H CH Et H F F OH XXXI-15-3 Ph H H CH(CH 3
)
2 Et H F F OH XXXI-15-4 Ph H H CH 2
CH(CH
3
)
2 Et H F F OH XXXI-15-5 Ph H H CH 2 Ph Et H F F OH XXXI-15-6 Ph H H CH 2 -indol-3-yl Et H F F OH XXXI-15-7 Ph H H CH 2
CH
2
SCH
3 Et H F F OH XXXI-15-8 Ph * H * Et H F F OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXXI-16. N2 R' R2 R3a R3b R 4 R' R 6 X Y XXXI-.16-1 p-Me-Ph H H H Et H F F OH XXXI-16-2 p-Me-Ph H H CH 3 Et H F F OH XXXI--16-3 p-Me-Ph H H CH(CH 3
)
2 Et H F F OH XXXI-16-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Et H F F OH XXXI-16-5 p-Me-Ph H H CH 2 Ph Et H F F OH XXXI--16-6 p-Me-Ph H H CH 2 -indol-3-yl Et H F F OH XXXI-16-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Et H F F OH XXXI-16-8 p-Me-Ph * H * Et H F F OH *R and Rib joined together by (CH 2
)
3 to form five-membered ring. 4'Z2 1 Table XiXXI-17. N2 Rl R 2
R
3 a R 3 b R' R' R 6 X Y XXXI-17-1 p-F-Ph H H H Et H F F OH XXXI-17-2 p-F-Ph H H CH 3 Et H F F OH XXXI-17-3 p-F-Ph H H CH(CH 3
)
2 Et H F F OH XXXI-17-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Et H F F OH XXXI-17-5 p-F-Ph H H CH 2 Ph Et H F F OH XXXI-17-6 p-F-Ph H H CH 2 -indol-3-yl Et H F F OH XXXI-17-7 p-F-Ph H H CH 2
CH
2
SCH
3 Et H F F OH XXXI-17-8 p-F-Ph * H * Et H F F OH *R and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXXI-18. N2 Rl R 2 R3a R 3 b R 4 R' R 6 X Y XXXI-18-1 p-Cl-Ph H H H Et H F F OH XXXI-18-2 p-Cl-Ph H H CH 3 Et H F F OH XXXI-18-3 p-Cl-Ph H H CH(CH 3
)
2 Et H F F OH XXXI-18-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Et H F F OH XXXI-18-5 p-Cl-Ph H H CH 2 Ph Et H F F OH XXXI-18-6 p-Cl-Ph H H CH 2 -indol-3-yl Et H F F OH XXXI-18-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Et H F F OH XXXI-18-8 p-Cl-Ph * H * Et H F F OH R and Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXXI-19. N2 Rl R 2
R
3 a R 3 b R 4 R' R 6 X Y XXXI-19-1 p-Br-Ph H H H Et H F F OH XXXI-19-2 p-Br-Ph H H CH 3 Et H F F OH XXXI-19-3 p-Br-Ph H H CH(CH 3
)
2 Et H F F OH XXXI-19-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Et H F F OH XXXI-19-5 p-Br-Ph H H CH2Ph Et H F F OH XXXI-19-6 p-Br-Ph H H CH 2 -indol-3-yl Et H F F OH XXXI-19-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Et H F F OH XXXI-19-8 p-Br-Ph * H * Et H F F OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XXXI-20. N2 Rl R 2 Ra R 3 b R 4 R' R 6 X Y XXXI-20-1 p-I-Ph H H H Et H F F OH XXXI-20-2 p-I-Ph H H CH 3 Et H F F OH XXXI-20-3 p-I-Ph H H CH(CH 3
)
2 Et H F F OH XXXI-20-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Et H F F OH XXXI-20-5 p-I-Ph H H CH 2 Ph Et H F F OH XXXI-20-6 p-I-Ph H H CH 2 -indol-3-yl Et H F F OH XXXI-20-7 p-I-Ph H H CH 2
CH
2
SCH
3 Et H F F OH XXXI-20-8 p-I-Ph * H * Et H F F OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXXI-2 1. N2 R' R 2
R
3 a Rb R' R' R 6 X Y XXXI-21-1 CH 3 H H H 'Pr H F F OH XXXI-21-2 CH 3 H H CH 3 'Pr H F F OH XXXI-21-3 CH 3 H H CH(CH 3
)
2 'Pr H F F OH XXXI-21-4 CH 3 H H CH 2
CH(CH
3
)
2 'Pr H F F OH XXXI-21-5 CH 3 H H CH 2 Ph 'Pr H F F OH XXXI-21-6 CH3 H H CH 2 -indol-3-yi 'Pr H F F OH XXXI.-21-7 CH3 H H CH 2
CH
2
SCH
3 'Pr H F F OH XXXI-21-8 CH3 * H * 'Pr H F F OH *R2and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXXI-22. N2 R' R 2
R
3 a R 3 b R' R' R 6 X Y XXXI-22-1 Et H H H 'Pr H F F OH XXXI-22-2 Et H H CH 3 'Pr H F F OH XXXI-22-3 Et H H CH(CH 3
)
2 'Pr H F F OH XXXI-22-4 Et H H CH 2
CH(CH
3
)
2 'Pr H F F OH XXXI-22-5 Et H H CH 2 Ph 'Pr H F F OH XXXI-22-6 Et H H CH 2 -indol-3-yl 'Pr H F F OH XXXI-22-7 Et H H CH 2
CH
2
SCH
3 'Pr H F F OH XXXI-22-8 Et * H * 'Pr H F F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. <'2'2 Table XXXI-23. N2 RI R 2
R
3 a R 3 b R 4 R' R 6 X Y XXXI-23-1 'Pr H H H 'Pr H F F OH XXXI-23-2 'Pr H H CH 3 'Pr H F F OH XXXI-23-3 'Pr H H CH(CH 3
)
2 'Pr H F F OH XXXI-23-4 'Pr H H CH 2
CH(CH
3
)
2 'Pr H F F OH XXXI-23-5 'Pr H H CH2Ph 'Pr H F F OH XXXI-23-6 'Pr H H CH 2 -indol-3-yI 'Pr H F F OH XXXI-23-7 'Pr H H CH 2
CH
2
SCH
3 'Pr H F F OH XXXI-23-8 'Pr * H * 'Pr H F F OH *R2 and R b joined together by (CH 2
)
3 to form five-membered ring. Table XXXI-24. N2 R' R2 R 3a R 3b R 4 R' R 6 X Y XXXI-24-1 'Bu H H H 'Pr H F F OH XXXI-24-2 'Bu H H CH 3 'Pr H F F OH XXXI..24-3 'Bu H H CH(CH 3
)
2 'Pr H F F OH XXXI-24-4 'Bu H H CH 2
CH(CH
3
)
2 'Pr H F F OH XXXI..24-5 'Bu H H CH 2 Ph 'Pr H F F OH XXXI-24-6 'Bu H H CH 2 -indol-3-yl 'Pr H F F OH XXXI-24-7 'Bu H H CH 2
CH
2
SCH
3 'Pr H F F OH XXXI-24-8 'Bu * H * 'Pr H F F OH *R'1alnd R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXXI-25. X2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y XXXI-25-1 Ph H H H 'Pr H F F OH XXXI-25-2 Ph H H CH 3 'Pr H F F OH XXXI-25-3 Ph H H CH(CH 3
)
2 'Pr H F F OH XXXI-25-4 Ph HR H CH 2
CH(CH
3
)
2 'Pr H F F OH XXXI-25-5 Ph H H CH 2 Ph 'Pr H F F OH XXXI-25-6 Ph H H CH 2 -indol-3-yl 'Pr H F F OH XXXI-25-7 Ph H H CH 2
CH
2
SCH
3 'Pr H F F OH XXXI-25-8 Ph * H * 'Pr H F F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 41 A Table XXXI-26. N2 R' R 2
R
3 a R 3 b R 4 R' R' X Y XXXI-26-1 p-Me-Ph H H H 'Pr H F F OH XXXI-26-2 p-Me-Ph H H CH 3 'Pr H F F OH XXXI-26-3 p-Me-Ph H H CH(CH 3
)
2 'Pr H F F OH XXXI-26-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 'Pr H F F OH XXXI-26-5 p-Me-Ph H H CH 2 Ph 'Pr H F F OH XXXI-26-6 p-Me-Ph H H CH 2 -indol-3-yl 'Pr H F F OH XXXI-26-7 p-Me-Ph H H CH 2
CH
2
SCH
3 'Pr H F F OH XXXI-26-8 p-Me-Ph * H * 'Pr H F F OH R and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXXI-27. X2 R2 R 3 a R 3 b R' RI R 6 X Y XXXI-27-1 p-F-Ph H H H 'Pr H F F OH XXXI-27-2 p-F-Ph H H CH 3 'Pr H F F OH XXXI-27-3 p-F-Ph H H CH(CH 3
)
2 'Pr H F F OH XXXI-27-4 p-F-Ph H H CH 2
CH(CH
3
)
2 'Pr H F F OH XXXI-27-5 p-F-Ph H H CH 2 Ph 'Pr H F F OH XXXI-.27-6 p-F-Ph H H CH 2 -indol-3-yl 'Pr H F F OH XXXI-27-7 p-F-Ph H H CH 2
CH
2
SCH
3 'Pr H F F OH XXXI-27-8 p-F-Ph * H * 'Pr H F F OH *RT and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXXI-28. N! R R 2
R
3 a Rb R 4 R' R' X Y XXXI-28-1 p-Cl-Ph H H H 'Pr H F F OH XXXI-28-2 p-Cl-Ph H H CH 3 'Pr H F F OH XXXI-28-3 p-Cl-Ph H H CH(CH 3
)
2 'Pr H F F OH XXXI-28-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 'Pr H F F OH XXXI-28-5 p-Cl-Ph H H CH 2 Ph 'Pr H F F OH XXXI-28-6 p-Cl-Ph H H CH 2 -indol-3-yl 'Pr H F F OH XXXI-28-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 'Pr H F F OH XXXI-28-8 p-Cl-Ph * H * 'Pr H F F OH R and Rb joined together by (CH 2
)
3 to form five-membered ring.
Table XXXI-29. N2 Rl R 2
R
3 a R 3 b R' R' R 6 X Y XXXI-29-1 p-Br-Ph H H H 'Pr H F F OH XXXI-29-2 p-Br-Ph H H CH 3 'Pr H F F OH XXXI-29-3 p-Br-Ph H H CH(CH 3
)
2 'Pr H F F OH XXXI-29-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 'Pr H F F OH XXXI-29-5 p-Br-Ph H H CH 2 Ph 'Pr H F F OH XXXI-29-6 p-Br-Ph H H CH 2 -indol-3-yl 'Pr H F F OH XXXI-29-7 p-Br-Ph H H CH 2
CH
2
SCH
3 'Pr H F F OH XXXI-29-8 p-Br-Ph * H * 'Pr H F F OH *Rl and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XXXI-30. N R I R 2 R 3 a R 3 b R 4 R' R' X Y XXXI-30-1 p-I-Ph H H H 'Pr H F F OH XXXI-30-2 p-I-Ph H H CH 3 'Pr H F F OH XXXI-30-3 p-I-Ph H H CH(CH 3
)
2 'Pr H F F OH XXXI-30-4 p-I-Ph H H CH 2
CH(CH
3
)
2 'Pr H F F OH XXXI-30-5 p-I-Ph H H CH 2 Ph 'Pr H F F OH XXXI-30-6 p-I-Ph H H CH 2 -indol-3-yl 'Pr H F F OH XXXI-30-7 p-I-Ph H H CH 2
CH
2
SCH
3 'Pr H F F OH XXXI-30-8 p-I-Ph * H * 'Pr H F F OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXXI-3 1. N2 R' R 2
R
3 a R 3 b R 4 R' R' X Y XXXI-31-1 CH 3 H H H "Bu H F F OH XXXI-31-2 CH 3 H H CH 3 "Bu H F F OH XXXI-31-3 CH 3 H H CH(CH 3 )2 "Bu H F F OH XXXI-31-4 CH 3 H H CH 2
CH(CH
3
)
2 "Bu H F F 01H XXXI-31-5 CH 3 H H CH 2 Ph "Bu H F F OH XXXI-31-6 CH 3 H H CH 2 -indol-3-yl "Bu H F F OH XXXI-31-7 CH 3 H H CH 2
CH
2
SCH
3 "Bu H F F OH XXXI-31-8 CH 3 * H * "Bu H F F OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XXXI-32. RI R 2 Ra R R 4 R' R' X Y XXXI-32-1 Et H H H "Bu H F F OH XXXI-32-2 Et H H CH 3 "Bu H F F OH XXXI-32-3 Et H H CH(CH 3
)
2 "Bu H F F OH XXXI-32-4 Et H H CH 2
CH(CH
3
)
2 "Bu H F F OH XXXI-32-5 Et H H CH 2 Ph "Bu H F F OH XXXI-32-6 Et H H CH 2 -indol-3-yl "Bu H F F OH XXXI-32-7 Et H H CH 2
CH
2
SCH
3 "Bu H F F OH XXXI-32-8 Et * H * "Bu H F F OH
*R
2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XXXI-33. N2 R' R 2 R3a R3b R4 R' R 6 X Y XXXI-33-1 'Pr H H H "Bu H F F OH XXXI-33-2 'Pr H H CH 3 "Bu H F F OH XXXI-33-3 'Pr H H CH(CH 3
)
2 "Bu H F F OH XXXI-33-4 'Pr H H CH 2
CH(CH
3
)
2 "Bu H F F OH XXXI-33-5 'Pr H H CH 2 Ph "Bu H F F OH XXXI-33-6 'Pr H H CH 2 -indol-3-yI "Bu H F F OH XXXI-33-7 'Pr H H CH 2
CH
2
SCH
3 "Bu H F F OH XXXI-33-8 'Pr * H * "Bu H F F OH *R2 and Rb joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXXI-34. N2 R R2 Ra R3b R' R' R 6 X Y XXXI-34-1 'Bu H H H "Bu H F F OH XXXI-34-2 'Bu H H CH 3 "Bu H F F OH XXXI-34-3 'Bu H H CH(CH 3
)
2 "Bu H F F OH XXXI-34-4 'Bu H H CH 2
CH(CH
3
)
2 "Bu H F F OH XXXI-34-5 'Bu H H CH 2 Ph "Bu H F F OH XXXI-34-6 'Bu H H CH 2 -indol-3-yl "Bu H F F OH XXXI-.34-7 'Bu H H CH 2
CH
2
SCH
3 "Bu H F F OH XXXI-34-8 'Bu * H * "Bu H F F OH *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring.
Table XXXI-35. X2 R' R2 R3a R3b R' R' R' X Y XXXI-35-1 Ph H H H "Bu H F F OH XXXI-35-2 Ph H H CH 3 "Bu H F F OH XXXI-35-3 Ph H H CH(CH 3
)
2 "Bu H F F OH XXXI-35-4 Ph H H CH 2
CH(CH
3
)
2 "Bu H F F OH XXXI-35-5 Ph H H CH2Ph "Bu H F F OH XXXI-35-6 Ph H H CH 2 -indol-3-yl "Bu H F F OH XXXI-35-7 Ph H H CH 2
CH
2
SCH
3 "Bu H F F OH XXXI-35-8 Ph * H * "Bu H F F OH *R2 and R3 joined together by (CH2)3 to form five-membered ring. Table XXXI-36. N2 Rl R 2 Ra Rib R 4 R' R 6 X Y XXXI-36-1 p-Me-Ph H H H "Bu H F F OH XXXI-36-2 p-Me-Ph H H CH 3 "Bu H F F OH XXXI-36-3 p-Me-Ph H H CH(CH 3
)
2 "Bu H F F OH XXXI-36-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 "Bu H F F OH XXXI-36-5 p-Me-Ph H H CH 2 Ph "Bu H F F OH XXXI-36-6 p-Me-Ph H H CH2-indol-3-yl "Bu H F F OH XXXI-36-7 p-Me-Ph H H CH 2
CH
2
SCH
3 "Bu H F F OH XXXI-36-8 p-Me-Ph * H * "Bu H F F OH *R2and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXXI-37. N Rl R2 R a R3b R 4 R' R' X Y XXXI-37-1 p-F-Ph H H H "Bu H F F OH XXXI-37-2 p-F-Ph H H CH 3 "Bu H F F OH XXXI-37-3 p-F-Ph H H CH(CH 3
)
2 "Bu H F F OH XXXI-37-4 p-F-Ph H H CH 2
CH(CH
3
)
2 "Bu H F F OH XXXI-37-5 p-F-Ph H H CH 2 Ph "Bu H F F OH XXXI-37-6 p-F-Ph H H CH2-indol-3-yl "Bu H F F OH XXXI-37-7 p-F-Ph H H CH 2
CH
2
SCH
3 "Bu H F F OH XXXI-37-8 p-F-Ph * H * "Bu H F F OH *R ad R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XXXI-38. N2 Rl R 2 R3a R 3 b R' R' R' X Y XXXI-38-1 p-Cl-Ph H H H "Bu H F F OH XXXI-38-2 p-Cl-Ph H H CH 3 "Bu H F F OH XXXI-38-3 p-Cl-Ph H H CH(CH 3
)
2 "Bu H F F OH XXXI-38-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 "Bu H F F OH XXXI-38-5 p-Cl-Ph H H CH 2 Ph "Bu H F F OH XXXI-38-6 p-Cl-Ph H H CH 2 -indol-3-yl "Bu H F F OH XXXI-38-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 "Bu H F F OH XXXI-38-8 p-Cl-Ph * H * "Bu H F F OH *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXXI-39. N2 Rl R 2
R
3 a R 3 b R' R' R' X Y XXXI-39-1 p-Br-Ph H H H "Bu H F F OH XXXI-39-2 p-Br-Ph H H CH 3 "Bu H F F OH XXXI-39-3 p-Br-Ph H H CH(CH 3
)
2 "Bu H F F OH XXXI-39-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 "Bu H F F OH XXXI-39-5 p-Br-Ph H H CH 2 Ph "Bu H F F OH XXXI-39-6 p-Br-Ph H H CH 2 -indol-3-yl "Bu H F F OH XXXI-39-7 p-Br-Ph H H CH 2
CH
2
SCH
3 "Bu H F F OH XXXI-39-8 p-Br-Ph * H * "Bu H F F OH RT and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXXI-40. X2 Rl R 2
R
3 a R 3 b R 4 R' R 6 X Y XXXI-40-1 p-I-Ph H H H "Bu H F F OH XXXI-40-2 p-I-Ph H H CH 3 "Bu H F F OH XXXI-40-3 p-I-Ph H H CH(CH 3
)
2 "Bu H F F OH XXXI-40-4 p-I-Ph H H CH 2
CH(CH
3
)
2 "Bu H F F OH XXXI-40-5 p-I-Ph H H CH 2 Ph "Bu H F F OH XXXI-40-6 p-I-Ph H H CH 2 -indol-3-yl "Bu H F F OH XXXI-40-7 p-I-Ph H H CH 2
CH
2
SCH
3 "Bu H F F OH XXXI-40-8 p-I-Ph * H * "Bu H F F OH *R and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XXXI-41. N2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y XXXI-41-1 CH 3 H H H Bz H F F OH XXXI-41-2 CH 3 H H CH 3 Bz H F F OH XXXI-41-3 CH 3 H H CH(CH 3
)
2 Bz H F F OH XXXI-41-4 CH 3 H H CH 2
CH(CH
3
)
2 Bz H F F OH XXXI-41-5 CH 3 H H CH 2 Ph Bz H F F OH XXXI-41-6 CH 3 H H CH 2 -indol-3-yl Bz H F F OH XXXI-41-7 CH 3 H H CH 2
CH
2
SCH
3 Bz H F F OH XXXI-41-8 CH 3 * H * Bz H F F OH *RTand R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXXI-42. N2 RI R 2
R
3 a R 3 b R 4 R' R 6 X Y XXXI-42-1 Et H H H Bz H F F OH XXXI-42-2 Et H H CH 3 Bz H F F OH XXXI-42-3 Et H H CH(CH 3
)
2 Bz H F F OH XXXI-42-4 Et H H CH 2
CH(CH
3
)
2 Bz H F F OH XXXI-42-5 Et H H CH 2 Ph Bz H F F OH XXXI-42-6 Et H H CH 2 -indol-3-yl Bz H F F OH XXXI-42-7 Et H H CH 2
CH
2
SCH
3 Bz H F F OH XXXI-42-8 Et * H * Bz H F F OH *R and R joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXXI-43. X2 R' R2 R 3 a R 3 b R 4 R'R X Y XXXI-43-1 'Pr H H H Bz H F F OH XXXI-43-2 'Pr H H CH 3 Bz H F F OH XXXI-43-3 'Pr H H CH(CH 3
)
2 Bz H F F OH XXXI-43-4 'Pr H H CH 2
CH(CH
3
)
2 Bz H F F OH XXXI-43-5 'Pr H H CH 2 Ph Bz H F F OH XXXI-43-6 'Pr H H CH 2 -indol-3-yl Bz H F F OH XXXI-43-7 'Pr H H CH 2
CH
2
SCH
3 Bz H F F (IM XXXI-43-8 'Pr * H * Bz H F F OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XXXI-44. N R' R2 R 3 a R 3 b R 4 R' R 6 X Y XXXI-44-1 'Bu H H H Bz H F F OH XXXI-44-2 'Bu H H CH 3 Bz H F F OH XXXI-44-3 'Bu H H CH(CH 3
)
2 Bz H F F OH XXXI-44-4 'Bu H H CH 2
CH(CH
3
)
2 Bz H F F OH XXXI-44-5 'Bu H H CH 2 Ph Bz H F F OH XXXI-44-6 'Bu H H CH 2 -indol-3-yl Bz H F F OH XXXI-44-7 'Bu H H CH 2
CH
2
SCH
3 Bz H F F OH XXXI-44-8 'Bu * H * Bz H F F OH *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXXI-45. N! RI R 2 RaR 3
R
4 R X R XY XXXI-45-1 Ph H H H Bz H F F OH XXXI-45-2 Ph H H CH 3 Bz H F F OH XXXI-45-3 Ph H H CH(CH 3
)
2 Bz H F F OH XXXI-45-4 Ph H H CH 2
CH(CH
3
)
2 Bz H F F OH XXXI-45-5 Ph H H CH 2 Ph Bz H F F OH XXXI-45-6 Ph H H CH 2 -indol-3-yl Bz H F F OH XXXI-45-7 Ph H H CH 2
CH
2
SCH
3 Bz H F F OH XXXI-45-8 Ph * H * Bz H F F OH *R and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXXI-46. N2 R R 2
R
3 a R 3 b R 4 R' R 6 X Y XXXI-46-1 p-Me-Ph H H H Bz H F F OH XXXI-46-2 p-Me-Ph H H CH 3 Bz H F F OH XXXI-46-3 p-Me-Ph H H CH(CH 3
)
2 Bz H F F OH XXXI-46-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Bz H F F OH XXXI-46-5 p-Me-Ph H H CH 2 Ph Bz H F F OH XXXI-46-6 p-Me-Ph H H CH 2 -indol-3-yl Bz H F F OH XXXI-46-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Bz H F F OH XXXI-46-8 p-Me-Ph * H * Bz H F F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. ,A 1 Table XXXI-47. N2 R2 R 3 a R 3 b R' R' R' X Y XXXI-47-1 p-F-Ph H H H Bz H F F OH XXXI-47-2 p-F-Ph H H CH 3 Bz H F F OH XXXI-47-3 p-F-Ph H H CH(CH 3
)
2 Bz H F F OH XXXI-47-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Bz H F F OH XXXI-47-5 p-F-Ph H H CH 2 Ph Bz H F F OH XXXI-47-6 p-F-Ph H H CH 2 -indol-3-yl Bz H F F OH XXXI-47-7 p-F-Ph H H CH 2
CH
2
SCH
3 Bz H F F OH XXXI-47-8 p-F-Ph * H * Bz H F F OH *R and R joined together by (CH 2
)
3 to form five-membered ring. Table XXXI-48. X2 Rl R 2
R
3 a R 3 b R' R' R 6 X Y XXXI-48-1 p-Cl-Ph H H H Bz H F F OH XXXI-48-2 p-Cl-Ph H H CH 3 Bz H F F OH XXXI-48-3 p-Cl-Ph H H CH(CH 3
)
2 Bz H F F OH XXXI-48-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Bz H F F OH XXXI-48-5 p-Cl-Ph H H CH 2 Ph Bz H F F OH XXXI-48-6 p-Cl-Ph H H CH 2 -indol-3-yl Bz H F F OH XXXI-48-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Bz H F F OH XXXI-48-8 p-Cl-Ph * H * Bz H F F OH *R nd Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXXI-49. N2 Rl R 2
R
3 a R 3 b R' R' R 6 X Y XXXI-49-1 p-Br-Ph H H H Bz H F F OH XXXI-49-2 p-Br-Ph H H CH 3 Bz H F F OH XXXI-49-3 p-Br-Ph H H CH(CH 3
)
2 Bz H F F OH XXXI-49-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Bz H F F OH XXXI-49-5 p-Br-Ph H H CH 2 Ph Bz H F F OH XXXI-49-6 p-Br-Ph H H CH 2 -indol-3-yl Bz H F F OH XXXI-49-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Bz H F F OH XXXI-49-8 p-Br-Ph * H * Bz H F F OH *R2Tand R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XXXI-50. Ng R' R2 R 3 a R 3 b R' R' R 6 X Y XXXI-50-1 p-I-Ph H H H Bz H F F OH XXXI-50-2 p-I-Ph H H CH 3 Bz H F F OH XXXI-50-3 p-I-Ph H H CH(CH 3
)
2 Bz H F F OH XXXI-50-4 p-I-Ph H H CH 2 CH(CH3) 2 Bz H F F OH XXXI-50-5 p-I-Ph H H CH 2 Ph Bz H F F OH XXXI-50-6 p-I-Ph H H CH 2 -indol-3-yl Bz H F F OH XXXI-50-7 p-I-Ph H H CH 2
CH
2
SCH
3 Bz H F F OH XXXI-50-8 p-I-Ph * H * Bz H F F OH *R7 and R3b joined together by (CH 2
)
3 to form five-membered ring. 0 N R2 O NH Rb I I, N
R
3 a N - 0 0 C0 2
R
4 OR
R
6
NH
2 Y X XXXII 5 Table XXXII-1. N2 R' R 2 Rsa R 3 ) R R' R 6 X Y XXXII-1-1 CH 3 H H H CH 3 H H F OH XXXII-1-2 CH 3 H H CH 3
CH
3 H H F OH XXXII-1-3 CR 3 H H CH(CH 3
)
2
CH
3 H H F OH XXXII-1-4 CH 3 H H CH1 2
CH(CH
3
)
2
CH
3 H H F OH XXXII-1-5 CH 3 H H CH 2 Ph CH 3 H H F OH XXXIl-1-6 CH 3 H H C1 2 -indol-3-yl CH 3 H H F OH XXXII-1-7 CH 3 H H CH 2
CH
2
SCH
3
CH
3 H H F OH XXXII-1-8 CH 3 * H * CH 3 H H F OH *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-2. N2 Rl R 2
R
3 a R 3 b R 4 R' R' X Y XXXII-2-1 Et H H H CH 3 H H F OH X2 RI R 2
R
3 a R 3 b R 4 R' R' X Y XXXII-2-2 Et H H CH 3
CH
3 H H F OH XXXU-2-3 Et H H CH(CH 3
)
2
CH
3 H H F OH XXXD-2-4 Et H H CH 2
CH(CH
3
)
2
CH
3 H H F OH XXXII-2-5 Et H H CH 2 Ph CH 3 H H F OH XXXL-2-6 Et H H CH 2 -indol-3-yl CH 3 H H F OH XXXU-2-7 Et H H CH 2
CH
2
SCH
3
CH
3 H H F OH XXXIl-2-8 Et * H * CH 3 H H F OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-3. N2 RI R 2
R
3 a R 3 b R 4 R' R 6 X Y XXXII-3-1 'Pr H H H CH 3 H H F OH XXXI-3-2 'Pr H H CH 3
CH
3 H H F OH XXXII-3-3 'Pr H H CH(CH 3
)
2
CH
3 H H F OH XXXII-3-4 'Pr H H CH 2
CH(CH
3
)
2
CH
3 H H F OH XXXII-3-5 'Pr H H CH 2 Ph CH 3 H H F OH XXXH-3-6 'Pr H H CH 2 -indol-3-yl CH 3 H H F OH XXXII-3-7 'Pr H H CH 2
CH
2
SCH
3
CH
3 H H F OH XXXII-3-8 'Pr * H * CH 3 H H F OH R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-4. X2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y XXXII-4-1 'Bu H H H CH 3 H H F OH XXXI-4-2 'Bu H H CH 3
CH
3 H H F OH XXXII-4-3 'Bu H H CH(CH 3
)
2
CH
3 H H F OH XXXII-4-4 'Bu H H CH 2
CH(CH
3
)
2
CH
3 H H F OH XXXII-4-5 'Bu H H CH 2 Ph CH 3 H H F OH XXXII-4-6 'Bu H H CH 2 -indol-3-yl CH 3 H H F OH XXXH-4-7 'Bu H H CH 2
CH
2
SCH
3
CH
3 H H F OH XXXII-4-8 'Bu * H * CH 3 H H F OH 5 *and RJb joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-5. N2 RI R 2
R
3 a R 3 b R 4 R' R 6 X Y XXXI-5-1 Ph H H H CH 3 H H F OH XXXII.-5-2 Ph H H CH 3
CH
3 H H F OH K A A 2 R R 2
R
3 a Rb R 4 R' R' X Y XXXII-5-3 Ph H H CH(CH 3
)
2
CH
3 H H F OH XXXII-5-4 Ph H H CH 2
CH(CH
3
)
2
CH
3 H H F OH XXXI]-5-5 Ph H H CH 2 Ph CH 3 H H F OH XXXI-5-6 Ph H H CH 2 -indol-3-yl CH 3 H H F OH XXXU-5-7 Ph H H CH 2
CH
2
SCH
3
CH
3 H H F OH XXXI-5-8 Ph * H * CH 3 H H F OH *TR ad R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-6. N'f2 R2 R 3 a R 3 b R 4 R' R' X Y XXXII-6-1 p-Me-Ph H H H CH 3 H H F OH XXXLI-6-2 p-Me-Ph H H CH 3
CH
3 H H F OH XXXJI-6-3 p-Me-Ph H H CH(CH 3
)
2
CH
3 H H F OH XXXII-6-4 p-Me-Ph H H CH 2
CH(CH
3
)
2
CH
3 H H F OH XXXUI-6-5 p-Me-Ph H H CH 2 Ph CH 3 H H F OH XXXII-6-6 p-Me-Ph H H CH 2 -indol-3-yl CH 3 H H F OH XXXII-6-7 p-Me-Ph H H CH 2
CH
2
SCH
3
CH
3 H H F OH XXXII-6-8 p-Me-Ph * H * CH 3 H H F OH *RTand R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-7. N2 R R 2
R
3 a R b R R' R 6 X Y XXXH-7-1 p-F-Ph H H H CH 3 H H F OH XXXII-7-2 p-F-Ph H H CH 3
CH
3 H H F OH XXXH-7-3 p-F-Ph H H CH(CH 3
)
2
CH
3 H H F OH XXXII-7-4 p-F-Ph H H CH 2
CH(CH
3
)
2
CH
3 H H F OH XXXI--7-6 p-F-Ph H H CH 2 Ph CH 3 H H F OH XXXII-7-7 p-F-Ph H H CH 2 -indol-3-yl CH 3 H H F OH XXXII.-7-8 p-F-Ph H H CH 2
CH
2
SCH
3
CH
3 H H F OH XXXII-7-20 p-F-Ph * H * CH 3 H H F OH 5 *R" and R 3 h joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-8. X2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y XXXH-8-1 p-Cl-Ph H H H CH 3 H H F OH XXXII.-8-2 p-Cl-Ph H H CH 3
CH
3 H H F OH XXXH-8-3 p-Cl-Ph H H CH(CH 3
)
2
CH
3 H H F OH X2 R R 2
R
3 a R b R 4 R' R' X Y XXXJI-8-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2
CH
3 H H F OH XXXfl-8-5 p-Cl-Ph H H CH 2 Ph CH 3 H H F OH XXXII-8-6 p-Cl-Ph H H CH 2 -indol-3-yl CH 3 H H F OH XXXII-8-7 p-Cl-Ph H H CH 2
CH
2
SCH
3
CH
3 H H F OH XXXI-8-8 p-Cl-Ph * H * CH 3 H H F OH *RTand R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-9. X2 R R2 R 3 1 R 3 b R 4 R' R 6 X Y XXXH-9-1 p-Br-Ph H H H CH 3 H H F OH XXXII-9-2 p-Br-Ph H H CH 3
CH
3 H H F OH XXXH-9-3 p-Br-Ph H H CH(CH 3
)
2
CH
3 H H F OH XXXH-9-4 p-Br-Ph H H CH 2
CH(CH
3
)
2
CH
3 H H F OH XXXH-9-6 p-Br-Ph H H CH 2 Ph CH 3 H H F OH XXXII-9-7 p-Br-Ph H H CH 2 -indol-3-yl CH 3 H H F OH XXXII-9-8 p-Br-Ph H H CH 2 CH2SCH 3
CH
3 H H F OH XXXII-9-20 p-Br-Ph * H * CH 3 H H F OH *R2 and Rab joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-10. N R' R 2
R
3 a R 3 b R 4 R R X Y XXXH-10-1 p-I-Ph H H H CH 3 H H F OH XXXI-10-2 p-I-Ph H H CH 3
CH
3 H H F OH XXXII-10-3 p-I-Ph H H CH(CH 3
)
2
CH
3 H H F OH XXXH-10-4 p-I-Ph H H CH 2
CH(CH
3
)
2
CH
3 H H F OH XXXH-10-5 p-I-Ph H H CH 2 Ph CH 3 H H F OH XXXH-10-6 p-I-Ph H H CH 2 -indol-3-yl CH 3 H H F OH XXXH.-1O-7 p-I-Ph H H CH 2
CH
2
SCH
3
CH
3 H H F OH XXXII-10-8 p-I-Ph * H * CH 3 H H F OH 5 *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXXII- 11. X R' R2 R 3 a R 3 b R 4 R' R' X Y XXXII.-11-1 CH 3 H H H Et H H F OH XXXH--11-2 CH 3 H H CH 3 Et H H F OH XXXU-11-3 CH 3 H H CH(CH 3
)
2 Et H H F OH XXXII.-11-4 CH 3 H H CH2CH(CH 3
)
2 Et H H F OH X2 R R2 R 3 a R 3 b R 4 R' R' X Y XXXH-11-5 CH 3 H H CH 2 Ph Et H H F OH XXXH-11-6 CH 3 H H CH 2 -indol-3-yl Et H H F OH XXXII-11-7 CH 3 H H CH 2
CH
2
SCH
3 Et H H F OH XXXLI-11-8 CH 3 * H * Et H H F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-12. N2 RI R 2 Ra Rb R4 R' R 6 X Y XXXU-12-1 Et H H H Et H H F OH XXXIH-12-2 Et H H CH: 3 Et H H F OH XXXII-12-3 Et H H CH(CH 3
)
2 Et H H F OH XXXII-12-4 Et H H CH 2
CH(CH
3
)
2 Et H H F OH XXX-12-5 Et H H CH 2 Ph Et H H F OH XXXII-12-6 Et H H CH 2 -indol-3-yl Et H H F OH XXXH-12-7 Et H H CH 2
CH
2
SCH
3 Et H H F OH XXXI-12-8 Et * H * Et H H F OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-13. N2 R' R 2 R3a R 3 b R 4 R' R 6 X Y XXXII-13-1 'Pr H H H Et H H F OH XXXH-13-2 'Pr H H CH 3 Et H H F OH XXXH--13-3 'Pr H H CH(CH 3
)
2 Et H H F OH XXXII-13-4 'Pr H H CH 2
CH(CH
3
)
2 Et H H F OH XXXI-13-5 'Pr H H CH 2 Ph Et H H F OH XXXII-13-6 'Pr H H CH 2 -indol-3-yl Et H H F OH XXXTI-13-7 'Pr H H CH 2
CH
2
SCH
3 Et H H F OH XXXH-13-8 'Pr * H * Et H H F OH 5 *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-14. N2 R' R 2 R3a R A R 4 R' R 6 X Y XXXII-14-1 'Bu H H H Et H H F OH XXXII-14-2 'Bu H H CH 3 Et H H F OH XXXII-14-3 'Bu H H CH(CH 3
)
2 Et H H F OH XXXII-14-4 'Bu H H CH 2
CH(CH
3
)
2 Et H H F OH XXXI-14-5 'Bu H H CH 2 Ph Et H H F OH 'A'7 X2 R' R 2 Ra R 3 b R 4 R' R' X Y XXXI-14-6 'Bu H H CH 2 -indol-3-yl Et H H F OH XXXD-14-7 'Bu H H CH 2
CH
2
SCH
3 Et H H F OH XXXII-14-8 'Bu * H * Et H H F OH *R'iand R b joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-15. X2 R' R 2
R
3 a R 3 b R 4 R' R 6 X Y XXXfl-15-1 Ph H H H Et H H F OH XXXII-15-2 Ph H H CH 3 Et H H F OH XXXJI-15-3 Ph H H CFI(CH 3
)
2 Et H H F OH XXXI-15-4 Ph H H CH 2
CH(CH
3
)
2 Et H H F OH XXX-15-5 Ph H H CH 2 Ph Et H H F OH XXXI-15-6 Ph H H CH 2 -indol-3-yl Et H H F OH XXXH-15-7 Ph H H CH 2
CH
2
SCH
3 Et H H F OH XXXU-15-8 Ph * H * Et H H F OH *R2 and R b joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-16. X R' R2 R 3 a R 3 b R 4 R' R 6 X Y XXXII-16-1 p-Me-Ph H H H Et H H F OH XXXII-16-2 p-Me-Ph H H CH 3 Et H H F OH XXXII-16-3 p-Me-Ph H H CH(CH 3
)
2 Et H H F OH XXXU-16-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Et H H F OH XXXII-16-5 p-Me-Ph H H CH 2 Ph Et H H F OH XXXII-16-6 p-Me-Ph H H CH 2 -indol-3-yl Et H H F OH XXXII-16-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Et H H F OH XXXH-16-8 p-Me-Ph * H * Et H H F OH 5 *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XLXXII-17. X R' R 2
R
3 aR R 4 R R 6 X Y XXXH-17-1 p-F-Ph H H H Et H H F OH XXXII-17-2 p-F-Ph H H CH 3 Et H H F OH XXXII-17-3 p-F-Ph H H CH(CH 3
)
2 Et H H F OH XXXH-17-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Et H H F OH XXXIH-17-5 p-F-Ph H H CH 2 Ph Et H H F OH XXXII-17-6 p-F-Ph H H CH 2 -indol-3-yl Et H H F OH AA Q N2 R[ R 2 R3a R3b R' R' R 6 X Y XXXL-17-7 p-F-Ph H H CH 2
CH
2
SCH
3 Et H H F OH XXXJ-17-8 p-F-Ph * H * Et H H F OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-18. N2 Rl R 2 RaR 3 b R 4 R R XY XXXI-18-1 p-Cl-Ph H H H Et H H F OH XXXII-18-2 p-Cl-Ph H H CH 3 Et H H F OH XXXH-18-3 p-Cl-Ph H H CH(CH 3
)
2 Et H H F OH XXXJI-18-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Et H H F OH XXXfl-18-5 p-Cl-Ph H H CH 2 Ph Et H H F OH XXXII-18-6 p-Cl-Ph H H CH 2 -indol-3-yl Et H H F OH XXXII-18-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Et H H F OH XXXII-18-8 p-Cl-Ph * H * Et H H F OH *R2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-19. N2 Rl Ri R31 R3b R 4 R' R' X Y XXXII-19-1 p-Br-Ph H H H Et H H F OH XXXH-19-2 p-Br-Ph H H CH 3 Et H H F OH XXXH-19-3 p-Br-Ph H H CH(CH 3
)
2 Et H H F OH XXXH-19-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Et H H F OH XXXH-19-5 p-Br-Ph H H CH 2 Ph Et H H F OH XXXH-19-6 p-Br-Ph H H CH 2 -indol-3-yl Et H H F OH XXXH-19-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Et H H F OH XXXH-19-8 p-Br-Ph * H * Et H H F OH 5 *R 2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-20. N2 Rl R 2 R3a R3b R 4 R' R 6 X Y XXXH-20-1 p-I-Ph H H H Et H H F OH XXXII-20-2 p-I-Ph H H CH 3 Et H H F OH XXXH-20-3 p-I-Ph H H CH(CH 3
)
2 Et H H F OH XXXII-20-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Et H H F OH XXXII-20-5 p-I-Ph H H CH 2 Ph Et H H F OH XXXII-20-6 p-I-Ph H H CH 2 -indol-3-yl Et H H F OH XXXI.-20-7 p-I-Ph H H CH 2
CH
2
SCH
3 Et H H F OH ,< 0A X2 R' R2 Ria R 3 b R 4 R' R' X Y XXXII-20-8 p-I-Ph * H * Et H H F OH *RT and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-21. N2 R R 2 R3a R 3 b R R' R 6 X Y XXXII-21-1 CH 3 H H H 'Pr H H F OH XXXII.-21-2 CH 3 H H CH 3 'Pr H H F OH XXXII-21-3 CH 3 H H CH(CH 3 )2 'Pr H H F OH XXXIH-21-4 CH 3 H H CH 2
CH(CH
3
)
2 'Pr H H F OH XXXII.-21-5 CH 3 H H CH 2 Ph 'Pr H H F OH XXXII-21-6 CH 3 H H CH 2 -indol-3-yl 'Pr H H F OH XXXLI-21-7 CH 3 H H CH 2
CH
2
SCH
3 'Pr H H F OH XXXII-21-8 CH 3 * H * 'Pr H H F OH * R and R"b joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-22. N2 R' R 2
R
3 aRb R 4 R R X Y XXX1H-22-1 Et H H H 'Pr H H F OH XXXII-22-2 Et H H CH1 3 'Pr H H F OH XXXII-22-3 Et H H CH(CH 3
)
2 'Pr H H F OH XXXII-22-4 Et H H CH 2
CH(CH
3
)
2 'Pr H H F OH XXX1H-22-5 Et H H CH 2 Ph 'Pr H H F OH XXXLJ-22-6 Et H H CH 2 -indol-3-yl 'Pr H H F OH XXXII-22-7 Et H H CH 2
CH
2
SCH
3 'Pr H H F OH XXXII-22-8 Et * H * 'Pr H H F OH 5 *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-23. N2 R' R 2
R
3 a R 31 R' R' R' X Y XXXI-23-1 'Pr H H H Pr H H F OH XXXII-23-2 'Pr H H CR 3 Pr H H F OH XXXII-23-3 'Pr H H CH(CH 3
)
2 Pr H H F OH XXXII-23-4 'Pr H H CH 2
CH(CH
3
)
2 'Pr H H F OH XXXIH-23-5 'Pr H H CH 2 Ph 'Pr H H F OH XXXI]-23-6 'Pr H H CH--indol-3-yl 'Pr H H F OH XXXIH-23-7 'Pr H H CH 2
CH
2
SCH
3 'Pr H H F OH XXX1]-23-8 'Pr * H * 'Pr H H F OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-24. N2 R' R 2
R
3 a R 3 b R 4 R' R 6 X Y XXXII-24-1 'Bu H H H 'Pr H H F OH XXXII-24-2 'Bu H H CH 3 'Pr H H F OH XXXI-24-3 'Bu H H CH(CH 3
)
2 'Pr H H F OH XXXI-24-4 'Bu H H CH 2
CH(CH
3
)
2 'Pr H H F OH XXXI-24-5 'Bu H H CH 2 Ph 'Pr H H F OH XXXII-24-6 'Bu H H CH 2 -indol-3-yl 'Pr H H F OH XXXII-24-7 'Bu H H CH 2
CH
2
SCH
3 'Pr H H F OH XXXH-24-8 'Bu * H * 'Pr H H F OH *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-25. N2 R' R 2
R
3 a Rb R 4 R' R XY XXXII-25-1 Ph H H H 'Pr H H F OH XXXfl-25-2 Ph H H CH 3 'Pr H H F OH XXXII-25-3 Ph H H CH(CH 3
)
2 'Pr H H F OH XXXII-25-4 Ph H H CH 2
CH(CH
3
)
2 'Pr H H F OH XXXH-25-5 Ph H H CH 2 Ph 'Pr H H F OH XXXII-25-6 Ph H H CH 2 -indol-3-yl 'Pr H H F OH XXXH-25-7 Ph H H CH 2
CH
2
SCH
3 'Pr H H F OH XXIXH-25-8 Ph * H * 'Pr H H F OH 5 *R and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-26. N2 R' R 2
R
3 a R 3 b R 4 R' R' X Y XXXH-26-1 p-Me-Ph H H H 'Pr H H F OH XXXII-26-2 p-Me-Ph H H CH 3 'Pr H H F OH XXXH-26-3 p-Me-Ph H H CH(CH 3
)
2 'Pr H H F OH XXXH-26-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 'Pr H H F OH XXXH-26-5 p-Me-Ph H H CH 2 Ph 'Pr H H F OH XXXII-26-6 p-Me-Ph H H CH 2 -indol-3-yl 'Pr H H F OH XXXI-26-7 p-Me-Ph H H CH 2
CH
2
SCH
3 'Pr H H F OH XXXII-26-8 p-Me-Ph * H * 'Pr H H F OH *R and Rib joined together by (CH 2
)
3 to form five-membered ring. 4c 1 Table XXXII-27. N2 Rl R 2
R
3 a R 3 b R 4 R' R 6 X Y XXXU-27-1 p-F-Ph H H H 'Pr H H F OH XXXJJ-27-2 p-F-Ph H H CH 3 'Pr H H F OH XXXH-27-3 p-F-Ph H H CH(CH 3
)
2 'Pr H H F OH XXXII-27-4 p-F-Ph H H CH 2
CH(CH
3
)
2 'Pr H H F OH XXXIJ-27-5 p-F-Ph H H CH 2 Ph 'Pr H H F OH XXXII-27-6 p-F-Ph H H CH 2 -indol-3-yl 'Pr H H F OH XXXH-27-7 p-F-Ph H H CH 2
CH
2
SCH
3 'Pr H H F OH XXXLI-27-8 p-F-Ph * H * 'Pr H H F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-28. N2 Rl R 2
R
3 a R 3 b R4 R' R' X Y XXXH-28-1 p-Cl-Ph H H H 'Pr H H F OH XXXH-28-2 p-Cl-Ph H H CH 3 'Pr H H F OH XXXfl-28-3 p-Cl-Ph H H CH(CH 3
)
2 Pr H H F OH XXXHI-28-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 'Pr H H F OH XXXII-28-5 p-Cl-Ph H H CH 2 Ph Pr H H F OH XXXII-28-6 p-Cl-Ph H H CH 2 -indol-3-yl Pr H H F OH XXXII-28-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 'Pr H H F OH XXXII-28-8 p-Cl-Ph * H * Pr H H F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXXII-29. N2 Rl R 2 Ra R 3 b R4 R' R' X Y XXXH-29-1 p-Br-Ph H H H 'Pr H H F OH XXXII-29-2 p-Br-Ph H H CH 3 'Pr H H F OH XXXII-29-3 p-Br-Ph H H CH(CH 3
)
2 'Pr H H F OH XXXII-29-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 'Pr H H F OH XXXH-29-5 p-Br-Ph H H CH 2 Ph 'Pr H H F OH XXXII-29-6 p-Br-Ph H H CH 2 -indol-3-yl 'Pr H H F OH XXXH-29-7 p-Br-Ph H H CH 2
CH
2
SCH
3 'Pr H H F OH XXXII-29-8 p-Br-Ph * H * 'Pr H H F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XXXII-30. N2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y XXXII-30-1 p-I-Ph H H H 'Pr H H F OH XXXfD-30-2 p-I-Ph H H CH 3 'Pr H H F OH XXXU-30-3 p-I-Ph H H CH(CH 3
)
2 'Pr H H F OH XXXI-30-4 p-I-Ph H H CH 2
CH(CH
3
)
2 'Pr H H F OH XXXB-30-5 p-I-Ph H H CH 2 Ph 'Pr H H F OH XXXJI-30-6 p-I-Ph H H CH 2 -indol-3-yl 'Pr H H F OH XXXIU-30-7 p-I-Ph H H CH 2
CH
2
SCH
3 'Pr H H F OH XXXII-30-8 p-I-Ph * H * 'Pr H H F OH *Rr and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-3 1. N2 Rl RRaRb R R' R' X Y XXXI7I-31-1 CH 3 H H H "Bu H H F OH XXXU-31-2 CH 3 H H CR 3 "Bu H H F OH XXXfl-31-3 CH 3 H H CH(CH 3
)
2 "Bu H H F OH XXXII-31-4 CH 3 H H CH 2
CH(CH
3
)
2 "Bu H H F OH XXXU-31-5 CH 3 H H CH 2 Ph "Bu H H F OH XXXII-31-6 CH 3 H H CH 2 -indol-3-yi "Bu H H F OH XXXII-31-7 CR 3 H H CH 2
CH
2
SCH
3 "Bu H H F OH XXXUl-31-8 CH 3 * H * "Bu H H F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXXII-32. NR R 2
R
3 a R 3 b R 4 R' R XY XXXII-32-1 Et H H H "Bu H H F OH XXXI-32-2 Et H H CH 3 "Bu H H F OH XXXII-32-3 Et H H CH(CH 3
)
2 "Bu H H F OH XXXII-32-4 Et H H CH 2
CH(CH
3
)
2 "Bu H H F OH XXXII-32-5 Et H H CH 2 Ph "Bu H H F OH XXXH-32-6 Et H H CH 2 -indol-3-yl "Bu H H F OH XXXH-32-7 Et H H CH 2
CH
2
SCH
3 "Bu H H F OH XXXJI-32-8 Et * H * "Bu H H F OH *R2Tand R36 joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-33. N2 R' R 2
R
3 a R 3 b R 4 R' R 6 X Y N2 RI R 2
R
3 a R 3 b R 4
R
5
R
6 XY XXXH-33-1 'Pr H H H "Bu H H F OH XXXII-33-2 'Pr H H CH 3 "Bu H H F OH XXXIH-33-3 'Pr H H CH(CH 3
)
2 "Bu H H F OH XXXI-33-4 'Pr H H CH 2
CH(CH
3
)
2 "Bu H H F OH XXXIH-33-5 'Pr H H CH 2 Ph "Bu H H F OH XXXH-33-6 'Pr H H CH 2 -indol-3-yl "Bu H H F OH XXXII-33-7 'Pr H H CH 2
CH
2
SCH
3 "Bu H H F OH XXXII-33-8 'Pr * H * "Bu H H F OH
*R
2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-34. N! R' R2 R 3 a R 3 b R 4 R' R' X Y XXXI-34-1 'Bu H H H "Bu H H F OH XXXIH-34-2 'Bu H H CH 3 "Bu H H F OH XXXIH-34-3 'Bu H H CH(CH 3
)
2 "Bu H H F OH XXXIH-34-4 'Bu H H CH 2
CH(CH
3
)
2 "Bu H H F OH XXXI-34-5 'Bu H H CH 2 Ph "Bu H H F OH XXXII-34-6 'Bu H H CH 2 -indol-3-yI "Bu H H F OH XXXLI-34-7 'Bu H H CH 2
CH
2
SCH
3 "Bu H H F OH XXXI-34-8 'Bu * H * "Bu H H F OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-35. N! R' R2 R 3 a R b R 4 R' R 6 X Y XXXH-35-1 Ph H H H "Bu H H F OH XXXLJ-35-2 Ph H H CH 3 "Bu H H F OH XXXII-35-3 Ph H H CH(CH 3
)
2 "Bu H H F OH XXXII-35-4 Ph H H CH 2
CH(CH
3
)
2 "Bu H H F OH XXXII-35-5 Ph H H CH1 2 Ph "Bu H H F OH XXXH-35-6 Ph H H CH 2 -indol-3-yl "Bu H H F OH XXXI-35-7 Ph H H CF 2
CH
2
SCH
3 "Bu H H F OH XXXH-35-8 Ph * H * "Bu H H F OH 5 *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring.
Table XXXII-36. R2 R 2
R
3 a R 3 b R R R 6 X Y XXXH-36-1 p-Me-Ph H H H "Bu H H F OH XXXH-36-2 p-Me-Ph H H CH 3 "Bu H H F OH XXXH-36-3 p-Me-Ph H H CH(CH 3
)
2 "Bu H H F OH XXXII-36-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 "Bu H H F OH XXXH-36-5 p-Me-Ph H H CH 2 Ph "Bu H H F OH XXXH-36-6 p-Me-Ph H H CH 2 -indol-3-yl "Bu H H F OH XXXII-36-7 p-Me-Ph H H CH 2
CH
2
SCH
3 "Bu H H F OH XXXH-36-8 p-Me-Ph * H * "Bu H H F OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-37. N2 Rt R 2 R3a R3b R 4 R' R 6 X Y XXXi-37-1 p-F-Ph H H H "Bu H H F OH XXXI-37-2 p-F-Ph H H CH 3 "Bu H H F OH XXXII-37-3 p-F-Ph H H CH(CH 3
)
2 "Bu H H F OH XXXU-37-4 p-F-Ph H H CH 2
CH(CH
3
)
2 "Bu H H F OH XXXU-37-5 p-F-Ph H H CH 2 Ph "Bu H H F OH XXXU-37-6 p-F-Ph H H CH 2 -indol-3-yl "Bu H H F OH XXXU-37-7 p-F-Ph H H CH 2
CH
2
SCH
3 "Bu H H F OH XXXfl-37-8 p-F-Ph * H * "Bu H H F OH *Riand Rib joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXXII-38. N2 Rl R 2
R
3 a R 3 b R 4 R' R 6 X Y XXXH-38-1 p-Cl-Ph H H H "Bu H H F OH XXXJI-38-2 p-Cl-Ph H H CH 3 "Bu H H F OH XXXII-38-3 p-Cl-Ph H H CH(CH 3
)
2 "Bu H H F OH XXXII-38-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 "Bu H H F OH XXXf-38-5 p-Cl-Ph H H CH 2 Ph "Bu H H F OH XXXH-38-6 p-Cl-Ph H H CH 2 -indol-3-yl "Bu H H F OH XXXU-38-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 "Bu H H F OH XXXH-38-8 p-Cl-Ph * H * "Bu H H F OH *RTand Rib joined together by (CH 2
)
3 to form five-membered ring.
Table XXXII-39. N R R 2 RaRb R 4 R' R XY XXXII-39-1 p-Br-Ph H H H "Bu H H F OH XXXII-39-2 p-Br-Ph H H CH 3 "Bu H H F OH XXXII-39-3 p-Br-Ph H H CH(CH 3
)
2 "Bu H H F OH XXXII-39-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 "Bu H H F OH XXXII-39-5 p-Br-Ph H H CH 2 Ph "Bu H H F OH XXXII-39-6 p-Br-Ph H H CH 2 -indol-3-yl "Bu H H F OH XXXII-39-7 p-Br-Ph H H CH 2
CH
2
SCH
3 "Bu H H F OH XXXII-39-8 p-Br-Ph * H * "Bu H H F OH *R2 and R b joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-40. N R! R 2
R
3 a R b R 4 R R 6 X Y XXXIl-40-1 p-I-Ph H H H "Bu H H F OH XXXLI-40-2 p-I-Ph H H CH 3 "Bu H H F OH XXXII-40-3 p-I-Ph H H CH(CH 3
)
2 "Bu H H F OH XXXL-40-4 p-I-Ph H H CH 2
CH(CH
3
)
2 "Bu H H F OH XXXII-40-5 p-I-Ph H H CH 2 Ph "Bu H H F OH XXXII-40-6 p-I-Ph H H CH 2 -indol-3-yl "Bu H H F OH XXXH-40-7 p-I-Ph H H CH 2
CH
2
SCH
3 "Bu H H F OH XXXI-40-8 p-I-Ph * H * "Bu H H F OH *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring. 5 Table XXXII-41. N2 R' R2 R 3 a R 3 b R 4 R' R 6 X Y XXXIJ-41-1 CH 3 H H H Bz H H F OH XXXH-41-2 CH 3 H H CH 3 Bz H H F OH XXXH-41-3 CH 3 H H CH(CH 3
)
2 Bz H H F OH XXXIJ-41-4 CH 3 H H CH 2
CH(CH
3
)
2 Bz H H F OH XXXIJ-41-5 CH 3 H H CH 2 Ph Bz H H F OH XXXIJ-41-6 CH 3 H H CH 2 -indol-3-yl Bz H H F OH XXXII-41-7 CH 3 H H CH 2
CH
2
SCH
3 Bz H H F OH XXXIJ-41-8 CH 3 * H * Bz H H F OH *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring.
Table XXXII-42. X R' R 2
R
3 a R 3 b R R' R' X Y XXXII-42-1 Et H H H Bz H H F OH XXXII-42-2 Et H H CH 3 Bz H H F OH XXXII-42-3 Et H H CH(CH 3
)
2 Bz H H F OH XXXII-42-4 Et H H CH 2
CH(CH
3
)
2 Bz H H F OH XXXII-42-5 Et H H CH 2 Ph Bz H H F OH XXXII-42-6 Et H H CH 2 -indol-3-yl Bz H H F OH XXXII-42-7 Et H H CH 2
CH
2
SCH
3 Bz H H F OH XXXII-42-8 Et * H * Bz H H F OH *R and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-43. X R' R 2
R
3 a R 3 b R4 R' R 6 X Y XXXIE-43-1 Pr H H H Bz H H F OH XXXH-43-2 'Pr H H CH 3 Bz H H F o XXXII-43-3 'Pr H H CH(CH 3
)
2 Bz H H F OH XXXII-43-4 'Pr H H CH 2
CH(CH
3
)
2 Bz H H F OH XXXI-43-5 'Pr H H CH 2 Ph Bz H H F OH XXXII-43-6 'Pr H H CH 2 -indol-3-yl Bz H H F OH XXXII-43-7 Pr H H CH 2
CH
2
SCH
3 Bz H H F OH XXXII-43-8 'Pr * H * Bz H H F OH 10 *R 2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-44. M R' R2 R 3 a R R' R' R' X Y XXXII-44-1 'Bu H H H Bz H H F OH XXXII-44-2 'Bu H H CH 3 Bz H H F OH XXXII-44-3 'Bu H H CH(CH 3
)
2 Bz H H F OH XXXI-44-4 'Bu H H CH 2
CH(CH
3
)
2 Bz H H F OH XXXII-44-5 'Bu H H CH 2 Ph Bz H H F OH XXXII-44-6 'Bu H H CH 2 -indol-3-yl Bz H H F OH XXXII-44-7 'Bu H H CH 2
CH
2
SCH
3 Bz H H F OH XXXI-44-8 'Bu * H * Bz H H F OH *Rrand R b joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-45.
N2 R' R 2
R
3 a R 3 b R' R' R' X Y XXXII-45-1 Ph H H H Bz H H F OH XXXII-45-2 Ph H H Ci 3 Bz H H F OH XXXII-45-3 Ph H H CH(CH 3
)
2 Bz H H F OH XXXI-45-4 Ph H H CH 2
CH(CH
3
)
2 Bz H H F OH XXXII-45-5 Ph H H CH 2 Ph Bz H H F OH XXXIH-45-6 Ph H H CH 2 -indol-3-yl Bz H H F OH XXXH-45-7 Ph H H CH 2
CH
2
SCH
3 Bz H H F OH XXXII-45-8 Ph * H * Bz H H F OH
*R
2 and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-46. N2 R' R 2 R a R 3 b R 4 R' R' X Y XXXI-46-1 p-Me-Ph H H H Bz H H F OH XXXII-46-2 p-Me-Ph H H CH 3 Bz H H F OH XXXIl-46-3 p-Me-Ph H H CH(CH 3
)
2 Bz H H F OH XXXIJ-46-4 p-Me-Ph H H CH 2
CH(CH
3
)
2 Bz H H F OH XXXII-46-5 p-Me-Ph H H CH 2 Ph Bz H H F OH XXXU-46-6 p-Me-Ph H H CH 2 -indol-3-yl Bz H H F OH XXXfl-46-7 p-Me-Ph H H CH 2
CH
2
SCH
3 Bz H H F OH XXXII-46-8 p-Me-Ph * H * Bz H H F OH *R and R3b joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-47. N2 R 1 R2 R 3 a R 3 b R 4 R' R 6 X Y XXXI-47-1 p-F-Ph H H H Bz H H F OH XXXII-47-2 p-F-Ph H H CH 3 Bz H H F OH XXXII-47-3 p-F-Ph H H CH(CH 3
)
2 Bz H H F OH XXXII-47-4 p-F-Ph H H CH 2
CH(CH
3
)
2 Bz H H F OH XXXII-47-5 p-F-Ph H H CH 2 Ph Bz H H F OH XXXII-47-6 p-F-Ph H H CH 2 -indol-3-yl Bz H H F OH XXXII-47-7 p-F-Ph H H CH 2
CH
2
SCH
3 Bz H H F OH XXXII-47-8 p-F-Ph * H * Bz H H F OH 5 *R 2 and Rib joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-48. N2 RK R 2
R
3 a R 3 b R 4 R' R 6 X Y XXXII-48-1 p-Cl-Ph H H H Bz H H F OH X2 Rl R 2 R3a R 3 b R' R' R' X Y XXXII-48-2 p-Cl-Ph H H CH 3 Bz H H F OH XXXII-48-3 p-Cl-Ph H H CH(CH 3
)
2 Bz H H F OH XXXII-48-4 p-Cl-Ph H H CH 2
CH(CH
3
)
2 Bz H H F OH XXXII-48-5 p-Cl-Ph H H CH 2 Ph Bz H H F OH XXXII-48-6 p-Cl-Ph H H CH 2 -indol-3-yl Bz H H F OH XXXH-48-7 p-Cl-Ph H H CH 2
CH
2
SCH
3 Bz H H F OH XXXII-48-8 p-Cl-Ph * H * Bz H H F OH * R and R b joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-49. N2 R2 R 3 a R 3 b R 4
R
5
R
6 X Y XXXI-49-1 p-Br-Ph H H H Bz H H F OH XXXH-49-2 p-Br-Ph H H CH 3 Bz H H F OH XXXH-49-3 p-Br-Ph H H CH(CH 3
)
2 Bz H H F OH XXXII-49-4 p-Br-Ph H H CH 2
CH(CH
3
)
2 Bz H H F OH XXXII-49-5 p-Br-Ph H H CH 2 Ph Bz H H F OH XXXU-49-6 p-Br-Ph H H CH 2 -indol-3-yl Bz H H F OH XXXU-49-7 p-Br-Ph H H CH 2
CH
2
SCH
3 Bz H H F OH XXXU-49-8 p-Br-Ph * H * Bz H H F OH *R2 and R 3 b joined together by (CH 2
)
3 to form five-membered ring. Table XXXII-50. N2 Ri R 2
R
3 a R 3 b R 4
R
5
R
6 X Y XXXII-50-1 p-I-Ph H H H Bz H H F OH XXXII-50-2 p-I-Ph H H CH 3 Bz H H F OH XXXII-50-3 p-I-Ph H H CH(CH 3
)
2 Bz H H F OH XXXII-50-4 p-I-Ph H H CH 2
CH(CH
3
)
2 Bz H H F OH XXXI-50-5 p-I-Ph H H CH 2 Ph Bz H H F OH XXXU-50-6 p-I-Ph H H CH 2 -indol-3-yl Bz H H F OH XXXH]-50-7 p-I-Ph H H CH 2
CH
2
SCH
3 Bz H H F OH XXXII-50-8 p-I-Ph * H * Bz H H F OH 5 *R2 and R3b joined together by (CH 2
)
3 to form five-membered ring.
DOSAGE, ADMINISTRATION, AND USE A sixth embodiment of the present invention is directed to a composition for the treatment of any of the viral agents disclosed herein said composition comprising a pharmaceutically acceptable medium selected from among an 5 excipient, carrier, diluent, and equivalent medium and a compound, that is intended to include its salts (acid or basic addition salts), hydrates, solvates, and crystalline forms can be obtained, represented by formula I. It is contemplated that the formulation of the sixth embodiment can contain any of the compounds contemplated in any of the aspects of the first, 10 second, third, fourth, and fifth embodiments or those specifically recited in the tables above or exemplified herein, either alone or in combination with another compound of the present invention. The compounds of the present invention may be formulated in a wide variety of oral administration dosage forms and carriers. Oral administration can 15 be in the form of tablets, coated tablets, hard and soft gelatin capsules, solutions, emulsions, syrups, or suspensions. Compounds of the present invention are efficacious when administered by suppository administration, among other routes of administration. The most convenient manner of administration is generally oral using a convenient daily dosing regimen which can be adjusted 20 according to the severity of the disease and the patient's response to the antiviral medication. A compound or compounds of the present invention, as well as their pharmaceutically acceptable salts, together with one or more conventional excipients, carriers, or diluents, may be placed into the form of pharmaceutical 25 compositions and unit dosages. The pharmaceutical compositions and unit dosage forms may be comprised of conventional ingredients in conventional proportions, with or without additional active compounds and the unit dosage forms may contain any suitable effective amount of the active ingredient commensurate with the intended daily dosage range to be employed. The 30 pharmaceutical compositions may be employed as solids, such as tablets or filled capsules, semisolids, powders, sustained release formulations, or liquids such as suspensions, emulsions, or filled capsules for oral use; or in the form of suppositories for rectal or vaginal administration. A typical preparation will contain from about 5% to about 95% active compound or compounds (w/w). The term "preparation" or "dosage form" is intended to include both solid and 5 liquid formulations of the active compound and one skilled in the art will appreciate that an active ingredient can exist in different preparations depending on the desired dose and pharmacokinetic parameters. The term "excipient" as used herein refers to a compound that is used to prepare a pharmaceutical composition, and is generally safe, non-toxic and 10 neither biologically nor otherwise undesirable, and includes excipients that are acceptable for veterinary use as well as human pharmaceutical use. The compounds of this invention can be administered alone but will generally be administered in admixture with one or more suitable pharmaceutical excipients, diluents or carriers selected with regard to the intended route of administration 15 and standard pharmaceutical practice. A "pharmaceutically acceptable salt" form of an active ingredient may also initially confer a desirable pharmacokinetic property on the active ingredient which were absent in the non-salt form, and may even positively affect the pharmacodynamics of the active ingredient with respect to its 20 therapeutic activity in the body. The phrase "pharmaceutically acceptable salt" of a compound as used herein means a salt that is pharmaceutically acceptable and that possesses the desired pharmacological activity of the parent compound. Such salts include: (1) acid addition salts, formed with inorganic acids such as hydrochloric acid, hydrobromic acid, sulfuric acid, nitric acid, phosphoric acid, 25 and the like; or formed with organic acids such as glycolic acid, pyruvic acid, lactic acid, malonic acid, malic acid, maleic acid, fumaric acid, tartaric acid, citric acid, 3-(4-hydroxybenzoyl)benzoic acid, cinnamic acid, mandelic acid, methanesulfonic acid, ethanesulfonic acid, 1,2-ethane-disulfonic acid, 2 hydroxyethanesulfonic acid, benzenesulfonic acid, 4-chlorobenzenesulfonic 30 acid, 2-naphthalenesulfonic acid, 4-toluenesulfonic acid, camphorsulfonic acid, lauryl sulfuric acid, gluconic acid, glutamic acid, salicylic acid, muconic acid, and the like or (2) basic addition salts formed with the conjugate bases of any of 44-Z1 the inorganic acids listed above, wherein the conjugate bases comprise a cationic component selected from among Na*, K*, Mg 2 +, Ca 2 +, and NHgR 4-g, in which R is a. C 1
.
3 alkyl and g is a number selected from among 0, 1, 2, 3, or 4. It should be understood that all references to pharmaceutically acceptable salts 5 include solvent addition forms (solvates) or crystal forms (polymorphs) as defined herein, of the same acid addition salt. Solid form preparations include powders, tablets, pills, capsules, suppositories, and dispersible granules. A solid carrier may be one or more substances which may also act as diluents, flavoring agents, solubilizers, 10 lubricants, suspending agents, binders, preservatives, tablet disintegrating agents, or an encapsulating material. In powders, the carrier generally is a finely divided solid which is a mixture with the finely divided active component. In tablets, the active component generally is mixed with the carrier having the necessary binding capacity in suitable proportions and compacted in the shape and size 15 desired. Suitable carriers include but are not limited to magnesium carbonate, magnesium stearate, talc, sugar, lactose, pectin, dextrin, starch, gelatin, tragacanth, methylcellulose, sodium carboxymethylcellulose, a low melting wax, cocoa butter, and the like. Solid form preparations may contain, in addition to the active component, colorants, flavors, stabilizers, buffers, artificial and natural 20 sweeteners, dispersants, thickeners, solubilizing agents, and the like. Liquid formulations also are suitable for oral administration include liquid formulation including emulsions, syrups, elixirs and aqueous suspensions. These include solid form preparations which are intended to be converted to liquid form preparations shortly before use. Emulsions may be prepared in 25 solutions, for example, in aqueous propylene glycol solutions or may contain emulsifying agents such as lecithin, sorbitan monooleate, or acacia. Aqueous suspensions can be prepared by dispersing the finely divided active component in water with viscous material, such as natural or synthetic gums, resins, methylcellulose, sodium carboxymethylcellulose, and other well known 30 suspending agents. The compounds of the present invention may be formulated for administration as suppositories. A low melting wax, such as a mixture of fatty acid glycerides or cocoa butter is first melted and the active component is dispersed homogeneously, for example, by stirring. The molten homogeneous mixture is then poured into convenient sized molds, allowed to cool, and to solidify. 5 The compounds of the present invention may be formulated for vaginal administration. Pessaries, tampons, creams, gels, pastes, foams or sprays containing in addition to the active ingredient such carriers as are known in the art to be appropriate. Suitable formulations along with pharmaceutical carriers, diluents and 10 expcipients are described in Remington: The Science and Practice of Pharmacy 1995, edited by E. W. Martin, Mack Publishing Company, 19th edition, Easton, Pennsylvania, which is hereby incorporated by reference. The compounds of the present invention can also be encapsulated in liposomes, such as those disclosed in U.S. Patent Nos. 6,180,134, 5,192,549, 5,376,380, 6,060,080, 6,132,763, each 15 of which is incorporated by reference. A skilled formulation scientist may modify the formulations within the teachings of the specification to provide numerous formulations for a particular route of administration without rendering the compositions of the present invention unstable or compromising their therapeutic activity. 20 The modification of the present compounds to render them more soluble in water or other vehicle, for example, may be easily accomplished by minor modifications (e.g., salt formulation), which are well within the ordinary skill in the art. It is also well within the ordinary skill of the art to modify the route of administration and dosage regimen of a particular compound in order to manage 25 the pharmacokinetics of the present compounds for maximum beneficial effect in patients. A seventh embodiment of the present invention is directed to a use of the compound represented by formula I in the manufacture of a medicament for the treatment of any condition the result of an infection by any one of the following 30 viral agents: hepatitis C virus, West Nile virus, yellow fever virus, dengue virus, rhinovirus, polio virus, hepatitis A virus, bovine viral diarrhea virus and Japanese encephalitis virus. The term "medicament" means a substance used in a method of treatment and/or prophylaxis of a subject in need thereof, wherein the substance includes, 5 but is not limited to, a composition, a formulation, a dosage form, and the like, comprising the compound of formula I. It is contemplated that the compound of the use of the compound represented by formula I in the manufacture of a medicament for the treatment of any of the antiviral conditions disclosed herein of the seventh embodiment can be any of the compounds contemplated in any of 10 the aspects of the first, second, third, fourth, fifth embodiments or those specifically recited in the tables above or exemplified herein, either alone or in combination with another compound of the present invention. A medicament includes, but is not limited to, any one of the compositions contemplated by the sixth embodiment of the present invention. 15 A eighth embodiment of the present invention is directed to a method of treatment and/or prophylaxis in a subject in need thereof said method comprises administering a therapeutically effective amount of the compound represented by formula I to the subject. A first aspect of the eighth embodiment is directed to a method of 20 treatment and/or prophylaxis in a subject in need thereof said method comprises administering a therapeutically effective of at least two or more different compounds falling within the scope of the compound represented by formula I to the subject. A second aspect of the eighth embodiment is directed to a method of 25 treatment and/or prophylaxis in a subject in need thereof said method comprises alternatively or concurrently administering a therapeutically effective of at least two compounds falling within the scope of the compound represented by formula I to the subject. It is intended that a subject in need thereof is one that has any condition 30 the result of an infection by any of the viral agents disclosed herein, which includes, but is not limited to, hepatitis C virus, West Nile virus, yellow fever virus, dengue virus, rhinovirus, polio virus, hepatitis A virus, bovine viral diarrhea virus or Japanese encephalitis virus, flaviviridae viruses or pestiviruses or hepaciviruses or a viral agent causing symptoms equivalent or comparable to any of the above-listed viruses. 5 The term "subject" means a mammal, which includes, but is not limited to, cattle, pigs, sheep, chicken, turkey, buffalo, llama, ostrich, dogs, cats, and humans, preferably the subject is a human. It is contemplated that in the method of treating a subject thereof of the sixth embodiment can be any of the compounds contemplated in any of the aspects of the first, second, and third 10 embodiments or those specifically recited in the tables above, either alone or in combination with another compound of the present invention. The term "therapeutically effective amount" as used herein means an amount required to reduce symptoms of the disease in an individual. The dose will be adjusted to the individual requirements in each particular case. That 15 dosage can vary within wide limits depending upon numerous factors such as the severity of the disease to be treated, the age and general health condition of the patient, other medicaments with which the patient is being treated, the route and form of administration and the preferences and experience of the medical practitioner involved. For oral administration, a daily dosage of between about 20 0.1 and about 10 g, including all values in between, such as 0.25, 0.5, 0.75, 1, 1.5, 2. 2.5, 3, 3.5, 4, 4.5, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, and 9.5, per day should be appropriate in monotherapy and/or in combination therapy. A preferred daily dosage is between about 0.5 and about 7.5 g per day, more preferred 1.5 and about 6.0 g per day. Generally, treatment is initiated with a large initial "loading 25 dose" to rapidly reduce or eliminate the virus following by a decreasing the dose to a level sufficient to prevent resurgence of the infection. One of ordinary skill in treating diseases described herein will be able, without undue experimentation and in reliance on personal knowledge, experience and the disclosures of this application, to ascertain a therapeutically effective amount of the compounds of 30 the present invention for a given disease and patient. Therapeutic efficacy can be ascertained from tests of liver function including, but not limited to protein levels such as serum proteins (e.g., albumin, clotting-factors, alkaline phosphatase, aminotransferases (e.g., alanine transaminase, aspartate transaminase), 5'-nucleosidase, Y glutaminyltranspeptidase, etc.), synthesis of bilirubin, synthesis of cholesterol, and synthesis of bile acids; a liver metabolic function, including, but not limited 5 to, carbohydrate metabolism, amino acid and ammonia metabolism. Alternatively the therapeutic effectiveness may be monitored by measuring HCV-RNA. The results of these tests will allow the dose to be optimized. A third aspect of the eighth embodiment, is directed to a method of treatment and/or prophylaxis in a subject in need thereof said method comprises 10 administering to the subject a therapeutically effective of a compound represented by formula I and a therapeutically effective amount of another antiviral agent; wherein the administration is concurrent or alternative. It is understood that the time between alternative administration can range between 1-24 hours, which includes any sub-range in between including, 2, 3, 4, 5, 6, 7, 15 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, and 23 hours. Examples of "another antiviral agents" include, but are not limited to: HCV NS3 protease inhibitors (see WO 2008010921, WO 2008010921, EP 1881001, WO 2007015824, WO 2007014925, WO 2007014926, WO 2007014921, WO 2007014920, WO 2007014922, US 2005267018, WO 2005095403, WO 20 2005037214, WO 2004094452, US 2003187018, WO 200364456, WO 2005028502, and WO 2003006490); HCV NS5B Inhibitors (see US 2007275947, US20072759300, W02007095269, WO 2007092000, WO 2007076034, WO 200702602, US 2005-98125, WO 2006093801, US 2006166964, WO 2006065590, WO 2006065335, US 2006040927, US 25 2006040890, WO 2006020082, WO 2006012078, WO 2005123087, US 2005154056, US 2004229840, WO 2004065367, WO 2004003138, WO 2004002977, WO 2004002944, WO 2004002940, WO 2004000858, WO 2003105770, WO 2003010141, WO 2002057425, WO 2002057287, WO 2005021568, WO 2004041201, US 20060293306, US 20060194749, US 30 20060241064, US 6784166, WO 2007088148, WO 2007039142, WO 2005103045, WO 2007039145, WO 2004096210, and WO 2003037895); HCV NS4 [nhibitors (see WO 2007070556 and WO 2005067900); HCV NS5a Inhibitors (see US 2006276511, WO 2006120252, WO 2006120251, WO 2006100310, WO 2006035061); Toll-like receptor agonists (seeWO 2007093901); and other inhibitors (see WO 2004035571, WO 2004014852, WO 2004014313, WO 2004009020, WO 2003101993, WO 2000006529). A fourth aspect of the eighth embodiment, is directed to a method of 5 treatment in a subject in need thereof said method comprises alternatively or concurrently administering a therapeutically effective of a compound represented by formula I and another antiviral agent to the subject. It is understood that the time between alternative administration can range between 1-24 hours, which includes any sub-range in between including, 2, 3, 4, 5, 6, 7, 10 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, and 23 hours. A fifth aspect of the eighth embodiment, is directed to a method of treatment and/or prophylaxis in a subject in need thereof said method comprises administering to the subject a therapeutically effective of at least one compound represented by formula I and a therapeutically effective amount of another 15 antiviral agent; wherein the administration is concurrent or alternative. It is understood that the time between alternative administration can range between 1-24 hours, which includes any sub-range in between including, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, and 23 hours. A sixth aspect of the eighth embodiment, is directed to a method of 20 treatment in a subject in need thereof said method comprises alternatively or concurrently administering a therapeutically effective of at least one compound represented by formula I and another antiviral agent to the subject. It is understood that the time between alternative administration can range between 1-24 hours, which includes any sub-range in between including, 2, 3, 4, 5, 6, 7, 25 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, and 23 hours. It is contemplated that the another antiviral agent includes, but is not limited to interferon -a , interferon-P, pegylated interferon-a, ribavirin, levovirin, viramidine, another nucleoside HCV polymerase inhibitor, a HCV non-nucleoside polymerase inhibitor, a HCV protease inhibitor, a HCV helicase 30 inhibitor or a HCV fusion inhibitor. When the active compound or its derivative or salt are administered in combination with another antiviral agent the activity may be increased over the parent compound. When the treatment is combination therapy, such administration may be concurrent or sequential with respect to that of the nucleoside derivatives. "Concurrent administration" as used herein thus includes administration of the agents at the same time or at different times. 5 Administration of two or more agents at the same time can be achieved by a single formulation containing two or more active ingredients or by substantially simultaneous administration of two or more dosage forms with a single active agent. It will be understood that references herein to treatment extend to 10 prophylaxis as well as to the treatment of existing conditions. Furthermore, the term "treatment" of a HCV infection, as used herein, also includes treatment or prophylaxis of a disease or a condition associated with or mediated by HCV infection, or the clinical symptoms thereof. PROCESS FOR PREPARATION 15 An ninth embodiment of the present invention is directed to a process for preparing the compound of formula I, which comprises reacting a suitably substituted phosphochloridate compound 4 with a nucleoside analog 5 R3 R 3 b R RO HOBase R 4 0 ' Y 4 5 wherein the substituents R , R 2 , R 3 a", R3 , R 4, R, X, Y, R 6 , and base have 20 their meanings as disclosed in the Detailed Description of the Invention and X' is a leaving group, such as Cl, Br, I, tosylate, mesylate, trifluoroacetate, trifluorosulfonate, pentafluorophenoxide, p-N0 2 -phenoxide, or other commonly used leaving groups as disclosed in Advanced Organic Chemistry by March, Fourth Edition. Leaving groups and methods that can be used to effect the 25 formation of a phosphoramidate nucleoside conjugate are found in US 20060142238 and WO 2007095269. Preferably, the leaving group is Cl. This reaction is performed in an anhydrous aprotic solvent such tetrahydrofuran, dioxane, or both tetrahydrofuran and dioxane, or any functional equivalent thereof, with tetrahydrofuran being the preferred solvent. The reaction is typically initiated at a temperature range from -78 0 C to 40 0 C with the preferred reaction temperature being between 0C and room temperature. The nucleoside is first stirred with a base (5 to 12 equivalents) such as N 5 methylimidazole, collidine, pyridine, 2,6-lutidine, 2, 6-'Bu-pyridine, etc. a tertiary amine base, such as triethylamine, diisopropylethylamine, etc., or an alkyl Grignard reagent, such as tBuMgCl, tBuMgBr, MeMgCl, MeMgBr, etc. The phosphorochloridate (3-10 equivalents) is dissolved in the reaction solvent and added to the mixture of the nucleoside and base. The reaction is then 10 allowed to stir over a period of time at a temperature between room temperature and 40'C for a period of 30 min to 24 hr. with the preferred reaction temperature being room temperature and time being 24 hr. The solvent is removed from the reaction mixture and the product is purified by chromatography on silica gel. A tenth embodiment of the present invention is directed to a product 15 obtained by a process which comprises reacting a suitably substituted phosphochloridate compound 4 with a nucleoside analog 5 F- Base R 2 5 4 5 wherein the substituentsR , R 2,Rl, , R 4, R', X, Y, R, X', and base have their meanings as disclosed in the Detailed Description of the Invention. 20 This reaction can be performed in an anhydrous aprotic solvent or other suitable solvent, such as tetrahydrofuran, dioxane, or a mixture of tetrahydrofuran and dioxane, with tetrahydrofuran being the preferred solvent. The reaction is typically initiated at a temperature range from -78'C to 40'C with the preferred reaction temperature being between 0C and room temperature. 25 The nucleoside is first stirred with a base (5 to 12 equivalents) such as N methylimidazole, a tertiary amine base or tButyl Magnesium Chloride. A phosphorochloridate (3-10 equivalents (or suitable "phosphoro-(leaving group) date")) is dissolved in the reaction solvent and added to the mixture of the nucleoside and base. The reaction is then allowed to stir over a period of time at a temperature between room temperature and 40'C for a period of 30 min to 24 hr. with the preferred reaction, temperature being room temperature and time being 24 hr. The solvent is removed from the reaction mixture and the product is purified by chromatography on silica gel. 5 Compounds and Preparation Phosphoramidate compounds of the present invention can be prepared by condensation of a nucleoside analog 5 with a suitably substituted phosphochloridate compound 4 (Scheme 1). The nucleoside analog is made by conventional procedures disclosed in any one of U.S. Published Application 10 Nos. 2005/0009737, 2006/0199783, 2006/0122146, and 2007/0197463, each of which is incorporated by reference in its entirety. Disclosed I H-NMR values were recorded on a Varian AS-400 instrument. Mass spectral data were obtain using either a Micromass Quattromicro API or a Waters Acquity. 15 Thus, by way of example only, a suitably substituted phenol can be reacted with phosphorus oxychloride (1) to afford an aryloxy phosphorodichloridate 2 (see Example 1) which is subsequently treated with a acid addition salt of an a-amino acid ester in the presence of TEA to afford an aryloxy phosphorochloridate 4. This arylalkoxy-amino acid phosphoramidate is 20 reacted with the nucleoside analog to provide the product I (for procedure see, e.g., C. McGuigan et al. Antiviral Res. 1992 17:311-321; D. Curley et al. Antiviral Res. 1990 14:345-356; McGuigan et al. Antiviral Chem. Chemother 1990 1(2):107-113).
Scheme I R31 ,R 3 TI
?,R
1
NH
2 A- 3 R40 I CI-(CI
-
C- C O O A-=ClorTs 1 2 R3a Rb -R 1 HO 0 Base R ,R3b R NYl 0 _CIY X R R0 0 Base 4 X R 6 4 The preparation of nucleoside phosphoramidates requires reacting an 5 appropriately substituted phosphochloridate with a nucleoside containing a free 5'-hydroxyl moiety. In cases where only one hydroxyl group is present, preparation of the phosphoramidate usually proceeds smoothly when the phosphochloridate is reacted with the desired nucleoside. In cases where the nucleoside contains more than one free hydroxyl group, preparation of the 10 appropriately protected nucleoside might be required. Silyl, acetonide or other alcohol protecting groups known in the art might be warranted for protection of the sugar moiety. For protection of the nucleoside base, protecting a free amino group may require amidine protection strategy. Condensation of the phosphochloridate can be carried out on the 15 unprotected nucleoside. Since the 5'-OH group of a nucleoside is much less hindered than the 3'-OH group, selective phosphoramidation is possible under carefully controlled conditions. After condensation to form a protected phosphoramidate nucleoside, deprotection to obtain the free phosphoramidate nucleoside can be carried out using standard protocols for nucleic acid 20 chemistry. In many cases, the desired product is readily separated from the starting material using column chromatography on silica gel. The synthetic scheme is summarized in Scheme 1. eZ'7 1 A further understanding of the disclosed embodiments will be appreciated by consideration of the following examples, which are only meant to be illustrative, and not limit the disclosed invention. EXAMPLE 1 5 General Procedure for Preparation of phosphorodichloridates ?R1 C-P-CI + R'-OH CI-P-CI 2 A solution of the appropriate phenol R'-OH (leq) and triethylamine (I eq.) in anhydrous ether was added dropwise to a stirred solution of phosphoryl trichloride 1 (1 eq) at 0 C over a period of 3 hours under nitrogen. Then the 10 temperature was warmed to room temperature, and the reaction was stirred overnight. The triethylamine salt was quickly removed with suction filtration and the filtrate concentrated in vacuo to dryness to afford 2 as an oil which was used without further purification. EXAMPLE 2 15 General Procedure for Preparation of phosphorochloridates
-R
1
R
3 Ra ,Rb - R 1 CI-P-CI + NH 2 *A- 0 N C || R 4 0 I R 4 0 1 0 0 R2 R2 A- = Cr or Ts 2 3 A solution of triethylamine (2eq) in anhydrous dichloromethane was added dropwise to a solution of aryloxy-phosphodichloridate 2 (1 eq) and the appropriate amino ester 3 ( I eq) in anhydrous dichloromethane with vigorous stirring at -78 C over a period of 30 to 120 minutes. Then the reaction temperature was allowed to warm to room temperature and stirred over night. Solvent was removed. The residue was washed with ethyl ether and filtered, the 5 filtrate was dried over reduced pressure to give 4. EXAMPLE 3 General Procedures for nucleoside phosphoramidate derivatives R;F R3b R 1 - 3a R 3 b -. R' O+ HO Base R N"-C +
I
5 .
R
4 0 R 4 200NXIWORBase R~2 R 5 X R6 4 5 10 A solution of the appropriate phosphorochloridate 4 (6.5 equivalents) in anhydrous tetrahydrofuran (THF) was added to a mixture of nucleoside 5 (1 equivalent) and N-methylimidazole (8 equivalents) in anhydrous THF with vigorous stirring at room temperature and the reaction mixture was stirred overnight. The solvent was removed in vacuo and the crude was purified by 15 column chromatography and/or preparative thin layer chromatography to give I.
EXAMPLE 4 Preparation of 2'-deoxy-2'-fluoro-2'-C-methyluridine O N H 2 N NHBz HO BzCI BzO 80% AcOH pyridine Bzd f reflux O O O NI/MeOH 0 O BzO HO BzO HOF 2'-Deoxy-2'-fluoro-2'-C-methylcytidine (1.0g, 1 eq) (Clark, J., et al., J. 5 Med. Chem., 2005, 48, 5504-5508) was dissolved in 10 ml of anhydrous pyridine and concentrated to dryness in vacuo. The resulting syrup was dissolved in 20 ml of anhydrous pyridine under nitrogen and cooled to 0*C with stirring. The brown solution was treated with benzoyl chloride (1.63g, 3eq) dropwise over 10 min. The ice bath was removed and stirring continued for 1.5h whereby 10 thin-layer chromatography (TLC) showed no remaining starting material. The mixture was quenched by addition of water (0.5 ml) and concentrated to dryness. The residue was dissolved in 50 mL of dichloromethane (DCM) and washed with saturated NaHCO 3 aqueous solution and H 2 0. The organic phase was dried over NaSO 4 and filtered, concentrated to dryness to give N 4 ,3',5'-tribenzoyl-2' 15 Deoxy-2'-fluoro-2'-C-methylcytidine (2.0 g, Yield: 91%).
N
4 ,3',5'-tribenzoyl-2'-Deoxy-2'-fluoro-2'-C-methylcytidine (2.0g, I eq ) was refluxed in 80% aqueous AcOH overnight. After cooling and standing at room temperature (15 *C), most of the product precipitated and then was filtered through a sintered funnel. White precipitate was washed with water and co evaporated with toluene to give a white solid. The filtrate was concentrated and co-evaporated with toluene to give additional product which was washed with water to give a white solid. Combining the two batches of white solid gave 1.50g 5 of 3',5'-dibenzoyl-2'-Deoxy-2'-fluoro-2'-C-methyluridine (Yield: 91%). To a solution of 3',5'-dibenzoyl-2'-Deoxy-2'-fluoro-2'-C-methyluridine (1.5 g, leq) in MeOH (10 mL) was added a solution of saturated ammonia in MeOH (20mL). The reaction mixture was stirred at 0 *C for 30 min, and then warmed to room temperature slowly. After the reaction mixture was stirred for 10 another 18 hours, the reaction mixture was evaporated under reduced pressure to give the residue, which was purified by column chromatography to afford pure compound 2'-deoxy-2'-fluoro-2'-C-methyluridine (500 mg, Yield: 60 %). EXAMPLE 5 Preparation of 2'-Deoxy-2'-fluoro-2'-C-methyluridine 5'-(phenyl methoxy 15 alanyl phosphate) ~CI o H H 3 CO N P OO N HO 0- 0 0 H 0_ _ _ _ _ _ _ _ _ 0 / HO N MO0O N HOF HO HO F Phenyl methoxyalaninyl phosphorochloridate (1 g, 6.5 eq ) dissolved in 3 mL of THF was added to a mixture of 2'-Deoxy-2'-fluoro-2'-C-methyluridine 20 (0.15 g,1 eq) and N-methylimidazole (0.3 g, 8 eq) in 3 mL THF with vigorous stirring at room temperature, then the reaction was stirred overnight. Solvent was removed by reduced pressure. The resulting crude product was dissolved in methanol purified by prep-HPLC on a YMC 25x30X2 mm column using a water / acetonitrile gradient elution mobile phase. The acetonitrile and water were removed under reduced pressure to give the desired product (50.1 mg, 15.6%). H NMR (DMSO-d 6 ) 6 1.20-1.27 (m, 6H), 3.58 (d, J= 16.0 Hz, 3H), 3.75-3.92 (m, 2H), 4.015-4.379 (m, 2H), 5.54 (t, J= 10.2 Hz, 1H), 5.83-5.91 (m, 1H), 6.00-6.16 (m, 1 H), 7.18 (d, J= 8.0 Hz, 2H), 7.22 (s, 1 H), 7.35 (t, J= 4.4 Hz, 5 2H), 7.55 (s, 1H), 11.52 (s, I H); MS, m/e 502 (M+1)*. EXAMPLE 6 Preparation of 2'-Deoxy-2'-fluoro-2'-C-methyluridine 5'-(phenyl methoxy valyl phosphate) o
H
3 CO O H HO N MO O O 10 Phenyl methoxy-valyl phosphorochloridate (0.6 g, 3.6 eq ) dissolved in 3 mL of THF was added to a mixture of 2'-Deoxy-2'-fluoro-2'-C-methyluridine (0.15 g,1 eq) and N-methylimidazole (0.44 g, 9 eq) in 3 mL THF with vigorous stirring at room temperature, then the reaction was stirred overnight. Solvent was 15 removed by reduced pressure. The resulting crude product was dissolved in methanol purified by prep-HPLC on a YMC 25x30X2 mm column using a water / acetonitrile gradient elution mobile phase. The acetonitrile and water were removed under reduced pressure to give the desired product (60 mng, 20%). 'H NMR (DMS-dl 6 ) 5 0.74-0.847 (mn, 6H), 1.20-1.28 (in, 3H), 1.89-1.92 (in, 1IH), 20 3.50-3.54 (in, 1H), 3.58 (d, J= 10.4Hz, 3H), 3.72-3.95 (in, 1H), 4.03-4.05 (in, 1H), 4.23-4.43 (in, 2H), 5.56 (t, J= 16.0 Hz, 1 H), 5.85-5.92 (mn, IH), 6.01-6.07 (in, 11H), 7.16-7.21 (in, 3H), 7.37 (t, J= 8 Hz, 2H), 7.55-7.60 (in, 1H), 11.52 (s, 10H); MS, m/e 530 (M+1).
EXAMPLE 7 Preparation of 2'-Deoxy-2'-fluoro-2'-C-methyluridine 5'-(4-bromophenyl methoxy-valyl phosphate)
H
3 C Br OH3CO ONr r 0 N I o r %- 0 HO N N IWO N MeO H HO 5 4-Bromophenyl methoxy-valyl phosphorochloridate (1 g, 3.4 eq) dissolved in 3 mL of THF was added to a mixture of 2'-deoxy-2'-fluoro-2'-C methyluridine (0.2 g,1 eq) and N-methylimidazole (0.35 g, 6 eq) in 3 mL THF with vigorous stirring at room temperature, then the reaction was stirred 10 overnight. Solvent was removed by reduced pressure. The resulting crude product was dissolved in methanol purified by prep-HPLC on a YMC 25x30X2 mm column using a water / acetonitrile gradient elution mobile phase. The acetonitrile and water were removed reduced pressure to give the desired product (120 mg, 26%). 'H NMR (DMSO-d 6 ) 6 0.72-0.82 (m, 6H), 1.19-1.26 (m, 3H), 15 1.86-1.92 (m, I H), 3.48-3.50 (m, I H), 3.56 (d, J= 12.0 Hz, 3H), 3.72-3.89 (m, 1H), 3.96-4.03 (m, 1H), 4.22-4.37 (m, 2H), 5.54-5.60 (m, 1H), 5.85-5.91 (m, 1H), 5.98-6.13 (m, 1H), 7.15 (d, J= 8.0 Hz, 2H), 7.49-7.56 (m, 3H), 11.53 (s, I H); MS, m/e 608 (M+1)*.
EXAMPLE 8 Preparation of 2'-Deoxy-2'-fluoro-2'-C-methyluridine 5'-(4-bromophenyl methoxy-alanyl phosphate) o H 3 o H O Br Br HO/g NI 11 N MeO HO0 HO O 5 4-Bromophenyl methoxy-alanyl phosphorochloridate (0.6 g, 5 eq) dissolved in 3 mL of THF was added to a mixture of 2'-deoxy-2'-fluoro-2'-C methyluridine (0.15 g,I eq)and N-methylimidazole (0.3 g, 7.8 eq) in 3 mL THF with vigorous stirring at room temperature, then the reaction was stirred 10 overnight. Solvent was removed by reduced pressure. The resulting crude product was dissolved in methanol purified by prep-HPLC on a YMC 25x3OX2 mm column using a water / acetonitrile gradient elution mobile phase. The acetonitrile and water were removed under reduced pressure to give the desired product (40 mg, 12 %); 'H NMR (DMSO-d 6 ) 5 1.20-1.26 (in, 6H), 3.57 (d, J= 15 2.8 Hz, 3H), 3.84 (s, 1H), 3.97-4.03 (m, 1H), 4.21-4.25 (m, 1H), 4.33-4.37 (m, 2H), .5.54-5.60 (m, 1H), 5.83-5.89 (m, 1 H), 5.98-6.19 (m, 1 H), 7.16 (t, J= 10.2 Hz, 2H), 7.52-7.57 (m, 3H), 11.52 (s, I H); MS, m/e 580(M+1)*. EXAMPLE 9 Preparation of N 4 -(NN-dimethylformamidinyl)-2'-deoxy-2'-fluoro-2'-C 20 methylcytidine Q-N NHI N N Nx- NH2O N N HO O N.- DMA-DMF H HO F HO F 2'-Deoxy-2'-fluoro-2'-C-methylcytidine (500 mg, 1.9 mmol) was stirred with dimethylformamide dimethyl acetal in DMF (10 mL). The resulting mixture was stirred at room temperature overnight. After solvent removal the jK.7Q crude product was used for next step without further purification. EXAMPLE 10 Preparation of 2'-Deoxy-2'-fluoro-2'-C-methylcytidine 5'-(phenyl methoxy alanyl phosphate)
H
3 CO CN'\OO N N. N NN HO 0 N ONH 2 HOe 5 HO F HO F Phenyl methoxyalaninyl phosphorochloridate (0.6 g, 6 eq ) dissolved in 3 mL of THF was added to a mixture of N 4 -(NN-dimethylformamidinyl)-2' deoxy-2'-fluoro-2'-C-methylcytidine (0.15 g,1 eq) and N-methylimidazole (0.3 g, 10 7.8 eq) in 3 mL THF with vigorous stirring at room temperature, then the reaction was stirred overnight. Solvent was removed by reduced pressure. The resulting crude product was dissolved in methanol purified by prep-HPLC on a YMC 25x3OX2 mm column using a water / acetonitrile gradient elution mobile phase. The acetonitrile and water were removed under reduced pressure to give 15 the desired product (62 mg, 20.6%). 'H NMR (DMSO-d 6 ) 6 1.16 (d, J= 23.2 Hz, 3H), 1.22 (d, J= 7.2 Hz, 3H), 3.56 (S, 3H), 3.69-3.75 (d, J= 25.6 Hz, lH), 3.82-3.86 (m, 1H), 3.96-3.98 (m, 1H), 4.21-4.34 (m, 2H), 5.68 (d, J= 7.2 Hz, 1H), 5.75-5.77 (m, I H), 6.07-6.16 (m, 1H), 7.15-7.19 (m, 3H), 7.2 (d, J= 9.2 Hz, 2H), 7.39 (t, J= 7.8 Hz, 2H), 7.48 (d, J= 9.2 Hz, 1H); MS, m/e 501(M+1)*. 20 EXAMPLE 11 Preparation of 2'-Deoxy-2'-fluoro-2'-C-methylcytidine 5'-(4-bromophenyl methoxy-valyl phosphate) - C1, '0 H3CO .. <"NNPO / \ Br Br N Cf o HO M HO NH2 5 HO Fe H &F0 4-Bromophenyl methoxy-valyl phosphorochloridate (1.0 g, 3.4 eq.) dissolved in 3 mL of THF was added to a mixture of N 4
-(N,N
dimethylformamidinyl)-2'-deoxy-2'-fluoro-2'-C-methylcytidine (0.2 g,1 eq.) and 10 N-methylimidazole (0.35 g, 6 eq.) in 3 mL THF with vigorous stirring at room temperature, then the reaction was stirred overnight. Solvent was removed by reduced pressure. The resulting crude product was dissolved in methanol purified by prep-HPLC on a YMC 25x30X2 mm column using a water / acetonitrile gradient elution mobile phase. The acetonitrile and water were 15 removed under reduced pressure to give the desired product as a white solid (59 mg, 13%); 1 H NMR (DMSO-d 6 ) 6 0.74-0.83 (m, 6H), 1.12-1.20 (in, 3H), 1.89 1.92 (m, IH), 3.49-3.51 (in, I H), 3.55 (s, 3H), 3.59-3.68 (in, I H), 3.72-.383 (m, 1H), 4.21-4.39 (in, 2H), 5.70-5.72 (m, 1H), 5.76-5.83 (m, 1H), 6.04-6.16 (in, IH), 7.15 (d, J = 13.0 Hz, 2H), 7.26 (s, 1 H), 7.33 (s, 1H), 7.46-7.55 (m, 1I H), 20 7.56 (d, J = 4.4 Hz, 2H) ; MS, m/e 607 (M+1)*.
ICO
EXAMPLE 12 Preparation of 2'-deoxy-2'-fluoro-2'-C-methylcytidine 5'-(phenyl methoxy valyl phosphate) O N-N H 3 CO O O N N YI N HO 0'~IN 0 NH 2 io MeO HO0 5 HO F O Phenyl methoxy-valyl phosphorochloridate (0.6 g, 6 eq ) dissolved in 3 mL of THF was added to a mixture of N 4 -(NN-dimethylformamidinyl)-2' deoxy-2'-fluoro-2'-C-methylcytidine (0.15 g,I eq) and N-methylimidazole (0.3 g, 10 7.8 eq) in 3 mL THF with vigorous stirring at room temperature, then the reaction was stirred overnight. Solvent was removed by reduced pressure The resulting crude product was dissolved in methanol purified by prep-HPLC on a YMC 25x30X2 mm column using a water / acetonitrile gradient elution mobile phase. The acetonitrile and water were removed under reduced pressure to give 15 the desired product as a white solid (86 mg, 42.9 %). 1 H NMR (DMSO-d) 6 0.72-0.80 (in, 6H), 1.09-1.18 (in, 3H), 1.87-1.92 (in, 1H), 3.47-3.51 (m, I H), 3.58 (s, 3H), 3.71-3.75 (in, I H), 3.97 (t, J= 11.2 Hz,1H), 4.22-4.37 (in, 2H), 5.70 (d, J= 8.0 Hz, IH), 5.76-5.84 (in, I H), 6.01-6.15 (m, IH), 7.13-7.18 (in, 3H), 7.27 (s, 2H), 7.34 (d, J= 4.0 Hz, 2H), 7.46-7.50 (m, IH); MS, m/e 529 20 (M+1)+. <Q 1 EXAMPLES Example numbers 13-54 and 56-66 are prepared using similar procedures described for examples 5-8. The example number, compound identification, and NMR/MS details are shown below: H
R
3 a R3b 0 OR' 0 N N 0 N 0 P1 HO' 5 F Ex. R' R 2 R 3 R A R4 NMR/MS 13 Ph H H Me Et I H NMR (DMSO-d) 1.12-1.16 (m, 3H), 1.20-l.28(m,6H), 3.70-3.90 (m, 2H), 4.00-4.08 (m, 3H), 4.18-4.45 (m, 2H), 5.52-5.58 (m, I H), 5.85-5.98 (m, I H), 6.00-6.20 (m, 2H), 7.16-7.23 (m, 3H), 7.37-7.40 (m, 2H), 7.54-7.60 (m, IlH), 11.54 (s.IH); MS, ne 516.1 (M+I)+ 14 1-Napth H H Me Bn I H NMR (DMSO-d) 6 1.18-1.30 (m, 6H), 3.784.10 (m, 3H), 4.38 4.49 (m, 2H), 4.99-5.11 (m, 2H), 5.28-5.40 (m, IlH), 5.85-6.10 (m, 2H), 6.30-6.41 (m, I H), 7.28-7.32 (m, 5H), 7.41-7.60 (m, 5H), 7.73 7.76(m, I H) , 7.94-8.1 1(m, I H) , 8.13-8.15(m, I H) , 11.50 (s.I H); MS, m/e 628.4 (M+1)+ 15 Ph H H H Me I H NMR (DMSO-d 6 ) 8 1.22 (d, J=22.4 Hz, 3H), 3.59(s, 3H), 3.63-3.69 (m, 2H), 3.74-3.8(m, I H), 4.02(d, J=I 1.2 Hz, I H), 4.23-4.28(m, I H), 4.404.43 (m, I H), 5.57-5.60 (m, I H), 5.89(d, J=6.8 Hz, I H), 6.00 6.06(m, 2H), 7.15-7.23 (m, 3H), 7.35-7.39 (m, 2H),7.52(d, J=8 Hz, IH), 1 1.52(s, IH); MS, n/e 487.97 (M+I)+ 16 2,4-Cl- H H Me Me I H NMR (DMSO-d 6 ) S 1.22-1.28 (m, 6H), 3.57-3.60 (m, 3H), 3.84 Ph 3.92 (m, 2H), 4.004.04 (m, I H), 4.314.44 (m, 2H), 5.54-5.61 (m, IH), 5.85-6.10 (m, 2H), 6.32-6.43 (m, IH), 7.44-7.54 (m, 3H), 7.72 7.75 (m, IH), 11.54 (s. IH); MS, m/e 570.2 (M+I)+ 17 1-Napth H H Me Me I H NMR (DMSO-d 6 ) 6 1.15-1.27 (m, 6H), 3.51-3.55 (d, 3H), 3.85 3.96 (m, 2H), 4.004.10(m, I H), 4.304.46 (m, 2H), 5.31-5.39 (m, IH), 5.89-6.05 (m, 2H), 6.22-6.34 (m, IH), 7.44-7.60 (m, 5H), 7.73-7.77 (m, I H), 7.93-7.96 (m, I H), 8.12-8.14 (m, I H), I 1.50(s. I H) ; MS, m/e 552.1 (M+1)+ 18 Ph * H * Me 1H NMR (DMSO-d) 6 1.19 (d, J=22.8 Hz, 3H), 1.69-1.84 (m, 3H), 1.99-2.04 (m, I H), 3.16-3 21 (m, 2H), 3.58 (s, 3 H), 3.68-3.8 (m, I H), 4.00 (m, I H), 4.014.13 (m, I H), 4.22-4.25 (m, I H), 4.5 (d, J = 11.2 Hz, IH), 5.54 (d, J = 8.0 H z, IlH), 5.86 (s, I H), 5.6 (d, J = 19.6 Hz, I I), 7.15-7.2 (m, 3H), 7 34 (t, J = 8.0 Hz, 2H), 7.51 (d, J = 8.0 Hz, lI I), 11.38 (s, I H) ; MS, m/e 527.93(M+I)+ 19 Ph H H Me n-Bu I H NMR (DMSO-d) 8 0.80-0.90 (m, 3H), 1.20-1.35 (m, 8H), 1.48 1.55 (m, 2H), 3.78-3.88 (m, 2H), 3.95-4.08 (m, 3H), 4.224.45 (m, 2H), 5.55-5.57(t, I H), 5.85-6.18 (m, 3H), 7.14-7.23 (m, 3H), 7.35-7.40 (m, 2H), 7.51-7.60 (d, I H), 11.50 (s.IH) ; MS, m/e 544.2 (M+l)+ 20 Ph H H Me Bn I H NMR (DMSO-d 6 ) S 1.20-1.30 (m, 6H), 3.72-4.05 (m, 3H), 4.23 4.27 (m, I H), 4.324.45 (m, I H), 5.07-5.10(t, 2H), 5.52-5.56(t , I H), Ex. R' R 2
R
3 8 R 3 b R 4 NMR/MS 5.86-6.10 (m, 2H), 6.13-6.21(m,I H), 7.15-7.21 (m, 3H), 7.29-7.40 (m, 7H), 7.51-7.56 (d, I H), 11.50 (s.1 H); MS, m/e 578.2 (M+1)+ 21 4-F-Ph H H Me Me I H NMR (DMSO-d 6 ) 8 1.28-1.34 (m, 6H), 3.65(d, J= 4 Hz, 3H), 3.85 3.96 (m, 2H), 4.06-4.12 (m, I H), 4.30-4.34 (m, I H), 4.40-4.47 (m, I H), 5.62-5.67 (m, I H), 5.94-6.01 (m, I H), 6.09 (d, J=l8.8 Hz, I H), 6.17 6.26 (m, I H), 7.27-7.33(m, 4H), 7.62 (d, J = 7.6 Hz, I H), 11.61 (s, 1 H) ; MS, m/e 519.94(M+1)+ 22 4-Cl-Ph H H Me Me I H NMR (DMSO-d 6 ) S 1.22-1.28 (m, 6H), 3.58 (d, 2H), 3.70 3.95(m,2H), 3.95-4.08 (m,I H), 4.23-4.45 (m, 2H), 5.55-5.61(t , 1 H), 5.85-6.10 (m, 2H), 6.15-6.23(m,I H), 7.20-7.26 (m, 2H), 7.43-7.46 (m, 2H), 7.54-7.57 (d, I H), 11.50 (s.I H) ; MS, m/e 536.1 (M+1)+ 23 3,4-Cl- H H Me Me I H NMR (DMSO-d) 5 1.13 (m, 6H), 3.49 (s, 3H), 3.61-3.85 (m, 2H), Ph 3.90-3.93 (m, I H), 4.16-4.22 (m, I H), 4.27-4.31 (m, IH), 5.47-5.52 (m, IH), 5.82 (d, J = 11.6 Hz, I H), 5.93(d, J = 19.2 Hz, 1H), 6.15-6.25 (m, I H), 7.13 (t, J =9.6 Hz, I H), 7,43 (d, J = 12Hz, 2H), 7.57 (d, J = 6.0 Hz, I H), I 1.43(s, I H) ; MS, m/e 569.85 (M+1)+ 24 Ph H H Me 2-Bu I H NMR (DMSO-d) 5 0.83 (d, J = 6.8 Hz, 6H), 1.20-1.26 (m, 6H), 1.79-1.86 (m, I H), 3.73-3.90 (m, 4H), 4.01 Ct, J= 11.2 Hz, I H), 4.21 4.28 (m, I H), 4.33-4.42 (m, I H), 5.54 (t, J = 7.6 Hz, I H), 5.85-5.92 (m, I H), 5.99-6.13 (m, 2H), 7.19 (t, J = 8 Hz, 3H), 7.36 (t, J = 7.6 Hz, 2H), 7.53 (d, J = 7.6 Hz, I H), 11.52 (s, l H) ; MS, rn/e 544.00 (M+1)+ 25 Ph H H Me i-Pr I H NMR (DMSO-d,) 8 1.13-1.28 (m, 12H), 3.74-3.81 (m, 2H), 3.95 4.08 (m,I H), 4.204.45 (m, 2H), 4.83-4.87 (m, I H), 5.52-5.58 (m, I H), 5.84-6.15 (m, 3H), 7.17-7.23 (m, 3H), 7.35-7.39 (m, 2H), 7.54-7.57 (m, I H), 11.50 (s.I H) ; MS, m/c 530.2 (M+1)+ 26 4-MeO- H H Me n-Bu I HNMR (400MHz, DMSO-d 6 ): 8 =0.78-0.82 (m, 3H), 1.29-1.47 (m, Ph 8H), 1.49-1.54 (m, 2H), 3.66-3.87 (m, 5H), 3.96-4.02 (m, 3H), 4.21 4.39 (m, 2H), 5.57 (t, J= 12.0Hz, I H), 5.84-6.05 (m, 3H), 690 (dd, JI =8.OHz, J2=4.OHz, 2H), 7.09-7.14 (dd, 11=16.0Hz, J2=4.OHz, 2H), 7.55 (d, J=8.0Hz, I H), 11.48-11.62 (s, IH) 27 4-F-Ph H H Me Et IH NMR (DMSO-d) 5 1.12-1.28 (m, 9H), 3.72-3.94(m,2H) ,3.98-4.10 (m,3H), 4.21-4.42(m,2H), 5.55-5.61 (t, I H), 5.85-6.20 (m, 3H), 7.18 7.25 (m,4H), 7.55-7.58 (d, IH), 1.50 (s.1H); MS, n/e 533.90 (M+I)+ 28 4-F-Ph H H Me i-Pr I H NMR (DMSO-d 6 ) 8 1.13-1.30 (m, 12H), 3.74-3.85(m,2H),3.98 4.06 (m,IH), 4.23-4.41(m,2H), 4.834.87 (m, IH), 5.55-5.61 (t, IH), 5.85-6.12 (m, 3H), 7.18-7.24 (m,4H), 7.55-7.58 (d, IH), 11.50 (s.tH) MS, rn/e 547.91 (M+1)+ 29 4-F-Ph H H Me Bn .1 H NMR (DMSO-d) 8 1.10-1.23 (m, 6H), 3.65-3.89(m,3H) ,4.10-4.30 (m,2H), 4.96-5.00(m,2H), 5.46-5.50 (t, I H), 5.75-5.96 (m, 2H), 6.04 6.12(m,IH), 7.05-7.11 (m,4H), 7.20-7.24 (d, SH), 7.42-7.45(d,IH), 11.50 (s.I H) ; MS, m/e 595.94 (M+1)+ 30 4-MeO- H H Me i-Pr I HNMR (400MHz, DMSO-d): 8=1.15-1.27 (m, 12H), 3.71-3.89 (m, Ph 5H), 3.984.02 (m, I H), 4.22-4.25 (m, I H), 4.33-4.39 (m, I H), 4.84 4.87 (m, I H), 5.57 (t, J= 12.0Hz, 1 H), 5.91-6.03 (m, 3H), 6.90 (d, J= 8.0Hz, 2H), 7.09-7.14 (m, 2H), 7.55 (d, J= 8.0Hz, IH), 11.51 (s, 1H) 31 2-Cl-Ph H H Me Bn I H NMR (DMSO-d) 5 1.23 (m, 6 H), 3.934.00 (m, 3 H), 4.274.40 (m, 2H), 5.0(t, J= 7.2 Hz, 2 H), 5.53 (m, , H), 5.80-6.0(m , 2 H), 6.30(m, I H), 7.15 (d, J= 2.4 Hz, I H), 7.27 (m, 6 H), 7.51 (m, 3 H), 11.5 (s, I H); MS, n/e 579.87(M+I)+ / 596.78 (M+18)+ Ex. R' R 2
R
3 2 R 3 b R 4 NMR/MS 32 2,4-Cl- H H Me n-Bu 1H NMR (DMSO-d,) 8=0.82 (m, 3 H),1.23 (m, 8 H), 1.47 (m, 2 H), Ph 3.86 (m, 2 H), 3.84 (m, 3 H),4.27-4.43 (m, 2H), 5.5 (m, I H), 6.02 (m ,2 H), 6.35(m, IH), 7.44 (m, 3 H), 7.77 (m, I H), 11.5 (s, I H); MS, m/e 611.87(M+[)+ 33 4-Me- H H Me i-Pr I H NMR (DMSO-d) 6 1.14-1.27 (m, 12H), 2.17-2.26 (m, 3H), 3.73 Ph 3.82 (m, I H), 3.99-4.02 (m, I H), 4.23-4.26 (m, I H), 4.37-4.40 (m, IH), 4.824.88 (m, 1H), 5.52-5.58 (m, IH), 5.85-6.07 (m, 3H), 7.01 7.20 (m, 4H), 7.55 (d, J = 16Hz, 1H), 11.51 (s, 11); MS, m/e 543.98 (M+1)+; 1108.86 (2M+23)+ 34 4-F-Ph H H Me n-Bu I H NMR (DMSO-d 6 ) 8 0.82-0.89 (m,3H), 1.20-1.31 (m, 8H), 1.48 1.53 (m,2H), 3.77-3.90 (m,2H),3.95-4.10 (m,3H), 4.21-4.45(i,2H), 5.56-5.61 (t, I H), 5.83-6.20 (m, 3H), 7.18-7.25 (m,4H), 7.55-7.58 (d, I H), 11.50 (s.I H); MS, rn/c 584.1 (M+23)+ 35 3,4- H H Me Et I H NMR (DMSO-d) S1.12-1.31 (m, 9H), 3.77-3.92 (m,2H), 3.95-4.08 diCl-Ph (m,3H), 4.21-4.45(m,2H), 5.56-5.62 (t, I H), 5.80-6.11 (m, 2H), 6.18 6.33(m, I H), 7.18-7.25 (m, I H), 7.49-7.56 (d, 2H), 7.62-7.67(m, I H), 11.50 (s.IH) ; MS, m/e 606.1 (M+23)+ 36 2-Cl-Ph H H Me i-Pr I HNMR (400MHz, DMSO-d): 6 =1.12-1.16 (m, 6H), 1.21-1.27 (m, 6H), 3.79-3.85 (m, 2H), 4.00-4.07 (m, I H), 4.28-4.32 (m, I H), 4.38 4.43 (m, I H), 4.83-4.87 (m, I H), 5.56 (dd, J I=16.OHz, J2=8.OHz, I H), 5.85-6.12 (m, 2H), 6.20-6.33 (m, I H), 7.19-7.22 (m, I H), 7.33 (t, J= 16.0Hz, 1H), 7.48-7.55 (m, 3H), 11.55 (s, 1H) 37 4-MeO- H H Me Bn I HNMR(400MHz, DMSO-d): &=1.19-1.26 (m, 6H), 3.69-3.70 (s, Ph 3H), 3.87 (m, 2H), 3.99 (m, I H), 4.204.21 (m, I H), 4.35 (m, I H), 5.07-5.09 (m, 2H), 5.54 (t, J = 16.0Hz, I H), 5.85-5.92 (m, I H), 6.04 6.10 (m, 2H), 6.86 (d, J= 8.0Hz, 2H), 7.09 (dd, J1=16.0 Hz, J2=4.OHz, 2H), 7.30-7.34 (m, 5H), 7.53 (s, 1H), 11.52 (s, 1 H) 38 Ph H H Me n-Pen I H NMR (DMSO-d 6 ) 6 0.79-0.81 (m, 3H), 1.17-1.23 (m, IOH), 3.74 3.81 (m, 2H), 3.94-3.96 (m, 3H), 4.194.36 (m, 2H), 5.49-5.54 (m, IH), 5.87-6.08 (m,3H), 7.14-7.33 (m, 3H), 7.31-7.35 (m, 2H), 7.51 (d, J = 8Hz, I H), 11.51 (s, IH); MS, / 557.9 (M+1)+; 1136.88 (2M+23)+ 39 4-Cl-Ph H H Me i-Pr IH NMR (DMSO-d 6 ) 6 1.04-1.19 (m, 12H), 3.76-3.80 (m, 2H), 3.98 4.08 (m, I H), 4.424.42 (m, 2H), 4.82-4.85 (m, I H), 5.55-5.60 (m, I H), 5.80-6.20 (m,3H),7.20-7.2 5(m, 2H), 7.43 (d, J = 8.8Hz, I H), 7.54 (d, J = 8Hz, IH), 11.51 (s, IH); MS, r/e 563.88 (M+1)+; 1148.73 (2M+23)+ 40 4-Cl-Ph H H Me n-Bu I H NMR (DMSO-d) 6 0.85 (t, J = 7.2 Hz, 3H), 1.22-1.33 (m, 8H),1.45-1.53 (m, 2H), 3.80-3.87 (m, 2H), 3.96-4.04 (m, 3H), 4.24 4.27 (m, I H), 4.35-4.39 (m, I H), 5.56-5.61 (m, I H), 5.82-6.11 (m, 2H), 6.15-6.18 (m, 1H), 7.20-7.56 (m, 4H), 7.51-7.57 (m. H), 11.54 (s, I H); MS, n/e577.95(M+1)+ 41 4-Cl-Ph H H Me Et I H NMR (DMSO-d) 5 1.14 (t, J= 7.OHz, 3H), 1.20-1.28 (m, 6H),3.77-3.88 (m, 2H), 3.994.07 (m, 3H), 4.24-4.28 (m, IH), 4.34 4.43 (m, IH), 5.56-5.61 (m, I H), 5.86-6.13 (m, 2H), 6.15-6.24 (m, 1 H), 7.20-7.26 (m, 2H), 7.44 (d, J = 7.6Hz, 2H), 7.55 (d, J = 7.6Hz, I H), 11.55 (s, IH); MS, i/e549.1 I(M+1)+ 42 4-Me- H H Me n-Bu I H NMR (DMSO-d) 8 0.79-0.83 (m, 3H), 1.17-1.28 (m, 8H), 1.45 Ph 1.47 (m, 2H), 2.22 (d, J = 2.8Hz, I H), 3.70-3.90 (m, 2H), 3.95-3.98 4oA Ex. R' R 2
R
3 R R 3 b R4 NMR/MS (m, 3 H), 4.10-4.40 (m, 2H), 5.51 (t, I H), 5.80-5.90 (m, I H), 5.95-6.05 (m, 2H), 7.02-7.06 (m, 2H), 7.51 (t, J= 4.2Hz, 4H), 7.51 (d, I H), 11.51 (s, IH) ; MS, m/e 557.99(M+l)+; 1 136.84(2M+23)+ 43 4-Me- H H Me Bn IHNMR(DMSO-d 6 )6 1.16-1.24 (m, 6H), 2.22 (s,3H), 3.65-4.03 Phe (m,3H), 4.11-4.38 (m, 2H), 5.04-5.05 (m, 2H), 5.48-5.50 (m, I H), 5.77-5.87 (m, IH),5.90-6. 11 (m, 2H), 6.98-7.10 (m, 4H), 7.28-7.32 (m, 5H), 7.50 (t ,IH), 11.48 (s, IH) ;MS, n/e 592.00 (M+1)+. 44 Ph H H Et Me IHNMR(DMSO-d)S0.70-0.80(m,3H), 1.11-1.26 (m, 3H), 1.42 1.61 (m, 2H), 3.50-3.54 (m, 3H), 3.58-3.80 (m, 2H), 3.914.02 (m, IH), 4.124.38 (m, 2H), 5.47-5.52 (m,l H),5.90-6.03 (m, 2H), 7.08 7.16 (m, 3H), 7.26-7.35 (m, 2H),7.48 (t, H),1 1.45 (s, IH); MS, m/e 515.95 (M+1)+; 1052.82 (2M+23)+ 45 Ph H H Me 4-F-Bn 'HNMR (400MHz, DMSO-d): S 1.20-1.26 (m, 6H), 3.80-3.93 (m, 2H), 3.98 (s, I H), 4.254.26 (m, I H), 4.364.37 (m, I H), 5.07 (s, 2H), 5.52-5.55 (m, I H), 5.86-5.87(m, I H), 5.98-6.04 (m, I H), 6.14-6.17 (m, I H), 7.15-7.20 (m, 5H), 7.36 (dd, J = 20.0, 8.0 Hz, 4H), 7.54 (s, I H), 11.55 (s, IH) 46 4-Cl-Ph H H Me n-Bu 'HNMR (400MHz, DMSO-d): 8 1.21-1.28 (m, 6H), 3.71-3.88 (m, I H), 3.91-3.98 (m, I H), 4.00-4.01 (m, I H), 4.23-4.27 (m, I H), 4.35 4.38 (m, I H), 5.08 (d, J = 4.0Hz, 2H), 5.57 (dd, J = 12.0, 8.0 Hz, I H), 5.91 (d, J = 8.0 Hz, I H), 6.01 (d, J = 8.0 Hz, I H), 6.22-6.24 (m, I H), 7.17-7.23 (m, 2H), 7.31-7.40 (m, 7H), 7.53 (s, I I), 11.50 (s, I H) 47 Ph H H Me 3-Me-I- 'H NMR (DMSO-d) 8 0.80-0.82 (m, 6H), 1.18-1.40 (m, 8H), 1.50 Bu 1.58 (m, I H), 3.71-3.82 (m, 3H), 3.97-3.4.01 (m, 3H), 4.214.40 (m, 2H), 5.30(t, J = 8.6 Hz, 1 H), 5.81-6.10 (m, 3H), 7.15-7.20 (m, 3H), 7.32-7.36 (m, 2H), 7.48 (d, J = 8.4 Hz, I H), 11.38 (s, I H); MS, m/e 557.98 (M+1)'; 1136.88 (2M+23)* 48 3,4- H H Me Bn 'H NMR (DMSO-d) & 1.05-1.37 (m, 6H), 3.71-3.82 (m, I H), 3.87 diCl-Ph 4.02 (m, 2H), 4.284.29 (m, I H),4.36-4.38 (m, I H),5.04 (d, J = 5.2Hz, 2H), 5.55-5.64 (m, 1 i), 5.85-5.94 (m, I H), 6.00-6.05 (m, I H), 6.29 6.40 (m, I H),7.17-7.24 (m, I H), 7.30-7.41 (m, 5H), 7.45-7.58 (m, 2H), 7.61 (d, J= 4.Hz, I H), 11.53 (s, IH); MS, m/e545.80(M+I)*; 49 Ph H H Me c-Hex 'H NMR (DMSO-ds) S 1.18-1.41 (m, 12H), 1.59-1.67 (m, 4H), 3.74 13.80 (m, I H), 3.96-4.02 (m, I H), 4.19-4.26 (m, I H), 4.31-4.39 (m, I H), 4.60 (s, I H), 5.52 (t, J= 7.8 Hz, I H), 5.80-6.09 (m, 3H), 7.15 7.20 (m, 3H), 7.32-7.36 (m, 2H), 7.52 (d, J = 8 Hz, 1 H), 11.50 (s, I H) MS, m/e 569.98 (M+I); 592.14 (M+23)* 50 Ph H Me H n-Bu I H NMR (DMSO-d) 8 0.76 (t, J = 7.2Hz, 3H), 1.10-1.22 (m, 8H), 1.38-1.43 (m, 2H), 3.72-3.75 (m, 2H), 3.87-3.93 (m, 3H), 4.14-4.21 (m, I H), 4.234.33 (m, I H), 5.46-5.54 (m, I H), 5.84-6.11 (m, 3H), 7.09-7.14 (m, 2H), 7.27-7.32 (m, 2H), 7.34-7.51 (m, IH), 11.47 (s, I H); MS, m/e543.98(M+1)+ 51 Ph H Me H i-Pr I H NMR (DMSO-d) 8 1.39 (d, J = 7.2Hz, 6H), 1.19-1.29 (m, 6H), 3.65-3.75 (m, 2H), 3.954.05 (m, I H), 4.204.22 (m, I H), 4.31-4.33 (m, 1 H), 4.79-4.82 (m, I H), 5.48-5.57 (m, I H), 5.84-5.91 (m, I H), 5.96-6.07 (m, 2H), 7.12-7.35 (m, 5H), 7.44-7.54 (m. H), 1 1.49(s, I H); MS, m/e529.96 (M+1)+ 52 Ph H Me H Bn 'H NMR (DMSO-d 6 ) 6 1.18-1.28 (m, 6H), 3.70-3.83 (m, I H), 3.87 3.94 (m, I H), 3.994.01 (m, I H), 4.234.26 (m, I H), 4.334.37 (m, Ex. R' R 2
R
3 a R A R 4 NMR/MS I H), 5.03-5.12 (in, 2H), 5.51-5.59 (in, I H), 5.87-5.90 (in, I H), 5.95 6.07 (m, I H), 6.10-6.27 (m, I H), 7.15-7.23 (m, 31), 7.31-7.38(m, 7H), 7.47-7.56 (in, IH), I 1.50 (s, IH); MS, m/e577.99 (M+1)+ 53 2-Cl-Ph H H Me n-Bu 'HNMR (400MHz, DMSO-d): 8 0.81-0.86 (in, 3H), 1.21-1.31 (m, 8H), 1.46-1.52 (in, 2H), 3.84-3.90 (m, 2H), 3.97-4.04 (m, 3H), 4.27 4.41 (m, 2H), 5.53-5.58 (in, I H), 5.82-5.95 (m, I H), 5.96-6.10 (m, I H), 6.27-6.31 (m, I H), 7.19-7.22 (m, I H), 7.34 (dd, J = 8.0, 4.0 Hz, 1 H), 7.47-7.55 (m, 3H), 11.55 (s, I H) 54 4-Br-Ph H H Me i-Pr 'HNMR (400MHz, DMSO-d): S 1.10-1.14 (in, 6H), 1.20-1.27 (m, 6H), 3.74-3.81 (in, 2H), 3.99-4.01 (in, I H), 4.21-4.25 (m, I H), 4.37 4.38 (m, IH), 4.81-4.85 (in, I H), 5.58 (dd, J = 8.0, 4.0 Hz, I H), 5.82 5.95 (in, I H), 5.96-6.09 (m, I H), 6.10-6.13 (m, I H), 7.18 (dd, J= 12.0, 8.0 Hz, 2H), 7.53-7.57 (in, 3H), 11.52 (s, I I) 55 4-F-Ph H H Me c-Hex 'H NMR (DMSO-d) S 1.20-1.44 (m, 12H), 1.60-1.71 (m, 4H), 3.75 4.02 (in, 2H), 3.94-4.02 (in, I H), 4.19-4.26 (in, 2H), 4.59-4.61 (m, I H), 5.57 (t, J = 8.4 Hz, I H), 5.85-6.06 (m, 3H), 7.17-7.23 (in, 4H), 7.54 (d, J= 8.4 Hz, I H), 11.50 (s, I H) ; MS, m/e 587.92 (M+1)* 56 4-Br-Ph H H Me c-Hex 'HNMR (400MHz, DMSO-d): S=1.18-1.46 (in, 12H), 1.61-1.69 (m, 4H), 3.75-3.82 (m, 2H), 3.95-4.08 (m, I H), 4.25-4.28 (in, I H), 4.38 (s, IH), 4.60-4.62 (in, I H), 5.56-5.60 (in, IH), 5.82-5.95 (in, I H), 6.02 6.20 (in, 2H), 7.09-7.20 (in, 2H), 7.53-7.57 (in, 3H), 11.52 (s, IH) MS, m/e 650.0 (M+3)* 57 Ph H H Et i-Pr 'HNMR (400MHz, DMSO-d 6 ): 8 =0.75-0.82 (in, 3H), 1.12-1.26 (in, 9H), 1.52-1.59 (in, 2H), 3.55-3.68 (m, IH), 3.72-3.85 (m, IH), 3.95 4.08 (m, IH), 4.18-4.28 (m, IH), 4.32-4.41 (in, IH), 4.83-4.86 (in, I H), 5.55 (in, J= 7.6Hz, I H), 5.99-6.04 (m, 2H), 6.05-6.10 (in, IH), 7.14-7.21 (in, 3H), 7.33-7.37 (in, 2H), 7.52-7.54 (in, IH), 11.53 (s, IH); MS, m/e566.07(M+23)* 58 Ph H H Et c-Hex 'HNMR (400MHz, DMSO-d): S 0.75-0.88 (in, 3H), 1.26-1.46 (in, 9H), 1.52-1.69 (in, 6H), 3.60-3.63 (in, IH), 3.72-3.90 (m, IH), 4.02 4.03 (in, IH), 4.244.27 (in, IH), 4.374.38 (in, IH), 4.63-4.65 (in, I H), 5.55 (dd, J=8.Hz, 4.4Hz, I H), 5.80-5.95 (in, 1 H), 6.00-6.07 (in, 2H), 7.15-7.22 (in, 3H), 7.34-7.38 (in, 2H), 7.54 (d, J =8.OHz, IH), I 1.55 (s, 1 H); MS, ne 584.0 1 (M+ 1) , 606. I 7 (M+23)* 59 4-F-Ph H H Et c-Hex 'H NMR (DMSO-ds) S 0.75-0.84 (m, 3H), 1.24 (d,J= 22.8Hz, 3H), 1.29-1.47 (in, 6H), 1.51-1.70 (in, 6H), 3.59-3.66 (in, I H), 3.77-3.84 (in, I H), 3.98-4.04 (in, IH), 4.21-4.27 (m, I H), 4.34-4.41 (in, I H), 4.60-4.65 (in, I H), 5.56-5.60 (in, I H), 5.84-5.90 (in, I H), 6.00-6.08 (in, 2H), 7.20-7.24 (in, 4H), 7.56(d, J= 8.OHz, IH), 11.49 (s, IH); MS, m/e 602.OO(M+1)* 60 Ph H H Me F-CH 2 - 'H NMR (DMSO-d) S 1.18-1.25(m, 6H), 3.71-3.89 (m, 2H), 3.92-3.99
CH
2 - (m, I H), 4.19-4.27 (m, 4H), 4.48-4.61 (m, 2H) , 3.94-3.98 (m, 2H), 4.11-4.23 (m, 4H), 5.47-5.52 (m, I H), 6.01-6. 11 (m, 1 H), 5.90-6.14 (in, 2H), 7.15-7.21 (in, 3H), 7.32-7.36 (m, 2H), 7.46-7.57 (m, 1H), 11.49 (s, I H) ; MS, m/e 533.86 (M+I)* 40o r Ex. R' R 2
R
3 a R 3 b R 4 NMR/MS 61 Ph H H Me F 2 CH- 'H NMR (DMSO-d) 8 1.17-1.24 (m, 6H), 3.67-3.81 (m, 1H), 3.89
CH
2 - 3.98 (m, 2H),4.21-4.36 (m, 4H), 5.48-5.53 (m, IH), 5.82-6.05 (m, 2H), 6.18-6.22 (m, 2H), 7.15-7.20 (m, 3H), 7.32-7.36 (m, 2H), 7.51 (s, IH),1150 (s, I H); MS, m/e 551.92 (M+1)'; 62 Ph H H Me (CF 3
)
2 - 'H NMR,(DMSo-d) 8 1.13-1.29 (m, 6H), 3.67-3.81 (m, 1H), 3.94 CH- 4.32 (m, 4H), 5.47 (t, J = 8 Hz I H), 5.82-6.01 (in, 2H), 6.33-6.36 (m, IH), 6.70-6.78 (m, IH), 7.09-7.15 (m, 3H), 7.28-7.32 (m , 2H), 7.43 7.46 (m, 1 H),1 1.44 (s, I H) ; MS, m/e 637.90 (M+1)' 63 Ph H H Me (CH 2
F)
2 'H NMR (DMSO-d) S 1.20-1.29 (m, 6H), 3.70-3.90 (m, 1H), 3.91 -CH- 4.12 (m, 2H), 4.20-4.33 (m, IH), 4.354.48 (m, 1H), 4.52-4.55 (m, 2H), 4.634.67 (m, 2H), 5.20-5.35 (m, I H), 5.56 (t, J = 8.4 Hz, 1H), 5.80-5.95 (m, 1H), 5.95-6.10 (m, 1H), 6.18-6.21 (m, IH), 7.18-7.23 (m, 3H), 7.35-7.39 (m , 2H), 7.54 (s, IH),11.55 (s, 1H) ; MS, m/e 565.98 (M+])* 64 Ph H H Me c-Pr- 'H NMR (DMSO-d) S 0.20-0.24(m, 2H), 0.47-0.48(m, 2H), 0.76
CH
2 - 0.84(m, 3H), 1.03-1.05(m, I H), 1.23(dd, J= 22.4 6.8 Hz 3H), 1.55 1.60(m, 2H), 3. 61-3.68(m, 1H), 3. 81-3.89 (m, 3H), 3.98-4.03(m, 1H), 4.23-4.29(m, 1H), 4.354.41(m, IH), 5.56-6.00(m, 1H), 5.88-5.91(m, 1H), 6.04-6.10(m, 2H), 7.20-7.24(m, 4H), 7.55 (d, J= 7.6 Hz IH),11.53 (s, 1H); MS, m/e 573.17 (M+I)* 65 Ph H H Et c-Pen 'H NMR (DMSO-d) 8 0.75-0.83 (m, 3H), 1.20-1.28 (m, 3H), 1.49 1.63 (m, 8H), 1.76-1.80 (m, 2H), 3.58-3.60 (m, 1H), 3.70-3.82 (m, 1H), 3.984.05 (m, IH), 4.24-4.26 (m, 1H), 4.37-4.42 (m, 1H), 5.03 (s, 1H), 5.54-5.57 (m, IH), 5.90-6.00 (m,IH), 6.02-6.07 (m, 2H), 7.15 7.22 (m, 3H), 7.35-7.39 (m, 2H) 7.55 (d, J = 8.0 Hz, IH), 11.55 (s, I H) ; MS, ne 570.03 (M+1)'
*R
2 and RJb together are -(CH 2 )3- as derived from L-proline The purification procedure by Prep-HPLC: Crude products were dissolved in methanol. Injection volumes of these 5 solutions were 5 mL. The preparative HPLC system including 2 sets of Gilson 306 pumps, a Gilson 156 UVNis detector, a Gilson 215 injector & fraction collector, with Unipoint control software. A Ymc 25x30x2 mm column was used. The mobile phase was HPLC grade water (A), and HPLC grade acetonitrile (B). Fractions 10 were collected into 100*15mm glass tubes. FIPLC gradient is shown in Table 1. Once the gradient was selected, acetonitrile solution was injected into HPLC system, and then fractions collected according to UV peaks. After the separation, each glass tubes were run MS test ro,7 to collect the desired compounds. The fractions with target MS were combined in a well-weighted flask. Most of acetonitrile was removed under reduce pressure and the remaining solution was freeze-dried to give desired compound. 5 Table 1: Preparative HPLC gradient Time (min) Flow rate % A % B (mL/min) 0 15 90 10 30 15 60 40 Preparation of Example 66 Scheme 0, NcC O O O OH N H BzO LiAI(OBu-t) 3 H / THF BzO \/ O N DEAD, PPh3 BzO EZO FZO F THF, rt, overnight BzO a b d N /N N NH 2 N NH 2
NH
3 /THF 0 N N NH-/MeOH O N N SBz ~'~<HO 90 0 C, overnight r,t overnight . BzO F HO F ef CIHH:N O H 0 O C 1 2 NhN Et 3 N/DCM 9 N N H 2 0 O O N N N CNH HO o HN- 0 N N HO F NMI/THF O HO 66 10 Preparation of compound (b) 4 OO To a solution of compound a (1 g, 2.69 mmol) in anhydrous THF (30 mL) was added dropwise 1 M solution of LiAl(OBu-t) 3 H in THF (2.69 mL, 2. 69 mmol) at -20 0 C. The reaction mixture was stirred for 2-3 h at the same temperature. EtOAc (100 mL) was added followed by saturated NH 4 Cl solution 5 (10 mL) and reaction mixture was slowly brought to room temperature. Reaction mixture was extracted with EtOAc and washed with IN HCI and water. Combined organic phase was evaporated to give 0.8 g of crude compound b as transparent oil, which was used directly for next reaction. Preparation of compound (d) 10 To a solution of compound b (0.8 g, 2.1mmol), compound c (0.45 g, 2.5 mmol) and Ph 3 P (0.56 g, 2.1 mmol) in anhydrous THF (20 mL) under nitrogen atmosphere was added DEAD (1.8 mL). The reaction mixture was stirred at room temperature overnight. The reaction solution was concentrated under reduce pressure. The residue was separated by preparative layer chromatography 15 (hexanes:EtOAc = 3:1) to give crude compound d (0.8 g). The crude compound d was used to the next step without further purification. Preparation of compound (e) Compound d (0.8 g, 1.57 mmol) was dissolved in THF (2 mL) and THF saturated with ammonia (5 mL) was then added to this solution. The reaction 20 mixture was heated to 90 C overnight. After 18 hours, the solution was cooled to room temperature by ice water, then the solvent was removed under reduced pressure and the residue was purified by column to give compound e (0.75 g) for the next step. Preparation of compound (f) 25 Compound e (0.5 g, 1.01 mmol) was dissolved in methanol (2 mL) and methanol was saturated with ammonia (5 mL) was then added to this solution. The reaction mixture was stirred at room temperature overnight. After 18 hours, the solvent was removed under reduced pressure and the residue was purified by column to give crude compound f (0.15 g) for the next step. 30 Preparation of compound (i) A solution of triethylamine (1.07 g, 10.6 mmol) in anhydrous dichloromethane (15 mL) was added dropwise to a solution of compound g (1.16 g, 5.3 mmol) and compound h (1.31 g, 5.3 mmol) in dichloromethane (10 mL) 'AQo with vigorous stirring at -78 C over a period of 2 hours. After completion of addition, the reaction temperature was allowed to warm to room temperature gradually and stirred over night. Then the solvent was removed under vacuum and anhydrous ether 20 mL was added and the precipitated salt was filtered and 5 the precipitate was washed with ether. The combined organic phase was concentrated to give the colorless oil of compound i (1.0 g). Preparation of Compound 66 To a solution of compound j (0.1 g, 0.35 mmol) dissolved in 10 mL of 10 anhydrous THF, stirred and added 0.4g NMI till the solution became clear, added compound i (0.8 g, 2.89 mmol) in 10 mL THF dropwise, stirred at r.t. overnight. Compound purity and identification was confirmed by LCMS. The solvent was evaporated and purified by Prep-HPLC to afford 66. (25 mg, Yield: 13.6%). 'H NMR (DMSO-d,) 6 1.08 (d, J= 22.8 Hz, 3H), 1.17-1.24 (in, 3H), 15 3.50-3.52 (in, 3H), 3.78-3.83 (m, I H), 4.10-4.13 (m, IH), 4.24-4.44 (in, 2H), 5.85-5.92 (in, 1H), 6.01-6.11 (m, 1H), 6.2.-6.27 (m, I H), 7.08-7.19 (in, 4H), 7.31-7.38 (m, 3H), 8.15 (s, 1H), 8.26 (s, 1H); MS, m/e 525 (M+1)*. Example numbers 67-74, identified below, were prepared using similar 20 procedures disclosed for Example 66, above. R" -O N RIO *0 0 HN-PO N N 0 HO F Example R R1 0 NMRJMS 67 OH NH 2 'H NMR (DMSO-d) 6 1.06-1.13 (m, 3H), 1.20-1.24 (m, 3H), 3.27-3.33(m, 3H), 3.56 (s, I H), 3.82-3.88 (m, I H), 4.07-4.13 (m, I H), 4.25-4.40 (m, 2H), 5.85-5.87 (m, I H), 5.98-6.09 (m, 2H), 6.59 (s, 32H), 7.14-7.37 (m, 3H), 7.35-7.37 (m, 2H), 7.79 (d, J=7.2 Hz, 1H), 10.69 (s, I H); MS, m/e 541 (M+1)'; 68 NH 2
NH
2 'H NMR (DMSO-d) 8 1.07 (d, J=22.8 Hz, 31H), 1.19 (d, J=7.2 Hz, 3 H), 3.51 (s, 3 H), 3.62 (s, I H), 3.75-3.81 (m, 11H), 4.05-4.11 (m, 1H), 4.27-4.42 (m, £OnA Example R" R1 0 NMR/MS 2H), 5.79-5.83 (m, I H), 5.92 (s, 2H), 6.00-6.09 (m, 2H), 6.75 (s, 2H), 7.08-7.17 (m, 3H), 7.31-7.35 (m, 2H), 7.78 (s, I H); MS, r/e 540 (M+1)*; 69 NH 2 c-Pentyl-NH- 'H NMR (DMSO-d) 6 1.05 (d, J=22.8 Hz, 3H), 1.09-1.19 (m, 3H), 1.48 (s, 4H), 1.66 (s, I H), 1.86 (s, I H), 3.54 (d, J=14 Hz, 3H), 3.65 (s, 11H), 4.25 4.43 (m, 4H), 5.71-5.82 (m, I H), 5.94-6.04 (m, 4H), 7.11-7.24 (m, 3H), 7.26-7.34 (m, 2H), 7.77(d, J=3.6 Hz, I H); MS, m/e 608(M+1)' 70 NH 2 'H NMR (DMSO-d) 6 1.07 (d, J=22.4 Hz, 3H), -- N 2.35-2.38 (m, 2H), 3.54 (d, J=9.2 Hz, 3H), 3.59-3.62 (m, 2H), 3.65 (s, I H), 3.75-3.82 (m, 1 H), 4.01-4.13 (m, 2H), 4.22-4.40 (m, 6H), 5.75-5.85 (m, IH), 6.00-6.07 (m, 4H), 7.15-7.21 (m, 3H), 7.32-7.35 (m, 2H), 7.79 (d, J=4.0 Hz, I H); MS, ne 580 (M+1)* 71 NH 2 Et 2 N- 'H NMR (DMSO-d) 8 1.06-1.28 (m, 12H), 3.55 (d, J=4.8 Hz, 3H), 3.79-3.87 (m, 4H), 4.074.12 (m, 2H), 4.29-4.42 (m, 3 H), 5.75-5.82 (m, I H), 5.94 (s, 2H), 6.04-6.10 (m, 2H), 7.14-7.22 (m, 3H), 7.3 1 7.37 (m, 2H), 7.82 (d, J=4.4 Hz, I H); MS, n/e 596 (M+1)* 72 NH 2 n-Propyl-NH- 'H NMR (DMSO-d) 5 0.84 (t, J=7.2 Hz, 3H), 1.01 1.01 (m, 3H), 1.09-1.12 (m, 3H), 1.51-1.56 (m, 2H), 3.48 (d, J=15.2 Hz, 3H), 3.79-3.82 (m, I H), 4.04 4.05 (m, 1H), 4.27-4.38 (m, 3H), 5.72-5.79 (m, 1H), 5.98-6.04 (m, 4H), 7.13-7.20 (m, 3H), 7.26-7.32 (m, 2H), 7.76 (d, J=5.2 Hz, 11H); MS, mle 582 (M+ 1)* 73 NH 2 c-Butyl-NH- 'H NMR (DMSO-d) 6 1.02-1.08 (m, 3H), 1.18 (d, J=4.8 Hz, 3H), 1.44-1.61 (m, 2H), 2.02-2.17 (m, 4H), 3.51 (d, J=10.8 Hz, 3H), 3.78-3.83 (m, 1H), 4.034.06 (m, I H), 4.27-4.38 (m, 2H), 4.53-4.62 (m, 1 H), 5.68-5.79 (m, H), 5.95-6.04 (m, 4H), 7.1 1 7.18 (m, 3H), 7.29-7.35 (m, 2H), 7.51-7.58 (m, I H), 7.78 (d, J=5.2 Hz, 1 H); MS, m/e 594 (M+1)* Example RM-r- R 0 NMR/MS 74 NH 2 / H NMR (DMSO-d,) 6 0.97-1.20 (m, 6H), 2.18 (s, 3 H), 2.19 (s, 4H), 3.43-3.47(m, 3 H), 3.75 (s, 1 H), 4.01-4.06 (m, 4 H), 4.22-4.35 (m, 3H), 5.69-5.75 (m, IH), 5.98-6.05 (m, 3H), 7.09-7.15 (m, 31H), 7.25 7.29 (m, 2H), 7.77 (d, J=3.6 Hz, I H); MS, m/e 623 (M+1) Example numbers 75-80 are prepared using similar procedures disclosed for Example 66, above. Ri N O O0 N R10 0/ -0 N N 0 HN- N N 0 5 HO f Example R" R10 75 H n-propyl-NH 76 H c-Butyl.NH 77 H c-Pentyl-NH 78 H 79 H 80 H
---
N EXAMPLE 81 Certain exemplified compounds were obtained as mixture of diastereomers because of the chirality at phosphorous. The diastereomers were 10 separated on a Chiralpak-AS-H (2 X 25 cm) column under Supercritical Fluid Chromatography (SFC) conditions using 20% methanol in carbon dioxide as solvent. The absolute stereochemistry of the P-chiral center of the diastereromers were not determined. However, chromatographic resolution of these two diastereomers provides for isomers that are characterized as fast 5 eluting and slow eluting isomers. Some examples are shown below. Compound EC90 (uM) Example 15 (Diastereomeric mixture) 0.86 Fast Moving isomer of Example 15 1.35 Slow Moving isomer of Example 15 0.26 Example 39 (Diastereomeric mixture) 0.47 Fast Moving isomer of Example 39 0.78 Slow Moving isomer of Example 39 0.02 Example 49 (Diastereomeric mixture) 0.126 Fast Moving isomer of Example 49 0.03 Slow Moving isomer of Example 49 5.78 EXAMPLE 82 HCV replicon assay. HCV replicon RNA-containing Huh7 cells (clone A cells; Apath, LLC, St. Louis, Mo.) were kept at exponential growth in 10 Dulbecco's modified Eagle's medium (high glucose) containing 10% fetal bovine serum, 4 mM L-glutamine and 1 mM sodium pyruvate, 1 x nonessential amino acids, and G418 (1,000 ig/ml). Antiviral assays were performed in the same medium without G418. Cells were seeded in a 96-well plate at 1,500 cells per well, and test compounds were added immediately after seeding. Incubation time 15 4 days. At the end of the incubation step, total cellular RNA was isolated (RNeasy 96 kit; Qiagen). Replicon RNA and an internal control (TaqMan rRNA control reagents; Applied Biosystems) were amplified in a single-step multiplex RT-PCR protocol as recommended by the manufacturer. The HCV primers and probe were designed with Primer Express software (Applied Biosystems) and covered highly conserved 5'-untranslated region (UTR) sequences (sense, 5' AGCCATGGCGTTAGTA(T)GAGTGT-3', and antisense, 5' TTCCGCAGACCACTATGG-3'; probe, 5'-FAM 5 CCTCCAGGACCCCCCCTCCC-TAMRA-3'). To express the antiviral effectiveness of a compound, the threshold RT PCR cycle of the test compound was subtracted from the average threshold RT PCR cycle of the no-drug control (ACtHCV). A ACt of 3.3 equals a 1-log 10 reduction (equal to the 90% effective concentration [ECoo]) in replicon RNA 10 levels. The cytotoxicity of the test compound could also be expressed by calculating the ACtrRNA values. The AACt specificity parameter could then be introduced (ACtHCv - ACtrRNA), in which the levels of HCV RNA are normalized for the rRNA levels and calibrated against the no-drug control. Ex LoglO EC90 # Compound Reduction at Eg9O 50pM (pM) 5 * -1.21 3.0 H OpF ' 'H 6 -0.45 ND 7 0.31 ND 8 -1.48 2.11 10 -1.25 19.15 HO F
C)A
Ex LoglO EC90 # Compound Reduction at E9) 50pM ( M) 1 "-0.55 ND 12 0.31 ND .M N~ 44 0 c'h 0 15 ND 0.86 0 HO 25 N -2.22 0.39 N O OHO F 27 -2.25 0.66 S0 O0 HO F F 28 NH-2.16 0.75 0 O N O cI N'NH 36 0 N -1.64 21.9 ^ O HO F Ex LoglO EC90 # Compound Reduction at (AM) 50pM C1 39 0 I -1.78 0.47 HO F 0 I9 NH 49 0 -2.69 0.126 0 N O H N F Q-0 Hb CI NH 53 -1.33 <0.3 HO F Br 0 54 0 -1.55 0.57 HO F F -OO 0 70 N N -2.25 <0.3 -o H F 70N9 N -2.25 < 0.3 HO F NH2 '(4-BrPh): 4-bromo-phenyl.
The entire contents of 60/909,315, filed March 30, 2007; 60/982,309, filed October 24, 2007; and 12/053,015, filed March 21, 2008 are hereby incorporated by reference in the present application so far as needed to supplement the present disclosure and/or rectify any errors. Moreover, the patent and non-patent references disclosed herein are incorporated by reference. In the event that the incorporated patent and non-patent reference contains a term that conflicts with a term disclosed in either one of the two Provisional Applications or the present application text, the meaning of the term contained in the present application text and the two Provisional Applications controls provided that the overall meaning of the incorporated subject matter is not lost. Throughout this specification, unless the context requires otherwise, the word "comprise" or variations such as "comprises" or "comprising", will be understood to imply the inclusion of a stated integer or group of integers but not the exclusion of any other integer or group of integers. The following discussion of the background to the invention is intended to facilitate an understanding of the present invention only. It should be appreciated that the discussion is not an acknowledgement or admission that any of the material referred to was published, known or part of the common general knowledge of the person skilled in the art in any jurisdiction as at the priority date of the invention. - 697 -
Claims (11)
1. A compound or its stereoisomer thereof selected from among (S)-2-{ [(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy
4-methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-propionic acid methyl 5 ester; (S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4- fluoro-3-hydroxy 4-methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-3-methyl-butyric acid methyl ester; (S)-2-f{(4-bromo-phenoxy)-[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl) 0 4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phosphorylamino}-3-methyl butyric acid methyl ester; (S)-2-{(4-bromo-phenoxy)-[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl) 4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phosphorylamino}-propionic acid methyl ester; 5 (S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy 4-methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-propionic acid ethyl ester; (S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy 4-methyl-tetrahydro-furan-2-ylmethoxy]-(naphthalen-1-yloxy)-phosphorylamino}-propionic 20 acid benzyl ester; {[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4 methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino} -acetic acid methyl ester; (S)-2-{(2,4-Dichloro-phenoxy)-[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1 yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phosphorylamino} 25 propionic acid methyl ester; (S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy 4-methyl-tetrahydro-furan-2-ylmethoxy]-(naphthalen-1-yloxy)-phosphorylamino}-propionic acid methyl ester; (S)-1- { [(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin- 1 -yl)-4-fluoro-3-hydroxy-4 methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphoryl}-pyrrolidine-2-carboxylic acid methyl ester; (S)-2-{ [(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy 5 4-methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-propionic acid butyl ester; (S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy 4-methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-propionic acid benzyl ester; 0 (S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy 4-methyl-tetrahydro-furan-2-ylmethoxy]-(4- fluoro-phenoxy)-phosphorylamino}-propionic acid methyl ester; (S)-2-{(4-Chloro-phenoxy)-[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl) 4-fluoro-3-hydroxy-4-methyl-tetrahydro- furan-2-ylmethoxy]-phosphorylamino}-propionic 5 acid methyl ester; (S)-2-{(3,4-Dichloro-phenoxy)-[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1 yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phosphorylamino} propionic acid methyl ester; (S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy 20 4-methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-propionic acid sec butyl ester; (S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy 4-methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-propionic acid isopropyl ester; 25 (S)-2-{ [(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1 -yl)-4-fluoro-3-hydroxy 4-methyl-tetrahydro-furan-2-ylmethoxy]-(4-methoxy-phenoxy)-phosphorylamino} propionic acid butyl ester; (S)-2-{ [(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy 4-methyl-tetrahydro-furan-2-ylmethoxy]-(4-fluoro-phenoxy)-phosphorylamino} -propionic acid ethyl ester; (S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1 -yl)-4-fluoro-3-hydroxy 5 4-methyl-tetrahydro-furan-2-ylmethoxy]-(4-fluoro-phenoxy)-phosphorylamino}-propionic acid isopropyl ester; (S)-2-{ [(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1 -yl)-4-fluoro-3-hydroxy 4-methyl-tetrahydro-furan-2-ylmethoxy]-(4-fluoro-phenoxy)-phosphorylamino}-propionic acid benzyl ester; 0 (S)-2-{ [(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy 4-methyl-tetrahydro-furan-2-ylmethoxy]-(4-methoxy-phenoxy)-phosphorylamino} propionic acid isopropyl ester; (S)-2-{(2-Chloro-phenoxy)-[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl) 4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phosphorylamino}-propionic 5 acid benzyl ester; (S)-2-{(2,4-Dichloro-phenoxy)-[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1 yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phosphorylamino} propionic acid butyl ester; (S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy 20 4-methyl-tetrahydro-furan-2-ylmethoxy]-p-tolyloxy-phosphorylamino}-propionic acid isopropyl ester; (S)-2-{ [(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy 4-methyl-tetrahydro-furan-2-ylmethoxy]-(4-fluoro-phenoxy)-phosphorylamino}-propionic acid butyl ester; 25 (S)-2-{(3,4-Dichloro-phenoxy)-[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin- 1 yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phosphorylamino} propionic acid ethyl ester; (S)-2-{(2-Chloro-phenoxy)-[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl) 4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phosphorylamino}-propionic acid isopropyl ester; (S)-2- { [(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin- 1 -yl)-4-fluoro-3 -hydroxy 5 4-methyl-tetrahydro-furan-2-ylmethoxy]-(4-methoxy-phenoxy)-phosphorylamino} propionic acid benzyl ester; (S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy 4-methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-propionic acid pentyl ester; 0 (S)-2-{(4-Chloro-phenoxy)-[(2R,3R,4 R,5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl) 4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phosphorylamino}-propionic acid isopropyl ester; (S)-2- {(4-Chloro-phenoxy)-[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin- 1-yl) 4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phosphorylamino}-propionic 5 acid butyl ester; (S)-2-{(4-Chloro-phenoxy)-[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl) 4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phosphorylamino}-propionic acid ethyl ester; (S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H -pyrimidin-1-yl)-4-fluoro-3-hydroxy 20 4-methyl-tetrahydro-furan-2-ylmethoxy]-p-tolyloxy-phosphorylamino}-propionic acid butyl ester; (S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy 4-methyl-tetrahydro-furan-2-ylmethoxy]-p-tolyloxy-phosphorylamino}-propionic acid benzyl ester; 25 (S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1 -yl)-4-fluoro-3-hydroxy 4-methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-butyric acid methyl ester; (S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H -pyrimidin-1-yl)-4-fluoro-3-hydroxy 4-methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-propionic acid 4 fluoro-benzyl ester; (S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy 5 4-methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-propionic acid 3 methyl-butyl ester; (S)-2-f{(2,4-Dichloro-phenoxy)-[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin- 1 yl)-4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phosphorylamino} propionic acid ethyl ester; 0 (S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1 -yl)-4-fluoro-3-hydroxy 4-methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-propionic acid cyclohexyl ester; (S)-2-{(2-Chloro-phenoxy)-[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl) 4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phosphorylamino}-propionic 5 acid butyl ester; (S)-2-{(4- Bromo-phenoxy)-[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl) 4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phosphorylamino}-propionic acid isopropyl ester; (S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy 20 4-methyl-tetrahydro-furan-2-ylmethoxy]-(4-fluoro-phenoxy)-phosphorylamino}-propionic acid cyclohexyl ester; (S)-2-{ [(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy 4-methyl-tetrahydro-furan-2-ylmethoxy]-(4-bromo-phenoxy)-phosphorylamino}-propionic acid cyclohexyl ester; 25 (S)-2-{ [(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy 4-methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-butyric acid isopropyl ester; (S)-2- { [(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin- 1 -yl)-4-fluoro-3 -hydroxy 4-methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-butyric acid cyclohexyl ester; (S)-2- { [(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin- 1 -yl)-4-fluoro-3-hydroxy 5 4-methyl-tetrahydro-furan-2-ylmethoxy]-(4-fluoro-phenoxy)-phosphorylamino}-butyric acid cyclohexyl ester; (S)-2- {(4-Chloro-phenoxy)- [(2R,3R,4 R,5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin- 1-yl) 4-fluoro-3-hydroxy-4-methyl-tetrahydro-furan-2-ylmethoxy]-phosphorylamino}-butyric acid isopropyl ester; 0 (S)-2- { [(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin- 1 -yl)-4-fluoro-3 -hydroxy 4-methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-propionic acid 2,2 difluoro-ethyl ester; (S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy 4-methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-propionic acid 2,2,2 5 trifluoro-1-trifluoromethyl-ethyl ester; (S)-2-{ [(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy 4-methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-propionic acid 2 fluoro-1-fluoromethyl-ethyl ester; (S)-2-{ [(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy 20 4-methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-propionic acid cyclopropyl methyl ester; (S)-2- { [(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin- 1 -yl)-4-fluoro-3-hydroxy 4-methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-butyric acid cyclopentyl ester; 25 (S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H -pyrimidin-1-yl)-4-fluoro-3-hydroxy 4-methyl-tetrahydro-furan-2-ylmethoxy]-(3,4-dichloro-phenoxy)-phosphorylamino} propionic acid benzyl ester; and (S)-2-{[(2R,3R,4R,5R)-5-(2,4-Dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy 4-methyl-tetrahydro-furan-2-ylmethoxy]-phenoxy-phosphorylamino}-propionic acid 2 fluoro-ethyl ester. 2. A compound selected from among 5 (S)-methyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro 3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate; (S)-methyl 2-(((R)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro 3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate; methyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-3 0 hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)acetate; methyl 2-(((R)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-3 hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)acetate; (S)-isopropyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4 fluoro-3-hydroxy-4-methyltetrahydrofuran-2 5 yl)methoxy)(phenoxy)phosphoryl)amino)propanoate; (S)-isopropyl 2-(((R)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4 fluoro-3-hydroxy-4-methyltetrahydrofuran-2 yl)methoxy)(phenoxy)phosphoryl)amino)propanoate; (S)-isopropyl 2-(((S)-(4-chlorophenoxy)(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4 20 dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2 yl)methoxy)phosphoryl)amino)propanoate; (S)-isopropyl 2-(((R)-(4-chlorophenoxy)(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4 dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2 yl)methoxy)phosphoryl)amino)propanoate; 25 (S)-cyclohexyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin- 1 (2H)-yl)-4 fluoro-3-hydroxy-4-methyltetrahydrofuran-2 yl)methoxy)(phenoxy)phosphoryl)amino)propanoate; (S)-cyclohexyl 2-(((R)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4 fluoro-3-hydroxy-4-methyltetrahydrofuran-2 yl)methoxy)(phenoxy)phosphoryl)amino)propanoate; (S)-cyclohexyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4 5 fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(4 fluorophenoxy)phosphoryl)amino)propanoate; and (S)-cyclohexyl 2-(((R)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-l(2H)-yl)-4 fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(4 fluorophenoxy)phosphoryl)amino)propanoate. 0 3. A pharmaceutical composition comprising the compound according to claim 1 or 2. 4. The pharmaceutical composition according to claim 3 further comprising a pharmaceutically acceptable medium.
5. The pharmaceutical composition according to claim 4 comprising an effective amount of the compound according to claim 1 or 2, or the composition according to claim 3 or 4, to treat a 5 hepatitis C virus infection.
6. A method of treating a subject infected by a virus selected from among hepatitis C virus, West Nile virus, a yellow fever virus, a dengue virus, a rhinovirus, a polio virus, a hepatitis A virus, a bovine viral diarrhea virus, and a Japanese encephalitis virus, comprising administering to the subject an effective amount of the compound according to claim 1 or 2, 20 or the composition according to claim 3 or 4.
7. The method of claim 6 wherein the virus is hepatitis C virus.
8. The method of claim 6 or 7, which further comprises administering to the subject an effective amount of another antiviral agent.
9. Use of the compound according to claim 1 or 2, or the composition according to claim 3 or 25 4, in the manufacture of a medicament for the treatment of a virus infection, wherein the virus is selected from among hepatitis C virus, West Nile virus, a yellow fever virus, a dengue virus, a rhinovirus, a polio virus, a hepatitis A virus, a bovine viral diarrhea virus, and a Japanese encephalitis virus.
10. The use according to claim 9, wherein the virus is hepatitis C virus.
11. The use according to claim 9 or 10, wherein the medicament further comprises another antiviral agent.
12. A compound or its stereoisomer thereof according to claim 1 or 2, substantially as hereinbefore described. 5 13. A method of treating a subject infected by a virus according to claim 6, substantially as hereinbefore described.
14. A use according to claim 9, substantially as hereinbefore described.
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2012241173A AU2012241173B2 (en) | 2007-03-30 | 2012-10-17 | Nucleoside Phosphoramidate Prodrugs |
| AU2014215983A AU2014215983B2 (en) | 2007-03-30 | 2014-08-21 | Nucleoside phosphoramidate prodrugs |
| AU2014233579A AU2014233579B2 (en) | 2007-03-30 | 2014-09-24 | Nucleoside phosphoramidate prodrugs |
| AU2016213882A AU2016213882A1 (en) | 2007-03-30 | 2016-08-12 | Nucleoside phosphoramidate prodrugs |
| AU2016231535A AU2016231535A1 (en) | 2007-03-30 | 2016-09-21 | Nucleoside phosphoramidate prodrugs |
| AU2017261454A AU2017261454A1 (en) | 2007-03-30 | 2017-11-13 | Nucleoside phosphoramidate prodrugs |
| AU2019203002A AU2019203002A1 (en) | 2007-03-30 | 2019-04-30 | Nucleoside phosphoramidate prodrugs |
| AU2021202327A AU2021202327B2 (en) | 2007-03-30 | 2021-04-19 | Nucleoside phosphoramidate prodrugs |
| AU2023263496A AU2023263496A1 (en) | 2007-03-30 | 2023-11-09 | Nucleoside phosphoramidate prodrugs |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60/909,315 | 2007-03-30 | ||
| US60/982,309 | 2007-10-24 | ||
| US12/053,015 | 2008-03-21 | ||
| AU2008232827A AU2008232827C1 (en) | 2007-03-30 | 2008-03-26 | Nucleoside phosphoramidate prodrugs |
| AU2012241173A AU2012241173B2 (en) | 2007-03-30 | 2012-10-17 | Nucleoside Phosphoramidate Prodrugs |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2008232827A Division AU2008232827C1 (en) | 2007-03-30 | 2008-03-26 | Nucleoside phosphoramidate prodrugs |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2014215983A Division AU2014215983B2 (en) | 2007-03-30 | 2014-08-21 | Nucleoside phosphoramidate prodrugs |
| AU2014233579A Division AU2014233579B2 (en) | 2007-03-30 | 2014-09-24 | Nucleoside phosphoramidate prodrugs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2012241173A1 AU2012241173A1 (en) | 2012-11-08 |
| AU2012241173B2 true AU2012241173B2 (en) | 2014-09-25 |
Family
ID=47144602
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2012241173A Active 2029-06-30 AU2012241173B2 (en) | 2007-03-30 | 2012-10-17 | Nucleoside Phosphoramidate Prodrugs |
| AU2023263496A Pending AU2023263496A1 (en) | 2007-03-30 | 2023-11-09 | Nucleoside phosphoramidate prodrugs |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2023263496A Pending AU2023263496A1 (en) | 2007-03-30 | 2023-11-09 | Nucleoside phosphoramidate prodrugs |
Country Status (1)
| Country | Link |
|---|---|
| AU (2) | AU2012241173B2 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3512863A4 (en) * | 2016-09-07 | 2020-06-03 | ATEA Pharmaceuticals, Inc. | 2 '-SUBSTITUTE-N6-PURINE NUCLEOTID SUBSTITUTED FOR THE TREATMENT OF RNA VIRUSES |
| RU2776918C2 (en) * | 2016-09-07 | 2022-07-28 | Atea Фармасьютикалс, Инк. | 2'-substituted-n6-substituted purine nucleotides for treatment of diseases caused by rna virus |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL308921A (en) | 2021-06-17 | 2024-01-01 | Atea Pharmaceuticals Inc | Advantageous anti-hcv combination therapy |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060241064A1 (en) * | 2005-04-25 | 2006-10-26 | Genelabs Technologies, Inc. | Nucleoside compounds for treating viral infections |
-
2012
- 2012-10-17 AU AU2012241173A patent/AU2012241173B2/en active Active
-
2023
- 2023-11-09 AU AU2023263496A patent/AU2023263496A1/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060241064A1 (en) * | 2005-04-25 | 2006-10-26 | Genelabs Technologies, Inc. | Nucleoside compounds for treating viral infections |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3512863A4 (en) * | 2016-09-07 | 2020-06-03 | ATEA Pharmaceuticals, Inc. | 2 '-SUBSTITUTE-N6-PURINE NUCLEOTID SUBSTITUTED FOR THE TREATMENT OF RNA VIRUSES |
| RU2776918C2 (en) * | 2016-09-07 | 2022-07-28 | Atea Фармасьютикалс, Инк. | 2'-substituted-n6-substituted purine nucleotides for treatment of diseases caused by rna virus |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2012241173A1 (en) | 2012-11-08 |
| AU2023263496A1 (en) | 2023-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2008232827B2 (en) | Nucleoside phosphoramidate prodrugs | |
| AU2023263496A1 (en) | Nucleoside phosphoramidate prodrugs | |
| AU2021202327B2 (en) | Nucleoside phosphoramidate prodrugs | |
| HK40104409A (en) | Nucleoside phosphoramidate prodrugs | |
| HK1150450A (en) | Nucleoside phosphoramidate prodrugs | |
| HK1150450B (en) | Nucleoside phosphoramidate prodrugs | |
| HK40006276B (en) | Nucleoside phosphoramidate prodrugs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| NC | Extension of term for standard patent requested (sect. 70) |
Free format text: PRODUCT NAME: SOVALDI SOFOSBUVIR Filing date: 20140630 |
|
| NDB | Extension of term for standard patent granted (sect.76) |
Free format text: PRODUCT NAME: SOVALDI SOFOSBUVIR Filing date: 20140630 Extension date: 20290630 |
|
| PC | Assignment registered |
Owner name: GILEAD SCIENCES, INC. Free format text: FORMER OWNER(S): GILEAD PHARMASSET LLC |